Citrus Sinensis ID: 041766
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.749 | 0.341 | 0.562 | 8e-98 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.811 | 0.369 | 0.545 | 6e-97 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.976 | 0.446 | 0.481 | 2e-95 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.976 | 0.448 | 0.479 | 2e-94 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.979 | 0.444 | 0.467 | 4e-94 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.987 | 0.452 | 0.447 | 7e-94 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.948 | 0.448 | 0.482 | 2e-93 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.953 | 0.438 | 0.449 | 4e-93 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.979 | 0.454 | 0.443 | 6e-93 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.979 | 0.445 | 0.466 | 1e-92 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 357 bits (916), Expect = 8e-98, Method: Compositional matrix adjust.
Identities = 176/313 (56%), Positives = 226/313 (72%), Gaps = 23/313 (7%)
Query: 69 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQG 128
K +LP+FS ++++ ATN F N+LG GGFGPVYKGVL+ G EIAVKRL G+SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566
Query: 129 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWS 188
+ E KNE +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626
Query: 189 ANYS---------------SR-------LKVSNILLDKDINPKISDFGMARICGGNELQA 226
+S SR LKVSN+LLD ++NPKISDFGMARI GGN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286
NT R+VGTYGYMSPEYA++G+FS+KSDV+SFGVLLLEIVSGK+ T ++ +L+GYAW
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746
Query: 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346
L+T R+ EL+DP + SK LR +++A+LCVQ+SA +RP M V+ ML + A
Sbjct: 747 YLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805
Query: 347 LFPPKQPAFSYVR 359
L P+QP F+ R
Sbjct: 806 LAAPRQPTFTSTR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 186/341 (54%), Positives = 238/341 (69%), Gaps = 27/341 (7%)
Query: 74 DQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMK 133
++L +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L G+E+A+KRL SGQGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569
Query: 134 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS- 192
NEA +IAK+QH NLV+LLGCC++KDEK+LIYEYMPNKSLD+FLFDP ++++LDW +
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629
Query: 193 --------------SRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRI 231
SRLKV NILLD+D+NPKISDFGMARI G E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS--LTLLGYAWDLW 289
GT+GYMSPEY +G+FS KSDVFSFGVL+LEI+ G+K F+ L L+ + W+L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML-TDEAAALF 348
NR E+IDP L D +LR V +ALLCVQ++ADDRP+M +VVSM+ D AL
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809
Query: 349 PPKQPAF--SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PK+PAF R++ + E+ S N+VTI+++EAR
Sbjct: 810 LPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 349 bits (896), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 197/409 (48%), Positives = 265/409 (64%), Gaps = 31/409 (7%)
Query: 9 LLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRS 68
++ SI ++ + +L I + ++ + R + T +DL +++ EL V + ++ S
Sbjct: 440 IIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNEL-VKASRSYTS 498
Query: 69 KKKEVD--QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG 126
K+ + D +LPL + +++ ATN FS NKLG+GGFG VYKG+L G EIAVKRL S
Sbjct: 499 KENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSS 558
Query: 127 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD 186
QG E NE +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD LFD T+ L+
Sbjct: 559 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 618
Query: 187 WSANY---------------SSR-------LKVSNILLDKDINPKISDFGMARICGGNEL 224
W + SR LK SN+LLDK++ PKISDFGMARI G E
Sbjct: 619 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 678
Query: 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD-SLTLLG 283
+ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI+SGK+ GFY ++ L LLG
Sbjct: 679 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 738
Query: 284 YAWDLWTSNRTLELIDPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ W W + LE++DPI D SS+ H +LR + I LLCVQE A+DRP M+ V+ ML
Sbjct: 739 FVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 798
Query: 341 TDEAAALFPPKQPAFSYVR--NTVTSTSSTGKTEDCSINQVTISLLEAR 387
E A+ PK+P F R V S+SST + ++C++NQVT+S+++AR
Sbjct: 799 GSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (887), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 196/409 (47%), Positives = 265/409 (64%), Gaps = 31/409 (7%)
Query: 9 LLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQ--TK 66
++ SI ++ + +L + + ++ + R + T ++D +++ + I V S++ T
Sbjct: 436 IIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVD-QVRSQDSLINDVVVSRRGYTS 494
Query: 67 RSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG 126
+ KK E +LPL +++TATN FS+ NKLG+GGFG VYKG L G EIAVKRL S
Sbjct: 495 KEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSS 554
Query: 127 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD 186
QG E NE +IAK+QH NLVRLLGCC+DK EK+LIYEY+ N SLD LFD T+ L+
Sbjct: 555 QGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLN 614
Query: 187 WSANY---------------SSR-------LKVSNILLDKDINPKISDFGMARICGGNEL 224
W + SR LK SN+LLDK++ PKISDFGMARI G E
Sbjct: 615 WQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREET 674
Query: 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD-SLTLLG 283
+ANT R+VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI+SGK+ GFY ++ L LLG
Sbjct: 675 EANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLG 734
Query: 284 YAWDLWTSNRTLELIDPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ W W LE++DPI D SSK H +LR + I LLCVQE A+DRP M+ V+ ML
Sbjct: 735 FVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML 794
Query: 341 TDEAAALFPPKQPAFSYVRNTVT--STSSTGKTEDCSINQVTISLLEAR 387
E A+ PK+P F R+ + S+SST + ++C++NQ+T+S+++AR
Sbjct: 795 GSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 193/413 (46%), Positives = 271/413 (65%), Gaps = 34/413 (8%)
Query: 4 APFLALLSLSIVLAAVAIL----GLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELP 59
P + ++ ++ AA+ ++ + RRK ++L ++ ++L + +I+
Sbjct: 445 TPVVLIIVVTFTSAAILVVLSSTASYVFLQRRKVN---KELGSIPRGVHLCDSERHIKEL 501
Query: 60 VNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK 119
+ S + K+ + +D +P F ++ AT+ FS+ANKLG+GGFGPVYKG+ EIAVK
Sbjct: 502 IESGRFKQDDSQGID-VPSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVK 560
Query: 120 RLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP 179
RL SGQGL E KNE +IAK+QH+NLVRLLG C+ +EK+L+YEYMP+KSLDFF+FD
Sbjct: 561 RLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDR 620
Query: 180 TKRMLLDWSA---------------NYSSRLKV-------SNILLDKDINPKISDFGMAR 217
LDW + SRL++ SNILLD+++NPKISDFG+AR
Sbjct: 621 KLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLAR 680
Query: 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD 277
I GG+E ANT+R+VGTYGYMSPEYA++G+FS KSDVFSFGV+++E +SGK+ TGF+ +
Sbjct: 681 IFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPE 740
Query: 278 -SLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
SL+LLG+AWDLW + R +EL+D L+ E L+ +N+ LLCVQE +DRPTM+ V
Sbjct: 741 KSLSLLGHAWDLWKAERGIELLDQALQ-ESCETEGFLKCLNVGLLCVQEDPNDRPTMSNV 799
Query: 337 VSML-TDEAAALFPPKQPAFSYVRN-TVTSTSSTGKTEDCSINQVTISLLEAR 387
V ML + EAA L PKQPAF R + + SS+ K E CS N++TI+L + R
Sbjct: 800 VFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 344 bits (882), Expect = 7e-94, Method: Compositional matrix adjust.
Identities = 186/416 (44%), Positives = 270/416 (64%), Gaps = 34/416 (8%)
Query: 1 GTSAPFLALLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELP- 59
G S +L L ++A V +L + F+C RK R R + + ++ ++E
Sbjct: 435 GASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSF 494
Query: 60 VNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK 119
+ + +S+ +E LPLF S+++TATN F+ NKLG GGFGPVYKGVL+ G EIAVK
Sbjct: 495 ILEELEDKSRSRE---LPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVK 551
Query: 120 RLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP 179
RL SGQG+ E KNE +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F
Sbjct: 552 RLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHE 611
Query: 180 TKRMLLDWSA---------------NYSSRLKV-------SNILLDKDINPKISDFGMAR 217
+R LDW + SRL++ SN+LLD ++ PKI+DFG+AR
Sbjct: 612 EQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLAR 671
Query: 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD 277
I GGN+++ +T+R+VGTYGYMSPEYA+ G FSIKSDV+SFGVL+LEI++GK+ + FY +
Sbjct: 672 IFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYE-E 730
Query: 278 SLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVV 337
SL L+ + WD W + +E+ID ++ +E + +++ ++I LLCVQE++ DRP M+ VV
Sbjct: 731 SLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVV 790
Query: 338 SMLTDEAAALFPPKQPAFS--YVRNTVTSTSS----TGKTEDCSINQVTISLLEAR 387
ML A L PK PAF+ RNT T SS +G+T +IN VT++ ++ R
Sbjct: 791 FMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSS-TINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 343 bits (879), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 194/402 (48%), Positives = 263/402 (65%), Gaps = 35/402 (8%)
Query: 13 SIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVN-SKQTKRSKKK 71
+++++ V +L +I + RR R T+D ++ L+ EL ++ S KR+++K
Sbjct: 425 TVLVSMVFLLTMIGFIRRRILSLRFGS--TIDQEMLLR------ELGIDRSCIHKRNERK 476
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
++L +FSF SV +AT+ FSD NKLGEGGFGPVYKG L G+E+A+KRL SGQGL E
Sbjct: 477 SNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLASGQGLVE 536
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANY 191
KNEA +IAK+QH NLV++LGCCI+KDEK+LIYEYM NKSLD+FLFDP ++ +LDW+ +
Sbjct: 537 FKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVLDWTLRF 596
Query: 192 S---------------SRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
SRLKV SNILLD+D+NPKISDFG+ARI G E +ANT
Sbjct: 597 RIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEETRANTK 656
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYR--TDSLTLLGYAWD 287
R+ GT+GYMSPEY +G+FS KSDVFSFGVL+LEI+ G+K F+ L L+ + W+
Sbjct: 657 RVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNLIVHVWN 716
Query: 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA-AA 346
L+ N+ E+ID L D +LR V +ALLCVQE+A+DRP+M +VVSM+ E A
Sbjct: 717 LFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIYGEGNNA 776
Query: 347 LFPPKQPAF-SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
L PK+PAF R + + + +TI++LEAR
Sbjct: 777 LSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 184/409 (44%), Positives = 257/409 (62%), Gaps = 40/409 (9%)
Query: 3 SAPFLALLSLSIVLAAVAILGLIFYCARRKP-RSRGEDLMTLDLDLNLKANNVNIELPVN 61
+AP + ++ ++ A +L Y R P + R +LM ++ +
Sbjct: 450 AAPVIGVM---LIAAVCVLLACRKYKKRPAPAKDRSAELMFKRME------------ALT 494
Query: 62 SKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL 121
S S + ++ +LPLF F ++T+T+ FS NKLG+GGFGPVYKG L +G EIAVKRL
Sbjct: 495 SDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRL 554
Query: 122 PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 181
+SGQGL E+ NE VI+K+QH+NLV+LLGCCI+ +E++L+YEYMP KSLD +LFDP K
Sbjct: 555 SRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMK 614
Query: 182 RMLLDWSANYS---------------SRLKV-------SNILLDKDINPKISDFGMARIC 219
+ +LDW ++ SRLK+ SNILLD+++NPKISDFG+ARI
Sbjct: 615 QKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIF 674
Query: 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD-S 278
NE +ANT R+VGTYGYMSPEYA++G FS KSDVFS GV+ LEI+SG++ + ++ + +
Sbjct: 675 RANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENN 734
Query: 279 LTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338
L LL YAW LW L DP + D+ K + + V+I LLCVQE A+DRP ++ V+
Sbjct: 735 LNLLAYAWKLWNDGEAASLADPAVFDKCFEKE-IEKCVHIGLLCVQEVANDRPNVSNVIW 793
Query: 339 MLTDEAAALFPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
MLT E +L PKQPAF R + SS ++ SIN V+++ + R
Sbjct: 794 MLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 182/410 (44%), Positives = 251/410 (61%), Gaps = 31/410 (7%)
Query: 1 GTSAPFLALLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPV 60
G S LL L ++AAV +L +I +C R+ R + AN +
Sbjct: 432 GLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSS-------SANFAPVPFDF 484
Query: 61 NSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR 120
+ K +LPLF +++ ATN FS NKLG GGFGPVYKGVL+ EIAVKR
Sbjct: 485 DESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKR 544
Query: 121 LPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT 180
L SGQG+ E KNE +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F
Sbjct: 545 LSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEE 604
Query: 181 KRMLLDWSA---------------NYSSRLKV-------SNILLDKDINPKISDFGMARI 218
+R LDW + SRL++ SNILLD ++ PKISDFGMARI
Sbjct: 605 QRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARI 664
Query: 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS 278
GGN+++ TSR+VGT+GYM+PEYA++G FSIKSDV+SFGVL+LEI++GKK + F+ +S
Sbjct: 665 FGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE-ES 723
Query: 279 LTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338
L+G+ WDLW + E+ID +++ E + +++ + I LLCVQE+A DR M+ VV
Sbjct: 724 SNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVI 783
Query: 339 MLTDEAAALFPPKQPAFSYVRNTVTSTSSTGKTE-DCSINQVTISLLEAR 387
ML A L PK PAF+ R + K + S+N VT S ++ R
Sbjct: 784 MLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 191/409 (46%), Positives = 259/409 (63%), Gaps = 30/409 (7%)
Query: 9 LLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRS 68
++ SI ++ + +L I + ++ + R + T +D L++ ++ + V S + S
Sbjct: 442 IIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHIS 501
Query: 69 KKKEVD--QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG 126
++ D +LPL F V+ ATN FS+ANKLG+GGFG VYKG L G E+AVKRL S
Sbjct: 502 RENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSV 561
Query: 127 QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD 186
QG E KNE +IA++QH NLVRLL CC+D EK+LIYEY+ N SLD LFD ++ L+
Sbjct: 562 QGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLN 621
Query: 187 WSANY---------------SSR-------LKVSNILLDKDINPKISDFGMARICGGNEL 224
W + SR LK SNILLDK + PKISDFGMARI G +E
Sbjct: 622 WQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDET 681
Query: 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD-SLTLLG 283
+ANT ++VGTYGYMSPEYA+ GIFS+KSDVFSFGVLLLEI+S K+ GFY +D L LLG
Sbjct: 682 EANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLG 741
Query: 284 YAWDLWTSNRTLELIDPILEDEYSS--KHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
W W + LE+IDPI+ D S+ +H +LR + I LLCVQE A+DRPTM+ V+ ML
Sbjct: 742 CVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLG 801
Query: 342 DEAAALFPPKQPAFSYVRNTVTSTSSTGKTED---CSINQVTISLLEAR 387
E+ + PK P + R+ + + SS+ K D ++NQ+T+S+L+AR
Sbjct: 802 SESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| 359484155 | 865 | PREDICTED: receptor-like serine/threonin | 0.956 | 0.427 | 0.600 | 1e-123 | |
| 297742753 | 637 | unnamed protein product [Vitis vinifera] | 0.956 | 0.580 | 0.600 | 1e-123 | |
| 356514857 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.912 | 0.423 | 0.596 | 1e-122 | |
| 359493705 | 830 | PREDICTED: receptor-like serine/threonin | 0.956 | 0.445 | 0.572 | 1e-118 | |
| 302143120 | 674 | unnamed protein product [Vitis vinifera] | 0.956 | 0.548 | 0.572 | 1e-118 | |
| 302143125 | 585 | unnamed protein product [Vitis vinifera] | 0.956 | 0.632 | 0.582 | 1e-116 | |
| 296090091 | 674 | unnamed protein product [Vitis vinifera] | 0.958 | 0.550 | 0.577 | 1e-116 | |
| 302143128 | 692 | unnamed protein product [Vitis vinifera] | 0.917 | 0.513 | 0.569 | 1e-115 | |
| 302143114 | 457 | unnamed protein product [Vitis vinifera] | 0.953 | 0.807 | 0.570 | 1e-115 | |
| 359493703 | 1658 | PREDICTED: uncharacterized protein LOC10 | 0.953 | 0.222 | 0.573 | 1e-115 |
| >gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1155), Expect = e-123, Method: Compositional matrix adjust.
Identities = 239/398 (60%), Positives = 290/398 (72%), Gaps = 28/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L + LA + + RR+ R +GE+L+ DL + + + N EL SK +KK
Sbjct: 474 LIVTLAISVTSAFVIWGIRRRLRRKGENLLLFDL--SNSSVDTNYELSETSK-LWSGEKK 530
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS ATN FS NKLGEGGFGPVYKG +KG E+AVKRL RSGQG E
Sbjct: 531 EVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEE 589
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNE +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPTK +L+W
Sbjct: 590 LKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRV 649
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL++ SNILLDKD+NP+ISDFGMARI GGNE +A T+
Sbjct: 650 HIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TN 708
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI+SGKK TGFY+TDSL LLGYAWDLW
Sbjct: 709 HIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLW 768
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+R EL+DP LE+ + H+LLRY+NI LLCVQESADDRPTM++VVSML +E+ L
Sbjct: 769 KDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPS 827
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PKQPAFS +R+ V S K + CS+N VT+S++EAR
Sbjct: 828 PKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-123, Method: Compositional matrix adjust.
Identities = 239/398 (60%), Positives = 290/398 (72%), Gaps = 28/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L + LA + + RR+ R +GE+L+ DL + + + N EL SK +KK
Sbjct: 246 LIVTLAISVTSAFVIWGIRRRLRRKGENLLLFDL--SNSSVDTNYELSETSK-LWSGEKK 302
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS ATN FS NKLGEGGFGPVYKG +KG E+AVKRL RSGQG E
Sbjct: 303 EVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQGWEE 361
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNE +IAK+QHKNLV+L G CI+KDEKILIYEYMPNKSLDFFLFDPTK +L+W
Sbjct: 362 LKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWKTRV 421
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL++ SNILLDKD+NP+ISDFGMARI GGNE +A T+
Sbjct: 422 HIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA-TN 480
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI+SGKK TGFY+TDSL LLGYAWDLW
Sbjct: 481 HIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLW 540
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+R EL+DP LE+ + H+LLRY+NI LLCVQESADDRPTM++VVSML +E+ L
Sbjct: 541 KDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVRLPS 599
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PKQPAFS +R+ V S K + CS+N VT+S++EAR
Sbjct: 600 PKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-122, Method: Compositional matrix adjust.
Identities = 228/382 (59%), Positives = 276/382 (72%), Gaps = 29/382 (7%)
Query: 31 RKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNK 90
R+ R +GEDL+ + +++K + + + + + KKKEV +LPLFSF SV+ ATN
Sbjct: 457 RRQRRKGEDLLRFHVSMSMKVEDSEL---AEAHRGAKVKKKEV-KLPLFSFVSVAAATNN 512
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
FSDANKLGEGGFGPVYKG+L GDE+AVKRL RSGQG E++NEA +IAK+QH NLVRL
Sbjct: 513 FSDANKLGEGGFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNNLVRL 572
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA----------------NYS-- 192
LGCCID+DEK+LIYE MPNKSLD FLFD TKR +LDW YS
Sbjct: 573 LGCCIDRDEKMLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQYSRF 632
Query: 193 ----SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
LK SNILLD ++NPKISDFGMARI G NELQANT+RIVGTYGYMSPEYA++G+F
Sbjct: 633 RIIHRDLKASNILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPEYAMEGLF 692
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE--- 305
SIKSDVFSFGVLLLEI+SGKK TGFY+T+S LLGYAWDLWT+N ++L+DP L+D
Sbjct: 693 SIKSDVFSFGVLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLMDPALDDSDTT 752
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTST 365
SS H + RYVNI LLCVQES DRPTM++VVSM+ ++ AL PK PAF VR S
Sbjct: 753 SSSMHTVPRYVNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGNQNSI 812
Query: 366 SSTGKTEDCSINQVTISLLEAR 387
E S+N +T +++EAR
Sbjct: 813 LPASMPESFSLNLITDTMVEAR 834
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1109), Expect = e-118, Method: Compositional matrix adjust.
Identities = 228/398 (57%), Positives = 285/398 (71%), Gaps = 28/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L I LA + Y + R +GEDL+ D + + + ++ + + R +K+
Sbjct: 439 LIITLAISLTSAFVIYGIWGRFRRKGEDLLVFDFGNSSEDTSYELD---ETNRLWRGEKR 495
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS +TN FS NKLGEGGFG VYKG ++ E+AVKRL RS QG E
Sbjct: 496 EVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEE 554
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK +L+W
Sbjct: 555 LKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRV 614
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL++ SNILLDKD+NPKISDFGMARI GGNE + T+
Sbjct: 615 HIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TN 673
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI+SGKK TGFY+TDSL LLGYAWDLW
Sbjct: 674 HIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLW 733
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+R LEL+DP LE+ + H+LLRY+N+ LLCVQESADDRPTM++VVSML +E+ L
Sbjct: 734 KDSRGLELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPS 792
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PKQPAFS +R+ V S + E CS+N VT+S++EAR
Sbjct: 793 PKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 830
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1106), Expect = e-118, Method: Compositional matrix adjust.
Identities = 228/398 (57%), Positives = 285/398 (71%), Gaps = 28/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L I LA + Y + R +GEDL+ D + + + ++ + + R +K+
Sbjct: 283 LIITLAISLTSAFVIYGIWGRFRRKGEDLLVFDFGNSSEDTSYELD---ETNRLWRGEKR 339
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS +TN FS NKLGEGGFG VYKG ++ E+AVKRL RS QG E
Sbjct: 340 EVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEE 398
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK +L+W
Sbjct: 399 LKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTRV 458
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL++ SNILLDKD+NPKISDFGMARI GGNE + T+
Sbjct: 459 HIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKV-TN 517
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEYA++G+FS KSDVFSFGVLLLEI+SGKK TGFY+TDSL LLGYAWDLW
Sbjct: 518 HIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAWDLW 577
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+R LEL+DP LE+ + H+LLRY+N+ LLCVQESADDRPTM++VVSML +E+ L
Sbjct: 578 KDSRGLELMDPGLEETLPT-HILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPS 636
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PKQPAFS +R+ V S + E CS+N VT+S++EAR
Sbjct: 637 PKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143125|emb|CBI20420.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-116, Method: Compositional matrix adjust.
Identities = 232/398 (58%), Positives = 279/398 (70%), Gaps = 28/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L I LA + Y K R +GEDL+ D N + EL + + R +KK
Sbjct: 194 LIITLAISLTSAFVIYGIWGKFRRKGEDLLVFDFG-NSSEDTSCYELG-ETNRLWRGEKK 251
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF SVS +TN F NKLGEGGFG VYKG ++G E+AVKRL RS QG E
Sbjct: 252 EVD-LPMFSFVSVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQGWEE 310
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W
Sbjct: 311 LKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWETRV 370
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL+V SNILLDKD+NPKISDFGMARI GGNE +A T
Sbjct: 371 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TK 429
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEY ++G+FS KSDVFSFGVLLLEI+SGKK T FY +DSL LLGYAWDLW
Sbjct: 430 HIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGYAWDLW 489
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+NR ELIDP+ +E SS+H+LLRY+N+ALLCVQE+ADDRPTM++VVSML E L
Sbjct: 490 KNNRGQELIDPV-PNEISSRHILLRYINVALLCVQENADDRPTMSDVVSMLGRENVLLSS 548
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
P +PAFSY+R V +S + E CS+N VT+S + AR
Sbjct: 549 PNEPAFSYLRG-VKPHASQERPEICSLNDVTLSSMGAR 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 230/398 (57%), Positives = 280/398 (70%), Gaps = 27/398 (6%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L + LA + Y + R +GEDL+ D N + EL + + R +KK
Sbjct: 282 LIVTLAISLTSAFVIYGIWGRFRRKGEDLLLFDFG-NSSEDTSCYELG-ETNRLWRGEKK 339
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS +TN F + NKLGEGGFG VYKG ++ E+AVKRL RS QG E
Sbjct: 340 EVD-LPMFSFASVSASTNNFCNENKLGEGGFGSVYKGKSQRRYEVAVKRLSKRSKQGWEE 398
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDPTK +L+W
Sbjct: 399 LKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPTKHGILNWKTWV 458
Query: 190 --------------NYSSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTS 229
YS LK SNILLDKD+NPKISDFGMARI GGNE +A T+
Sbjct: 459 HIIEGVAQGLLYLHQYSRMRIIHRDLKASNILLDKDMNPKISDFGMARIFGGNEPKA-TN 517
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEYA++G+FS KSDVFSFGVLL+EI+SGKK TGFY+TDSL LLGYAWDLW
Sbjct: 518 HIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLMEILSGKKNTGFYQTDSLNLLGYAWDLW 577
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+R EL+DP LE E S H+LLRY+N+ LLCVQESADDRPTM++VVSML +E+ L
Sbjct: 578 KDSRGQELMDPGLE-ETSPTHILLRYINVGLLCVQESADDRPTMSDVVSMLGNESVRLPS 636
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
PKQPAFS +R+ V S + S+N VT+S++EAR
Sbjct: 637 PKQPAFSNLRSGVEPHISQNRPGIYSLNGVTLSVMEAR 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1085), Expect = e-115, Method: Compositional matrix adjust.
Identities = 224/393 (56%), Positives = 275/393 (69%), Gaps = 38/393 (9%)
Query: 26 FYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRS--------KKKEVD-QL 76
+ C R+ R + + MT D+ L E + SK T+ K K D L
Sbjct: 307 YICYRQMKRVQDREEMTTSQDILL------YEFGMGSKATENELNEGNRVGKDKNKDAWL 360
Query: 77 PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEA 136
PLFSF+SVS AT FS NKLG+GGFGPVYKG L G EIAVKRL SGQGL E+KNE
Sbjct: 361 PLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKRLSRSSGQGLEELKNET 420
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS---- 192
++A++QH+NLVRLLGCCI++ EKILIYEYMPNKSLD FLFDP KR LDW+ S
Sbjct: 421 VLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPNKRGQLDWAKRVSIIEG 480
Query: 193 -----------SRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
SRL++ SNILLD D+NPKISDFGMAR+ GGNE ANT+RIVGT
Sbjct: 481 IAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARMFGGNESYANTNRIVGT 540
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294
YGYMSPEYA++G+FS KSDVFSFGVL+LEI+SGKK TGFY +D+L L+GYAW+LW S+
Sbjct: 541 YGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDTLNLIGYAWELWKSDMA 600
Query: 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354
+ L+DP+LE + SS++MLLRY+N+ LLCV+E A DRPT++EVVSMLT+E A L PK PA
Sbjct: 601 INLMDPMLEGQ-SSQYMLLRYINVGLLCVEEIAADRPTLSEVVSMLTNELAVLPSPKHPA 659
Query: 355 FSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
FS VR+ SS + E S N ++IS++EAR
Sbjct: 660 FSTVRSMENPRSSMSRPEIYSANGLSISVMEAR 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143114|emb|CBI20409.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1083), Expect = e-115, Method: Compositional matrix adjust.
Identities = 227/398 (57%), Positives = 282/398 (70%), Gaps = 29/398 (7%)
Query: 12 LSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKK 71
L I LA + Y + R +GEDL+ D + + + + EL + + R +KK
Sbjct: 67 LIITLAISLTSAFVIYGIWGRFRRKGEDLLVFDFGNS--SEDTSYELG-ETNRLWRGEKK 123
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE 131
EVD LP+FSF+SVS +TN FS NKLGEGGFG VYKG L++G E+AVKRL RS QG E
Sbjct: 124 EVD-LPMFSFASVSASTNNFSIENKLGEGGFGSVYKGKLQRGYEVAVKRLSKRSKQGWEE 182
Query: 132 MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-- 189
+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W
Sbjct: 183 LKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWEMRV 242
Query: 190 -------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
+ SRL+V SNILLDKD+NPKISDFGMARI GGNE +A T
Sbjct: 243 RIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA-TK 301
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289
IVGTYGYMSPEY ++G+FS KSDVFSFGVLLLEI+SGKK T FY + SL LLGYAWDLW
Sbjct: 302 HIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSGSLNLLGYAWDLW 361
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+N+ ELIDP+L +E S +H++LRY+N+ALLCVQESADDRPTM +VVSML E L
Sbjct: 362 KNNKGQELIDPVL-NEISLRHIMLRYINVALLCVQESADDRPTMFDVVSMLVKENVLLSS 420
Query: 350 PKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
P +PAFS + +++ +S + E CS+N VT+S + AR
Sbjct: 421 PNEPAFSNL-SSMKPHASQDRLEICSLNDVTLSSMGAR 457
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493703|ref|XP_002281224.2| PREDICTED: uncharacterized protein LOC100245158 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1082), Expect = e-115, Method: Compositional matrix adjust.
Identities = 230/401 (57%), Positives = 286/401 (71%), Gaps = 32/401 (7%)
Query: 9 LLSLSIVLAAVAILGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRS 68
+++L+I L +V + Y R+ R +GEDL+ D + + N EL + + R
Sbjct: 1268 IVTLAISLTSV----FVNYGIWRRFRRKGEDLLVFDFGNSSEDTNC-YELG-ETNRLWRD 1321
Query: 69 KKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQG 128
+KKEVD LP+FSF+SVS +TN F NKLGEGGFG VYKG ++G E+AVKRL RS QG
Sbjct: 1322 EKKEVD-LPMFSFASVSASTNNFCIENKLGEGGFGSVYKGKSQRGYEVAVKRLSKRSKQG 1380
Query: 129 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWS 188
E+KNEA +IAK+QHKNLV++LG CI++DEKILIYEYM NKSLDFFLFDP KR +L+W
Sbjct: 1381 WEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIYEYMSNKSLDFFLFDPAKRGILNWE 1440
Query: 189 A---------------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQA 226
+ SRL+V SNILLDKD+NPKISDFGMARI GGNE +A
Sbjct: 1441 TRVHIIEGVAQGLLYLHQYSRLRVIHRDLKASNILLDKDMNPKISDFGMARIFGGNESKA 1500
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286
T IVGTYGYMSPEY ++G+FS KSDVFSFGVLLLEI+SGKK T FY +DSL LLGYAW
Sbjct: 1501 -TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFGVLLLEILSGKKITEFYHSDSLNLLGYAW 1559
Query: 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346
DLW SNR ELIDP+L +E S +H+LLRY+N+ALLCVQESADDRPTM++VVSML E
Sbjct: 1560 DLWKSNRGQELIDPVL-NEISLRHILLRYINVALLCVQESADDRPTMSDVVSMLVKENVL 1618
Query: 347 LFPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 387
L P +PAF + +++ +S + E CS+N VT+S + AR
Sbjct: 1619 LSSPNEPAFLNL-SSMKPHASQDRLEICSLNDVTLSSMGAR 1658
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.498 | 0.227 | 0.567 | 3.9e-92 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.498 | 0.228 | 0.562 | 3.9e-92 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.498 | 0.227 | 0.515 | 5.5e-91 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.496 | 0.226 | 0.515 | 6e-90 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.498 | 0.227 | 0.552 | 5.5e-88 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.496 | 0.226 | 0.494 | 1.8e-87 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.493 | 0.226 | 0.494 | 5.2e-84 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.475 | 0.275 | 0.515 | 7.3e-84 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.483 | 0.279 | 0.502 | 2.6e-83 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.462 | 0.264 | 0.521 | 1.4e-82 |
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 570 (205.7 bits), Expect = 3.9e-92, Sum P(2) = 3.9e-92
Identities = 113/199 (56%), Positives = 148/199 (74%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SN+LLDK++ PKISDFGMARI G E +ANT R+VGTYGYMSPEYA+ GIFS+KSDV
Sbjct: 649 LKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDV 708
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD-SLTLLGYAWDLWTSNRTLELIDPILEDEYSSK---H 310
FSFGVLLLEI+SGK+ GFY ++ L LLG+ W W + LE++DPI D SS+ H
Sbjct: 709 FSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTH 768
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNT--VTSTSST 368
+LR + I LLCVQE A+DRP M+ V+ ML E A+ PK+P F R++ V S+SST
Sbjct: 769 EILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSST 828
Query: 369 GKTEDCSINQVTISLLEAR 387
+ ++C++NQVT+S+++AR
Sbjct: 829 QRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 3.9e-92, Sum P(2) = 3.9e-92
Identities = 112/199 (56%), Positives = 146/199 (73%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SN+LLDK++ PKISDFGMARI G E +ANT R+VGTYGYMSPEYA+ GIFS+KSDV
Sbjct: 645 LKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDV 704
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD-SLTLLGYAWDLWTSNRTLELIDPILEDEYSSK---H 310
FSFGVLLLEI+SGK+ GFY ++ L LLG+ W W LE++DPI D SSK H
Sbjct: 705 FSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTH 764
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVT--STSST 368
+LR + I LLCVQE A+DRP M+ V+ ML E A+ PK+P F R+ + S+SST
Sbjct: 765 EILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSST 824
Query: 369 GKTEDCSINQVTISLLEAR 387
+ ++C++NQ+T+S+++AR
Sbjct: 825 QRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 5.5e-91, Sum P(2) = 5.5e-91
Identities = 102/198 (51%), Positives = 135/198 (68%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K NILLD+D+NPKISDFGMARI G E +ANT R+ GT+GYMSPEY +G+FS KSDV
Sbjct: 653 IKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDV 712
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDS--LTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312
FSFGVL+LEI+ G+K F+ L L+ + W+L+ NR E+IDP L D +
Sbjct: 713 FSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQV 772
Query: 313 LRYVNIALLCVQESADDRPTMNEVVSMLT-DEAAALFPPKQPAF--SYVRNTVTSTSSTG 369
LR V +ALLCVQ++ADDRP+M +VVSM+ D AL PK+PAF R++
Sbjct: 773 LRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPP 832
Query: 370 KTEDCSINQVTISLLEAR 387
+ E+ S N+VTI+++EAR
Sbjct: 833 EMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.0e-90, Sum P(2) = 6.0e-90
Identities = 101/196 (51%), Positives = 141/196 (71%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LKVSN+LLD ++NPKISDFGMARI GGN+ +ANT R+VGTYGYMSPEYA++G+FS+KSDV
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDV 714
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314
+SFGVLLLEIVSGK+ T ++ +L+GYAW L+T R+ EL+DP + SK LR
Sbjct: 715 YSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVT-CSKREALR 773
Query: 315 YVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVR-NTVTSTSSTGKTED 373
+++A+LCVQ+SA +RP M V+ ML + A L P+QP F+ R N++ + ++
Sbjct: 774 CIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQ 833
Query: 374 --CSINQVTISLLEAR 387
S N++T +++ R
Sbjct: 834 YIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 5.5e-88, Sum P(2) = 5.5e-88
Identities = 110/199 (55%), Positives = 143/199 (71%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SNILLDK + PKISDFGMARI G +E +ANT ++VGTYGYMSPEYA+ GIFS+KSDV
Sbjct: 652 LKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDV 711
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD-SLTLLGYAWDLWTSNRTLELIDPILEDEYSS--KHM 311
FSFGVLLLEI+S K+ GFY +D L LLG W W + LE+IDPI+ D S+ +H
Sbjct: 712 FSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHE 771
Query: 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTSTSSTGKT 371
+LR + I LLCVQE A+DRPTM+ V+ ML E+ + PK P + R+ + + SS+ K
Sbjct: 772 ILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQ 831
Query: 372 ED---CSINQVTISLLEAR 387
D ++NQ+T+S+L+AR
Sbjct: 832 RDDESWTVNQITVSVLDAR 850
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 1.8e-87, Sum P(2) = 1.8e-87
Identities = 96/194 (49%), Positives = 136/194 (70%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SNILLD D+ PKISDFGMAR+ GG++ Q NT+R+VGT+GYMSPEYA++GIFS+KSDV
Sbjct: 656 LKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDV 715
Query: 255 FSFGVLLLEIVSGKKTTGFY-RTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313
+ FGVL+LEI++GK+ F+ DSL + GYAW W + ELIDP++ S + +L
Sbjct: 716 YGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVL- 774
Query: 314 RYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTSTSSTGKTED 373
R ++IALLCVQ+ AD+RP + V+ ML++++++L P+ P + S+ S+ K
Sbjct: 775 RCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREIESSKSSEKDRS 834
Query: 374 CSINQVTISLLEAR 387
SI VT++ L R
Sbjct: 835 HSIGTVTMTQLHGR 848
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 5.2e-84, Sum P(2) = 5.2e-84
Identities = 96/194 (49%), Positives = 131/194 (67%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SNILLD ++NPKISDFGMARI + ANT R+VGTYGYM+PEYA++GIFS KSDV
Sbjct: 651 LKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDV 710
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314
+SFGVL+LEIVSG+K F TD +L+GYAW LW+ +T E+IDPI++D + R
Sbjct: 711 YSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAM-R 769
Query: 315 YVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAF-SYVRNTVTSTSSTGKTED 373
+++ +LC Q+S RP M V+ ML + + L PP+QP F S++ + + G +
Sbjct: 770 CIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGH-DV 828
Query: 374 CSINQVTISLLEAR 387
S+N VT + + R
Sbjct: 829 ASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 7.3e-84, Sum P(2) = 7.3e-84
Identities = 100/194 (51%), Positives = 132/194 (68%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SNILLD D+NPKI+DFGMARI G ++ + NTSRIVGTYGYMSPEYA+ G +S+KSDV
Sbjct: 474 LKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDV 533
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSL-TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313
+SFGVL+LEI+SGKK + FY+TD L+ YAW LW++ R LEL+DP + E ++ ++
Sbjct: 534 YSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIV-ENCQRNEVV 592
Query: 314 RYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSY--------VRNTVTST 365
R V+I LLCVQE +RPT++ +V MLT L P+QP + + TS
Sbjct: 593 RCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSK 652
Query: 366 SSTGKTEDCSINQV 379
S G +D SI +
Sbjct: 653 SLLGSVDDASITDI 666
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 2.6e-83, Sum P(2) = 2.6e-83
Identities = 98/195 (50%), Positives = 128/195 (65%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK SNILLD D+NPKI+DFGMARI G ++ QANT RI GT+GYMSPEYA++G FS+KSDV
Sbjct: 471 LKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDV 530
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSL--TLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312
+SFGVL+LEI+SGKK + FY D L+ +AW LW + LEL+DP + + Y S
Sbjct: 531 YSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEAT 590
Query: 313 LRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAF-----SYVRNTVTSTSS 367
R ++IALLCVQE DRP + ++ MLT L P+ P F ++ V T S
Sbjct: 591 -RCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTES 649
Query: 368 TGKTEDCSINQVTIS 382
T ++ SIN +I+
Sbjct: 650 TSRSIPGSINDASIT 664
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 466 (169.1 bits), Expect = 1.4e-82, Sum P(2) = 1.4e-82
Identities = 97/186 (52%), Positives = 127/186 (68%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILL D+N KI+DFGMARI G ++ +ANT RIVGTYGYMSPEYA+ G FS+KSDV
Sbjct: 477 LKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDV 536
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLT---LLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311
+SFGVL+LEI+SGKK + Y+ D + L+ Y W LW++ LEL+DP D Y +
Sbjct: 537 YSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEV 596
Query: 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTSTSSTGKT 371
R ++IALLCVQE A+DRPTM+ +V MLT + AL P++P F + R++ G
Sbjct: 597 S-RCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGF-FFRSS--KHEQVGLV 652
Query: 372 EDCSIN 377
+ SIN
Sbjct: 653 DRLSIN 658
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 387 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-38 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-34 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-07 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.003 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.003 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.004 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.004 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.004 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-42
Identities = 81/270 (30%), Positives = 128/270 (47%), Gaps = 43/270 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGD-----EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
KLGEG FG VYKG LK E+AVK L S Q + E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------NY-SSR---- 194
LLG C +++ ++ EYM L +L + LL ++ Y S+
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIH 125
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIK 251
L N L+ +++ KISDFG++R ++ + +M+PE +++ G F+ K
Sbjct: 126 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPE-SLKEGKFTSK 183
Query: 252 SDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310
SDV+SFGVLL EI + G++ + + +L Y + L
Sbjct: 184 SDVWSFGVLLWEIFTLGEQP--YPGMSNEEVLEYL----KNGYRLPQP------PNCPPE 231
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ ++ L C E +DRPT +E+V +L
Sbjct: 232 L----YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 91/291 (31%), Positives = 131/291 (45%), Gaps = 73/291 (25%)
Query: 95 NKLGEGGFGPVYKGVLKKGD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVR 149
KLGEG FG VYKG LK D E+AVK L S + ++ EA V+ K+ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRM------LLDWSA------NY 191
LLG C +++ L+ EYM L +L F ++ LL ++ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 192 SSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMS 239
+ K N L+ +D+ KISDFG++R ++ + T G +M+
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIRWMA 175
Query: 240 PEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLWTSNRTLE 296
PE GIF+ KSDV+SFGVLL EI + LG Y L E
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT---------------LGATPY-PGL----SNEE 215
Query: 297 LIDPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
+++ + + EY + Y + L C Q +DRPT +E+V L
Sbjct: 216 VLEYLRKGYRLPKPEYCPDEL---Y-ELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 5e-42
Identities = 83/279 (29%), Positives = 131/279 (46%), Gaps = 60/279 (21%)
Query: 96 KLGEGGFGPVYKGVLKKGD-----EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
KLGEG FG VYKG LK E+AVK L S Q + E EA ++ K+ H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWSA------NY-SSR--- 194
LLG C +++ +++ EYMP L +L + + LL ++ Y S+
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI 125
Query: 195 ---LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFS 249
L N L+ +++ KISDFG++R + + + ++ +M+PE +++ G F+
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPE-SLKEGKFT 182
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNRTLELID-------PI 301
KSDV+SFGVLL EI + LG + ++ LE + P
Sbjct: 183 SKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEYLKKGYRLPKP- 226
Query: 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ + L C E +DRPT +E+V +L
Sbjct: 227 ---PNCPPEL----YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 85/276 (30%), Positives = 123/276 (44%), Gaps = 54/276 (19%)
Query: 96 KLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
KLGEG FG VYKG LK E +AVK L G S + E EAS++ K+ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSA------NYSSRLKV-- 197
LLG C + ++ EYMP L FL +++ LL + Y
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVH 125
Query: 198 -----SNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
N L+ +++ KISDFG++R I + + + +M+PE G F+ K
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSK 184
Query: 252 SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------PILED 304
SDV+SFGVLL EI + + + ++ LEL++ P
Sbjct: 185 SDVWSFGVLLWEIFTLGEQP--------------YPGMSNEEVLELLEDGYRLPRP---- 226
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
E + Y + L C +DRPT +E+V L
Sbjct: 227 ENCPDEL---Y-ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 62/189 (32%), Positives = 93/189 (49%), Gaps = 23/189 (12%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREM-KNEASVIAKVQHKNLVRLLGCC 154
LGEGGFG VY KK G ++A+K + L E E ++ K+ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------LKV 197
D++ L+ EY SL L + ++ D + LK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 198 SNILLDKD-INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVF 255
NILLD D K++DFG++++ ++ T IVGT YM+PE + G +S KSD++
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 256 SFGVLLLEI 264
S GV+L E+
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLV 148
+ KLGEG FG VY KK G +A+K + + + RE + E ++ K++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------------- 193
RL D+D+ L+ EY L F L R+ D + Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 194 -R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
R LK NILLD+D + K++DFG+AR E + VGT YM+PE + +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 252 SDVFSFGVLLLEIVSGK 268
D++S GV+L E+++GK
Sbjct: 177 VDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 28/196 (14%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
KLG G FG VYK K G +AVK L + + + E ++ ++ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW------------------SANYSSR 194
DKD L+ EY L +L L S R
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSNGIIHR 122
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-YAIQGIFSIKS 252
LK NILLD++ KI+DFG+A+ + ++ + VGT YM+PE + K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 253 DVFSFGVLLLEIVSGK 268
DV+S GV+L E+++GK
Sbjct: 181 DVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 21/195 (10%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LG G FG VY + K G+ +AVK L G S + L ++ E +++ +QH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 152 GCCIDKDEK-ILIY-EYMPNKSLDFFL-----FDPTK-----RMLLD-----WSANYSSR 194
G D+++ + I+ EY+ SL L R +L+ S R
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K +NIL+D D K++DFG A+ G E T + GT +M+PE + +D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185
Query: 254 VFSFGVLLLEIVSGK 268
++S G ++E+ +GK
Sbjct: 186 IWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 69/194 (35%), Positives = 100/194 (51%), Gaps = 30/194 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 153
KLG G FG V+ G ++AVK L PG S + + EA ++ K++H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAV 69
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWSA------------NYSSR-L 195
C +++ ++ EYM SL FL + L+D +A NY R L
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIQGIFSIKS 252
NIL+ +++ KI+DFG+AR+ +E A I T +PE A G F+IKS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGRFTIKS 185
Query: 253 DVFSFGVLLLEIVS 266
DV+SFG+LL EIV+
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 20/194 (10%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
F+ KLG G FG V++G+ K +A+K L ++ + E + +++HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-----LLDWSA------------NYSS 193
C + +I E M SL FL P ++ L+D + N
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIH 127
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
R L NIL+ +D+ K++DFG+AR+ + ++ +I Y + +PE A G FS KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185
Query: 253 DVFSFGVLLLEIVS 266
DV+SFG+LL E+ +
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 23/198 (11%)
Query: 90 KFSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
F K+G+GGFG VYK + G E+A+K + S + ++ NE ++ K +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
+ G + KDE ++ E+ SL L + + A Y +
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-YVCKELLKGLEYLHSNGI 119
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
+K +NILL D K+ DFG++ + NT +VGT +M+PE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT--MVGTPYWMAPEVINGKPYDY 176
Query: 251 KSDVFSFGVLLLEIVSGK 268
K+D++S G+ +E+ GK
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 61/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 156
+G+G FG V G + G ++AVK L + EASV+ ++H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 157 KDEKILIYEYMPNKSL-DF----------------FLFDPTKRMLLDWSANYSSR-LKVS 198
+ ++ EYM SL D+ F D + M N+ R L
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGIFSIKSDVFS 256
N+L+ +D+ K+SDFG+A+ +A+ + G + +PE + FS KSDV+S
Sbjct: 132 NVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 257 FGVLLLEIVS 266
FG+LL EI S
Sbjct: 185 FGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 90/270 (33%), Positives = 129/270 (47%), Gaps = 45/270 (16%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 153
KLG G FG V+ G ++AVK L PG S Q E EA+++ +QH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAV 69
Query: 154 CIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLL----DWSA------------NYSSR-L 195
++ +I EYM SL DF D ++LL D+SA NY R L
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
+ +N+L+ + + KI+DFG+AR+ NE A + +PE G F+IKSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVW 188
Query: 256 SFGVLLLEIVSGKKT--TGFYRTDSLTLLGYAWDL-WTSNRTLELIDPILEDEYSSKHML 312
SFG+LL EIV+ K G +D ++ L + + N EL D
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD------------- 235
Query: 313 LRYVNIALLCVQESADDRPTMNEVVSMLTD 342
I C +E A++RPT + + S+L D
Sbjct: 236 -----IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 8e-24
Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 45/282 (15%)
Query: 95 NKLGEGGFGPVYKGVL-----KKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
+LGEG FG V G+++AVK L Q + + E ++ + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 149 RLLGCCIDKDEKI--LIYEYMPNKSLDFFL----------------FDPTKRMLLDWSAN 190
+ G C + LI EY+P+ SL +L K M S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 191 YSSR-LKVSNILLDKDINPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYAIQGI 247
Y R L NIL++ + KISDFG+A++ + + Y +PE
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSK 188
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------- 299
FS SDV+SFGV L E+ + + + L ++G A R LEL+
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
P DE + L++ LC + DRP+ +++ ++
Sbjct: 249 PSCPDEV---YDLMK------LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 28/193 (14%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
KLG G FG V++G+ +AVK L PG ++ EA ++ K++H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRM-----LLDWSA------------NYSSR-LK 196
++ ++ E M SL +L R L+D +A NY R L
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSD 253
N+L+ ++ K++DFG+AR+ + +A G + +PE A+ FSIKSD
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSD 186
Query: 254 VFSFGVLLLEIVS 266
V+SFG+LL EIV+
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 55/275 (20%)
Query: 97 LGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G G FG V +G LK + +A+K L G S + + EAS++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL------FDPTK--RMLLDWSA--------NYSSR- 194
G ++I EYM N SLD FL F + ML ++ NY R
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRD 131
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTS--RIVGTYGYMSPEYAIQ-GIFSIK 251
L NIL++ ++ K+SDFG++R +E T +I + +PE AI F+
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPE-AIAYRKFTSA 188
Query: 252 SDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDE 305
SDV+SFG+++ E++S G++ Y WD ++ ++ ++ P D
Sbjct: 189 SDVWSFGIVMWEVMSYGERP---Y-----------WD-MSNQDVIKAVEDGYRLPPPMDC 233
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
S+ + L+ L C Q+ ++RPT +++VS L
Sbjct: 234 PSALYQLM------LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 67/192 (34%), Positives = 99/192 (51%), Gaps = 27/192 (14%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMK---NEASVIAKVQHKNLVRLLG 152
KLG G FG V+ G ++A+K L QG + EA+++ ++QH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 153 CCIDKDEKILIYEYMPNKSL-DFFLFDPTKRM----LLDWSA------------NYSSR- 194
+ ++ +I EYM N SL DF ++ L+D +A NY R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
L+ +NIL+ + + KI+DFG+AR+ NE A + +PE G F+IKSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDV 186
Query: 255 FSFGVLLLEIVS 266
+SFG+LL EIV+
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-23
Identities = 78/271 (28%), Positives = 117/271 (43%), Gaps = 47/271 (17%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 154
K+G+G FG VYKGVLK E+AVK L+ EA ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWSA--------NYSSR-LKV 197
+ K ++ E +P SL FL R M LD +A N R L
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
N L+ ++ KISDFGM+R G + + +PE G ++ +SDV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY 181
Query: 258 GVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------PILEDEYSSKH 310
G+LL E S T Y ++ +T E I+ P L E +
Sbjct: 182 GILLWETFSLGDTP--YPG------------MSNQQTRERIESGYRMPAPQLCPEEIYRL 227
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
M L C ++RP+ +E+ + L
Sbjct: 228 M--------LQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 83/275 (30%), Positives = 119/275 (43%), Gaps = 48/275 (17%)
Query: 95 NKLGEGGFGPVYKGV--LKKGDEI--AVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LG G FG V KGV +K G E+ AVK L G +E EASV+A++ H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDP---TKRMLLDW------------SANYSSR 194
L+G C + +L+ E P L +L L + S ++ R
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 195 -LKVSNILLDKDINPKISDFGMARI--CGGNELQANTSRIVGTY--GYMSPEYAIQGIFS 249
L N+LL KISDFGM+R G + +A T+ G + + +PE G FS
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPECINYGKFS 176
Query: 250 IKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307
KSDV+S+GV L E S K + + +L S L + ++ YS
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-------ESGERLPRPEECPQEIYS 229
Query: 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
I L C + +DRPT +E+ S
Sbjct: 230 ----------IMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 46/215 (21%)
Query: 97 LGEGGFGPVYKG---VLKKGDE---IAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVR 149
LGEG FG V+ G L+ ++ +AVK L + R+ + EA ++ QH+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWSA-----NYSSRLKVS---- 198
G C + D I+++EYM + L+ FL P L + S L+++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 199 -------------------NILLDKDINPKISDFGMARICGGNELQANTSRIVGT----Y 235
N L+ D+ KI DFGM+R + + R+ G
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTMLPI 188
Query: 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKK 269
+M PE + F+ +SDV+SFGV+L EI + GK+
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 39/209 (18%)
Query: 97 LGEGGFGPVYKGVL------KKGDEIAVKRLPGRSGQGLR-EMKNEASVIAKVQHKNLVR 149
LGEG FG VYKG L +A+K L + ++ E + EA +++ +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKRMLLDWS-------- 188
LLG C + +++EY+ + L FL D T + LD S
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 189 ----ANY-SSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
Y SS L N L+ + + KISDFG++R + S+ + +
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 238 MSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
M PE + G F+ +SD++SFGV+L EI S
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 65/261 (24%), Positives = 109/261 (41%), Gaps = 43/261 (16%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPG-RSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
LG+G G VYK K G A+K++ + +++ E + + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 154 CIDKDEKILIYEYMPNKSLD-----------FFLFDPTKRMLLDWSANYSSR------LK 196
+ E ++ EYM SL L +++L ++ R +K
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIK 127
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVF 255
SN+L++ KI+DFG++++ Q NT VGT YMSPE IQG +S +D++
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPE-RIQGESYSYAADIW 184
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI----DPILEDEYSSKHM 311
S G+ LLE GK + + ++L ++ I P L E S
Sbjct: 185 SLGLTLLECALGK-----FPFLPPGQPSF-FEL------MQAICDGPPPSLPAEEFSPEF 232
Query: 312 LLRYVNIALLCVQESADDRPT 332
+ C+Q+ RP+
Sbjct: 233 ----RDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-21
Identities = 80/269 (29%), Positives = 123/269 (45%), Gaps = 44/269 (16%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
KLG G FG V+ K ++AVK + PG + EA+V+ +QH LV+L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKL-HAV 69
Query: 155 IDKDEKILIYEYMPNKSL-DFFLFDPTKRM----LLDWSA------------NYSSR-LK 196
+ K+ +I E+M SL DF D + L+D+SA NY R L+
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 129
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
+NIL+ + KI+DFG+AR+ NE A + +PE G F+IKSDV+S
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWS 188
Query: 257 FGVLLLEIVSGKKT--TGFYRTDSLTLLGYAWDLW-TSNRTLELIDPILEDEYSSKHMLL 313
FG+LL+EIV+ + G + + L + + N EL + ++
Sbjct: 189 FGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR---------- 238
Query: 314 RYVNIALLCVQESADDRPTMNEVVSMLTD 342
C + ++RPT + S+L D
Sbjct: 239 --------CWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKR--LPGRSGQGLREMKNEASVIAKVQHKNL 147
F NK+G+G FG V+K V K A+K+ L + + E +EA V+AK+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------------MLLDWSANYSSR 194
+R +DK + ++ EY N L L R +LL + +S +
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 195 -----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
+K N+ LD N KI D G+A++ N ANT IVGT Y+SPE ++
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYN 179
Query: 250 IKSDVFSFGVLLLEIVSGK 268
KSDV++ GV+L E +GK
Sbjct: 180 EKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 97 LGEGGFGPVYKGVLK-KGD----EIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRL 150
LG G FG VYKGV +G+ +A+K L + + +E+ +EA V+A V H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSA------NYSSR------ 194
LG C+ + LI + MP L ++ + + LL+W +Y
Sbjct: 75 LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
L N+L+ + KI+DFG+A++ +E + + +M+ E + I++ KSD
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193
Query: 254 VFSFGVLLLEIVS-GKK 269
V+S+GV + E+++ G K
Sbjct: 194 VWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-21
Identities = 62/191 (32%), Positives = 99/191 (51%), Gaps = 21/191 (10%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+KLG G +G VY+GV KK +AVK L + E EA+V+ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRML----LDWSA-------------NYSSR-L 195
C + +I E+M +L +L + ++ + L + A N+ R L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
N L+ ++ K++DFG++R+ G+ A+ + +PE FSIKSDV+
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVW 189
Query: 256 SFGVLLLEIVS 266
+FGVLL EI +
Sbjct: 190 AFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 43/269 (15%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKR--LPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
++G+G FG VY K ++ +K L S + + NE ++ K+ H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWSA------NY-SSR--- 194
+K + ++ EY L + K +LDW Y SR
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSI 250
+K NI L + K+ DFG++++ A T +VGT Y+SPE Q ++
Sbjct: 126 HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE-LCQNKPYNY 182
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310
KSD++S G +L E+ + K F + L L + L+ P + +YSS+
Sbjct: 183 KSDIWSLGCVLYELCTLKHP--FEGENLLELA---------LKILKGQYPPIPSQYSSE- 230
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSM 339
LR N+ +Q+ ++RP++ +++
Sbjct: 231 --LR--NLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 27/201 (13%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKR--LPGRSGQGLREMKNEASVIAKVQHKN 146
+ + +G G FG VYKG+ L+ GD +A+K+ L + L+ + E ++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWSANYSSR---------- 194
+V+ +G D +I EY N SL + F P L A Y +
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAVYVYQVLQGLAYLHE 117
Query: 195 -------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
+K +NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSG 175
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
S SD++S G ++E+++G
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 35/206 (16%)
Query: 95 NKLGEGGFGPVYKGVL--KKGD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNL 147
LG G FG VY+G+ + GD ++AVK LP S Q + EA +++K H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------PTKRMLLDW------------- 187
VRL+G ++ + ++ E M L FL + P+ + D
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 188 --SANYSSR-LKVSNILLDKDINP----KISDFGMARICGGNELQANTSRIVGTYGYMSP 240
++ R + N LL P KI+DFGMAR R + +M P
Sbjct: 132 LEENHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVS 266
E + GIF+ K+DV+SFGVLL EI S
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 42/266 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCI 155
LG G FG V+ G + ++A+K + R G + EA V+ K+ H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 156 DKDEKILIYEYMPNKSLDFFLFDPTKR----MLLDW------------SANYSSR-LKVS 198
+ ++ EYM N L +L + + LLD S + R L
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAAR 129
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVF 255
N L+ +D K+SDFG+AR ++ ++ GT + PE FS KSDV+
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315
SFGVL+ E+ S K ++ ++++ +E + Y K
Sbjct: 186 SFGVLMWEVFSEGKM--------------PYERFSNSEVVESVSAGYR-LYRPKLAPTEV 230
Query: 316 VNIALLCVQESADDRPTMNEVVSMLT 341
I C E +DRP +++S LT
Sbjct: 231 YTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-20
Identities = 70/193 (36%), Positives = 103/193 (53%), Gaps = 29/193 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 153
KLG G FG V+ G ++AVK L PG S + E EA ++ K++H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQLYAV 69
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWSA------------NYSSR-L 195
+ ++ ++ EYM SL FL D R L+D +A NY R L
Sbjct: 70 -VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGIFSIKSD 253
+ +NIL+ + KI+DFG+AR+ NE T+R + + +PE A+ G F+IKSD
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 254 VFSFGVLLLEIVS 266
V+SFG+LL E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 23/190 (12%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
KLG+G FG V+ G +A+K L PG EA V+ K++H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV- 69
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRML-----LDWSA------------NYSSR-LK 196
+ ++ ++ EYM SL FL + L +D +A NY R L+
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
+NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IKSDV+S
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 257 FGVLLLEIVS 266
FG+LL E+ +
Sbjct: 189 FGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 88 TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN 146
+ + K+GEG G VYK G E+A+K++ R Q + NE ++ +H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDPTKRML----------LDW--SAN 190
+V + DE ++ EYM SL + + L++ S N
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 191 YSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R +K NILL KD + K++DFG A + + N+ +VGT +M+PE + +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 250 IKSDVFSFGVLLLEIVSG 267
K D++S G++ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 33/203 (16%)
Query: 97 LGEGGFGPVYKGVLK---KGD---EIAVKRLPGRSGQGLR-EMKNEASVIAKVQHKNLVR 149
LG+G FG VY+G+ K KG+ +A+K + + R E NEASV+ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 150 LLGCCIDKDEKILIYEYM-------------PNKSLDFFLFDPTKRMLLDWSA------N 190
LLG +++ E M P + L PT + + +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 191 YSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
Y + K N ++ +D+ KI DFGM R + + + +M+PE
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193
Query: 244 IQGIFSIKSDVFSFGVLLLEIVS 266
G+F+ KSDV+SFGV+L E+ +
Sbjct: 194 KDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCC 154
++G G FG V+ G + ++A+K + R G + EA V+ K+ H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 155 IDKDEKILIYEYMPNKSLDFFL----------------FDPTKRMLLDWSANYSSR-LKV 197
++ L++E+M + L +L D + M S+N R L
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDV 254
N L+ ++ K+SDFGM R ++ ++T GT + SPE +S KSDV
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDS 278
+SFGVL+ E+ S KT R++S
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 73/263 (27%), Positives = 125/263 (47%), Gaps = 43/263 (16%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLP----GRSGQG-LREMKNEASVIAKVQHKNLVRL 150
LG G FG VY+G+ L GD AVK + G++GQ +++++ E ++++K+QH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 151 LGCCIDKDEKILIY-EYMPNKSL-----DF-FLFDPTKRM----LLDWSANYSSR----- 194
LG + ++ + I+ E +P SL + +P R+ +L R
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY-AIQGIFSIKS 252
+K +NIL+D + K++DFGMA+ + G+ +M+PE A QG + + +
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 253 DVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312
D++S G +LE+ +GK L + + + S + L I L DE
Sbjct: 184 DIWSLGCTVLEMATGKPPWS-----QLEGVAAVFKIGRS-KELPPIPDHLSDEAK----- 232
Query: 313 LRYVNIALLCVQESADDRPTMNE 335
+ L C+Q RPT E
Sbjct: 233 ----DFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 48/271 (17%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 154
KLG+G FG V+ G ++A+K L + G + E EA ++ K++H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWSA------------NYSSR-LK 196
+ ++ ++ E+M SL FL + + L+D +A NY R L+
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLR 129
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
+NIL+ ++ KI+DFG+AR+ NE A + +PE A+ G F+IKSDV+S
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWS 188
Query: 257 FGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDEYSSKHM 311
FG+LL E+V+ + + + LE ++ P + S H
Sbjct: 189 FGILLTELVTKGRV--------------PYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234
Query: 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
L++ LC ++ D+RPT + S L D
Sbjct: 235 LMK------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 38/207 (18%)
Query: 97 LGEGGFGPVYKGVLKKGD-------EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
LG G FG VY+G +AVK L G + Q +E EA +++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------------MLLDWS--ANYS 192
+LLG C+ + + +I E M L +L D + LD + Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 193 SRLK------------VSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 239
++ VS D D KI DFG+AR I + + ++ +M+
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMA 181
Query: 240 PEYAIQGIFSIKSDVFSFGVLLLEIVS 266
PE + G F+ +SDV+SFGVL+ EI++
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 61/198 (30%), Positives = 101/198 (51%), Gaps = 33/198 (16%)
Query: 97 LGEGGFGPVYKGVLK----KGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G G FG V++G+LK K +A+K L PG + + ++ +EAS++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWSA--------NYSSR- 194
G ++I EYM N +LD +L D ML +A NY R
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRD 132
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQGIF 248
L NIL++ ++ K+SDFG++R+ L+ + T G + +PE F
Sbjct: 133 LAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 249 SIKSDVFSFGVLLLEIVS 266
+ SDV+SFG+++ E++S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.9 bits (203), Expect = 2e-17
Identities = 65/321 (20%), Positives = 118/321 (36%), Gaps = 37/321 (11%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQH-KNLVRLL 151
KLGEG FG VY +K +A+K L + + + E ++A + H N+V+L
Sbjct: 7 KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWSANYSSRL-------------- 195
D+ L+ EY+ SL+ L + + +++
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124
Query: 196 ---KVSNILLDKDIN-PKISDFGMARICGGN----ELQANTSRIVGTYGYMSPEYAIQGI 247
K NILLD+D K+ DFG+A++ + A S VGT GYM+PE +
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184
Query: 248 F---SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
S SD++S G+ L E+++G F + + + T L P+
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTS 364
++ + + +R + + +S L ++
Sbjct: 243 NPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPL 300
Query: 365 TSSTGKTEDCSINQVTISLLE 385
S + + I+ + +
Sbjct: 301 RLSLPPSLEALISSLNSLAIS 321
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
KLGEG +G VYK + K+ G +A+K +P + L+E+ E S++ + +V+ G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 155 IDKDEKILIYEY-----------MPNKSLD-----FFLFDPTKRMLLDWSANYSSR-LKV 197
+ ++ EY + NK+L L+ K + S R +K
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFS 256
NILL+++ K++DFG++ + NT ++GT +M+PE IQ I ++ K+D++S
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE-VIQEIGYNNKADIWS 184
Query: 257 FGVLLLEIVSGK 268
G+ +E+ GK
Sbjct: 185 LGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-16
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 53/211 (25%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSG---QGLREMKNEASVIAKVQHKNL 147
++GEG +G VYK KK G+ +A+K++ + G +RE+K ++ K++H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60
Query: 148 VRLLGCCIDKDEK--ILIYEYMP--------NKSLDF------FLFDPTKRML--LDW-- 187
VRL K + +++EYM + + F K++L L +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---KQLLEGLQYLH 117
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE----- 241
S R +K SNIL++ D K++DFG+AR T+R++ T Y PE
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGA 176
Query: 242 ----YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ D++S G +L E+ GK
Sbjct: 177 TRYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 29/190 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+GEG FG V +G G ++AVK + + Q E E +V+ K+ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68
Query: 155 IDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWSANYSS-------------RLK 196
+ I++ E M +L FL + LL +S + + L
Sbjct: 69 LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
NIL+ +D K+SDFG+AR+ + + S++ + +PE FS KSDV+S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWS 182
Query: 257 FGVLLLEIVS 266
+GVLL E+ S
Sbjct: 183 YGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 70/284 (24%)
Query: 97 LGEGGFGPVYKGVLK----KGDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G G FG V +G LK + +A+K L G + + R+ +EAS++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL------FDPTKR--MLLDWSA--------NYSSR- 194
G ++I E+M N +LD FL F + ML +A NY R
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRD 131
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG--------YMSPEYAIQG 246
L NIL++ ++ K+SDFG++R L+ +TS T + +PE
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 247 IFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
F+ SDV+S+G+++ E++S G++ WD+ SN+ ++I+ I E +
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPY--------------WDM--SNQ--DVINAI-EQD 227
Query: 306 Y---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
Y ++ H L+ L C Q+ + RP ++VS L
Sbjct: 228 YRLPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 76/263 (28%), Positives = 117/263 (44%), Gaps = 40/263 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
+LG G FG V G + ++A+K + S E EA V+ K+ H+ LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 156 DKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDW------------SANYSSR-LKVS 198
+ ++ EYM N L +L + KR LL+ S + R L
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDVF 255
N L+D K+SDFG++R +E ++ VG+ + PE + FS KSDV+
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315
+FGVL+ E+ S K +S T+ + + L L P L E +
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVS-------QGLRLYRPHLASE--------KV 230
Query: 316 VNIALLCVQESADDRPTMNEVVS 338
I C E A++RPT +++S
Sbjct: 231 YAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 72/277 (25%), Positives = 108/277 (38%), Gaps = 51/277 (18%)
Query: 96 KLGEGGFGPVYKGVLKK--GDEI--AVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
KLG+G FG V +G G I AVK L + + + EA+++ + H+NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWSAN--------YSSR--- 194
G + ++ E P SL L L D++ S R
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAIQGIF 248
L NILL D KI DFG+ R NE ++ + V + + +PE F
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCAPESLRTRTF 177
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW---TSNRTLELIDPILEDE 305
S SDV+ FGV L E+ + Y + W + ++ L+ ID E
Sbjct: 178 SHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQILKKIDKEGERL 220
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ N+ L C + DRPT + L +
Sbjct: 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 30/196 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDE------IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+G FG V V KK + K+ + + E ++++++ H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKL 58
Query: 151 LGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS---------------- 193
+EK+ L+ EY P L F R + + Y++
Sbjct: 59 H-YAFQTEEKLYLVLEYAPGGEL-FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
R LK NILLD D + K++DFG+A+ +E + GT Y++PE + +
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKE-LSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKAV 174
Query: 253 DVFSFGVLLLEIVSGK 268
D +S GVLL E+++GK
Sbjct: 175 DWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 38/212 (17%)
Query: 96 KLGEGGFGPVY----KGVLKKGDE--IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LGEG FG V+ +L + D+ +AVK L S ++ + EA ++ +QH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRML----------------LDWSANY 191
G C + ++++EYM + L+ FL P ++L L ++
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 192 SS-------------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
+S L N L+ + + KI DFGM+R + R + +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191
Query: 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKK 269
PE + F+ +SD++SFGV+L EI + GK+
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 65/224 (29%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMK-----NEASVIAKV-QHKNLVR 149
+GEG F V K+ E A+K L R Q ++E K E V+ ++ H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 150 LLGCCIDKDEKILIYEYMPN----------KSLDFFLFDPTKRMLLDWSANYSSR----- 194
L D++ + EY PN SLD + Y++
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-----------KCTRFYAAEILLAL 115
Query: 195 ------------LKVSNILLDKDINPKISDFGMARICGGNEL------------------ 224
LK NILLDKD++ KI+DFG A++ N
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ + VGT Y+SPE + SD+++ G ++ ++++GK
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 8e-16
Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 45/278 (16%)
Query: 97 LGEGGFG--------PVYKGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNL 147
LGEG FG P G G+ +AVK L GQ K E +++ + H+N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 148 VRLLGCCIDKDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDW----------------SA 189
V+ GCC ++ K LI EY+P SL +L P ++ L S
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 190 NYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
+Y R L N+LLD D KI DFG+A+ + G+E + + E +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PIL 302
FS SDV+SFGV L E+++ + ++G T R +EL++ P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246
Query: 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
++ ++L++ C + A RPT ++ +L
Sbjct: 247 KNCPQEVYILMKN------CWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 53/283 (18%)
Query: 96 KLGEGGFGPVY----KGVLKKGDE--IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LGEG FG V+ + D+ +AVK L + ++ + EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDW-------------------- 187
G C D D I+++EYM + L+ FL P +L+D
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 188 ---------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
S ++ R L N L+ ++ KI DFGM+R + + +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
Query: 238 MSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297
M PE + F+ +SDV+SFGV+L EI + K F +++ + + T R LE
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-----ECITQGRVLER 246
Query: 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
++ Y +I L C Q R + E+ +L
Sbjct: 247 PRVCPKEVY----------DIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 59/275 (21%)
Query: 97 LGEGGFGP--VYKGVLKKGD-------EIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
LG+G FG +Y+ + D E+ + RL S + R+ NE +++ +QH N+
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNI 61
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDW------------S 188
+ +D + ++ EY +L LF+ + M+L +
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHK 119
Query: 189 ANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
A R +K NI L K K+ DFG+++I G A T +VGT YMSPE QG+
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPEL-CQGV 176
Query: 248 -FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306
++ KSD+++ G +L E+++ K+T F T+ L L+ + N T + Y
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRT--FDATNPLNLV---VKIVQGNYTPVV------SVY 225
Query: 307 SSK-HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
SS+ L+ +Q+ + RPT +EV+
Sbjct: 226 SSELISLVHS------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 68/278 (24%), Positives = 111/278 (39%), Gaps = 47/278 (16%)
Query: 97 LGEGGFGPVYKGVLKKGDE------IAVKRLPGRSGQG-LREMKNEASVIAKVQHKNLVR 149
LG G FG V+ K +E + VK L + E + E + K+ HKN+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVS----------- 198
LLG C + + +I EY L FL + S++ KV+
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 199 --------------NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
N L+ K+S +++ +E + ++ +++PE
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQ 191
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+ FS KSDV+SFGVL+ E+ + + + +D L LEL P+ E
Sbjct: 192 EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR------LQAGKLEL--PVPEG 243
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
S + L+ C + DRP+ +E+VS L +
Sbjct: 244 CPSRLYKLM------TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSG-----QGLREMKNEASVIAKVQHKNLV 148
+LG G G V K + + +I AVK + Q LRE+ ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM---LLDWSAN---------YSSR-- 194
G + + + EYM SLD L + R+ +L A +
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYAIQGI 247
+K SNIL++ K+ DFG++ +L A T VGT YM+PE IQG
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKTF--VGTSSYMAPE-RIQGN 174
Query: 248 -FSIKSDVFSFGVLLLEIVSGK 268
+S+KSD++S G+ L+E+ +G+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 54/293 (18%)
Query: 96 KLGEGGFGPVY----KGVLKKGDE-------------IAVKRLPGRSGQGLR-EMKNEAS 137
KLGEG FG V+ +G+ K D+ +AVK L + + R + E
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL------------------FDP 179
++++++ N++RLL CI D +I EYM N L+ FL +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 180 TKRMLLDWSA--------NYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230
M ++ N+ R L N L+ K+ KI+DFGM+R + R
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGR 191
Query: 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYR-TDSLTLLGYAWDLW 289
V +MS E + G F+ SDV++FGV L EI++ K + + +D +
Sbjct: 192 AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR 251
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
R + L P L + K M L C + +A +RP+ E+ + L +
Sbjct: 252 DQGRQVYLPKPALCPDSLYKLM--------LSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 30/202 (14%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKR--LPGRSGQG-------LREMKNEASVIAKVQHKN 146
+G G FG VY G+ G+ +AVK+ LP S L + E +++ ++QH+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPT-----KRMLLDWSANYSSR-- 194
+V+ LG +D D + EY+P S+ L F+ T R +L +R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQA--NTSR--IVGTYGYMSPEYAIQG 246
+K +NIL+D KISDFG+++ N L N +R + G+ +M+PE Q
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187
Query: 247 IFSIKSDVFSFGVLLLEIVSGK 268
++ K+D++S G L++E+++GK
Sbjct: 188 SYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 64/280 (22%)
Query: 97 LGEGGFGPVYKGVLK----KGDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G G FG V G LK + +A+K L G + + R+ +EAS++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL------------------FDPTKRMLLDWSANYSS 193
G +++ EYM N SLD FL + L D Y
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVH 129
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQG 246
R L NIL++ ++ K+SDFG++R+ + A T+R G + +PE
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYR 184
Query: 247 IFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----P 300
F+ SDV+S+G+++ E++S G++ W++ ++ ++ I+ P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPY--------------WEM-SNQDVIKAIEEGYRLP 229
Query: 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
D ++ H L+ L C Q+ ++RP ++VS+L
Sbjct: 230 APMDCPAALHQLM------LDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 39/210 (18%)
Query: 96 KLGEGGFGPVYKGVL-----KKGDEIAVKRLPG-RSGQGLREMKNEASVIAKVQHKNLVR 149
+LGE FG +YKG L +A+K L + Q E + EAS++A++ H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLF--------------DPTKRMLLD--------- 186
LLG + +++EY+ L FL D T + LD
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 187 --------WSANY--SSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
S+++ L NIL+ + ++ KISD G++R + + +
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M PE + G FS SD++SFGV+L EI S
Sbjct: 192 WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 59/223 (26%)
Query: 96 KLGEGGFGPVY----KGVLKKGDEI-------------AVKRL-PGRSGQGLREMKNEAS 137
KLGEG FG V+ G+ ++ AVK L P S + E
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--- 194
+++++ N+ RLLG C +I EYM N L+ FL K + +S+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL---QKHVAETSGLACNSKSLS 128
Query: 195 ---------------------------LKVSNILLDKDINPKISDFGMARICGGNELQAN 227
L N L+ K+ KI+DFGM+R N ++
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184
Query: 228 TSRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
R+ G +M+ E + G F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 19/188 (10%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCCI 155
LG+G FG V+KG LK +AVK Q L+ + +EA ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 156 DKDEKILIYEYMPN----------------KSLDFFLFDPTKRMLLDWSANYSSR-LKVS 198
+ ++ E +P K L F D M S N R L
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFG 258
N L+ ++ KISDFGM+R ++ + + + +PE G +S +SDV+S+G
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESDVWSYG 181
Query: 259 VLLLEIVS 266
+LL E S
Sbjct: 182 ILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-15
Identities = 59/189 (31%), Positives = 97/189 (51%), Gaps = 27/189 (14%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI- 155
+G+G FG V G + G+++AVK + ++ + EASV+ +++H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 156 DKDEKILIYEYMPNKSL-DF----------------FLFDPTKRMLLDWSANYSSR-LKV 197
+K ++ EYM SL D+ F D + M + N+ R L
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
N+L+ +D K+SDFG+ + + +T ++ + +PE + FS KSDV+SF
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSDVWSF 185
Query: 258 GVLLLEIVS 266
G+LL EI S
Sbjct: 186 GILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 9e-15
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 44/204 (21%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRLP------GRSGQGLREMKNEASVIAKVQHKNLV 148
KLGEG +G VYK KK EI A+K++ G LRE+ S++ +++H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNIV 61
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFL------FDPTK-----RMLLD-----WSANYS 192
+LL + + L++EY + L +L P LL S
Sbjct: 62 KLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-------YAI 244
R LK NIL+++D K++DFG+AR G L+ T +V T Y +PE Y
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLGSKHY-- 176
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
S D++S G + E+++GK
Sbjct: 177 ----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 96 KLGEGGFGPVY----KGVLKKGDEI--AVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LGEG FG V+ + + D+I AVK L S ++ EA ++ +QH+++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLF-------------DPTKR-------------- 182
G C++ D I+++EYM + L+ FL P +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 183 -MLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSP 240
M+ S ++ R L N L+ +++ KI DFGM+R + + +M P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVS-GKK 269
E + F+ +SDV+S GV+L EI + GK+
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 68/228 (29%), Positives = 112/228 (49%), Gaps = 53/228 (23%)
Query: 84 VSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLPGRSGQGLRE-MKNEA 136
++ +T +F + +LGE FG VYKG L ++ +A+K L ++ LRE K+EA
Sbjct: 2 INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLF-------------DPTKR 182
+ +++QH N+V LLG + K++ + +I+ Y + L FL D T +
Sbjct: 60 MMRSRLQHPNIVCLLG-VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 183 MLLDWSANY--------------SSR------LKVSNILLDKDINPKISDFGMARICGGN 222
L+ A++ SS L N+L+ +N KISD G+ R
Sbjct: 119 STLE-PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----E 173
Query: 223 ELQANTSRIVGT----YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
A+ +++G +MSPE + G FSI SD++S+GV+L E+ S
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 34/204 (16%)
Query: 95 NKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQG--LREMKNEASVIAKVQHKNLVRLL 151
NK+G G FG VY V L G+ +AVK + + ++E+ +E V+ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL----FDP-------TKRMLLDWSANYSSR-----L 195
G + +++ + EY +L+ L T ++L + +S +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRI-------VGTYGYMSPEYAIQGIF 248
K +NI LD + K+ DFG A L+ NT+ + GT YM+PE G
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 249 SIK---SDVFSFGVLLLEIVSGKK 269
+D++S G ++LE+ +GK+
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 44/215 (20%)
Query: 96 KLGEGGFGPVY----KGVLK-----------KGDEIAVKRL-PGRSGQGLREMKNEASVI 139
KLGEG FG V+ +G+ + + +AVK L + + E ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 140 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP---------------TKRML 184
+++++ N++RLLG C+ D +I EYM N L+ FL + L
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 185 LDWSANYSSRLK-------------VSNILLDKDINPKISDFGMARICGGNELQANTSRI 231
L + +S +K N L+ KI+DFGM+R + R
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
V +M+ E + G F+ SDV++FGV L E+ +
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 26/201 (12%)
Query: 97 LGEGGFGPVYKGV-LKKGDEI----AVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRL 150
LG G FG VYKG+ + +G+ + A+K L +G + E +EA ++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWSANYSS------------- 193
LG C+ + L+ + MP+ L ++ + ++LL+W +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 194 RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
L N+L+ + KI+DFG+AR+ G+E + N +M+ E F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193
Query: 254 VFSFGVLLLEIVS--GKKTTG 272
V+S+GV + E+++ GK G
Sbjct: 194 VWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 5e-14
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 66/293 (22%)
Query: 97 LGEGGFGPVYKGVLK--KG----DEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVR 149
LGEG FG V K KG +AVK L S LR++ +E +++ +V H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL----------------------FDPTKR----- 182
L G C +LI EY SL FL +P +R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 183 MLLDWS------ANYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS 229
L+ ++ Y + +K+ N+L+ + KISDFG++R + S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLTLLGYAWD 287
+ +M+ E I++ +SDV+SFGVLL EIV+ G G ++
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-------LFN 240
Query: 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
L + +E + E+ Y N+ L C ++ D RPT ++ L
Sbjct: 241 LLKTGYRMERPENCSEEMY----------NLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 28/202 (13%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-PGRSGQGLREMKNEASVIAKVQ 143
+F LG G FG VYKG+ + +G+++ A+K L S + +E+ +EA V+A V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSA------NYSS 193
+ ++ RLLG C+ + LI + MP L ++ + + LL+W NY
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 194 R-------LKVSNILLDKDINPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYAI 244
L N+L+ + KI+DFG+A++ G +E A ++ +M+ E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESIL 184
Query: 245 QGIFSIKSDVFSFGVLLLEIVS 266
I++ +SDV+S+GV + E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 38/174 (21%)
Query: 96 KLGEGGFGPVYK-GVLKKGDEIAVKRLPGRSGQG------LREMKNEASVIAKVQHKNLV 148
++GEG G V+K + G+ +A+K++ R +G LRE+K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 149 RLL-----GCCIDKDEKILIYEYMPN------KSLDFFLFDP-TK---RMLLD-WSANYS 192
+LL G +L+ EYMP+ + + L + K RMLL + ++
Sbjct: 63 KLLDVFPHGSGF-----VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 193 SR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
+ LK +N+L+ D KI+DFG+AR+ E + + + V T Y +PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 45/205 (21%)
Query: 97 LGEGGFGPVYKGVL-----KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LG+G FG V G+ +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 152 GCCID--KDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWSANYSSR--------- 194
G C + L+ EY+P SL +L D +++LL Y+S+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLL-----YASQICKGMEYLG 125
Query: 195 --------LKVSNILLDKDINPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPE 241
L NIL++ + KI DFG+ ++ ++ + S I + +PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPE 181
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVS 266
+ FS+ SDV+SFGV+L E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 57/221 (25%)
Query: 97 LGEGGFGPVYK----GVLKKGDE--IAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVR 149
+G+G FG V++ G+L +AVK L S + + EA+++A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------------------------- 182
LLG C L++EYM L+ FL + R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 183 --MLLDWSAN--YSSR-------LKVSNILLDKDINPKISDFGMAR------ICGGNELQ 225
+ +A Y S L N L+ +++ KI+DFG++R +E
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
A R +M PE ++ +SDV+++GV+L EI S
Sbjct: 193 AIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 87 ATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLPGRSGQGLR-EMKNEASVI 139
A K + + +LG+G FG VY+G+ K DE +A+K + + R E NEASV+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 140 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD--------------PTKRML- 184
+ ++VRLLG ++I E M L +L K+M+
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 185 -----------LDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233
L+ + L N ++ +D KI DFGM R + + +
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293
+MSPE G+F+ SDV+SFGV+L EI TL + ++ +
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--------------TLAEQPYQGMSNEQ 229
Query: 294 TLELI--DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
L + +L+ + ML + +C Q + RP+ E++S + +
Sbjct: 230 VLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 56/291 (19%)
Query: 96 KLGEGGFGPVYKGVLK---KGD---EIAVKRLPGRSGQGLRE---MKNEASVIAKVQHKN 146
+LG+G FG VY+G + KG+ +AVK + LRE NEASV+ +
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 70
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWSANYSS 193
+VRLLG +++ E M + L +L PT + ++ +A +
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 194 -------------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSP 240
L N ++ D KI DFGM R + + + +M+P
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300
E G+F+ SD++SFGV+L EI S L + ++ + L+
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS--------------LAEQPYQGLSNEQVLKF--- 233
Query: 301 ILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349
+++ Y + R ++ +C Q + RPT E+V++L D+ FP
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 42/214 (19%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEI--AVKRLPGRSGQG-LREMKNEASVIAKV-QH 144
KF D +GEG FG V + ++KK G ++ A+K L + + R+ E V+ K+ H
Sbjct: 5 KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLL 185
N++ LLG C ++ + EY P +L FL DP T + LL
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 186 DWSANYSS-------------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
++++ ++ L N+L+ +++ KI+DFG++R G E+ +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179
Query: 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+ E +++ KSDV+SFGVLL EIVS
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 38/206 (18%)
Query: 97 LGEGGFGPVYKGVLKKGD----EIAVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LGEG FG V +G L + D ++AVK +L + + E +EA+ + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 151 LGCCIDKDEK------ILIYEYMPNKSLDFFLF------DPTK---RMLLDWSAN----- 190
+G C + ++I +M + L FL P K + LL + +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 191 --YSSR------LKVSNILLDKDINPKISDFGMAR-ICGGNEL-QANTSRIVGTYGYMSP 240
S+R L N +L +D+ ++DFG+++ I G+ Q +++ +++
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWIAI 184
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVS 266
E +++ KSDV++FGV + EI +
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 46/274 (16%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKR--LPGRSGQGLRE--------MKNEASVIAKVQHK 145
+G+G +G VY + + G+ +AVK+ LP +++E + + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 146 NLVRLLGCCIDKDEKILIY-EYMPNKSLDFFL-----FDPT-----KRMLLDWSANYSSR 194
N+V+ LG +E + I+ EY+P S+ L F+ +L+ A S+
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 195 ------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE--YAIQG 246
LK N+L+D D KISDFG+++ + G+ +M+PE ++
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ 187
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306
+S K D++S G ++LE+ +G++ + + L PI D
Sbjct: 188 GYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKRSA----PPIPPDVS 238
Query: 307 SSKHMLLRYVNIALL--CVQESADDRPTMNEVVS 338
M L V + L C + D+RPT E++
Sbjct: 239 ----MNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 42/214 (19%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLPGRSGQG-LREMKNEASVIAKV-QH 144
KF D +GEG FG V K +KK + A+KR+ + + R+ E V+ K+ H
Sbjct: 10 KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLL 185
N++ LLG C + L EY P+ +L FL DP + + LL
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 186 DWSAN------YSSR-------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
++A+ Y S+ L NIL+ ++ KI+DFG++R G E+ +
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 184
Query: 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+ E +++ SDV+S+GVLL EIVS
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 59/227 (25%)
Query: 96 KLGEGGFGPV---------------YKGVLKKGDE--IAVKRL-PGRSGQGLREMKNEAS 137
KLGEG FG V + ++KG +AVK L P + + E
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSAN------- 190
++++++ N++RLLG C+D+D +I EYM N L+ FL + L D N
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 191 --------YSSRLKVS-----------------------NILLDKDINPKISDFGMARIC 219
YSS L V+ N L+ +++ KI+DFGM+R
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+ R V +M+ E + G F+ SDV++FGV L EI+
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 57/212 (26%), Positives = 84/212 (39%), Gaps = 44/212 (20%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKV 142
K + ++LGEG G V K LK I + P Q LRE++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 143 QHKNLVRLLGCCID-KDEKILI-YEYMPNKSLDFFLFDPTKRML---------------- 184
+ +V+ G +D I I EY SLD K++
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKIAE 112
Query: 185 -----LDW--SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
L + S R +K SNILL + K+ DFG++ G + + GT
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
YM+PE +SI SDV+S G+ LLE+ +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 36/206 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGD--EIAVKRLP-GRSGQGLREM-KNEASVIAKVQHKNLVRL 150
+G+G FG V K V +K D + K + G + ++ +E +++ +++H N+VR
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 151 LGCCIDKDEKILIYEYM-----------------PNKSLD-FFLFDPTKRMLL-----DW 187
ID+ + +Y M K ++ F++ ++LL
Sbjct: 65 YDRIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 188 SANYSSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
++ + LK +NI LD + N K+ DFG+A+I G + A T VGT YMSPE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQ 181
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ KSD++S G L+ E+ +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 31/199 (15%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLP-GRSGQGLRE----MKNEASVIAKVQHKNLVRL 150
LG+G FG VY + G E+AVK++P ++ ++ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 151 LGCCIDKDEKILIY-EYMPNKSLDFFL--FDP---------TKRMLLDWSANYSSR---- 194
GC D DE + I+ EYMP S+ L + T+++L +S+
Sbjct: 70 YGCLRD-DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 195 -LKVSNILLDKDINPKISDFGMAR----ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
+K +NIL D N K+ DFG ++ IC + GT +MSPE +
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 250 IKSDVFSFGVLLLEIVSGK 268
K+DV+S G ++E+++ K
Sbjct: 186 RKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 42/211 (19%)
Query: 97 LGEGGFGPVYKGVLKKGDE------IAVKRLPG-RSGQGLREMKNEASVIAKV-QHKNLV 148
LGEG FG V K D +AVK L + + L ++ +E ++ + +HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWSANYSSRLKVS-------- 198
LLG C + ++ EY + +L FL P ++
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRP-PGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 199 -----------------------NILLDKDINPKISDFGMARICGGNELQANTSRIVGTY 235
N+L+ +D KI+DFG+AR + T+
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198
Query: 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++ +SDV+SFGVLL EI +
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 78/274 (28%), Positives = 115/274 (41%), Gaps = 61/274 (22%)
Query: 29 ARRKPRSRGEDLMTLDL---DLNLKANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVS 85
RR+P DL TL L D +L V + LP S + S + S
Sbjct: 24 PRRRP-----DL-TLPLPQRDPSLA---VPLPLPPPSSSSSSSSSSS-------ASGSAP 67
Query: 86 TATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLR-EMKNEASVIA 140
+A S+ N++G G G VYK + + G A+K + G +R ++ E ++
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFDPTKRMLLDWSANYSS 193
V H N+V+ E ++ E+M SL+ FL D R +L A
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-VARQILSGIAYLHR 186
Query: 194 R------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------ 241
R +K SN+L++ N KI+DFG++RI N+S VGT YMSPE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDL 244
Query: 242 -------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
YA D++S GV +LE G+
Sbjct: 245 NHGAYDGYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 26/200 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGL------REMKNEASVIAKVQHKNLV 148
LG+G +G VY G+ +G IAVK++ + L +++ E ++ ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFL--FDP---------TKRML-----LDWSANYS 192
+ LG C+D + + E++P S+ L F P TK++L L +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 193 SRLKVSNILLDKDINPKISDFGMA-RIC--GGNELQANTSRIV-GTYGYMSPEYAIQGIF 248
+K +N++L + K+ DFG A R+ G + +N + + GT +M+PE + +
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185
Query: 249 SIKSDVFSFGVLLLEIVSGK 268
KSD++S G + E+ +GK
Sbjct: 186 GRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 27/196 (13%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
LG+G +G VY L IA+K +P R + ++ + E ++ + ++H+N+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 156 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA-NYSSR-----LKV--SNILLDKDIN 207
+ + E +P SL L + + + ++ LK N ++ +DI
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 208 P------------KISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQGI--FSIKS 252
KISDFG + R+ G N T GT YM+PE +G + +
Sbjct: 136 GDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYGAPA 192
Query: 253 DVFSFGVLLLEIVSGK 268
D++S G ++E+ +GK
Sbjct: 193 DIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 40/207 (19%)
Query: 97 LGEGGFGPVYKGVLKKGD---EIAVKRLPGRSGQG-LREMKNEASVIAKV-QHKNLVRLL 151
+GEG FG V K +KK + A+KR+ + + R+ E V+ K+ H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLLDWSANYS 192
G C + L EY P+ +L FL DP + + LL ++A+ +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 193 S-------------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMS 239
L NIL+ ++ KI+DFG++R G E+ + +M+
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 179
Query: 240 PEYAIQGIFSIKSDVFSFGVLLLEIVS 266
E +++ SDV+S+GVLL EIVS
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 40/266 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 154
+LG G FG V+ G + ++A+K + G E EA V+ K+ H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDW------------SANYSSR-LKV 197
+ ++ E+M N L +L +K MLL ++ R L
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
N L+ K+SDFGM R +E ++S + PE +S KSDV+SF
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187
Query: 258 GVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE-DEYSSKHMLLRYV 316
GVL+ E+ + K + E+++ I + V
Sbjct: 188 GVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRLYRPKLASMTV 230
Query: 317 -NIALLCVQESADDRPTMNEVVSMLT 341
+ C E + RPT E++ +T
Sbjct: 231 YEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 31/197 (15%)
Query: 97 LGEGGFGPVY------KGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+GGFG V G + ++ KRL R G+ + NE ++ KV + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM--ALNEKKILEKVSSRFIVSL 58
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWSANYSS----------- 193
KD+ L+ M L + +++ P R + ++A
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF-YAAQIICGLEHLHQRRIV 117
Query: 194 --RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK N+LLD N +ISD G+A + R GT GYM+PE ++
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYDFS 174
Query: 252 SDVFSFGVLLLEIVSGK 268
D F+ G L E+++G+
Sbjct: 175 VDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 28/197 (14%)
Query: 97 LGEGGFGPVY------KGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
LGEG FG V +G G+++AVK L P G + ++K E ++ + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 150 LLGCCI-DKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYS-----------SR-- 194
G C D I LI E++P+ SL +L ++ L Y+ SR
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130
Query: 195 ----LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
L N+L++ + KI DFG+ + I E + + +PE IQ F
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190
Query: 250 IKSDVFSFGVLLLEIVS 266
I SDV+SFGV L E+++
Sbjct: 191 IASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 50/195 (25%), Positives = 97/195 (49%), Gaps = 19/195 (9%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-LREMKNEASVIAKVQHKNLV 148
F+ ++G+G FG VYKG+ + E+ A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 149 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPT---------KRMLLDWSANYSSR---- 194
R G + + +I EY+ S LD P + +L +S R
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K +N+LL + + K++DFG+A +++ NT VGT +M+PE Q + K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDFKAD 183
Query: 254 VFSFGVLLLEIVSGK 268
++S G+ +E+ G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 97 LGEGGFGPVYKGV-LKKGDEI----AVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRL 150
LG G FG V+KG+ + +GD I A+K + RSG Q +E+ + + + H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWSANYSS----------- 193
LG C + L+ + P SL + DP + LL+W +
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHRMV 131
Query: 194 --RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
L NILL D +I+DFG+A + ++ + S +M+ E + G ++ +
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 252 SDVFSFGVLLLEIVS 266
SDV+S+GV + E++S
Sbjct: 192 SDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 30/197 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSGQGLREMKNEASVIAKVQHKNLV 148
K+GEG +G VYK K EI A+K++ G LRE+K ++ ++ H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 149 RLLGCCIDKDEKILIYEYM---------------PNKSLDFFLFDPTKRMLLDWSANYSS 193
+LL K + L++E+M P + +L+ + + S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIK 251
R LK N+L++ + K++DFG+AR G + V T Y +PE + +S
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 252 SDVFSFGVLLLEIVSGK 268
D++S G + E++S +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 43/200 (21%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMK------NEASVIAKVQHKNLVR 149
LG G FG V K + A+K L S + ++K NE ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKIL---SKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
L G D L+ EY+P L F + R + Y+++
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVY 124
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK- 251
LK N+LLD D KI+DFG A+ ++ T + GT Y++PE I K
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-----IILSKG 174
Query: 252 ----SDVFSFGVLLLEIVSG 267
D ++ G+L+ E+++G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 29/201 (14%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGL---REMKNEASVIAKVQH 144
F ++G+GG+G V+ K EI A+KR+ L R + E ++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSAN-------------- 190
+ LV+LL D + L EY+P DF +L + A
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 191 ---YSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
Y R LK N L+D + K++DFG+++ G AN+ +VG+ YM+PE
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPEVLRGK 173
Query: 247 IFSIKSDVFSFGVLLLEIVSG 267
+ D +S G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMK-NE 135
L + SV K++ K+G+G G VY + + G E+A+K++ Q +E+ NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 136 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL---------DFFLFDPTKRMLLD 186
V+ + +H N+V L + DE ++ EY+ SL D R L
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 187 WSANYSSR------LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMS 239
S +K NILL D + K++DFG A+I Q+ S +VGT +M+
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMA 183
Query: 240 PEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
PE + + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 26/198 (13%)
Query: 96 KLGEGGFGPVYKGVLK---KGDEIAVKRLPGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 151
+LG G FG V KGV K K ++A+K L + + +R EM EA ++ ++ + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWSA---------NYSSR- 194
G C + + +L+ E L+ FL L+ + N+ R
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYAIQGIFSIKS 252
L N+LL KISDFG+++ G ++ +R G + + +PE FS +S
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRKFSSRS 179
Query: 253 DVFSFGVLLLEIVS-GKK 269
DV+S+G+ + E S G+K
Sbjct: 180 DVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEA 136
L S SV K++ K+G+G G VY + + G E+A+K++ + + NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----------KRMLLD 186
V+ + ++ N+V L + DE ++ EY+ SL + + + L
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 127
Query: 187 WSANYSSR-----LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSP 240
+S++ +K NILL D + K++DFG A+I Q+ S +VGT +M+P
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 184
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
E + + K D++S G++ +E+V G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 100 GGFGPVYKGVLKK--GDEIAVKRLPGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCC 154
G +G V+ KK GD A+K + + ++ E ++++ Q +V+L
Sbjct: 4 GAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------LKV 197
K L+ EY+P L L + + D + Y + LK
Sbjct: 63 QGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 198 SNILLDKDINPKISDFG------MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
NIL+D + + K++DFG + R N+ + RIVGT Y++PE + S
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 252 SDVFSFGVLLLEIVSG 267
D +S G +L E + G
Sbjct: 182 VDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 40/204 (19%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKRL---PGRSG---QGLREMKNEASVIAKVQHKNL 147
N++ EG +G VY+ KK EI A+K+L + G LRE+ +++ K+QH N+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66
Query: 148 VRL----LGCCIDK----------DEKILIYEYMPN-------KSLDFFLFDPTKRMLLD 186
V + +G +DK D K L+ E M K L L + +
Sbjct: 67 VTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 187 WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI- 244
W R LK SN+LL+ KI DFG+AR G L+ T +V T Y +PE +
Sbjct: 126 W---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVV-TLWYRAPELLLG 180
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
+S D++S G + E+++ K
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 39/200 (19%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRS--GQGLREM-KNEASVIAKVQHKNLVRLLG 152
LG GGFG V +K + A+K + R G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 153 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------------- 194
KD+K + + EY L L D R L D Y++R
Sbjct: 60 -RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFD---EYTARFYIACVVLAFEYLHNR 112
Query: 195 ------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
LK N+LLD + K+ DFG A+ + T GT Y++PE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 249 SIKSDVFSFGVLLLEIVSGK 268
D +S G+LL E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 30/198 (15%)
Query: 97 LGEGGFGPVYKGV---LKKGD---EIAVKRLPGRSGQGLRE-MKNEASVIAKV-QHKNLV 148
LG G FG V + L K D ++AVK L + RE + +E +++ + H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW-----------------SANY 191
LLG C ++I EY L FL + L S N
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 192 SSR-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
R L N+LL KI DFG+AR + N + +R+ +M+PE ++
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFNCVY 220
Query: 249 SIKSDVFSFGVLLLEIVS 266
+ +SDV+S+G+LL EI S
Sbjct: 221 TFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 37/199 (18%)
Query: 96 KLGEGGFGPVYKGVLKKGD---------EIAVKRL-PGRSGQGLREMKNEASVIAKVQHK 145
+LG+G FG VY KK EI V L P + Q EA +++K+ H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLSKLDHP 62
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------RMLLDW------SANYS 192
+V+ +++D +I EY + LD L + + +W +Y
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 193 SR-------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+ LK NI L ++ KI DFG++R+ G+ A T GT YMSPE
Sbjct: 123 HQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKH 179
Query: 246 GIFSIKSDVFSFGVLLLEI 264
+ KSD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 24/193 (12%)
Query: 97 LGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSANYSS------------- 193
LG C+ + L+ + MP L ++ + R+ LL+W +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR 133
Query: 194 RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
L N+L+ + KI+DFG+AR+ +E + + +M+ E + F+ +SD
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193
Query: 254 VFSFGVLLLEIVS 266
V+S+GV + E+++
Sbjct: 194 VWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEA 136
L S SV K++ K+G+G G VY + + G E+A++++ + + NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT----------KRMLLD 186
V+ + ++ N+V L + DE ++ EY+ SL + + + L
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 187 WSANYSSR-----LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSP 240
+S++ +K NILL D + K++DFG A+I Q+ S +VGT +M+P
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAP 185
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
E + + K D++S G++ +E++ G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 45/207 (21%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRL-PGRSGQG--------LREMKNEASVIAKVQH 144
KLGEG + VYK K+ G +A+K++ G + LRE+K ++ +++H
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61
Query: 145 KNLVRLLGCCIDKDEKILIYEYMP--------NKSLDFFLFDPTKRML-----LDWSANY 191
N++ LL K L++E+M +KS+ D ML L++ +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 192 S--SR-LKVSNILLDKDINPKISDFGMARICG--GNELQANTSRIVGTYGYMSPEYAIQG 246
R LK +N+L+ D K++DFG+AR G ++ T ++V T Y +PE
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV-TRWYRAPEL---- 173
Query: 247 IFSIKS-----DVFSFGVLLLEIVSGK 268
+F + D++S G + E++
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 37/209 (17%)
Query: 97 LGEGGFGPVYKGVLKKGDEI---AVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LGEG FG V +G L + D I AVK ++ + + + +EA + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 152 GCCIDKDEK--------------------ILIYE-------YMPNKSLDFFLFDPTKRML 184
G C+ E L+Y Y+P + L F+ D M
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 185 LDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNEL-QANTSRIVGTYGYMSPE 241
S ++ R L N +L++++N ++DFG+++ I G+ Q +++ +++ E
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWIAIE 184
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270
+++ KSDV+SFGV + EI + +T
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQT 213
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGD--EIAVKRLP--GRSGQGLREMKNEASVIAKVQHK 145
K+ +G G FG V+ +K D + +K++P + +NE V+ + H
Sbjct: 1 KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-----LDW------------S 188
N++ ++ +++ EY P +L ++ +L L + +
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 189 ANYSSR-LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
R LK NILLDK KI DFG+++I ++ +VGT Y+SPE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGK 176
Query: 247 IFSIKSDVFSFGVLLLEIVSGKK 269
++ KSD+++ G +L E+ S K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------PGRSGQGLREMKNEAS 137
+KF ++GEG +G VYK K G+ +A+K++ G +RE+K
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKI----------LIYEYMPNK---SLDFFLFDPTK--- 181
++ ++ H+N+V L DK + + L++EYM + L+ L ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 182 ----RMLLDWSA-----NYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231
+ LL+ N+ R +K SNILL+ K++DFG+AR+ E + T+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 232 VGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIVSGK 268
+ T Y PE + + + DV+S G +L E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 66/267 (24%), Positives = 119/267 (44%), Gaps = 48/267 (17%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLP---GRSGQGLREMKNEASVIAKVQHKN 146
FSD ++G G FG VY + E +A+K++ +S + +++ E + K++H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW-----------------SA 189
++ GC + + L+ EY + D L + K+ L + S
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 190 NYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---Q 245
N R +K NILL + K+ DFG A I A + VGT +M+PE + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 188
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
G + K DV+S G+ +E+ ++ + ++++ L + N + P L+
Sbjct: 189 GQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PALQSG 237
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPT 332
+ S++ + N C+Q+ DRPT
Sbjct: 238 HWSEY----FRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------PGRSGQGLREMKNEASVIAKV 142
++ K+GEG +G VYKG KK G +A+K++ G +RE+ S++ ++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56
Query: 143 QHKNLVRLLGCCIDKDEKILIYE-----------------YMPNKSLDFFLFDPTKRMLL 185
QH N+V L + + LI+E YM + + +L+ + +L
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 186 DWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
S R LK N+L+D K++DFG+AR G ++ T +V T Y +PE +
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 245 QGI-FSIKSDVFSFGVLLLEIVSGK 268
+S D++S G + E+ + K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 47/195 (24%), Positives = 97/195 (49%), Gaps = 19/195 (9%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-LREMKNEASVIAKVQHKNLV 148
F+ ++G+G FG V+KG+ + ++ A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 149 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDP---------TKRMLLDWSANYSSR---- 194
+ G + + +I EY+ S LD P K +L +S +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K +N+LL + + K++DFG+A +++ NT VGT +M+PE Q + K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKAD 183
Query: 254 VFSFGVLLLEIVSGK 268
++S G+ +E+ G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 47/203 (23%), Positives = 95/203 (46%), Gaps = 36/203 (17%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKVQHKNLVR 149
LG G F Y+ +K G +AVK++ + + ++ E ++A++ H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL--FDP---------TKRMLLDWSANYSSR---- 194
+LG + L E+M S+ L + T+++L S + ++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 195 -LKVSNILLD---KDINPKISDFGMA-----RICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+K +N+L+D + + +I+DFG A + G E Q +++GT +M+PE
Sbjct: 128 DVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMAPEVLRG 182
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
+ DV+S G +++E+ + K
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 27/192 (14%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
LG+G FG VYK K+ A K + S + L + E ++++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 156 DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------LKV 197
+++ ++ E+ +LD + +R L + Y R LK
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS-----IKS 252
NILL D + K++DFG++ + LQ + +GT +M+PE F K+
Sbjct: 132 GNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 253 DVFSFGVLLLEI 264
D++S G+ L+E+
Sbjct: 190 DIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 33/204 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG-LREMKNEASVIAKVQHKN 146
F+ +G+G FG VYK + K+ +A+K + + + +++ E +++ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA------------NY--S 192
+ + G + + +I EY S D K LD + Y
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116
Query: 193 SR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAI 244
+K +NILL ++ + K++DFG++ +L + S+ VGT +M+PE
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
Q + K+D++S G+ +E+ G+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEA 136
L + S+ K++ K+G+G G V+ + + G E+A+K++ + + NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWS-------- 188
V+ ++++ N+V L + DE ++ EY+ SL D +D +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 189 ---------AN--YSSRLKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYG 236
AN +K N+LL D + K++DFG A+I Q+ S +VGT
Sbjct: 124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPY 180
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+M+PE + + K D++S G++ +E+V G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 48/272 (17%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLP---GRSGQGLREMKNEASVIAKVQHKN 146
F+D ++G G FG VY + +E+ A+K++ +S + +++ E + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD-----------------WSA 189
+ GC + + L+ EY + D L + K+ L + S
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 190 NYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---Q 245
N R +K NILL + K++DFG A I AN+ VGT +M+PE + +
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVILAMDE 198
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
G + K DV+S G+ +E+ K + ++++ L + N + P L+
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHI----AQNES-----PTLQSN 247
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVV 337
S + + N C+Q+ DRPT E++
Sbjct: 248 EWSDY----FRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 67/287 (23%)
Query: 93 DANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKN---EASVIAKVQH-KNL 147
D ++G G FG V K + K G +AVKR+ RS +E K + V+ + +
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFF---LFDPTKRML----LDWSA-------NYSS 193
V+ G + + + E M + SLD F +++ K ++ L A NY
Sbjct: 66 VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 194 R--------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 241
+K SNILLD++ N K+ DFG I G +R G YM+PE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS--NRTLELID 299
A G + ++SDV+S G+ L E+ +GK + + W S ++ +++
Sbjct: 182 SARDG-YDVRSDVWSLGITLYEVATGK---------------FPYPKWNSVFDQLTQVVK 225
Query: 300 ---PIL----EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339
PIL E E+S + ++N LC+ + RP E++
Sbjct: 226 GDPPILSNSEEREFSPS--FVNFIN---LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 25/197 (12%)
Query: 96 KLGEGGFGPVYKGV--LKKGDEI--AVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRL 150
+GEG FG VY+GV + ++I AVK + +RE EA ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 151 LGCCIDKDEKILI---------------YEYMPNKSLDFFLFDPTKRMLLDWSANYSSR- 194
+G + I++ + SL + + + + S + R
Sbjct: 73 IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRD 132
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+ N+L+ K+ DFG++R +A+ ++ +M+PE F+ SD
Sbjct: 133 IAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFTSASD 190
Query: 254 VFSFGVLLLEIVS-GKK 269
V+ FGV + EI+ G K
Sbjct: 191 VWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 28/200 (14%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+ K+GEG G V K G ++AVK++ R Q + NE ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
+ + DE ++ E++ +L + RM + A
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLHAQGVI 137
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIQGIF 248
+K +ILL D K+SDFG C ++ R +VGT +M+PE + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGF---CA--QVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 249 SIKSDVFSFGVLLLEIVSGK 268
+ D++S G++++E+V G+
Sbjct: 193 GTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 31/199 (15%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
++G G +G VYK E+ A+K + G ++ E S++ + +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------L 195
+ +D+ ++ EY SL ++ T+ L + Y R +
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYA---IQGIFS 249
K +NILL +D + K++DFG++ +L A ++ +GT +M+PE A +G +
Sbjct: 128 KGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182
Query: 250 IKSDVFSFGVLLLEIVSGK 268
K D+++ G+ +E+ +
Sbjct: 183 GKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSGQGLREMKNEASVIAKVQHKNLV 148
K+GEG +G VYK K EI A+K++ G +RE+ S++ ++ H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61
Query: 149 RLLGCCIDKDEKILIYEYM-----------PNKSLDFFLFDPTKRMLLDWSANYSSR--- 194
RLL +++ L++E++ P LD L LL A S
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSI 250
LK N+L+D++ K++DFG+AR G ++ T +V T Y +PE + +S
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 251 KSDVFSFGVLLLEIVSGK 268
D++S G + E+V+ +
Sbjct: 180 PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 35/199 (17%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
LG+G FG V LK DE+ AVK L + L++ E V+A +H L +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWSANYSS----------- 193
L C KD + EY+ L F + FD + ++A
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF--YAAEIVLGLQFLHERGII 118
Query: 194 --RLKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
LK+ N+LLD + + KI+DFGM + I GG TS GT Y++PE +
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSYQPYG 174
Query: 250 IKSDVFSFGVLLLEIVSGK 268
D ++ GVLL E+++G+
Sbjct: 175 PAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 91 FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH 144
F LG+GGFG V G + ++ KR+ R G+ + NE ++ KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWSAN-------- 190
+ +V L KD L+ M L F ++ R + ++A
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDL 118
Query: 191 YSSR-----LKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAI 244
+ R LK NILLD + +ISD G+A + G ++ VGT GYM+PE
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVK 174
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
++ D ++ G LL E+++G+
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 31/203 (15%)
Query: 91 FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH 144
F LG+GGFG V G + + KR+ R G+ + NE ++ KV
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNS 59
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRML------------LD 186
+ +V L KD L+ M L F +++ +R L L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 187 WSANYSSRLKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQ 245
LK NILLD + +ISD G+A +I G ++ VGT GYM+PE
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNN 175
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
+++ D + G L+ E++ G+
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 31/197 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAKV------QHKNLVR 149
LG+G FG V+ LK ++ A+K L + L + E +++ K +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
L K+ + EY+ L F + + L + Y++
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK+ NILLD D + KI+DFGM C N L A T GT Y++PE + ++
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 252 SDVFSFGVLLLEIVSGK 268
D +SFGVLL E++ G+
Sbjct: 177 VDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 19/190 (10%)
Query: 96 KLGEGGFGPVYKGVLKKGDE-IAVKRLPGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGC 153
++G G FG V+ G L+ + +AVK L+ + EA ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSANYSS-------------RLK 196
C K ++ E + FL R+ L+ N ++ L
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
N L+ + KISDFGM+R + + +PE G +S +SDV+S
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWS 181
Query: 257 FGVLLLEIVS 266
FG+LL E S
Sbjct: 182 FGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 43/275 (15%)
Query: 91 FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLP---GRSGQGLREMKNEASVIAKVQHKN 146
F K+G G F VY+ L G +A+K++ + + E ++ ++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WS--ANYSSRLKV-- 197
+++ I+ +E ++ E L + F KR++ + W S L+
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 198 SNILLDKDINP-----------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
S ++ +DI P K+ D G+ R A++ +VGT YMSPE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID--PILED 304
++ KSD++S G LL E+ + + + FY G +L++ + +E D P+ D
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSLCKKIEQCDYPPLPSD 231
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339
YS + L + VN +C+ + RP + V +
Sbjct: 232 HYSEE--LRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 79/290 (27%), Positives = 122/290 (42%), Gaps = 65/290 (22%)
Query: 97 LGEGGFGPVYK----GVLKKGDE----IAVKRLPGR-SGQGLREMKNEASVIAKV-QHKN 146
LGEG FG V + G+ K + +AVK L + + L ++ +E ++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWSANYSS 193
++ LLG C + +I EY +L FL FD TK L + S
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 194 RLKVS-------------------NILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
+V+ N+L+ +D KI+DFG+AR + TS
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLTLL--GYAWDLWT 290
+M+PE +++ +SDV+SFG+L+ EI + G G + LL G+ D
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDK-P 258
Query: 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
SN T EL +ML+R C RPT ++V L
Sbjct: 259 SNCTHEL------------YMLMRE------CWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 47/206 (22%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMK-------------NEASVIAKV 142
KLG+G +G VYK VKRL L+E+ NE ++A V
Sbjct: 7 KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDW 187
H N++ +D ++ ++ EY P L + K ++L
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 188 SANYSSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
A + + LK +NILL + KI D G++++ N A T +GT YM+PE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTPHYMAPEV 172
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSGK 268
+S KSD++S G LL E+ +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 33/201 (16%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRL-----PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+G FG VY + G E+A K++ + + + ++ E ++ +QH+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 151 LGCCIDKDEKIL--IYEYMPNKSL-----------DFFLFDPTKRMLLDWSANYSSR--- 194
GC D+ EK L EYMP S+ + T+++L S +S+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 195 --LKVSNILLDKDINPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIQGI 247
+K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----VTGTPYWMSPEVISGEG 185
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
+ K+DV+S G ++E+++ K
Sbjct: 186 YGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 33/204 (16%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-----LREMKNEASVIAKVQH 144
F KLGEG + VYKG + EI A+K + + +G +RE+ S++ +++H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPN---KSLDFF----LFDP------TKRMLLDWSANY 191
+N+VRL +++ +L++EYM K +D DP T ++L + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 192 SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQ 245
+R LK N+L++K K++DFG+AR G + NT S V T Y +P+ +
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLLG 174
Query: 246 G-IFSIKSDVFSFGVLLLEIVSGK 268
+S D++S G ++ E+++G+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 41/188 (21%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKR-LPGRSGQG-----LREMKNEASVIAK 141
+K+ K+G+G FG V+K KK +I A+K+ L +G LRE+K ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67
Query: 142 VQHKNLVRLLGCCIDKDEK--------ILIYEY--------MPNKSLDFFLFDPTK--RM 183
++H+N+V L+ C K L++E+ + NK++ F L + K +M
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 184 LLDWSANYSSR-------LKVSNILLDKDINPKISDFGMARICGGNELQAN---TSRIVG 233
LL+ Y R +K +NIL+ KD K++DFG+AR ++ T+R+V
Sbjct: 128 LLN-GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 234 TYGYMSPE 241
T Y PE
Sbjct: 186 TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 35/197 (17%)
Query: 97 LGEGGFGPVYKGVLKKGDE-IAVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
+G G FG V+ + + A+K + L++ + NE V+ +V H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 153 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWSAN-YSSR--------------- 194
+ D++ L + EY+P L F + + + Y+S
Sbjct: 68 -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVY 124
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
LK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE IQ K+
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE-VIQSKGHNKA 178
Query: 253 -DVFSFGVLLLEIVSGK 268
D ++ G+L+ E++ G
Sbjct: 179 VDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K SNIL++ K+ DFG++ G + + VGT YMSPE G +++KSDV
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314
+S G+ ++E+ GK F D L + ++ P L + +
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL-RD 244
Query: 315 YVNIALLCVQESADDRPTMNEVVSM 339
+V+ C+ + +RPT ++ +M
Sbjct: 245 FVDA---CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 47/195 (24%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-LREMKNEASVIAKVQHKNLV 148
F+ K+G+G FG V+KG+ + ++ A+K + + + +++ E +V+++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 149 RLLGCCIDKDEKILIYEYMPNKS-LDFFLFDPT---------KRMLLDWSANYSSR---- 194
+ G + + +I EY+ S LD P + +L +S +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 125
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K +N+LL + K++DFG+A +++ NT VGT +M+PE Q + K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKAD 183
Query: 254 VFSFGVLLLEIVSGK 268
++S G+ +E+ G+
Sbjct: 184 IWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 34/199 (17%)
Query: 96 KLGEGGFGPVYKGV-LKKGDE-IAVKRL---PGRSGQGLREMKNEASV--IAKVQHKNLV 148
++GEG +G V+K LK G +A+KR+ G G L ++ A + + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 149 RLLGCCI----DKDEKI-LIYEYMPNKSLDFFLF---DP------TKRMLLDWSAN---- 190
RL C D++ K+ L++E++ ++ L +L +P K M+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 191 YSSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+S R LK NIL+ K++DFG+ARI Q + +V T Y +PE +Q
Sbjct: 127 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 246 GIFSIKSDVFSFGVLLLEI 264
++ D++S G + E+
Sbjct: 184 SSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 58/207 (28%), Positives = 106/207 (51%), Gaps = 34/207 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL------PGRSGQGLREMKNEASVIAK 141
+++ K+GEG +G VYK + +E IA+K++ G +RE+ S++ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKE 57
Query: 142 VQHKNLVRLLGCCIDKDEKI-LIYEYMP---NKSLDF---FLFDPT------KRMLLDWS 188
+QH N+VRL + ++++ L++EY+ K +D F +P ++L +
Sbjct: 58 MQHGNIVRLQD-VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 189 ANYSSR-----LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
+S R LK N+L+D+ N K++DFG+AR G ++ T +V T Y +PE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAPEI 174
Query: 243 AIQG-IFSIKSDVFSFGVLLLEIVSGK 268
+ +S D++S G + E+V+ K
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 71/267 (26%), Positives = 112/267 (41%), Gaps = 40/267 (14%)
Query: 97 LGEGGFGPVYKGVLKKGDEI----AVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLL 151
+G+G FG VY G L D AVK L + + + + E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 152 GCCIDKD-EKILIYEYMPNKSLDFFLFDPT----------------KRMLLDWSANYSSR 194
G C+ + +++ YM + L F+ T K M S + R
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYAIQGIFSIK 251
L N +LD+ K++DFG+AR E + N + +M+ E F+ K
Sbjct: 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTK 182
Query: 252 SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311
SDV+SFGVLL E+++ + + DS + Y R L L+ EY +
Sbjct: 183 SDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQ----GRRL------LQPEYCPDPL 231
Query: 312 LLRYVNIALLCVQESADDRPTMNEVVS 338
+ L C + RPT +E+VS
Sbjct: 232 Y----EVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG+G FG VYK K+ G A K + +S + L + E ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 155 IDKDEKILIYEYMPNKSLDFFLFD-------PT-----KRMLLDWSANYSSR-----LKV 197
+ ++ E+ P ++D + + P ++ML +S + LK
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIKS 252
N+LL D + K++DFG++ LQ S +GT +M+PE + + K+
Sbjct: 139 GNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTPYDYKA 196
Query: 253 DVFSFGVLLLEI 264
D++S G+ L+E+
Sbjct: 197 DIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 97 LGEGGFGPV------YKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+GGFG V G + ++ KR+ R G+ + NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNSRFVVSL 65
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWSAN--------YSSR-- 194
KD L+ M L F +++ +R + ++A + R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-YAAEITCGLEDLHRERIV 124
Query: 195 ---LKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
LK NILLD + +ISD G+A I G ++ VGT GYM+PE ++
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNERYTF 180
Query: 251 KSDVFSFGVLLLEIVSGK 268
D + G L+ E++ GK
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 30/200 (15%)
Query: 96 KLGEGGFGPVYKGVL--KKGDE-IAVKRLPGRSG-QGLR-EMKNEASVIAKVQHKNLVRL 150
+LG G FG V KG+ KK ++ +AVK L + L+ E+ EA+V+ ++ + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 151 LGCCIDKDEKILIYE---------------YMPNKSLDFFLFDPTKRMLLDWSANYSSR- 194
+G C + + +L+ E ++ K++ + + M N+ R
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNE--LQANTSRIVGTY--GYMSPEYAIQGIFSI 250
L N+LL KISDFG+++ G +E +A T G + + +PE FS
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH---GKWPVKWYAPECMNYYKFSS 177
Query: 251 KSDVFSFGVLLLEIVS-GKK 269
KSDV+SFGVL+ E S G+K
Sbjct: 178 KSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 20/135 (14%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSD 253
LK +NILLD+ + +ISD G+A C ++ + + S VGT+GYM+PE +G+ + +D
Sbjct: 123 LKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSAD 178
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS----- 308
FS G +L +++ G ++T D +R + L D +S
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLTMAVELPDSFSPELRSL 229
Query: 309 -KHMLLRYVNIALLC 322
+ +L R VN L C
Sbjct: 230 LEGLLQRDVNRRLGC 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 62/288 (21%)
Query: 99 EGGFGPVYKGVLKKGD-----EIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
EG FG ++ G+L E+ VK + S + + E+ ++ + H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 153 CCI-DKDEKILIYEYMPNKSLDFFLFDP-----------TKRMLLDWSAN------YSSR 194
CI D + ++Y YM +L FL + + L+ + Y +
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 195 LKV-------SNILLDKDINPKISDFGMARI-------CGGNELQANTSRIVGTYGYMSP 240
V N ++D+++ KI+D ++R C G+ N +R V +M+
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRPVK---WMAL 188
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300
E + +S SDV+SFGVLL E+++ +T + D + Y D + L P
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTP-YVEIDPFEMAAYLKDGY------RLAQP 241
Query: 301 I-LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347
I DE + C ++RP+ +++V LTD A L
Sbjct: 242 INCPDE---------LFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 49/199 (24%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 95 NKLGEGGFGPVYKGV-LKKGDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+G G VY + L +++A+KR+ + + E++ E +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 153 CCIDKDEKILIYEYM-------------PNKSLDFFLFDPTKRMLLDWSANYSSR----- 194
+ DE L+ Y+ P LD + + +L Y
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK-GLEYLHSNGQIH 125
Query: 195 --LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSR-IVGTYGYMSPEYAIQGI-FS 249
+K NILL +D + KI+DFG+ A + G + + VGT +M+PE Q +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 250 IKSDVFSFGVLLLEIVSGK 268
K+D++SFG+ +E+ +G
Sbjct: 186 FKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAK------VQHKNLVR 149
LG+G FG V LK+ + AVK L + L++ E ++ K H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKR-----------MLLDWSANYSS 193
L C D + E++ L F + FD + M L
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 194 RLKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK+ N+LLD + + K++DFGM + I G TS GT Y++PE + ++
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 252 SDVFSFGVLLLEIVSG 267
D ++ GVLL E++ G
Sbjct: 177 VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 81 FSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL------PGRSGQGLREMK 133
F +V TN++ D +G G FG V G +A+K++ P + + RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 134 NEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYM-------------PNKSLDFFLFDP 179
++ ++H+N++ L I E I + E + + + +FL+
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 180 TKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
+ + SA R LK SNIL++++ + KI DFG+ARI + V T Y
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172
Query: 239 SPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGK 268
+PE + + ++ D++S G + E++ GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 31/74 (41%), Positives = 46/74 (62%), Gaps = 2/74 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK+ N+LLDKD + KI+DFGM + E +A+T GT Y++PE ++ D
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQKYNESVDW 179
Query: 255 FSFGVLLLEIVSGK 268
+SFGVLL E++ G+
Sbjct: 180 WSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 57/280 (20%)
Query: 93 DANKLGEGGFGPVYKGVLKKGD-EIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+ N + G G YKG K + VK + + E + + K+QH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPSS--EIADMGKLQHPNIVKLI 749
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWS-----------------ANYSSR 194
G C + LI+EY+ K+L L + L W S
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 195 LKVSN-----ILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
+ V N I++D P + L ++ + Y++PE +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856
Query: 250 IKSDVFSFGVLLLEIVSGKKTTG--FYRTDSLTLLG-YAW-----DLWTSNRTLELIDPI 301
KSD++ FG++L+E+++GK F S+ Y + D+W IDP
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW--------IDPS 908
Query: 302 LEDEYSS-KHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ + S ++ ++ +N+AL C RP N+V+ L
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 44/186 (23%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKVQHKNLV 148
KLGEG FG VYK +K G +A+K++ G LRE+K ++ K++H N+V
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----ILKKLKHPNVV 70
Query: 149 RLLGCCIDKDEKIL-----IYEYMPNKSLDF--FLFDPTKRM-----------LLD---- 186
L+ +++ +K +Y P D L +P+ ++ LL+
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 187 -WSANYSSR-LKVSNILLDKDINPKISDFGMARI---------CGGNELQANTSRIVGTY 235
+ R +K +NIL+D KI+DFG+AR GG + +V T
Sbjct: 131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 236 GYMSPE 241
Y PE
Sbjct: 191 WYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 18/186 (9%)
Query: 97 LGEGGFGPVYKG-VLKKGDEIAVKRLPGRSGQGL-REMKNEASVIAKVQHKNLVRLLGCC 154
LG G G VYK L +AVK +P L +++ +E ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDP-----------TKRMLLDWSANYSSR-LKVSNILL 202
++ + E+M SLD + P K + WS R +K SN+L+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV 128
Query: 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLL 262
+ K+ DFG++ + + VGT YM+PE + I SDV+S G+ +
Sbjct: 129 NTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 263 EIVSGK 268
E+ G+
Sbjct: 185 ELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 24/192 (12%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
K+GEG G V +K G +AVK++ R Q + NE ++ QH+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRM-----------------LLDWSANYSSRLKV 197
+ DE ++ E++ +L + RM +L +K
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 198 SNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
+ILL D K+SDFG A++ E+ S +VGT +M+PE + + + D++S
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQV--SKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIWS 201
Query: 257 FGVLLLEIVSGK 268
G++++E+V G+
Sbjct: 202 LGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 9e-09
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 40/202 (19%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQ-----GLREMKNEASVIAKVQHKNLVR 149
+LG+G FG VY K+ E+ A+K++ + LRE+K S+ +H N+V+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPNIVK 62
Query: 150 LLGCCIDKDEKILIYEYMPN------KSLDFFLFDPT--KRML------LDW--SANYSS 193
L + DE ++EYM K F + + ++ L +
Sbjct: 63 LKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-----IVGTYGYMSPEYAIQ-G 246
R LK N+L+ KI+DFG+AR E++ SR V T Y +PE ++
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAPEILLRST 174
Query: 247 IFSIKSDVFSFGVLLLEIVSGK 268
+S D+++ G ++ E+ + +
Sbjct: 175 SYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 29/203 (14%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQ------GLREMKNEASVIAK 141
NK+ +GEG +G V K K EI A+K+ LRE+K V+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQ 56
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDW----SANYS 192
++H+N+V L K L++EY+ L+ P W + Y
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 193 SRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+ NIL+ + K+ DFG AR T V T Y +PE +
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRAPELLVG 175
Query: 246 GIFSIKS-DVFSFGVLLLEIVSG 267
K DV++ G ++ E++ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 47/237 (19%)
Query: 72 EVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLPG 123
E+ + P + FS +K + LGEG FG V K K+ +AVK L
Sbjct: 3 ELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57
Query: 124 RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL----- 176
+ + L ++ +E ++ + +HKN++ LLG C +I EY +L +L
Sbjct: 58 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 177 ------FD----PTKRMLLD--WSANYS---------------SRLKVSNILLDKDINPK 209
+D P ++M S Y L N+L+ ++ K
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177
Query: 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
I+DFG+AR + T+ +M+PE +++ +SDV+SFGVL+ EI +
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 48/272 (17%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--PGRSGQ-GLREMKNEASVIAKVQHKN 146
F+D ++G G FG VY + +E+ A+K++ G+ +++ E + +++H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML---------------LDWSANY 191
+ GC + + L+ EY + D + + K+ L L + ++
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 192 SS---RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---Q 245
+K NILL + K++DFG A + AN+ VGT +M+PE + +
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMDE 188
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
G + K DV+S G+ +E+ K + ++++ L + N + P L
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHI----AQNDS-----PTL--- 234
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVV 337
SS + N C+Q+ DRP+ E++
Sbjct: 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 42/212 (19%)
Query: 97 LGEGGFGPVY--------KGVLKKGDEIAVKRLPG-RSGQGLREMKNEASVIAKV-QHKN 146
LGEG FG V K + ++AVK L + + L ++ +E ++ + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPT---------KRML-- 184
++ LLG C +I EY +L +L ++PT K ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 185 -------LDWSANYS---SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
+++ A+ L N+L+ +D KI+DFG+AR + T+
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE I++ +SDV+SFGVLL EI +
Sbjct: 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 38/207 (18%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSGQGLREMKNEASVIAKVQ 143
F N++GEG +G VY+ EI A+K++ G LRE+ +++ ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI----TLLLNLR 64
Query: 144 HKNLVRLLGCCIDK--DEKILIYEY-----------MPN-------KSLDFFLFDPTKRM 183
H N+V L + K D L+ EY MP K L L + +
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 184 LLDWSANYSSRLKVSNILL-DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
++ + LKVSN+LL DK KI+DFG+AR G + T ++V T Y +PE
Sbjct: 125 HENFIIHRD--LKVSNLLLTDKGC-LKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPEL 179
Query: 243 AIQGIFSIKS-DVFSFGVLLLEIVSGK 268
+ + D+++ G +L E+++ K
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 55/283 (19%)
Query: 88 TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKN---------EAS 137
F K+G+G F VYK + L G +A+K++ + EM + E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WSANY- 191
++ ++ H N+++ L I+ +E ++ E L + F KR++ + W
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 192 ---------SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
S R +K +N+ + K+ D G+ R A++ +VGT Y
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 238 MSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297
MSPE + ++ KSD++S G LL E+ + + + FY G +L++ + +E
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--------GDKMNLYSLCKKIEK 222
Query: 298 ID--PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338
D P+ D YS + LR ++ C+ + RP ++ V+
Sbjct: 223 CDYPPLPADHYSEE---LR--DLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 39/200 (19%)
Query: 97 LGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LG G FG + +G LK + +A+ L G S + R EA + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSANYSS-------------R 194
G + +++ EYM N +LD FL ++ L+ +S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYG------YMSPEYAIQ-G 246
L +L++ D+ KIS F LQ + S I T + +PE AIQ
Sbjct: 133 LAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPE-AIQYH 183
Query: 247 IFSIKSDVFSFGVLLLEIVS 266
FS SDV+SFG+++ E++S
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 31/203 (15%)
Query: 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------PGRSGQGLREMKNEASVIAKVQ 143
F K+GEG +G VYK K G+ +A+K++ G +RE+ S++ ++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 57
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANY------------ 191
H N+V+LL +++ L++E++ F P + L +Y
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 192 SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-Q 245
S R LK N+L++ + K++DFG+AR G ++ T +V T Y +PE +
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLGC 175
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
+S D++S G + E+V+ +
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 33/201 (16%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLP-----GRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG G FG VY G E+AVK++P + + + ++ E ++ ++H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 151 LGCCIDKDEKIL--IYEYMPNKSLDFFL-----------FDPTKRMLLDWSANYSSR--- 194
GC D +EK L EYMP S+ L T+++L S +S+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 195 --LKVSNILLDKDINPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIQGI 247
+K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMSPEVISGEG 185
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
+ K+DV+S ++E+++ K
Sbjct: 186 YGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKG---------DEIAVKRLPGRSGQGLREMKNEASVIA 140
K+ K+GEG FG K +L K EI + ++ + + E + E +V++
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLS 54
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK------RMLLDWSANYSSR 194
++H N+V+ + ++ +Y L + + + +LDW
Sbjct: 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 195 LK-------------VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
LK NI L KD K+ DFG+AR+ A T +GT Y+SPE
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLSPE 171
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
++ KSD+++ G +L E+ + K
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 43/195 (22%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQG-LREMKNEASVIAKVQH---KNLVRLL 151
+G G +G VY+G + G +A+K + + + +++ E +++++++ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 152 GCCIDKDEKILIYEYMPNKSL----------DFFLFDPTKRMLLDWSANYSS-----RLK 196
G + +I EY S+ + ++ + +L+ + +K
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIK 128
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIQGI-FSIKS 252
+NIL+ N K+ DFG+A L N+S+ VGT +M+PE +G + K+
Sbjct: 129 AANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183
Query: 253 DVFSFGVLLLEIVSG 267
D++S G+ + E+ +G
Sbjct: 184 DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 36/201 (17%)
Query: 97 LGEGGFGPVY------KGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+GGFG V G L ++ KRL R +G E ++AKV + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFD-----P----------TKRMLLDWSANYSSR- 194
K + L+ M L + +++ P T +++ + R
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYAIQGI 247
LK N+LLD D N +ISD G+A EL Q+ T GT G+M+PE
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
+ D F+ GV L E+++ +
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 31/197 (15%)
Query: 97 LGEGGFGPV------YKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+GGFG V G + ++ KR+ R G+ + NE ++ KV + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNSRFVVSL 65
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFL-------FDPTKRML-----------LDWSANYS 192
KD L+ M L F + FD + + L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 193 SRLKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK NILLD + +ISD G+A +I G ++ VGT GYM+PE ++
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEKYTFS 181
Query: 252 SDVFSFGVLLLEIVSGK 268
D + G L+ E++ G+
Sbjct: 182 PDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 64/282 (22%), Positives = 123/282 (43%), Gaps = 56/282 (19%)
Query: 97 LGEGGFGPVYKGVLKKGD--------EIAVKRLPGRSG-----QGLREMKNEASVIAK-V 142
LG G FG VYK V KK + EI V + + ++ +E ++I + +
Sbjct: 8 LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFF--------------LFDPTKRMLLDW 187
+H N+VR ++ D ++ + + L + F +++ +M+L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 188 SANYSSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
+ + L +NI+L +D I+DFG+A+ + +VGT Y PE
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPE 183
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE-LIDP 300
+ K+DV++FG +L ++ + + FY T+ L+L + + +E + +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLSL---------ATKIVEAVYEP 232
Query: 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ E YS + C+ A+ RP + +V +M++D
Sbjct: 233 LPEGMYSEDVTDV-----ITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 31/197 (15%)
Query: 97 LGEGGFGPV------YKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+GGFG V G + ++ KRL +SG+ + ++ E ++ KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-----LDWSANYSS------------ 193
K L+ M L + +++ +R L + +SA +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 194 -RLKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
+K N+LLD N ++SD G+A + G ++ GT GYM+PE + +S
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYP 174
Query: 252 SDVFSFGVLLLEIVSGK 268
D F+ G + E+V+G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 33/198 (16%)
Query: 97 LGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAK------VQHKNLVR 149
LG+G FG V LK KG+ AVK L + L + E +++ K ++ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
L K+ + E++ L F + D R L + Y++
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYAIQGI-FSI 250
LK+ N++LD+D + KI+DFGM C N N S GT Y++PE +QG+ ++
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPE-ILQGLKYTF 175
Query: 251 KSDVFSFGVLLLEIVSGK 268
D +SFGVLL E++ G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 68/276 (24%), Positives = 108/276 (39%), Gaps = 66/276 (23%)
Query: 97 LGEGGFGPVYKG-VLKKGDEIAVKRLPGRSGQGLREMKN---EASVIAKVQH-KNLVRLL 151
+G G G VYK K G +AVK++ R+G E K + V+ K +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNK-EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 152 GC----------------CIDKDEKILIYEYMPN-----------KSLDFFLFDPTKRML 184
G C+DK I +P K+L + L + +
Sbjct: 81 GYFITDSDVFICMELMSTCLDK-LLKRIQGPIPEDILGKMTVAIVKALHY-LKEKHGVIH 138
Query: 185 LDWSANYSSRLKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY- 242
D +K SNILLD N K+ DFG++ R+ + +A T R G YM+PE
Sbjct: 139 RD--------VKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERI 186
Query: 243 ---AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299
+ I++DV+S G+ L+E+ +G+ +T+ L + L+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL----------TKILQEEP 236
Query: 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNE 335
P L +V+ LC+ + RP E
Sbjct: 237 PSLPPNEGFSPDFCSFVD---LCLTKDHRKRPKYRE 269
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 45/209 (21%)
Query: 91 FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQG------LREMKNEASVIAKVQ 143
+ + ++GEG +G VYK L G +A+K++ + LRE+ +++ +++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI----ALLKQLE 56
Query: 144 ---HKNLVRLLGCC--IDKDEKI---LIYEYMPNKSLDFFL-------FDP------TKR 182
H N+VRLL C D ++ L++E++ ++ L +L P ++
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 183 ML--LDWSANYSSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTY 235
+L +D+ +S R LK NIL+ D KI+DFG+ARI A TS +V T
Sbjct: 116 LLRGVDFL--HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVVTL 170
Query: 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEI 264
Y +PE +Q ++ D++S G + E+
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 5e-08
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 31/197 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAK------VQHKNLVR 149
LG+G FG V LK DE+ A+K L + L++ + ++ K +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTKR-----------MLLDWSANYSS 193
L C KD + EY+ L F + FD + M L
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 194 RLKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK+ NILLD + + K++DFGM + I G T+ GT Y++PE + +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQELEYGPS 176
Query: 252 SDVFSFGVLLLEIVSGK 268
D ++ GVL+ E+++G+
Sbjct: 177 VDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLPGR--SGQGLREMKNEASVIAKVQH 144
F+ LG+G FG V + LK D ++AVK L S + E EA+ + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 145 KNLVRLLGCCIDKDEK------ILIYEYM---------------------PNKSLDFFLF 177
N+++L+G + K ++I +M P ++L F+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 178 DPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNEL-QANTSRIVGT 234
D M S N+ R L N +L++++ ++DFG+++ I G+ Q S++
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--P 178
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270
+++ E +++ SDV++FGV + EI++ +T
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 42/212 (19%)
Query: 97 LGEGGFGPVY--------KGVLKKGDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKN 146
LGEG FG V K K +AVK L + + L ++ +E ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FD----PTKRML------- 184
++ LLG C ++ EY +L +L FD P +++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 185 -------LDWSANYS---SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
+++ A+ L N+L+ +D KI+DFG+AR + T+
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++ +SDV+SFGVLL EI +
Sbjct: 200 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 43/272 (15%)
Query: 91 FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---PGRSGQGLREMKNEASVIAKVQHKN 146
F K+G G F VY+ L +A+K++ + ++ E ++ ++ H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWSA-NYSSRL------KV 197
+++ L I+ +E ++ E L + F KR++ + + Y +L
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 198 SNILLDKDINP-----------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
S ++ +DI P K+ D G+ R A++ +VGT YMSPE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 181
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID--PILED 304
++ KSD++S G LL E+ + + + FY D + L + +E D P+ +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQ--SPFY-GDKMNLFSLC-------QKIEQCDYPPLPTE 231
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
YS K LR + +C+ D RP + V
Sbjct: 232 HYSEK---LR--ELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 28/75 (37%), Positives = 42/75 (56%), Gaps = 3/75 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K NILLD+ + I+DF +A + L +TS GT GYM+PE + +S+ D
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSVAVDW 182
Query: 255 FSFGVLLLEIVSGKK 269
+S GV E + GK+
Sbjct: 183 WSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 43/209 (20%)
Query: 97 LGEGGFGPVYKGVLK---------KGDEIAVKR-LPGRSGQGLREMKNEASVIAKVQHKN 146
LG+G F +YKGVL+ G E++V + G + AS+++++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLD------WSANYSSRLK 196
LV+L G C+ +DE I++ EY+ LD FL + + LD + +Y K
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 197 V-------SNILLDK-DINP------KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
+ NIL+ + +N K+SD G+ E + RI +++PE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERI----PWIAPEC 175
Query: 243 --AIQGIFSIKSDVFSFGVLLLEIVSGKK 269
Q +I +D +SFG LLEI S +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 49/193 (25%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLPGRSGQG-------LREMKNEASVI 139
K+ +G G +G VYK K G E A+K+ G Q RE+ +++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI----ALL 56
Query: 140 AKVQHKNLVRLLGCCIDKDEKI--LIYEY-------------------MPN---KSLDFF 175
+++H+N+V L+ ++ +K L+++Y +P KSL +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 176 LFDPTKRMLLDWSANYSSR-LKVSNILLDKDINP----KISDFGMARICGGNELQ--ANT 228
+ + + +W + R LK +NIL+ + KI D G+AR+ L+ A+
Sbjct: 117 ILNGVHYLHSNWVLH---RDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLADL 172
Query: 229 SRIVGTYGYMSPE 241
+V T Y +PE
Sbjct: 173 DPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 35/204 (17%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE----MKNEASVIAKVQHK 145
F +++G G FG VY +E+ AVK++ SG+ E + E + +++H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM-SYSGKQTNEKWQDIIKEVKFLQQLKHP 81
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML------------------LDW 187
N + GC + + L+ EY + D L + K+ L L
Sbjct: 82 NTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 188 SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI--- 244
+K NILL + K++DFG A AN+ VGT +M+PE +
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVILAMD 193
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
+G + K DV+S G+ +E+ K
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 40/209 (19%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGD---------EIAVKRLPGRSGQGLREMKNEASVIA 140
++ K+GEG FG +Y L K EI + ++P + + K E ++A
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEA---SKKEVILLA 54
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWSANYSS 193
K++H N+V + ++ EY L LF + +L W S
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQISL 112
Query: 194 RL-------------KVSNILLDKD-INPKISDFGMARICGGNELQANTSRIVGTYGYMS 239
L K NI L K+ + K+ DFG+AR + A T VGT Y+S
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPYYLS 170
Query: 240 PEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
PE ++ K+D++S G +L E+ + K
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 11/94 (11%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSD 253
LK +NILLD+ + +ISD G+A C ++ + + S VGT+GYM+PE +G + +D
Sbjct: 123 LKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSAD 178
Query: 254 VFSFGVLLLEIVSG------KKTTGFYRTDSLTL 281
FS G +L +++ G KT + D +TL
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 33/201 (16%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRL-----PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+G FG VY G E+AVK++ + + + ++ E ++ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 151 LGCCIDKDEKIL--IYEYMPN-------KSLDFFLFDPTK---RMLLDWSANYSSRL--- 195
GC D E+ L E+MP KS + T+ R +L+ + S +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 196 ---KVSNILLDKDINPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMSPEYAIQGI 247
K +NIL D N K+ DFG ++ IC G +++ + GT +MSPE
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMSPEVISGEG 185
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
+ K+D++S G ++E+++ K
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 38/216 (17%)
Query: 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAKV-QH 144
T F +GEG +G VYK KK ++ A+K + E+K E +++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 145 KNLVRLLGCCIDKDEKI------LIYEYMPNKS---LDFFLFDPTKRMLLDWSANYSSR- 194
N+ G I K+ L+ E S L L KR+ +W A Y R
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-YILRE 121
Query: 195 -----------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
+K NILL K+ K+ DFG++ + NT +GT +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYW 179
Query: 238 MSPE-----YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
M+PE + +SDV+S G+ +E+ GK
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 43/197 (21%)
Query: 100 GGFGPVYKGVLKK---GDEIAVKRLPGRSGQGLREMKN----EASVIAKVQHKNLVRLLG 152
G FG VY + KK GD A+K L ++ N A ++ + + + +L
Sbjct: 7 GAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRML----LDWSANYSSR-------------- 194
KD L+ EY+ + + L DW+ Y +
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
+K N+L+D+ + K++DFG++R N+ + VGT Y++PE I G+ K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILGVGDDK 172
Query: 252 -SDVFSFGVLLLEIVSG 267
SD +S G ++ E + G
Sbjct: 173 MSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 27/193 (13%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAV-KRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG+G FG VYK K+ +A K + +S + L + E ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTK-----------RMLLDWSANY-------SSRLK 196
++ ++ E+ ++D + + + + L+ + NY LK
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE-ALNYLHENKIIHRDLK 130
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIK 251
NIL D + K++DFG++ +Q S +GT +M+PE + + K
Sbjct: 131 AGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPYDYK 188
Query: 252 SDVFSFGVLLLEI 264
+DV+S G+ L+E+
Sbjct: 189 ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 51/283 (18%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIA---VKRL-----PGRSGQGLREMKNEASVIAKVQHKN 146
+++G G FG V G +G A VK L P L+E++ ++ H N
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQP----YRELNHPN 56
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------FDPTKRMLLDWS---------- 188
+++ LG CI+ +L+ E+ P L +L K +L +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 189 --ANY-SSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI- 244
A++ S L + N L D++ KI D+G+A + +++PE
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 245 --QGIFSIK----SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298
Q + S+++S GV + E+ + +L + ++L
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL-FTAADQPYPDLSDEQVLKQV----VREQDIKLP 231
Query: 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
P L+ +YS R+ + C + + RPT EV +LT
Sbjct: 232 KPQLDLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 35/205 (17%)
Query: 90 KFSDAN---KLGEGGFGPVYKGVLKKGD--EIAVKRLPG----RSGQGLREMKNEASVIA 140
K+ D N LG G FG V K D +A+KR + Q + + +E ++
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILN 86
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWSANYSSR----- 194
+ H V L G D+ L+ E++ +FF F KR D Y+++
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 195 ------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
LK N+LLDKD K++DFG A++ + T + GT Y++PE
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEI 199
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSG 267
+ +D ++ G+ + EI+ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
++ D LG G G V+ V D+ +AVK++ Q ++ E +I ++ H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 149 RLL------GCCIDKDEKIL-----IY---EYM-------------PNKSLDFFLFDPTK 181
++ G + +D L +Y EYM + F++ +
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 182 RMLLDWSANYSSR-LKVSNILLD-KDINPKISDFGMARICGGN-ELQANTSRIVGTYGYM 238
+ SAN R LK +N+ ++ +D+ KI DFG+ARI + + S + T Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 239 SPEYAIQGIFSIKS-DVFSFGVLLLEIVSGK 268
SP + K+ D+++ G + E+++GK
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 27/154 (17%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSGQGLREMKNEASVIAKV 142
K+ K+GEG +G V+K ++ EI A+KR+ G LRE+ ++ ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKEL 56
Query: 143 QHKNLVRLLGCCIDKDEKILIYEY---------------MPNKSLDFFLFDPTKRMLLDW 187
+HKN+VRL + L++EY + + + F+F K +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICG 220
S N R LK N+L++K+ K++DFG+AR G
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-07
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 2/47 (4%)
Query: 343 EAAALFPPKQPAFSYVRNTV--TSTSSTGKTEDCSINQVTISLLEAR 387
E + PKQP F R+ S+SST + E ++NQVT+S+++AR
Sbjct: 2 ETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 28/75 (37%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSD 253
LK+ N++LD + + KI+DFGM C N T+R GT Y++PE + D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 254 VFSFGVLLLEIVSGK 268
++FGVLL E+++G+
Sbjct: 184 WWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 24/192 (12%)
Query: 96 KLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
K+GEG G V K G ++AVK++ R Q + NE ++ H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRM-----------------LLDWSANYSSRLKV 197
+ DE ++ E++ +L + RM L +K
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 198 SNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
+ILL D K+SDFG A++ E+ S +VGT +M+PE + + + D++S
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 257 FGVLLLEIVSGK 268
G++++E++ G+
Sbjct: 204 LGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQ-----GLREMKNEASVIAKVQH 144
+ + + +GEG +G V K G ++A+K++ Q LRE+K ++ + +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKH 62
Query: 145 KNLVRLLGCCIDKD-----EKILIYEYMP-------------NKSLDFFLFDPTKRMLLD 186
+N++ +L + ++ E M N + +FL+ + +
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 187 WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAI 244
SAN R LK SN+LL+ + + KI DFG+ARI + V T Y +PE +
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 245 QGIFSIKS-DVFSFGVLLLEIVSGK 268
K+ D++S G +L E++S +
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 32/212 (15%)
Query: 81 FSSVSTATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKN-- 134
F+ T++ K SD LG G FG V K G+ A+K L R ++++++
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66
Query: 135 -EASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS 193
E S++ ++ H +V ++ D++ + E++ L F R D + Y +
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYHA 125
Query: 194 R-----------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
LK N+LLD + K++DFG A+ ++ T + GT
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 237 YMSPEYAIQGIFSIKS-DVFSFGVLLLEIVSG 267
Y++PE IQ K+ D ++ GVLL E ++G
Sbjct: 181 YLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 49/204 (24%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG G G V K + + I ++L P Q +RE+K V+ + +V
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK----VLHECNSPYIVGF 64
Query: 151 LGCCIDKDEKILIYEYMPNKSLDF-------------------------FLFDPTKRMLL 185
G E + E+M SLD +L + K M
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHR 124
Query: 186 DWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
D +K SNIL++ K+ DFG++ G + + + VGT YMSPE +Q
Sbjct: 125 D--------VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQ 171
Query: 246 GI-FSIKSDVFSFGVLLLEIVSGK 268
G ++++SD++S G+ L+E+ G+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 54/206 (26%), Positives = 78/206 (37%), Gaps = 50/206 (24%)
Query: 97 LGEGGFGPV----YKG--------VLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH 144
LG G FG V YK LKKGD IA + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-----ESLMCEKRIFETANSERH 61
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSL------DFFLFDPTKRMLLDWSANYSS----- 193
LV L C +D + EY L D F R + Y++
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-----YAACVVLG 113
Query: 194 ------------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
LK+ N+LLD + KI+DFG+ + G TS GT +++PE
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPE 171
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSG 267
+ ++ D + GVL+ E++ G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 40/205 (19%)
Query: 97 LGEGGFGPVYKGVLKK-GD-------EIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
LG+G F ++KG+ ++ GD E+ +K L AS+++++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVS---------- 198
G C+ DE I++ EY+ SLD +L + + W + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 199 -------NILL-----DKDINP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
N+LL K NP K+SD G++ E+ RI ++ PE
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWVPPECI 176
Query: 244 IQG-IFSIKSDVFSFGVLLLEIVSG 267
S+ +D +SFG L EI SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 35/203 (17%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVK--RLP-GRSGQGLREMKNEASVIAKVQ---HKNLV 148
++G G +G VYK G +A+K R+ G L ++ E +++ +++ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 149 RLLGCC----IDKDEKI-LIYEYMPNKSLDFFL-------------FDPTKRMLLDWSAN 190
RL+ C D++ K+ L++E++ ++ L +L D ++ L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 191 YSSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+++ LK NIL+ K++DFG+ARI Q + +V T Y +PE +Q
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
++ D++S G + E+ K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKN----EASVIAKVQ 143
NKF +GEG +G V K K+ EI A+K+ + + E+K E ++ ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVS----- 198
+N+V L + + L++EY+ L+ P + + +Y +L +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG-VPPEKVRSYIYQLIKAIHWCH 117
Query: 199 -NILLDKDINP-----------KISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQ 245
N ++ +DI P K+ DFG AR + G+ AN + V T Y SPE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLG 175
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
+ D++S G +L E+ G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 33/204 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKV 142
+ F ++LG G G V+K K I ++L P Q +RE++ V+ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-----------------RMLL 185
+V G E + E+M SLD L + L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 186 DWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+ +K SNIL++ K+ DFG++ G + + + VGT YMSPE +Q
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQ 175
Query: 246 GI-FSIKSDVFSFGVLLLEIVSGK 268
G +S++SD++S G+ L+E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 28/74 (37%), Positives = 43/74 (58%), Gaps = 4/74 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
L NILL ++ KI DFG+AR + ++ +R+ +M+PE +++ +S
Sbjct: 199 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQS 256
Query: 253 DVFSFGVLLLEIVS 266
DV+SFGVLL EI S
Sbjct: 257 DVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 2e-06
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 32/201 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155
+G G +G VYKG K ++A ++ +G E+K E +++ K H+N+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 156 DK------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
K D+ L+ E+ S+ + + L + Y R
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----QG 246
+K N+LL ++ K+ DFG++ + NT +GT +M+PE
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDA 191
Query: 247 IFSIKSDVFSFGVLLLEIVSG 267
+ KSD++S G+ +E+ G
Sbjct: 192 TYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 48/190 (25%), Positives = 89/190 (46%), Gaps = 20/190 (10%)
Query: 96 KLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
K+GEG G V K G ++AVK + R Q + NE ++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDP----------TKRMLLDWSANYSS-----RLKVSN 199
+ +E ++ E++ +L + + +L +S +K +
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 200 ILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFG 258
ILL D K+SDFG A+I ++ +VGT +M+PE + + + D++S G
Sbjct: 148 ILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204
Query: 259 VLLLEIVSGK 268
++++E+V G+
Sbjct: 205 IMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 27/73 (36%), Positives = 47/73 (64%), Gaps = 2/73 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLD++ + K++DFG+++ +E +A + GT YM+PE + + +D
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADW 181
Query: 255 FSFGVLLLEIVSG 267
+SFGVL+ E+++G
Sbjct: 182 WSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 27/196 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE-IAVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+KLGEG + VYKG K D +A+K RL G ++ E S++ ++H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFD--------PTKRMLLDW--SANYSSRLKV---- 197
+ L++EY+ +K L +L D K L NY R KV
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 198 ---SNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQGI-FSIKS 252
N+L+++ K++DFG+AR + T S V T Y P+ + +S +
Sbjct: 130 LKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 253 DVFSFGVLLLEIVSGK 268
D++ G + E+ +G+
Sbjct: 187 DMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHK 145
+ + KLGEG + VYKG K G +A+K RL G ++ EAS++ ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNK---------------SLDFFLFDPTKRMLLDWSAN 190
N+V L K+ L++EY+ ++ FLF + +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 191 YSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQGI- 247
R LK N+L+ K++DFG+AR + ++T S V T Y P+ +
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 248 FSIKSDVFSFGVLLLEIVSG 267
+S D++ G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 28/75 (37%), Positives = 47/75 (62%), Gaps = 6/75 (8%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSD 253
+K SNIL++ K+ DFG++ G + + + VGT YMSPE +QG +S++SD
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGTHYSVQSD 184
Query: 254 VFSFGVLLLEIVSGK 268
++S G+ L+E+ G+
Sbjct: 185 IWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 63/223 (28%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP--------GRSGQGLREMKNEASVIA 140
++ +G G +G V V K+ G ++A+K++ + + LRE+K ++
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK----LLR 54
Query: 141 KVQHKNLVRLLGCCIDKDEK-----ILIYEYMP---------NKSLD-----FFLFDPTK 181
++H+N++ LL + ++ E M + L +FL+
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY---- 110
Query: 182 RMLLDW----SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQAN--TSRIVGT 234
++L SAN R LK SNIL++ + + KI DFG+AR +E + T +V T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 235 YGYMSPE---------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y +PE AI D++S G + E+++ K
Sbjct: 170 RWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 26/75 (34%), Positives = 45/75 (60%), Gaps = 4/75 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSD 253
LK+ N++LD + + KI+DFGM C + + T+R GT Y++PE + D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 254 VFSFGVLLLEIVSGK 268
+++GVLL E+++G+
Sbjct: 184 WWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 27/75 (36%), Positives = 44/75 (58%), Gaps = 4/75 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSD 253
LK+ N++LD + + KI+DFGM C N T++ GT Y++PE + D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 254 VFSFGVLLLEIVSGK 268
++FGVLL E+++G+
Sbjct: 184 WWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 24/193 (12%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+GEG FG D+ A+K RLP +S + + + EA ++AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSAN--------YSSR-----L 195
++ EY L + + +L W + R +
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
K NI L ++ K+ DFG AR+ A T VGT Y+ PE ++ KSD++
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 256 SFGVLLLEIVSGK 268
S G +L E+ + K
Sbjct: 185 SLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 97 LGEGGFGPVYKGVLKKGDEI----AVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLL 151
+G G + V LKK + I VK+ + + ++ E V + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
C + + EY+ L F + +R L + A + S
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
LK+ N+LLD + + K++D+GM + G TS GT Y++PE + D
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 254 VFSFGVLLLEIVSGK 268
++ GVL+ E+++G+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 97 LGEGGFGPVYKGVLKKGDEI----AVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+G G + V LKK D+I VK+ + + ++ E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 153 CCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
C ++ L+ EY+ L F + +R L + A + +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
LK+ N+LLD D + K++D+GM + G TS GT Y++PE + D
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 254 VFSFGVLLLEIVSGK 268
++ GVL+ E+++G+
Sbjct: 179 WWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQ------GLREMKNEASVIAK 141
K+ + +GEG +G V K K+ +I A+K+ +RE++ ++ +
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQ 56
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-------TKRML------LDW- 187
++H+NLV L+ K L++E++ + LD P ++ L +++
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 188 -SANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAI 244
S N R +K NIL+ + K+ DFG AR + E+ + V T Y +PE +
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLV 173
Query: 245 QGI-FSIKSDVFSFGVLLLEIVSG 267
+ D+++ G L+ E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 25/75 (33%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI--FSIKS 252
+K+ NILLD + + ++DFG+++ E + S GT YM+PE G
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAV 189
Query: 253 DVFSFGVLLLEIVSG 267
D +S GVL E+++G
Sbjct: 190 DWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 29/74 (39%), Positives = 44/74 (59%), Gaps = 4/74 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
L NILL ++ KI DFG+AR + ++ +R+ +M+PE +++I+S
Sbjct: 205 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQS 262
Query: 253 DVFSFGVLLLEIVS 266
DV+SFGVLL EI S
Sbjct: 263 DVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 62/224 (27%), Positives = 92/224 (41%), Gaps = 57/224 (25%)
Query: 83 SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLPGRSGQGLREMKN---EA 136
S T ++ + +G G G V Y V G +A+K+L R Q + K E
Sbjct: 10 STFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKL-SRPFQNVTHAKRAYREL 66
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RML 184
++ V HKN++ LL + P KSL+ F L D +M
Sbjct: 67 VLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMD 114
Query: 185 LDW------------------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQ 225
LD SA R LK SNI++ D KI DFG+AR G + +
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174
Query: 226 ANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGK 268
T +V Y Y +PE I G+ + D++S G ++ E++ G
Sbjct: 175 --TPYVVTRY-YRAPE-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 38/203 (18%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGR-SGQGLREMKNEASVIAKVQH-KNLVRLLGC 153
LG G +G V K I AVKR+ + Q + + + + + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 154 CIDKDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWSANYS-----------SRLKV-- 197
+ + + E M + SLD F ++D + D + S+L V
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127
Query: 198 -----SNILLDKDINPKISDFGMARICGGNELQANTSRIV--GTYGYMSPE-----YAIQ 245
SN+L++++ K+ DFG I G L + ++ + G YM+PE +
Sbjct: 128 RDVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
G + +KSDV+S G+ ++E+ +G+
Sbjct: 183 G-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 4/74 (5%)
Query: 195 LKVSNILLDKDINPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
L NILL ++ KI DFG+AR + ++ ++R+ +M+PE +++ +S
Sbjct: 200 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQS 257
Query: 253 DVFSFGVLLLEIVS 266
DV+SFGVLL EI S
Sbjct: 258 DVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLR-EMKNEASVIAKVQH 144
A + + KLGEG + VYKG+ + G +A+K + ++ +G+ EAS++ ++H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNK---------------SLDFFLFDPTKRMLLDWSA 189
N+V L K+ ++EYM ++ F+F + +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 190 NYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI- 247
+ R LK N+L+ K++DFG+AR Q +S +V T Y P+ +
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDVLLGATD 180
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
+S D++ G + +E++ G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 53/222 (23%)
Query: 95 NKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQG------------------LREMKNE 135
LGEG +G V K G +A+K++ LRE+K
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72
Query: 136 ASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTKRMLLDW--- 187
++ +++H+N++ L+ ++ D L+ + M + K +D L + + +L
Sbjct: 73 --IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 188 ------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQAN------------- 227
+ R L +NI ++ KI+DFG+AR G
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 228 TSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGK 268
TS++V T Y +PE + + D++S G + E+++GK
Sbjct: 191 TSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 62/246 (25%), Positives = 104/246 (42%), Gaps = 41/246 (16%)
Query: 83 SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRL--PGRSGQGLREMKNEAS 137
S T ++ +G G G V + VL G +AVK+L P ++ + E
Sbjct: 15 STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELV 72
Query: 138 VIAKVQHKNLVRLLGC------------------CIDKDEKILIYEYMPNKSLDFFLFDP 179
++ V HKN++ LL +D + +I+ + ++ + + L+
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 180 TKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
+ SA R LK SNI++ D KI DFG+AR N + T +V Y Y
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YR 189
Query: 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298
+PE + + D++S G ++ E+V G + F TD + D W N+ +E +
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG--SVIFQGTDHI-------DQW--NKVIEQL 238
Query: 299 -DPILE 303
P E
Sbjct: 239 GTPSAE 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 53/222 (23%)
Query: 83 SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRL--PGRSGQGLREMKNEAS 137
S T ++ + +G G G V Y +L++ +A+K+L P ++ + E
Sbjct: 18 STFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYRELV 75
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF--------LFDPTK----RMLL 185
++ V HKN++ LL + P KSL+ F L D +M L
Sbjct: 76 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 186 DW------------------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQA 226
D SA R LK SNI++ D KI DFG+AR G + +
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 182
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
T +V Y Y +PE + + D++S G ++ E++ G
Sbjct: 183 -TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 22/189 (11%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
++G G +G VYK L G+ AVK + G ++ E ++ + +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 155 IDKDEKILIYEYMPNKSLD--FFLFDPTK--------RMLLDWSANYSSR------LKVS 198
+ +++ + EY SL + + P R L A S+ +K +
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGA 135
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI---QGIFSIKSDVF 255
NILL + + K++DFG+A A +GT +M+PE A G ++ D++
Sbjct: 136 NILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIW 193
Query: 256 SFGVLLLEI 264
+ G+ +E+
Sbjct: 194 AVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 25/146 (17%)
Query: 96 KLGEGGFGPVYKGVLKKG---DEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLL 151
++G G FG V G + G ++ VK L + Q + EA +QH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLF----------DPT--KRMLLDWSA--------NY 191
G C + +L+ E+ P L +L DPT +RM + + N+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 192 S-SRLKVSNILLDKDINPKISDFGMA 216
S L + N LL D+ KI D+G++
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 30/202 (14%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------PGRSGQGLREMKNEASVIAKV 142
K+ +K+GEG +G V+K ++ G +A+K+ P LRE++ ++ ++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQL 57
Query: 143 QHKNLVRLLGCCIDKDEKILIYEY---------------MPNKSLDFFLFDPTKRMLLDW 187
+H NLV L+ K + L++EY +P + ++ + +
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
N R +K NIL+ K K+ DFG ARI G + + V T Y +PE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGD 175
Query: 247 I-FSIKSDVFSFGVLLLEIVSG 267
+ DV++ G + E+++G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 22/114 (19%)
Query: 159 EKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMAR 217
E +L + Y K + F S N R L NILL KI DFG+AR
Sbjct: 214 EDLLSFSYQVAKGMSFLA-----------SKNCIHRDLAARNILLTHGRITKICDFGLAR 262
Query: 218 ICGGNELQANTSRIVGTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+++ +++ +V +M+PE +++ +SDV+S+G+LL EI S
Sbjct: 263 -----DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 48/202 (23%), Positives = 92/202 (45%), Gaps = 28/202 (13%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKN 146
+++ ++G G +G V + + G+++A+K+L P +S + E +++ +QH+N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 147 LVRLLGCCIDK---DEKILIYEYMPNKSLD---------------FFLFDPTKRMLLDWS 188
++ LL DE Y MP D + ++ + S
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 189 ANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
A R LK N+ +++D KI DFG+AR A + V T Y +PE + +
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190
Query: 248 FSIKS-DVFSFGVLLLEIVSGK 268
++ D++S G ++ E+++GK
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 43/195 (22%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 91 FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
F ++G G +G VYK + G+ A+K + G+ ++ E ++ +H N+V
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 150 LLGCCIDKDEKILIYEYMPNKSLD--FFLFDPTKRMLLDWSANYSSR------------- 194
G + +D+ + E+ SL + + P + + + + +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 195 -LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAI---QGIFS 249
+K +NILL + + K++DFG+ A+I A +GT +M+PE A +G ++
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 250 IKSDVFSFGVLLLEI 264
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 41/207 (19%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRL------PGRSGQGLREMKNEASVIAKVQHKN-L 147
K+GEG +G VYK G +A+K+ G LRE+ S++ + +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI----SLLQMLSESIYI 63
Query: 148 VRLLGC--CIDKDEKILIY---EY-------------------MPNKSLDFFLFDPTKRM 183
VRLL +K+ K +Y EY +P K++ F++ K +
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 184 LLDWSANYSSR-LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
R LK N+L+DK KI+D G+ R +++ T IV T Y +PE
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-TLWYRAPE 181
Query: 242 YAIQGI-FSIKSDVFSFGVLLLEIVSG 267
+ +S D++S G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 83 SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRL--PGRSGQGLREMKNEAS 137
S T ++ + +G G G V Y VL + +A+K+L P ++ + E
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELV 68
Query: 138 VIAKVQHKNLVRLLGC------------------CIDKDEKILIYEYMPNKSLDFFLFDP 179
++ V HKN++ LL +D + +I + ++ + + L+
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 180 TKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
+ SA R LK SNI++ D KI DFG+AR G + + T +V Y Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YR 185
Query: 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+PE + + D++S G ++ E+V K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 44/185 (23%), Positives = 84/185 (45%), Gaps = 30/185 (16%)
Query: 113 GDEIAVKRLPGRSGQGLREMKN---EASVIAKVQHKNLVRLL--GCCIDKDEKILIYEYM 167
G E+A+K L + + + E ++ A++ H N+V LL G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 168 PNKSLDFFL--------FDPTKRML--LDWSANYSSR------LKVSNILL---DKDINP 208
P ++L L + + ML LD A ++ LK NI++ +
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 209 KISDFGMARICGG----NELQAN-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 263
K+ DFG+ + G + T+ ++GT Y +PE + SD++++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 264 IVSGK 268
++G+
Sbjct: 182 CLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 62/247 (25%), Positives = 108/247 (43%), Gaps = 60/247 (24%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKN-----EASVIAKVQ 143
N++ K+G G FG V+ K+ E + S +GL+E + E +V+ +++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70
Query: 144 HKNLVRLLGCCIDK-DEKILI-YEY---------------MPNKSLDFFLFDPTKRML-- 184
HKN+VR + ++K ++K+ I E+ M K + + D T+++L
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 185 LDWSANYSS----------RLKVSNILLDKDIN-----------------PKISDFGMAR 217
L + N LK NI L I KI DFG+++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI--KSDVFSFGVLLLEIVSGKKTTGFYR 275
G +++ VGT Y SPE + S KSD+++ G ++ E+ SGK T F++
Sbjct: 191 NIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHK 245
Query: 276 TDSLTLL 282
++ + L
Sbjct: 246 ANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 7e-05
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 60/216 (27%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKRLPG------------RSGQGLREMKNEASVIAK 141
KLG+G +G V+K + ++ E+ A+K++ R L+E+ +
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65
Query: 142 VQHKNLVRLLGCC-IDKDEKI-LIYEYMPN----------------KSLDFFLFDPTKRM 183
H N+V+LL + D+ I L++EYM + + + L K +
Sbjct: 66 --HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYI 123
Query: 184 LLDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQANT--SRIVGTYGYMS 239
S N R LK SNILL+ D K++DFG+AR + E N + V T Y +
Sbjct: 124 ---HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 240 PE-------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
PE Y +G+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYT-KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155
+G G +G VYKG K ++A ++ + E+K E +++ K H+N+ G I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 156 DK------DEKILIYEYMPNKSLDFFLFDPTKRMLL--DWSANYSSR------------- 194
K D+ L+ E+ S+ L TK L DW A Y R
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVT-DLVKNTKGNALKEDWIA-YICREILRGLAHLHAHK 141
Query: 195 -----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI----- 244
+K N+LL ++ K+ DFG++ + NT +GT +M+PE
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENP 199
Query: 245 QGIFSIKSDVFSFGVLLLEIVSG 267
+ +SD++S G+ +E+ G
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 25/74 (33%), Positives = 40/74 (54%), Gaps = 2/74 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK N+ L + K+ D G+AR+ A+T ++GT YMSPE ++ KSDV
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDV 185
Query: 255 FSFGVLLLEIVSGK 268
++ G + E+ + K
Sbjct: 186 WALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 25/195 (12%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE-IAVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
KLGEG + V+KG K + +A+K RL G ++ E S++ ++H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 152 GCCIDKDEKILIYEY---------------MPNKSLDFFLFDPTKRMLLDWSANYSSR-L 195
L++EY M ++ FL+ + + R L
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAI-QGIFSIKSD 253
K N+L+++ K++DFG+AR + T S V T Y P+ + +S + D
Sbjct: 131 KPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 254 VFSFGVLLLEIVSGK 268
++ G + E+ SG+
Sbjct: 188 MWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 95 NKLGEGGFGPVYKG-VLKKGDEIAVKRLPGRSGQGLREMKNEASVIA--KVQ-HKNLVRL 150
K+GEG F V K K G A+K + + L ++ N + A ++ H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 151 LGCCIDKDEKIL----------IYEYM-------PNKSLDFFLFDPTKRM-LLDWSANYS 192
+ D+ L +YE + P K + +++ K + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 193 SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIK 251
+K NIL+ DI K++DFG R G T I T Y +PE + G + K
Sbjct: 124 RDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLTDGYYGPK 179
Query: 252 SDVFSFGVLLLEIVS 266
D+++ G + EI+S
Sbjct: 180 MDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK+ N++LDKD + KI+DFG+ + G + A GT Y++PE + D
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD 277
+ GV++ E++ G+ FY D
Sbjct: 180 WGLGVVMYEMMCGR--LPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 25/76 (32%), Positives = 44/76 (57%), Gaps = 6/76 (7%)
Query: 195 LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
LK+ N+LLD + + K++D+GM + I G+ TS GT Y++PE +
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 253 DVFSFGVLLLEIVSGK 268
D ++ GVL+ E+++G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 67/247 (27%)
Query: 129 LREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEY----------MPNKSLDF 174
+ +NE + ++ N++++ G ID + LI EY K L F
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF 121
Query: 175 FLFDPTK-RMLLDWSA------NYSSR----LKVSNILLDKDINPKISDFGMARICGGNE 223
TK M +D Y+++ L + L+ ++ KI IC G E
Sbjct: 122 K----TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI-------ICHGLE 170
Query: 224 --LQANTSRIVGTYGYMSPEYAIQGIFS---IKSDVFSFGVLLLEIVSGKKTTGFYRTDS 278
L + + V Y S + + IFS IK D++S GV+L EI +GK F
Sbjct: 171 KILSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKDDIYSLGVVLWEIFTGK--IPFENLT- 226
Query: 279 LTLLGYAWDLWTSNRTLELIDPILEDEYSSK-----HMLLRYVNIALLCVQESADDRPTM 333
T E+ D I+ S K + ++ + A C + RP +
Sbjct: 227 ---------------TKEIYDLIINKNNSLKLPLDCPLEIKCIVEA--CTSHDSIKRPNI 269
Query: 334 NEVVSML 340
E++ L
Sbjct: 270 KEILYNL 276
|
Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 25/70 (35%), Positives = 41/70 (58%), Gaps = 4/70 (5%)
Query: 199 NILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
N+LL KI DFG+AR + N + +R+ +M+PE +++++SDV+S
Sbjct: 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWS 299
Query: 257 FGVLLLEIVS 266
+G+LL EI S
Sbjct: 300 YGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/83 (31%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K+ N++LDKD + KI+DFG+ + G A GT Y++PE + D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD 277
+ GV++ E++ G+ FY D
Sbjct: 179 WGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK+ N++LDKD + KI+DFG+ + G A GT Y++PE + D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD 277
+ GV++ E++ G+ FY D
Sbjct: 179 WGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK+ N++LDKD + KI+DFG+ + G A GT Y++PE + D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 255 FSFGVLLLEIVSGKKTTGFYRTD 277
+ GV++ E++ G+ FY D
Sbjct: 179 WGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 45/203 (22%), Positives = 96/203 (47%), Gaps = 29/203 (14%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKN 146
++ D ++G G +G V + + G ++A+K+L P +S + E ++ ++H+N
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 147 LVRLLGC-----CIDKDE--------------KILIYEYMPNKSLDFFLFDPTKRMLLDW 187
++ LL +D+ K++ +E + + F ++ K +
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
+A R LK N+ +++D KI DFG+AR + + + V T Y +PE +
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNW 190
Query: 247 I-FSIKSDVFSFGVLLLEIVSGK 268
+ ++ D++S G ++ E+++GK
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 50/217 (23%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKN 146
++ + + +G G +G V K G +AVK+L P +S + E ++ ++H+N
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 147 LVRLLGC------------------CIDKD-EKILIYEYMPNKSLDFFLFDPTKRMLLDW 187
++ LL + D I+ + + + + F ++ + +
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
SA+ R LK SN+ +++D KI DFG+AR + V T Y +PE +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNW 192
Query: 247 I-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282
+ ++ D++S G ++ E+++G+ T F TD + L
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 37/171 (21%)
Query: 135 EASVIAKVQHKNLVRLLGCCIDKDEKIL--IYEYMPNKSLDFFLFD---PTKRMLLDWSA 189
E ++A + +V+L +D+K L + EYMP L + + P K W+
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WAR 145
Query: 190 NYSSRL-----------------KVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
Y++ + K N+LLDK + K++DFG N + V
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAV 204
Query: 233 GTYGYMSPEY----AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL 279
GT Y+SPE G + + D +S GV L E++ G T FY DSL
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 175 FLFDPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIV 232
F + + M S N R L N+LL + KI DFG+AR I + + S +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++ SDV+S+G+LL EI S
Sbjct: 302 PV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 183 MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
++LDW A +L+ LLD D++ + + I G +IVGT YM+PE
Sbjct: 153 VILDWGAAIFKKLE-EEDLLDIDVDERNICYSSMTIPG---------KIVGTPDYMAPER 202
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVS 266
+ S +D+++ GV+L ++++
Sbjct: 203 LLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 53/216 (24%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL--PGRSGQGLREMKNEASVIAKVQHK 145
+++ + + +G G +G V K +A+K+L P +S + E ++ + H+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSL----DFFLFDP-----------TKRMLLD---- 186
N++ LL + P SL D +L +++ D
Sbjct: 75 NVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 187 ------------WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233
SA R LK SNI +++D KI DFG+AR + V
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVA 177
Query: 234 TYGYMSPEYAIQGIFSIKS-DVFSFGVLLLEIVSGK 268
T Y +PE + + ++ D++S G ++ E+++GK
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 54/211 (25%)
Query: 97 LGEGGFGPVYKGVLKK---------GDEIAVKRLPGRSGQGLREMK----NEASVIAKVQ 143
LG G +Y G+L E +K + R++ AS++ +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVS----- 198
HK++V L G C+ E I++ E++ LD F+ + + W + +L +
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 199 ------------NILL-----DKDINP--KISDFG-----MARICGGNELQANTSRIVGT 234
NILL D + P K+SD G ++R Q RI
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERI--- 172
Query: 235 YGYMSPE-YAIQGIFSIKSDVFSFGVLLLEI 264
+++PE SI +D +SFG L EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 95 NKLGEGGFGPVYKGVLK-KGDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+KLGEG + V+KG K + +A+K RL G ++ E S++ ++H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 152 GCCIDKDEKILIYEYMPNK---------------SLDFFLFDPTKRMLLDWSANYSSR-L 195
+ L++EY+ + ++ F+F + + R L
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQGI-FSIKSD 253
K N+L+++ K++DFG+AR + T S V T Y P+ + +S D
Sbjct: 130 KPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 254 VFSFGVLLLEIVSGK 268
++ G +L E+ +G+
Sbjct: 187 MWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 34/199 (17%)
Query: 97 LGEGGFGPVYKGVLK-----KGDEIAVKRLPG----RSGQGLREMKNEASVIAKVQHKNL 147
LG+GG+G V++ V K G A+K L R+ + K E +++ V+H +
Sbjct: 4 LGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
V L+ + LI EY+ L F + + D + Y S
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL-FMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 195 ----LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
LK NILLD + K++DFG+ + I G T GT YM+PE ++
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILMRSGH 177
Query: 249 SIKSDVFSFGVLLLEIVSG 267
D +S G L+ ++++G
Sbjct: 178 GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/73 (32%), Positives = 42/73 (57%), Gaps = 2/73 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLD + + DFG+ ++ ++ + NT GT Y++PE + ++ D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDW 176
Query: 255 FSFGVLLLEIVSG 267
++ GVLL E+++G
Sbjct: 177 WTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 31/85 (36%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGN--ELQANTSRIVGTYGYMSPEYAI 244
SAN R LK N+L++ D KI DFG+AR N E + V T Y +PE +
Sbjct: 123 SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 245 QGIFSIKS-DVFSFGVLLLEIVSGK 268
K+ DV+S G +L E++ K
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 31/205 (15%)
Query: 97 LGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 151
+G+G FG V K G AVK L ++ +E + E +V+ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWSANYSSR----------- 194
++ + +Y+ L F L +P R ++A +S
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF---YAAEVASAIGYLHSLNIIY 119
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
LK NILLD + ++DFG+ + G E + TS GT Y++PE + +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 253 DVFSFGVLLLEIVSGKKTTGFYRTD 277
D + G +L E++ G FY D
Sbjct: 178 DWWCLGAVLYEMLYG--LPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 45/203 (22%), Positives = 91/203 (44%), Gaps = 29/203 (14%)
Query: 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKN 146
++ + +G G +G V + ++AVK+L P +S R E ++ ++H+N
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 147 LVRLLGCCI------DKDEKILIYEYM-------------PNKSLDFFLFDPTKRMLLDW 187
++ LL + +E L+ M ++ + F ++ + +
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
SA R LK SN+ +++D +I DFG+AR + + V T Y +PE +
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNW 190
Query: 247 I-FSIKSDVFSFGVLLLEIVSGK 268
+ ++ D++S G ++ E++ GK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 26/76 (34%), Positives = 45/76 (59%), Gaps = 2/76 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSIKSD 253
+K +NILL + K+ DFG +++ + + R GT Y++PE + +S K+D
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYA-ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227
Query: 254 VFSFGVLLLEIVSGKK 269
+FS GVLL E+++ K+
Sbjct: 228 MFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 48/271 (17%)
Query: 37 GEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKK--KEVDQLPLFSFSSVSTATNKFSDA 94
G + + LDLD N NI+ +N R +K +++ +L + +
Sbjct: 2 GLNSLVLDLDFPALRKNKNIDNFLN-----RYEKIVRKIRKLQM--------KAEDYDVV 48
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE----MKNEASVIAKVQHKNLVRL 150
+G G FG V K ++ +L + R E ++A +V+L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 151 LGCCIDKDEKIL--IYEYMPNKSLDFFL--FDP--------TKRMLLDWSANYSSRL--- 195
C +D+K L + EYMP L + +D T ++L A +S L
Sbjct: 109 F--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHR 166
Query: 196 --KVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY----AIQGIF 248
K N+LLDK + K++DFG ++ ++ +T+ VGT Y+SPE G +
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYY 224
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL 279
+ D +S GV L E++ G T FY DSL
Sbjct: 225 GRECDWWSVGVFLFEMLVGD--TPFY-ADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 25/193 (12%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 151
+G+G FG V K + AVK L ++ +E K+ E +V+ K V+H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
D+ + +Y+ L FF + + Y++
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL-FFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLD + ++DFG+ + G E TS GT Y++PE + + D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 255 FSFGVLLLEIVSG 267
+ G +L E++ G
Sbjct: 180 WCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 30/208 (14%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE----MKNEASVIAKVQ 143
F + +G G FG V K GD A+K + +S +E + E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSL----------------DFFLFDPTKRMLLDW 187
+ +L DKD L+ EY P L F+L + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 242
Y R +K N+L+D+ + K++DFG A N+ N+ VGT Y++PE
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTM 178
Query: 243 --AIQGIFSIKSDVFSFGVLLLEIVSGK 268
+G + ++ D +S GV+ E++ G+
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 24/74 (32%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIKSD 253
+K+ NILLD + + ++DFG+++ E + T GT YM+PE +G D
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVD 189
Query: 254 VFSFGVLLLEIVSG 267
+S G+L+ E+++G
Sbjct: 190 WWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.003
Identities = 27/107 (25%), Positives = 43/107 (40%), Gaps = 29/107 (27%)
Query: 195 LKVSNILLDKDINPKISDFGMA------------------RICGGNELQANTSR------ 230
+K NIL+D D + K++DFG+ + N L
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 231 ---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFY 274
VGT Y++PE + ++ D +S GV+L E++ G FY
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG--FPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 24/75 (32%), Positives = 43/75 (57%), Gaps = 3/75 (4%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI--FSIKS 252
+K+ NILLD + + ++DFG+++ +E++ S GT YM+P+ G
Sbjct: 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAPDIVRGGDGGHDKAV 189
Query: 253 DVFSFGVLLLEIVSG 267
D +S GVL+ E+++G
Sbjct: 190 DWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 46/221 (20%)
Query: 82 SSVSTATNK-FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---PGRSGQGLREMKNEA 136
+ ++ + NK + N +G G FG VY+ + + +++A+K++ P + L MKN
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN-- 115
Query: 137 SVIAKVQHKNLVRLLGC----CIDKDEKIL----IYEYMP-------------NKSLDFF 175
+ H N++ L C K+EK + + E++P N +L F
Sbjct: 116 -----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170
Query: 176 LFDPTKRMLLDWSANYSSR------LKVSNILLDKDINP-KISDFGMAR-ICGGNELQAN 227
L L A S+ LK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRS 227
Query: 228 TSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSG 267
S I + Y +PE + ++ D++S G ++ E++ G
Sbjct: 228 VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 9/87 (10%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQAN--TSRIVGTYGYMSPEYAI-QGIFSIK 251
LK NILLD + + DFG+++ L N T+ GT Y++PE + + ++
Sbjct: 122 LKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 252 SDVFSFGVLLLEIVSGKKTTGFYRTDS 278
D +S GVL+ E+ G + FY D+
Sbjct: 178 VDFWSLGVLVFEMCCG--WSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEA 136
+ S+ T+ + +G+G +G VYK KK G AVK L S E++ E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 137 SVIAKV-QHKNLVRLLGCCIDKDEKI-----LIYEYMPNKSLDFF---LFDPTKRM---- 183
+++ + H N+V+ G D+ + L+ E S+ L +R+
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 184 --------LLDWSANYSSRL-----KVSNILLDKDINPKISDFGMARICGGNELQANTSR 230
LL +++R+ K +NILL + K+ DFG++ L+ NTS
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 231 IVGTYGYMSPEY-----AIQGIFSIKSDVFSFGVLLLEIVSG 267
VGT +M+PE + + DV+S G+ +E+ G
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 28/93 (30%), Positives = 43/93 (46%), Gaps = 1/93 (1%)
Query: 175 FLFDPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233
F + M S N R L N+L+ + KI DFG+AR + +
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++ SDV+SFG+LL EI +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQAN-TSRIVGTYGYMSPEYAI 244
SAN R LK SN+L+++D +I DFGMAR + + V T Y +PE +
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 245 Q-GIFSIKSDVFSFGVLLLEIV 265
++ D++S G + E++
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 11/91 (12%)
Query: 195 LKVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--AIQ---GIF 248
+K N+LLDK+ + +++DFG R+ +Q+N + VGT Y+SPE A++ G +
Sbjct: 128 IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEILQAMEDGKGRY 185
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL 279
+ D +S GV + E++ G T FY +SL
Sbjct: 186 GPECDWWSLGVCMYEMLYG--ETPFY-AESL 213
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.41 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.78 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.72 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.52 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.51 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.85 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.83 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.31 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.12 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.76 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.51 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.48 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.47 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.0 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 95.97 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.63 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.55 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.27 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.99 | |
| PLN02236 | 344 | choline kinase | 93.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.85 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.22 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 93.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.13 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.02 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 91.99 | |
| PF12273 | 130 | RCR: Chitin synthesis regulation, resistance to Co | 91.41 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 90.25 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 89.3 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 88.04 | |
| PF05568 | 189 | ASFV_J13L: African swine fever virus J13L protein; | 86.34 | |
| KOG3021 | 313 | consensus Predicted kinase [General function predi | 85.45 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=360.77 Aligned_cols=268 Identities=42% Similarity=0.740 Sum_probs=224.9
Q ss_pred CCCccchhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeE
Q 041766 75 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154 (387)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 154 (387)
....+++.++..++++|.....||+|+||.||+|.+.++..||||++.........+|..|++++++++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999998899999988765433135699999999999999999999999
Q ss_pred EeCC-ceEEEEEecCCCCcchhhcCCccc------------------cccchh---hhhhcccCCCceEEcCCCCeEEee
Q 041766 155 IDKD-EKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWS---ANYSSRLKVSNILLDKDINPKISD 212 (387)
Q Consensus 155 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~---~~~h~dlk~~Nill~~~~~~kl~D 212 (387)
.+.+ +.+||+||+++|+|.++++..... .+||.. .++||||||+|||||.++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 599999999999999999876541 134442 268999999999999999999999
Q ss_pred ccCceecCCCCcccccccc-cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC-CCcchHhHHHHHHhh
Q 041766 213 FGMARICGGNELQANTSRI-VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYR-TDSLTLLGYAWDLWT 290 (387)
Q Consensus 213 fg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~ 290 (387)
||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+... .....+..|.+....
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999765431 1111222 78999999999999999999999999999999999998876544 334457888888888
Q ss_pred cCccccccccccc-cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 291 SNRTLELIDPILE-DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 291 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.....+++|+.+. ...........+..++.+|++.+|++||+|.||++.|+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8889999999987 33232257778999999999999999999999999996654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=383.88 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=204.1
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
.+....+.+..+.||+|.||+||+|+... ...||||.++..... ..++|.+|+++|..++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34455667778999999999999998543 346999999876554 78899999999999999999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCccc------------------------------cccchhhhhhcccCCCceEEcCCC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTKR------------------------------MLLDWSANYSSRLKVSNILLDKDI 206 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------~~l~~~~~~h~dlk~~Nill~~~~ 206 (387)
++..|||+|||..|||.+||+..... .+|...+.+||||..+||||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999643211 123344458999999999999999
Q ss_pred CeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHH
Q 041766 207 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYA 285 (387)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~ 285 (387)
.|||+|||+++.....+++.......-+.+|||||.+..++||++||||||||+|||+++ |+.|+....
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---------- 710 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---------- 710 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc----------
Confidence 999999999999988888776655566889999999999999999999999999999999 888864322
Q ss_pred HHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 286 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.+.+.+.+...-. -..++.++.++++||..||+.+|++||+|+||-.+|+....+
T Consensus 711 -----n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 -----NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -----hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2222222222211 236778889999999999999999999999999999988654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=356.29 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=192.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-ceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~ 164 (387)
...+...+.||+|+||+||+|.++....||||.+.... ....+.|.+|+.+|.+++|||||+++|+|..+. ..++||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 34455667799999999999999944449999997542 222569999999999999999999999999987 789999
Q ss_pred EecCCCCcchhhcCC-ccc-----------------cccchhh-hhhcccCCCceEEcCCC-CeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDP-TKR-----------------MLLDWSA-NYSSRLKVSNILLDKDI-NPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~-~~~-----------------~~l~~~~-~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++|+|..+++.. ... .++|... +|||||||+|||++.++ ++||+|||+++......
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999999773 211 2678888 89999999999999997 99999999998765432
Q ss_pred ccccccccCCCccccccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAI--QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.......||..|||||++. ...|+.|+||||||+++|||+||+.||..... . . ......... .
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-~---~~~~v~~~~---------~ 263 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-Q---VASAVVVGG---------L 263 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-H---HHHHHHhcC---------C
Confidence 2233368999999999999 56899999999999999999999999854332 1 1 111111000 1
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+ ...+..++..+..|+..||+.||+.||++.+++..|+.+....
T Consensus 264 R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 264 R-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred C-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 1 1122236678899999999999999999999999999886643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=364.25 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=199.0
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++...+.+...+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++++|+|||+++|+|..++.+|||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 33444555667899999999999999997779999999754 34447899999999999999999999999998899999
Q ss_pred EEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 164 YEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+.|+|.++|+..... .+|+....|||||.++||||+++..+||+|||+|+...++.+.
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999999999999873321 2577778899999999999999999999999999965544443
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
. .....-+..|.|||++..+.|+.|||||||||+||||+| |+.|+... ......+.++...+-
T Consensus 360 ~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m---------------sn~ev~~~le~GyRl 423 (468)
T KOG0197|consen 360 A-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM---------------SNEEVLELLERGYRL 423 (468)
T ss_pred e-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC---------------CHHHHHHHHhccCcC
Confidence 3 333455789999999999999999999999999999999 88775321 112222223322222
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
+.+..|+..+.++|..||+.+|++||||+.+...|++....
T Consensus 424 -p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 -PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 35677888999999999999999999999999999887543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=340.78 Aligned_cols=234 Identities=25% Similarity=0.354 Sum_probs=191.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-ceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~e 165 (387)
++++....||+|+.|+||+++++. +..+|+|.+... +....+++.+|++++++++||+||.+||.|.... ..+|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 466778899999999999999986 777999999543 4556678999999999999999999999999998 4999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccc-hhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLD-WSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~-~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||.+|+|+.++..... ..+|| ..++|||||||+|||++..|.+||||||.++.+... ..
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 9999999998874221 23466 388999999999999999999999999999877543 45
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc--
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-- 306 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 306 (387)
.++.||..|||||.+.+..|+.++||||||+.++|+++|+.|+........... ++++.+..+++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~-------------~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF-------------ELLCAIVDEPPPR 301 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-------------HHHHHHhcCCCCC
Confidence 678999999999999999999999999999999999999999865422222222 22222222111
Q ss_pred ccH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSK-HMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~-~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+. .+++++.+++..||+.||.+|||+.|+++.
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122 477889999999999999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=335.85 Aligned_cols=183 Identities=29% Similarity=0.471 Sum_probs=162.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..+|...+.||+|+||+||+|+++. +..||||.+... .....+.+..|+.+|+.++|||||+++++++.++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678899999999999999999876 889999999765 5566778899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC------CCeEEeeccCceecCCC
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD------INPKISDFGMARICGGN 222 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~------~~~kl~Dfg~a~~~~~~ 222 (387)
|||.||||.++++.... ...+|..+++||||||.||||+.. -.+||+|||+|+.+...
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99999999999987643 135788899999999999999765 56899999999988643
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
. ...+.||++.|||||++..+.|+.|+|+||+|+++|+|++|+.||..
T Consensus 169 ~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 169 S---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred h---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 3 34567999999999999999999999999999999999999999854
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=335.34 Aligned_cols=237 Identities=23% Similarity=0.325 Sum_probs=187.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
+.+.|.+.+.||+|+||.|-+|..+. |+.||||.+.+... .....+.+|+++|++++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 55678888999999999999998665 99999999965411 12234679999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC---CCeEEeeccCceec
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARIC 219 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~ 219 (387)
..||||||++||+|.+.+-.... -.++|..+++||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999877754322 136899999999999999999766 78999999999987
Q ss_pred CCCCcccccccccCCCccccccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
+.. ....+.|||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.....+..... .
T Consensus 330 g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e-Q------------ 393 (475)
T KOG0615|consen 330 GEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE-Q------------ 393 (475)
T ss_pred ccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH-H------------
Confidence 633 3456789999999999998654 34588999999999999999999864433321110 0
Q ss_pred cccccc-ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 LIDPIL-EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 ~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+..... -.+........+..+||.+||..||++|||+.|+++.
T Consensus 394 I~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 394 ILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111111 1112345567889999999999999999999999973
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=347.91 Aligned_cols=231 Identities=23% Similarity=0.375 Sum_probs=194.8
Q ss_pred cCCCCCCcccccCCeeEEEEEE-cCCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+|...+.||+|+|+.||+++. ..|+.||+|++.+. .....+.+.+|++|.++|+|||||+++++|++.+..|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999998 66999999999753 4566788999999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+|.+++|..++.+... ..++|..+++|||||..|++|+++.++||+|||+|..+.... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--ccc
Confidence 99999999888874322 236899999999999999999999999999999999886443 234
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-c
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-S 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 307 (387)
.+.|||+.|.|||++....++..+||||+||+||-|+.|++||... ...+....+....+ .
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------------------~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------------------TVKETYNKIKLNEYSM 237 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------------------hHHHHHHHHHhcCccc
Confidence 5689999999999999999999999999999999999999997422 12222222221111 2
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+...+.+..+||.++|+.||.+|||+++|+..
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 34566788999999999999999999999963
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=324.22 Aligned_cols=235 Identities=23% Similarity=0.358 Sum_probs=184.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeee-eEEeCCc-eEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLG-CCIDKDE-KIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~-~~~~~~~-~~l 162 (387)
...|++.++||+|+||+||++... +|..||.|.++.. +....+.+.+|+.+|++++|||||++++ .+.+... ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356888999999999999999854 5889999988633 5566788999999999999999999999 4444444 789
Q ss_pred EEEecCCCCcchhhcCCcccc--------------------ccch--hh--hhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 163 IYEYMPNKSLDFFLFDPTKRM--------------------LLDW--SA--NYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~~--------------------~l~~--~~--~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
|||||.+|||..++....... ..|. .+ ++||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999998886433210 1222 33 68999999999999999999999999998
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
+.... ......+||+.||+||.+.+.+|+.|+||||+||++|||+.-.+||... +..++.
T Consensus 178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------------------n~~~L~ 237 (375)
T KOG0591|consen 178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------------------NLLSLC 237 (375)
T ss_pred hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------------------cHHHHH
Confidence 86543 2334579999999999999999999999999999999999999997432 112222
Q ss_pred cccccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 299 DPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 299 ~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.++-..+. .....+..+..|+..|+..||+.||+.-.++..+..
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22222222 236678899999999999999999985555544443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.43 Aligned_cols=230 Identities=23% Similarity=0.341 Sum_probs=187.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++++.||+|+||+||.++.++ ++.+|+|++++. .........+|..+|.+++||+||+++-.|++++.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3689999999999999999999776 888999999754 234566788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
+||+.||+|..+|.+... ..+||..+++||||||+|||||.+|+++|+|||+++..-... ..
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~ 181 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DA 181 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--Cc
Confidence 999999999998875432 135899999999999999999999999999999998543222 23
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc-c
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE-Y 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 306 (387)
+.++|||+.|||||++.+..|+..+|+||+|+++|||++|.+||... +..+..+.++... .
T Consensus 182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~------------------~~~~~~~~I~~~k~~ 243 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE------------------DVKKMYDKILKGKLP 243 (357)
T ss_pred cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc------------------cHHHHHHHHhcCcCC
Confidence 45689999999999999999999999999999999999999997432 2222222222222 1
Q ss_pred -ccHHHHHHHHHHHHhcccCCCCCCC----CHHHHH
Q 041766 307 -SSKHMLLRYVNIALLCVQESADDRP----TMNEVV 337 (387)
Q Consensus 307 -~~~~~~~~~~~li~~cl~~dP~~RP----t~~~v~ 337 (387)
.+........+++.+.|..||++|. .+.+|-
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 2223456788999999999999995 455543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=366.85 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=204.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC--CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK--GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.+....+.||+|.||.||.|.+.+ +. .||||.++.. +.....+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455677899999999999999764 33 3999999755 4566789999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
|++|||++|||..||++.... .+|+..+.|||||..+||||+....+||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 999999999999999876221 256777889999999999999999999999999998
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
....+++.......-+.+|||||.+..+.|+.|+|||||||+|||++| |..||....+ ......+.. ..
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~~~~---gg----- 921 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLDVLE---GG----- 921 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHHHHh---CC-----
Confidence 877777766655566789999999999999999999999999999999 7788643221 111111111 00
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceee
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSY 357 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~ 357 (387)
....+..|+..++++|.+||+.+|++||+|..+++++........+......+.
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a 975 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPA 975 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccccc
Confidence 112456678889999999999999999999999999988877554444444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=336.67 Aligned_cols=238 Identities=23% Similarity=0.333 Sum_probs=192.9
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++++.+....++.||.|+.|.||+|+++ ++.||||+++.-. ..++..|++|+||||+.|.|+|....-+|||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 4445555566889999999999999998 7889999985322 2468899999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||||..|-|...|..... ..+||...+||||||.-||||+.+..+||+|||.++...+. ..
T Consensus 191 MEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST 267 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST 267 (904)
T ss_pred eeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence 999999999988865432 24689999999999999999999999999999999877544 22
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.-.++||..|||||++...+.+.|+|||||||+||||+||..||..-... ...|. +-......+.
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwG----------VGsNsL~Lpv 332 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWG----------VGSNSLHLPV 332 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEe----------ccCCcccccC
Confidence 34579999999999999999999999999999999999999996321111 00111 1111111224
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+..++..+.-|+++||+..|..||+|.+++..|+=..+++
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 5667788999999999999999999999999998776654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.60 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=203.0
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+.+...+.++||+|.||.|.++....+..||||+++... .+.+.+|.+|+++|.+++|||||+++|+|..++.+|+|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3455677889999999999999999878999999998654 455689999999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||+++|+|..|+..+... .+|.....+||||.++|||++.++++||+|||+++.+...+++.
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999999765221 25677788999999999999999999999999999888777777
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....+-+.+|||||.+.-+.+++++|||+||+++||+++ ...||....++ ...+.....+..+.....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--~vven~~~~~~~~~~~~~------- 765 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--QVVENAGEFFRDQGRQVV------- 765 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--HHHHhhhhhcCCCCccee-------
Confidence 7777788899999999999999999999999999999987 55675432211 111111122222111111
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
...+.-++..++++|.+||..|.++||+|+++...|++..
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1134556778899999999999999999999999988753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=331.86 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=201.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 161 (387)
...+|.+++.||.|+|++|++|+... +..+|||++.+. .......+..|-+.|.+| .||.|++++-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34689999999999999999999665 889999998654 223345677899999999 8999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+|+||+++|+|..+|.+... ..++|..++|||||||+|||||++|++||+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999876533 23689999999999999999999999999999999987542211
Q ss_pred ---------ccc--ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 226 ---------ANT--SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 226 ---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
... ..++||..|.+||++.++..+..+|+|+|||++|+|+.|++||.... .
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N------------------e 292 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN------------------E 292 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc------------------H
Confidence 112 45899999999999999999999999999999999999999974322 1
Q ss_pred cccccccccccc-ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH-------hhhhhhccCCCCCCceee
Q 041766 295 LELIDPILEDEY-SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM-------LTDEAAALFPPKQPAFSY 357 (387)
Q Consensus 295 ~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~-------L~~~~~~~~~~~~~~~~~ 357 (387)
..++++++.-.+ .+...++.+.+|+.+.|..||.+|+|..+|-+. .+++....+|+-+|.-+.
T Consensus 293 yliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~ 363 (604)
T KOG0592|consen 293 YLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPA 363 (604)
T ss_pred HHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCc
Confidence 112222222211 234445678899999999999999999999875 245555566666665443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.20 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=197.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-C---CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
....+.+.||.|.||.|++|+++. | ..||||.++.. ....+.+|+.|+.||.+++||||+++.|+........||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345667899999999999999774 3 46999999854 456677999999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcccc-----------------ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-c
Q 041766 164 YEYMPNKSLDFFLFDPTKRM-----------------LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL-Q 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~~-----------------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~ 225 (387)
+|||++|+|+.||+....+. +|..+..+||||.++|||++.+..+|++|||+++.+.+... .
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 99999999999999876642 46667779999999999999999999999999998865441 1
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......-+.+|.|||.+....++.++|||||||+|||.++ |..||- + +..+.+...++...+-
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--------------d-mSNQdVIkaIe~gyRL 853 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--------------D-MSNQDVIKAIEQGYRL 853 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--------------c-cchHHHHHHHHhccCC
Confidence 11222334679999999999999999999999999999988 888862 1 2222233333333332
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
+ .+.+|+..+.+||..||++|-.+||.|.||+..|+++..+
T Consensus 854 P-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 854 P-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred C-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2 4567788999999999999999999999999999999753
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=327.51 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=203.4
Q ss_pred ccchhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 041766 78 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155 (387)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 155 (387)
..+..++++..+.+.+.+.||+|+||+||+|+|. ..||||+++.. .....+.|..|+..+++-+|.||+-++|+|.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 3445778888889999999999999999999997 46999999754 3456789999999999999999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.++. .||+.+|+|.+|..+++.... -.+||...|||+|||..||++.++++|||+|||++..
T Consensus 459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 8877 899999999999999876433 2479999999999999999999999999999999975
Q ss_pred cCCCCcccccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
...-..........|...|||||++.. .+|++.+|||||||++|||++|..||..... .
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~------------------d 599 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR------------------D 599 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh------------------h
Confidence 432222222344567889999999963 5799999999999999999999999752111 1
Q ss_pred ccccccccc------ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCC
Q 041766 296 ELIDPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQ 352 (387)
Q Consensus 296 ~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~ 352 (387)
+++-..-++ ......+...+.+|+..||..++++||.+.+|+..|+++...++.-.+
T Consensus 600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~R 662 (678)
T KOG0193|consen 600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINR 662 (678)
T ss_pred heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccccc
Confidence 111111111 012345567899999999999999999999999999999876544444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.29 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=182.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|+.+.++|+|+||.||+++.++ |+.||||++.... +...+-.++|+++|++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468889999999999999999887 9999999997543 3334456799999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||+..-|.++-+...+ -.+.|...+|||||||+||||+.++.+||||||.|+.+..... ..+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YT 159 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYT 159 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhh
Confidence 9987655443322221 1245667789999999999999999999999999998864321 233
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh---------HHHHHHhhcCcccc-cc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL---------GYAWDLWTSNRTLE-LI 298 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~-~~ 298 (387)
..+.|..|+|||.+.+ .+|+..+||||+||++.||++|.+-|....+-..... ....+.+....... +.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 4577999999999988 6799999999999999999999988764433221111 00111111111110 00
Q ss_pred cccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
-|...... ..+....-+.+++++||+.||.+|++-+|++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 01111000 11233456789999999999999999999885
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=318.69 Aligned_cols=232 Identities=22% Similarity=0.352 Sum_probs=190.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..|...+.||+|+||.||+|.... ++.||+|.+.-. .....+++.+|+.+|.+++++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777999999999999999776 788999999744 445567899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|.+|++.+.+..... ..++|..+.+|||||+.|||+..+|.+||+|||++..+...... ..+
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~t 170 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKT 170 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc--ccc
Confidence 999999888765432 23578888899999999999999999999999999877644332 367
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+ .+..-++.+...... ...
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~PP~L-~~~ 234 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSAPPRL-DGD 234 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCCCCcc-ccc
Confidence 8999999999999988999999999999999999999999643221 111222222111111 225
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+.+.+.+++..||+.||+.||+|.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 6778999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.50 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=191.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.+.|+..+.||.|..+.||+|++.. ++.||||+++-. ...+.+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4789999999999999999999665 889999999633 33446889999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||.+|++.+++...-. ..++|..+.||||+|+.||||+++|.|||+|||.+..+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 9999999888754321 2468999999999999999999999999999998876654432221
Q ss_pred --cccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 228 --TSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 228 --~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
..++.||++|||||++.. ..|+.|+||||||++..||.+|..||..+++-...+... ..... .......
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-----qn~pp--~~~t~~~ 257 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-----QNDPP--TLLTSGL 257 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-----cCCCC--CcccccC
Confidence 156789999999999654 359999999999999999999999987665443322211 11110 0000011
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...........+.+++..||+.||++|||++++++
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11123344568899999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=322.35 Aligned_cols=237 Identities=26% Similarity=0.376 Sum_probs=193.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
....|....+||+|.-|.||.++.. .++.||||++........+-+..|+.+|+..+|+|||+++..|...+.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4467888899999999999999854 488899999987777777788999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 166 YMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|+++|+|.+.+..... ..+||..+++|||||.+|||++.+|.+||+|||++..+..... ...+
T Consensus 351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRST 428 (550)
T ss_pred ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cccc
Confidence 9999999888765421 2468999999999999999999999999999999987754432 4456
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.+||++|||||++....|++|+||||||++++||+.|.+||-... ... .-+. ...... +.++ ..+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--Plr-AlyL---Ia~ng~-----P~lk---~~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLR-ALYL---IATNGT-----PKLK---NPEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHH-HHHH---HhhcCC-----CCcC---Cccc
Confidence 799999999999999999999999999999999999999974311 100 0000 000111 1111 2345
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+..+.+++.+||+.|+++|+++.++|+.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 56789999999999999999999999974
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=327.74 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=195.7
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCC----CE-EEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeee
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKG----DE-IAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGC 153 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~----~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 153 (387)
..++...++....++||+|.||.||+|.+..+ .. ||||..... ......+|++|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34555566677789999999999999997642 23 899998752 35567789999999999999999999999
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
+....++++|||+|.||+|.++|...... .++|...++||||.++|||++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999876531 3588899999999999999999999999999998
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
+... .+........-+.+|+|||.+....|+.++|||||||++||+++ |..||..- .......++.
T Consensus 310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--~~~~v~~kI~--------- 376 (474)
T KOG0194|consen 310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--KNYEVKAKIV--------- 376 (474)
T ss_pred cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--CHHHHHHHHH---------
Confidence 7643 11111212245789999999999999999999999999999999 78775321 1111111110
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCC
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~ 349 (387)
....+ ...+...+..+..++.+||..+|++||||.++.+.|+.+.....+
T Consensus 377 ---~~~~r-~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 377 ---KNGYR-MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---hcCcc-CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 00001 112224456788899999999999999999999999998765543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=320.88 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=185.9
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
...++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999742 24579999987542 23446788999999999 899999999998765
Q ss_pred C-ceEEEEEecCCCCcchhhcCCcc-------------------------------------------------------
Q 041766 158 D-EKILIYEYMPNKSLDFFLFDPTK------------------------------------------------------- 181 (387)
Q Consensus 158 ~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 181 (387)
+ ..+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999888754210
Q ss_pred -----------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccc
Q 041766 182 -----------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238 (387)
Q Consensus 182 -----------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 238 (387)
..++|..+++||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 123677778999999999999999999999999998654322222223345677899
Q ss_pred cccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHH
Q 041766 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVN 317 (387)
Q Consensus 239 aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (387)
|||++.+..++.++|||||||++|||++ |..||....... .. .......... ..+...+..+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~----~~~~~~~~~~----------~~~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EF----CQRLKDGTRM----------RAPENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HH----HHHHhcCCCC----------CCCCCCCHHHHH
Confidence 9999999999999999999999999997 998875432211 10 1111111100 011223457889
Q ss_pred HHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 318 IALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 318 li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
++.+||+.||++|||+.++++.|+++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=310.84 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=185.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--ceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv~e 165 (387)
.++...+.||+|+||.||++...+ |...|||.+...+....+.+.+|+.+|++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999999776 8899999987554333677899999999999999999999855554 5889999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecCC-CCccc
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICGG-NELQA 226 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-~~~~~ 226 (387)
|+++|+|.+++...... .++|..+++||||||+|||++. ++.+||+|||+++.... .....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99999999999875521 2578888999999999999999 79999999999987653 11112
Q ss_pred ccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
......||+.|||||++..+ ....++|||||||++.||+||+.||... ................ |
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~-----P----- 242 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL-----P----- 242 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC-----C-----
Confidence 23457899999999999853 3345999999999999999999997543 1111111111111100 1
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
..+...+....+++.+|++.||+.||||+++++...-
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1233456678899999999999999999999986543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=323.03 Aligned_cols=244 Identities=28% Similarity=0.406 Sum_probs=198.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.++-...+.....+||-|.||.||.|.|+. .-.||||.++. +....++|++|+.+|+.++|||+|+++|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 334344445566789999999999999987 67799999975 4466789999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
||+|||.+|+|.++|++.... .+|+....|||||..+|||+.++..+|++|||+++.+....
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999999876653 24566777999999999999999999999999999987665
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
+... ....-+..|.|||.+....++.|+|||+|||+|||+.| |..||.... + ..++. +++...
T Consensus 420 YTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----l-SqVY~---------LLEkgy 483 (1157)
T KOG4278|consen 420 YTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----L-SQVYG---------LLEKGY 483 (1157)
T ss_pred eecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----H-HHHHH---------HHhccc
Confidence 5443 33445789999999999999999999999999999999 777764211 1 11122 222222
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
+-. .+..|++.+++||+.||+++|.+||+|+|+.+.++.+.
T Consensus 484 RM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 RMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 221 45678889999999999999999999999999887664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=319.14 Aligned_cols=230 Identities=26% Similarity=0.375 Sum_probs=192.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|.+.+.||+|+||.||+|+.+. .+.||+|.+.+. ...+...+.+|++|+++++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999999665 788999999654 44566789999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||.| +|..++.+... ..++|..+++|||+||.|||++.++.+|+||||+|+.+..+. ...+
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeee
Confidence 9977 99988876543 236888999999999999999999999999999999876543 3345
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-cc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-SS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 308 (387)
...||+.|||||++.+.+|+..+|.||+||++|||++|++||. .....++++.++..+. .+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------------------a~si~~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------------------ARSITQLVKSILKDPVKPP 220 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------------------HHHHHHHHHHHhcCCCCCc
Confidence 6789999999999999999999999999999999999999973 1222233333333222 23
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
......+.+++...|+.||..|.|-.+++..
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 4567789999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=309.93 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=185.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 161 (387)
..+.|+.+++||+|.||.||+|+.. +|+.||+|++... ......-..+|+.||++++||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3467888999999999999999955 4899999998654 345556677999999999999999999998886 6899
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+|||++ ||.-++..... ..++|..+++|||||.+|||||.+|.+||+|||+|+.......
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999976 77666654321 2357888899999999999999999999999999997765443
Q ss_pred ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--cc------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--TL------ 295 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------ 295 (387)
.. .+..+-|+.|+|||.+.|. .|+.++|+||.||||.||++|++.+....+ .......+....... ..
T Consensus 274 ~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--veQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 274 AP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--VEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred cc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--HHHHHHHHHHhCCCChhccccccCC
Confidence 32 3445679999999999975 599999999999999999999988654322 222222222111110 00
Q ss_pred --ccccc------ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 --ELIDP------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 --~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+.+ .+.. .....+....+|+..+|..||.+|.|+.++++
T Consensus 351 ~~~~~kp~~~y~r~l~E--~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRE--TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHH--HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 1111 12234567789999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=310.93 Aligned_cols=238 Identities=20% Similarity=0.270 Sum_probs=183.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|+.+..||+|+||.||+|+-++ |..+|+|++++. .......+..|-.+|...++|.||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999776 899999999765 23445678889999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCccc----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC----
Q 041766 163 IYEYMPNKSLDFFLFDPTKR----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN---- 222 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~---- 222 (387)
||||++|||+..+|...... ..+|..++|||||||+|+|||..|++||+||||+..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999999998888654321 2477888899999999999999999999999999543210
Q ss_pred ------------------Ccc-----c------------------ccccccCCCccccccccccCCCCccccchhHHHHH
Q 041766 223 ------------------ELQ-----A------------------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261 (387)
Q Consensus 223 ------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil 261 (387)
+.. . .....+||+.|||||++.+..|+..+|+||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 000 0 01125799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 041766 262 LEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNEVVS 338 (387)
Q Consensus 262 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~~v~~ 338 (387)
|||+.|.+||....+...--.-..|.. .+.. +....+..++.+||.+|+. ||++|.- +.||-+
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~------------~l~f-P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRE------------TLKF-PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhh------------hccC-CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 999999999865443321111111110 0000 0112233688999999999 9999975 566554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.32 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=183.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-----------------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
.++|.+.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678889999999999999998642 2369999987543 334567899999999999999999
Q ss_pred eeeeEEeCCceEEEEEecCCCCcchhhcCCcc-----------------------------------ccccchhhhhhcc
Q 041766 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-----------------------------------RMLLDWSANYSSR 194 (387)
Q Consensus 150 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------~~~l~~~~~~h~d 194 (387)
+++++.+.+..++||||+++|+|.+++..... ..++|..+++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 99999999999999999999999887743210 1246777889999
Q ss_pred cCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCC--CCCC
Q 041766 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK--KTTG 272 (387)
Q Consensus 195 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~--~p~~ 272 (387)
|||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++. .||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999998664433322233445678899999998888999999999999999999754 4543
Q ss_pred CCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 273 FYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.. .................. ... ...+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 244 ~~--~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 EL--TDEQVIENAGEFFRDQGR-QVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cC--CHHHHHHHHHHHhhhccc-ccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 22 221111111111111000 000 00112334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=314.72 Aligned_cols=232 Identities=23% Similarity=0.331 Sum_probs=185.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC----Cc-ccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR----SG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~ 159 (387)
..++|.+.+.||+|+||+|+.|.+.. +..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34689999999999999999998664 899999976543 11 23456668999999998 9999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGN 222 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 222 (387)
.++|||||.+|+|.+++..... -.++|..+++||||||+|+|++.+ +++||+|||++....
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-- 172 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-- 172 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--
Confidence 9999999999999988876322 125778888999999999999999 999999999998763
Q ss_pred CcccccccccCCCccccccccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGI-FS-IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.......+.+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...... . +...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~----------------l~~k 234 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--N----------------LYRK 234 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--H----------------HHHH
Confidence 1122356679999999999999987 85 7899999999999999999998641111 1 1111
Q ss_pred ccccccc-cHHH-HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILEDEYS-SKHM-LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~~~~~-~~~~-~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+....+. +... +..+..|+.+|+..||..|+|+.++++
T Consensus 235 i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111111 1222 667889999999999999999999994
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.15 Aligned_cols=220 Identities=26% Similarity=0.347 Sum_probs=184.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|+..+.||.|+||+|.+++.+. |.-+|+|++.+.. -...+....|..+|+.+.||+++++++.|.+....|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678999999999999999999876 7789999997543 23445667899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||.+||.|..+++.... ..++|...++.|||||+|||||.+|.+||+|||.|+...+.
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----
Confidence 999999999999976432 13578888999999999999999999999999999987543
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY- 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (387)
+.+.|||+.|+|||++...+|+.++|.|||||++|||+.|.+||..... .++.++++....
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------IQIYEKILEGKVK 259 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------HHHHHHHHhCccc
Confidence 4567999999999999999999999999999999999999999743322 222223333222
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCC
Q 041766 307 SSKHMLLRYVNIALLCVQESADDR 330 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~R 330 (387)
.+......+.+|+.+.++.|-.+|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 345556678899999999999999
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=302.08 Aligned_cols=229 Identities=21% Similarity=0.259 Sum_probs=177.0
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCccc---HHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceEEEEEec
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYM 167 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~~ 167 (387)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|+.+|.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999985 8899999997543322 4677899999999999999999999877 34678999999
Q ss_pred CCCCcchhhcCCccc----------------cccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTKR----------------MLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~----------------~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
++|+|..++...... ..+|. .+.+||||||+|||+++++.+||+|||+++...... ..
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~ 179 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FK 179 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----cc
Confidence 999999988654321 12443 366799999999999999999999999987654321 23
Q ss_pred ccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 231 IVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .. .......... . ..+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~---~~~i~~~~~~-----~-----~~~ 244 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EI---YDLIINKNNS-----L-----KLP 244 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HH---HHHHHhcCCC-----C-----CCC
Confidence 467889999999976 67999999999999999999999998533211 11 1111000000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 134567899999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=279.81 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=189.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|...++||+|.||.||+|+... |+.||||+++... ........+|+..|+.++|+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467888999999999999999655 8999999996432 2223467799999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|++- +|+..+++... ..++|...++||||||.|+||+.+|.+||+|||+|+..........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~- 159 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT- 159 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc-
Confidence 9965 88877765432 2357888899999999999999999999999999998875443222
Q ss_pred ccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc---cc---c--
Q 041766 229 SRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE---LI---D-- 299 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~-- 299 (387)
..+-|..|+|||.+.|. .|+..+||||.||++.||+-|.+-|. ...+- +.....+..+......+ +. +
T Consensus 160 -~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~sDi-dQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 160 -HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDSDI-DQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred -cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCchH-HHHHHHHHHcCCCCcccCccccccccHH
Confidence 22678899999999875 59999999999999999999876543 22222 22223333222221111 00 0
Q ss_pred -----cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCcee
Q 041766 300 -----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFS 356 (387)
Q Consensus 300 -----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~ 356 (387)
+..............+.+|+.++|..||.+|+|+.|++++= -....+.|.+|...
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~l 296 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKL 296 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhC
Confidence 00000001122345678999999999999999999998741 11224555554443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=314.82 Aligned_cols=228 Identities=24% Similarity=0.353 Sum_probs=187.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
...++|.++++||+|+||+|+++.++. ++.+|||.+++. ...+.+..+.|-+|+... +||.++++++.|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999876 778999999876 345567788899999887 699999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||||+.||++..+.+...- ..++|..++|+||||.+|||||.+|++||+|||+++..-.. .
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g 522 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--G 522 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC--C
Confidence 999999999995444432111 24689999999999999999999999999999999865322 2
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
..++++|||+.|||||++.+..|+.++|.|||||+||||+.|..||.... ..++++.++..+
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd------------------Eee~FdsI~~d~ 584 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD------------------EEEVFDSIVNDE 584 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC------------------HHHHHHHHhcCC
Confidence 35678999999999999999999999999999999999999999975332 223333333332
Q ss_pred c-ccHHHHHHHHHHHHhcccCCCCCCCCH
Q 041766 306 Y-SSKHMLLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 306 ~-~~~~~~~~~~~li~~cl~~dP~~RPt~ 333 (387)
. -+..++.+..+++++++..+|++|.-+
T Consensus 585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2 344567788999999999999999865
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=295.79 Aligned_cols=234 Identities=22% Similarity=0.366 Sum_probs=192.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+.+-|.++++||+|+||.||++.++. |+.||||.++-. .+.+++.+|+.||.++..|++|++||.+.....+|+|||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 34567788999999999999999876 899999999643 567899999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||..|++.++++..++ ..++|....+|||||..|||+..+|.+||+|||.|..+.+ .....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 9999999988865433 2468899999999999999999999999999999987653 33445
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-c
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-S 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 307 (387)
++..||+.|||||++..-.|++++||||||++..||..|++||....+-. ..-++.......+ .
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPPTF~K 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPPTFKK 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCCCCCC
Confidence 67899999999999999999999999999999999999999974322111 0001111111111 2
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+...+..+-+++++||..+|++|-|+.++++.
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 45667889999999999999999999998873
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.27 Aligned_cols=241 Identities=24% Similarity=0.372 Sum_probs=196.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC---CC--EEEEEEccC-CCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK---GD--EIAVKRLPG-RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
..+.....+.||.|.||.||+|.+.+ |+ .||||..+. ......+.|+.|..+|++++|||||+++|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 33445566789999999999999653 33 489999876 4556688999999999999999999999999764 57
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||||.++.|.|..+++..... .+++....+||||..+|||+.....+||+|||+++.+.+..
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999876542 35788888999999999999999999999999999988776
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
++... ...-+..|||||.+.-.+++.++|||-|||++||++. |..||..-.+ ..+.-.++..
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------------sDVI~~iEnG- 608 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------------SDVIGHIENG- 608 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------------cceEEEecCC-
Confidence 65544 4455789999999999999999999999999999988 9999753221 1111111111
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+.++.|++.++.|+.+||+.+|.+||++.++...|.++..
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1223677889999999999999999999999999998877764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=305.56 Aligned_cols=248 Identities=21% Similarity=0.274 Sum_probs=184.8
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHH-HHHHHHHHHHhcC-CCceeeeeeeEEeCC-ceE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLR-EMKNEASVIAKVQ-HKNLVRLLGCCIDKD-EKI 161 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~nIv~~~~~~~~~~-~~~ 161 (387)
...++|...++||.|+||.||+|+... ++.||||+++..-....+ .=.+|+..|++++ |||||++..++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 455789999999999999999999654 889999999765433222 2357999999998 999999999999988 899
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+|||||+. +|.+++.+.... .++|..+..|||+||+|||+.....+||+|||+|+......
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp- 164 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP- 164 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC-
Confidence 99999955 888888765332 24677778999999999999988899999999999876543
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc---c----
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL---E---- 296 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 296 (387)
..+..+.|..|+|||++.. +-|+.+.|+||+||+++|+.+-++-|....+-+. .....+........ +
T Consensus 165 --PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq--i~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 165 --PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ--IYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred --CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH--HHHHHHHhCCCccccchhHHHH
Confidence 2344578999999999875 5689999999999999999999887754332111 11111111111100 0
Q ss_pred -----cccccccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 -----LIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 -----~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.--+...+.. -....+.++.+|+.+|+++||.+||||.|+++.
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0001111100 012256788999999999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.99 Aligned_cols=243 Identities=26% Similarity=0.345 Sum_probs=184.3
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
...++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+.++..+ +||||++++++|...
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34567899999999999999999742 25579999986432 33456788999999999 899999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------------------------------------------------
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK-------------------------------------------------------- 181 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 181 (387)
+..++|||||++|+|..++.....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999888754210
Q ss_pred -----------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 182 -----------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 182 -----------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
..++|..+++|+||||+|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 013566778999999999999999999999999998764433222
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
......++..|+|||++.+..++.++|||||||++|||++ |..||.....+. ..... ...... ..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~----~~~~~~-----~~---- 337 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKM----IKEGYR-----ML---- 337 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHH----HHhCcc-----CC----
Confidence 2223345678999999999999999999999999999998 777764332211 11111 111100 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.+...+..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=313.77 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=186.5
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
+....++|++.+.||+|+||.||+|+... +..||+|++.... ......+.+|+.+++.+ +|+|||+++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 34455789999999999999999998532 3579999997542 33456788999999999 8999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc------------------------------------------------------
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------------------------------ 181 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 181 (387)
..+..++|||||++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999887743210
Q ss_pred --------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 182 --------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 182 --------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
..++|..+++||||||+|||+++++.+||+|||+++............
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 013566778999999999999999999999999998654332222222
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ........ ... .+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~----~~~~~~~~-----~~~-----~~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KF----YKMVKRGY-----QMS-----RP 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HH----HHHHHccc-----Ccc-----CC
Confidence 2345678999999998899999999999999999997 999975432211 00 11111000 000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=311.70 Aligned_cols=230 Identities=23% Similarity=0.303 Sum_probs=190.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+-|+.++.||.|+-|.|.+|++.. |+.+|||.+.+. .......+.+|+-+|+-+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457889999999999999999765 999999999765 2233456889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTKR----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|.|.+++...... .+.|..+++||||||+|+|||..+++||+|||+|....... ..
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---cc
Confidence 999999999888665432 24677778999999999999999999999999998754433 23
Q ss_pred ccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-
Q 041766 229 SRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY- 306 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 306 (387)
.+-||++.|.|||++.|.+| +.++||||+|||||.|+||+.||+. ++...++.+..++.+
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------------------dNir~LLlKV~~G~f~ 230 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------------------DNIRVLLLKVQRGVFE 230 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------------------ccHHHHHHHHHcCccc
Confidence 45699999999999999999 5889999999999999999999752 222222222223322
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+...+.++.+|+.+|+..||+.|.|++||++.
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 345567789999999999999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=307.09 Aligned_cols=231 Identities=23% Similarity=0.304 Sum_probs=192.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc-eEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-KILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-~~lv~ 164 (387)
++|..++++|+|+||.++..+++. +..+++|.+... .........+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578899999999999999999775 778999988643 34455578899999999999999999999999888 89999
Q ss_pred EecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+||+||++.+.+....+. .++|..+++|||||+.||+++.+..|||+|||+|+.+.... .
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--S 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--h
Confidence 999999999888665421 24778889999999999999999999999999999886543 2
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc--
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED-- 304 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 304 (387)
...+..||+.||+||.+.+.+|+.|+|||||||++|||++-+++|...... .++..+...
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------------------~Li~ki~~~~~ 223 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------------------ELILKINRGLY 223 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------------------HHHHHHhhccC
Confidence 345679999999999999999999999999999999999999997533221 111111111
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+.+...+..+..++..|++.+|+.||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12445567789999999999999999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.81 Aligned_cols=270 Identities=21% Similarity=0.262 Sum_probs=195.1
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
...+.|+.+..|++|+||.||+|+.+. ++.||+|+++... ...--...+|+.+|.+++|||||.+-.+.... +.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 345678899999999999999999876 7889999997442 22223557999999999999999999888764 468
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||||||+. ||..++...... .++|...++|||||++|+|++..|.+||+|||+|+..+...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999966 888877654421 35788889999999999999999999999999999887542
Q ss_pred cccccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh--cCccccccc-
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT--SNRTLELID- 299 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~- 299 (387)
...+..+-|..|+|||.+.+.+ |+++.|+||+|||+.||+++++.|.....-. .....+.... .+.....+.
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCccc
Confidence 2344567799999999999864 9999999999999999999998875433221 1111111111 111000000
Q ss_pred --------------cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhhhccCCCCCCceeeeec
Q 041766 300 --------------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEAAALFPPKQPAFSYVRN 360 (387)
Q Consensus 300 --------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~~~~~~~~~~~~~~~~~ 360 (387)
..++..+........-++|+...|..||.+|.|++|.++. +.+.-....|..-|.++..+.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 0011111111134677899999999999999999999873 555444455555555664443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=334.26 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=192.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
....|...+.||+|+||.||+|+.. ++..||||++...... ...|++.+++++|||||+++|+|.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3456777889999999999999975 5889999998644322 2356889999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-------------ccccc---hhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK-------------RMLLD---WSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-------------~~~l~---~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+++|+|.++++.... ..++| ..+++||||||+||+++.++.+++. ||.+..... ..
T Consensus 764 y~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~ 836 (968)
T PLN00113 764 YIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DT 836 (968)
T ss_pred CCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CC
Confidence 9999999998864221 12456 4578999999999999999888876 666543221 12
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc-ccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE-YSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 308 (387)
...++..|+|||++.+..++.++|||||||++|||+||+.|++...........|....+........+++.+... ...
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 2367899999999999999999999999999999999999986544444455556554444444444455554332 123
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
......+.+++.+||+.||++||||+|+++.|+++..
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 4556678899999999999999999999999998754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=297.04 Aligned_cols=233 Identities=22% Similarity=0.351 Sum_probs=191.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEE-cCCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
...+|++.+.||+|.||+|-+|.. ..|+.||||.+++. +..+.-.+.+|++||+.++||||+.+|.+|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346899999999999999999985 55999999999754 34455567899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCccc----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||..+|.|.+++.+.... .+.|..+.+|||||.+|||+|.++++||+|||++..+.+..
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--- 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--- 207 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc---
Confidence 99999999999999664431 24566777999999999999999999999999998765443
Q ss_pred ccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
...++||++.|.+||++.|.+| ++.+|.|||||+||-|+.|..||+.... ..++..+-.+.
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------------k~lvrQIs~Ga 269 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------------KRLVRQISRGA 269 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------------------HHHHHHhhccc
Confidence 3456899999999999999998 5889999999999999999999854321 11222222333
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
+..++.+....-||++||..||++|.|+.+|...-
T Consensus 270 YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 YREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 33333344667899999999999999999998853
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=307.77 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=187.2
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 155 (387)
.....++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+++|+++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 33445789999999999999999998632 2469999996442 334567899999999995 999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc------------------------------------------------------
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------------------------------ 181 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 181 (387)
..+..|+|||||++|+|..++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999887753210
Q ss_pred ----------------------------------------------------------ccccchhhhhhcccCCCceEEc
Q 041766 182 ----------------------------------------------------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 182 ----------------------------------------------------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
..++|..+++|+||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 0135666778999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHh
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLL 282 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 282 (387)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--- 348 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--- 348 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH---
Confidence 999999999999986543322222233456788999999998899999999999999999997 8888753221111
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
......... . .......+..+.+++.+||+.||++|||+.+|.+.|+.+.
T Consensus 349 --~~~~~~~~~-----~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 --FYNKIKSGY-----R-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHhcCC-----C-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111110 0 0012234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.02 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=183.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+++... +..+|+|.+... .......+.+|+++|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3689999999999999999999775 788999988654 23345678999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++|+|.+++..... ..++|.. +++|+||||+|||++.++.+||+|||++...... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 159 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----cc
Confidence 9999999988864321 0134543 4789999999999999999999999998765322 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh-hcCc--c-----------
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW-TSNR--T----------- 294 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~--~----------- 294 (387)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+........ .... .
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCccccccc
Confidence 3357899999999999989999999999999999999999998533211 1111000000 0000 0
Q ss_pred ----------------cccccccc---ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 295 ----------------LELIDPIL---EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 295 ----------------~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+..+... .........+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 0000111245678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=295.31 Aligned_cols=238 Identities=27% Similarity=0.449 Sum_probs=185.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-C-----CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 568889999999999999998653 2 469999986443 334467889999999999999999999999988999
Q ss_pred EEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 162 LIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
++|||+++++|.+++..... ...+|..+++|+||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 99999999999888854311 0236777889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ... ..
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~----~~ 238 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI----EM 238 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HH
Confidence 999999986644333223334466788999999988899999999999999999998 98887432211 111 10
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...... ...+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus 239 i~~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111100 01223456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.10 Aligned_cols=229 Identities=23% Similarity=0.280 Sum_probs=180.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|++.. ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578889999999999999999875 789999998643 2233467889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++..... .
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----T 172 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----c
Confidence 99999999888764322 12467788899999999999999999999999999866432 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ..... .... .. .+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~---~~~~i-~~~~--------~~---~p 235 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FR---IYEKI-LAGR--------LK---FP 235 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HH---HHHHH-hcCC--------cC---CC
Confidence 235789999999999999999999999999999999999999743211 10 11111 0000 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~~ 339 (387)
......+.+++.+||+.||++||+ ++++++.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112346789999999999999997 6777754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=294.08 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=185.9
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--------------cccHHHHHHHHHHHHhcCCCceee
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--------------GQGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
....++|++.+.||+|.||.|-+|+... ++.||||++.+.. -...+.+.+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3455789999999999999999999664 8899999985421 112457889999999999999999
Q ss_pred eeeeEEeC--CceEEEEEecCCCCcchhhcCC----------------ccccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 150 LLGCCIDK--DEKILIYEYMPNKSLDFFLFDP----------------TKRMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 150 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
++.+..++ +.+|||+|||..|.+...=... .+..+||..++|||||||+|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99998775 4789999999988874332211 12357999999999999999999999999999
Q ss_pred eccCceecCCC---CcccccccccCCCccccccccccCC---C-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHH
Q 041766 212 DFGMARICGGN---ELQANTSRIVGTYGYMSPEYAIQGI---F-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGY 284 (387)
Q Consensus 212 Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~ 284 (387)
|||.+...... ..........||+.|+|||.+.++. + +.+.||||+||+||.|+.|+.||..
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~----------- 321 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD----------- 321 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-----------
Confidence 99999765221 1122233468999999999998732 3 5788999999999999999999742
Q ss_pred HHHHhhcCcccccccccccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 285 AWDLWTSNRTLELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
....++.+++..... ..++....+.+||.++|+.||+.|.+..+|.....-...
T Consensus 322 -------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 322 -------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 122222222222211 122446678899999999999999999999987655543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=293.12 Aligned_cols=238 Identities=26% Similarity=0.416 Sum_probs=185.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++|.+.+.||+|+||.||+|...+ +..||+|.+...... ....+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999998643 467999998755433 4568999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 162 LIYEYMPNKSLDFFLFDPTK------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
+||||+++++|..++..... ...+|..+++|+||||+||+++.++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 99999999999988864321 024677788999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...... .
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~----~ 238 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI----T 238 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH----H
Confidence 9999986543332222233455788999999999999999999999999999998 99887432211 111111 1
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.... ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 239 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 QGRL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0000 00112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=306.68 Aligned_cols=230 Identities=25% Similarity=0.391 Sum_probs=183.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+...|..++.||.|+||.||.|++.. .+.||||++.... ...++++.+|+..|.+++|||+|.+-|+|......||
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 34567788999999999999999765 6789999996543 3446788999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||| -|+-.+++.-..+ ..++|....||||||..|||+++.|.|||+|||.|....
T Consensus 104 VMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----- 177 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----- 177 (948)
T ss_pred HHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence 99999 4566666543322 246888999999999999999999999999999987543
Q ss_pred cccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
....++||++|||||++. .+.|+-++||||||+++.||..+++|... -+.+. -.+. +.+.-.|.
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--MNAMS---ALYH------IAQNesPt- 244 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMS---ALYH------IAQNESPT- 244 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--chHHH---HHHH------HHhcCCCC-
Confidence 356689999999999986 57799999999999999999999998521 11111 0010 11111122
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+.+..+.+++..||+.-|.+|||.++++.
T Consensus 245 ---Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 245 ---LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 235677889999999999999999999998776
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=301.25 Aligned_cols=237 Identities=21% Similarity=0.307 Sum_probs=183.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|++.. ++.||+|++... .......+..|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999875 889999998643 1233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ...+|..+++|+||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999988854321 1247788889999999999999999999999999976532 23
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... . ........... ..+.... ..
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~---~~~i~~~~~~~--~~~~~~~--~~ 226 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--T---WENLKYWKETL--QRPVYDD--PR 226 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--H---HHHHHhccccc--cCCCCCc--cc
Confidence 34578999999999999999999999999999999999999975432111 0 00000000000 0000000 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...+..+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2335678899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.30 Aligned_cols=232 Identities=25% Similarity=0.302 Sum_probs=178.2
Q ss_pred CCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999975 48899999886432 22234677899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++|+|..++..... ..++|..+++||||||+|||+++++.+||+|||++....... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---ee
Confidence 999999877643211 124677788999999999999999999999999998754322 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||..|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. ....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~--------~~---~~~~ 225 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKE--------DQ---EEYS 225 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhc--------cc---ccCC
Confidence 334789999999999999999999999999999999999999864322110 0000000000 00 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
...+..+.+|+.+||+.||++||+ ++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 223557889999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=291.33 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=181.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+++++. ++.||+|++... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368889999999999999999875 788999998643 22344678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|++++.+..+...... ...+|..+++|+||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 159 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYT 159 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-cccc
Confidence 9998877655432211 1246777889999999999999999999999999986543221 1223
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH----------HHHh-hcCcccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA----------WDLW-TSNRTLELI 298 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~-~~~~~~~~~ 298 (387)
...|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..... ...+ .........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 35688999999999988899999999999999999999999864322111 00000 0000 000000000
Q ss_pred cccccccc-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...... .....+..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 01123557899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.24 Aligned_cols=229 Identities=22% Similarity=0.260 Sum_probs=180.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368889999999999999999774 8899999985431 233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++..... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----c
Confidence 99999999888754322 12478888899999999999999999999999999765422 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... . ........ .. . ..+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~---~~~~~i~~-~~--------~---~~~ 218 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--F---GIYEKILA-GK--------L---EFP 218 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHh-CC--------c---CCC
Confidence 235789999999999998899999999999999999999999753221 1 11111100 00 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~~ 339 (387)
......+.+++.+||+.||.+||+ +.++++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 222456889999999999999995 8888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=291.04 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=183.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|.++ .+..||+|.++... ......+.+|+..+.+++||||++++|++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999864 25679999987543 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|..++...... ..+|..+++|+||||+|||++.++.+|++|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999888653221 2467778899999999999999999999999987654222111
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||.+.+..++.++|||||||++||+++ |..||...... .. ... ..... .
T Consensus 164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~---~~~-~~~~~---------~- 226 (266)
T cd05064 164 -TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DV---IKA-VEDGF---------R- 226 (266)
T ss_pred -cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HH---HHH-HHCCC---------C-
Confidence 1112345678999999999999999999999999999875 99887432211 11 111 11000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
...+..++..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223456788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=300.86 Aligned_cols=226 Identities=22% Similarity=0.247 Sum_probs=176.0
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+++... ++.||+|.+... .......+.+|+.++.+++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999764 889999998643 2233456778999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 171 SLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 171 ~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ......+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecC
Confidence 99877754321 125788889999999999999999999999999987532211 122345789
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... . ...... ..+......
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~---~-~~~~~~-----------~~p~~~~~~ 221 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFE---L-ILMEEI-----------RFPRTLSPE 221 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--HHHHH---H-HHcCCC-----------CCCCCCCHH
Confidence 999999999999999999999999999999999999743211 11110 0 000000 011233557
Q ss_pred HHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 315 YVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 88999999999999999 79998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=298.10 Aligned_cols=240 Identities=26% Similarity=0.411 Sum_probs=183.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.+|+..+.||+|+||.||+|++.. +. .||+|.+.... ....+.+..|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 568999999999999999998653 33 38999986543 34456788999999999999999999999764 5679
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+++|+|.+++..... ..++|..+++|+||||+|||+++++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 9999999999888865432 12578888899999999999999999999999999876533222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... . . ......... .
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~---~-~~~~~~~~~-------~-- 230 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E---I-SSILEKGER-------L-- 230 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H---H-HHHHhCCCC-------C--
Confidence 22222344678999999999999999999999999999998 88887432111 1 1 111110000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..+...+.+++.+||+.+|++|||+.+++..|..+..
T Consensus 231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0111233467899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.69 Aligned_cols=234 Identities=26% Similarity=0.382 Sum_probs=181.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
+.|++.+.||+|+||.||++.++++..+|+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577889999999999999999887889999886432 334678899999999999999999999999999999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+|+|.+++...... .++|..+++|+||||+||++++++.+||+|||.++........ .....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGA 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCC
Confidence 99999888643211 2467778899999999999999999999999998765432221 11223
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... . .... . ..+..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~-~~~~--~--------~~~~~ 225 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---S-RGFR--L--------YRPKL 225 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---H-CCCC--C--------CCCCC
Confidence 45668999999988889999999999999999999 8888643211 1111111 0 0000 0 01111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
....+.+++.+||+.+|++|||++++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 234688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=290.62 Aligned_cols=231 Identities=32% Similarity=0.498 Sum_probs=173.0
Q ss_pred CCcccccCCeeEEEEEEc-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 94 ANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.+.||.|.||.||+|.+. .+..|+||.+.... ....+.+.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999987 14579999996543 334688999999999999999999999999888899999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++|+|.+++..... ..++|..+++|++|+++||+++.++.+||+|||++.............
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999998876511 124677788999999999999999999999999998774333333333
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
.......|+|||.+.+..++.++||||||+++|||++ |+.|+... +..... ... ..... ...+
T Consensus 164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~~~---~~~-~~~~~----------~~~~ 227 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEEII---EKL-KQGQR----------LPIP 227 (259)
T ss_dssp TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHHHH---HHH-HTTEE----------TTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--cccccc---ccc-ccccc----------ceec
Confidence 4456789999999999889999999999999999999 67775332 111111 111 11100 1122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
..++..+.+++.+||+.||++|||+.++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23455788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=296.88 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=181.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||++.+.. +..+|+|.+... .......+.+|++++++++||||++++++|...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999875 778999988654 23344678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCccc----------------cccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTKR----------------MLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~----------------~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++|+|.+++...... .++|.. +++|+||||+|||++.++.+||+|||++...... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~ 159 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 159 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----cc
Confidence 99999999888643220 134543 5889999999999999999999999998754321 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--------------
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT-------------- 294 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------- 294 (387)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ............
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCccch
Confidence 3346889999999999888999999999999999999999998643221110 000000000000
Q ss_pred --------------cccccccccc---ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 295 --------------LELIDPILED---EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 295 --------------~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000000 00011134568899999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.71 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=178.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|+... ++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 3679999999999999999999874 88999999864422 233467789999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|++ ++|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 160 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TY 160 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cC
Confidence 996 566665543221 1246778889999999999999999999999999976432221 12
Q ss_pred ccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--------ccccc
Q 041766 229 SRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT--------LELID 299 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 299 (387)
....+++.|+|||++.+ ..++.++|||||||++|||++|..||....+....+..... ....... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL-VLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-HhCCCChhhccchhhccccc
Confidence 33567899999999875 45899999999999999999999998643321111111111 0000000 00000
Q ss_pred cc---------cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PI---------LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+. +............+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0000000012346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=313.68 Aligned_cols=234 Identities=17% Similarity=0.162 Sum_probs=181.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..|.+.+.||+|+||.||+|.... +..||+|.+..........+..|+.+|+.++|||||++++++...+..|+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 348888999999999999998553 567888887655545556778899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 167 MPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++.........
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999877643110 124677788999999999999999999999999998765433222
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... . . .
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~-~----~------~ 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK-Y----D------P 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC-C----C------C
Confidence 33456799999999999999999999999999999999999999743211 11111111100 0 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...+..+.+++.+||+.||++||++++++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11223457889999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=272.08 Aligned_cols=231 Identities=23% Similarity=0.268 Sum_probs=187.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|++.+.||+|.||.||.|+.+. +-.||+|++.+. .......+.+|++|-+.++||||.++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34789999999999999999999775 778999998643 22334578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 163 IYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++||.+.|++...|+.... ..+.|...+|||||||+|+|++..+.+||+|||-+-...
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 9999999999888873221 135677888999999999999999999999999987543
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||..... .+....+.+.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------------------~etYkrI~k~ 237 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------------------SETYKRIRKV 237 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh------------------HHHHHHHHHc
Confidence 2234567999999999999999999999999999999999999999753221 1111111111
Q ss_pred c-cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 305 E-YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 305 ~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. ..+...+..+.++|.+|+..+|.+|.+..|++..
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 1234456678899999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=307.65 Aligned_cols=236 Identities=28% Similarity=0.353 Sum_probs=187.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC--CC--EEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK--GD--EIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
..++....++||+|.||.|++|.|.. |. .||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 34556677899999999999999875 33 5899999755433 67899999999999999999999999887 5667
Q ss_pred EEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
||||+++.|+|.+.|+..... .+|...+.|||||..+|+|+.....+||+|||+.+.++.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999888772221 25677788999999999999999999999999999887654
Q ss_pred cccc-cccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 LQAN-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.... .....-+..|+|||.+....|+.++|||+|||++|||+| |..||-.- ..-.+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~---------------~g~qIL~~iD~- 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC---------------RGIQILKNIDA- 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC---------------CHHHHHHhccc-
Confidence 4332 223345678999999999999999999999999999999 77785321 11112233331
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
-.....++.|++.++++++.||..+|++||||..|.+.
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 11223566788899999999999999999999999854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=286.42 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=182.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCCceeeeeeeEEeCC----ceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD----EKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~----~~~lv 163 (387)
..+..+.+|+|.||.||+|.+. ++.||||+++.. ..+.|..|-+|.+. ++|+||++++++-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4556789999999999999998 589999999753 44678888888876 48999999999877655 78999
Q ss_pred EEecCCCCcchhhcCCccc---------------cc---------cchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 164 YEYMPNKSLDFFLFDPTKR---------------ML---------LDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~---------------~~---------l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
+||-+.|+|.++|..+... .+ .+...++|||||+.||||.+|+++.|+|||+|..+
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999999998654321 11 23355789999999999999999999999999887
Q ss_pred CCCCcccccccccCCCccccccccccCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGI-FS-----IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
.........-..+||.+|||||++.+.. +. .+.||||+|.+||||+++..-..........+ .+.........
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql-pfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL-PFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC-chhHHhcCCCC
Confidence 6444333344478999999999997642 22 45899999999999999876543211111100 00000000011
Q ss_pred --------cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 294 --------TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 294 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+.+..+|.+............+.+.+..||..||+.|.|+.-|.+++.++....
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111112222222222334567889999999999999999999999999886544
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=298.63 Aligned_cols=237 Identities=23% Similarity=0.323 Sum_probs=178.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|+..+.||+|+||.||+|++.. ++.||||.+.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3567788999999999999999764 8899999986442 3344678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 166 YMPNKSLDFFLFDPTK------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+++|+|......... ..++|..+++|+||||+|||++.++.+||+|||+++...... .......|
T Consensus 153 ~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 230 (353)
T PLN00034 153 FMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVG 230 (353)
T ss_pred cCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cccccccc
Confidence 9999998654322111 135788889999999999999999999999999998654321 11233578
Q ss_pred CCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 234 TYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 234 t~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
|..|+|||.+.. ...+.++|||||||++|||++|+.||....... .......... . ......
T Consensus 231 t~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~-~----------~~~~~~ 297 (353)
T PLN00034 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICM-S----------QPPEAP 297 (353)
T ss_pred CccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhc-c----------CCCCCC
Confidence 999999998843 224568999999999999999999986322111 1111100000 0 000012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
......+.+++.+||+.||++|||+.|+++.
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2335578899999999999999999999984
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.18 Aligned_cols=239 Identities=28% Similarity=0.426 Sum_probs=189.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
...+|.+.+.||.|+||.||+|....+..+|+|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34678899999999999999999888889999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++...... ..+|..+++|+||||+||++++++.+||+|||.+......... .
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--S 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--c
Confidence 9999999988653221 2467777899999999999999999999999999765432211 1
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....... ... .. ...
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~----~~~---------~~-~~~ 225 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQI----TAG---------YR-MPC 225 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHH----HhC---------Cc-CCC
Confidence 23345678999999988889999999999999999998 7888743221 1111111 100 00 011
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=288.52 Aligned_cols=255 Identities=26% Similarity=0.331 Sum_probs=183.7
Q ss_pred cCC-CCCCcccccCCeeEEEEEE-----cCCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cc
Q 041766 89 NKF-SDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE 159 (387)
Q Consensus 89 ~~~-~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~ 159 (387)
++| +..+.||+|+||.||++.+ .++..||+|.+.... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 7889999999999988753 236789999986543 23456788999999999999999999988764 35
Q ss_pred eEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
.+++|||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 7899999999999888754321 1246778889999999999999999999999999986543221
Q ss_pred cc-ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QA-NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.++....
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 11 11223456679999999888899999999999999999999999754332111111000000000001111111111
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
. ..+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 243 ~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 L-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred C-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1 112334568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.41 Aligned_cols=240 Identities=27% Similarity=0.399 Sum_probs=182.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998542 4579999886432 2334578899999999999999999999998899
Q ss_pred eEEEEEecCCCCcchhhcCCcc--------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK--------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~--------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
.++||||+++++|.+++..... ..++|..+++|+||||+||++++++.+||+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 9999999999999988754211 02366777899999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~----~~~ 237 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFV----MEG 237 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HcC
Confidence 99876543332222223355778999999998889999999999999999999 6777643211 1111100 000
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.... .+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 238 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 GLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000 111234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=290.00 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=181.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC---------------CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK---------------GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLL 151 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~ 151 (387)
.++|++.+.||+|+||.||+++... ...||+|.+... .......+.+|++++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4678999999999999999987642 224899998654 233456788999999999999999999
Q ss_pred eeEEeCCceEEEEEecCCCCcchhhcCCcc----------------------------ccccchhhhhhcccCCCceEEc
Q 041766 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------------------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
+++...+..++||||+++++|.+++..... ...+|..+++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999999999888753210 0236777889999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhC--CCCCCCCCCCcchH
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG--KKTTGFYRTDSLTL 281 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg--~~p~~~~~~~~~~~ 281 (387)
+++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||+++ ..||... .....
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~--~~~~~ 241 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL--SDEQV 241 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc--ChHHH
Confidence 9999999999999765433222222334557789999999988899999999999999999984 4454322 11111
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.......+......... ..+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111100000000 0111234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=290.74 Aligned_cols=242 Identities=27% Similarity=0.412 Sum_probs=187.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999852 234689999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
||||+++++|.+++..... ...+|..+++|+||||+|||+++++.+||+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 9999999999888753221 02367778899999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
|+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. . ......
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~---~-~~i~~~ 238 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV---I-ECITQG 238 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH---H-HHHHcC
Confidence 99986543332222233455778999999998889999999999999999999 88886432211 00 0 111111
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.... .....+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 239 ~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQ----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1000 1112345689999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=286.63 Aligned_cols=239 Identities=29% Similarity=0.418 Sum_probs=186.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 346789999999999999999998878889999886432 3356889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++......... ..
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR 161 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence 999999988754221 12467778899999999999999999999999999876433221 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... ...... . ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~----~~~~~~-----~-----~~ 225 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA----LQRGYR-----M-----PR 225 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH----HHcCCC-----C-----CC
Confidence 22345678999999988889999999999999999998 88887432211 11111 110000 0 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
....+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.83 Aligned_cols=223 Identities=20% Similarity=0.220 Sum_probs=172.8
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||+|+||.||+++... ++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999775 788999998642 233445778899999999999999999999999999999999999999
Q ss_pred chhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 173 DFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 173 ~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcc
Confidence 888754321 124777888999999999999999999999999987543221 12234578999
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV 316 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (387)
|+|||++.+..++.++|||||||++|||++|+.||..... .......... .. ..+......+.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~---------~~---~~~~~~~~~~~ 221 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQE---------PL---RFPDGFDRDAK 221 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcC---------CC---CCCCcCCHHHH
Confidence 9999999999999999999999999999999999753211 1111111100 00 01223345788
Q ss_pred HHHHhcccCCCCCCCC---HHHHHH
Q 041766 317 NIALLCVQESADDRPT---MNEVVS 338 (387)
Q Consensus 317 ~li~~cl~~dP~~RPt---~~~v~~ 338 (387)
+++.+||+.||++||+ +.+++.
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 9999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=301.91 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=187.0
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~ 155 (387)
.+...++|.+.+.||+|+||.||+|++.. +..||+|++.... ....+.+.+|+.+|.++. |||||+++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 44455678889999999999999998642 3579999997542 233457889999999997 999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc------------------------------------------------------
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------------------------------ 181 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 181 (387)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999888854211
Q ss_pred ------------------------------------------------------------ccccchhhhhhcccCCCceE
Q 041766 182 ------------------------------------------------------------RMLLDWSANYSSRLKVSNIL 201 (387)
Q Consensus 182 ------------------------------------------------------------~~~l~~~~~~h~dlk~~Nil 201 (387)
..++|..+++|+||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 01356677899999999999
Q ss_pred EcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcch
Q 041766 202 LDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLT 280 (387)
Q Consensus 202 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~ 280 (387)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999986533221112223456788999999998889999999999999999998 888864322111
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
............ ..+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus 350 ---~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---QFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111111000 011123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=310.25 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=192.4
Q ss_pred CCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
...++||+|+||+||+|.|-. |+ +||+|++... ......++++|+-+|.+++|||+++++|+|.... +-||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 445789999999999998643 44 5899998654 3445678999999999999999999999998766 679999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|++.|+|.++++.+... .+++..+.+||||..+|||+.....+||.|||+++.+.........
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 99999999999775442 2466677799999999999999999999999999988765544444
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....-.+.|||-|.+....|+.++|||||||++||++| |..|++... ...+.+.++...+ ..+
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---------------~~eI~dlle~geR-Lsq 921 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---------------AEEIPDLLEKGER-LSQ 921 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---------------HHHhhHHHhcccc-CCC
Confidence 44455789999999999999999999999999999999 888864221 2222222322222 235
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
++.+...++-++.+||..|+..||+|+++...+.++..+
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 667778899999999999999999999999998888754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.71 Aligned_cols=237 Identities=21% Similarity=0.244 Sum_probs=182.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 158 (387)
..++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.++..++|+||++++..+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999865 4889999998643 3344567889999999999999999988775432
Q ss_pred ---ceEEEEEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 159 ---EKILIYEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 159 ---~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
..++||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 35799999999999888754211 1246778889999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... .
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~~-~-- 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLAG-R-- 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcC-C--
Confidence 987643322223345679999999999999999999999999999999999999975321 11111111100 0
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. ..+...+..+.+++.+||+.||++||++.++++.
T Consensus 262 --~~------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 --YD------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CC------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 0122335678899999999999999999999863
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=289.25 Aligned_cols=238 Identities=28% Similarity=0.414 Sum_probs=182.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+.|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|++++++++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999999852 35689999997433 3334678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc---------------------------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 163 IYEYMPNKSLDFFLFDPTK---------------------------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~---------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
+|||+++++|..++..... ..++|..+++|+||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 9999999999888742110 1246778889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... .......
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~--- 239 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV--- 239 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---
Confidence 999999986643332222333455778999999988889999999999999999999 8888643211 1111111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...... ..+..++..+.+++.+||+.||++||++.++++.|..
T Consensus 240 -~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 -RKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111000 0112234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.38 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=190.8
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCCceeeeeeeEEeCC---
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD--- 158 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~--- 158 (387)
-.+...+....+.||+|.||.||+|+|+ |+.||||++...++ ..+.+|.+|.+. ++|+||..+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 3456677888999999999999999998 89999999975443 577889998876 49999999999866543
Q ss_pred -ceEEEEEecCCCCcchhhcCCccc---------------cccch--------hhhhhcccCCCceEEcCCCCeEEeecc
Q 041766 159 -EKILIYEYMPNKSLDFFLFDPTKR---------------MLLDW--------SANYSSRLKVSNILLDKDINPKISDFG 214 (387)
Q Consensus 159 -~~~lv~e~~~~g~L~~~l~~~~~~---------------~~l~~--------~~~~h~dlk~~Nill~~~~~~kl~Dfg 214 (387)
++|||++|-+.|+|.++|.+..-. ..||. ..+.|||||+.|||+.+++.+.|+|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 579999999999999999775431 11221 235799999999999999999999999
Q ss_pred CceecCCC--CcccccccccCCCccccccccccCC----C-C-ccccchhHHHHHHHHHhCC----------CCCCCCCC
Q 041766 215 MARICGGN--ELQANTSRIVGTYGYMSPEYAIQGI----F-S-IKSDVFSFGVLLLEIVSGK----------KTTGFYRT 276 (387)
Q Consensus 215 ~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~~~DiwS~Gvil~el~tg~----------~p~~~~~~ 276 (387)
+|-..... ......+..+||.+|||||++...- | + ..+||||||.++||++.+. .||..-.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99765432 3334456679999999999996532 2 2 4589999999999998643 34433222
Q ss_pred CcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 277 DSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..... +.+..-.-.+.+.|.+.......+....+.+||+.||..||.-|-|+--+-+.|.++.+
T Consensus 442 ~DPs~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPSF-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCH-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22221 11222222334445555555667788899999999999999999999999999988864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.56 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=184.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC-
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK- 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~- 157 (387)
+.++|++.+.||+|+||.||+|...+ ++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45689999999999999999997432 4689999986432 23345678899999999 899999999988754
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------------------------------------------------
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK-------------------------------------------------------- 181 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 181 (387)
...+++|||+++++|..++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999887743210
Q ss_pred ---------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccc
Q 041766 182 ---------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSP 240 (387)
Q Consensus 182 ---------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 240 (387)
..++|..+++||||||+|||++.++.+||+|||+++...............++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 02356777899999999999999999999999999876433222223334567789999
Q ss_pred cccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHH
Q 041766 241 EYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIA 319 (387)
Q Consensus 241 E~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 319 (387)
|++.+..++.++|||||||++|||++ |..||....... . ........... ..+......+.+++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~----~~~~~~~~~~~----------~~~~~~~~~~~~l~ 309 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-E----FCRRLKEGTRM----------RAPEYATPEIYSIM 309 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-H----HHHHHhccCCC----------CCCccCCHHHHHHH
Confidence 99999999999999999999999998 988875322111 0 00111111000 01122345788999
Q ss_pred HhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 320 LLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 320 ~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.+||+.+|++||++.++++.|+++..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.02 Aligned_cols=230 Identities=22% Similarity=0.266 Sum_probs=180.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++..++||||+++++++.+.+..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998654 357999988532 22344678889999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 9999999999988865322 12467788899999999999999999999999999865422
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ......... ..
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~----~~~~i~~~~--------~~--- 246 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--LL----IYQKILEGI--------IY--- 246 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--HH----HHHHHhcCC--------CC---
Confidence 2345789999999999988899999999999999999999999853221 10 011111100 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
.+......+.+++.+||+.||++|+ +++++++.
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1112234578999999999999995 89988874
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=284.30 Aligned_cols=239 Identities=27% Similarity=0.386 Sum_probs=184.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|.+.. ...||+|.+... .......+.+|+.++.+++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999753 347999998654 333456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|..++...... ..+|..+++|+||||+|||++.++.+||+|||+++.........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999888653321 24677788999999999999999999999999998764222111
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .... .........
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~----~~~~~~~~~---------- 227 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVI----KAVEDGYRL---------- 227 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHH----HHHHcCCCC----------
Confidence 1222345678999999998899999999999999999998 8888643211 1111 111000000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=288.12 Aligned_cols=245 Identities=19% Similarity=0.249 Sum_probs=178.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|+..+.||+|+||.||+|+... +..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 568889999999999999999764 7899999986432 23345678999999999999999999999998899999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++..... ...+|..+++||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~ 161 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYS 161 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--ccc
Confidence 975 88777653321 1247888899999999999999999999999999976532221 123
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC------------cccc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN------------RTLE 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 296 (387)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ............. ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 3467899999999875 56899999999999999999999998543221 1111111100000 0000
Q ss_pred cccccccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+...... ........+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001000000 00112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=289.50 Aligned_cols=242 Identities=27% Similarity=0.402 Sum_probs=188.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.+|.+.+.||+|+||.||+|.... +..+++|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457788999999999999998532 44689999876655556788999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEE
Q 041766 163 IYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl 210 (387)
||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 9999999999998854221 02467778899999999999999999999
Q ss_pred eeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHh
Q 041766 211 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 211 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ... ...
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~----~~~ 238 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVI----ECI 238 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHH
Confidence 99999976544332222334456788999999999999999999999999999999 88886433211 111 111
Q ss_pred hcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
....... ....++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 239 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111100 1112345788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=283.97 Aligned_cols=239 Identities=27% Similarity=0.371 Sum_probs=185.8
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..++|++.+.||+|+||.||+|.+..++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788899999999999999998778889999986543 3356788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++..... ...+|..+++|+||||+||++++++.+||+|||+++........ ..
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~ 161 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AR 161 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-cc
Confidence 999999988865331 12467778899999999999999999999999999876532211 11
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......... ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~----~~~~~~~~~----------~~~ 225 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEV----LQQVDQGYR----------MPC 225 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHH----HHHHHcCCC----------CCC
Confidence 11223457999999998899999999999999999999 8888743211 110 011111000 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
....+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 122345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=284.05 Aligned_cols=241 Identities=19% Similarity=0.309 Sum_probs=186.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999976 4889999987532 2333457889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++++|..++..... ..++|..+++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999877642110 1246778889999999999999999999999999887643321
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.....+... ..... . .....
T Consensus 162 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~---~~~~~-~---------~~~~~ 226 (267)
T cd08228 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS---LCQKI-E---------QCDYP 226 (267)
T ss_pred --HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH---HHHHH-h---------cCCCC
Confidence 122346788999999998888999999999999999999999997432221111 11110 0 00001
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.......+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1112234567899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=281.97 Aligned_cols=231 Identities=24% Similarity=0.329 Sum_probs=175.4
Q ss_pred CcccccCCeeEEEEEEc-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 95 NKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999976 48889999876432 33456789999999999999999999999999999999999999999
Q ss_pred chhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCC
Q 041766 173 DFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTY 235 (387)
Q Consensus 173 ~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 235 (387)
.+++...... .++|..+++|+||||+||+++.++.+||+|||++.................+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9888543211 24677788999999999999999999999999987544221111111122345
Q ss_pred ccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 236 ~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
.|+|||.+.+..++.++||||||+++|||++ |..|+...... . ........ ... ..+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~----~~~~~~~~---------~~~-~~~~~~~~~ 224 (252)
T cd05084 161 KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q----TREAIEQG---------VRL-PCPELCPDA 224 (252)
T ss_pred eecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H----HHHHHHcC---------CCC-CCcccCCHH
Confidence 7999999998889999999999999999998 77776422110 0 00100000 000 012233557
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 315 YVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
+.+++.+||+.+|++|||+.++++.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=285.54 Aligned_cols=241 Identities=26% Similarity=0.364 Sum_probs=181.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|+..+.||+|+||.||+|.+.. +. .+++|.+..... ....++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 567888999999999999999754 43 478888754322 334567788889999999999999998754 45689
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+++|+|.+++...... .++|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999999888653221 2467778899999999999999999999999999876433322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...... ........
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~~~~-------- 231 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDL----LEKGERLA-------- 231 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----HHCCCcCC--------
Confidence 22334456778999999998899999999999999999998 8888743221 111111 11111000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.+..+...+.+++.+||..||++|||+.++++.|..+..+
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 --QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0111234578899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=295.46 Aligned_cols=226 Identities=22% Similarity=0.262 Sum_probs=174.9
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+++... +..||+|.+... .......+.+|+.++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999999764 889999998643 2234456778999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 171 SLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 171 ~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCC
Confidence 99877754321 124778889999999999999999999999999987532221 112335789
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
..|+|||++.+..++.++|||||||++|||++|+.||...... ... .... ... . ..+...+..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~---~~~~-~~~--------~---~~p~~~~~~ 221 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLF---ELIL-MEE--------I---RFPRTLSPE 221 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHH---HHHh-cCC--------C---CCCCCCCHH
Confidence 9999999999999999999999999999999999997532211 100 0000 000 0 011223457
Q ss_pred HHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 315 YVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 88999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=306.56 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=187.0
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcCC-CEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeE-EeC----
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKKG-DEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC-IDK---- 157 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~-~~~---- 157 (387)
.....++.+.+.|.+|||+.||.|....+ ..||+|++-..+....+.+.+|+++|++|. |+|||.+++.. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 33445677888999999999999998775 999999998778888899999999999995 99999999932 221
Q ss_pred --CceEEEEEecCCCCcchhhcCCccc------------------cccchhh--hhhcccCCCceEEcCCCCeEEeeccC
Q 041766 158 --DEKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSA--NYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 158 --~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~--~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
-..+|.||||++|.|-+++...... ..+|... +||||||.+||||+.++..||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2457999999999998888632111 1355555 79999999999999999999999999
Q ss_pred ceecCCCCccc-------ccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH
Q 041766 216 ARICGGNELQA-------NTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA 285 (387)
Q Consensus 216 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 285 (387)
|.......... ..-....|+.|+|||.+. +.+.++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 86432211000 001124688999999884 6779999999999999999999999975321
Q ss_pred HHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 286 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...++.....-+ ..+..+..+.+||..||+.||.+||++.||+..+.++..
T Consensus 263 --------~laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 263 --------KLAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --------ceeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 122222222211 235678899999999999999999999999999988865
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=290.65 Aligned_cols=238 Identities=28% Similarity=0.378 Sum_probs=181.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.+|.+.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346778899999999999998642 46799999975432 33467889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCc---------------c-----------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 162 LIYEYMPNKSLDFFLFDPT---------------K-----------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~---------------~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
+++||+++++|..++.... . ...+|..+++|+||||+|||+++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 9999999999988874210 0 1246777889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~- 238 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIEM- 238 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH-
Confidence 999999886543332222333456778999999988889999999999999999998 77776432111 11111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
....... ..+..++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 239 i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111100 1122345568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=294.97 Aligned_cols=226 Identities=22% Similarity=0.250 Sum_probs=175.7
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+++... +..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999999765 889999998643 2234467788999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 171 SLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 171 ~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCC
Confidence 99877754321 124778888999999999999999999999999987532221 122345789
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
+.|+|||++.+..++.++|||||||++|||++|+.||...... . ...... .. .. ..+......
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~---~~~~~~-~~------~~-----~~p~~~~~~ 221 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--K---LFELIL-ME------DI-----KFPRTLSAD 221 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--H---HHHHhc-cC------Cc-----cCCCCCCHH
Confidence 9999999999889999999999999999999999997432111 0 000000 00 00 011223456
Q ss_pred HHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 315 YVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=288.04 Aligned_cols=240 Identities=28% Similarity=0.399 Sum_probs=183.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+|++.+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998542 2468998886442 3345678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------------------------------ccccchhhhhhcccCCCceEE
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------------------------------RMLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------------------------------~~~l~~~~~~h~dlk~~Nill 202 (387)
++||+++++|..++..... ...+|..+++|+||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 9999999999888753210 124677788999999999999
Q ss_pred cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchH
Q 041766 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTL 281 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~ 281 (387)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---- 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---- 236 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 9999999999999976543322222233456778999999988889999999999999999998 88887432111
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+...... .... .+...+..+.+++.+||+.+|++||+++++++.|+++..
T Consensus 237 --~~~~~~~~~---------~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --RLFNLLKTG---------YRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHHhCC---------CCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111110 0000 112234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.96 Aligned_cols=237 Identities=21% Similarity=0.285 Sum_probs=177.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.|+.++.||+|+||.||+|+... +..||+|++... .......+..|+.++.+++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999999765 788999998643 22344578899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-----
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL----- 224 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~----- 224 (387)
|+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999888754321 1247788889999999999999999999999999754311000
Q ss_pred ----------------------------------------ccccccccCCCccccccccccCCCCccccchhHHHHHHHH
Q 041766 225 ----------------------------------------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 264 (387)
Q Consensus 225 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el 264 (387)
.......+||..|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 0001234799999999999988999999999999999999
Q ss_pred HhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHh--cccCCCCCCCCHHHHHHH
Q 041766 265 VSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALL--CVQESADDRPTMNEVVSM 339 (387)
Q Consensus 265 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPt~~~v~~~ 339 (387)
++|..||......... ......... .... .....+..+.+++.+ |+..+|..||++.++++.
T Consensus 242 ltG~~Pf~~~~~~~~~-----~~i~~~~~~-------~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 242 LVGQPPFLAPTPTETQ-----LKVINWENT-------LHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HhCCCCCcCCCHHHHH-----HHHHccccc-------cCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999998543221100 000000000 0000 111234567788887 556666779999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=287.49 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=185.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
...++|++.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345789999999999999999997542 4479999886443 233456788999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc--------------------------ccccchhhhhhcccCCCceEEcCCCCeEEee
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK--------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISD 212 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~D 212 (387)
..++||||+++|+|.+++..... ..++|..+++|+||||+|||+++++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999998854210 0246777889999999999999999999999
Q ss_pred ccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhc
Q 041766 213 FGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTS 291 (387)
Q Consensus 213 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 291 (387)
||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... . ..... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~---~~~~~-~~~ 236 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--E---QVLKF-VMD 236 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--H---HHHHH-HHc
Confidence 999986543332222233345678999999998899999999999999999998 6777642111 1 11110 000
Q ss_pred CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 292 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..... .+...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 237 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 GGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 10000 111224578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=284.80 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=184.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-----------------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
.++|++.+.||+|+||.||++.... +..||+|.+.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3678999999999999999998653 2358999987543 344567889999999999999999
Q ss_pred eeeeEEeCCceEEEEEecCCCCcchhhcCCc-----------c----------------ccccchhhhhhcccCCCceEE
Q 041766 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPT-----------K----------------RMLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 150 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~----------------~~~l~~~~~~h~dlk~~Nill 202 (387)
+++++...+..+++|||+++++|..++.... . ...+|..+++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999998876533 0 024677788999999999999
Q ss_pred cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCcch
Q 041766 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLT 280 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t--g~~p~~~~~~~~~~ 280 (387)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ +..|+.... ...
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--~~~ 241 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--DQQ 241 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--hHH
Confidence 9999999999999986654433333334556788999999988889999999999999999998 555653221 111
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
........+......... ..+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 VIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111110000000 0112234578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.76 Aligned_cols=243 Identities=16% Similarity=0.156 Sum_probs=176.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..+|++.+.||+|+||.||++.... ++.||+|.... ..+.+|++++++++|||||++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3679999999999999999999765 78899997532 3567899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+. ++|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+...... ......
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 242 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYG 242 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccccc
Confidence 95 577666643221 135778889999999999999999999999999997533211 112234
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc------chHhHHHHHHhhcC-c--------cc
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS------LTLLGYAWDLWTSN-R--------TL 295 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~-~--------~~ 295 (387)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ..+........... . ..
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 579999999999999999999999999999999999998864322110 01110000000000 0 00
Q ss_pred ccc---------cccccccc-ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ELI---------DPILEDEY-SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ~~~---------~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+.. .+...... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000000 01133557889999999999999999999996
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=285.76 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=182.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-----------------CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
.++|++.+.||+|+||.||++.... +..||+|.+... .......+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578999999999999999986431 335899998754 3334567899999999999999999
Q ss_pred eeeeEEeCCceEEEEEecCCCCcchhhcCCcc---------------------------ccccchhhhhhcccCCCceEE
Q 041766 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK---------------------------RMLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 150 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------~~~l~~~~~~h~dlk~~Nill 202 (387)
+++++...+..+++|||+++++|..++..... ...+|..+++|+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 99999999999999999999999888764321 124677778999999999999
Q ss_pred cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCcch
Q 041766 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS--GKKTTGFYRTDSLT 280 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t--g~~p~~~~~~~~~~ 280 (387)
+.++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||..... ..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--~~ 241 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--EQ 241 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--HH
Confidence 9999999999999986543322222223345678999999888889999999999999999998 5566532211 11
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
........+...... ... ..+..++..+.+++.+||+.||++|||+.+|++.|++
T Consensus 242 ~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQGRQ-VYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhcccc-ccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111000 000 0112234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=283.89 Aligned_cols=237 Identities=28% Similarity=0.410 Sum_probs=183.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
..|.+.+.||+|+||.||+|.+.+ +..||+|.+... ......+.+|++++.+++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457778899999999999999765 788999998643 334567889999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|.+++...... ..+|..+++|+||||+||++++++.+||+|||++......... ...
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~ 163 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA 163 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccC
Confidence 999999887543211 2467778899999999999999999999999999866433221 111
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||.+.+..++.++|||||||++|||++ |..|+...... .. +...... ... ..+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~-~~~~~~~---------~~~-~~~ 227 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QV-YELLEKG---------YRM-ERP 227 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH-HHHHHCC---------CCC-CCC
Confidence 2234567999999998999999999999999999998 88886432111 11 1111110 000 012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22356789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.10 Aligned_cols=237 Identities=22% Similarity=0.378 Sum_probs=179.8
Q ss_pred CCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc-----
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----- 159 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----- 159 (387)
|.+.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998653 367999998643 23345678899999999999999999998876544
Q ss_pred -eEEEEEecCCCCcchhhcCCcc----------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 160 -KILIYEYMPNKSLDFFLFDPTK----------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 160 -~~lv~e~~~~g~L~~~l~~~~~----------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
.++++||+++|+|..++..... ..++|..+++|+||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 7899999999999877733210 12467778899999999999999999999999999
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~~~ 234 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL----RHGNRL 234 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCCC
Confidence 87654433222222345678999999988889999999999999999999 7777643221 1111111 111100
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 235 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.44 Aligned_cols=238 Identities=26% Similarity=0.369 Sum_probs=183.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999743 245789999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 163 IYEYMPNKSLDFFLFDPTK-------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
+|||+++++|..++..... ...+|..+++|+||||+|||+++++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEEC
Confidence 9999999999888754321 024677778999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. .... .
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~---~~~~-~ 238 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EA---IECI-T 238 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HH---HHHH-H
Confidence 9999976543322222233345678999999999999999999999999999998 88886422111 00 0000 0
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
..... ..+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus 239 ~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00000 0112334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=302.62 Aligned_cols=235 Identities=22% Similarity=0.370 Sum_probs=186.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.+.|.++..||.|+||.||+|..++ +-.-|.|++........++++-|++||..+.||+||++++.|...+.+||+.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3556778889999999999999876 334577888877788889999999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+||-.+.++..... ...||...+||||||..|||++-+|.++|+|||.+..... ......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD 188 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD 188 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence 999998777654332 1258888999999999999999999999999999865432 222345
Q ss_pred cccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 230 RIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.+.||++|||||++. ..+|+.++||||||++|.||..+.+|...... +......... . .+.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVllKiaKS-e-----PPTL-- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKS-E-----PPTL-- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHHHHHhhc-C-----CCcc--
Confidence 689999999999985 46899999999999999999999998432111 0000000000 0 0111
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+......+.+++.+||..||+.||+++++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 145667788999999999999999999999987
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=292.84 Aligned_cols=230 Identities=22% Similarity=0.309 Sum_probs=174.0
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHH---HhcCCCceeeeeeeEEeCCceEEE
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVI---AKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
|.+.+.||+|+||.||+|.+.. ++.||||.+... .....+.+..|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5677899999999999999765 889999998643 123345566676655 466899999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 164 YEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||+++++|...+..... ..++|..+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--Ccc
Confidence 999999999877754321 124788889999999999999999999999999987532211 122
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...... . ...... .... ..+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~---~~~~i~-~~~~-----------~~p 221 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E---VFDSIV-NDEV-----------RYP 221 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H---HHHHHH-hCCC-----------CCC
Confidence 3457899999999999989999999999999999999999997532211 0 111100 0000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
...+..+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 22345678999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.97 Aligned_cols=235 Identities=28% Similarity=0.409 Sum_probs=181.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
++|.+.+.||+|+||.||+|.+..+..+|+|.+.... .....+.+|+.++.+++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777779999887432 334678999999999999999999999998888999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+|+|.+++...... .++|..+++|+||||+||+++.++.+||+|||.++........ .....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~ 161 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGS 161 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCC
Confidence 99999888643211 2467778899999999999999999999999998865433221 11123
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...... . ..... ..... . .....
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~---~~~~~-~~~~~-----~-----~~~~~ 225 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--E---TVEKV-SQGLR-----L-----YRPHL 225 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--H---HHHHH-hcCCC-----C-----CCCCC
Confidence 45678999999988889999999999999999999 88887432211 0 01111 00000 0 01111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=292.31 Aligned_cols=226 Identities=23% Similarity=0.270 Sum_probs=174.3
Q ss_pred CcccccCCeeEEEEEEc----CCCEEEEEEccCC----CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+.||+|+||.||+++.. .++.||+|.+... .......+..|+.+|+.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999853 3778999998642 223334677899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+++|+|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++....... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHT 159 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccc
Confidence 999999887754321 1246788889999999999999999999999999875432221 1233
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ......... ... .+..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~---------~~~---~~~~ 222 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKG---------KLN---LPPY 222 (323)
T ss_pred cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcC---------CCC---CCCC
Confidence 57899999999999888999999999999999999999997532211 111111100 000 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
....+.+++.+||+.||++|| ++.++++.
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 345688999999999999999 78888773
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.74 Aligned_cols=225 Identities=25% Similarity=0.332 Sum_probs=171.1
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999765 788999998643 223344556677777755 899999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccC
Confidence 999887754321 124788889999999999999999999999999997643222 22334578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||...... ...... ... .+. .+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i-~~~------~~~-----~~~~~~~ 221 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSI-LND------RPH-----FPRWISK 221 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHH-HcC------CCC-----CCCCCCH
Confidence 99999999999989999999999999999999999997532211 111111 000 000 1122345
Q ss_pred HHHHHHHhcccCCCCCCCCHH-HHHH
Q 041766 314 RYVNIALLCVQESADDRPTMN-EVVS 338 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~-~v~~ 338 (387)
.+.+++.+||+.||++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 678999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=299.85 Aligned_cols=227 Identities=24% Similarity=0.384 Sum_probs=187.3
Q ss_pred cccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcch
Q 041766 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 174 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~ 174 (387)
+||+|.||+||-|++.+ ...+|||.++..+....+-+..|+.+-+.++|.|||+++|.|..++..-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999776 45689999998888888889999999999999999999999999888889999999999999
Q ss_pred hhcCCcc-------------------ccccchhhhhhcccCCCceEEc-CCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 175 FLFDPTK-------------------RMLLDWSANYSSRLKVSNILLD-KDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 175 ~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
+++..-+ ..++|...++|||||-+||||. -.|.+||+|||.++.+.. ....+.++.||
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGT 739 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccccccc
Confidence 8865322 2368999999999999999995 568999999999987753 23445678999
Q ss_pred CccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 235 YGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 235 ~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
+.|||||++..++ |+.++|||||||++.||.||++||......... .+..+ --...++.+.+..
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------MFkVG-------myKvHP~iPeels 805 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------MFKVG-------MYKVHPPIPEELS 805 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------hhhhc-------ceecCCCCcHHHH
Confidence 9999999998665 899999999999999999999998543322111 01000 0012233567788
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+..++|.+|+.+||.+||++.+++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 89999999999999999999999987
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=287.02 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=186.1
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 156 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 156 (387)
....++|+..+.||+|+||.||++.... ...+|+|.+... .......+.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3445678889999999999999998653 357899988753 233445688999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDK 204 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~ 204 (387)
.+..+++|||+++|+|..++..... ..++|..+++|+||||+|||++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999988853210 12467778899999999999999
Q ss_pred CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhH
Q 041766 205 DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLG 283 (387)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 283 (387)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~--- 242 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E--- 242 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--H---
Confidence 99999999999987654332222223345678999999988889999999999999999998 88886432111 0
Q ss_pred HHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 284 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
........... ..+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 243 -~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111000 011223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=281.80 Aligned_cols=237 Identities=22% Similarity=0.393 Sum_probs=177.2
Q ss_pred CCCCCcccccCCeeEEEEEEcCC-C--EEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------Cc
Q 041766 91 FSDANKLGEGGFGPVYKGVLKKG-D--EIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DE 159 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~ 159 (387)
|.+.+.||+|+||.||+|.+... . .||+|.++.. .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678899999999999997653 2 5899988643 234456788999999999999999999987542 24
Q ss_pred eEEEEEecCCCCcchhhcCCc-----c-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 160 KILIYEYMPNKSLDFFLFDPT-----K-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~-----~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
.+++|||+++|+|..++.... . ..++|..+++|+||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 689999999999987763210 0 124677788999999999999999999999999998
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~----~~~~~~~~~~~ 234 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEI----YDYLRQGNRLK 234 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHHcCCCCC
Confidence 7654332222223345678999999998899999999999999999999 7777643211 111 11111111100
Q ss_pred ccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.....+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 235 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 ----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=293.65 Aligned_cols=247 Identities=18% Similarity=0.278 Sum_probs=175.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~ 161 (387)
+|++.+.||+|+||.||+|+... +..||||++... .......+.+|+.++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999999764 889999998643 2233456889999999999999999999886532 479
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL- 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 224 (387)
+|||||+ ++|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999995 578777654321 1357888899999999999999999999999999975432211
Q ss_pred ccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc-----------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS----------- 291 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 291 (387)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||...... ............
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhhh
Confidence 111233578999999999875 67899999999999999999999997543211 111111110000
Q ss_pred Ccccccccccccccc-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 292 NRTLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 292 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+.+........ ........+.+++.+||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 001123567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=278.71 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEcc--CCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 159 (387)
...|...+.||+|+||.|..+.... |+.||||++. .......++..+|+.+|+.++|+||+.+++++..+ ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3556667899999999999999775 8899999997 34556677889999999999999999999998762 35
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+|+|+| +-+|...+..... ..++|...++||||||+|+|++.+..+||+|||+|+......
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 79999999 5588877765541 236888999999999999999999999999999999876432
Q ss_pred cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc-----------
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS----------- 291 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 291 (387)
.....+..+.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|.....- ............
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHHHHHHhcc
Confidence 2223345577999999999864 57999999999999999999999887543221 111111111110
Q ss_pred Cccccccccccc---ccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhhh
Q 041766 292 NRTLELIDPILE---DEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEAA 345 (387)
Q Consensus 292 ~~~~~~~~~~~~---~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~~ 345 (387)
......+..... .++ ..+...+...+|+.+||..||.+|+|++|+++. |.....
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 111111110000 000 012334678899999999999999999999974 555544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=283.16 Aligned_cols=244 Identities=22% Similarity=0.276 Sum_probs=173.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEc--CCCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCCceeeeeeeEEe-----
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLPGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID----- 156 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~----- 156 (387)
++|++.+.||+|+||.||+|+.. .+..||+|.+.... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999864 36789999886432 22334566788777765 69999999999863
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
....++||||++ ++|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 346799999996 578777754221 1247788889999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC---ccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN---RTL 295 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 295 (387)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............. ...
T Consensus 160 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 160 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhch
Confidence 5432 1233457899999999999889999999999999999999999997543221 1111111110000 000
Q ss_pred -------cccccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 -------ELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 -------~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+....... ......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=279.13 Aligned_cols=237 Identities=26% Similarity=0.386 Sum_probs=182.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|.+.++||+|+||.||+|.+.++..||+|.+..... ....+.+|++++++++||||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467899999999999999999987777899999975332 3467889999999999999999999874 45678999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++|+|.+++..... ...+|..+++|+||||+||++++++.+||+|||.++........ ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~ 161 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 161 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-ccc
Confidence 99999988864221 12467778899999999999999999999999999866433221 112
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||...+..++.++||||||+++|||++ |..||...... .. ........ . ....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~----~~~~~~~~---------~-~~~~ 225 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV----LDQVERGY---------R-MPCP 225 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HH----HHHHhcCC---------C-CCCc
Confidence 2345678999999988889999999999999999999 77776432211 00 01000000 0 0112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
...+..+.+++.+||+.||++|||++++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 33456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=282.42 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=183.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|+..+.||+|+||.||+|.+.. +. .||+|.+... .......+.+|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 578889999999999999998643 44 4899998654 334456788999999999999999999998754 4679
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+++|+|.+++...... .++|..+++|+||||+|||+++++.+||+|||+++........
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 99999999999888653321 2578888899999999999999999999999999876433222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... .....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~----~~~~~---------- 229 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLL----EKGER---------- 229 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH----HCCCc----------
Confidence 12222344678999999998899999999999999999998 8888643221 1111111 00000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.......+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 001122345788999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.49 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|+.. ++..||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357999999999999999999975 4788999998755444556788899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+++++|.+++..... ...+|..+++|+||||+||++++++.+||+|||++....... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCc
Confidence 999999887754321 124677788999999999999999999999999998653221 11233
Q ss_pred ccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 231 IVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 231 ~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
..++..|+|||.+. ...++.++|||||||++|||++|+.|+......... . . .... ....+... .
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~----~-~~~~---~~~~~~~~---~ 233 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F----L-MSKS---NFQPPKLK---D 233 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e----e-eecC---CCCCCCCc---c
Confidence 46788999999884 345788999999999999999999987422111000 0 0 0000 00000000 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
....+..+.+++.+||+.+|++|||++++++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 122346788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.35 Aligned_cols=238 Identities=29% Similarity=0.410 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......+..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3678889999999999999999753 4578999886443 23345788999999999999999999999998899
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------------ccccchhhhhhcccCCCceEEcCCC---CeEEeecc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------------RMLLDWSANYSSRLKVSNILLDKDI---NPKISDFG 214 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~l~~~~~~h~dlk~~Nill~~~~---~~kl~Dfg 214 (387)
++||||+++++|..++..... ..++|..+++|+||||+|||++.++ .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 999999999999988754321 0246777889999999999998654 59999999
Q ss_pred CceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
+++................+..|+|||++.+..++.++|||||||++|||++ |..||...... ..... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~----~~~~~ 238 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEF----VTGGG 238 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH----HHcCC
Confidence 9987643322222222334568999999998899999999999999999997 88887532211 11111 10000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
. . ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 239 ~---------~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 R---------L-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c---------C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0 011223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=281.86 Aligned_cols=237 Identities=22% Similarity=0.326 Sum_probs=180.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||+|... .++.||+|.+... .......+..|++++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35788899999999999999865 4788999988644 233446788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 167 MPNKSLDFFLFDPTK------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
+++++|..+...... ..++|..+++|+||||+|||++.++.+||+|||++...... ......|+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~ 156 (279)
T cd06619 81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGT 156 (279)
T ss_pred CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCC
Confidence 999998654321111 13577788899999999999999999999999999765422 12335788
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH--hHHHHHHhhcCccccccccccccccccHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL--LGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ...... ..... .+.. ......
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-----~~~~----~~~~~~ 226 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDED-----PPVL----PVGQFS 226 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccC-----CCCC----CCCcCC
Confidence 99999999999899999999999999999999999985432221110 000000 00000 0000 111234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+.+++.+||+.+|++||+++++++.
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=297.54 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=183.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+|+... ++.||+|++... .......+..|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 368889999999999999999774 889999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC-----
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE----- 223 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----- 223 (387)
||+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999888865421 124777888999999999999999999999999997654322
Q ss_pred ----------------------cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH
Q 041766 224 ----------------------LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281 (387)
Q Consensus 224 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~ 281 (387)
.........||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---- 236 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH----
Confidence 001223457899999999999999999999999999999999999997543211
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNEVVSM 339 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~~v~~~ 339 (387)
.......... ...... .....+..+.+++.+||+ ||.+||+ ++++++.
T Consensus 237 -~~~~~i~~~~-------~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -ETYNKIINWK-------ESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -HHHHHHhccC-------CcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0111110000 000000 011135678899999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=290.49 Aligned_cols=244 Identities=25% Similarity=0.354 Sum_probs=182.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC-
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK- 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~- 157 (387)
..++|++.+.||+|+||.||+|.+. .++.||||.++... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3468999999999999999999742 36789999997543 23345788999999999 789999999988764
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------------------------------------------------
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK-------------------------------------------------------- 181 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 181 (387)
...+++||||++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999888753210
Q ss_pred ---------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 182 ---------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 182 ---------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
..++|..+++|+||||+|||++.++.+||+|||++................++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 01356677899999999999999999999999999765332222222233456
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ........... .+.....
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~----~~~~~~~~~~~----------~~~~~~~ 309 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF----CRRLKEGTRMR----------APDYTTP 309 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH----HHHHhccCCCC----------CCCCCCH
Confidence 78999999998899999999999999999997 888864322111 00 01111110000 0111234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 314 RYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.69 Aligned_cols=236 Identities=20% Similarity=0.254 Sum_probs=185.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.+.|+.++.||+|.-|+||+++..+ +..+|+|++.+.. .....+...|-+||+.++||.++.+|+.++.+...|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3567888999999999999999886 5789999997542 23345677899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC----
Q 041766 164 YEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG---- 221 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~---- 221 (387)
||||+||+|..+.+..... .+||..++|.|||||+||||.++|++.|+||.++..+..
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999888765443 358889999999999999999999999999998753311
Q ss_pred -----------------------------C-C--------------------cccccccccCCCccccccccccCCCCcc
Q 041766 222 -----------------------------N-E--------------------LQANTSRIVGTYGYMSPEYAIQGIFSIK 251 (387)
Q Consensus 222 -----------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 251 (387)
. . .......++||-.|+|||++.|...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0011234689999999999999999999
Q ss_pred ccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCC
Q 041766 252 SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP 331 (387)
Q Consensus 252 ~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 331 (387)
+|+|+|||++|||+.|..||......... ..++...+.-. .....+..+.+||++.|..||++|.
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl--------------~NIv~~~l~Fp-~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETL--------------RNIVGQPLKFP-EEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhH--------------HHHhcCCCcCC-CCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999997543322111 11111111111 1124456788999999999999999
Q ss_pred C----HHHHHH
Q 041766 332 T----MNEVVS 338 (387)
Q Consensus 332 t----~~~v~~ 338 (387)
. ++||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 777765
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=291.58 Aligned_cols=236 Identities=24% Similarity=0.306 Sum_probs=182.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEcc--CCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP--GRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..|+++++||+||.+.||++...+.+.+|+|++. ..+......|..|+..|.++ .|.+||++++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4688999999999999999998877888888774 34667778899999999999 69999999999999999999999
Q ss_pred ecCCCCcchhhcCCcccc-----------------ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTKRM-----------------LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~~-----------------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|- .-||..+|.+..... ..|..++||.||||.|+|+-+ |.+||+|||+|.....+......
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred cc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence 65 568888886654321 257788899999999999866 48999999999988766665566
Q ss_pred ccccCCCccccccccccCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGI-----------FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
...+||+.||+||.+.... .+.++||||+|||||+|+.|+.||..+.. .... ...+
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aK------l~aI 585 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAK------LHAI 585 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHH------HHhh
Confidence 6789999999999986322 56899999999999999999999853221 1111 1111
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.++...-++.......++.++|+.||+.||.+|||..++++.
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122111111110111238899999999999999999999873
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=298.07 Aligned_cols=237 Identities=22% Similarity=0.286 Sum_probs=179.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 368889999999999999999765 889999998643 2233456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc--
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA-- 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 226 (387)
||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999888764322 124777888999999999999999999999999987643211000
Q ss_pred ----------------------------------ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041766 227 ----------------------------------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTG 272 (387)
Q Consensus 227 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~ 272 (387)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112468999999999999999999999999999999999999985
Q ss_pred CCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 041766 273 FYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNEVVSM 339 (387)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~~v~~~ 339 (387)
..... . ............. .. .....+..+.+++.+|+. +|.+|++ +.++++.
T Consensus 241 ~~~~~--~---~~~~i~~~~~~~~-----~~---~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQ--E---TYRKIINWKETLQ-----FP---DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHH--H---HHHHHHcCCCccC-----CC---CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 33211 1 1111110000000 00 011234567889999996 9999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=283.31 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=182.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 161 (387)
.+|++.+.||+|+||.||++.++ .+..||+|.+..........+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888999999999999999853 3778999998766555567889999999999999999999987643 4678
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++++|.+++..... ..++|..+++|+||||+||+++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 99999999999998864321 1246778889999999999999999999999999986643221
Q ss_pred cc-ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--------c
Q 041766 225 QA-NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT--------L 295 (387)
Q Consensus 225 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~ 295 (387)
.. ......++..|+|||.+.+..++.++|||||||++|||++|..++...... +... ...... .
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~ 236 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRM-MGNDKQGQMIVYHLI 236 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhh-cccccccccchHHHH
Confidence 11 111123345699999999888999999999999999999987764322110 0000 000000 0
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
+.+..... .......+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 001223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=278.29 Aligned_cols=234 Identities=28% Similarity=0.406 Sum_probs=180.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.+|++.+.||+|+||.||++.++.+..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3578889999999999999998777789999886432 234578899999999999999999999999999999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++|.+++...... ..+|..+++|+||||+||++++++.+||+|||+++......... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 161 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGT 161 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc-cCCC
Confidence 99999888643211 24677788999999999999999999999999997654322111 1112
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ... .... ... ..+..
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~---~~~-~~~~-----~~~-----~~~~~ 225 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EV---VES-VSAG-----YRL-----YRPKL 225 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HH---HHH-HHcC-----CcC-----CCCCC
Confidence 33457999999998899999999999999999999 78887532211 11 011 0000 000 01122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
.+..+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 355788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=277.22 Aligned_cols=241 Identities=20% Similarity=0.311 Sum_probs=187.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 5889999988532 2333567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++++|..++..... ...+|..+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999888753211 1246777889999999999999999999999999876543221
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....+. ...... ... ....
T Consensus 162 --~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-~~~---------~~~~ 226 (267)
T cd08224 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKK-IEK---------CDYP 226 (267)
T ss_pred --ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH---HHHHhh-hhc---------CCCC
Confidence 1223467889999999998889999999999999999999999974332111 111100 000 0001
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.......+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1112234567889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.90 Aligned_cols=239 Identities=25% Similarity=0.376 Sum_probs=182.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999864 35679999986543 23346788999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc--------------------------------------ccccchhhhhhcccCCCceEE
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK--------------------------------------RMLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~--------------------------------------~~~l~~~~~~h~dlk~~Nill 202 (387)
+++|||+++|+|..++..... ...+|..+++|+||||+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 999999999999988853210 023677778999999999999
Q ss_pred cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchH
Q 041766 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTL 281 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~ 281 (387)
+.++.+||+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~----- 238 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH----- 238 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999876543322222222344677999999988899999999999999999998 7777632111
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...... ....... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ~~~~~~-~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYY-VRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH-HhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 1111100 0112234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=278.99 Aligned_cols=235 Identities=25% Similarity=0.387 Sum_probs=171.6
Q ss_pred CcccccCCeeEEEEEEcC---CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998654 35689998865432 33357888999999999999999999999988899999999999
Q ss_pred CcchhhcCCcc---------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 171 SLDFFLFDPTK---------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 171 ~L~~~l~~~~~---------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+|.+++..... ..++|..+++|+||||+||+++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 99988753211 013566678999999999999999999999999997654333222223
Q ss_pred cccCCCccccccccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQG-------IFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-------~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||....... .... . . .........+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~--~-~-~~~~~~~~~~~ 234 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY--T-V-REQQLKLPKPR 234 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH--H-h-hcccCCCCCCc
Confidence 34677889999998642 35789999999999999996 998975432211 1000 0 0 00011111111
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
+. ......+.+++.+|| .+|++|||+++|+..|+
T Consensus 235 ~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 235 LK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 112345778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=289.96 Aligned_cols=226 Identities=24% Similarity=0.332 Sum_probs=174.2
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+... .......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999775 789999998643 223345677899999876 899999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|...+..... ..++|..+++||||||+|||++.++.+||+|||++........ ......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccccccc
Confidence 999877754321 1247788899999999999999999999999999875432221 2234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||...... .......... . ..+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~----~--------~~p~~~~~ 221 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD----V--------LYPVWLSK 221 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC----C--------CCCCCCCH
Confidence 99999999999989999999999999999999999998533211 1111111000 0 01112345
Q ss_pred HHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 041766 314 RYVNIALLCVQESADDRP-------TMNEVVSM 339 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RP-------t~~~v~~~ 339 (387)
.+.+++.+||+.||++|| ++.++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 688999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.63 Aligned_cols=231 Identities=20% Similarity=0.323 Sum_probs=174.2
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+++... ++.||+|.+... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999998643 223445677899888877 899999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccC
Confidence 999877654321 124777888999999999999999999999999987532211 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc---chHhHHHHHHhhcCccccccccccccccccHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS---LTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||....... .....+.......... ..+..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----------~~p~~ 227 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----------RIPRS 227 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------CCCCC
Confidence 999999999999999999999999999999999999985322111 1111111111111100 01122
Q ss_pred HHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPT------MNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt------~~~v~~ 338 (387)
....+.+++.+||+.||++||+ +.++++
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 3456789999999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.42 Aligned_cols=239 Identities=21% Similarity=0.242 Sum_probs=182.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|++.+.||+|+||.||+++... +..||+|.+... .......+..|+.+++.++||||+++++++.+.+..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34678999999999999999999765 788999998532 22233457789999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||++........ ..
T Consensus 121 v~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-cc
Confidence 9999999999888755321 1247788889999999999999999999999999986543221 12
Q ss_pred cccccCCCccccccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQG----IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~----~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .............. ..
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~~~~~-----~~ 269 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHKNSLT-----FP 269 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCCcCC-----CC
Confidence 2345799999999998653 3789999999999999999999998532211 11111111100000 00
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
.....+..+.+++.+||+.+|++ |||+.++++.
T Consensus 270 ---~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 ---DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11123457889999999999987 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=287.31 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=185.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC--------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 156 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 156 (387)
..++|.+.+.||+|+||.||++.... ...+|+|.+... .......+..|++++.++ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34678999999999999999998532 246999998754 233456788899999999 89999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDK 204 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~ 204 (387)
.+..++||||+++|+|..++..... ...+|..+++|+||||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence 9999999999999999988864311 02366777899999999999999
Q ss_pred CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhH
Q 041766 205 DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLG 283 (387)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 283 (387)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~~ 250 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----EE 250 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HH
Confidence 99999999999876543221111222234568999999998889999999999999999998 7777642211 11
Q ss_pred HHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 284 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.. ......... ..+...+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 251 ~~-~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 LF-KLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HH-HHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 111111000 01123345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=292.65 Aligned_cols=226 Identities=21% Similarity=0.233 Sum_probs=174.0
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+++... +..||+|.+... .......+..|++++..++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999764 889999998643 2233456778999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 171 SLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 171 ~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
+|..++..... ..++|. .+++||||||+|||++.++.+||+|||+++....... ......|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccC
Confidence 99877754321 124665 6889999999999999999999999999875432211 1233578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||...... ... .. ..... .. .+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~---~~-i~~~~------~~-----~p~~~~~ 221 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF---EL-ILMEE------IR-----FPRTLSP 221 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHH---HH-HhcCC------CC-----CCCCCCH
Confidence 99999999999999999999999999999999999997432211 000 00 00000 00 1112345
Q ss_pred HHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 314 RYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
.+.+++.+||+.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 688999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.66 Aligned_cols=236 Identities=21% Similarity=0.277 Sum_probs=180.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+++... ++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368888999999999999999764 889999998643 2234456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++|+|..++...... ..+|..+++||||||+|||++.++.+||+|||++......... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence 999999999888654211 2467778899999999999999999999999999876433221 2
Q ss_pred cccccCCCccccccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAI------QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~------~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~------ 228 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFL------ 228 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCcc------
Confidence 23347899999999986 456789999999999999999999997532211 1111111111000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. ......+..+.+|+.+||+ +|++|||+.++++.
T Consensus 229 -~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 -KF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -CC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 0111234568899999998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=281.05 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=200.3
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeee
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 153 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 153 (387)
..++....+++.....+-+|.||.||.|.|.+ .+.|-+|.++.. ++.....+..|.-.|..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 35555667788888899999999999997654 335777877643 44556788899999999999999999999
Q ss_pred EEeC-CceEEEEEecCCCCcchhhcCCcc-----c-------------------cccchhhhhhcccCCCceEEcCCCCe
Q 041766 154 CIDK-DEKILIYEYMPNKSLDFFLFDPTK-----R-------------------MLLDWSANYSSRLKVSNILLDKDINP 208 (387)
Q Consensus 154 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----~-------------------~~l~~~~~~h~dlk~~Nill~~~~~~ 208 (387)
+.+. ..+++++.++.-|+|+.|+..... . ..+|..+++|.||..+||+||+..++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 8764 577899999999999999973221 0 24677788999999999999999999
Q ss_pred EEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHH
Q 041766 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 209 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 287 (387)
||+|=.+++.+-..++..-......+..||+||.+....|+.++|||||||+||||+| |+.|+...+ ..+...+..+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~~ylkd 513 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEMEHYLKD 513 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHHHHHhc
Confidence 9999999999887777777766777899999999999999999999999999999999 888863222 1111111111
Q ss_pred HhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
. .++ .++.+|+.+++.+|..||..+|++||+++|++..|.+....+
T Consensus 514 G-----------yRl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 514 G-----------YRL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred c-----------cee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1 011 145567789999999999999999999999999999875543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.35 Aligned_cols=237 Identities=23% Similarity=0.273 Sum_probs=177.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+++... ++.||||++... .......+.+|++++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368889999999999999998764 889999988542 2233457788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc---
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ--- 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 225 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999888754321 12478888999999999999999999999999998633110000
Q ss_pred --------c----------------------------------ccccccCCCccccccccccCCCCccccchhHHHHHHH
Q 041766 226 --------A----------------------------------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 263 (387)
Q Consensus 226 --------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~e 263 (387)
. .....+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0 0012468999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 041766 264 IVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR---PTMNEVVSM 339 (387)
Q Consensus 264 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~~v~~~ 339 (387)
|++|..||...... . ............. .. ........+.+++.+|++ +|.+| +|+.++++.
T Consensus 241 lltG~~Pf~~~~~~--~---~~~~i~~~~~~~~-----~p---~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSH--E---TYRKIINWRETLY-----FP---DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHH--H---HHHHHHccCCccC-----CC---CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999998532211 1 0111110000000 00 111234568899999997 77765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=285.22 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=186.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc--------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
...++|.+.+.||+|+||.||++++. ++..||+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34577889999999999999999742 1346999988643 234456788999999999 8999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEc
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
.....+++|||+++|+|..++..... ..++|..+++|+||||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 99999999999999999988864311 0236777889999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHh
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLL 282 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 282 (387)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... ..
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~ 246 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----VE 246 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----HH
Confidence 999999999999987654332222233345678999999998889999999999999999998 677753221 11
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..... ....... ..+..++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 247 ~~~~~-~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKL-LKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHH-HHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111 1111100 0112335578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=283.75 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=182.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568889999999999999998765 33 4788888643 333456788999999999 799999999999998899999
Q ss_pred EEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
+||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999999999888854210 124677788999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... . . .....
T Consensus 162 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~---~-~~~~~ 232 (297)
T cd05089 162 DFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--E---L-YEKLP 232 (297)
T ss_pred CcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--H---H-HHHHh
Confidence 99998643211 11111233567999999998899999999999999999998 98887432211 0 0 01110
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. ... ..+..++..+.+++.+||+.+|.+|||++++++.|+++....
T Consensus 233 ~~---------~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 QG---------YRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred cC---------CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00 000 011223457889999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=309.54 Aligned_cols=243 Identities=21% Similarity=0.263 Sum_probs=184.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578899999999999999999765 8899999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc---------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 165 EYMPNKSLDFFLFDPTK---------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~---------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999887753100 124677788999999999999999999999999998
Q ss_pred ecCCCCc----------------ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH
Q 041766 218 ICGGNEL----------------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281 (387)
Q Consensus 218 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~ 281 (387)
....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~- 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS- 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh-
Confidence 6521110 00112346899999999999999999999999999999999999997532211000
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhhhhh
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP-TMNEVVSMLTDEAA 345 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~~v~~~L~~~~~ 345 (387)
.. . ....+... ......+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 241 ----~~----~---~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 ----YR----D---VILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ----hh----h---hccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0 00000000 01123445688999999999999996 67777777877654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=286.97 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=185.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC--------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
..+|.+.+.||+|+||.||+++... +..||+|.+.... ......+.+|+.++.++ +||||++++++|...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568889999999999999997531 2368999886432 33456788999999999 899999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKD 205 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~ 205 (387)
+..++++||+++|+|.+++..... ..++|..+++|+||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 999999999999999988764210 024677788999999999999999
Q ss_pred CCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHH
Q 041766 206 INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGY 284 (387)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 284 (387)
+.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~~ 245 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----EEL 245 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHH
Confidence 9999999999986643322222222344567999999999999999999999999999998 7777643211 111
Q ss_pred HHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 285 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
. .......... .+...+..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 246 ~-~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 F-KLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H-HHHHcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 1111111000 11123457889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.25 Aligned_cols=235 Identities=21% Similarity=0.279 Sum_probs=174.7
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.|+..+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++|||||++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999999765 7889999986432 2334578889999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC------
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE------ 223 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------ 223 (387)
||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999888754321 124678889999999999999999999999999975321000
Q ss_pred ---------------------------------------cccccccccCCCccccccccccCCCCccccchhHHHHHHHH
Q 041766 224 ---------------------------------------LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEI 264 (387)
Q Consensus 224 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el 264 (387)
........+||+.|+|||++.+..++.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00001234689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 041766 265 VSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNEVVS 338 (387)
Q Consensus 265 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~~v~~ 338 (387)
++|+.||....... ......... ...... ........+.+++.+++ .+|++|++ +.++++
T Consensus 242 ltG~~Pf~~~~~~~-----~~~~i~~~~-------~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 242 LVGQPPFLAQTPLE-----TQMKVINWQ-------TSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HhCCCCCCCCCHHH-----HHHHHHccC-------CCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999985332110 000000000 000000 11123446677787765 59999997 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=289.56 Aligned_cols=225 Identities=24% Similarity=0.335 Sum_probs=173.2
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+.+. ++.||+|.+... .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999765 788999998642 223445677888898877 799999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccccccc
Confidence 999887754322 124778888999999999999999999999999987542221 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... . ...... .... ..+...+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~---~~~~i~-~~~~-----------~~~~~~~~ 221 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--D---LFEAIL-NDEV-----------VYPTWLSQ 221 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--H---HHHHHh-cCCC-----------CCCCCCCH
Confidence 99999999999989999999999999999999999998532211 1 111110 0000 01112345
Q ss_pred HHHHHHHhcccCCCCCCCCH------HHHHH
Q 041766 314 RYVNIALLCVQESADDRPTM------NEVVS 338 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~------~~v~~ 338 (387)
.+.+++.+||+.||++||++ +++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 68899999999999999998 55554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=286.70 Aligned_cols=236 Identities=21% Similarity=0.265 Sum_probs=177.7
Q ss_pred CCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCC----CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR----SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
+|++.+.||+|+||.||+++.. .+..||+|.+... .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999853 4788999998532 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 999999999999887754321 1247788899999999999999999999999999976432221
Q ss_pred ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......||..|+|||++.+. .++.++|||||||++|||++|+.||......... ......... .++.
T Consensus 161 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~-------~~~~-- 229 (332)
T cd05614 161 E-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK-------CDPP-- 229 (332)
T ss_pred C-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc-------CCCC--
Confidence 1 12345789999999999865 4789999999999999999999998543222111 111111100 0000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
.+......+.+++.+||+.||++|| +++++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 ---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1122345678999999999999999 67788763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=278.30 Aligned_cols=241 Identities=19% Similarity=0.297 Sum_probs=185.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||++... ++..+|||.+... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999965 5889999987542 2234467889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++++|..++..... ...+|..+++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999887753111 1246777889999999999999999999999999876543221
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||.+.+..++.++|+||||+++|||++|..||.....+. ....... .... ..
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~------~~~~----~~ 226 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKI------EQCD----YP 226 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhhh------hcCC----CC
Confidence 1223467889999999988889999999999999999999999974322111 1110000 0000 01
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.......+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1112234567889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=276.40 Aligned_cols=236 Identities=28% Similarity=0.427 Sum_probs=181.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 467889999999999999999988888899999865432 3467899999999999999999999875 45678999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|.+++..... ...+|..+++|+||||+||++++++.+||+|||++......... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 161 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQ 161 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-ccc
Confidence 99999988764221 12467788899999999999999999999999999876433211 112
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...... . ..... .. ..+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~---~-~~~~~---------~~-~~~ 225 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLE---Q-VERGY---------RM-PCP 225 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHH---H-HHcCC---------CC-CCC
Confidence 2345668999999988889999999999999999999 788864321 111111 1 10000 00 012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=286.98 Aligned_cols=231 Identities=20% Similarity=0.326 Sum_probs=175.0
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||++++.. +..||+|.++.. .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999765 788999998643 223345678899999998 799999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccC
Confidence 999877754321 124778888999999999999999999999999987432111 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc---chHhHHHHHHhhcCccccccccccccccccHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS---LTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||....... .....+......... .. .+..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~---~p~~ 227 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IR---IPRS 227 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CC---CCCC
Confidence 999999999999999999999999999999999999986422111 111111111111110 00 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPT------MNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt------~~~v~~ 338 (387)
.+..+.+++.+||+.||.+||| +.++++
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 3456889999999999999997 667765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=281.57 Aligned_cols=240 Identities=27% Similarity=0.410 Sum_probs=184.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
..++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678889999999999999998653 3579999986443 2334578899999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc--------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK--------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~--------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
.++||||+++|+|..++..... ..++|..+++|+||||+|||++.++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 9999999999999988753211 12467778899999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
|+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||...... ... ......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~----~~~~~~ 237 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVL----KFVIDG 237 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHH----HHHhcC
Confidence 99986544332222333456788999999988889999999999999999998 88886432211 111 111111
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.... .+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 238 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 238 GHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1000 111225578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=281.98 Aligned_cols=234 Identities=25% Similarity=0.284 Sum_probs=179.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.|+..+.||+|+||.||++.... ++.||+|.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 37778899999999999999764 7899999986432 1223456789999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|+++|+|..++..... ..++|..+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 9999999877643211 1247778889999999999999999999999999986543221
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....|+..|+|||++.+..++.++|||||||++|||++|..||....... ......... .... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~---------~~~~--~~~ 224 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRV---------KEDQ--EEY 224 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHh---------hhcc--ccc
Confidence 223478999999999998889999999999999999999999985432111 000000000 0000 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
+...+..+.+++.+||+.||++|| +++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 223456788999999999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=283.98 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=184.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 158 (387)
..++|.+.+.||+|+||.||++... .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467889999999999999999752 24479999887543 33446788999999999 8999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
..+++|||+++|+|..++...... .++|..+++|+||||+|||++.++.+||+|||+++...
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999999888643211 24677788999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
............++..|+|||.+.+..++.++|||||||++|||++ |..||....... .. ........
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~----~~~~~~~~------ 261 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KF----YKLIKEGY------ 261 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HH----HHHHHcCC------
Confidence 3322112223345778999999998899999999999999999998 888864322111 00 01111000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.. ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 262 ---~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ---RM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---cC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 01112245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=276.56 Aligned_cols=238 Identities=29% Similarity=0.434 Sum_probs=183.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
...++|++.++||+|+||.||+|..+++..||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3457789999999999999999998888999999987543 33468899999999999999999999874 456899999
Q ss_pred ecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|+++++|.+++..... ...+|..+++|+||||+||++++++.++|+|||++......... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 159 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-A 159 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-c
Confidence 9999999888754321 12467778899999999999999999999999999766432221 1
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... . ...... . .
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~---~-~~~~~~-----~-----~ 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQ---N-LERGYR-----M-----P 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHH---H-HHcCCC-----C-----C
Confidence 122345678999999988889999999999999999999 9988753221 11111 0 110000 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.....+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=274.35 Aligned_cols=230 Identities=24% Similarity=0.337 Sum_probs=176.5
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
+.||+|+||.||+|...++..+|+|.+..... .....+.+|++++.+++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988788999999865432 33457889999999999999999999999999999999999999998
Q ss_pred hhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 174 FFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 174 ~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
.++...... ..+|..+++|+||||+||+++.++.+||+|||++......... ......++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~ 159 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIK 159 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCccc
Confidence 887543211 2367778899999999999999999999999998754332211 1122234567
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (387)
|+|||++.+..++.++||||||+++||+++ |..||...... .. ... ...... . ..+...+..+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~---~~~-~~~~~~-----~-----~~~~~~~~~~ 223 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QA---REQ-VEKGYR-----M-----SCPQKCPDDV 223 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HH---HHH-HHcCCC-----C-----CCCCCCCHHH
Confidence 999999988889999999999999999998 88887432111 00 001 111000 0 0111234578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 316 VNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 316 ~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHhc
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=293.16 Aligned_cols=185 Identities=23% Similarity=0.315 Sum_probs=154.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|+..+.||+|+||.||+++... ++.||+|++.... ......+..|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998765 8899999986431 233456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc---
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ--- 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 225 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999888864322 12478888999999999999999999999999998754321100
Q ss_pred ------------------------------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 226 ------------------------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 226 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001235799999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=279.98 Aligned_cols=227 Identities=22% Similarity=0.310 Sum_probs=172.7
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||+|+||+||++.... ++.||+|.+.... ....+.+..|+.++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999764 7899999986432 12335677899999999999999999999999999999999999999
Q ss_pred chhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 173 DFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 173 ~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
...+..... ..++|..+++|+||||+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence 876632110 1247778889999999999999999999999999976543221 123357
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
||..|+|||.+.+..++.++|||||||++|||++|+.||......... ...... ...... ..+...+
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~---------~~~~~~---~~~~~~~ 225 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQR---------ILNDSV---TYPDKFS 225 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHh---------hcccCC---CCcccCC
Confidence 899999999999999999999999999999999999998543221100 000000 000000 0122345
Q ss_pred HHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 313 LRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
..+.+++.+||+.||++|| |++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 6788999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=281.81 Aligned_cols=236 Identities=22% Similarity=0.348 Sum_probs=184.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
...+|+..+.||+|+||.||+|+.. .+..||+|.+........+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3468889999999999999999965 488999999876555556778899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 166 YMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRST 175 (296)
T ss_pred ccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--ccCc
Confidence 9999999988754321 1246778889999999999999999999999999876432211 1223
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+. ...... . +.. ..+..
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~-~~~~~~-~-----~~~---~~~~~ 241 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALY-LIATNG-T-----PEL---QNPEK 241 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHH-HHhcCC-C-----CCC---CCccc
Confidence 467889999999998889999999999999999999999985332211 000 000000 0 000 01223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+.+++.+||..+|++|||+.++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 4456889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.97 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=185.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv 163 (387)
.|...+++|+|+||.||+|.... ++.||||++-.... .--+|+++|+++.|||||++.-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999999776 68999998853322 1236899999999999999988876532 23589
Q ss_pred EEecCCCCcchhhcCC---cc-----------------ccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCC
Q 041766 164 YEYMPNKSLDFFLFDP---TK-----------------RMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGN 222 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~---~~-----------------~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 222 (387)
|||+|. +|...++.. +. ..++|..++.||||||.|+|+|.+ |.+||||||.|+.+..+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 999987 777777632 11 135788899999999999999876 89999999999988644
Q ss_pred CcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh---------cC
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT---------SN 292 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~ 292 (387)
... ....-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...... ..+.....-... ..
T Consensus 180 epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 180 EPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHhhcCc
Confidence 322 223457899999999875 6999999999999999999999887653322 222221111000 00
Q ss_pred cccccccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhhh-----ccCCCCCCceeeeec
Q 041766 293 RTLELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEAA-----ALFPPKQPAFSYVRN 360 (387)
Q Consensus 293 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~~-----~~~~~~~~~~~~~~~ 360 (387)
+..+...+.+.... ......++..+++.++++.+|.+|.++.|++.. .+++.. ....+.+|.|++.+.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~ 334 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRA 334 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHH
Confidence 11111112222111 234456788999999999999999999999863 333332 234466666666554
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=286.45 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=185.2
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
...++|.+.+.||+|+||.||++... ....+|+|.+.... ......+..|+.++.++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34567889999999999999999752 13468999887442 33456788999999999 6999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEc
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
..+..+++|||+++|+|..++..... ..++|..+++|+||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 98899999999999999988854210 1246777889999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHh
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLL 282 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 282 (387)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EEL- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHH-
Confidence 999999999999986543222222222234567999999998889999999999999999999 7877642211 111
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..........+ .+..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 246 ---~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 ---FKLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ---HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111110000 1122345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=286.75 Aligned_cols=225 Identities=25% Similarity=0.344 Sum_probs=171.9
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999875 788999998643 123345566788888765 999999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecC
Confidence 999888764321 124778888999999999999999999999999987532211 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||..... ... .... ... .+. .+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~---~~~i-~~~------~~~-----~~~~~~~ 221 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EEL---FQSI-RMD------NPC-----YPRWLTR 221 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHH---HHHH-HhC------CCC-----CCccCCH
Confidence 9999999999998999999999999999999999999753221 111 1110 000 000 1112345
Q ss_pred HHHHHHHhcccCCCCCCCCHH-HHHH
Q 041766 314 RYVNIALLCVQESADDRPTMN-EVVS 338 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~-~v~~ 338 (387)
.+.+++.+||+.||++||++. ++.+
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 678999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=276.51 Aligned_cols=230 Identities=28% Similarity=0.367 Sum_probs=174.1
Q ss_pred cccccCCeeEEEEEEc---CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 96 KLGEGGFGPVYKGVLK---KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
.||+|+||.||+|.++ ++..+|+|.+.... ....+.+..|+.++..++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 36789999886432 234567889999999999999999999885 45678999999999
Q ss_pred CcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc-ccccccC
Q 041766 171 SLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA-NTSRIVG 233 (387)
Q Consensus 171 ~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~g 233 (387)
+|..++..... ...+|..+++|+||||.||+++.++.+||+|||+++......... ......+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99888754321 124677788999999999999999999999999998664332211 1122234
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
+..|+|||.+....++.++|||||||++|||++ |..||..... ...... ....... ..+..++
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----i~~~~~~----------~~~~~~~ 224 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQM----IESGERM----------ECPQRCP 224 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCCCC----------CCCCCCC
Confidence 578999999988889999999999999999998 8888753221 111111 1111000 0112245
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
..+.+++.+||+.||++||++.+|.+.|++
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.76 Aligned_cols=229 Identities=23% Similarity=0.309 Sum_probs=172.7
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||+|+||.||+++.+. |+.||+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999765 8899999985321 12233456799999999999999999999999999999999999999
Q ss_pred chhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 173 DFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 173 ~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
..++..... ..++|..+++|+||||+||+++.++.+||+|||++....... ......|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCC
Confidence 877643221 124677788999999999999999999999999987654322 12234688
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
..|+|||++.+..++.++|||||||++|||++|+.||........ ......... ..... ......+..
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~---------~~~~~--~~~~~~~~~ 225 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTL---------EDEVK--FEHQNFTEE 225 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhh---------ccccc--cccccCCHH
Confidence 999999999988899999999999999999999999754322111 011111100 00000 011123556
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 315 YVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
+.+++.+||+.||++||+++|+++.+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhh
Confidence 88999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=273.32 Aligned_cols=232 Identities=28% Similarity=0.405 Sum_probs=178.1
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
+.||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999988754333 4567899999999999999999999999999999999999999998
Q ss_pred hhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 174 FFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 174 ~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
.++...... ..+|..+++|+||||+|||++.++.+||+|||++.................+..
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 160 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceec
Confidence 887543211 246777889999999999999999999999999976542222111122234567
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (387)
|+|||.+.+..++.++||||||+++|||++ |..||...... ... ....... . ...+...+..+
T Consensus 161 y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~----~~~~~~~---------~-~~~~~~~~~~~ 224 (251)
T cd05041 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTR----ERIESGY---------R-MPAPQLCPEEI 224 (251)
T ss_pred cCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHH----HHHhcCC---------C-CCCCccCCHHH
Confidence 999999988899999999999999999999 77776432211 000 0000000 0 00122335578
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 316 VNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 316 ~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.+++.+||+.+|++|||+.++++.|+.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.56 Aligned_cols=237 Identities=22% Similarity=0.266 Sum_probs=177.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+++... ++.||+|.+... .......+.+|+++|.+++||||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999999765 889999998642 1223456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC-----
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE----- 223 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~----- 223 (387)
|||++|+|.+++..... ...+|..+++||||||+|||++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999988765321 124677888999999999999999999999999975321000
Q ss_pred ------------------------------------cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhC
Q 041766 224 ------------------------------------LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG 267 (387)
Q Consensus 224 ------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg 267 (387)
.........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00001234789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHH
Q 041766 268 KKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP---TMNEVVSM 339 (387)
Q Consensus 268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---t~~~v~~~ 339 (387)
+.||........ .......... ... .........+.+++.+|+ .+|.+|+ |+.++++.
T Consensus 241 ~~Pf~~~~~~~~-----~~~i~~~~~~-------~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 241 QPPFLADTPAET-----QLKVINWETT-------LHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHH-----HHHHhccCcc-------ccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999854322110 0010000000 000 011123445677888876 5999999 88999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=288.30 Aligned_cols=225 Identities=24% Similarity=0.280 Sum_probs=173.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~ 164 (387)
+|++.+.||+|+||.||+|+... ++.||+|.+... .....+.+..|.+++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999775 678999998643 23345677889999999965 56889999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--Cce
Confidence 99999999887754321 124778888999999999999999999999999987532211 122
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... . ...... ... .. .+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~---~~~~i~-~~~------~~-----~~ 221 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--E---LFQSIM-EHN------VS-----YP 221 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--H---HHHHHH-cCC------CC-----CC
Confidence 3457899999999999999999999999999999999999997532211 1 111110 000 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~ 333 (387)
...+..+.+++.+||+.||++|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=293.22 Aligned_cols=240 Identities=20% Similarity=0.230 Sum_probs=180.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
...++|++.+.||+|+||.||+++... ++.||+|.+... .......+.+|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999875 788999988532 2223456778999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+||||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||++........ .
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-V 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-e
Confidence 99999999999988854321 1247888889999999999999999999999999987643221 1
Q ss_pred ccccccCCCccccccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGI----FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ............... .
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~-----~ 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSLN-----F 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcccC-----C
Confidence 223467999999999997543 78999999999999999999999853221 111111111000000 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
+.....+..+.+++.+|+..++.+ |||+.++++.
T Consensus 269 ---p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 ---PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011123456778999999855543 8899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.49 Aligned_cols=235 Identities=21% Similarity=0.359 Sum_probs=181.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.+.|++.+.||.|+||.||+|+... +..|++|.+........+.+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4678999999999999999999765 788999999766666677888999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++....... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccc
Confidence 999999877643221 124677888999999999999999999999999987543221 1123
Q ss_pred cccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 230 RIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
...++..|+|||.+. ...++.++|||||||++|||++|..||...... ....... ... .+..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~-~~~-----~~~~-- 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIA-KSE-----PPTL-- 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHHh-cCC-----CccC--
Confidence 346788999999985 345788999999999999999999997533211 0111110 000 0000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+......+.+++.+||+.||++||+++++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112233456889999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=280.84 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=186.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~ 160 (387)
.++|.+.+.||+|+||.||+|.+.. +..|++|.+... .......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999775 678999988644 33445678899999999999999999998876 4678
Q ss_pred EEEEEecCCCCcchhhcCCcc------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
++++||+++++|..++..... ..++|..+++|+||||+||++++++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 899999999999988754211 01367777899999999999999999999999999
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
+...............++..|+|||++.+..++.++|||||||++||+++ |+.||.... ......+.. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~----~~~~- 237 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK----DGYR- 237 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH----cCCC-
Confidence 86543332222223356778999999998889999999999999999999 998874321 111111111 1100
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.. ....++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 238 ------~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 ------LA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ------CC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 111234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=277.62 Aligned_cols=239 Identities=26% Similarity=0.405 Sum_probs=182.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC---EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|...+.||+|+||.||+|.... +. .+|+|.+... .....+.+..|++++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999999753 33 6899988654 233456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|..++...... ..+|..+++|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999888653221 24677778999999999999999999999999997664322111
Q ss_pred c-cccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 227 N-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 227 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
. ......+..|+|||++.+..++.++|||||||++|||++ |..||...... ..... .... ..
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~-i~~~---------~~- 228 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKA-INDG---------FR- 228 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHH-HhcC---------CC-
Confidence 1 111223457999999988889999999999999999998 99997432211 11111 1100 00
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=281.01 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=181.3
Q ss_pred CCCCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 161 (387)
-|++.+.||+|+||.||++.+. .+..||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4678899999999999999853 36789999986443 34456789999999999999999999998875 5678
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++++|..++...... ..+|..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 999999999999888543211 246778889999999999999999999999999986543221
Q ss_pred c-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 Q-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. .......++..|+|||.+.+..++.++||||||+++|||++++.|.........................+.+.....
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc
Confidence 1 112234567789999999888899999999999999999998766422110000000000000000000000000000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
......++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 245 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 245 -LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001122456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.94 Aligned_cols=245 Identities=21% Similarity=0.209 Sum_probs=186.1
Q ss_pred HHhcCCCCCCcccccCCeeEEEEE-EcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----c
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----E 159 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~ 159 (387)
+..++|.+.+.||+|||+.||+++ ..++..+|+|++......+.+..++|++.-++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345789999999999999999998 4458889999998777778889999999999999999999999876543 4
Q ss_pred eEEEEEecCCCCcchhhcCCccc--------------------cccchhh--hhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 160 KILIYEYMPNKSLDFFLFDPTKR--------------------MLLDWSA--NYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~--~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
.|++++|...|+|.+.+...... ..+|... ..|+||||.|||+++++.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999999998887653321 1244444 6799999999999999999999999987
Q ss_pred ecCCCCcc-----c--ccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHH
Q 041766 218 ICGGNELQ-----A--NTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 218 ~~~~~~~~-----~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 287 (387)
...-.-.. . .-.....|..|+|||.+.- ...++++|||||||+||+|+.|..||+.....+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 54211000 0 0111345889999999863 456899999999999999999999985332211
Q ss_pred HhhcCcccccc-ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 288 LWTSNRTLELI-DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 288 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
+...-.+ ...+.-+ .....+..+.+++++|++.||.+||++.+++..++++.
T Consensus 249 ----gSlaLAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 ----GSLALAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----CeEEEeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111 1111111 22226778999999999999999999999999998764
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=283.53 Aligned_cols=239 Identities=28% Similarity=0.371 Sum_probs=180.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|.+.. +. .+|+|.+... .......+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 568888999999999999999764 44 4688877643 233445788999999999 899999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
|||+++++|..++..... ...+|..+++|+||||+|||++.++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 999999999988854210 124677888999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||++..... ........++..|+|||.+.+..++.++|||||||++|||+| |..||...... .. . ....
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~---~-~~~~ 237 (303)
T cd05088 167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL---Y-EKLP 237 (303)
T ss_pred ccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HH---H-HHHh
Confidence 9999864221 111112234567999999988889999999999999999998 88887432211 11 0 1111
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..... . .+...+..+.+++.+||+.+|++||++.+++..|.++.+.
T Consensus 238 ~~~~~-------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 QGYRL-------E---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCcC-------C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 0 1112344688999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.89 Aligned_cols=222 Identities=22% Similarity=0.301 Sum_probs=167.8
Q ss_pred CcccccCCeeEEEEEEcC-------------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 95 NKLGEGGFGPVYKGVLKK-------------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
+.||+|+||.||+|.+.. ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258999887655455567888999999999999999999999988999
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCC-------eEEeeccCce
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDIN-------PKISDFGMAR 217 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~-------~kl~Dfg~a~ 217 (387)
++|||+++|+|..++...... .++|..+++|+||||+|||++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999998887543221 2477888899999999999987654 8999999986
Q ss_pred ecCCCCcccccccccCCCccccccccc-cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
..... ....++..|+|||.+. +..++.++|||||||++|||++ |..|+...... ... . +....
T Consensus 161 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~----~-~~~~~-- 225 (262)
T cd05077 161 TVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--EKE----R-FYEGQ-- 225 (262)
T ss_pred cccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--HHH----H-HHhcC--
Confidence 54321 2245788899999987 4668999999999999999984 77775322110 000 0 00000
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
.. ........+.+|+.+||+.||++||++.++++.|
T Consensus 226 ------~~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 ------CM---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------cc---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0011234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=273.01 Aligned_cols=247 Identities=20% Similarity=0.240 Sum_probs=182.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCC-----
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKN-LVRLLGCCIDKD----- 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~----- 158 (387)
...|+..++||+|+||+||+|+.+. |+.||+|++.-... .......+|+.+|++++|+| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3457778899999999999999665 88999999864422 23346689999999999999 999999999877
Q ss_pred -ceEEEEEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 159 -EKILIYEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 159 -~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
..++|+||+.. +|..++..... ..++|..+++||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 78899999954 88877765442 125788889999999999999999999999999998
Q ss_pred ecCCCCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc---
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--- 293 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 293 (387)
...-.. .......+|..|+|||++.+. .|++..||||+|||+.||++++.-|....+-. .....+.....+.
T Consensus 169 a~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCccC
Confidence 654222 124456789999999999987 69999999999999999999888776544311 1111111111110
Q ss_pred cccc-----ccccccccccc-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 294 TLEL-----IDPILEDEYSS-------KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 294 ~~~~-----~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.... .+........+ +.......+++.+|++.+|.+|.|++.++..
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 00000000000 1111478899999999999999999999985
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.85 Aligned_cols=179 Identities=24% Similarity=0.353 Sum_probs=150.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-C-----CceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-H-----KNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~~~~~~~~~~~~ 160 (387)
..+|++.+.||+|+||.|.+|.... ++.||||++++... ...+...|+.+|..++ | -|+|+++++|...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3478899999999999999999765 88999999986543 3455667999999996 4 3899999999999999
Q ss_pred EEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCC--CCeEEeeccCceecC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKD--INPKISDFGMARICG 220 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~--~~~kl~Dfg~a~~~~ 220 (387)
|||+|.+ .-+|.+++...... ..|+..++||+||||+||||.+. ..+||+|||.|....
T Consensus 264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 9999998 55899998765432 35788889999999999999654 469999999998765
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
...+ +...+..|+|||++.|.+|+.+.||||||||+.||++|.+.|..
T Consensus 343 q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 343 QRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred Ccce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 4432 34678899999999999999999999999999999999776543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=287.16 Aligned_cols=230 Identities=23% Similarity=0.302 Sum_probs=175.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+|.+.+.||+|+||.||+|+... +..||+|.+... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999775 778999998643 122334567788888877 6899999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--Ccc
Confidence 99999999877754321 124777888999999999999999999999999997543221 122
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... .. . ..+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~---~~i~~-~~--------~---~~p 221 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF---QSIME-HN--------V---AYP 221 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHH---HHHHh-CC--------C---CCC
Confidence 3457899999999999999999999999999999999999998532211 111 11100 00 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTM-----NEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~-----~~v~~ 338 (387)
...+..+.+++.+||+.||++|++. .++.+
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 2234578899999999999999985 55543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.62 Aligned_cols=238 Identities=29% Similarity=0.423 Sum_probs=185.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..++|.+.+.||+|+||.||+|..+++..||+|.+.... .....+.+|+.++++++|+||+++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457889999999999999999998878889999987433 3446789999999999999999999999988889999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++..... ...+|..+++|+||||+||++++++.+||+|||++......... ..
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 161 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AR 161 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh-hh
Confidence 999999988865331 12467778899999999999999999999999999876432211 11
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... . .... ... ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~---~-~~~~-----~~~-----~~ 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLE---Q-VERG-----YRM-----PR 225 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---H-HHcC-----CCC-----CC
Confidence 22234568999999998889999999999999999999 8888743211 11111 1 0000 000 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11224578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=286.52 Aligned_cols=226 Identities=24% Similarity=0.312 Sum_probs=174.7
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||++++.. +..||+|.+... .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 788999998643 223445677899999888 799999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++...... ......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccceec
Confidence 999877754321 124788888999999999999999999999999987532221 11233578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
+..|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...... ..+...+.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~-i~~~~~-----------~~~~~~~~ 221 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQS-ILEDEV-----------RYPRWLSK 221 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHH-HHcCCC-----------CCCCcCCH
Confidence 99999999999999999999999999999999999998532211 11111 111000 01122345
Q ss_pred HHHHHHHhcccCCCCCCCCH-----HHHHHH
Q 041766 314 RYVNIALLCVQESADDRPTM-----NEVVSM 339 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~-----~~v~~~ 339 (387)
.+.+++.+||+.||++|||+ .++++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 78899999999999999999 888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.48 Aligned_cols=235 Identities=22% Similarity=0.325 Sum_probs=169.5
Q ss_pred CcccccCCeeEEEEEEcC---CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997543 3468888876432 233456889999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc---------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 171 SLDFFLFDPTK---------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 171 ~L~~~l~~~~~---------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+|.+++..... ..++|..+++|+||||+|||+++++.+||+|||++.............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99988854321 024677788999999999999999999999999987543332222223
Q ss_pred cccCCCcccccccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
...++..|+|||++.. ..++.++|||||||++|||++ |..||...... .. ...... ........+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~---~~~~~~-~~~~~~~~~~ 234 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QV---LKQVVR-EQDIKLPKPQ 234 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HH---HHHHhh-ccCccCCCCc
Confidence 3455678999998742 356889999999999999999 67776432111 00 001000 1111111111
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
........+.+++..|| .||++|||+++|++.|.
T Consensus 235 -----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 -----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11223456677889999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.13 Aligned_cols=231 Identities=25% Similarity=0.351 Sum_probs=173.6
Q ss_pred cccccCCeeEEEEEEc---CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 96 KLGEGGFGPVYKGVLK---KGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999865 245699999865432 33467889999999999999999999885 456789999999999
Q ss_pred cchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-cccccccC
Q 041766 172 LDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-ANTSRIVG 233 (387)
Q Consensus 172 L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~g 233 (387)
|.+++...... ..+|..+++|+||||+|||++.++.+||+|||++......... .......+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 99888643221 2467788899999999999999999999999999755332211 11111233
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
+..|+|||.+.+..++.++|||||||++||+++ |..||...... . .. ........ ...+..++
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~---~~-~~~~~~~~----------~~~~~~~~ 224 (257)
T cd05115 161 PLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--E---VM-SFIEQGKR----------LDCPAECP 224 (257)
T ss_pred CcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--H---HH-HHHHCCCC----------CCCCCCCC
Confidence 578999999988889999999999999999997 88887432111 1 11 11111100 00122335
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 6788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=272.87 Aligned_cols=232 Identities=27% Similarity=0.347 Sum_probs=182.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|.+.+.||+|+||.||++.... +..|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 36777899999999999999764 888999988633 344567888999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hh
Confidence 999999988865311 1246777889999999999999999999999999987654322 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||++.+..++.++||||||+++|||++|+.||..... .. ..... ..... + ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~-~~~~~-----~-----~~~ 222 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GA---LILKI-IRGVF-----P-----PVS 222 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHH-HcCCC-----C-----CCc
Confidence 334678899999999998899999999999999999999999753321 11 01110 00000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
......+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.55 Aligned_cols=232 Identities=27% Similarity=0.363 Sum_probs=183.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999876 78899999976543 4578899999999999999999999999988999999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|.+++..... ..++|..+++|+||||+||+++.++.+||+|||.++...... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~ 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----D 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----c
Confidence 99999998865431 124677888999999999999999999999999998653221 1
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....+..|+|||.+....++.++||||||+++|||++ |..||...... .+ ......... . ..+
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~----~~~~~~~~~-----~-----~~~ 221 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV----VPHVEKGYR-----M-----EAP 221 (256)
T ss_pred cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HH----HHHHhcCCC-----C-----CCc
Confidence 2344668999999988889999999999999999998 88886432211 11 011110000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=279.76 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=184.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~ 160 (387)
..|+..+.||+|+||.||++.+. .+..||+|.+...... ....+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45778899999999999999864 2578999999755432 45789999999999999999999999887 5578
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+++|||+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 999999999999988865431 124677888999999999999999999999999998765322
Q ss_pred cc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence 11 11112244567999999988889999999999999999999998864332211110000000000000000000000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.. ..+..++..+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 244 ~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 RL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 01223346788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=286.33 Aligned_cols=224 Identities=25% Similarity=0.333 Sum_probs=171.0
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... +..||+|.+... .......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999875 789999998643 123345667788888765 899999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCC
Confidence 999877754321 124677889999999999999999999999999987532111 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... .+. .+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~----~~~~~~------~~~-----~~~~~~~ 221 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF----ESIRVD------TPH-----YPRWITK 221 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HHHHhC------CCC-----CCCCCCH
Confidence 99999999999999999999999999999999999998532211 111 111000 000 1112345
Q ss_pred HHHHHHHhcccCCCCCCCCHH-HHH
Q 041766 314 RYVNIALLCVQESADDRPTMN-EVV 337 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~-~v~ 337 (387)
.+.+++.+||+.||++||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 678999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.51 Aligned_cols=238 Identities=23% Similarity=0.276 Sum_probs=191.0
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~ 160 (387)
.....|++.+.||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+.+|+++. |||||.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678999999999999999999887 89999999975532 34568999999999998 99999999999999999
Q ss_pred EEEEEecCCCCcchhhcCC--cc-------------ccccchhhhhhcccCCCceEEcCC----CCeEEeeccCceecCC
Q 041766 161 ILIYEYMPNKSLDFFLFDP--TK-------------RMLLDWSANYSSRLKVSNILLDKD----INPKISDFGMARICGG 221 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~--~~-------------~~~l~~~~~~h~dlk~~Nill~~~----~~~kl~Dfg~a~~~~~ 221 (387)
++|||+|.||.|.+.+... .. -.++|..+++||||||+|+|+... +.+|++|||+|.....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999998877654 11 125788999999999999999543 4799999999998764
Q ss_pred CCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.......... ... .... .
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~-~~~~------~ 256 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AIL-RGDF------D 256 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHH-cCCC------C
Confidence 233456799999999999999999999999999999999999999985443222111 000 0000 1
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.... ..+.....+.++++.|+..||..|+|+.++++.
T Consensus 257 f~~~-~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 FTSE-PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCC-CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 223346688899999999999999999999983
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=274.07 Aligned_cols=236 Identities=25% Similarity=0.350 Sum_probs=180.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|+..+.||+|++|.||++.... +..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468889999999999999999754 8899999886432 1233568889999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
++||+++++|.+++..... ...+|..+++|+||+|+||+++.++.+||+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999887754221 124677888999999999999999999999999997654321111
Q ss_pred c-cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 N-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ............ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~---~~~~~~~~~~~~-----~----- 226 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--M---AAIFKIATQPTN-----P----- 226 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--H---HHHHHHhccCCC-----C-----
Confidence 1 1234677899999999998899999999999999999999999743211 0 001111000000 0
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+......+.+++.+||+.+|.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0122334578899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.59 Aligned_cols=248 Identities=21% Similarity=0.213 Sum_probs=177.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 158 (387)
..++|+..+.||+|+||.||++.... +..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999999765 889999998643 2334567789999999999999999999987543
Q ss_pred -ceEEEEEecCCCCcchhhcCC-c-------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 -EKILIYEYMPNKSLDFFLFDP-T-------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 -~~~lv~e~~~~g~L~~~l~~~-~-------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+||||++++ |...+... . ...++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc
Confidence 468999999764 44433221 1 1135788899999999999999999999999999997543221
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH------------------
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA------------------ 285 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~------------------ 285 (387)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ......
T Consensus 178 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 178 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHHHHHHH
Confidence 1233478899999999999999999999999999999999999986432110 000000
Q ss_pred HHHhhcCcc------cccccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 286 WDLWTSNRT------LELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 286 ~~~~~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
......... .+........ ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000 0000000000 00011124567899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.96 Aligned_cols=222 Identities=23% Similarity=0.305 Sum_probs=166.8
Q ss_pred cccccCCeeEEEEEEcC-------------------------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeee
Q 041766 96 KLGEGGFGPVYKGVLKK-------------------------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL 150 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 150 (387)
+||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 12489998865544445678889999999999999999
Q ss_pred eeeEEeCCceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCC-------
Q 041766 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDI------- 206 (387)
Q Consensus 151 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~------- 206 (387)
+++|......++||||+++|+|..++...... .++|..+++|+||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 99999999999999999999998888653221 246778889999999999997643
Q ss_pred CeEEeeccCceecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCcchHhHH
Q 041766 207 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIV-SGKKTTGFYRTDSLTLLGY 284 (387)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~-tg~~p~~~~~~~~~~~~~~ 284 (387)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....... ....
T Consensus 162 ~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~ 233 (274)
T cd05076 162 FIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--KERF 233 (274)
T ss_pred eeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--HHHH
Confidence 3899999987643211 12356788999998875 56899999999999999995 6888864322111 0000
Q ss_pred HHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 285 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.... ... +......+.+++.+||+.+|++|||+.++++.|.
T Consensus 234 ----~~~~-------~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 ----YEKK-------HRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----HHhc-------cCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0000 000 0111246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=278.89 Aligned_cols=234 Identities=23% Similarity=0.348 Sum_probs=179.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
-|++.+.||+|+||.||+|.... +..+++|.+..........+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 36777899999999999999875 67789999876555566788899999999999999999999999999999999999
Q ss_pred CCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++....... ......
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~ 163 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSF 163 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccccc
Confidence 9999887653221 124677888999999999999999999999999987543221 122335
Q ss_pred cCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 232 VGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 232 ~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.++..|+|||++. +..++.++|||||||++|||++|+.||...... ........... +.. .
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~------~~~---~ 229 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEP------PTL---A 229 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhhcCC------CCC---C
Confidence 6889999999984 345788999999999999999999997532211 11111100000 000 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234578899999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=273.93 Aligned_cols=235 Identities=27% Similarity=0.365 Sum_probs=173.3
Q ss_pred CcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceEEEEEecC
Q 041766 95 NKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYMP 168 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~~~ 168 (387)
+.||+|+||.||+|.+.+ ...||+|.+... .......+.+|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 346999988543 33445678899999999999999999998764 456789999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc--ccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA--NTS 229 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~ 229 (387)
+|+|..++...... ..+|..+++|+||||+|||++.++.+||+|||+++......... ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999888643211 24677788999999999999999999999999997654322111 112
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...++..|+|||.+.+..++.++|||||||++|||++|..|+.... +...... ....... . ..+.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~---~~~~~~~------~-----~~~~ 225 (262)
T cd05058 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITV---YLLQGRR------L-----LQPE 225 (262)
T ss_pred cCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH---HHhcCCC------C-----CCCC
Confidence 2345678999999988889999999999999999999655432111 1111111 1110000 0 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
..+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 22456889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.04 Aligned_cols=239 Identities=24% Similarity=0.370 Sum_probs=181.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-C---CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
..|++.+.||+|+||.||+|.+.. + ..||+|.+... .......|..|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778999999999999999764 3 35999998654 334456899999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|..++...... ..+|..+++|+||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999999888653221 24677788999999999999999999999999987654322111
Q ss_pred cccccc---CCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 227 NTSRIV---GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 227 ~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
...... .+..|+|||.+.+..++.++|||||||++|||++ |..||..... ........ .. .
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~----~~---------~ 228 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIE----QD---------Y 228 (269)
T ss_pred ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHH----cC---------C
Confidence 111111 2457999999998999999999999999999987 8888743221 11111110 00 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
. ...+..++..+.+++.+||+.+|++||++.+++..|+++
T Consensus 229 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 R-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 001123345688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=279.22 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=185.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
....+|...+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34478999999999999999999965 48899999997655555567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 165 EYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 173 (297)
T cd06656 96 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRS 173 (297)
T ss_pred cccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcC
Confidence 99999999888754321 1246777889999999999999999999999999876543321 122
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......... ............+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------------~~~~~~~~~~~~~~ 239 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------------LIATNGTPELQNPE 239 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------------eeccCCCCCCCCcc
Confidence 3467889999999998889999999999999999999999974322111000 00000000000122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34456789999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=290.18 Aligned_cols=241 Identities=20% Similarity=0.225 Sum_probs=180.3
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
....++|++.+.||+|+||.||++++.. ++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3345789999999999999999999875 788999998532 222344577899999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~- 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM- 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-
Confidence 999999999999888754321 1247788899999999999999999999999999987643321
Q ss_pred cccccccCCCccccccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGI----FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ................
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~~---- 268 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKNSLTF---- 268 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCcccC----
Confidence 1223457999999999997543 78999999999999999999999853221 1111111111100000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
......+..+.+++.+|+..++.+ ||+++++++.
T Consensus 269 ----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 269 ----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 011234556789999999844433 7799998885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.38 Aligned_cols=223 Identities=24% Similarity=0.366 Sum_probs=169.0
Q ss_pred CcccccCCeeEEEEEEcC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+.||+|+||.||+|.... ...|++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 224888888655555567888999999999999999999999998899999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCC--------eEEeeccCceecCC
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDIN--------PKISDFGMARICGG 221 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~--------~kl~Dfg~a~~~~~ 221 (387)
+++|+|..++...... .++|..+++|+||||+|||++.++. +|++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999999988653321 2467778899999999999987765 69999998865432
Q ss_pred CCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCC-CCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKK-TTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.....++..|+|||++.+. .++.++||||||+++|||++|.. |+...... ... ......
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--~~~----~~~~~~------- 221 (258)
T cd05078 161 ------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--KKL----QFYEDR------- 221 (258)
T ss_pred ------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--HHH----HHHHcc-------
Confidence 2234678899999999864 57999999999999999999854 43211110 000 000000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.. .+......+.+++.+||+.||++|||++++++.|+
T Consensus 222 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ-----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc-----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11112346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=289.95 Aligned_cols=222 Identities=23% Similarity=0.253 Sum_probs=170.8
Q ss_pred CcccccCCeeEEEEEEc----CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 95 NKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
+.||+|+||.||+++.. .++.||+|++.... ......+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998752 47889999986432 2233456789999999999999999999999999999999999
Q ss_pred CCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 169 NKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 169 ~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
+|+|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++...... .......
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cceeccc
Confidence 9999887754321 124778888999999999999999999999999987653321 1223457
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .. ......... .. .+...+
T Consensus 160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~---~~~~i~~~~---------~~---~p~~~~ 222 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KE---TMTMILKAK---------LG---MPQFLS 222 (318)
T ss_pred CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HH---HHHHHHcCC---------CC---CCCCCC
Confidence 89999999999988899999999999999999999999753221 11 111110000 00 112234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHH
Q 041766 313 LRYVNIALLCVQESADDRPTMNE 335 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~ 335 (387)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 56789999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=275.86 Aligned_cols=235 Identities=23% Similarity=0.370 Sum_probs=178.3
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC------
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~------ 157 (387)
.+.+.|+..+.||+|+||.||+|.... ++.||+|.+.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 355778889999999999999999765 7889999986543 3345788999999998 799999999998753
Q ss_pred CceEEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
...+++|||+++++|..++...... .++|..+++|+||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 3578999999999998887653211 2467788899999999999999999999999999865
Q ss_pred CCCCcccccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
.... .......|+..|+|||++. +..++.++|||||||++|||++|+.||....... ... . .....
T Consensus 162 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~-~-~~~~~- 232 (272)
T cd06637 162 DRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALF-L-IPRNP- 232 (272)
T ss_pred cccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHH-H-HhcCC-
Confidence 3221 1233457889999999986 3458899999999999999999999974322110 000 0 00000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 233 ----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ----APRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 11123456889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=275.16 Aligned_cols=239 Identities=25% Similarity=0.368 Sum_probs=182.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... ......+..|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 568888999999999999998642 3369999986432 33456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|..++...... ..+|..+++|+||||+|||++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999999999888654221 23577778999999999999999999999999998664322111
Q ss_pred -ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 227 -NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 227 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||.+.+..++.++|+||||+++||+++ |..||...... ..... ..... .
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~-----~----- 227 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKA----IEEGY-----R----- 227 (267)
T ss_pred eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHH----HhCCC-----c-----
Confidence 1111233567999999998889999999999999999887 99887432211 11110 11000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=272.52 Aligned_cols=235 Identities=25% Similarity=0.409 Sum_probs=180.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.+|++.+.||+|+||.||++.+..+..+|+|.+.... .....+.+|++++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778889999886432 234578899999999999999999999999899999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++|.+++...... ..+|..+++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 161 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGT 161 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCC
Confidence 99998887543211 23677778999999999999999999999999988654332111 1122
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ... ..... +..
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-~~~--~~~~~--------~~~ 225 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETI-NAG--FRLYK--------PRL 225 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHH-hCC--CCCCC--------CCC
Confidence 34678999999998889999999999999999998 88886432211 111111 000 00001 111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=288.53 Aligned_cols=246 Identities=18% Similarity=0.207 Sum_probs=179.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC---CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
...+|.+.+.||+|+||.||++...+ +..||+|.+... ....+|+++|++++|||||++++++......|++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34579999999999999999997543 567999988643 2346899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||++. ++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++..........
T Consensus 165 ~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99995 577666633211 1257888899999999999999999999999999986654433333
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--chHhHHHHHHhhcCcc-------ccc-
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS--LTLLGYAWDLWTSNRT-------LEL- 297 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~-------~~~- 297 (387)
.....||..|+|||++.+..|+.++|||||||++|||++|+.||....... ..+.... ........ ...
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCccchhHH
Confidence 344678999999999999999999999999999999999999985433221 0111110 00000000 000
Q ss_pred -----cccccccccc------cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 -----IDPILEDEYS------SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 -----~~~~~~~~~~------~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....+.... .......+.+++.+||..||++|||+.+++..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 11224567899999999999999999999975
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=269.12 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=181.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+.+.|++.+.||+|.|+.|+++.+.. |+.+|+|.++.. .....+++.+|++|-+.++|||||+++..+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 45778889999999999999998765 888888887532 445678899999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCC----------------ccccccchhhhhhcccCCCceEEcC---CCCeEEeeccCceecCCCCc
Q 041766 164 YEYMPNKSLDFFLFDP----------------TKRMLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARICGGNEL 224 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~----------------~~~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+|++.|++|-.-+-.. ....+.|..+++|||+||+|+|+.. .--+||+|||+|..+.+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 9999999984333211 0112467788899999999999943 3458999999999887322
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.-....||+.|||||++...+|+..+|||+.||+||-|+.|..||..... ..+. +....... + +..
T Consensus 168 --~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rly----e~I~~g~y----d--~~~ 233 (355)
T KOG0033|consen 168 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLY----EQIKAGAY----D--YPS 233 (355)
T ss_pred --ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHH----HHHhcccc----C--CCC
Confidence 22346899999999999999999999999999999999999999742111 1111 10000000 0 000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..-+...++..+|+++||..||.+|.|+.|.++
T Consensus 234 -~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 -PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 022344567889999999999999999999876
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=278.68 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=180.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... ......+.+|++++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368889999999999999999765 7788999886442 23345688999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|..++..... ..++|. .+++|+||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~ 156 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccc
Confidence 999999988865321 123554 46899999999999999999999999998754322 123
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc---------------
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT--------------- 294 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------- 294 (387)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCCCcc
Confidence 357889999999998888999999999999999999999997532211 111000000000000
Q ss_pred -----ccccccccc---cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 295 -----LELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 295 -----~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+..+.... ...........+.+++.+||+.+|++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 000011234568899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=272.69 Aligned_cols=232 Identities=20% Similarity=0.247 Sum_probs=180.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+|++.+.||+|+||.||++.... +..+|+|.++.. .....+.+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47788999999999999999764 888999988533 3344567888999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|..++...... ..+|..+++|+||||+||++++++.++|+|||++........ ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccc
Confidence 999998776532111 246777889999999999999999999999999976643221 122
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...++..|+|||++.+..++.++|+||||+++|+|++|..||..... ........ ..... ..+.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~----------~~~~ 222 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVC-QGSYK----------PLPS 222 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHh-cCCCC----------CCCc
Confidence 35688899999999888899999999999999999999999753211 01111110 00000 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+..+.+++.+||+.||++|||+.+++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=287.39 Aligned_cols=226 Identities=21% Similarity=0.221 Sum_probs=169.1
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999775 6789999986421 122234444444 46778999999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccC
Confidence 999887754321 124788889999999999999999999999999987543221 12334578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|..||..... .. ........ ... .......
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~---~~~~i~~~---------~~~---~~~~~~~ 221 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AE---MYDNILNK---------PLQ---LKPNITN 221 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--HH---HHHHHHhC---------CcC---CCCCCCH
Confidence 9999999999999999999999999999999999999753221 11 11111100 000 1112345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 314 RYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+.+++.+||+.||.+||++.+.+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 67899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=287.29 Aligned_cols=221 Identities=22% Similarity=0.250 Sum_probs=167.4
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999864 889999998643 1222344555555 45778999999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccC
Confidence 999877754321 124778889999999999999999999999999987532221 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||..... .......... ... .....+.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~---------~~~---~~~~~~~ 221 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNK---------PLR---LKPNISV 221 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcC---------CCC---CCCCCCH
Confidence 9999999999999999999999999999999999999753211 1111111100 000 1112245
Q ss_pred HHHHHHHhcccCCCCCCCCHH
Q 041766 314 RYVNIALLCVQESADDRPTMN 334 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~ 334 (387)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=272.40 Aligned_cols=236 Identities=28% Similarity=0.402 Sum_probs=181.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|.+.+.||+|+||.||++.+..+..+|+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688889999999999999998877789999886433 33467889999999999999999999875 45678999999
Q ss_pred CCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|.+++...... ..+|..+++|+||||+||++++++.+||+|||++......... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~ 161 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQ 161 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccC
Confidence 999998888643211 2467778899999999999999999999999999866433221 112
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ...... . ..+
T Consensus 162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~-----~-----~~~ 225 (260)
T cd05069 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQ----VERGYR-----M-----PCP 225 (260)
T ss_pred CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcCCC-----C-----CCC
Confidence 2345678999999988889999999999999999999 8888643211 111111 110000 0 012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...+..+.+++.+||+.||++||+++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.70 Aligned_cols=231 Identities=28% Similarity=0.385 Sum_probs=174.4
Q ss_pred CcccccCCeeEEEEEEcC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GD--EIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+..+ +. .+++|.+... .....+.+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999765 33 4788888643 334456788999999999 899999999999999999999999999
Q ss_pred CCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 170 KSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 170 g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
|+|.+++..... ..++|..+++|+||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 999888754210 023677788999999999999999999999999986
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
.... .........+..|+|||++....++.++|||||||++|||++ |..||...... .. ..........+
T Consensus 161 ~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~-~~~~~~~~~~~ 231 (270)
T cd05047 161 GQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----EL-YEKLPQGYRLE 231 (270)
T ss_pred ccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HH-HHHHhCCCCCC
Confidence 3221 111111234567999999988889999999999999999997 88887432111 11 11111110000
Q ss_pred ccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
........+.+++.+||+.||.+|||+.+++..|+++.
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 ----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11123456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=271.64 Aligned_cols=232 Identities=32% Similarity=0.425 Sum_probs=176.1
Q ss_pred CcccccCCeeEEEEEEcC-C---CEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-G---DEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|.+.. + ..+|+|.+..... .....+.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998643 2 5799999875433 34467889999999999999999999876 4567999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc-cccccc
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA-NTSRIV 232 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~ 232 (387)
|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 999988865431 124677888999999999999999999999999998664332111 111123
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........ .... ...+...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~----~~~~----------~~~~~~~ 223 (257)
T cd05060 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLE----SGER----------LPRPEEC 223 (257)
T ss_pred ccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH----cCCc----------CCCCCCC
Confidence 3568999999998889999999999999999998 8888753221 11111111 1100 0112223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 45788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.53 Aligned_cols=232 Identities=27% Similarity=0.366 Sum_probs=177.9
Q ss_pred CcccccCCeeEEEEEEcC--C--CEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK--G--DEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|.+.. + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999754 2 2589999976554 556788999999999999999999999988 888999999999
Q ss_pred CCcchhhcCCcc-c-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-ccccc
Q 041766 170 KSLDFFLFDPTK-R-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-ANTSR 230 (387)
Q Consensus 170 g~L~~~l~~~~~-~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~ 230 (387)
++|..++..... . ..+|..+++|+||||+||+++.++.+||+|||+++........ .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 999988865431 1 2467778899999999999999999999999999876432211 11123
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
..++..|+|||.+.+..++.++|||||||++|||++ |..||...... ............ . ..+.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~-------~---~~~~ 224 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGER-------L---ERPE 224 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCc-------C---CCCc
Confidence 456788999999998899999999999999999999 99987432111 111111100000 0 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
..+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 234578899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=272.04 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=180.1
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
...+++.....||+|+||.||+|.+.+ +..||+|.+........+.+.+|+.++++++|+||+++++++...+..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344556666789999999999999665 6789999987665556678899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++++|..++..... ..++|..+++|+||||+||+++. ++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 99999999988864311 02467788899999999999976 67899999999876532221
Q ss_pred ccccccccCCCccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.......... +..... .
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~----------~-- 228 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMF----------K-- 228 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhh----------c--
Confidence 122345788999999987644 7899999999999999999999974322111000 000000 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+......+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000012234557889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=269.88 Aligned_cols=231 Identities=33% Similarity=0.467 Sum_probs=181.4
Q ss_pred CcccccCCeeEEEEEEcC----CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK----GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|.... +..|++|.+...... ....+.+|++.+..++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 678999999755333 367888999999999999999999999998899999999999
Q ss_pred CCcchhhcCCc--------cc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 170 KSLDFFLFDPT--------KR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 170 g~L~~~l~~~~--------~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++|..++.... .. ..+|..+++|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 99999987641 11 246778889999999999999999999999999987654432
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
........++..|+|||.+....++.++||||||+++|||++ |..||..... ... .........
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~----~~~~~~~~~--------- 225 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEV----LEYLRKGYR--------- 225 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHH----HHHHHcCCC---------
Confidence 222334567889999999988889999999999999999999 5888754311 111 111111000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=284.88 Aligned_cols=221 Identities=21% Similarity=0.231 Sum_probs=166.5
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... ++.||+|.+... .......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 788999998643 1222344555554 57788999999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|...+..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccC
Confidence 999776654221 124777888999999999999999999999999987532221 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|..||..... ......... . .. ..+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~-~--------~~---~~~~~~~~ 221 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILH-K--------PL---QLPGGKTV 221 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhc-C--------CC---CCCCCCCH
Confidence 9999999999988999999999999999999999999743211 111111110 0 00 01112345
Q ss_pred HHHHHHHhcccCCCCCCCCHH
Q 041766 314 RYVNIALLCVQESADDRPTMN 334 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~ 334 (387)
.+.+++.+||+.||++||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=275.83 Aligned_cols=240 Identities=26% Similarity=0.388 Sum_probs=183.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.+|++.+.||+|+||.||+|.++. +. .+|+|.+..... .....+.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568888999999999999998654 33 589998865533 345678899999999999999999999987 78899
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|.+++...... .++|..+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 99999999999888654321 2467788899999999999999999999999999876433221
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||.+....++.++||||||+++||+++ |+.||...... ..... ......
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~-~~~~~~---------- 229 (279)
T cd05057 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----EIPDL-LEKGER---------- 229 (279)
T ss_pred eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH-HhCCCC----------
Confidence 11222234568999999988889999999999999999999 99997533211 11111 111000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..+...+.+++.+||..||.+|||+.++++.|.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00111233468899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=270.55 Aligned_cols=233 Identities=22% Similarity=0.386 Sum_probs=183.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|+..+.||+|+||.||+|.... +..+++|.+..... .+.+.+|++++++++||||+++++++......|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678999999999999999999876 78899999865432 57899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|.+++..... ...+|..+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRN 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccc
Confidence 999999988754221 1246777889999999999999999999999999886543321 122
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...++..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ..... ...... ..+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--------~~~~~---~~~~~~---~~~~ 223 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--------FMIPN---KPPPTL---SDPE 223 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--------hhhcc---CCCCCC---Cchh
Confidence 345788999999999889999999999999999999999997532211100 00000 000000 0122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 34457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=272.25 Aligned_cols=231 Identities=26% Similarity=0.358 Sum_probs=179.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~~ 167 (387)
.+|++.+.||+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++|+|++++++++.. .+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999876 7889999886432 34678899999999999999999997654 56789999999
Q ss_pred CCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++++|..++...... ..+|..+++|+||||+||++++++.+||+|||++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~ 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----C
Confidence 999999887653221 24677888999999999999999999999999987643221 2
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....... ..... . ...
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~-~~~~~-----~-----~~~ 221 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRV-EKGYK-----M-----DAP 221 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-hcCCC-----C-----CCC
Confidence 2344568999999988889999999999999999998 8888642211 1111110 00000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 23356788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=289.34 Aligned_cols=246 Identities=20% Similarity=0.257 Sum_probs=176.3
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~ 161 (387)
+|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 4889999998643 2234467889999999999999999999998776 789
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+||||+. ++|...+..... ..++|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~- 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES- 158 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-
Confidence 9999996 466665543221 1247888899999999999999999999999999986543221
Q ss_pred cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc--------
Q 041766 226 ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE-------- 296 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 296 (387)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...............+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHhhHHH
Confidence 112234678899999999874 47999999999999999999999985433211 1111110000000000
Q ss_pred --cc-c-----cccccc-cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 --LI-D-----PILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 --~~-~-----~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+ . +..... .........+.+++.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 0 000000 0011224578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=273.36 Aligned_cols=233 Identities=21% Similarity=0.368 Sum_probs=182.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|+..+.||.|+||.||+|+... ++.||+|.+.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 368888999999999999999765 7889999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++++|..++..... ...+|..+++|+||+|+||++++++.++|+|||+++...... ......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~ 158 (274)
T cd06609 81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTF 158 (274)
T ss_pred eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccc
Confidence 999999888865321 124677788999999999999999999999999998765332 122335
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...... . ..... ... ..+.+. ....
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~-~~~-----~~~~~~----~~~~ 223 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--R---VLFLI-PKN-----NPPSLE----GNKF 223 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--H---HHHHh-hhc-----CCCCCc----cccc
Confidence 6788999999999888999999999999999999999997533211 0 00000 000 001110 1114
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..+.+++.+||..+|++|||++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 557889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.40 Aligned_cols=244 Identities=16% Similarity=0.147 Sum_probs=175.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
..|.+.+.||+|+||.||++.+.. ++.||||.... ..+.+|+++|++++|+|||++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 468889999999999999999876 78899996432 24568999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
. ++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.............
T Consensus 243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 5 677776643221 1247788899999999999999999999999999987643322222234
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-c-----chHhHHHHHHh-hcCcccccc-----
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD-S-----LTLLGYAWDLW-TSNRTLELI----- 298 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~-~-----~~~~~~~~~~~-~~~~~~~~~----- 298 (387)
..||..|+|||++.+..++.++|||||||++|||++|..++...... . ..+........ .........
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 57999999999999999999999999999999999988664322111 0 11111111100 000000000
Q ss_pred -----------cccccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 299 -----------DPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 299 -----------~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+...... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 000123467899999999999999999999974
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=278.35 Aligned_cols=236 Identities=22% Similarity=0.365 Sum_probs=184.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..+|+..+.||.|+||.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 356888999999999999999865 4889999999765555567888999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++........ .....
T Consensus 98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 175 (296)
T cd06655 98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTM 175 (296)
T ss_pred cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCc
Confidence 999999887754321 1246777889999999999999999999999999876543221 12234
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ........ . +.+. .+...
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~-~-----~~~~---~~~~~ 241 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNG-T-----PELQ---NPEKL 241 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcC-C-----cccC---CcccC
Confidence 678899999999988899999999999999999999999754321110 00000000 0 0000 12223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+..+.+++.+||+.||++|||+.+++..
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4568899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.40 Aligned_cols=249 Identities=21% Similarity=0.224 Sum_probs=177.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 158 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---- 158 (387)
...++|+..+.||+|+||.||++.... ++.||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 345789999999999999999998764 788999998643 2334467788999999999999999999886542
Q ss_pred --ceEEEEEecCCCCcchhhcCCc--------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 159 --EKILIYEYMPNKSLDFFLFDPT--------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 159 --~~~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
..++||||+++ ++...+.... ...++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 46899999976 4544433211 113578888999999999999999999999999999865432
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH--------------
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL-------------- 288 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-------------- 288 (387)
. ......||..|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 173 F---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred c---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhcHH
Confidence 1 1233578999999999999899999999999999999999999985432110 000000000
Q ss_pred ---hhcC--cccccc------cccccc-ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 289 ---WTSN--RTLELI------DPILED-EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 289 ---~~~~--~~~~~~------~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+... ...... +..... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 000000 000000 00111224567899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=278.12 Aligned_cols=237 Identities=23% Similarity=0.379 Sum_probs=183.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+.++|++.+.||.|+||.||++.+.. +..||+|.+........+.+..|++++++++||||+++++.+......++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 34679999999999999999999764 78899999876655566788999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++++|..++...... .++|..+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR 160 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence 99999998887653211 24677788999999999999999999999999987543221 112
Q ss_pred ccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...... . ......... .+.+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~~------~~~~~ 229 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--R---VLLKILKSE------PPTLD 229 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--H---HHHHHhcCC------CCCcC
Confidence 3356888999999985 345788999999999999999999997532211 0 011100000 00110
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+...+..+.+++.+||+.+|++||++.++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 ---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 122334568899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.01 Aligned_cols=247 Identities=16% Similarity=0.244 Sum_probs=171.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------- 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-------- 157 (387)
...+|.+.+.||+|+||.||+|.... ++.||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 34679999999999999999999764 7899999885432 2345799999999999999999886532
Q ss_pred CceEEEEEecCCCCcchhhcC----Cc----------------cccccchhhhhhcccCCCceEEcCCC-CeEEeeccCc
Q 041766 158 DEKILIYEYMPNKSLDFFLFD----PT----------------KRMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMA 216 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~----~~----------------~~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a 216 (387)
...++||||+++ +|..++.. .. ...++|..+++||||||+|||++.++ .+||+|||+|
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 135799999986 55444421 10 11357888899999999999998664 6999999999
Q ss_pred eecCCCCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC---
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN--- 292 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 292 (387)
+...... ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||....... .+... .......
T Consensus 219 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i-~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRI-IQVLGTPTED 293 (440)
T ss_pred hhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HHHhCCCCHH
Confidence 8654322 12234678999999998764 68999999999999999999999975432211 11111 1100000
Q ss_pred -------cccccccccccc----ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 293 -------RTLELIDPILED----EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 293 -------~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
...+...+.... ...+...+..+.+|+.+||+.||.+|||+.|+++. ++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000000000000 00111234578899999999999999999999953 4444
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=280.66 Aligned_cols=231 Identities=21% Similarity=0.346 Sum_probs=174.6
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+++... ++.||+|.+... .......+..|..++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999765 788999999643 223445678899999888 699999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccC
Confidence 999877654321 124777888999999999999999999999999987532211 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-chHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS-LTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
|..|+|||++.+..++.++|||||||++|||++|+.||....... ............... .. .+...+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~---~p~~~~ 227 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IR---IPRFLS 227 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CC---CCCCCC
Confidence 999999999999999999999999999999999999985433221 111111222111100 00 112234
Q ss_pred HHHHHHHHhcccCCCCCCCCH------HHHHH
Q 041766 313 LRYVNIALLCVQESADDRPTM------NEVVS 338 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~------~~v~~ 338 (387)
..+.+++.+||+.||++||++ .++.+
T Consensus 228 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 228 VKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 567899999999999999984 56655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=277.55 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=177.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|...+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 568889999999999999999764 7789999986432 22334677899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++..... ...+|..+++||||||+|||++.++.+||+|||+++....... ...
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 162 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYS 162 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccc
Confidence 975 67666543221 1246778889999999999999999999999999976432221 122
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc-----------c-cc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR-----------T-LE 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~-~~ 296 (387)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ............. . ..
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED--ELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 3467889999999865 458999999999999999999999985432211 1111111000000 0 00
Q ss_pred ccccccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.-.+..... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 001123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=273.35 Aligned_cols=239 Identities=22% Similarity=0.314 Sum_probs=182.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|.+.+.||+|+||.||+|.+.+ ...||+|...... ....+.+..|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 567888999999999999998653 2468999887554 3455688999999999999999999999875 457899
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++|+|.+++...... ..+|..+++|+||||+||+++.++.+||+|||+++.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 9999999999988653221 23677788999999999999999999999999998765432221
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....++..|+|||.+....++.++||||||+++||+++ |..||...... ...... ......
T Consensus 165 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~----~~~~~~---------- 227 (270)
T cd05056 165 -ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI----ENGERL---------- 227 (270)
T ss_pred -cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH----HcCCcC----------
Confidence 122234568999999988889999999999999999996 99997533211 111110 000000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0112334578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=273.95 Aligned_cols=232 Identities=28% Similarity=0.432 Sum_probs=176.8
Q ss_pred CcccccCCeeEEEEEEcC-------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2468999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------------ccccchhhhhhcccCCCceEEcCCC-----CeEEeeccCcee
Q 041766 167 MPNKSLDFFLFDPTK-----------------------RMLLDWSANYSSRLKVSNILLDKDI-----NPKISDFGMARI 218 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------------~~~l~~~~~~h~dlk~~Nill~~~~-----~~kl~Dfg~a~~ 218 (387)
+++++|.+++..... ..++|..+++|+||||+||+++.++ .+||+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 999999988854211 0146677789999999999999877 899999999976
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~---- 230 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHV----TAGG---- 230 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHH----hcCC----
Confidence 543332222233355778999999999999999999999999999998 8888743221 1111100 0000
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.. ......+..+.+++.+||+.+|++||++.++++.|++
T Consensus 231 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---RL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---cc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1122345678899999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=281.52 Aligned_cols=238 Identities=18% Similarity=0.216 Sum_probs=175.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+++... ++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999765 889999998632 2233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++|+|..++...... .++|..+++||||||+|||++.++.+||+|||++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-Q 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-c
Confidence 999999999888542211 2467788899999999999999999999999998765432211 1
Q ss_pred cccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ...............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~~------ 228 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKEHFQ------ 228 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCccc------
Confidence 223468999999999863 4578899999999999999999999753211 111111111110000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCC--CCCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESAD--DRPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~--~RPt~~~v~~~ 339 (387)
........+..+.+++.+|+..+++ .||++.++++.
T Consensus 229 -~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0001112345678888887755333 37899999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.06 Aligned_cols=236 Identities=21% Similarity=0.339 Sum_probs=179.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
++|.+.+.||+|+||.||+|+... +..||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 578888999999999999998764 8889999987655455567888999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 168 PNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 168 ~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
++++|.+++..... ..++|..+++|+||||+||+++.++.+||+|||++....... ......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 166 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSF 166 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccc
Confidence 99999988754321 124677788999999999999999999999999987654221 122345
Q ss_pred cCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 232 VGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 232 ~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
.|+..|+|||++. ...++.++|||||||++|||++|..|+........ . ....... ...+... ..
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~----~~~~~~~----~~~~~~~---~~ 234 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L----FLMTKSN----FQPPKLK---DK 234 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-H----HhhhccC----CCCCccc---cc
Confidence 7889999999974 45688999999999999999999998743221110 0 0000000 0000000 01
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+++.+||+.+|++|||++++++
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 122346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=270.81 Aligned_cols=237 Identities=20% Similarity=0.327 Sum_probs=184.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||.|+||.||++.... +..+++|.+........+.+.+|++++++++||||+++++++...+..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 3678889999999999999999764 778999998766555667899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|..++..... ...+|..+++|+||+|+||++++++.+||+|||++....... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccc
Confidence 999999888765411 124677788999999999999999999999999987654221 1122
Q ss_pred cccCCCccccccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQG---IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~---~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... ... ... ...+.. ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-----~~~-~~~----~~~~~~--~~ 227 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-----FLI-SKS----NFPPPK--LK 227 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHH-Hhc----cCCCcc--cc
Confidence 34678899999999776 7899999999999999999999997532211100 000 000 000000 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.01 Aligned_cols=233 Identities=21% Similarity=0.359 Sum_probs=183.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..|+..+.||.|+||.||+|.... +..||+|.+.... ......+..|+.++++++||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 457788899999999999999765 7889999886442 34456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++++|.+++..... ...+|..+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06640 84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccc
Confidence 999999888764321 1235777889999999999999999999999999976643321 12234
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++|+|||||++|||++|..|+....... ... .+... .........
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~----------~~~~~-~~~~~~~~~ 225 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLF----------LIPKN-NPPTLTGEF 225 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhh----------hhhcC-CCCCCchhh
Confidence 67888999999988889999999999999999999999975322110 000 00000 001123345
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+..+.+++.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 6778899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=285.50 Aligned_cols=248 Identities=19% Similarity=0.204 Sum_probs=177.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 157 (387)
..++|++.+.||+|+||.||++.... ++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999999765 788999998643 233446788999999999999999999987653
Q ss_pred CceEEEEEecCCCCcchhhcCCc--------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPT--------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
...|+||||+++ +|...+.... ...++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 346999999976 5544443211 1135788889999999999999999999999999998654322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHH----------------
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD---------------- 287 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~---------------- 287 (387)
......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 181 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred ---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhhHHH
Confidence 1233578999999999999999999999999999999999999985432110 00000000
Q ss_pred --HhhcCccc------ccccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 288 --LWTSNRTL------ELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 288 --~~~~~~~~------~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........ ......... ..........+.+++.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=286.67 Aligned_cols=224 Identities=21% Similarity=0.234 Sum_probs=168.3
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|+... |+.||+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999764 889999998643 2223345555655 46678999999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccC
Confidence 999877654321 124788889999999999999999999999999987532211 12234578
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|..|+|||++.+..++.++|||||||++|||++|..||...... ........ . ... .......
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~-~--------~~~---~~~~~~~ 221 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILH-K--------PLV---LRPGASL 221 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHc-C--------Ccc---CCCCCCH
Confidence 99999999999999999999999999999999999997532211 11111110 0 000 0112345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHH
Q 041766 314 RYVNIALLCVQESADDRPTMNEVV 337 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~ 337 (387)
.+.+++.+||+.+|++||++.+.+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCH
Confidence 678999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=278.64 Aligned_cols=241 Identities=27% Similarity=0.423 Sum_probs=181.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|+..+.||+|+||.||+|.+.. +. .||+|.+..... .....+.+|+.++++++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 567888999999999999998653 43 478898865432 3334688999999999999999999998754 4679
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+++|+|.+++..... ..++|..+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 9999999999888765321 12478888899999999999999999999999999866433222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....+ ...... .
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~----~~~~~~-------~-- 230 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDL----LEKGER-------L-- 230 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHCCCC-------C--
Confidence 22223345678999999998899999999999999999998 8888643211 111111 111000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.....+...+.+++.+||..+|++||+++++++.|+++...
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112344688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=262.25 Aligned_cols=234 Identities=24% Similarity=0.312 Sum_probs=184.2
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC----C----cccHHHHHHHHHHHHhc-CCCceeeeeeeE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR----S----GQGLREMKNEASVIAKV-QHKNLVRLLGCC 154 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~----~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 154 (387)
..+..+|...+.||.|..+.|.++.++. |.+.|+|++... . ...++.-.+|++||+++ -||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4455778888999999999999998776 788999988421 1 12234556799999998 799999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
+.+...++|+|.|+.|.|.+++...-. -.++|...++||||||+|||++++.++||+|||.|+.
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 999999999999999999999864311 1358889999999999999999999999999999998
Q ss_pred cCCCCcccccccccCCCcccccccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQ------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
+.... .....|||++|+|||.+.. ..|+..+|+||+||++|.|+.|++||-. .
T Consensus 173 l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH------------------R 231 (411)
T KOG0599|consen 173 LEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH------------------R 231 (411)
T ss_pred cCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH------------------H
Confidence 76443 3445799999999999863 2488899999999999999999999621 0
Q ss_pred cccccccccccccc-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 293 RTLELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 293 ~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...-++..++.+.+ .-.+.+....+||.+||+.||.+|.|++|++..
T Consensus 232 kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 01111111111111 223456678899999999999999999999873
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=270.19 Aligned_cols=237 Identities=28% Similarity=0.418 Sum_probs=182.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..++|.+.+.||+|+||.||++.+.++..+|+|.+... ......+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 45688899999999999999999877788999988643 2334678899999999999999999999887 778999999
Q ss_pred cCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++...... ..+|..+++|+||||+||+++.++.+||+|||.+......... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 160 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AR 160 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cc
Confidence 9999999888653211 2467777899999999999999999999999999765432221 11
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....++..|+|||.+....++.++|+|||||++|++++ |..||..... ...... ....... ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~----~~~~~~~----------~~ 224 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRA----LERGYRM----------PR 224 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HhCCCCC----------CC
Confidence 22345677999999988889999999999999999999 8888743211 111111 1111000 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=272.42 Aligned_cols=232 Identities=25% Similarity=0.320 Sum_probs=177.4
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
|+..+.||+|+||.||++.... ++.||+|.+.... ......+..|+.++.+++|+||+.+++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6677899999999999999775 7899999886432 12234567899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ..++|..+++|+||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~ 158 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 158 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---c
Confidence 999999887743211 1246778889999999999999999999999999876542221 1
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... . .... ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~-~-----~~~~-----~~ 225 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVK-E-----VQEE-----YS 225 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhh-h-----hhhh-----cC
Confidence 234689999999999998999999999999999999999999854322110 000000000 0 0000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
......+.+++.+||+.||++||| ++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 223456789999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=289.10 Aligned_cols=237 Identities=21% Similarity=0.274 Sum_probs=176.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|+..+.||+|+||.||+++... ++.||+|.+... .......+..|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 367888999999999999999765 889999998632 2234457788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc---
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ--- 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 225 (387)
||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999988764322 12477888899999999999999999999999998754221000
Q ss_pred ------------------------------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041766 226 ------------------------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYR 275 (387)
Q Consensus 226 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~ 275 (387)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00113478999999999999999999999999999999999999985332
Q ss_pred CCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 041766 276 TDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNEVVSM 339 (387)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~~v~~~ 339 (387)
.. . ............. .. ........+.+++.+|+ .||.+|++ +.++++.
T Consensus 241 ~~--~---~~~~i~~~~~~~~-----~p---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQ--E---TYRKVMNWKETLV-----FP---PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HH--H---HHHHHHcCCCcee-----cC---CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 11 1 1111110000000 00 00112446778888876 49999985 5666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.67 Aligned_cols=235 Identities=21% Similarity=0.327 Sum_probs=169.0
Q ss_pred CcccccCCeeEEEEEEcCC---CEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 95 NKLGEGGFGPVYKGVLKKG---DEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999985543 346677765432 334568899999999999999999999999999999999999999
Q ss_pred CcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 171 SLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 171 ~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+|..++..... ..++|..+++|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 99988764211 1246777889999999999999999999999999864332222222334
Q ss_pred ccCCCcccccccccc-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 231 IVGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIVSG-KKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~-------~~~~~~~DiwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
..++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .. ...... ........++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~---~~~~~~-~~~~~~~~~~~~ 234 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--RE---VLNHVI-KDQQVKLFKPQL 234 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HH---HHHHHH-hhcccccCCCcc
Confidence 567889999998853 2457899999999999999974 556532211 11 111111 111112222222
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 235 ~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 EL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 13346778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=280.26 Aligned_cols=238 Identities=18% Similarity=0.186 Sum_probs=176.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+++... ++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468889999999999999999775 788999998642 2233445778999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++|+|..++...... ..+|..+++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence 999999999888653211 236778889999999999999999999999999986643321 11
Q ss_pred cccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~------- 227 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEERF------- 227 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCCcc-------
Confidence 233578999999999875 46889999999999999999999997532211 1111111100000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
.........+..+.+++.+|+..++++ |++++++++.
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000011123457889999999876544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=281.95 Aligned_cols=225 Identities=24% Similarity=0.309 Sum_probs=172.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+|+..+.||+|+||.||+|+... ++.||+|.+... .......+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999999765 889999998643 2233456778999998884 678889999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cc
Confidence 99999999887754321 1257788889999999999999999999999999875432211 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ .. .+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~---~~~i~~~~---------~~---~p 221 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--EL---FQSIMEHN---------VS---YP 221 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCC---------CC---CC
Confidence 3456899999999999989999999999999999999999997533211 11 11111000 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~ 333 (387)
...+..+.+++.+||+.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 2234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=270.85 Aligned_cols=235 Identities=22% Similarity=0.356 Sum_probs=179.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998778999999886432 12234688899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC----
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE---- 223 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~---- 223 (387)
+||+++++|..++.+... ...+|..+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999988865322 124677778999999999999999999999999987542211
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.........++..|+|||.+.+..++.++||||||+++|||++|..||....... ... ........ .+.
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~-~~~~~~~~----~~~-- 229 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMF-YIGAHRGL----MPR-- 229 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHH-HhhhccCC----CCC--
Confidence 1111223467889999999998889999999999999999999999975321110 000 00000000 000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........+.+++.+||+.+|++|||+.++++
T Consensus 230 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 ---LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11223456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=299.59 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=192.0
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC--------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeee
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLG 152 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 152 (387)
.++...+++.+.+.||+|.||.|++|.... ...||||.++.. ...+.+.+..|+++|+.+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455556666777899999999999998441 236999999754 345667899999999999 7999999999
Q ss_pred eEEeCCceEEEEEecCCCCcchhhcCCc-----------------c---------------ccccchhhhhhcccCCCce
Q 041766 153 CCIDKDEKILIYEYMPNKSLDFFLFDPT-----------------K---------------RMLLDWSANYSSRLKVSNI 200 (387)
Q Consensus 153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~---------------~~~l~~~~~~h~dlk~~Ni 200 (387)
+|...+..++|+||+..|+|..+++... . ..++.....+||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999899999999999999999998765 0 0134555669999999999
Q ss_pred EEcCCCCeEEeeccCceecCCCCccccc-ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 041766 201 LLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDS 278 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~ 278 (387)
|+..+..+||+|||+|+.......+... +...-+..|||||.+....|+.++|||||||+||||+| |..|+..-. ..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cH
Confidence 9999999999999999976554444322 11113567999999999999999999999999999999 777864311 01
Q ss_pred chHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 279 LTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..+. ... .....+..+..+++++|+.||+.+|++||+|.++.+.++....
T Consensus 529 ~~l~~~l-------------~~G-~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 EELLEFL-------------KEG-NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHH-------------hcC-CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1111111 111 1112455667789999999999999999999999999998654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=280.54 Aligned_cols=238 Identities=18% Similarity=0.199 Sum_probs=176.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+++++. ++.+|+|.+... .......+..|..++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999999876 778999998532 2223345788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++|+|..++...... .++|..+++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence 999999999888652211 246778889999999999999999999999999876532221 12
Q ss_pred cccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~------- 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHKERF------- 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-----HHHHHHHhCCCccc-------
Confidence 23357899999999986 34588999999999999999999999753211 11111111100000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
.........+..+.+++.+|+..++.. |+++.++++.
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000011223556788999988665444 6899999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=274.33 Aligned_cols=243 Identities=22% Similarity=0.340 Sum_probs=179.8
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe--
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-- 156 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-- 156 (387)
+..+....++|++.+.||+|+||.||++.... ++.+|+|.+.... .....+..|+.+++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34455677899999999999999999999765 7889999876432 2235678899999999 79999999998853
Q ss_pred ---CCceEEEEEecCCCCcchhhcCC---cc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 157 ---KDEKILIYEYMPNKSLDFFLFDP---TK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 157 ---~~~~~lv~e~~~~g~L~~~l~~~---~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
.+..++||||+++++|..++... .. ..++|..+++|+||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 35689999999999998776421 11 12467778899999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+....... ....
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~~~- 240 (286)
T cd06638 169 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----ALFK- 240 (286)
T ss_pred CceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HHhh-
Confidence 99986643221 1223468899999999853 457899999999999999999999975332110 0000
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
.... ..+... .+......+.+++.+||+.||++|||+.++++.+
T Consensus 241 ~~~~-----~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPRN-----PPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccc-----CCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 000000 1112234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=272.99 Aligned_cols=243 Identities=21% Similarity=0.266 Sum_probs=171.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCCceeeeeeeEEeC-----C
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDK-----D 158 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~-----~ 158 (387)
+|++.+.||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999999775 8889999886432 22223556777777665 699999999988652 3
Q ss_pred ceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
..+++|||+++ +|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 57899999975 77776654221 124677888999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc---cc--
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR---TL-- 295 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~-- 295 (387)
... ......++..|+|||++.+..++.++|||||||++|||++|++||....... .+. .......... ..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 160 CQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLG-KIFDLIGLPPEDDWPRD 234 (288)
T ss_pred Ccc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHH-HHHHHhCCCChhhCccc
Confidence 321 1223467889999999998899999999999999999999999875432211 111 1111000000 00
Q ss_pred -----cccccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 -----ELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 -----~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+..... .........+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 011223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.12 Aligned_cols=233 Identities=26% Similarity=0.394 Sum_probs=178.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc---------cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ---------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
+|.+...||+|+||.||+|.... +..+|+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 46778899999999999999754 788999988543221 22467889999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.+++|||+++++|..++..... ...+|..+++|+||+|+||++++++.+||+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999888854322 124677788999999999999999999999999988664321
Q ss_pred ccc----ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 224 LQA----NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 224 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
... ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~------~~~ 229 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGE------NAS 229 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhc------cCC
Confidence 111 112245788999999999888999999999999999999999997532110 00111000 000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+. .+...+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 PE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Cc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 11233557889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=267.43 Aligned_cols=233 Identities=22% Similarity=0.296 Sum_probs=182.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||.|+||.||.++... ++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999998654 888999987643 334456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ...+|..+++|+||+|+||++++++.+||+|||++........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence 999999988865411 1246777889999999999999999999999999987643331 22
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....++..|+|||.+.+..++.++||||||+++|||++|..||..... ......... ... . ...
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~-~~~--------~--~~~ 222 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQ-GNY--------T--PVV 222 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc-CCC--------C--CCc
Confidence 345688999999999888899999999999999999999999743211 111111110 000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
...+..+.+++.+||+.+|++||+++++++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 23345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.41 Aligned_cols=242 Identities=22% Similarity=0.299 Sum_probs=178.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-- 157 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-- 157 (387)
..+...++|.+.+.||+|+||.||++.+.. +..||+|.+... .......+..|+.+|.+++|||||+++++|...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 344556789999999999999999999776 677899988643 333456788999999999999999999988654
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------------ccccch-------hhhhhcccCCCceEEcCC-----
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK--------------------RMLLDW-------SANYSSRLKVSNILLDKD----- 205 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~-------~~~~h~dlk~~Nill~~~----- 205 (387)
..+||||||+++|+|..++..... ..++|. ..++|+||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 468999999999999888754210 113454 238999999999999642
Q ss_pred ------------CCeEEeeccCceecCCCCcccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCC
Q 041766 206 ------------INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 206 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 348999999998654322 1234578999999999864 45899999999999999999999998
Q ss_pred CCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhh
Q 041766 272 GFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDE 343 (387)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~ 343 (387)
..... ....... .... +.+ .....+..+.+||..||+.+|.+||++.|++. .+...
T Consensus 244 ~~~~~----~~qli~~-lk~~-------p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANN----FSQLISE-LKRG-------PDL----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCc----HHHHHHH-HhcC-------CCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 53221 1111111 1100 000 11122457889999999999999999999984 45433
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=271.97 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=182.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++|+..+.||+|+||.||+|+.+. ...|++|.+...... ....+.+|++++.+++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999999642 456999988654433 4568899999999999999999999999988999
Q ss_pred EEEEecCCCCcchhhcCCc---------c----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 162 LIYEYMPNKSLDFFLFDPT---------K----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~---------~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
+||||+++|+|.+++.... . ..++|..+++|+||||+||+++.++.+||+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999998886433 1 02478888899999999999999999999999998
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... . .... .......
T Consensus 165 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~---~~~~-~~~~~~~ 237 (275)
T cd05046 165 KDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--E---VLNR-LQAGKLE 237 (275)
T ss_pred cccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--H---HHHH-HHcCCcC
Confidence 754322211 1223355778999999988889999999999999999999 77776422111 1 1111 1101100
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
. .....++..+.+++.+||+.+|++|||+.+++..|.+
T Consensus 238 ~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 L---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 0111234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=273.63 Aligned_cols=233 Identities=21% Similarity=0.377 Sum_probs=180.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+.|+..+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 345667889999999999998764 7789999886432 34456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++++|..++..... ..++|..+++|+||+|+||+++.++.+||+|||++........ .....
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcc
Confidence 999999887754321 1246777889999999999999999999999999976543221 12234
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++|||||||++|||++|+.|+....... .... ..... .+. .....
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~-~~~~~-----~~~-----~~~~~ 225 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLFL-IPKNS-----PPT-----LEGQY 225 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHhh-hhcCC-----CCC-----CCccc
Confidence 67889999999998889999999999999999999999974322110 0000 00000 011 11123
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4568899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=274.88 Aligned_cols=179 Identities=22% Similarity=0.344 Sum_probs=139.6
Q ss_pred CCcccccCCeeEEEEEEc---CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceEEEEEecC
Q 041766 94 ANKLGEGGFGPVYKGVLK---KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMP 168 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 168 (387)
..+||+|+||.||+|+.. .+..||+|.+.... ....+.+|+.++++++||||+++++++.. ....|++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 35789999986442 23467789999999999999999999865 346789999986
Q ss_pred CCCcchhhcCCc-------------------------cccccchhhhhhcccCCCceEE----cCCCCeEEeeccCceec
Q 041766 169 NKSLDFFLFDPT-------------------------KRMLLDWSANYSSRLKVSNILL----DKDINPKISDFGMARIC 219 (387)
Q Consensus 169 ~g~L~~~l~~~~-------------------------~~~~l~~~~~~h~dlk~~Nill----~~~~~~kl~Dfg~a~~~ 219 (387)
+ +|..++.... ...++|..+++||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 4 6655543210 0124677888999999999999 45678999999999876
Q ss_pred CCCCcc-cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 041766 220 GGNELQ-ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYR 275 (387)
Q Consensus 220 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~ 275 (387)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 432211 122345789999999999774 58999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=274.25 Aligned_cols=238 Identities=23% Similarity=0.303 Sum_probs=181.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||++.... +..||+|.+... .......+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 568888999999999999999765 788999987543 234456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|..++..... ..++|. .+++|+||||+||++++++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~ 160 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccC
Confidence 999999887754321 012443 46899999999999999999999999998654221 122
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc------hHhHHHHHHhhcCccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL------TLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ............. .
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 230 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----------P 230 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----------C
Confidence 35788999999999888899999999999999999999999864332210 0011111110000 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
........+..+.+++.+||+.||++|||+.++++..
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0011122456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=270.71 Aligned_cols=232 Identities=25% Similarity=0.328 Sum_probs=176.1
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
|+..+.||+|+||+||++.+.. ++.||+|.+.... ......+.+|+++|++++|+||+.+++.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5667889999999999999764 8889999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ..++|..+++|+||||+||++++++.+||+|||++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~ 158 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SI 158 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cc
Confidence 999999877754221 124778888999999999999999999999999997653221 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||.+.+..++.++|+|||||++|||++|..||........ ......... .. ... ..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~-~~--~~~---------~~ 225 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVL-ET--EEV---------YS 225 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhh-cc--ccc---------cC
Confidence 234789999999999988999999999999999999999999853221100 000000000 00 000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
......+.+++.+||+.||++||+ +.+++.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 223446789999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.75 Aligned_cols=221 Identities=26% Similarity=0.405 Sum_probs=168.3
Q ss_pred CcccccCCeeEEEEEEcCCC-----------EEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 95 NKLGEGGFGPVYKGVLKKGD-----------EIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+.||+|+||.||+|.+.... .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999986533 4788877544332 5788899999999999999999999988 778999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCC-------CeEEeeccCceec
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDI-------NPKISDFGMARIC 219 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~-------~~kl~Dfg~a~~~ 219 (387)
|||+++|+|..++...... .++|..+++|+||||+|||++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 9999999999888654311 246777889999999999999887 7999999999865
Q ss_pred CCCCcccccccccCCCccccccccccC--CCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLLEIVSG-KKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
.. .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... ....+ +.....
T Consensus 159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~----~~~~~~-- 224 (259)
T cd05037 159 LS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERF----YQDQHR-- 224 (259)
T ss_pred cc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHH----HhcCCC--
Confidence 32 1223567789999999876 789999999999999999994 6665332211 10000 000000
Q ss_pred ccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.... . ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 225 -----~~~~-~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 -----LPMP-D----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----CCCC-C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 157889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=267.63 Aligned_cols=239 Identities=24% Similarity=0.366 Sum_probs=183.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||.|+||.||+|.... +..+++|++.... ......+.+|+..++.++|+||+++++.+...+..+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999999664 7889999986432 23557889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc-
Q 041766 167 MPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA- 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 226 (387)
+++++|..++..... ...+|..+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 999999888854311 124677788999999999999999999999999987665432221
Q ss_pred -ccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 227 -NTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 227 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......|+..|+|||.+... .++.++|+|||||++|||++|+.||....... .. ...... ..+....
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~----~~~~~~------~~~~~~~ 229 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VL----MLTLQN------DPPSLET 229 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hH----HHHhcC------CCCCcCC
Confidence 22334688899999998876 78999999999999999999999975332211 00 010000 0011111
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.......+..+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=276.87 Aligned_cols=246 Identities=17% Similarity=0.182 Sum_probs=173.1
Q ss_pred CCCccccc--CCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 93 DANKLGEG--GFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 93 ~~~~lG~G--~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+.++||+| +|++||++..+. ++.||+|.+... .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 788999998765 889999998643 2233456778999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc----
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ---- 225 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~---- 225 (387)
++|+|.+++..... ..++|..+++|+||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 99999888754211 12477788899999999999999999999999865433211110
Q ss_pred -cccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH-------------HHh
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW-------------DLW 289 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~-------------~~~ 289 (387)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 01122356778999999976 45899999999999999999999998543221110000000 000
Q ss_pred hcCcccccccc-------------cc---ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 290 TSNRTLELIDP-------------IL---EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 290 ~~~~~~~~~~~-------------~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.........+. .. ............+.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000000 00 000011234567889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.70 Aligned_cols=245 Identities=20% Similarity=0.279 Sum_probs=177.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|...+.||+|+||.||+|+... ++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 568889999999999999999764 788999998643 233345677899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++ ++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ...
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 162 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYS 162 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--ccc
Confidence 97 578776654321 1246778889999999999999999999999999875432211 122
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC---cccccc-------
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN---RTLELI------- 298 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------- 298 (387)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ............. ......
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhccccccc
Confidence 33568899999998754 5789999999999999999999998543221 1111111110000 000000
Q ss_pred --ccccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 --DPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 --~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+..... ......+..+.+|+.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 001123456789999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=279.54 Aligned_cols=174 Identities=18% Similarity=0.230 Sum_probs=143.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..+|.+.+.||+|+||.||+|+... +..||+|..... ....|+.++++++||||+++++++...+..++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4579999999999999999999775 678999975432 234689999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+. ++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 214 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFL 214 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccc
Confidence 95 577766643222 125778888999999999999999999999999987532211 123
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
...||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 356899999999999999999999999999999999966554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=267.52 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=182.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|+..+.||+|+||.||++.++. ++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357788999999999999999875 8889999886543 34456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ...+|. .+++|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----A 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----h
Confidence 999999988865311 124677 788999999999999999999999999987553221 1
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+................... .. .+.+ ..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-----~~~~----~~ 226 (265)
T cd06605 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EP-----PPRL----PS 226 (265)
T ss_pred hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CC-----CCCC----Ch
Confidence 12567889999999999899999999999999999999999975432211111111111100 00 0000 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...+..+.+++.+||..||++|||+.+++..
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1145678899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=280.80 Aligned_cols=244 Identities=19% Similarity=0.254 Sum_probs=175.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 157 (387)
..++|...+.||+|+||.||+|.... +..||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999999754 7889999986432 22345677899999999999999999988643
Q ss_pred CceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
...|+++|++ +++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 3468999988 7788776643211 12578888999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc-
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP- 300 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 300 (387)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .......... .....+....
T Consensus 172 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~-~~~~~~~~~~~ 243 (343)
T cd07878 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVV-GTPSPEVLKKI 243 (343)
T ss_pred -----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHh-CCCCHHHHHhc
Confidence 233478999999999876 56899999999999999999999997542211 1000000000 0000000000
Q ss_pred ----------cccccc------ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 301 ----------ILEDEY------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 301 ----------~~~~~~------~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+.... ......+.+.+|+.+||+.||++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000123357899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.22 Aligned_cols=246 Identities=19% Similarity=0.202 Sum_probs=171.5
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCC------CceeeeeeeEEe
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQH------KNLVRLLGCCID 156 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~~~~~~~~ 156 (387)
+....++|++.+.||+|+||.||+|.+.. ++.||||+++... .....+..|+.++.+++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34456789999999999999999999765 7789999986432 223455667777777654 458889998876
Q ss_pred C-CceEEEEEecCCCCcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCC------------
Q 041766 157 K-DEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDI------------ 206 (387)
Q Consensus 157 ~-~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~------------ 206 (387)
. .+.|+|||++ +++|..++..... ..++|. .+++||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 4 4788999998 6677666644221 124676 5899999999999998765
Q ss_pred ----CeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh
Q 041766 207 ----NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282 (387)
Q Consensus 207 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~ 282 (387)
.+||+|||.+..... ......||..|+|||++.+..|+.++|||||||++|||++|+.||...... ...
T Consensus 282 ~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~ 354 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL--EHL 354 (467)
T ss_pred CCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHH
Confidence 499999998764321 223468899999999999999999999999999999999999998643321 111
Q ss_pred HHHHHH-------hhc----Ccccccc------cccccc----------ccccHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 041766 283 GYAWDL-------WTS----NRTLELI------DPILED----------EYSSKHMLLRYVNIALLCVQESADDRPTMNE 335 (387)
Q Consensus 283 ~~~~~~-------~~~----~~~~~~~------~~~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~ 335 (387)
...... +.. ....+.. .+.... ..........+.+|+.+||+.||++|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 110000 000 0000000 000000 0000111346789999999999999999999
Q ss_pred HHH
Q 041766 336 VVS 338 (387)
Q Consensus 336 v~~ 338 (387)
+++
T Consensus 435 ~L~ 437 (467)
T PTZ00284 435 MTT 437 (467)
T ss_pred Hhc
Confidence 997
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.47 Aligned_cols=235 Identities=22% Similarity=0.369 Sum_probs=177.8
Q ss_pred CCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCC----------CcccHHHHHHHHHHHHh-cCCCceeeeeeeEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGR----------SGQGLREMKNEASVIAK-VQHKNLVRLLGCCID 156 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~ 156 (387)
.|++.+.||+|+||.||+|.+.. ++.+|+|.+... .......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999765 678999987532 12234557788888875 699999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCC---cc-----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDP---TK-----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~---~~-----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
.+..+++|||+++++|.+++... .. ...+|. .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998776321 10 123554 5678999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ... ...... ....
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--~~~---~~~~~~-~~~~- 230 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--MLS---LATKIV-EAVY- 230 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--HHH---HHHHHh-hccC-
Confidence 98754332 2234568889999999998889999999999999999999999974221 111 111100 0000
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.+. ........+.+++.+||+.||++||++.|+..++++
T Consensus 231 ---~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 ---EPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---CcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 000 111234578899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=271.93 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=174.8
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||+|+||.||+|+... |..||+|.+... .......+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47788999999999999999865 889999988643 222335677899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++..... ..++|..+++|+||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcC
Confidence 975 66665543221 1246778889999999999999999999999999876543211 122
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc------ccccc---
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT------LELID--- 299 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--- 299 (387)
...++..|+|||++.+. .++.++|||||||++|||++|..|+....+....+ ............ .+..+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHhHHhhhcccccc
Confidence 34568899999998764 47999999999999999999998864322211111 111110000000 00000
Q ss_pred -cccccc----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 -PILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 -~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..... ......+..+.+++.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 011123467789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=268.83 Aligned_cols=235 Identities=28% Similarity=0.395 Sum_probs=177.4
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHH--HHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
|+..+.||+|+||+||++.... ++.||+|.+......... ...+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999886 568999999766443322 3456999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 168 PNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 168 ~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
++++|..++..... ...+|..+++|+||||+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccc
Confidence 99999988862111 12477888899999999999999999999999999864211 1223445
Q ss_pred cCCCccccccccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc-ccH
Q 041766 232 VGTYGYMSPEYAI-QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-SSK 309 (387)
Q Consensus 232 ~gt~~y~aPE~~~-~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 309 (387)
.++..|+|||++. +..++.++||||+|+++|+|++|..|+.... ............. ....... ...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~~ 227 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN--SDDQLEIIEKILK---------RPLPSSSQQSR 227 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS--HHHHHHHHHHHHH---------THHHHHTTSHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc--chhhhhhhhhccc---------ccccccccccc
Confidence 7889999999998 7889999999999999999999999975431 0011101100000 0000000 000
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+.+++.+||+.||++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11267899999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=270.69 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=175.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|++.+.||+|+||.||+|+... +..||+|.+... .......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47788999999999999999764 889999988643 223346788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
++ ++|..++..... ..++|..+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--cc
Confidence 97 577766643221 124677888999999999999999999999999987653221 11
Q ss_pred cccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC------------cc
Q 041766 228 TSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN------------RT 294 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~ 294 (387)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..... ...... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIF-RILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH-HHhCCCChhhhhcchhhHHH
Confidence 2233568899999988754 578999999999999999999998754321110 00000 000000 00
Q ss_pred ccccccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........... ......+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 001123457789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=270.96 Aligned_cols=234 Identities=20% Similarity=0.317 Sum_probs=178.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||++... .+..||+|.+... .......+.+|++++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999987 4889999988643 333346788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc--c-----------------cccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 167 MPNKSLDFFLFDPTK--R-----------------MLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~--~-----------------~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+++++|..++..... . .++|. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 999999888765310 0 13454 478999999999999999999999999987653221
Q ss_pred ccccccCCCccccccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ........ .....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-~~~~~------ 227 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLSAI-VDGDP------ 227 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHHHH-hhcCC------
Confidence 2234578899999998543 35889999999999999999999975322111 00000000 00000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00122355678899999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=271.11 Aligned_cols=239 Identities=21% Similarity=0.338 Sum_probs=179.4
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe---
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID--- 156 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~--- 156 (387)
.+.....+.|++.+.||+|+||.||+|+... ++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3444566889999999999999999999765 7889999886443 2335678899999998 79999999999863
Q ss_pred ---CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 157 ---KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 157 ---~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
.+..|++|||+++|+|..++..... ..++|..+++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 3467999999999999888754221 1246777889999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
+....... .......|+..|+|||.+. +..++.++|||||||++|||++|..||......... ..
T Consensus 168 ~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----~~--- 237 (282)
T cd06636 168 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----FL--- 237 (282)
T ss_pred hhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----hh---
Confidence 87543221 1223356889999999986 345888999999999999999999997432211000 00
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+.............+..+.+++.+||+.||.+|||+.++++
T Consensus 238 -------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000001112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=267.25 Aligned_cols=229 Identities=28% Similarity=0.381 Sum_probs=177.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999975 47889999986432 346788999999999999999999998764 4689999999
Q ss_pred CCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 169 NKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 169 ~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+++|..++...... ..+|..+++|+||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~ 156 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDN 156 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCC
Confidence 99999888643221 2467778899999999999999999999999998764321 112
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... ..... .... .... ...
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~-~~~~---------~~~~-~~~ 220 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKEC-VEKG---------YRME-PPE 220 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHH-HhCC---------CCCC-CCC
Confidence 234567999999988899999999999999999998 88886432211 11111 1110 0000 112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
..+..+.+++.+||+.+|++||+++++++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=263.08 Aligned_cols=233 Identities=32% Similarity=0.483 Sum_probs=179.8
Q ss_pred CCCCCcccccCCeeEEEEEEcC-C----CEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-G----DEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
|++.+.||.|+||.||+++... + ..||+|.+...... ....+..|+..+..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999765 3 78999999755432 5678899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||+++++|..++...... ..+|..+++|+||||+||++++++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 999999998888653321 24677788999999999999999999999999998765442222
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |..||.... .... .... ......
T Consensus 161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~---~~~~-~~~~~~---------- 223 (258)
T smart00219 161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEV---LEYL-KKGYRL---------- 223 (258)
T ss_pred cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHH---HHHH-hcCCCC----------
Confidence 11 2236789999999988889999999999999999998 677754311 1111 1111 111100
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
......+..+.+++.+||..||++|||+.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112455788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=269.48 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=179.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999875 8899999885432 2234567899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|++++.|..++..... ...+|..+++|+||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--ccc
Confidence 9999888776643221 1246777889999999999999999999999999987643321 122
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHH----------HhhcCccc-cc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD----------LWTSNRTL-EL 297 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~-~~ 297 (387)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....... .+...... ..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccccccc
Confidence 3356788999999876 4588999999999999999999999854332111 1000000 00000000 00
Q ss_pred ccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+...... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 01123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=270.45 Aligned_cols=237 Identities=23% Similarity=0.357 Sum_probs=184.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|.+.+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3478999999999999999999865 478899999865544555778899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 166 YMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRST 174 (293)
T ss_pred cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--cccc
Confidence 9999999988765321 1246778889999999999999999999999999876543321 1223
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..++..|+|||.+.+..++.++||||||+++|++++|+.||......... ....... .+.. .....
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-----~~~~~~~------~~~~---~~~~~ 240 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNG------TPEL---QNPEK 240 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-----eehhcCC------CCCC---CCccc
Confidence 46788999999998888999999999999999999999998533221100 0000000 0000 01223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=266.47 Aligned_cols=234 Identities=24% Similarity=0.353 Sum_probs=174.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
.+|+..+.||+|+||.||++.... +..||+|.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368889999999999999999764 8899999885331 12345688899999999999999999988763 567
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++++||+++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 899999999999888754321 1246778889999999999999999999999999876532111
Q ss_pred -ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 -QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
........++..|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ..+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~~~-----~~~--- 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIATQP-----TNP--- 228 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcCC-----CCC---
Confidence 11112345788999999999888999999999999999999999997532110 0000000000 001
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+......+.+++ +||..+|++||+++++++
T Consensus 229 --~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 --QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11223344566777 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=271.07 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=178.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|+..+.||+|+||.||+|.+++ ++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 367888999999999999999875 88999998864322 234567889999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+++++|..+...... ..++|..+++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccC
Confidence 9999988776543221 124677888999999999999999999999999988654322 1122
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc--Ccccc----------
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS--NRTLE---------- 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~---------- 296 (387)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............. .....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 3457889999999875 4478899999999999999999988753221 1100000000000 00000
Q ss_pred ccccccccc----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..... ......+..+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001233567889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=266.62 Aligned_cols=232 Identities=20% Similarity=0.336 Sum_probs=179.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.|+..+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47778899999999999999754 889999998644 3344567889999999996 999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 165 EYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||+++++|..++..... ...+|..+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~ 159 (277)
T cd06917 82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRS 159 (277)
T ss_pred ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccc
Confidence 99999999888755321 1246778889999999999999999999999999987654331 123
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .... ... ...+.+ ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~-~~~-----~~~~~~----~~ 224 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMML-IPK-----SKPPRL----ED 224 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhc-ccc-----CCCCCC----Cc
Confidence 3468889999999875 447899999999999999999999975322110 0000 000 000111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+++.+||+.||++||++.++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 225 NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 113457889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=274.08 Aligned_cols=240 Identities=15% Similarity=0.197 Sum_probs=179.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|+..+.||+|+||.||++.... ++.|++|.+.... ......+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999775 7889999886442 233457789999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc----
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL---- 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---- 224 (387)
||+++++|..++..... ..++|..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999988854321 1246777889999999999999999999999999864211000
Q ss_pred ---------ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 225 ---------QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 225 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
........++..|+|||.+.+..++.++|||||||++|||++|..||..... . ........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~---~~~~~~~~-~~-- 232 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--E---ELFGQVIS-DD-- 232 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHHh-cc--
Confidence 0011123577889999999888899999999999999999999999742211 1 11111000 00
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
...+. .....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 233 -~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 -IEWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -cCCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000 111235568899999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=275.33 Aligned_cols=235 Identities=22% Similarity=0.303 Sum_probs=180.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+.|.....||+|+||.||++.... +..||||.+........+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 444556789999999999999764 7899999987655555667889999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 168 PNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 168 ~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
++++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++....... .......
T Consensus 102 ~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (292)
T cd06658 102 EGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLV 179 (292)
T ss_pred CCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceee
Confidence 99999887744321 124677888999999999999999999999999987543221 1123346
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ... ... .. ........ ......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~---~~~-~~-----~~~~~~~~---~~~~~~ 245 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--LQA---MRR-IR-----DNLPPRVK---DSHKVS 245 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHH-HH-----hcCCCccc---cccccC
Confidence 78899999999888899999999999999999999999753211 000 000 00 00111111 111234
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+.+++.+||+.||.+|||++++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 467899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=264.95 Aligned_cols=232 Identities=19% Similarity=0.296 Sum_probs=178.7
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e 165 (387)
+|++.+.||+|++|.||++.... ++.||+|.+... .......+..|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999765 788999998643 223445788899999999999999999987644 45789999
Q ss_pred ecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|+++++|.+++...... ..+|..+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--Cc
Confidence 99999998887542211 24677788999999999999999999999999998664322 12
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....++..|+|||++.+..++.++||||||+++|||++|+.||..... ......... ... + ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~-~~~-----~-----~~ 222 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIE-GKL-----P-----PM 222 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHh-cCC-----C-----CC
Confidence 2335678899999999998999999999999999999999998753221 111111111 000 0 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 22345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=270.85 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=180.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+|.+.+ ++.||+|.+... .......+.+|++++++++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999875 788999988643 23345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|++++.+..+...... ...+|..+++|+||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~ 159 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLT 159 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cccc
Confidence 9998877665543221 1246778889999999999999999999999999887643321 1223
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh-----------hcCccc--
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW-----------TSNRTL-- 295 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~-- 295 (387)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ......... ......
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 34678889999999887 78999999999999999999999875432211 000000000 000000
Q ss_pred ----cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ----ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+...........+...+..+.+++++||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.30 Aligned_cols=232 Identities=22% Similarity=0.311 Sum_probs=180.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||+|+||.||++.... ++.||+|.+... .......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47888999999999999999764 789999988632 233446788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|..++..... ...+|..+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence 999999887754221 1246777889999999999999999999999999986543221 12
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||++.+..++.++|+|||||++|+|++|+.|+..... ........... . ...+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~-~----------~~~~ 222 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGS-Y----------PPVS 222 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCC-C----------CCCc
Confidence 234578889999999988899999999999999999999999743211 11111111000 0 0012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
......+.+++.+||+.+|++||++.+|++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2335578899999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=266.79 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=177.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc----------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG----------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
+|...+.||.|+||.||+|.... ++.||+|.+..... ...+.+..|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46778899999999999998654 88999998753210 11346778999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
..++||||+++++|..++..... ...+|..+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999888765322 12467778899999999999999999999999998764322
Q ss_pred CcccccccccCCCccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
..........++..|+|||.+.... ++.++|+||||+++||+++|..|+..... ........... ....+..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~~~~~~~ 235 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFKLGNKR-SAPPIPP 235 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHHhhccc-cCCcCCc
Confidence 1111223346788999999987654 89999999999999999999999742211 01111111000 0000000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .....+..+.+++.+||+.+|++|||++++++.
T Consensus 236 ----~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 236 ----D-VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----c-ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 112245678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=265.59 Aligned_cols=235 Identities=23% Similarity=0.293 Sum_probs=176.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
.+|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999999765 8899999875321 12345788899999999999999999988764 457
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+++|||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999888754321 1246777889999999999999999999999999876532211
Q ss_pred c-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 Q-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ... ....... .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~-~~~~~~~----------~ 226 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAI-FKIATQP----------T 226 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHH-HHHhcCC----------C
Confidence 1 1122346788999999998888999999999999999999999997432111 000 0100000 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+......+.+++.+||. +|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111233445678889999995 99999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=264.66 Aligned_cols=231 Identities=26% Similarity=0.402 Sum_probs=179.6
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+..|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999977 58899999885432 22456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
+||+++++|..++..... ...+|..+++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999888765331 124677788999999999999999999999999988654332 1
Q ss_pred cccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............. ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~----------~~ 222 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKEL----------PP 222 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccC----------CC
Confidence 23356788999999987766 89999999999999999999999754321 1111111000000 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11223456789999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=268.29 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=175.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 4678899999999999999998764 8899999986442 2223467789999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+. +++..++..... ...+|..+++|+||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 160 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TY 160 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CC
Confidence 996 566555433211 1246778889999999999999999999999999876433221 12
Q ss_pred ccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc------------Ccc-
Q 041766 229 SRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS------------NRT- 294 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~- 294 (387)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||.........+. ..+..... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE-KIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH-HHHHHcCCCChhhhhhhhhccccc
Confidence 234568899999998764 578999999999999999999999864332111111 11110000 000
Q ss_pred cccccc----ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDP----ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+.... ..............+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 00000000011356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=272.23 Aligned_cols=178 Identities=22% Similarity=0.344 Sum_probs=138.2
Q ss_pred CCcccccCCeeEEEEEEcC---CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceEEEEEecC
Q 041766 94 ANKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIYEYMP 168 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 168 (387)
..+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999653 4679999886442 23467889999999999999999999864 456789999987
Q ss_pred CCCcchhhcCCc-------------------------cccccchhhhhhcccCCCceEE----cCCCCeEEeeccCceec
Q 041766 169 NKSLDFFLFDPT-------------------------KRMLLDWSANYSSRLKVSNILL----DKDINPKISDFGMARIC 219 (387)
Q Consensus 169 ~g~L~~~l~~~~-------------------------~~~~l~~~~~~h~dlk~~Nill----~~~~~~kl~Dfg~a~~~ 219 (387)
+ +|..++.... ...++|..+++|+||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 5 5555442110 0124677788999999999999 56678999999999866
Q ss_pred CCCCcc-cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 041766 220 GGNELQ-ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFY 274 (387)
Q Consensus 220 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~ 274 (387)
...... .......+|..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 433211 122335678999999999764 5899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=279.26 Aligned_cols=224 Identities=20% Similarity=0.247 Sum_probs=166.2
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc---CCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
||+|+||.||+|+... ++.||+|++... .......+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999765 889999998532 112233455677777665 699999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ......+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccC
Confidence 999877754321 124788889999999999999999999999999987542221 12234578
Q ss_pred CCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 234 TYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 234 t~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
|..|+|||++.+. .++.++|||||||++|||++|+.||...... ..... ...... .+ ......
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~~~~~-i~~~~~------~~----~~~~~~ 222 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----QMYRN-IAFGKV------RF----PKNVLS 222 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----HHHHH-HHcCCC------CC----CCccCC
Confidence 9999999998764 4899999999999999999999997432111 11111 110000 00 111234
Q ss_pred HHHHHHHHhcccCCCCCCC----CHHHHHH
Q 041766 313 LRYVNIALLCVQESADDRP----TMNEVVS 338 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RP----t~~~v~~ 338 (387)
..+.+++.+||+.||++|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 5678999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=267.93 Aligned_cols=237 Identities=21% Similarity=0.349 Sum_probs=177.0
Q ss_pred CCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 91 FSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
|.+.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 2578999988643 2334567889999999999999999999886542
Q ss_pred ceEEEEEecCCCCcchhhcCCcc----------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK----------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
..++++||+++|+|..++..... ..++|..+++|+||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 24789999999999776532110 12467788899999999999999999999999999
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
+...............++..|++||.+.+..++.++|||||||++|||++ |+.||..... ....... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~~~- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL----IKGNR- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHH----HcCCc-
Confidence 86643332222233345678999999988889999999999999999999 7777643211 1111111 00000
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.. .....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 234 ------~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ------LK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 1112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=273.35 Aligned_cols=233 Identities=21% Similarity=0.294 Sum_probs=179.2
Q ss_pred CCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
|.....||+|+||.||++... ++..||+|.+........+.+.+|+.++..++||||+++++++...+..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 444568999999999999976 4889999998655445556788999999999999999999999999999999999999
Q ss_pred CCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 170 KSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 170 g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++....... .......++
T Consensus 103 ~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~ 180 (297)
T cd06659 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGT 180 (297)
T ss_pred CCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecC
Confidence 999887654221 124677788999999999999999999999999987543221 112335688
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
..|+|||.+.+..++.++|||||||++|||++|+.||...... .. ... ...... .... ........
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~---~~~-~~~~~~-----~~~~---~~~~~~~~ 246 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QA---MKR-LRDSPP-----PKLK---NAHKISPV 246 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH---HHH-HhccCC-----CCcc---ccCCCCHH
Confidence 9999999999888999999999999999999999997532211 10 001 000000 0000 11122446
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 315 YVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+.+++.+||+.+|++||+++++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=269.83 Aligned_cols=231 Identities=24% Similarity=0.383 Sum_probs=175.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+...|+..+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+++++.++||||++++++|.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34668899999999999999999764 8899999886432 2334568899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||+++ ++..++..... ..++|..+++|+||+|+||++++++.+||+|||++......
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9999974 55554432111 12467788899999999999999999999999998754321
Q ss_pred cccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
....++..|+|||++. ...++.++||||||+++|||++|+.|+...... ........ ..
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~-~~--------- 230 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQ-ND--------- 230 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhc-CC---------
Confidence 2346788999999884 356889999999999999999999997422110 00011000 00
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
............+.+++.+||+.+|++||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=264.29 Aligned_cols=241 Identities=23% Similarity=0.269 Sum_probs=178.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~ 164 (387)
++|+..+.||.|++|.||++.... ++.+|+|.+..... .....+.+|++++++++||||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 357788999999999999999865 78899998864422 3456788999999999999999999998654 4689999
Q ss_pred EecCCCCcchhhcCCc---c-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPT---K-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~---~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+++++|.+++.... . ..++|..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 9999999987754211 0 124677788999999999999999999999999987543221
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||.................. ....... ....
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~-- 232 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPEL-KDEP-- 232 (287)
T ss_pred ---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhh-ccCC--
Confidence 12345778899999999889999999999999999999999998654221111111111110 1000000 0000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+..+.+++.+||+.+|++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123567889999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=269.75 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=178.9
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC--
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK-- 157 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~-- 157 (387)
.++..+.++|.+.+.||+|+||.||++.... ++.+|+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 4455567889999999999999999999764 7889999886432 2335677899999998 899999999998754
Q ss_pred ---CceEEEEEecCCCCcchhhcCC---cc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeecc
Q 041766 158 ---DEKILIYEYMPNKSLDFFLFDP---TK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFG 214 (387)
Q Consensus 158 ---~~~~lv~e~~~~g~L~~~l~~~---~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg 214 (387)
+..++||||+++++|..++... .. ...+|..+++|+||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 3579999999999998876421 11 124677788999999999999999999999999
Q ss_pred CceecCCCCcccccccccCCCccccccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAIQG-----IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||...... .. ....
T Consensus 174 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~----~~~~- 245 (291)
T cd06639 174 VSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KT----LFKI- 245 (291)
T ss_pred cchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HH----HHHH-
Confidence 98765432211 2234678899999998643 3689999999999999999999997532111 00 0010
Q ss_pred hcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...... .+. ........+.+++.+||+.+|++||++.++++.
T Consensus 246 ~~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPP-----TLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCC-----CCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000000 000 112234568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=267.39 Aligned_cols=245 Identities=20% Similarity=0.252 Sum_probs=177.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc-----cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+|+..+.||+|+||.||+|.... ++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 47778899999999999999764 889999998654322 234567899999999999999999999998899999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+ +++|..++...... ..+|..+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 88998888654311 246777889999999999999999999999999987643221
Q ss_pred ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC---------cccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN---------RTLE 296 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 296 (387)
......++..|+|||.+.+ ..++.++|||||||++|||++|.+||..... .............. ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhcccccc
Confidence 1222356778999998865 4578999999999999999999766543221 11111111110000 0000
Q ss_pred cccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 LIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 ~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......... ........+.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 112235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=263.04 Aligned_cols=231 Identities=22% Similarity=0.358 Sum_probs=178.6
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||+|+||.||++.... ++.+|+|.+... .......+..|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47788999999999999999754 788999998643 233456788999999999999999999999988999999999
Q ss_pred cCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
+++++|.+++...... ..+|..+++|+||+|+||+++.+ +.+||+|||.+....... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence 9999999888653211 24677788999999999999855 458999999998764332 1
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... . ........ .... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~---~~~~~~~~-~~~~----------~ 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--A---LVLKIMSG-TFAP----------I 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--H---HHHHHHhc-CCCC----------C
Confidence 22346788999999999888999999999999999999999997432211 1 11110000 0000 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=270.26 Aligned_cols=231 Identities=20% Similarity=0.287 Sum_probs=186.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+-|...+.||+|.|..|-+|++- .|+.||||++.+. +......+.+|++.|+-++|||||++|.+....-.+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456788899999999999999855 4999999999754 3444567889999999999999999999998888999999
Q ss_pred EecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEE-cCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILL-DKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|+-.+|+|.+|+-.+... .+.|..+.+||||||+||.+ ..-|-+||+|||++..+....
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999998665432 13566677899999999976 556899999999997654332
Q ss_pred ccccccCCCccccccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
...+.||++.|-|||++.|..|+ +++||||||||||-|+.|+.||....+.. .+-.++.-.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------------TLTmImDCK 235 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------------TLTMIMDCK 235 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------------------hhhhhhccc
Confidence 34567999999999999999996 67999999999999999999986433221 111111111
Q ss_pred c-ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 306 Y-SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 306 ~-~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+ .+.....+..+||..||..||.+|.+.++|+..
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1 355667788999999999999999999999863
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=264.39 Aligned_cols=233 Identities=21% Similarity=0.362 Sum_probs=180.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+-|+..+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 346778899999999999998754 7889999886432 23446788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++++|..++..... ...+|..+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTF 161 (277)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccc
Confidence 999999888754321 1246777889999999999999999999999999876543221 12234
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++|+|||||++|+|++|..|+...... ...... ..... +. .....
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~-----~~-----~~~~~ 225 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFLI-PKNNP-----PT-----LEGNY 225 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHHH-hcCCC-----CC-----CCccc
Confidence 6788999999998888999999999999999999999997432211 011110 00000 00 11223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+..+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=286.24 Aligned_cols=252 Identities=18% Similarity=0.210 Sum_probs=171.0
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC--CCEEEEE------------------EccCCCcccHHHHHHHHHHHHhcCC
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVK------------------RLPGRSGQGLREMKNEASVIAKVQH 144 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h 144 (387)
....++|++.+.||+|+||.||++.++. +...+.| .+. ........+.+|+.+|.+++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence 4456789999999999999999987643 2222222 111 112234567899999999999
Q ss_pred CceeeeeeeEEeCCceEEEEEecCCCCcchhhcCCc---------------------cccccchhhhhhcccCCCceEEc
Q 041766 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPT---------------------KRMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 145 ~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~h~dlk~~Nill~ 203 (387)
||||++++++...+..|+++|++.+ +|..++.... ...++|..+++||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 9999999999999999999999854 5544443211 01247778899999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC-Cc-chH
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRT-DS-LTL 281 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~-~~-~~~ 281 (387)
.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..++..... .. ..+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987643321 122345789999999999999999999999999999999998764322221 11 111
Q ss_pred hHHHHHHh-hcCccc-------ccccc--------ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 282 LGYAWDLW-TSNRTL-------ELIDP--------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 282 ~~~~~~~~-~~~~~~-------~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........ ...... +.+.. .+............+.+++.+||+.||++|||+.|++..
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110000 000000 00000 000000001123456788999999999999999999873
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=267.27 Aligned_cols=246 Identities=22% Similarity=0.260 Sum_probs=175.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|+..+.||+|+||.||+|.... ++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 578889999999999999999764 7899999986432 22234567899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++...... .++|..+++|+||||+||+++.++.+||+|||+++....... ...
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~ 161 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYS 161 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--ccc
Confidence 975 887776543221 246778889999999999999999999999999875432211 112
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc------------c
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL------------E 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------~ 296 (387)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+......... .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 2346788999999875 458999999999999999999999985433111 1111111111000000 0
Q ss_pred ccc-----cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LID-----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... ..+............+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 000000000011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=264.98 Aligned_cols=235 Identities=25% Similarity=0.370 Sum_probs=178.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~------ 158 (387)
..++|++.+.||+|+||.||+|.... ++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45889999999999999999999864 77899998865433 346788999999999 7999999999997654
Q ss_pred ceEEEEEecCCCCcchhhcCCc---c-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 159 EKILIYEYMPNKSLDFFLFDPT---K-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~---~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
..++||||+++++|.+++.... . ...+|..+++|+||+|+||+++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 3799999999999988775422 1 1246778889999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||....... . ..... ...
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~~~~~-~~~ 234 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-A----LFKIP-RNP 234 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-H----HHHhh-ccC
Confidence 54322 12233568889999998853 347889999999999999999999975321110 0 00100 000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+ ...........+.+++.+||..||++|||+.++++
T Consensus 235 -----~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 -----PP---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----CC---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 01112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=265.23 Aligned_cols=232 Identities=21% Similarity=0.329 Sum_probs=170.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHH-HHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||++.... |..||+|.++... ......+..|..+ ++..+||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 368888999999999999999775 8899999986542 2233456667765 455689999999999999999999999
Q ss_pred ecCCCCcchhhcCCc---c-----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 166 YMPNKSLDFFLFDPT---K-----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~---~-----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
|++ |+|..++.... . ...+|.. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 57766654311 0 1235654 78999999999999999999999999987653221
Q ss_pred ccccccccCCCcccccccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||......... ....... ..+
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~------~~~ 226 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ----LKQVVEE------PSP 226 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH----HHHHHhc------CCC
Confidence 1122467889999998865 45789999999999999999999997432211110 0000000 000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.......+..+.+++.+||+.+|++|||+.++++
T Consensus 227 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 ----QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011223557889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=260.48 Aligned_cols=237 Identities=21% Similarity=0.361 Sum_probs=180.1
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999864 48899999886432 1134678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||+++++|.+++..... ...+|..+++|+||+|+||+++.++ .+||+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999988754321 1246778889999999999998775 5999999998766432111
Q ss_pred --cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 226 --ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 226 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.......++..|+|||.+.+..++.++||||+|+++|+|++|..||....... .......... ...
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~----------~~~ 228 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIAS----------ATT 228 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhc----------cCC
Confidence 11223467889999999988889999999999999999999999975332211 1111111000 000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+......+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11123345567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=268.63 Aligned_cols=228 Identities=24% Similarity=0.311 Sum_probs=178.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||++.... ++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367888999999999999999765 789999988643 2234467889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++++|.+++..... ...+|..+++|+||+|+|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999888754322 12467788899999999999999999999999999865433 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .. ......... .. .+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~----~~~~~~~~~------~~-----~~ 218 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQ----IYEKILEGK------VR-----FP 218 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH----HHHHHhcCC------cc-----CC
Confidence 334688999999999888899999999999999999999999753221 00 011000000 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
......+.+++.+||+.||.+|| +++++++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 12245788999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=270.75 Aligned_cols=235 Identities=20% Similarity=0.235 Sum_probs=179.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|+..+.||+|+||.||+|.... +..||+|.+..... .....+..|++++..++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999775 88999999865432 24457889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-
Q 041766 165 EYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ- 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 225 (387)
||+.+++|.+++..... ..++|..+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999988764321 12467778899999999999999999999999998754321100
Q ss_pred --------------------------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 041766 226 --------------------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL 279 (387)
Q Consensus 226 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~ 279 (387)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~- 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE- 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH-
Confidence 01123467889999999998889999999999999999999999975332111
Q ss_pred hHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 041766 280 TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT----MNEVVS 338 (387)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt----~~~v~~ 338 (387)
...... ....... .....+..+.+++.+||+.||++||| +++++.
T Consensus 240 ----~~~~~~---------~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ----TFSNIL---------KKEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----HHHHHh---------cCCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 000100 0000000 11114567899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=280.51 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=183.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------ceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------EKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------~~~ 161 (387)
.+...+.||+|+||.||+|+.+. |+.||||.++.. .....+.+.+|+++|++++|+|||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34566889999999999999765 999999999754 3455678899999999999999999999876543 468
Q ss_pred EEEEecCCCCcchhhcCCccc-------------------cccchhhhhhcccCCCceEEc--CCC--CeEEeeccCcee
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-------------------MLLDWSANYSSRLKVSNILLD--KDI--NPKISDFGMARI 218 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-------------------~~l~~~~~~h~dlk~~Nill~--~~~--~~kl~Dfg~a~~ 218 (387)
+|||||.+|+|...+.+.... .+|+..+++||||||.||++- .+| -.||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999999765432 257888999999999999983 323 379999999999
Q ss_pred cCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC--ccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN--RTL 295 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 295 (387)
+.++. ......||..|.+||.+.. ..|+..+|.|||||++||++||..||..+....... ...|...... ...
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITKKPSGVA 249 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhccCCCcee
Confidence 87665 4566899999999999984 788999999999999999999999997665542111 1112111111 111
Q ss_pred ccccccccccc-----------ccHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHhhhhh
Q 041766 296 ELIDPILEDEY-----------SSKHMLLRYVNIALLCVQESADDRP--TMNEVVSMLTDEA 344 (387)
Q Consensus 296 ~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~dP~~RP--t~~~v~~~L~~~~ 344 (387)
-...+...++. ........+...+..++..+|++|- .+.+....+.++.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 11111111100 1223344566777788888888887 5555555544443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=261.24 Aligned_cols=236 Identities=24% Similarity=0.330 Sum_probs=185.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|++|.||++.... ++.|++|.+..... .....+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 357888999999999999999876 88999999875543 4457899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|..++..... ...+|. .+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence 999999988864321 124787 88999999999999999999999999999876433221 12
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ......... ..... + . ...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~-~~~~~-----~----~-~~~ 225 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAI-CDGPP-----P----S-LPA 225 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHH-hcCCC-----C----C-CCc
Confidence 346788999999998888999999999999999999999997543320 111111110 00000 0 0 111
Q ss_pred H-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 310 H-MLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 310 ~-~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .+..+.+++.+||+.+|++|||+.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 45678999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=260.77 Aligned_cols=236 Identities=25% Similarity=0.409 Sum_probs=181.1
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||+|+||.||+|... ++..|++|.+..... .....+..|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999976 478999999875543 3567889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc--c
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN--T 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--~ 228 (387)
+++++|.+++..... ...+|..+++|+||+|+||++++++.+||+|||++........... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999999988865421 1246777889999999999999999999999999887643322111 1
Q ss_pred ccccCCCccccccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~---~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||....... ........ . . .+.+.
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~-~----~~~~~-- 228 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGA-G-H----KPPIP-- 228 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhc-C-C----CCCCC--
Confidence 2346788999999998766 8899999999999999999999985332111 01111000 0 0 00010
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........+.+++.+||+.+|++|||+.+++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 -DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11122456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=265.82 Aligned_cols=244 Identities=20% Similarity=0.274 Sum_probs=174.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|+..+.||.|+||.||+|+... ++.||||.+.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47788999999999999999764 8899999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+. ++|..++..... ..++|..+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence 96 577776643221 1246777889999999999999999999999999875532211 12
Q ss_pred ccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc------------c
Q 041766 229 SRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT------------L 295 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~ 295 (387)
....++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ ..... ........ .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIF-RTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH-HHhCCCChhhhhhhhHHHHHH
Confidence 2235678899999887654 68899999999999999999999754322111 11100 00000000 0
Q ss_pred ccccccccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ELIDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+........ ........+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 01122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=252.76 Aligned_cols=234 Identities=24% Similarity=0.363 Sum_probs=175.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+..+.+..||.|+.|.|++++++. |...|||.+... .....++++..++++.+.+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345567789999999999999886 788999999755 4455677888888888774 8999999999999999999999
Q ss_pred ecCCCCcchhhcCCcccc------------------ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTKRM------------------LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~~------------------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
.| ..+++.++.+..... +-+..+++|||+||+|||+|+.|++||||||++..+-+...
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 87 335555554332211 12234568999999999999999999999999977654332
Q ss_pred cccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.+...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.....+-. ....+.+ ...+.+..
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~ltkvln---------~ePP~L~~ 317 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLTKVLN---------EEPPLLPG 317 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHHHHHh---------cCCCCCCc
Confidence 333467889999999963 4589999999999999999999999754332211 1111111 11122222
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. ..+++.+++++..||..|+.+||...++++.
T Consensus 318 ~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 H---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c---cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1256789999999999999999999998874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=259.58 Aligned_cols=232 Identities=24% Similarity=0.332 Sum_probs=178.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv~ 164 (387)
+|++.+.||.|+||.||++.... +..||+|.+... .....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999998664 788999988643 33445678889999999999999999998764 34578999
Q ss_pred EecCCCCcchhhcCCc---c-----------------ccccc-----hhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 165 EYMPNKSLDFFLFDPT---K-----------------RMLLD-----WSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~---~-----------------~~~l~-----~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
||+++++|..++.... . ...+| ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999988875421 0 02356 667899999999999999999999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ... .. ........
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~---~~-~~~~~~~~----- 227 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQ---LA-SKIKEGKF----- 227 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHH---HH-HHHhcCCC-----
Confidence 54322 1223468899999999998889999999999999999999999975432 111 11 11111100
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+ ..+......+.+++.+||+.+|++|||+.+|++.
T Consensus 228 ~-----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 R-----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 1122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=264.67 Aligned_cols=233 Identities=23% Similarity=0.311 Sum_probs=179.5
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.|...+.||+|++|.||++... .+..+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4555679999999999999965 478899998865544455678899999999999999999999999999999999999
Q ss_pred CCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 169 NKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 169 ~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
+++|.+++..... ...+|..+++|+||+|+||+++.++.++|+|||.+....... .......|
T Consensus 100 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~ 177 (285)
T cd06648 100 GGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVG 177 (285)
T ss_pred CCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccC
Confidence 9999988765221 124677888999999999999999999999999887543221 11223468
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
+..|+|||.+.+..++.++||||||+++|||++|+.||..... .. ..... .... .+... .....+.
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--~~---~~~~~-~~~~-----~~~~~---~~~~~~~ 243 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--LQ---AMKRI-RDNL-----PPKLK---NLHKVSP 243 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--HH---HHHHH-HhcC-----CCCCc---ccccCCH
Confidence 8899999999888899999999999999999999999743211 11 11110 0000 01111 1112345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 314 RYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+.+++.+||+.+|++|||+.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 7899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=262.51 Aligned_cols=246 Identities=21% Similarity=0.263 Sum_probs=179.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 47788999999999999999764 8899999986543 33456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+ +++|..++..... ...+|..+++|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYS 158 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Cccc
Confidence 9 9999888754321 1246777889999999999999999999999999886643321 1123
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc------------ccc
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR------------TLE 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 296 (387)
...++..|+|||.+.+. .++.++||||||+++|||++|.+||..... ............... ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 34688899999998654 468999999999999999999766543221 111111111110000 000
Q ss_pred ccccccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 LIDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 ~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...+..... .........+.+++.+||+.+|++|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0011234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=264.02 Aligned_cols=245 Identities=21% Similarity=0.285 Sum_probs=177.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv 163 (387)
++|+..+.||.|+||.||+|.... +..+|+|.++... ......+.+|+.++.+++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 578889999999999999999875 7889999986432 22234567899999999999999999999887 789999
Q ss_pred EEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++ +|..++..... ..++|..+++|+||||+||+++.++.+||+|||++....... .
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--K 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--c
Confidence 999974 88776654322 124778888999999999999999999999999998765432 1
Q ss_pred ccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH-----------HHHhhc---
Q 041766 227 NTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-----------WDLWTS--- 291 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~-----------~~~~~~--- 291 (387)
......++..|+|||.+.+. .++.++||||||+++|||++|..||...... ...... |..+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHhhccch
Confidence 12234568889999998764 4689999999999999999999997543221 111100 000000
Q ss_pred ---CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 292 ---NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 292 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..........+............+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000001111111113566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=264.16 Aligned_cols=237 Identities=23% Similarity=0.352 Sum_probs=184.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
...+.|+..+.||+|+||.||++.+. ++..|++|.+..... ....+.+|++.+++++|+||+++++.+...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888999999999999999987 488899999975443 4567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCc-c----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPT-K----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~-~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++++|.+++.... . ...+|..+++|+||+|+||+++.++.+||+|||++........ .
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 172 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K 172 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence 9999999999887653 1 1246777889999999999999999999999998865433211 1
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... . .... ..... .....
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~---~~~~-~~~~~--------~~~~~ 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--A---LFLI-TTKGI--------PPLKN 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--H---HHHH-HhcCC--------CCCcc
Confidence 223457789999999988889999999999999999999999974322110 0 0000 00000 00001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+++.+||+.+|.+|||+.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 12245678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=265.86 Aligned_cols=248 Identities=22% Similarity=0.280 Sum_probs=175.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 161 (387)
..++|+..+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++.+++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34679999999999999999999765 8899999886432 22223566899999999999999999998765 4679
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+.+ +|..++..... ...+|..+++|+||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999965 67666654221 1246778889999999999999999999999999987653321
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC--cc-------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN--RT------- 294 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~------- 294 (387)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .............. ..
T Consensus 164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 164 --PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred --CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchhhhcc
Confidence 1122345778999999875 4589999999999999999999999753221 11111111110000 00
Q ss_pred --ccccc--c-cccc-ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 295 --LELID--P-ILED-EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 295 --~~~~~--~-~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..... . .... ..........+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0 0000 00011135567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=265.09 Aligned_cols=233 Identities=24% Similarity=0.374 Sum_probs=175.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..|...+.||+|+||.||+++... +..||+|.+.... ......+.+|++++++++|||++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 347788899999999999999764 7889999986432 233457888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++ +|.+++..... ...+|..+++|+||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 66555532211 1246778889999999999999999999999999865432
Q ss_pred cccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||...... . .......... .
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~---~~~~~~~~~~----------~ 242 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S---ALYHIAQNES----------P 242 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--H---HHHHHHhccC----------C
Confidence 22346788999999974 456899999999999999999999997432111 0 0001000000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..........+.+++.+||+.+|.+||++.++++.+.-.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 011223345688999999999999999999999865544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.16 Aligned_cols=232 Identities=21% Similarity=0.294 Sum_probs=189.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
-...|.+...||+|.|+.|.+|++.. +..||||.+.+. +...++.+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34678899999999999999999765 889999998755 233445688999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+.+|.+.+++..... ..++|...++|||||++|+||+.+.++||+|||++..+... ..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~ 210 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LM 210 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc---cc
Confidence 999999999999865432 13578888999999999999999999999999999887533 23
Q ss_pred cccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
..+++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||+. ....++-.+.+...+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG------------------~~lk~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG------------------QNLKELRPRVLRGKY 272 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC------------------cccccccchheeeee
Confidence 456799999999999999887 5889999999999999999999742 222222222222222
Q ss_pred c-cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 S-SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~-~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. +..+.....++++++|..+|.+|++.+++.+.
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 12223456689999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=265.74 Aligned_cols=245 Identities=15% Similarity=0.152 Sum_probs=165.8
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCC----CEEEEEEccCCCcccH-----------HHHHHHHHHHHhcCCCceeeee
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKG----DEIAVKRLPGRSGQGL-----------REMKNEASVIAKVQHKNLVRLL 151 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~~~ 151 (387)
..++|++.+.||+|+||.||+|.+.++ ..+|+|.......... .....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997653 3456665432221110 0112233445567899999999
Q ss_pred eeEEeCC----ceEEEEEecCCCCcchhhcCCc---c-------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 152 GCCIDKD----EKILIYEYMPNKSLDFFLFDPT---K-------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 152 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~---~-------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
+++.... ..++++|++.. ++...+.... . ...+|..+++||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 9776543 34678887643 4444433211 0 125778888999999999999999999999
Q ss_pred eccCceecCCCCcc-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH
Q 041766 212 DFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286 (387)
Q Consensus 212 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~ 286 (387)
|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||...............
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 99999866422211 1122346899999999999999999999999999999999999998654322211110000
Q ss_pred HHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.. +............++..+.+++..||+.+|++||++.++.+.|+
T Consensus 249 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 249 DF---------IKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HH---------HHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 00 00000111111223467889999999999999999999998763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=261.68 Aligned_cols=231 Identities=21% Similarity=0.265 Sum_probs=180.5
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+|++.+.||.|+||.||++.... +..||+|.+.... ......+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999874 8899999986432 2345688899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+++++|..++..... ...+|..+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 9999999888765411 124677888999999999999999999999999987654332 122
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
...|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........... .....+.
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----------~~~~~~~ 223 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET-----------ADVLYPA 223 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc-----------ccccCcc
Confidence 346788999999998888999999999999999999999997544322 01111111000 0011122
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 041766 310 HMLLRYVNIALLCVQESADDRPTM--NEVV 337 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~--~~v~ 337 (387)
..+..+.+++.+||+.||.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 334678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.95 Aligned_cols=248 Identities=21% Similarity=0.248 Sum_probs=177.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 157 (387)
..++|+..+.||+|+||.||+|.... +..||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999999764 889999998642 233445677899999999999999999988643
Q ss_pred CceEEEEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
...|+||||+.+ +|...+..... ...+|..+++|+||||+||+++.++.+||+|||+++......
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 346999999965 66665532211 124677888999999999999999999999999998754322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH-----------------H
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-----------------W 286 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~-----------------~ 286 (387)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ...... .
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 173 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhh
Confidence 1 223467889999999999999999999999999999999999985432110 000000 0
Q ss_pred HHhhcCcc-------cccccccccc---ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 287 DLWTSNRT-------LELIDPILED---EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 287 ~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+..... .+........ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000000000 00012235567899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=300.39 Aligned_cols=237 Identities=23% Similarity=0.325 Sum_probs=186.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+-+++...+||.|.||.||.|...+ |+..|+|-+...+ ......+.+|+.+|..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3466778899999999999999554 8889999876442 334456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc--c
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ--A 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~ 226 (387)
|||.+|+|.+.+..... ...+|..+++||||||+||+|+.+|.+|++|||.|.....+... .
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 99999999998866532 23589999999999999999999999999999999887654211 1
Q ss_pred ccccccCCCccccccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
......||+.|||||++.+.. ...++||||+||+..||+||+.||...+.+-... +.+.. . .
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM----y~V~~-g----------h 1458 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM----YHVAA-G----------H 1458 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH----hHHhc-c----------C
Confidence 223468999999999997643 4678999999999999999999986544332111 11100 0 1
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+..+...+..-.+++..||+.||+.|-++.|+++.
T Consensus 1459 ~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111233366677899999999999999988888764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=263.12 Aligned_cols=236 Identities=25% Similarity=0.387 Sum_probs=172.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|+..+.||+|+||.||++.... +..||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 456677899999999999999765 7899999986432 234567889999999995 9999999999999889999999
Q ss_pred ecCCCCcchhhc---CCc-c-----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 166 YMPNKSLDFFLF---DPT-K-----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 166 ~~~~g~L~~~l~---~~~-~-----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|++. ++..+.. ... . ..++|. .+++|+||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9864 4433221 110 0 113444 378999999999999999999999999987553221
Q ss_pred cccccccccCCCccccccccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQG---IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..... ........... ..+
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~------~~~ 229 (288)
T cd06616 163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKG------DPP 229 (288)
T ss_pred ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCC------CCC
Confidence 11233678899999999766 689999999999999999999999753320 00111110000 001
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+... .....+..+.+++.+||+.||++|||+++|++.
T Consensus 230 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 112345678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=265.62 Aligned_cols=248 Identities=20% Similarity=0.269 Sum_probs=174.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcC---CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~ 161 (387)
+|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788899999999999999754 6889999987532 33446778899999999999999999999988 7889
Q ss_pred EEEEecCCCCcchhhcCCc---c------------------ccccchhhhhhcccCCCceEEcC----CCCeEEeeccCc
Q 041766 162 LIYEYMPNKSLDFFLFDPT---K------------------RMLLDWSANYSSRLKVSNILLDK----DINPKISDFGMA 216 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~---~------------------~~~l~~~~~~h~dlk~~Nill~~----~~~~kl~Dfg~a 216 (387)
+||||+++ +|..++.... . ..++|..+++|+||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 5544442211 0 12467778899999999999999 899999999999
Q ss_pred eecCCCCc-ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH-------hHHHHH
Q 041766 217 RICGGNEL-QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL-------LGYAWD 287 (387)
Q Consensus 217 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~-------~~~~~~ 287 (387)
........ ........++..|+|||.+.+. .++.++|||||||++|||++|..||.......... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 86543322 1122334678899999988764 58999999999999999999999986543332000 000000
Q ss_pred HhhcC------------ccccccccccccccc--------cH--HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 288 LWTSN------------RTLELIDPILEDEYS--------SK--HMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 288 ~~~~~------------~~~~~~~~~~~~~~~--------~~--~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+... ......+........ .. .....+.+++.+||+.||++|||+.++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 000000000000000 00 22346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=253.41 Aligned_cols=232 Identities=26% Similarity=0.431 Sum_probs=181.7
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.|...+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|+||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999987 478899999976554456788999999999999999999999999999999999999
Q ss_pred CCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++|.+++..... ...+|..+++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~ 157 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTM 157 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccce
Confidence 9999988765421 1246677789999999999999999999999999876643321 2345
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ..... ....... .. .....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~~-----~~---~~~~~ 223 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-----ALFKI-ATNGPPG-----LR---NPEKW 223 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHH-HhcCCCC-----cC---ccccc
Confidence 67889999999988889999999999999999999999975332111 00000 0000000 00 11112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 457889999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=254.68 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=173.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++.+.+..||.|+||+|++-.++. |+..|||++.... ..+..++..|.+...+- +.||||++||.+..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 456667889999999999999876 8899999997543 35667888898877665 78999999999999999999999
Q ss_pred ecCCCCcchhhcC---C-----ccc--------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 166 YMPNKSLDFFLFD---P-----TKR--------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 166 ~~~~g~L~~~l~~---~-----~~~--------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+|.- +|+.+-.. . ... .+-....+||||+||+|||++..|.+||||||++..+.+.-
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9943 55433211 0 000 11233567999999999999999999999999987664322
Q ss_pred cccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
..+.-.|-..|||||.+.. ..|+.++||||||++|||+.||+.|+..-.+ ..+......... .+.
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gd------pp~ 289 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGD------PPI 289 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCC------CCe
Confidence 1122356788999999963 3489999999999999999999999742211 111111111111 122
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+.......+....+..++..|+..|-++||...++.+.
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22222233467789999999999999999999998874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=255.76 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=191.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCccc---HHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
-++|..+++||+|.||+|.+++-+. ++.+|+|.+++..-.. ...-..|-++|...+||.+..+--.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678899999999999999999665 8899999997653222 23345688999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+.||.|..+|.+... ..++|...++.||||.+|.|+|.+|++||+|||+++.-- .+...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--cccce
Confidence 999999999887755321 236888888999999999999999999999999997532 22334
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc-c
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE-Y 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 306 (387)
..++|||+.|+|||++....|+.++|.|.+||++|||+.|+.||.....+ .++.-++-.+ .
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------------------kLFeLIl~ed~k 386 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------------------KLFELILMEDLK 386 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh------------------HHHHHHHhhhcc
Confidence 66789999999999999999999999999999999999999997432211 1111111111 1
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH--hh-----h-hhhccCCCCCCcee
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM--LT-----D-EAAALFPPKQPAFS 356 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~--L~-----~-~~~~~~~~~~~~~~ 356 (387)
.+....++...|+...|..||.+|. .+++|.+. +. . ....+.||-.|+..
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 3444566788899999999999995 34555442 11 1 12346777777644
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=267.77 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=178.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~ 160 (387)
.++|++.+.||+|+||.||+|.... ++.||+|.+... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999999764 889999998643 2334456888999999999999999999876543 47
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++++||+++ +|...+..... ...+|..+++|+||||+|||++.++.+||+|||++.........
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 899999965 77665543211 13478888999999999999999999999999999765432211
Q ss_pred c-ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc---ccccc
Q 041766 226 A-NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL---ELIDP 300 (387)
Q Consensus 226 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 300 (387)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ................. .....
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 1123467889999998765 4689999999999999999999999853221 11111111111100000 00000
Q ss_pred c-------c-cccc-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhh
Q 041766 301 I-------L-EDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEA 344 (387)
Q Consensus 301 ~-------~-~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~ 344 (387)
. . .... ........+.+++.+||+.||++|||+.++++. ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 0 0000 011224568899999999999999999999985 54443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=258.00 Aligned_cols=232 Identities=22% Similarity=0.304 Sum_probs=178.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|...+.||+|+||.||++..+. +..||+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47778899999999999999775 788999988543 223445778999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
+++++|..++..... ..++|..+++|+||||+||++++++ .+||+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~ 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence 999999888754321 1246777889999999999998875 469999999876543221 1
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....|+..|+|||++.+..++.++|+||||+++|||++|..||..... ........ ... ..+ .
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~----~~~------~ 222 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKIC-QGY----FAP------I 222 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh-ccc----CCC------C
Confidence 2234678899999999888899999999999999999999999743211 11111111 000 000 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=256.88 Aligned_cols=226 Identities=23% Similarity=0.262 Sum_probs=166.3
Q ss_pred cccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHH---hcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIA---KVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.||+|+||.||++.... +..+|+|.+.... ......+..|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999765 7899999886432 111223344443333 3479999999999999899999999999
Q ss_pred CCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 169 NKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 169 ~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
+|+|..++..... ...+|..+++|+||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 9999887754321 135777888999999999999999999999999987553221 12346
Q ss_pred CCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 233 GTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
|+..|+|||.+.+ ..++.++|||||||++|||++|..||........... .... .. .. ...+...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~-~~-----~~-----~~~~~~~ 222 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMT-LT-----VN-----VELPDSF 222 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH---HHHh-hc-----CC-----cCCcccc
Confidence 8999999999864 5689999999999999999999999854332211110 0000 00 00 0112234
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
+..+.+++.+||+.||++|| |++++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 56788999999999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.17 Aligned_cols=245 Identities=20% Similarity=0.235 Sum_probs=172.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCc-----
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE----- 159 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~----- 159 (387)
++|+..+.||+|+||.||+|.+.. ++.||+|.+.... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468888999999999999999764 8899999875432 22345788899999999 56999999999887665
Q ss_pred eEEEEEecCCCCcchhhcCCcc---------------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCce
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMAR 217 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~ 217 (387)
.|+||||+++ +|..++..... ..++|..+++|+||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999985 77766643211 12477788899999999999998 8899999999987
Q ss_pred ecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc-
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL- 295 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 295 (387)
....... ......++..|+|||++.+ ..++.++||||||+++|||++|..||....... ..... ..........
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~-~~~~~~~~~~~ 235 (295)
T cd07837 160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHI-FKLLGTPTEQV 235 (295)
T ss_pred ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH-HHHhCCCChhh
Confidence 6532211 1122356788999998865 457999999999999999999999875422111 11000 0000000000
Q ss_pred --cc---c----cccccc---ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 --EL---I----DPILED---EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 --~~---~----~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.. . .+.... ....+.....+.+++.+||+.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 000000 0011234567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=262.33 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=173.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 158 (387)
..++|+..+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34678999999999999999999764 8899999885432 222345678999999999999999999987654
Q ss_pred ---ceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 159 ---EKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 159 ---~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
..++||||+++ +|...+..... ...+|..+++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 34999999965 67666543321 1246778889999999999999999999999999976
Q ss_pred cCCCCcc--cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh-----
Q 041766 219 CGGNELQ--ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT----- 290 (387)
Q Consensus 219 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 290 (387)
....... .......++..|+|||.+.+. .++.++||||||+++|||++|..||...... ...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGSITPE 246 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChh
Confidence 5432211 112234577889999988764 4789999999999999999999887543221 11111111000
Q ss_pred ---cCcccccccc---------ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 291 ---SNRTLELIDP---------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 291 ---~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........+. ..............+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000 00000000011345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.33 Aligned_cols=226 Identities=24% Similarity=0.349 Sum_probs=170.6
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||+|+||+||++.... ++.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998664 8899999886431 22344667899999999999999999999999999999999999999
Q ss_pred chhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 173 DFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 173 ~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
.+++...... ..+|..+++|+||+|+||+++.++.+||+|||++....... ......++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCC
Confidence 8887553311 24677888999999999999999999999999987653211 12234577
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
..|+|||.+.+..++.++||||||+++|+|++|+.||......... .... . .. .. .....+......
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~-~----~~----~~---~~~~~~~~~~~~ 224 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELK-R----RT----LE---MAVEYPDKFSPE 224 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHH-h----cc----cc---ccccCCccCCHH
Confidence 8999999998888999999999999999999999997543321100 0000 0 00 00 000012223567
Q ss_pred HHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 315 YVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
+.+++.+||+.||++|| ++.++++
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 88999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=257.99 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=176.2
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEEEE
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIYE 165 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~e 165 (387)
|++.+.||.|+||.||+|...+ ++.+|+|.+.... ......+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999875 7889999997552 33446788999999999999999999999988 78999999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++ +|..++...... ..+|..+++|+||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADY 158 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccc
Confidence 9975 777776543211 246777789999999999999999999999999987654321 112
Q ss_pred ccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc------c-----
Q 041766 229 SRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL------E----- 296 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~----- 296 (387)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ................ .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhccccccchhhh
Confidence 22356788999998765 45799999999999999999999997543321 1111111110000000 0
Q ss_pred cc------ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LI------DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.. ...+... ....++..+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREF-FKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHH-hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000 00112567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=250.27 Aligned_cols=235 Identities=26% Similarity=0.394 Sum_probs=183.4
Q ss_pred CCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIY 164 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~ 164 (387)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999987 488999999865432 4467888999999999999999999999988 7899999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++++|.+++..... ...+|..+++|+||+|+||+++.++.+||+|||.+............
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99999999988765421 12467778899999999999999999999999999876544321112
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....+........ ...+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~----------~~~~ 226 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAALYKIGSSGEP----------PEIP 226 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHhccccCCC----------cCCC
Confidence 3356788999999998888999999999999999999999997544311 1111111000000 0112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+++.+||+.||++||++.+++.
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 223567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=261.85 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=176.8
Q ss_pred CCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 93 DANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
....||+|+||.||++... ++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3467999999999999876 488999999865544555678899999999999999999999999999999999999999
Q ss_pred cchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 172 LDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 172 L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
|..++..... ...+|..+++|+||+|+||+++.++.++|+|||++........ ......++..
T Consensus 104 L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 181 (292)
T cd06657 104 LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPY 181 (292)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCcc
Confidence 9887744321 1246777889999999999999999999999999876543221 1223467889
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV 316 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (387)
|+|||.+.+..++.++|+||||+++|||++|..||..... ......... ....... ........+.
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~---------~~~~~~~---~~~~~~~~l~ 247 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRD---------NLPPKLK---NLHKVSPSLK 247 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---------hCCcccC---CcccCCHHHH
Confidence 9999999888899999999999999999999999743211 110000000 0000110 1112344678
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 041766 317 NIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 317 ~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+++.+||+.+|.+||++.++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhc
Confidence 8999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=255.27 Aligned_cols=226 Identities=23% Similarity=0.299 Sum_probs=175.1
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||.|+||.||+++... +..||+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999875 8899999986432 23446788999999999999999999999999999999999999999
Q ss_pred chhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 173 DFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 173 ~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
.+++..... ...+|..+++|+||+|+||+++.++.+||+|||++....... ......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 988865322 124677788999999999999999999999999998764332 1223467889
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV 316 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (387)
|+|||.+.+..++.++|+||||+++|+|++|..||.....+... .......... ....+...+..+.
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~----------~~~~~~~~~~~~~ 224 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGNG----------KLEFPNYIDKAAK 224 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccCC----------CCCCCcccCHHHH
Confidence 99999998888999999999999999999999998544321111 1111110000 0001122256789
Q ss_pred HHHHhcccCCCCCCCC-----HHHHHH
Q 041766 317 NIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 317 ~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
+++.+||+.+|++||+ ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=263.54 Aligned_cols=244 Identities=19% Similarity=0.216 Sum_probs=171.2
Q ss_pred Cccccc--CCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEG--GFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
..||+| +||+||++++. .++.||+|.+... .....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999976 4899999998643 223446788899999999999999999999999999999999999
Q ss_pred CCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-----c
Q 041766 170 KSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-----A 226 (387)
Q Consensus 170 g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~ 226 (387)
++|..++..... ..++|..+++|+||||+|||++.++.+|++||+.+......... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 999888765321 12467778899999999999999999999999865332111100 0
Q ss_pred ccccccCCCccccccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH---------------HH-
Q 041766 227 NTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW---------------DL- 288 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~---------------~~- 288 (387)
......++..|+|||++.+. .++.++|||||||++|||++|+.||............... ..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 11112345679999999764 4789999999999999999999998543221111000000 00
Q ss_pred ------hhcCcc---------ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 289 ------WTSNRT---------LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 289 ------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...... .......+. ......+...+.+|+.+||+.||++|||++++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000 000000011 11233456788999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=267.10 Aligned_cols=251 Identities=18% Similarity=0.266 Sum_probs=178.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 159 (387)
.++|.+.+.||+|+||.||+++... +..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3578899999999999999999764 889999988643 223345677899999999999999999988754 24
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+++||+. ++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 799999996 577766644321 124777888999999999999999999999999998654322
Q ss_pred cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh-----------c
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT-----------S 291 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 291 (387)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ........... .
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 --DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred --ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCChHHhhhcCc
Confidence 11223467889999998865 46899999999999999999999997533211 11111111000 0
Q ss_pred Ccccccccccc---cc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 292 NRTLELIDPIL---ED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 292 ~~~~~~~~~~~---~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
......++... .. .......+..+.+++.+||+.+|++|||++++++. +...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000000 00 00112345678899999999999999999999976 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.21 Aligned_cols=231 Identities=26% Similarity=0.392 Sum_probs=173.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..|+..+.||+|+||.||+|+... +..||+|.+... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 447778899999999999999765 778999988532 2233456788999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+. |++...+..... ...+|..+++|+||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 9996 566655532211 1246777889999999999999999999999999876532
Q ss_pred cccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....++..|+|||.+. ...++.++|||||||++|||++|..|+...... ...... .... .+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~-~~~~-----~~---- 232 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHI-AQNE-----SP---- 232 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHH-hhcC-----CC----
Confidence 12346788999999975 356789999999999999999999986432111 000000 0000 00
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
..........+.+++.+||+.+|++||++.++++...
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0112234556889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=257.28 Aligned_cols=241 Identities=20% Similarity=0.256 Sum_probs=170.9
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCceeeeeeeEEeC--CceEEEEE
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIYE 165 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~~lv~e 165 (387)
|++.+.||+|+||.||+|.... +..||+|.+.... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5667889999999999999764 7889999886532 222234557899999885 99999999999987 78999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++ +|..++..... ...+|..+++|+||||+||+++. +.+||+|||++........ .
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~ 155 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---Y 155 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---c
Confidence 9975 66666643221 12467788899999999999999 9999999999986543221 1
Q ss_pred ccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh-----------hcCcccc
Q 041766 229 SRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW-----------TSNRTLE 296 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 296 (387)
....++..|+|||.+.. ..++.++|||||||++|||++|..||..... ........... .......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 22457889999998754 5578999999999999999999998754321 11111111100 0000000
Q ss_pred ccccc-ccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 LIDPI-LED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~~~~~-~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+. ... .......+..+.+++.+||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 000 0011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=262.53 Aligned_cols=227 Identities=26% Similarity=0.338 Sum_probs=180.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+.|..-++||+|+||.||-++.+. |+-+|.|++.+.. .......+.|-.+|.+++.+.||.+--.|+.++.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 457788899999999999999765 8889999885431 122345678999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
..|.||||..+|.+.... ..+|...++.|||||+|||+|+.|+++|+|+|+|..+.....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 999999999998775521 236667778899999999999999999999999998765432
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc-
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE- 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 305 (387)
....+||.+|||||++.++.|+..+|.|||||++|||+.|+.||..+. .....+-++.....+
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---------------eKvk~eEvdrr~~~~~ 406 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---------------EKVKREEVDRRTLEDP 406 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---------------hhhhHHHHHHHHhcch
Confidence 233489999999999999999999999999999999999999974322 122222223222211
Q ss_pred -cccHHHHHHHHHHHHhcccCCCCCCCCH
Q 041766 306 -YSSKHMLLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 306 -~~~~~~~~~~~~li~~cl~~dP~~RPt~ 333 (387)
.-++..++...+|....|+.||++|.-.
T Consensus 407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1245667788899999999999999743
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=257.84 Aligned_cols=230 Identities=20% Similarity=0.287 Sum_probs=174.8
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||.|+||.||+++... ++.+++|.+..... .....+.+|++++.+++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999876 88999999865432 3456788999999999999999999999999999999999999999
Q ss_pred chhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc------cccccc
Q 041766 173 DFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL------QANTSR 230 (387)
Q Consensus 173 ~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~ 230 (387)
..++..... ...+|..+++|+||+|+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 888765321 1246778889999999999999999999999999875432211 112233
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..++..|+|||.+.+..++.++||||||+++|||++|..||...... ........ ... ... ....
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~--------~~~-~~~~ 225 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILN-GKI--------EWP-EDVE 225 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc-CCc--------CCC-cccc
Confidence 46788999999998888999999999999999999999997533211 11111100 000 000 0001
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 2567889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=266.52 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=177.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC--Cce
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~--~~~ 160 (387)
..++|++.+.||+|+||.||+|.... +..+|+|++... .......+.+|+.++.++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 45789999999999999999999764 788999988532 223345677899999999 999999999998654 357
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||||++ ++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 85 YLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEEecccc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999997 488776654211 12467788899999999999999999999999999865433211
Q ss_pred ---cccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH-----------hh
Q 041766 226 ---ANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL-----------WT 290 (387)
Q Consensus 226 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~ 290 (387)
.......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........ ..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHHH
Confidence 12223467889999998865 457899999999999999999999975332211 00000000 00
Q ss_pred cCccccccccccccc-----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 291 SNRTLELIDPILEDE-----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......++...... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000111000000 0011135678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.45 Aligned_cols=244 Identities=17% Similarity=0.167 Sum_probs=170.6
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
.+.+|.|+++.|+++.. +++.||+|++... .......+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34444555555555444 4889999998644 34455689999999999999999999999999999999999999999
Q ss_pred cchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-----cccc
Q 041766 172 LDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL-----QANT 228 (387)
Q Consensus 172 L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~~~~ 228 (387)
|..++..... ..++|..+++|+||||+||+++.++.+||+|||.+........ ....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 9888764321 1246778889999999999999999999999998875532211 1112
Q ss_pred ccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh----h-------cCccc
Q 041766 229 SRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW----T-------SNRTL 295 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~-------~~~~~ 295 (387)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ....... . .....
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL-EKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCccccccCchhhhcCCcC
Confidence 23456778999999876 358899999999999999999999986432211110 0000000 0 00000
Q ss_pred c----cccccc---ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 E----LIDPIL---EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ~----~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. ...+.. ............+.+++.+||+.||++|||++++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000000 0011123345678899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=263.84 Aligned_cols=247 Identities=17% Similarity=0.267 Sum_probs=177.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~ 161 (387)
++|++.+.||+|+||.||+|.... +..||+|++.... ......+.+|+.+|++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 678899999999999999999765 8899999986432 2345677889999999999999999998764 34679
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+||||+. ++|..++..... ..++|..+++|+||||+||++++++.+||+|||++.........
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999995 588777754322 12477888899999999999999999999999999765432211
Q ss_pred --cccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc------
Q 041766 226 --ANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE------ 296 (387)
Q Consensus 226 --~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 296 (387)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......... ......+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~-~g~~~~~~~~~~~ 240 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSV-LGSPSEEVLNRIG 240 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHH-hCCChhHhhhhhc
Confidence 11123468889999999865 45899999999999999999999998543211 111110000 0000000
Q ss_pred ------cccccccc-cc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 ------LIDPILED-EY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 ------~~~~~~~~-~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+..... .. .....+..+.+++.+||+.+|++|||+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 00 012235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=256.67 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=175.8
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+|+..+.||.|++|.||+|+... +..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47888999999999999999865 8889999986542 233456778999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 168 PNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 168 ~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
++ +|..++..... ...+|..+++|+||||+||++++++.+||+|||++........ ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cc
Confidence 85 77776644221 1246777789999999999999999999999999875432211 12
Q ss_pred ccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--------ccccc
Q 041766 229 SRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT--------LELID 299 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 299 (387)
....++..|++||.+.+. .++.++||||||+++|||++|+.||...... ............... .....
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 234567889999998664 4789999999999999999999997543221 111111110000000 00000
Q ss_pred cccc---c---ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILE---D---EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~---~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.... . .......+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0 0001223457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=256.78 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=177.4
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
|+..+.||+|++|.||++.... ++.+++|.+..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 5667899999999999999764 88899999865422 24567888999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
++ +|..++...... ..+|..+++|+||||+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccC
Confidence 75 777666543211 24677888999999999999999999999999998765432 11222
Q ss_pred ccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc---cccccc-------
Q 041766 231 IVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR---TLELID------- 299 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------- 299 (387)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... ............... ......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 4577889999999876 789999999999999999999988743321 111000000000000 000000
Q ss_pred --c---ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 --P---ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 --~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+ ...........+..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000012335678899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=252.26 Aligned_cols=233 Identities=21% Similarity=0.232 Sum_probs=172.8
Q ss_pred hhHHHHhcCCCCCCcc--cccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 82 SSVSTATNKFSDANKL--GEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~l--G~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
.+.....++|++.+.+ |+|+||.||+++.+. +..+|+|.+........ |......+ +||||+++++.+...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 3344455677777776 999999999999765 77899998864322111 22222222 799999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICG 220 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 220 (387)
+..++||||+++++|..++..... ...+|..+++|+||||+||+++.++ .++|+|||+++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999999988865421 1246777889999999999999988 99999999987654
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.. ....++..|+|||++.+..++.++||||||+++|||++|+.||............+.... .
T Consensus 162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-------- 224 (267)
T PHA03390 162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q-------- 224 (267)
T ss_pred CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---c--------
Confidence 22 223678899999999988999999999999999999999999863332221111111110 0
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPT-MNEVVS 338 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~~v~~ 338 (387)
.........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 --KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000112234567899999999999999996 688875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=256.76 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=174.2
Q ss_pred CCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
|+..+.||.|++|.||+|... +|..||+|++.... ......+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999976 48899999886432 223356888999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+ ++|..++..... ...+|..+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccC
Confidence 5 578877754331 1246777889999999999999999999999999875432211 112
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC--------ccccc---
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN--------RTLEL--- 297 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--- 297 (387)
...++..|+|||++.+. .++.++||||||+++|||++|+.||....... ............. ...+.
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 23567889999988764 57899999999999999999999975432211 1111100000000 00000
Q ss_pred ccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+...... .......+..+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0011123357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.24 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=173.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|+..+.||+|++|.||+|.... ++.||+|.+.... ......+..|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468888999999999999999764 8899999886432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecCCCCccc
Q 041766 166 YMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|+++ +|..++..... ...+|..+++|+||+|+||+++. ++.+||+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~ 158 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--R 158 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--c
Confidence 9964 66555533211 12467778899999999999985 5679999999997543221 1
Q ss_pred ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--c-------cc
Q 041766 227 NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--T-------LE 296 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------~~ 296 (387)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .... ......... . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFK-IFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHhCCCChhhccccccchh
Confidence 1123356789999999876 457899999999999999999999975432211 1000 000000000 0 00
Q ss_pred c--cccccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 L--IDPILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~--~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. ..+..... .........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000000 001223456889999999999999999999987
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=251.36 Aligned_cols=231 Identities=24% Similarity=0.382 Sum_probs=181.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|++.+.||+|++|.||++.... ++.|++|.+..... .....+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47788999999999999998764 78899999975543 4556889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+++++|.+++..... ...+|..+++|+||+|+||+++.++.+||+|||.+......... ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence 999999888754322 12467788899999999999999999999999999876543221 233
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ....+.... ... +. .+..
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-----~~-----~~~~ 222 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIVQ-DDH-----PP-----LPEG 222 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc-cCC-----CC-----CCCC
Confidence 4678899999999887889999999999999999999999753221 011111100 000 00 1122
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+.+++.+||..+|++|||+.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 3457889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=253.31 Aligned_cols=232 Identities=22% Similarity=0.345 Sum_probs=181.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|...+.||.|+||.||++.... +..+++|.+.... ......+.+|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 47788899999999999999764 8899999986543 24556788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCc---c-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 167 MPNKSLDFFLFDPT---K-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~---~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+++++|..++.... . ...+|..+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence 99999988886532 1 124677788999999999999999999999999998764432 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ....... ..... .+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~----~~------ 222 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKI-LKGQY----PP------ 222 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHH-hcCCC----CC------
Confidence 22334678899999999888899999999999999999999999743321 1111111 00000 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+......+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=256.75 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=176.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 158 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---- 158 (387)
...++|++.+.||+|+||.||+|..+. ++.||+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 455789999999999999999999875 7899999986432 233356778999999999999999999987654
Q ss_pred ------ceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 159 ------EKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 159 ------~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
..++|+||+++ ++...+..... ..++|..+++|+||||+||++++++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 68999999986 55454443211 1247788889999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
+........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... .................
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCh
Confidence 986543321 11122345778999998865 357899999999999999999998875322 11111111111111000
Q ss_pred ---cccc--------c------cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 ---LELI--------D------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ---~~~~--------~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.... + ..... .....+..+.+++.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLRE--EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhh--hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0 00000 01123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=254.56 Aligned_cols=228 Identities=21% Similarity=0.227 Sum_probs=168.6
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHH-hcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|.... ++.||+|.+..... .....+..|..++. ..+|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999764 88999999864321 12233445555544 45899999999999999999999999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
++|..++..... ..++|..+++|+||+|+||+++.++.+||+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999988854322 1246777889999999999999999999999999875432 223467
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
+..|+|||.+.+..++.++||||||+++|||++|..||..... .. . +......... . .......++.
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~---~-~~~~~~~~~~------~-~~~~~~~~~~ 222 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DA---V-FDNILSRRIN------W-PEEVKEFCSP 222 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HH---H-HHHHHhcccC------C-CCcccccCCH
Confidence 8899999999888899999999999999999999999743221 11 1 1111100000 0 0001113456
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 314 RYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
.+.+++.+||+.+|++||++.++.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 7889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.37 Aligned_cols=241 Identities=20% Similarity=0.238 Sum_probs=186.1
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
+.-..++|.+++.||+|+||.|..++++. ++.+|+|++++. .......|..|-++|..-+.+=||.++-.|++..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 33445789999999999999999999876 777899999753 23445678899999998899999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+|+||||++||||-.++..... ...+|..+.|||||||+|||||..|++||+|||.+-.+..++
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999999999888876651 123778888999999999999999999999999987776433
Q ss_pred cccccccccCCCccccccccc----c-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAI----Q-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
.......+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||... .+..-+-..+.......+
T Consensus 230 -~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~hk~~l~F- 302 (1317)
T KOG0612|consen 230 -TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMNHKESLSF- 302 (1317)
T ss_pred -cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhchhhhcCC-
Confidence 34556689999999999996 3 57999999999999999999999997421 111111111111111111
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPT---MNEVVSM 339 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~~v~~~ 339 (387)
+ .....+..+.+||.+.+ .+|+.|.. ++++-..
T Consensus 303 ------P-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 303 ------P-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------C-cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1 11224567788888766 57888887 8888764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=253.09 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=173.8
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-ccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEEec
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
|.+.+.||+|+||.||+|+..+ ++.|++|++..... .......+|+..+.+++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999865 78899999865422 22234557999999998 999999999999999999999999
Q ss_pred CCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 168 PNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 168 ~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+|+|..++..... ...+|..+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 156 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YT 156 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cC
Confidence 7788777754331 1246778889999999999999999999999999986543221 22
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh-----------HHHHHHhhcCccccc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL-----------GYAWDLWTSNRTLEL 297 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~ 297 (387)
...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||........... .|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 3467889999998854 4579999999999999999999988754322110000 000000000000000
Q ss_pred ccccccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 IDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+........ ........+.+++.+||+.+|++|||++|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 001114578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=258.61 Aligned_cols=235 Identities=25% Similarity=0.373 Sum_probs=172.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.++|++.+.||+|+||.||+|.++. ++.||||.+.... ......+..|+.++.+. .||||+++++++......|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3678889999999999999999876 8899999986542 23345667788877777 4999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||+++ ++..++..... ..++|. .+++|+||+|+||++++++.+||+|||++........
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-- 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-- 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--
Confidence 99854 55554433111 123564 4789999999999999999999999999876532211
Q ss_pred ccccccCCCccccccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGI----FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.....+. .......... . +..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~-----~~~ 239 (296)
T cd06618 171 -KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEE-P-----PSL 239 (296)
T ss_pred -ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCC-C-----CCC
Confidence 12235678899999987554 7899999999999999999999975322111 0011111110 0 000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. ........+.+++.+||+.||++||++.++++.
T Consensus 240 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 P---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 011234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=258.08 Aligned_cols=228 Identities=24% Similarity=0.397 Sum_probs=171.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.|...+.||+|+||.||+|+... +..|++|.+.... ......+.+|+++++.++|||++++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36667889999999999999754 7889999986432 2334567889999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+.+ ++..++..... ..++|..+++|+||+|+||+++.++.+||+|||++.... ..
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PA 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CC
Confidence 9964 66555533211 124677888999999999999999999999999986432 12
Q ss_pred ccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
....|+..|+|||++. ...++.++|||||||++|||++|..|+..... .. ......... . +..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--~~---~~~~~~~~~-~-----~~~--- 240 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MS---ALYHIAQND-S-----PTL--- 240 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HH---HHHHHHhcC-C-----CCC---
Confidence 3356888999999984 45688999999999999999999999643211 11 111110000 0 000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233468899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=252.75 Aligned_cols=230 Identities=24% Similarity=0.301 Sum_probs=179.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|++.+.||+|+||.||++.... ++.+++|.+... .......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999998664 788999998643 233455778899999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 167 MPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+++++|..++..... ...+|..+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 999999888754110 12467777899999999999999999999999999766543
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||...... . ..... .... . ..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~---~~~~~-~~~~--------~--~~ 220 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--D---LRYKV-QRGK--------Y--PP 220 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHH-hcCC--------C--CC
Confidence 122245788999999999988999999999999999999999997533211 1 11110 0000 0 01
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........+.+++.+||+.+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 122445678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=272.57 Aligned_cols=237 Identities=22% Similarity=0.354 Sum_probs=187.4
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe--
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-- 156 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-- 156 (387)
+..+...++.|++.+.||.|.+|.||+++..+ ++..|+|++...... .++...|.++|+.. +|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34445567889999999999999999999654 788899988654332 35677889999887 89999999999875
Q ss_pred ---CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 157 ---KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 157 ---~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
++.+|||||||.+|+..+++..... ...+|...++|||+|-.|||++.++.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 4679999999999999888765432 1346777789999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCccccccccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQG-----IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
+..+.... ....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+..
T Consensus 170 SaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D----------------- 230 (953)
T KOG0587|consen 170 SAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD----------------- 230 (953)
T ss_pred eeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC-----------------
Confidence 98775432 344567999999999999643 378899999999999999999999532
Q ss_pred cCcccccccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 291 SNRTLELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
-.....+.++.+.++ .+.....++.++|..||..|-+.||++.++++
T Consensus 231 -mHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 231 -MHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -cchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 222222222222221 35667889999999999999999999998876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=247.78 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=191.1
Q ss_pred CcccccCCeeEEEEE-EcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 95 NKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
+.||+|+|+.|--+. ...|.++|||++.+...+.+.++.+|++++.+. .|+||+.++.+|+++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999998 566999999999988888899999999999999 699999999999999999999999999999
Q ss_pred chhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCceecCCCC-----ccccc
Q 041766 173 DFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMARICGGNE-----LQANT 228 (387)
Q Consensus 173 ~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~-----~~~~~ 228 (387)
...+++... ..++|..++.||||||+|||-.+... +|||||.++.....+. .....
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 887765321 24688999999999999999966544 7999998875432211 12223
Q ss_pred ccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.+.+|+..|||||+.. ..-|+.++|.||||||+|-|++|.+||......+ .+|............++..+..
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCccCCCccHHHHHHHHHHHhc
Confidence 4578999999999874 2348999999999999999999999986543321 1121111111111112222222
Q ss_pred cccc-----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhhhhhhccCCCCCCcee
Q 041766 304 DEYS-----SKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEAAALFPPKQPAFS 356 (387)
Q Consensus 304 ~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~~~~~~~~~~~~~ 356 (387)
+.+. -...+....+++...+..|+.+|.++.++++ +.+...+.-.-|+++.+.
T Consensus 321 GkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v~~ 380 (463)
T KOG0607|consen 321 GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQVLQ 380 (463)
T ss_pred cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcccc
Confidence 2211 2345667789999999999999999999998 344444444444444433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=259.20 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=177.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKI 161 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~ 161 (387)
...++|++.+.||.|+||.||++... ++..||+|++... .......+.+|++++.+++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999866 4889999987532 22344677899999999999999999999876 45788
Q ss_pred EEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+++||+ +++|..++..... ...+|..+++|+||+|+|||++.++.+||+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 999998 5688777654221 12467788899999999999999999999999998754321
Q ss_pred ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH----------HHHhhcCccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA----------WDLWTSNRTL 295 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~ 295 (387)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .... ..........
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhccchhhH
Confidence 123456788999998866 56899999999999999999999997543221100 0000 0000000001
Q ss_pred ccccccccccc-c----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 ELIDPILEDEY-S----SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ~~~~~~~~~~~-~----~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+.+........ . .......+.+++.+||+.+|++|||+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11100000000 0 01234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=260.62 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=174.7
Q ss_pred hcCCCC-CCcccccCCeeEEEEEEcC-CCEEEEEEccCCCccc--------------HHHHHHHHHHHHhcCCCceeeee
Q 041766 88 TNKFSD-ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG--------------LREMKNEASVIAKVQHKNLVRLL 151 (387)
Q Consensus 88 ~~~~~~-~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~~~ 151 (387)
.++|.. .+.||.|+||.||+|.... ++.||+|.+....... ...+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356654 4679999999999999764 8899999885432111 12467899999999999999999
Q ss_pred eeEEeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
+++...+..++||||+. |+|..++..... ...+|..+++|+||+|+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999996 578777644221 1247788899999999999999999999999999
Q ss_pred ceecCCCCc------------ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh
Q 041766 216 ARICGGNEL------------QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282 (387)
Q Consensus 216 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~ 282 (387)
+........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--~~~ 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI--DQL 243 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH
Confidence 976541110 1111223467889999998764 4789999999999999999999997543321 111
Q ss_pred HHHHHHhhcCcc---ccc--------cccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 283 GYAWDLWTSNRT---LEL--------IDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 283 ~~~~~~~~~~~~---~~~--------~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
............ ... ........ ......+..+.+++.+||+.+|++|||+++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111100000 000 00000000 001123457889999999999999999999997
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=251.22 Aligned_cols=234 Identities=23% Similarity=0.302 Sum_probs=176.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
.+|.+.+.||+|+||.||+|.... +..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999999765 889999987432 123345788899999999999999999998764 457
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++++||+++++|..++..... ...+|..+++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 899999999999887754321 1246777889999999999999999999999999976532111
Q ss_pred -ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 -QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
........++..|+|||.+.+..++.++|+|||||++|||++|+.||..... .. ...+..... .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~-~~~~~~~~~----------~ 226 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MA-AIFKIATQP----------T 226 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HH-HHHHHHcCC----------C
Confidence 0111234678899999999888899999999999999999999999743211 00 011110000 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+......+.+++.+||+ +|..|||+.+++.
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 011233445678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=256.56 Aligned_cols=225 Identities=25% Similarity=0.321 Sum_probs=178.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 161 (387)
-..+|.++.+||+|+||.|.+|.-+. .+.+|||++++. ...+.+.-+.|-++|.-. +-|.+++++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34578889999999999999998765 667999999765 223334445677777665 6789999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+||||+.||+|...+++..+ ..+||..++|.||||.+|||+|.+|++||+|||+++.---. .
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~ 504 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--G 504 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC--C
Confidence 99999999999988876433 24688899999999999999999999999999999853222 2
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc-
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED- 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 304 (387)
..+.+++||+.|+|||++...+|+..+|.|||||+||||+.|++||+...++.. +..+...
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------------------F~aI~ehn 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------------------FQAIMEHN 566 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------HHHHHHcc
Confidence 245668999999999999999999999999999999999999999864433211 1111111
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCC
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRP 331 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RP 331 (387)
...+...+.+..++....+...|.+|.
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 113455667888899999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=261.96 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=182.7
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ceE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKI 161 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~ 161 (387)
+|.+.+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999765 8899999987543 344567889999999999999999999998775 789
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++|||+++ +|..++..... ...+|..+++|+||||+|||++.++.++|+|||++.........
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999974 77777654321 12467788899999999999999999999999999876543210
Q ss_pred -cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh-----------cC
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT-----------SN 292 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 292 (387)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ........... ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHhhhcccc
Confidence 112334678899999999887 7899999999999999999999997543321 10000000000 00
Q ss_pred ccccccccccccc-----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhh
Q 041766 293 RTLELIDPILEDE-----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEA 344 (387)
Q Consensus 293 ~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~ 344 (387)
.....+....... ......+..+.+++.+||+.+|++|||++++++. +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000000000000 0011235678899999999999999999999984 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=262.85 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=175.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
.++|...+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468889999999999999999975 4889999998643 2223456789999999999999999999987543
Q ss_pred ceEEEEEecCCCCcchhhcCC-c-------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 159 EKILIYEYMPNKSLDFFLFDP-T-------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~-~-------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
..++|+||+.. +|..+.... . ....+|..+++|+||||+||+++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 45899999864 665544211 0 013467788899999999999999999999999998754321
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC-----------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN----------- 292 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 292 (387)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..............
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 171 ---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred ---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHHHHHhccc
Confidence 223466888999999876 4689999999999999999999999854321 11111111100000
Q ss_pred ccccccc--cc-ccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhhh
Q 041766 293 RTLELID--PI-LEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEAA 345 (387)
Q Consensus 293 ~~~~~~~--~~-~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~~ 345 (387)
.....+. +. ..... ........+.+++.+||+.||++||++++++.. ++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 00 00000 001123567899999999999999999999954 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=261.63 Aligned_cols=248 Identities=20% Similarity=0.223 Sum_probs=174.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC---------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--------- 157 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--------- 157 (387)
..+|.+.+.||.|+||.||+|.... +..||+|.+..........+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3688999999999999999999765 889999998766555667788999999999999999999876653
Q ss_pred -----CceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEc-CCCCeEEeeccCc
Q 041766 158 -----DEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLD-KDINPKISDFGMA 216 (387)
Q Consensus 158 -----~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~a 216 (387)
...|+||||++ ++|..++..... ..++|..+++|+||||+||+++ +++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 34689999997 578766643211 1357888899999999999997 4567899999999
Q ss_pred eecCCCCccc-ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc-
Q 041766 217 RICGGNELQA-NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR- 293 (387)
Q Consensus 217 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 293 (387)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........ .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~ 240 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILES-VPVVRE 240 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-cCCCCh
Confidence 7653221111 1122357889999998754 558899999999999999999999985332110 00000000 00000
Q ss_pred ---------cccccc-ccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 ---------TLELID-PILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ---------~~~~~~-~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...... ....... ........+.+++.+||+.||++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000000 01123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=256.77 Aligned_cols=233 Identities=24% Similarity=0.311 Sum_probs=180.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 163 (387)
++|.+.+.||+|+||.||++... ++..||+|.+... .......+..|.+++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 4889999988642 2233456788999999998 99999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc--
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-- 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 225 (387)
|||+++++|.+++..... ...+|..+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999888865422 12467778899999999999999999999999998765433211
Q ss_pred ----------------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh
Q 041766 226 ----------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 226 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
.......++..|+|||++.+..++.++||||||+++|++++|..||...... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~ 235 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----LTFQKIL 235 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHH
Confidence 1223346788999999998888999999999999999999999997533210 0000000
Q ss_pred hcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 041766 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTM----NEVVS 338 (387)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~----~~v~~ 338 (387)
.. . ...+...+..+.+++.+||+.+|.+|||+ +++++
T Consensus 236 ---------~~--~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 ---------KL--E-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---------hc--C-CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0 00112235578899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=250.20 Aligned_cols=225 Identities=24% Similarity=0.264 Sum_probs=165.3
Q ss_pred cccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHH---HHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEAS---VIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.||+|+||.||++.... ++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 78999998864321 11122333433 4444579999999999999999999999999
Q ss_pred CCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 169 NKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 169 ~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
+|+|..++..... ..++|..+++|+||||+||+++.++.+||+|||++....... .....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 9999887754321 124677788999999999999999999999999987553221 22347
Q ss_pred CCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 233 GTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
|+..|+|||.+.+. .++.++||||||+++|||++|+.||........... .... . ..... .+...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~~~~-~------~~~~~-----~~~~~ 222 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMT-L------TMAVE-----LPDSF 222 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--HHHh-h------ccCCC-----CCCcC
Confidence 89999999999754 689999999999999999999999854322111100 0000 0 00000 11123
Q ss_pred HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
+..+.+++.+||..+|++|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 56788999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=252.41 Aligned_cols=240 Identities=22% Similarity=0.259 Sum_probs=178.6
Q ss_pred CCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
+|++.+.||+|+||.||+++.. ++..||||.+.... ......+..|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 36789999886431 22345678899999999 699999999999998999
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++||||+++|+|..++..... ...+|..+++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 999999999999887754321 1246777889999999999999999999999999876543321
Q ss_pred ccccccccCCCccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ............ ..
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-------~~-- 229 (288)
T cd05583 161 E-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS-------KP-- 229 (288)
T ss_pred c-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-------CC--
Confidence 1 122346788999999987655 7889999999999999999999975322111 111111111000 00
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+......+.+++.+||+.||++|||+.++.+.|+..
T Consensus 230 ---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 230 ---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 01122345678999999999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=251.75 Aligned_cols=235 Identities=21% Similarity=0.262 Sum_probs=175.4
Q ss_pred CCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 90 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
+|++.+.||+|+||.||+++.. +|..||+|.+.... ....+.+..|+.++.++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677899999999999999863 57889999986432 22345678899999999 699999999999998889
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++||||+++++|.+++..... ...+|..+++|+||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 999999999999888754322 1246777889999999999999999999999999986543221
Q ss_pred ccccccccCCCccccccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.......|+..|+|||.+.+. .++.++||||||+++|+|++|..|+...... ..............
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~---------- 228 (290)
T cd05613 161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSE---------- 228 (290)
T ss_pred -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhccC----------
Confidence 112235688899999998753 4688999999999999999999997532211 11111111111000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
...+......+.+++.+||+.||++|| ++++++.
T Consensus 229 --~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 001222445778999999999999997 6666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.88 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=178.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-----CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CC
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID-KD 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~ 158 (387)
....|+....||+|.||.||+|.-.+ ...+|+|+++... ........+|+.+++.++||||+.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34578899999999999999996433 2368999997542 2334567799999999999999999999987 67
Q ss_pred ceEEEEEecCCCCcchhhcCCcc---------------------ccccchhhhhhcccCCCceEEcCC----CCeEEeec
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWSANYSSRLKVSNILLDKD----INPKISDF 213 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~h~dlk~~Nill~~~----~~~kl~Df 213 (387)
..++++||++. +|-.+++.+.. -.++|..-++||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 88999999976 67666643321 135788888999999999999877 99999999
Q ss_pred cCceecCCCCccc-ccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcch----Hh---HH
Q 041766 214 GMARICGGNELQA-NTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT----LL---GY 284 (387)
Q Consensus 214 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~----~~---~~ 284 (387)
|+++.....-..- .....+-|..|+|||.+.|. .|+.+.||||.|||+.||+|-++-|.....+... .. ..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999876543222 23445678999999999985 4999999999999999999988877543322111 11 11
Q ss_pred HHHHhhcCc---cccc---------ccccccccccc----------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 285 AWDLWTSNR---TLEL---------IDPILEDEYSS----------KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 285 ~~~~~~~~~---~~~~---------~~~~~~~~~~~----------~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+....... ...+ +...-.....+ ..-++...+|+.++|..||-+|.|++++++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111111000 0000 00000000000 0012347799999999999999999999875
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=249.43 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=172.7
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhc---CCCceeeeeeeEEeCCc-----
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDKDE----- 159 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~~~----- 159 (387)
|++.+.||+|+||.||+|+++. +..||+|.+.... ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 8899999986432 22234566788777666 59999999999998776
Q ss_pred eEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
.+++|||+.+ +|..++..... ...+|..+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 8999999974 77766644221 1246777789999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc------
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL------ 295 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 295 (387)
... .....++..|+|||.+.+..++.++|||||||++|||++|..||...... ...... ..........
T Consensus 160 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 160 EMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKI-FDVIGLPSEEEWPRNV 234 (287)
T ss_pred Ccc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHH-HHHcCCCChHhcCCCc
Confidence 321 12335788899999999989999999999999999999998887532211 111111 1110000000
Q ss_pred ----cccccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ----ELIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ----~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.......... .........+.+++.+||+.||++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 011234567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=254.70 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=171.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
.++|++.+.||+|+||.||+|.... ++.+|+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999765 7889999885332 222346678999999999999999999876543
Q ss_pred --ceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 159 --EKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 159 --~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
..++|+||+.+ ++...+..... ...+|..+++|+||||+||++++++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 35899999965 55554443221 12467788899999999999999999999999999765
Q ss_pred CCCCcc---------cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh
Q 041766 220 GGNELQ---------ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 220 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
...... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--~~~~~~~~~~ 243 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--DQLHLIFKLC 243 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHh
Confidence 332211 111223567889999988654 5899999999999999999999987532221 1111111111
Q ss_pred hcCcc---------cc----ccccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 290 TSNRT---------LE----LIDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 290 ~~~~~---------~~----~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..... .. ......... .........+.+++.+||+.||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 00 000000000 001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=260.26 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=177.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD---- 158 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~---- 158 (387)
...++|++.+.||+|+||.||++... ++..||||.+... .......+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999865 4889999998543 2223456789999999999999999999987653
Q ss_pred --ceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC
Q 041766 159 --EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 159 --~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
..++||||+ +++|..++..... ...+|..+++|+||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 358999999 6788776643221 1246778889999999999999999999999999876532
Q ss_pred CCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH----------HHhh
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW----------DLWT 290 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~----------~~~~ 290 (387)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ....... ....
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhc
Confidence 2 123456889999999876 458899999999999999999999975332110 0000000 0000
Q ss_pred cCcccccccc--ccc-ccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 291 SNRTLELIDP--ILE-DEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 291 ~~~~~~~~~~--~~~-~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
.......... ... ... ........+.+++.+|++.||++|||+.+++. .++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 0000000000 000 000 01123446889999999999999999999995 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=259.96 Aligned_cols=251 Identities=18% Similarity=0.232 Sum_probs=177.0
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK- 157 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~- 157 (387)
.++....++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 445566789999999999999999999865 48899999986432 22345678899999999999999999988643
Q ss_pred -----CceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 158 -----DEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 158 -----~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
...+++++++ +++|..++..... ..++|..+++|+||||+||++++++.+||+|||++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3467888887 7788766543211 124777888999999999999999999999999987
Q ss_pred ecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh-hcCccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW-TSNRTL 295 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 295 (387)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+........ ......
T Consensus 169 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 169 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL 242 (345)
T ss_pred ccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 64321 223467889999999876 568899999999999999999999974322111 1100000000 000000
Q ss_pred ---------cc---ccccccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 ---------EL---IDPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ---------~~---~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. +........ ........+.+++.+||+.||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000000 000124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=248.56 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=177.0
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567889999999999999775 8899999987542 334467788999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+ ++|..++..... ...+|..+++|+||+|+||++++++.+||+|||++........ ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCc
Confidence 7 588888765411 1247778889999999999999999999999999876543221 1222
Q ss_pred ccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH-----------hhcCc-cccc
Q 041766 231 IVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL-----------WTSNR-TLEL 297 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~-~~~~ 297 (387)
..++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ......... ..... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 3457789999998776 7899999999999999999998887432211 111111000 00000 0000
Q ss_pred cccccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDPILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........ .........+.+++.+||+.||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 001122557899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=248.76 Aligned_cols=230 Identities=24% Similarity=0.318 Sum_probs=171.9
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
+|.+.+.||+|+||.||+++... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998764 444555555321 222334677899999999999999999999998899999
Q ss_pred EEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+||+++++|..++..... ...+|..+++|+||||+||++++ +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999877743110 12467778899999999999976 569999999987664322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+.... .......... . ..+
T Consensus 160 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~-~-----~~~--- 223 (260)
T cd08222 160 D--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVE-G-----PTP--- 223 (260)
T ss_pred c--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHc-C-----CCC---
Confidence 1 1223467889999999988889999999999999999999999974221 1111111000 0 000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 012344567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=264.42 Aligned_cols=227 Identities=21% Similarity=0.313 Sum_probs=171.8
Q ss_pred CCCCcccccCCeeEEEEEEcC-CCEEEEEEcc----CCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc--eEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP----GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--KILIY 164 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--~~lv~ 164 (387)
.....||+|+|-+||+|.+.. |-.||--.++ .......++|..|+.+|+.|+|||||++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 345789999999999999765 6667643332 2245566899999999999999999999999988665 67999
Q ss_pred EecCCCCcchhhcCCcc---ccccc---------------hhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCCCcc
Q 041766 165 EYMPNKSLDFFLFDPTK---RMLLD---------------WSANYSSRLKVSNILLDKD-INPKISDFGMARICGGNELQ 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~---~~~l~---------------~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|.+..|+|..|+.+... +..-. ...+||||||.+||+|+.+ |.|||+|+|+|+......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999999876543 11222 2346899999999999765 899999999998775432
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....||+.|||||... ..|+..+||||||++++||+|+..||..-. ...+.+..+.. +.....+
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~S-GiKP~sl------- 265 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTS-GIKPAAL------- 265 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHc-CCCHHHh-------
Confidence 33468999999999886 789999999999999999999999974322 11222222211 1111111
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..-..+.+.++|.+|+.. .++|||+.|+|+
T Consensus 266 --~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 --SKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --hccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111135788999999999 999999999997
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=254.23 Aligned_cols=246 Identities=20% Similarity=0.219 Sum_probs=170.8
Q ss_pred CCCCCCcccccCCeeEEEEEEcC---CCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC----Cc
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK---GDEIAVKRLPGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DE 159 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~----~~ 159 (387)
+|.+.+.||+|+||.||+++... +..||+|.+... .....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999763 568999988643 222345778899999999 599999999876432 35
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.++++||+. ++|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 689999986 578777643221 124788889999999999999999999999999998654322
Q ss_pred cc--cccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh-----------
Q 041766 224 LQ--ANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW----------- 289 (387)
Q Consensus 224 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 289 (387)
.. .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..........
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHHHHHhh
Confidence 11 11223468899999998865 46899999999999999999999987543211 0000000000
Q ss_pred hcCcccccccc---c--cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 290 TSNRTLELIDP---I--LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 290 ~~~~~~~~~~~---~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........... . ..-..........+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0 0000000112457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=249.90 Aligned_cols=253 Identities=21% Similarity=0.241 Sum_probs=187.2
Q ss_pred cchhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC--CC----ceeeee
Q 041766 79 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ--HK----NLVRLL 151 (387)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----nIv~~~ 151 (387)
.-+...+....+|.+..++|+|.||.|-.+..+. +..||||+++... ...+..+-|+++|.++. .| -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 4455666778999999999999999999999766 6889999987543 34566777999999993 23 378888
Q ss_pred eeEEeCCceEEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcC---------
Q 041766 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDK--------- 204 (387)
Q Consensus 152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~--------- 204 (387)
+||...++.|||+|.+ |.++.+++...... .++|..+++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999987 66888888764432 2477788899999999999842
Q ss_pred -----------CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 205 -----------DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 205 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
+..+||+|||.|+..... .+..+.|..|.|||++.+-.++.++||||+||||.|++||...|..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 235899999999865433 3556889999999999999999999999999999999999998876
Q ss_pred CCCCcch-HhHHHHH--------------HhhcCc--------------cccccccccccccccHHHHHHHHHHHHhccc
Q 041766 274 YRTDSLT-LLGYAWD--------------LWTSNR--------------TLELIDPILEDEYSSKHMLLRYVNIALLCVQ 324 (387)
Q Consensus 274 ~~~~~~~-~~~~~~~--------------~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 324 (387)
+.+.... +++.... .+.... ..+..++.-......+....++++|+++||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 6533211 1111100 000000 0000111111111234456689999999999
Q ss_pred CCCCCCCCHHHHHH
Q 041766 325 ESADDRPTMNEVVS 338 (387)
Q Consensus 325 ~dP~~RPt~~~v~~ 338 (387)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=262.95 Aligned_cols=227 Identities=22% Similarity=0.210 Sum_probs=179.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
+.+.|.....+|.|+|+.|..+.+.. ++..++|.+.... .+-.+|+.++... +||||+++++++.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46788888899999999999998765 7789999997552 2234677677666 8999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEE-cCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILL-DKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|++.++.+..-+..... -.++|..+++||||||+|||+ ++.++++|+|||.++..... .
T Consensus 396 e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C 470 (612)
T ss_pred hhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence 99999877554433211 125788889999999999999 58899999999999876533 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
.+.+-|..|.|||++....|+.++||||||++||+|++|+.||...+.+ . ++........ ..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~----------------ei~~~i~~~~-~s 532 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I----------------EIHTRIQMPK-FS 532 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H----------------HHHHhhcCCc-cc
Confidence 3346688999999999999999999999999999999999998655443 1 1111111111 22
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
...+..+.+|+.+||+.||.+||++.++...-
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 45567889999999999999999999998753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=259.35 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=176.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE---- 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~---- 159 (387)
..++|+..+.||+|+||.||+|+... +..||+|.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45789999999999999999999865 788999988643 22334567789999999999999999998876554
Q ss_pred --eEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 160 --KILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 160 --~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
.++|+||+ +++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 89999998 5688877654221 12467788899999999999999999999999998765322
Q ss_pred CcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh-----------
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT----------- 290 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 290 (387)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred -----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCHHHHhhcc
Confidence 223467888999999865 3678999999999999999999999753221 111111000000
Q ss_pred cCcccccccccccc---cc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 291 SNRTLELIDPILED---EY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 291 ~~~~~~~~~~~~~~---~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......+...... .. .....+..+.+++.+||+.||++|||+.+|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 00 001225678899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=277.59 Aligned_cols=239 Identities=24% Similarity=0.332 Sum_probs=163.3
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc---
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--- 159 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--- 159 (387)
.....+|+.++.||+|+||.||+++.+ +|..+|||+++-. .......+.+|+..|++++|||||+++..+.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345577889999999999999999976 5999999999754 33445678899999999999999999876533211
Q ss_pred --------------------------------------------------------------------------------
Q 041766 160 -------------------------------------------------------------------------------- 159 (387)
Q Consensus 160 -------------------------------------------------------------------------------- 159 (387)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ------------------------------------eEEEEEecCCCCcchhhcCCcc-----------------ccccc
Q 041766 160 ------------------------------------KILIYEYMPNKSLDFFLFDPTK-----------------RMLLD 186 (387)
Q Consensus 160 ------------------------------------~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~ 186 (387)
+||-||||+.-.+.+++.+... ..++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1233333333333222222111 12467
Q ss_pred hhhhhhcccCCCceEEcCCCCeEEeeccCceecC----C------------CCcccccccccCCCccccccccccC---C
Q 041766 187 WSANYSSRLKVSNILLDKDINPKISDFGMARICG----G------------NELQANTSRIVGTYGYMSPEYAIQG---I 247 (387)
Q Consensus 187 ~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~---~ 247 (387)
..++|||||||.||++|.+..|||+|||+|+... . .......+...||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 7778999999999999999999999999998721 0 0111123456899999999999764 4
Q ss_pred CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCC
Q 041766 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESA 327 (387)
Q Consensus 248 ~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 327 (387)
|+.|+|+||+||+++||+. ||.... +-...... ........- .++ .....+.-..+|+++++.||
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsM----ERa~iL~~-LR~g~iP~~------~~f-~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSM----ERASILTN-LRKGSIPEP------ADF-FDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchH----HHHHHHHh-cccCCCCCC------ccc-ccccchHHHHHHHHHhcCCC
Confidence 9999999999999999985 343221 11111111 111111100 111 12223345689999999999
Q ss_pred CCCCCHHHHHH
Q 041766 328 DDRPTMNEVVS 338 (387)
Q Consensus 328 ~~RPt~~~v~~ 338 (387)
.+||||.|+++
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999987
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=243.30 Aligned_cols=220 Identities=24% Similarity=0.285 Sum_probs=170.8
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
||.|+||.||++.... ++.+|+|.+..... .....+..|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999765 88999999865422 2445788999999999999999999999999999999999999999
Q ss_pred chhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 173 DFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 173 ~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
.+++..... ...+|..+++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 888765421 124677788999999999999999999999999997654332 11233467889
Q ss_pred cccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHH
Q 041766 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYV 316 (387)
Q Consensus 237 y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (387)
|+|||...+..++.++|+||||+++|++++|..||..... . ........ ... ..+...+..+.
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~~~---------~~~---~~~~~~~~~l~ 221 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--K---EIYEKILK---------DPL---RFPEFLSPEAR 221 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--H---HHHHHHhc---------CCC---CCCCCCCHHHH
Confidence 9999999888889999999999999999999999743321 1 11111100 000 01111245778
Q ss_pred HHHHhcccCCCCCCCCHHH
Q 041766 317 NIALLCVQESADDRPTMNE 335 (387)
Q Consensus 317 ~li~~cl~~dP~~RPt~~~ 335 (387)
+++.+||..||++|||+++
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-33 Score=255.59 Aligned_cols=227 Identities=22% Similarity=0.344 Sum_probs=179.5
Q ss_pred CCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
.+.||.|.||+||-|+++. |+.||||++.+. .......+..|+.||.+++||.||.+...|+.++..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4689999999999999776 999999998643 3344478889999999999999999999999999999999999665
Q ss_pred CcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCC---CCeEEeeccCceecCCCCccccccc
Q 041766 171 SLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 171 ~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
-|+.+|.....+ -++|...++|+||||+|||+.+. -++||||||.|+..+.... ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---Rrs 725 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRS 725 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhh
Confidence 565555443332 25889999999999999999543 5799999999999875543 345
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.+||+.|+|||++..+.|...-|+||.|||+|--++|..||....+-+..+. +. . .+-....-.+
T Consensus 726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ----NA-------a----FMyPp~PW~e 790 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ----NA-------A----FMYPPNPWSE 790 (888)
T ss_pred hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh----cc-------c----cccCCCchhh
Confidence 7999999999999999999999999999999999999999865433221111 10 0 0011112345
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+||...|+..-++|.|....+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 5677889999999999999999887664
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=239.26 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=176.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEcc--CCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 157 (387)
..+.|+...++|+|.||.||+|+.+. |+.||+|++- +.....-....+|+.+|..+.|+|++.++..|...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34567778899999999999999776 7778988652 22333345677999999999999999999988642
Q ss_pred --CceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 158 --DEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 158 --~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
...|+||.+|+. +|.-++..... ..++|...++|||+|++|+||+.++.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 247999999966 77666654422 2357888899999999999999999999999999986
Q ss_pred cCCCC--cccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcch-HhHH--------HH
Q 041766 219 CGGNE--LQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT-LLGY--------AW 286 (387)
Q Consensus 219 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~-~~~~--------~~ 286 (387)
+.... ........+-|+.|++||.+.|. .|+++.|||.-||++.||+||.+-+....+.... +... +|
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 64332 22223334568999999999875 5999999999999999999998876443322110 0000 01
Q ss_pred HHhhcCcccccc--ccccccccc-cHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 287 DLWTSNRTLELI--DPILEDEYS-SKH------MLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 287 ~~~~~~~~~~~~--~~~~~~~~~-~~~------~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....-...+.+ .+..++... .++ -.+..++|+.+++..||.+|+++.++++.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110000000111 111111100 011 12367899999999999999999998863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=218.17 Aligned_cols=245 Identities=21% Similarity=0.258 Sum_probs=173.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+|...++||+|.||+||+|+..+ ++.||+|+++-. +........+|+.+|+.+.|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999665 888999988633 344456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCc-----------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPT-----------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~-----------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|.. +|..+....+ +..+.|....+||||||.|.||..+|.+||+|||+++..+-.. .-.+
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcys 159 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYS 159 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eeee
Confidence 953 5544443322 2235677778999999999999999999999999998765332 1223
Q ss_pred cccCCCccccccccccCC-CCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh--cCccc---cccc---
Q 041766 230 RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT--SNRTL---ELID--- 299 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~--- 299 (387)
..+-|..|.+|.++.+.. |++..|+||-||++.|+.. |++.|... +-...+....+.... .+... .+-+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 346689999999998754 8999999999999999998 54444322 222222222222111 11111 1111
Q ss_pred -cccccccccHHH----HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 -PILEDEYSSKHM----LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 -~~~~~~~~~~~~----~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+.......-.+. ...-.+++++.+..+|.+|.++++.++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111111 223358999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=274.27 Aligned_cols=129 Identities=22% Similarity=0.300 Sum_probs=111.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+|++.. ++.||||++.... ......+..|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 578889999999999999999874 8899999986432 233467888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
||+.+++|..++..... ..++|..+++|+||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999888754321 125777889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=247.50 Aligned_cols=241 Identities=24% Similarity=0.305 Sum_probs=173.8
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC-------CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-C
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR-------SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-K 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~ 157 (387)
..++|-.+.+||+|+|+.||+|.+- ..+.||+|.-.-. .........+|.+|-+.++||.||++|+++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3456677889999999999999844 4677899965311 12223456789999999999999999999875 5
Q ss_pred CceEEEEEecCCCCcchhhcCCcccc----------------cc--chhhhhhcccCCCceEEcC---CCCeEEeeccCc
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTKRM----------------LL--DWSANYSSRLKVSNILLDK---DINPKISDFGMA 216 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~~~----------------~l--~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a 216 (387)
+.+|-|+|||+|.+|+.+|.++..-. +| ....+||-||||.|||+.+ .|.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67899999999999999997654210 01 1233589999999999944 478999999999
Q ss_pred eecCCCCcc-----cccccccCCCccccccccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHH
Q 041766 217 RICGGNELQ-----ANTSRIVGTYGYMSPEYAIQG----IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 217 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 287 (387)
+.+.+..+. ..++...||..|++||++.-+ ..+.|+||||.|||+|.++.|+.||+........+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq----- 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ----- 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh-----
Confidence 998765443 234457899999999998643 378999999999999999999999865433221111
Q ss_pred HhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+ +...-..-+..+.......++|++||+..-++|....++..
T Consensus 696 ---eNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ---ENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---hhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0000 00000000112223456789999999999999988777654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=233.82 Aligned_cols=230 Identities=19% Similarity=0.199 Sum_probs=174.1
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC----Cce
Q 041766 88 TNKFSDA-NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK----DEK 160 (387)
Q Consensus 88 ~~~~~~~-~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~----~~~ 160 (387)
+++|.+. ++||-|-.|.|..+.++. ++.+|+|++... ....+|+++--.. .|||||.++++|.+. .-+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556543 579999999999999876 788999998543 4556777765555 699999999998763 345
Q ss_pred EEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcC---CCCeEEeeccCceec
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARIC 219 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 219 (387)
.+|||+++||.|..-+++.... .++|...+.||||||+|+|... +..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 6899999999998877665432 3588889999999999999954 456999999999875
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
..+ ....+.+-|+.|.|||++....|+..+|+||+||++|-|+.|.+||...... .+..-...
T Consensus 215 ~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~------------ 277 (400)
T KOG0604|consen 215 QEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKR------------ 277 (400)
T ss_pred CCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHh------------
Confidence 432 2334568899999999999899999999999999999999999997543321 11100000
Q ss_pred ccccc--cc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 PILED--EY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 ~~~~~--~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
++..+ .+ .-...++...++|+++|..+|++|.|+.++++.
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 01111 11 123446778899999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=234.87 Aligned_cols=232 Identities=21% Similarity=0.331 Sum_probs=181.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 161 (387)
..++|..++.||+|+|++|..++++. .+.+|+|++++. +..+..-+..|-.++.+. +||.+|.++.+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34678999999999999999999876 778999988643 344555667788888776 7999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+|.||.+||+|..++++..+. .++|..++|.||||.+|+|+|..|++||+|+|+++.--...
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-- 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-- 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC--
Confidence 999999999998888664432 24777888899999999999999999999999998543222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch--HhHHHHHHhhcCccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT--LLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
..+++++||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+.-..++.. -..+.++... .+.++
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil--------ekqir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL--------EKQIR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------hhccc
Confidence 2356789999999999999999999999999999999999999999754433322 1222222211 11111
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCC
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRP 331 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RP 331 (387)
.+...+.+...+++.-|+.||.+|.
T Consensus 478 ---iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ---IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2333455667888999999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-33 Score=254.21 Aligned_cols=233 Identities=20% Similarity=0.261 Sum_probs=185.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCC-EEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+++.+..||-|+||.|-+...+... .+|+|.+++. +....+.+..|-.||..++.|.||++|-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35566778999999999999877533 4788888654 4455567888999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|-|-||.|-..+++... -.+||..++|.|||||+|+|++.+|.+||.|||.|+.+.... .+
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC---ce
Confidence 99999999888875432 136888999999999999999999999999999999886554 46
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
.++|||+.|.|||++.....+.++|.||||+++|||++|.+||.... .+... ..+-..+.....+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktY-------------n~ILkGid~i~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTY-------------NLILKGIDKIEFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHH-------------HHHHhhhhhhhcc
Confidence 67899999999999999999999999999999999999999974322 11100 1111111112234
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~~ 339 (387)
........+|+++.+..+|.+|.. +.++-+.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 555667889999999999999975 5566543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=233.93 Aligned_cols=204 Identities=17% Similarity=0.102 Sum_probs=155.1
Q ss_pred cCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcchhhcC
Q 041766 100 GGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 178 (387)
Q Consensus 100 G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 178 (387)
|.||.||+++... ++.||+|.+.... .+..|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999765 7889999986542 233455555566799999999999999999999999999999887754
Q ss_pred Ccc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccc
Q 041766 179 PTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242 (387)
Q Consensus 179 ~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 242 (387)
... ...+|..+++|+||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~ 153 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEV 153 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcc
Confidence 321 12467778899999999999999999999999987654322 122345678999999
Q ss_pred cccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhc
Q 041766 243 AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLC 322 (387)
Q Consensus 243 ~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 322 (387)
+.+..++.++||||+|+++|||++|..|+....... ..... . ..+......+.+++.+|
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~~~~~--~---~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------NTHTT--L---NIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------ccccc--c---CCcccCCHHHHHHHHHH
Confidence 988889999999999999999999998753211100 00000 0 01122345788999999
Q ss_pred ccCCCCCCCCHH
Q 041766 323 VQESADDRPTMN 334 (387)
Q Consensus 323 l~~dP~~RPt~~ 334 (387)
|+.||++||++.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=255.52 Aligned_cols=227 Identities=25% Similarity=0.332 Sum_probs=173.1
Q ss_pred CCCCCcccccCCe-eEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecC
Q 041766 91 FSDANKLGEGGFG-PVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 91 ~~~~~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
|...+.+|.|+-| .||+|.+. |+.||||++-.. ...-..+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4455678999988 68999987 789999998532 224567899999988 79999999999999999999999995
Q ss_pred CCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcC---C--CCeEEeeccCceecCCCC
Q 041766 169 NKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDK---D--INPKISDFGMARICGGNE 223 (387)
Q Consensus 169 ~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~~~~ 223 (387)
- +|.+++..... ...||..+++||||||.||||+. + .+++|+|||+++.+....
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 4 88888766310 13588899999999999999975 2 578999999999885433
Q ss_pred c-ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 L-QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG-KKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
. .....+..||-+|+|||++....-+.++||+|+||++|..++| ..||+..-....++ .........+.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~L~-- 736 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVHLE-- 736 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceeeec--
Confidence 2 2235667899999999999988888899999999999999995 88986432221111 11111111111
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...++ ...+||.+|++.+|..||++.+|+.
T Consensus 737 -----~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -----PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11222 7789999999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=228.01 Aligned_cols=222 Identities=27% Similarity=0.322 Sum_probs=171.3
Q ss_pred CCeeEEEEEEcC-CCEEEEEEccCCCccc-HHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcchhhcC
Q 041766 101 GFGPVYKGVLKK-GDEIAVKRLPGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD 178 (387)
Q Consensus 101 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 178 (387)
+||.||+|.... ++.+++|.+....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999997654433 67899999999999999999999999998999999999999999888755
Q ss_pred Ccc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccc
Q 041766 179 PTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242 (387)
Q Consensus 179 ~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 242 (387)
... ...+|..+++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEV 157 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHH
Confidence 331 123566778999999999999999999999999998765332 2233467889999999
Q ss_pred cccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhc
Q 041766 243 AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLC 322 (387)
Q Consensus 243 ~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 322 (387)
+.+..++.++||||||+++|+|++|..||...... .... ....... .............+.+++.+|
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~----~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELF----KKIGKPK--------PPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH----HHHhccC--------CCCccccccCCHHHHHHHHHH
Confidence 98888999999999999999999999987432111 0100 0000000 000000000345788999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 041766 323 VQESADDRPTMNEVVS 338 (387)
Q Consensus 323 l~~dP~~RPt~~~v~~ 338 (387)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=255.10 Aligned_cols=242 Identities=17% Similarity=0.178 Sum_probs=152.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-----CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeee------EE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC------CI 155 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~------~~ 155 (387)
..++|++.+.||+|+||.||+|++.. +..||+|++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 34689999999999999999999764 578999988643221 112211 1222223333333222 23
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc------------------------------------ccccchhhhhhcccCCCc
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------------RMLLDWSANYSSRLKVSN 199 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------~~~l~~~~~~h~dlk~~N 199 (387)
.....++|+||+++++|.+++..... ..++|..+++||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999877753210 124677778999999999
Q ss_pred eEEcC-CCCeEEeeccCceecCCCCcccccccccCCCccccccccccC----------------------CCCccccchh
Q 041766 200 ILLDK-DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG----------------------IFSIKSDVFS 256 (387)
Q Consensus 200 ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwS 256 (387)
||++. ++.+||+|||+|+....... .......+++.|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99985 57899999999986543221 122346789999999976432 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc----cccccccc----cccc-ccHHHHHHHHHHHHhcccCCC
Q 041766 257 FGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT----LELIDPIL----EDEY-SSKHMLLRYVNIALLCVQESA 327 (387)
Q Consensus 257 ~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~-~~~~~~~~~~~li~~cl~~dP 327 (387)
|||++|||+++..++.. ....+.......... ...+.+.. ...+ ..+.......+|+.+||+.||
T Consensus 365 lGviL~el~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDS------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCch------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999987655321 111111000000000 00000000 0000 000112245689999999999
Q ss_pred CCCCCHHHHHHH
Q 041766 328 DDRPTMNEVVSM 339 (387)
Q Consensus 328 ~~RPt~~~v~~~ 339 (387)
++|||++++++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=244.64 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=159.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEE-----------------cCCCEEEEEEccCCCcccHHHH--------------HHH
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVL-----------------KKGDEIAVKRLPGRSGQGLREM--------------KNE 135 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 135 (387)
..++|++.++||+|+||.||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 1246799999865433222333 346
Q ss_pred HHHHHhcCCCce-----eeeeeeEEe--------CCceEEEEEecCCCCcchhhcCCcc---------------------
Q 041766 136 ASVIAKVQHKNL-----VRLLGCCID--------KDEKILIYEYMPNKSLDFFLFDPTK--------------------- 181 (387)
Q Consensus 136 ~~~l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 181 (387)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677887753 3467999999999999887753210
Q ss_pred -------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccc
Q 041766 182 -------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242 (387)
Q Consensus 182 -------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 242 (387)
...+|..+++||||||+|||++.++.+||+|||++........ .......+++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhh
Confidence 0135666789999999999999999999999999976532211 11112344789999998
Q ss_pred cccCC--------------------CC--ccccchhHHHHHHHHHhCCC-CCCCCCCCcchHhH-----HHHHHhhcCcc
Q 041766 243 AIQGI--------------------FS--IKSDVFSFGVLLLEIVSGKK-TTGFYRTDSLTLLG-----YAWDLWTSNRT 294 (387)
Q Consensus 243 ~~~~~--------------------~~--~~~DiwS~Gvil~el~tg~~-p~~~~~~~~~~~~~-----~~~~~~~~~~~ 294 (387)
+.... |+ .+.||||+||+++||++|.. |+.....-...... ..|.......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~- 460 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK- 460 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC-
Confidence 85422 11 34799999999999999875 44211100000000 0000000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHH
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESA---DDRPTMNEVVSM 339 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPt~~~v~~~ 339 (387)
..-. ..+.......+|+.+++..+| .+|+|++|+++.
T Consensus 461 -------~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 -------YDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -------CCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000 112235578899999999766 689999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-30 Score=240.49 Aligned_cols=188 Identities=23% Similarity=0.306 Sum_probs=152.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
-|..++.||-|+||.|.+++-.+ ...+|+|.+++.+- .....+..|-+||...+.+=||++|-.|.+++.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36667889999999999998555 56789999976543 223456789999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC---CCcc-
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG---NELQ- 225 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~---~~~~- 225 (387)
|++||++..+|.+... -...|..+.|||||||+|||||.+|++||+||||++-+.. ..++
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 9999999877754321 1236778889999999999999999999999999964411 0000
Q ss_pred ------------------------------------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCC
Q 041766 226 ------------------------------------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKK 269 (387)
Q Consensus 226 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~ 269 (387)
...-..+||..|+|||++....|+..+|.||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 00112469999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 041766 270 TTGFYRTD 277 (387)
Q Consensus 270 p~~~~~~~ 277 (387)
||......
T Consensus 870 pf~~~tp~ 877 (1034)
T KOG0608|consen 870 PFLADTPG 877 (1034)
T ss_pred CccCCCCC
Confidence 98655443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=210.54 Aligned_cols=186 Identities=25% Similarity=0.322 Sum_probs=143.6
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
++...+....+..||+|+||.|-+-++.. |...|+|++... ..+...+..+|+++..+. ..|.+|++||........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 45556667778899999999998888664 888999999754 334455777888887765 799999999999999999
Q ss_pred EEEEEecCCCCcchhhcCC---ccc-----------------ccc-chhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 161 ILIYEYMPNKSLDFFLFDP---TKR-----------------MLL-DWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~---~~~-----------------~~l-~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
|+.||.|. -+|+.+-.+. ... .++ ....++|||+||+||||+.+|++|+||||++..+
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999984 3665543221 110 112 2345689999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcccccccccc----CCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQ----GIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
.+.-.. +...|-..|||||.+.. ..|+-++||||||+++.||.+++.||+.
T Consensus 200 ~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 543211 11245678999999863 3699999999999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=246.32 Aligned_cols=238 Identities=21% Similarity=0.311 Sum_probs=184.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+.++|+....+|.|+||.||+++... ++..|+|.++-.......-..+|+-+++..+|||||.++|.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45789999999999999999999665 88899999987766667778899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCC----------------ccccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDP----------------TKRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~----------------~~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||.+|+|.+.-+-. ....++|..+.+|||||-.|||+++.|.+|++|||.+...... .....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Krk 170 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRK 170 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hhhhh
Confidence 99999997765322 1234688888899999999999999999999999998765432 22344
Q ss_pred cccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.+.||++|||||+.. .+.|...+|||++|++..|+-.-++|-....+-. +.- +... ..+++.-..
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~-LmTk---S~~qpp~lk-- 238 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALF-LMTK---SGFQPPTLK-- 238 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHH-Hhhc---cCCCCCccc--
Confidence 579999999999874 4568999999999999999988777732111100 000 0000 111111111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........+-++++.|+-.+|++|||++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12234567889999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=236.90 Aligned_cols=253 Identities=18% Similarity=0.211 Sum_probs=182.7
Q ss_pred chhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCC------Cceeeeee
Q 041766 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQH------KNLVRLLG 152 (387)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~~~~ 152 (387)
.+...+..-.+|.+....|+|-|++|..|.... |+.||||++.+... ....=++|++||.+|+. -|+++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 334445556778888889999999999999775 88999999976432 22344679999999952 38999999
Q ss_pred eEEeCCceEEEEEecCCCCcchhhcCCcccc-------------------ccchhhhhhcccCCCceEEcCC-CCeEEee
Q 041766 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-------------------LLDWSANYSSRLKVSNILLDKD-INPKISD 212 (387)
Q Consensus 153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~l~~~~~~h~dlk~~Nill~~~-~~~kl~D 212 (387)
.|...+++|||+|-+ .-+|.++|....... +|..++++|.||||+|||+... ..+||||
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 999999999999987 558888886654432 2445667899999999999765 5689999
Q ss_pred ccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH-------
Q 041766 213 FGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA------- 285 (387)
Q Consensus 213 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~------- 285 (387)
||.|.....+.... ..-+..|.|||++.|.+|+...|+||.||+||||.||+..|+...++.+.-....
T Consensus 581 fGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 581 FGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred CccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99998876654332 2345679999999999999999999999999999999998866554432211100
Q ss_pred ----HHHhhcCccc----------------------ccccc------cccc----ccccHHHHHHHHHHHHhcccCCCCC
Q 041766 286 ----WDLWTSNRTL----------------------ELIDP------ILED----EYSSKHMLLRYVNIALLCVQESADD 329 (387)
Q Consensus 286 ----~~~~~~~~~~----------------------~~~~~------~~~~----~~~~~~~~~~~~~li~~cl~~dP~~ 329 (387)
...+..+... ..+.| .+.. +.........+.+|+.+|+..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0001111100 00111 0000 0012334667889999999999999
Q ss_pred CCCHHHHHH
Q 041766 330 RPTMNEVVS 338 (387)
Q Consensus 330 RPt~~~v~~ 338 (387)
|.|..+++.
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999999886
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-29 Score=210.98 Aligned_cols=245 Identities=17% Similarity=0.280 Sum_probs=180.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC--ceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--EKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~--~~~lv 163 (387)
.++|++.+++|+|.|+.||.|.. .+.+.++||.++... ...+.+|+.||..+. ||||++++++..++. .+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46899999999999999999984 447889999997543 357889999999996 999999999998864 46799
Q ss_pred EEecCCCCcchhhcCCc-------------cccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCCCcccccc
Q 041766 164 YEYMPNKSLDFFLFDPT-------------KRMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+||+.+.+...+-.... ...+.|..+++|||+||.|++||.. -.++|+|+|+|......... +
T Consensus 114 FE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---n 190 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 190 (338)
T ss_pred hhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee---e
Confidence 99998887654432221 1235788999999999999999865 46999999999876544322 2
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh--------------cCcc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT--------------SNRT 294 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------------~~~~ 294 (387)
-.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||....++...+...+.-... +...
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 2356778899999976 458999999999999999999999997777766665544321110 0011
Q ss_pred cccccccccccc------ccHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDPILEDEY------SSKH-MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~~~~~~~------~~~~-~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..++....+... .... ..+++.+++.+.|..|-.+|||++|.+.
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111000 0111 1367889999999999999999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=215.87 Aligned_cols=249 Identities=18% Similarity=0.210 Sum_probs=174.1
Q ss_pred HHHHh-cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----C---Cceeeeeee
Q 041766 84 VSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-----H---KNLVRLLGC 153 (387)
Q Consensus 84 ~~~~~-~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~~~~~ 153 (387)
.+.+. .+|.+.++||.|.|++||++.+.. .+.||+|+.+.. ....+..+.|+.+|++++ | .+||++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34455 788999999999999999999765 567999988643 455678889999999983 3 379999999
Q ss_pred EEeC----CceEEEEEecCCCCcchhhcCCccc------------------cc-cchhhhhhcccCCCceEEcC------
Q 041766 154 CIDK----DEKILIYEYMPNKSLDFFLFDPTKR------------------ML-LDWSANYSSRLKVSNILLDK------ 204 (387)
Q Consensus 154 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~-l~~~~~~h~dlk~~Nill~~------ 204 (387)
|... .++|||+|++ |.+|..++.....+ .+ ...+++||-||||+|||+..
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchh
Confidence 9864 4789999999 44665555433221 12 23466789999999998830
Q ss_pred --------------------------------------------------------------------------------
Q 041766 205 -------------------------------------------------------------------------------- 204 (387)
Q Consensus 205 -------------------------------------------------------------------------------- 204 (387)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 041766 205 -------------------------------------------------------------------------------- 204 (387)
Q Consensus 205 -------------------------------------------------------------------------------- 204 (387)
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence
Q ss_pred CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch----
Q 041766 205 DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT---- 280 (387)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~---- 280 (387)
+.++||+|||-|.....+ .+.-..|..|+|||++.+..|++.+|||||+|++|||+||...|+.+..++..
T Consensus 390 di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 012567777766654321 22235688899999999999999999999999999999999988766554321
Q ss_pred -HhHHH-------HHH-hhcCccccccccc-----------------c-ccccccHHHHHHHHHHHHhcccCCCCCCCCH
Q 041766 281 -LLGYA-------WDL-WTSNRTLELIDPI-----------------L-EDEYSSKHMLLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 281 -~~~~~-------~~~-~~~~~~~~~~~~~-----------------~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~ 333 (387)
+...+ +.. .......+.+... + ..-..+.+...++.+++.-||+.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 11111 111 1111122222110 0 1112355667889999999999999999999
Q ss_pred HHHHHH
Q 041766 334 NEVVSM 339 (387)
Q Consensus 334 ~~v~~~ 339 (387)
.+.++.
T Consensus 545 ~~cl~h 550 (590)
T KOG1290|consen 545 AQCLKH 550 (590)
T ss_pred HHHhcC
Confidence 999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-29 Score=211.78 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=174.0
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----ceEE
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-----EKIL 162 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-----~~~l 162 (387)
.+-.+-||.|.||.||...+.. |+.||.|++.+.-. .....+.+|+.+|..++|.|+...++.-.... .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4556789999999999998664 89999999975422 33467889999999999999999999876553 4578
Q ss_pred EEEecCCCCcchhhcCCc----------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPT----------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
++|.+.. +|..++-... +..++|..+++||||||.|.|++.+..+||||||+++.....+ ..
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~ 212 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RL 212 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh-hh
Confidence 8888844 6665553322 2346899999999999999999999999999999998754332 22
Q ss_pred ccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc-----------c
Q 041766 227 NTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR-----------T 294 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~ 294 (387)
..+..+-|.+|+|||+++|.+ |+.+.||||.||++.||+.++..|....+-. ..+...+...... .
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 334456688999999999864 9999999999999999998887765433221 1111111111000 0
Q ss_pred ccccccccccc--------cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 295 LELIDPILEDE--------YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 295 ~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
.-+++...+.+ ............+..+++..||+.|.+.++.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01111111110 01122234567888899999999999999988754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=199.56 Aligned_cols=194 Identities=33% Similarity=0.522 Sum_probs=162.9
Q ss_pred ccccCCeeEEEEEEcC-CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcch
Q 041766 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 174 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~ 174 (387)
||+|.+|.||++.... ++.+++|.+...... ....+.+|+..+..++|++|+++++++......++++||+++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 889999999754332 34678999999999999999999999999889999999999999998
Q ss_pred hhcCCc--c---------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecCCCCcccccccccCCCc
Q 041766 175 FLFDPT--K---------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICGGNELQANTSRIVGTYG 236 (387)
Q Consensus 175 ~l~~~~--~---------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 236 (387)
++.... . ...+|..+++|+||+|.||+++. ++.++|+|||.+........ ......+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCC
Confidence 886541 1 12466678899999999999999 89999999999986643321 1223456788
Q ss_pred cccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHH
Q 041766 237 YMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315 (387)
Q Consensus 237 y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (387)
|++||.+... .++.+.|+|++|+++++| ..+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~ 190 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PEL 190 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHH
Confidence 9999999877 788999999999999999 467
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 316 VNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 316 ~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
.+++.+|++.+|++||++.++++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=202.50 Aligned_cols=243 Identities=16% Similarity=0.242 Sum_probs=174.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeee-eEEeCCceEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLG-CCIDKDEKIL 162 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~-~~~~~~~~~l 162 (387)
...+.|.+.+.||+|.||.+-+++++. ...+++|.++... ....+|.+|...--.+ .|.||+.-|+ .|+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 345788999999999999999999887 5678999887543 3456899998766666 6999998886 4666777889
Q ss_pred EEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEE--cCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILL--DKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+|.|+|...+..... -.++|...++|||||.+|||| .+..++||||||+.+..+.....
T Consensus 100 ~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred eeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999999887755332 135788889999999999999 33457999999999865432211
Q ss_pred cccccccCCCcccccccccc---CC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQ---GI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~---~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
..-+..|.+||.... +. ..+.+|||.||+++|.++||+.||.......... |.|..+..+.....
T Consensus 180 -----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~~~--- 249 (378)
T KOG1345|consen 180 -----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNPAL--- 249 (378)
T ss_pred -----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCccC---
Confidence 223567999998753 22 4688999999999999999999986433332222 22333322222211
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
+.......+.+..+.++-+..+|++|--..++.+.....
T Consensus 250 ----P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 250 ----PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ----chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 111223456788899999999999996666666554333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=219.55 Aligned_cols=179 Identities=24% Similarity=0.326 Sum_probs=146.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--------cccHHHHHHHHHHHHhcC---CCceeeeeeeEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--------GQGLREMKNEASVIAKVQ---HKNLVRLLGCCID 156 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~ 156 (387)
..|..++.+|.|+||.|+.|.++. ...|+||.+.+.. ......+-.|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358889999999999999999887 5679999885431 112223456999999997 9999999999999
Q ss_pred CCceEEEEEecC-CCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 157 KDEKILIYEYMP-NKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 157 ~~~~~lv~e~~~-~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
.+.+||+||--. +-+|.+++..... -..+|..+++|||||-+|+.++.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999753 3466666654322 13588899999999999999999999999999998754
Q ss_pred CCCCcccccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCC
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
... ....++||..|.|||++.|..| +..-|||++|++||.++....||
T Consensus 721 ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 721 KSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 332 3456799999999999999998 56689999999999999988886
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-27 Score=204.65 Aligned_cols=242 Identities=21% Similarity=0.236 Sum_probs=169.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------c
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------E 159 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------~ 159 (387)
.+|..++.+|.|.- .|..+-+. .+++||+|++... ......+..+|...+..+.|+||++++.++.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777888888887 55555433 2788999987432 3344567789999999999999999999997653 4
Q ss_pred eEEEEEecCCCCcchhhcCCc--------------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 160 KILIYEYMPNKSLDFFLFDPT--------------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
.|+|||||.. +|...+.... .-..+|..+++||||||+||++..++.+||.|||+|+.....
T Consensus 96 ~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--- 171 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--- 171 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---
Confidence 6899999954 6655543211 123588899999999999999999999999999999864322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH-----------------
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL----------------- 288 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~----------------- 288 (387)
-..+..+.|..|.|||++.+..|...+||||.||++.||++|+.-|.... .+.+|..-.
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 22344577889999999999889999999999999999999998765211 111111000
Q ss_pred ---hhcCc-------ccccccc-ccccc-cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 289 ---WTSNR-------TLELIDP-ILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 289 ---~~~~~-------~~~~~~~-~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+.... ..+.+.. ..... ..++-....+.+++.+||-.||++|.++.++++.
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00000 0000000 00000 0111223457799999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=196.30 Aligned_cols=181 Identities=31% Similarity=0.408 Sum_probs=151.0
Q ss_pred CCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
|...+.||.|++|.||++...+ +..+++|.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999876 789999999765444 56788999999999999999999999998889999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+++|..++...... ..+|..+++|+|++|.||+++.++.++|+|||.+........ ......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 159 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTV 159 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccce
Confidence 99998887653320 135666778999999999999999999999999987653320 012334
Q ss_pred cCCCcccccccc-ccCCCCccccchhHHHHHHHHHhCCCCCC
Q 041766 232 VGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEIVSGKKTTG 272 (387)
Q Consensus 232 ~gt~~y~aPE~~-~~~~~~~~~DiwS~Gvil~el~tg~~p~~ 272 (387)
.++..|++||.+ ....++.++|+|+||++++||++|+.||.
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 677889999998 66778889999999999999999999974
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=206.86 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=185.8
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 158 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 158 (387)
+....+.|...++||.|+|+.||++.+. ..+.||+|.+...... .++..|++.|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455678889999999999999999854 3567999999755433 5688999999999 6999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc-------------ccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCC---
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGG--- 221 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~--- 221 (387)
..++|+||.++-...++...... ...+|..+++|||+||+|+|.+.. +.-.|.|||+|.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99999999999887777655432 235788999999999999999754 6688999999972100
Q ss_pred -------------------------------CCccc--------ccccccCCCccccccccccC-CCCccccchhHHHHH
Q 041766 222 -------------------------------NELQA--------NTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLL 261 (387)
Q Consensus 222 -------------------------------~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil 261 (387)
..+.. ......||++|.|||++... ..++++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00000 01113589999999999865 478999999999999
Q ss_pred HHHHhCCCCCCCCCCCcchHhHHHHHHh---------hcCc--cc---------------ccc--cccc-------cccc
Q 041766 262 LEIVSGKKTTGFYRTDSLTLLGYAWDLW---------TSNR--TL---------------ELI--DPIL-------EDEY 306 (387)
Q Consensus 262 ~el~tg~~p~~~~~~~~~~~~~~~~~~~---------~~~~--~~---------------~~~--~~~~-------~~~~ 306 (387)
+-+++++.||....++...+.+.+.... ..+. .. +-+ .... ....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999999777666555544321110 0011 00 000 0000 0111
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+..+..+++++.+|+..||.+|.|++++++.
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 122334578899999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-24 Score=225.22 Aligned_cols=178 Identities=20% Similarity=0.213 Sum_probs=118.0
Q ss_pred cCC-CceeeeeeeEE-------eCCceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccC
Q 041766 142 VQH-KNLVRLLGCCI-------DKDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLK 196 (387)
Q Consensus 142 l~h-~nIv~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk 196 (387)
++| +||++++++|. .....+.++||+ +++|..++...... .++|..+++|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 455 68888888872 223567888987 66999888643211 25788899999999
Q ss_pred CCceEEcC-------------------CCCeEEeeccCceecCCCCc--------------ccccccccCCCcccccccc
Q 041766 197 VSNILLDK-------------------DINPKISDFGMARICGGNEL--------------QANTSRIVGTYGYMSPEYA 243 (387)
Q Consensus 197 ~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~ 243 (387)
|+||||+. ++.+|++|||+++....... ........||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999964 34566666666653211000 0001123578899999999
Q ss_pred ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcc
Q 041766 244 IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCV 323 (387)
Q Consensus 244 ~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 323 (387)
.+..|+.++|||||||+||||++|..|+.... ......... ...+ ..........+++.+||
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~---------~~~~------~~~~~~~~~~~~~~~~L 249 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHR---------VLPP------QILLNWPKEASFCLWLL 249 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHh---------hcCh------hhhhcCHHHHHHHHHhC
Confidence 99999999999999999999999887742110 000000000 0000 00111234568889999
Q ss_pred cCCCCCCCCHHHHHH
Q 041766 324 QESADDRPTMNEVVS 338 (387)
Q Consensus 324 ~~dP~~RPt~~~v~~ 338 (387)
+.+|.+||++.|+++
T Consensus 250 ~~~P~~Rps~~eil~ 264 (793)
T PLN00181 250 HPEPSCRPSMSELLQ 264 (793)
T ss_pred CCChhhCcChHHHhh
Confidence 999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.4e-23 Score=174.50 Aligned_cols=138 Identities=18% Similarity=0.176 Sum_probs=98.6
Q ss_pred hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCC
Q 041766 189 ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268 (387)
Q Consensus 189 ~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~ 268 (387)
..+|..-||+|||++.++.+|+ ||+++..... ...||+.|||||++.+..|+.++|||||||++|||++|+
T Consensus 31 ~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 101 (176)
T smart00750 31 RELHRQAKSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE 101 (176)
T ss_pred HHHHhcCCcccEeEcCccceee--ccceEeeccc-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCC
Confidence 3467666999999999999999 9998865432 126789999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH--HHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 269 KTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL--RYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 269 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.||................. .... + ........... .+.+++.+||+.+|++|||+.++++.+....
T Consensus 102 ~p~~~~~~~~~~~~~~~~~~-~~~~------~--~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 102 LPYNEERELSAILEILLNGM-PADD------P--RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred CCccccchhcHHHHHHHHHh-ccCC------c--cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 99753322111111111110 0000 0 00001122222 6899999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=189.78 Aligned_cols=167 Identities=17% Similarity=0.172 Sum_probs=123.2
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCCceee-eeeeEEe
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGR-----SGQGLREMKNEASVIAKVQHKNLVR-LLGCCID 156 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-~~~~~~~ 156 (387)
....++|...+.||+|+||+||+|++.. +..||||++... .......+.+|+++|.+++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3445789999999999999999998753 667899986532 1223457899999999999999985 4432
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc---------ccccchhhhhhccc-CCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK---------RMLLDWSANYSSRL-KVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~h~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+..|+||||+++++|......... ...+|..+++|||| ||+|||++.++.+||+|||+|+.........
T Consensus 91 -~~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred -CCcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 457999999999999632111111 12478888999999 9999999999999999999998765432111
Q ss_pred ------ccccccCCCccccccccccCC------CCccccch
Q 041766 227 ------NTSRIVGTYGYMSPEYAIQGI------FSIKSDVF 255 (387)
Q Consensus 227 ------~~~~~~gt~~y~aPE~~~~~~------~~~~~Diw 255 (387)
......++..|+|||.+...+ .+..+|-|
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 113457888999999986432 23446766
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-22 Score=171.50 Aligned_cols=231 Identities=22% Similarity=0.315 Sum_probs=162.8
Q ss_pred CCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 91 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.....+|.+...|..|+|+|+ |..+++|.+.-. ......+|..|.-.|+-+.||||..++|.|..+.++.++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344567888999999999998 566667877532 33444678889999998999999999999999999999999999
Q ss_pred CCCcchhhcCCccccc---------cchhh---hhh--------cccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 169 NKSLDFFLFDPTKRML---------LDWSA---NYS--------SRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 169 ~g~L~~~l~~~~~~~~---------l~~~~---~~h--------~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
.|+|...++....-.. ++..+ .+| ..|.+..++||++.+++|+- +-++... ..
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsf------qe 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QE 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeee------ec
Confidence 9999988876543211 11111 112 24788899999999888762 2122110 01
Q ss_pred ccccCCCccccccccccCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFS---IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~---~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
....-.+.||+||.++..+-+ .++|+|||.+++|||.|+..||....+-.- .-+-..+.+...
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------gmkialeglrv~---- 409 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------GMKIALEGLRVH---- 409 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------hhhhhhcccccc----
Confidence 111235789999999877643 579999999999999999999753221100 000111122211
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.++.....+.+|+.-|.+.||.+||.+..++-.|+++.
T Consensus 410 -ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 -IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 23344567888999999999999999999999998763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=167.65 Aligned_cols=241 Identities=25% Similarity=0.330 Sum_probs=175.7
Q ss_pred CCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc---cHHHHHHHHHHHHhcCCC-ceeeeeeeEEeCCceEEEEEe
Q 041766 91 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ---GLREMKNEASVIAKVQHK-NLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~~~~~~~~~~~~~lv~e~ 166 (387)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|..++..+.|+ +|+++++.+......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 78899988654322 367899999999999888 799999999777778999999
Q ss_pred cCCCCcchhhcCCc---c----------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCccc
Q 041766 167 MPNKSLDFFLFDPT---K----------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQA 226 (387)
Q Consensus 167 ~~~g~L~~~l~~~~---~----------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~ 226 (387)
+.++++..++.... . ...+|..+++|||+||+||+++..+ .++++|||.++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence 99999986665432 1 0146667789999999999999988 79999999998654433221
Q ss_pred ----ccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCC--cchHhHHHHHHhhcCccccc
Q 041766 227 ----NTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD--SLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 227 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 297 (387)
......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+...... .............. .
T Consensus 160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~ 234 (384)
T COG0515 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----S 234 (384)
T ss_pred cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----c
Confidence 2355689999999999987 57889999999999999999999995443321 11111111111000 0
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........ ........+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 001223467789999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-22 Score=195.06 Aligned_cols=237 Identities=19% Similarity=0.235 Sum_probs=165.0
Q ss_pred CCCCcccccCCeeEEEEEEcC-CCEEEEEEcc----CC-Ccc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP----GR-SGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.....+|.|.+|.|+...... ....+.|.+. .. ... ....+..|..+-..++|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888776443 3334444332 11 111 1122566888888899999999888877766555569
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc--c
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ--A 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~ 226 (387)
|||++ ||..++..... ..++|..++.|||+|++|++++.++.+||+|||.+....-.... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 88777655311 13578888899999999999999999999999998765433222 3
Q ss_pred ccccccCCCccccccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIK-SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||.......... ...... .... ...+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~--~~~~----~~~~~ 550 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYS--DQRN----IFEGP 550 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccc--cccc----cccCh
Confidence 4456789999999999999999765 899999999999999999986543332211 000000 0000 00000
Q ss_pred -cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 -YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 -~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+..-..++.++|+.||.+|.|+++|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 012233456678999999999999999999996
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=167.71 Aligned_cols=164 Identities=13% Similarity=0.081 Sum_probs=123.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccH---HH------HHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGL---RE------MKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
...++|...+.+|.|+||.||+... ++..+|+|.+........ +. +.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568999999999999999999766 467899999965432221 22 5789999999999999999888664
Q ss_pred C--------CceEEEEEecCCCCcchhhcCCcc--------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 157 K--------DEKILIYEYMPNKSLDFFLFDPTK--------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 157 ~--------~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
. ...+++|||++|.+|.++...... ...+|..+++|+|+||+|++++.++ ++|+|||......
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 3 347899999999999776422111 1247778889999999999999888 9999999876442
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHH
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIV 265 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~ 265 (387)
.... . ...+....|+.++|+||||+++.-+.
T Consensus 186 e~~a-------~-------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 186 QRKA-------K-------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred chhh-------H-------HHHHHHhHhcccccccceeEeehHHH
Confidence 1110 0 11344556788999999999887654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=167.08 Aligned_cols=256 Identities=21% Similarity=0.224 Sum_probs=177.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcCC--CEEEEEEccCCCcccHHHHHHHHHHHHhcCC----CceeeeeeeE-EeCCceEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKG--DEIAVKRLPGRSGQGLREMKNEASVIAKVQH----KNLVRLLGCC-IDKDEKIL 162 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~~~~~~-~~~~~~~l 162 (387)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997663 4788887754432222267788999988863 5888888888 46667899
Q ss_pred EEEecCCCCcchhhcCCc-cc-----------------cccchhhhhhcccCCCceEEcCC-----CCeEEeeccCce--
Q 041766 163 IYEYMPNKSLDFFLFDPT-KR-----------------MLLDWSANYSSRLKVSNILLDKD-----INPKISDFGMAR-- 217 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~-~~-----------------~~l~~~~~~h~dlk~~Nill~~~-----~~~kl~Dfg~a~-- 217 (387)
||+.+ |.+|.++..... .. ..+|..+.+||||||+|+++... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99987 778988764433 11 24788899999999999999755 468999999998
Q ss_pred ecCCCCc-----ccc-cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc
Q 041766 218 ICGGNEL-----QAN-TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291 (387)
Q Consensus 218 ~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 291 (387)
....... ... ...+.||..|+++.+..+...+.+.|+||++-++.|++.|..||........ .......
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~---- 252 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD---- 252 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH----
Confidence 3322111 111 2335699999999999999999999999999999999999999743332111 0000000
Q ss_pred CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 292 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
........ .....+..+.++...+-..+..++|....+...|++............++|.
T Consensus 253 -~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 253 -PRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred -hhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 00000000 0111223455555555568999999999999999888766544443444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-20 Score=175.54 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=142.1
Q ss_pred HHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcchhhcCCccc-----------------cccchhhh-hhcccCCCce
Q 041766 139 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSAN-YSSRLKVSNI 200 (387)
Q Consensus 139 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~-~h~dlk~~Ni 200 (387)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...... .++|...+ +|+.|++.||
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35679999999999999999999999999999999988763322 12333333 8999999999
Q ss_pred EEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCC-------CCccccchhHHHHHHHHHhCCCCCCC
Q 041766 201 LLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-------FSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
++|....+||+|||+.................-...|.|||.+.+.. .+.++||||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99999999999999987664211111111122346799999997631 46779999999999999999999876
Q ss_pred CCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 274 YRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
....... .+.+..... .....+.|.+... .+..+.+..++..||..+|++||+++++...++....
T Consensus 161 ~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 161 RNLVEDP-DEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccCCh-HHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 4433321 112222111 1111222222211 1334478899999999999999999999998876643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=154.49 Aligned_cols=262 Identities=16% Similarity=0.216 Sum_probs=190.3
Q ss_pred hcCCCCCCcccccCCeeEEEEE-EcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|.++++||.|+||.+|.|. ..+|+.||||.-...... ..+.-|..+...++| ..|.++..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999998 455999999976543222 356678888888864 677778888888888899999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCC---CCeEEeeccCceecCCCC--
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARICGGNE-- 223 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~-- 223 (387)
.. |.+|+++..-.... .++|....+||||||+|.|..-+ ..+-|+|||+|+...+..
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 88 88998776443321 24677778999999999998533 468999999998775432
Q ss_pred ---cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 224 ---LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 224 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.........||.+|.+--...+...+.+-|+=|+|-+|..+-.|..||.......... . ++........-.+..
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--K-yEkI~EkK~s~~ie~ 247 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--K-YEKISEKKMSTPIEV 247 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--H-HHHHHHhhcCCCHHH
Confidence 2223445789999999888888888999999999999999999999986433221110 0 000000000000000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeeeecc
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNT 361 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~~~~ 361 (387)
.....+.++...+.-|-..--++-|.-.-+.+.++-+...+.-..+-.++|....
T Consensus 248 ------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 248 ------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 1122355777888899999999999998888888888888888888888887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-21 Score=180.39 Aligned_cols=208 Identities=23% Similarity=0.259 Sum_probs=161.3
Q ss_pred cccccCCeeEEEEE----EcCCCEEEEEEccCCCc--ccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEEecC
Q 041766 96 KLGEGGFGPVYKGV----LKKGDEIAVKRLPGRSG--QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 96 ~lG~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.+|+|.||.|++++ ...|..+|+|.+++... ........|..++..++ ||.+|+++-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 22366788888764421 11124456788888886 9999999999999999999999999
Q ss_pred CCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccccc
Q 041766 169 NKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 169 ~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
+|+|...+..... ...+|..+++++|+|++||+++.+|++|+.|||+++..-... ..|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IAC 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hcc
Confidence 9998766644332 134778888999999999999999999999999998654322 128
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc-cccccHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE-DEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 311 (387)
||..|||||++. ....++|.||||++++||+||..||.. +....+++ ....+...
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~~~p~~l 210 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAELEMPREL 210 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhccCCchhh
Confidence 999999999997 567889999999999999999999742 11122222 22356667
Q ss_pred HHHHHHHHHhcccCCCCCCCCH
Q 041766 312 LLRYVNIALLCVQESADDRPTM 333 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~ 333 (387)
...+.+++..++..+|..|.-.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 7788899999999999999755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=155.51 Aligned_cols=254 Identities=17% Similarity=0.214 Sum_probs=183.7
Q ss_pred CCCCCCcccccCCeeEEEEE-EcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEec
Q 041766 90 KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.|.++++||+|+||.++.|+ +-.++.||||.-+..+. .-.+..|.+..+.| ..++|..+|-+-..+-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68999999999999999998 45589999997654332 24667788888877 5789998887777777778999988
Q ss_pred CCCCcchhhcCCcccc-----------------ccchhhhhhcccCCCceEEcCC-----CCeEEeeccCceecCCCCc-
Q 041766 168 PNKSLDFFLFDPTKRM-----------------LLDWSANYSSRLKVSNILLDKD-----INPKISDFGMARICGGNEL- 224 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~~-----------------~l~~~~~~h~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~~~~~- 224 (387)
|.+|+++..-...+. .+|....|.|||||+|+||... ..+.|+|||+|+...+...
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 789987764333221 3455555679999999999654 3489999999998755432
Q ss_pred ----ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 225 ----QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
+.......||.+||+--.-.+...+.+-|.=|+|-++...+.|..||.....+ ...+..++
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---------------tnK~kYeK 250 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---------------TNKEKYEK 250 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc---------------chHHHHHH
Confidence 22334567999999999989999999999999999999999999997543322 11111111
Q ss_pred cc---cccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeeeecc
Q 041766 301 IL---EDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNT 361 (387)
Q Consensus 301 ~~---~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~~~~ 361 (387)
+- +... .....+.++..-+.-.-..+-.+-|..+-+...+.++...+..-.+-.++|....
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 10 0000 1122344555555555577888999999998888888887777777777776544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-18 Score=145.55 Aligned_cols=123 Identities=15% Similarity=0.088 Sum_probs=87.6
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--c------------------------HHHHHHHHHHHHhcCCCce
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--G------------------------LREMKNEASVIAKVQHKNL 147 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI 147 (387)
...||+|+||.||+|...+|+.||||+++..... . ......|+.++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999998643110 1 0122349999999988777
Q ss_pred eeeeeeEEeCCceEEEEEecCCCCcchhh-cCCcc---------------cccc-chhhhhhcccCCCceEEcCCCCeEE
Q 041766 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-FDPTK---------------RMLL-DWSANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 148 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~---------------~~~l-~~~~~~h~dlk~~Nill~~~~~~kl 210 (387)
.....+.. ...+|||||++++++.... ..... ...+ |..+++|+||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 44333222 2238999999988765432 21110 0124 567899999999999998 478999
Q ss_pred eeccCceec
Q 041766 211 SDFGMARIC 219 (387)
Q Consensus 211 ~Dfg~a~~~ 219 (387)
+|||+|...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=140.91 Aligned_cols=124 Identities=19% Similarity=0.142 Sum_probs=91.1
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--c------------------------HHHHHHHHHHHHhcCCCce
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--G------------------------LREMKNEASVIAKVQHKNL 147 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI 147 (387)
...||+|+||.||+|+..+|+.||||.++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998654211 0 1223578999999999987
Q ss_pred eeeeeeEEeCCceEEEEEecCCCCcchh-hcCCcc---------------ccccch-hhhhhcccCCCceEEcCCCCeEE
Q 041766 148 VRLLGCCIDKDEKILIYEYMPNKSLDFF-LFDPTK---------------RMLLDW-SANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 148 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~---------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl 210 (387)
.....+... ..++||||++++++... +..... ...+|. .+++|+||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 544443332 24899999998855332 222111 013666 8899999999999999 789999
Q ss_pred eeccCceecC
Q 041766 211 SDFGMARICG 220 (387)
Q Consensus 211 ~Dfg~a~~~~ 220 (387)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-18 Score=173.14 Aligned_cols=236 Identities=17% Similarity=0.148 Sum_probs=157.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC-cccHHHHHHHHHH--HHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS-GQGLREMKNEASV--IAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.+...+.||.+.|=+|.+|+++.|. |+||++-+.+ ......|.++++- +..++|||.+.+.-+-......|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998777 8999986553 4444555544333 4445899999988876666666788888
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC-----cc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE-----LQ 225 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-----~~ 225 (387)
..+ +|.+-+....- ....|..++.|+|||.+||||+.-..+.|+||..-+...-.. +.
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 754 66555433211 112466777899999999999999999999998655432111 11
Q ss_pred cccccccCCCccccccccccC----------C-CCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQG----------I-FSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
....+...-.+|.|||.+... . .+++-||+|+||++.||++ |+++|... .-.. +....
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~a---Yr~~~ 251 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLA---YRSGN 251 (1431)
T ss_pred EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHh---HhccC
Confidence 111222233579999988531 2 5788999999999999998 67776321 0001 11111
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.......+... ....+.+|+..|++.||+.|.++++.++.-++.
T Consensus 252 -~~~~e~~Le~I-----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 252 -ADDPEQLLEKI-----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -ccCHHHHHHhC-----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111111111 112577899999999999999999999874443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-17 Score=138.83 Aligned_cols=175 Identities=16% Similarity=0.089 Sum_probs=124.1
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc----cHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEe
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ----GLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.....|++|+||+||.+.- .+..++.+.+.....- ....+.+|+++|.++ +|++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 4778887777644221 122578999999999 45889999886 346899999
Q ss_pred cCCCCcchhhcCCcc---------ccccchhhhhhccc-CCCceEEcCCCCeEEeeccCceecCCCCc-----c-cc---
Q 041766 167 MPNKSLDFFLFDPTK---------RMLLDWSANYSSRL-KVSNILLDKDINPKISDFGMARICGGNEL-----Q-AN--- 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------~~~l~~~~~~h~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~-~~--- 227 (387)
+.|.+|...+..... ...+|..+++|+|| ||+|||++.++.++|+|||+|........ . ..
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~ 159 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRH 159 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHH
Confidence 999988654422111 12367788899999 79999999999999999999985543221 0 00
Q ss_pred --cccccCCCccccccccccC-CCC-ccccchhHHHHHHHHHhCCCCC
Q 041766 228 --TSRIVGTYGYMSPEYAIQG-IFS-IKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 228 --~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwS~Gvil~el~tg~~p~ 271 (387)
......++.|++|+.-.-- ..+ ...+.++-|.-+|.++|+..+.
T Consensus 160 llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 160 LLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0011245667777644321 234 4567789999999999998874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=140.46 Aligned_cols=123 Identities=20% Similarity=0.234 Sum_probs=93.8
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-----CCCceeeeeeeEEeCC---ceE-E
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-----QHKNLVRLLGCCIDKD---EKI-L 162 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~~~~~~~~---~~~-l 162 (387)
...+.||+|+||.||. ++.....+||++........+.+.+|+.++..+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4457899999999996 444333479988655444557889999999999 5799999999998863 333 7
Q ss_pred EEEe--cCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcC----CCCeEEeeccCc
Q 041766 163 IYEY--MPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDK----DINPKISDFGMA 216 (387)
Q Consensus 163 v~e~--~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~----~~~~kl~Dfg~a 216 (387)
|+|| +++|+|.+++.+... ..++|..+++||||||+|||++. ++.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 558999988864311 02467788899999999999974 347999995544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.1e-18 Score=169.63 Aligned_cols=210 Identities=16% Similarity=0.206 Sum_probs=137.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|..++.+..|+||.||..+++. .+.+|+ ++++.. .+.+- ++.....|.+| |=|.. .+.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv---gDc~t------llk 143 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV---GDCAT------LLK 143 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee---chhhh------hcc
Confidence 34689999999999999999999886 667888 443221 11111 44444556555 11110 000
Q ss_pred ecCCCCcchhhcCCccccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC-------------ccccccccc
Q 041766 166 YMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE-------------LQANTSRIV 232 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~~ 232 (387)
-+ |.|-.-+ .....++|..+++|||+||+|.+|+.-|++|++|||+++...... ..-.....+
T Consensus 144 ~~--g~lPvdm--vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 144 NI--GPLPVDM--VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVC 219 (1205)
T ss_pred cC--CCCcchh--hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcccc
Confidence 00 0010000 112347888999999999999999999999999999987532100 011123468
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
||+.|.|||++....|+..+|+|++|+|+||.+.|+.||+...++.. +-.++.. .+.-........
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd-------------~i~wpE~dea~p 285 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISD-------------DIEWPEEDEALP 285 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhh-------------hccccccCcCCC
Confidence 99999999999999999999999999999999999999754432211 0001100 000001122234
Q ss_pred HHHHHHHHhcccCCCCCCC
Q 041766 313 LRYVNIALLCVQESADDRP 331 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RP 331 (387)
.++.+++.+.|+.+|.+|-
T Consensus 286 ~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 286 PEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHHHHHHhChHhhc
Confidence 5788999999999999996
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-17 Score=147.65 Aligned_cols=182 Identities=21% Similarity=0.227 Sum_probs=119.9
Q ss_pred CCCceeeeeeeEEeC---------------------------CceEEEEEecCCCCcchhhcCCccc-------------
Q 041766 143 QHKNLVRLLGCCIDK---------------------------DEKILIYEYMPNKSLDFFLFDPTKR------------- 182 (387)
Q Consensus 143 ~h~nIv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~------------- 182 (387)
.|||||++.++|.+. ...|+||.-.+. +|..++......
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 599999999887542 135788877644 677777543321
Q ss_pred --cccchhhhhhcccCCCceEE--cCC--CCeEEeeccCceecCCCCcc----cccccccCCCccccccccccCC-----
Q 041766 183 --MLLDWSANYSSRLKVSNILL--DKD--INPKISDFGMARICGGNELQ----ANTSRIVGTYGYMSPEYAIQGI----- 247 (387)
Q Consensus 183 --~~l~~~~~~h~dlk~~Nill--~~~--~~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----- 247 (387)
..++..++.|||||++|||| |+| -.+.|+|||.+-....+... ...-...|...-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 24677788999999999998 444 34689999987654332221 1222245777899999986432
Q ss_pred C-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCC
Q 041766 248 F-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQES 326 (387)
Q Consensus 248 ~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 326 (387)
. -.|+|.|+.|.+.||+++...||..... +.+. .....+. +-+..+..+++.+.+++...|+.|
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~--------~r~Yqe~-----qLPalp~~vpp~~rqlV~~lL~r~ 497 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLD--------TRTYQES-----QLPALPSRVPPVARQLVFDLLKRD 497 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccch--heec--------hhhhhhh-----hCCCCcccCChHHHHHHHHHhcCC
Confidence 1 3689999999999999999999743111 1100 0000000 111123445667889999999999
Q ss_pred CCCCCCHHHHHHHh
Q 041766 327 ADDRPTMNEVVSML 340 (387)
Q Consensus 327 P~~RPt~~~v~~~L 340 (387)
|++|++..-..+.|
T Consensus 498 pskRvsp~iAANvl 511 (598)
T KOG4158|consen 498 PSKRVSPNIAANVL 511 (598)
T ss_pred ccccCCccHHHhHH
Confidence 99999876665554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-16 Score=162.18 Aligned_cols=181 Identities=18% Similarity=0.190 Sum_probs=136.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv 163 (387)
..+.|.+.+.||+|+||.||+|...+|+.||+|.-+....- +|.=-.+++.+|+ -+.|.++...+...+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34678888899999999999999888999999987543221 1111122333333 35666777777777778899
Q ss_pred EEecCCCCcchhhcCCccc----------------cccchhhhhhcccCCCceEEcC-------CCCeEEeeccCceecC
Q 041766 164 YEYMPNKSLDFFLFDPTKR----------------MLLDWSANYSSRLKVSNILLDK-------DINPKISDFGMARICG 220 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~----------------~~l~~~~~~h~dlk~~Nill~~-------~~~~kl~Dfg~a~~~~ 220 (387)
+||.+.|+|.+++.....- ..+|..+|||+||||+|+||.. ...++|+|||.|-.+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 9999999999888733221 2478899999999999999942 3458999999986543
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p 270 (387)
--..........+|-.+-.+|...|.+++..+|.|.|..+++-|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 21111234456788899999999999999999999999999999999754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=142.34 Aligned_cols=212 Identities=18% Similarity=0.192 Sum_probs=127.7
Q ss_pred CCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCC----------CceeeeeeeEE--
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQH----------KNLVRLLGCCI-- 155 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~nIv~~~~~~~-- 155 (387)
...+.||.|+++.||.+++.. ++.+|+|.+... .....+.+.+|.-....+.+ -.++--++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 446789999999999999887 889999987422 22345566666544444322 12222222211
Q ss_pred -------eCC--------ceEEEEEecCCCCcchhhcC-----Ccc------------------ccccchhhhhhcccCC
Q 041766 156 -------DKD--------EKILIYEYMPNKSLDFFLFD-----PTK------------------RMLLDWSANYSSRLKV 197 (387)
Q Consensus 156 -------~~~--------~~~lv~e~~~~g~L~~~l~~-----~~~------------------~~~l~~~~~~h~dlk~ 197 (387)
... ..+++|+-+ .+||..++.. ... ...+|..+++|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 235677766 5577666431 010 1247788889999999
Q ss_pred CceEEcCCCCeEEeeccCceecCCCCcccccccccCCCcccccccccc--------CCCCccccchhHHHHHHHHHhCCC
Q 041766 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ--------GIFSIKSDVFSFGVLLLEIVSGKK 269 (387)
Q Consensus 198 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwS~Gvil~el~tg~~ 269 (387)
+|++++.+|.+.|+||+.....+... .. ...+..|.+||.... -.++.+.|.|++|+++|.|.++..
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999998776543211 11 234577999997743 247899999999999999999999
Q ss_pred CCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCC
Q 041766 270 TTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR 330 (387)
Q Consensus 270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 330 (387)
||+......... ..+. .+. +.+..+..||.++|+.||++|
T Consensus 249 Pf~~~~~~~~~~------------------~~f~--~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPE------------------WDFS--RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSG------------------GGGT--TSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCcccccc------------------ccch--hcC-CcCHHHHHHHHHHccCCcccC
Confidence 976432211100 0111 134 678889999999999999988
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.2e-17 Score=153.49 Aligned_cols=159 Identities=23% Similarity=0.302 Sum_probs=109.6
Q ss_pred ceEEEEEecCCCCcchhhcCCccc------c----------ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTKR------M----------LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~~------~----------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
..|+.|++|...+|.+++...... . .....+.+|+|+||.||....+..+||.|||+.......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~ 409 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKD 409 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeecccC
Confidence 468999999999999999643221 1 122356689999999999999999999999998776543
Q ss_pred C----cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 223 E----LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG-KKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 223 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
. .....+...||..||+||.+.+..|+.++||||||++|+|++.. ...+ .......++
T Consensus 410 ~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~-----------------er~~t~~d~ 472 (516)
T KOG1033|consen 410 ETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF-----------------ERIATLTDI 472 (516)
T ss_pred CcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH-----------------HHHHhhhhh
Confidence 3 12234456899999999999999999999999999999999972 1111 000000111
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v 336 (387)
-+..+... .....+.-..|+.+++...|.+||++.++
T Consensus 473 r~g~ip~~--~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPE--FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChH--HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 11111100 00111234578899999999999955444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3e-15 Score=129.85 Aligned_cols=127 Identities=17% Similarity=0.126 Sum_probs=95.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc----------------------ccHHHHHHHHHHHHhcCCCc-
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG----------------------QGLREMKNEASVIAKVQHKN- 146 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n- 146 (387)
.|...+.||+|+||.||++...+|+.||||++..... .....+..|..++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3677899999999999999987899999998653210 01123567899999997774
Q ss_pred -eeeeeeeEEeCCceEEEEEecCCCCcchhhc-CCcc---------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 147 -LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF-DPTK---------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 147 -Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~---------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
+...++ ....++||||+++++|..... .... ...+|..+++|+||||+||+++.++.++|+|||+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 444443 234589999999999876653 1111 1235667789999999999999999999999999
Q ss_pred ceecC
Q 041766 216 ARICG 220 (387)
Q Consensus 216 a~~~~ 220 (387)
+....
T Consensus 172 ~~~~~ 176 (198)
T cd05144 172 MVSTD 176 (198)
T ss_pred cccCC
Confidence 86543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=130.13 Aligned_cols=122 Identities=17% Similarity=0.235 Sum_probs=97.7
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--------cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
+.||+|++|.||+|.+ .+..|++|........ ....+.+|+.++..+.|++|.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 4778999976533211 123577899999999999998877777777888999999
Q ss_pred cCCCCcchhhcCCcc------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 167 MPNKSLDFFLFDPTK------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
++|++|..++..... ...+|..+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999887754321 1246777789999999999999 78899999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.2e-15 Score=127.52 Aligned_cols=121 Identities=21% Similarity=0.286 Sum_probs=94.2
Q ss_pred cccccCCeeEEEEEEcCCCEEEEEEccCCCc--c------cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG--Q------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.||+|+||.||+|.+. +..|++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 67899998643211 1 1245678999999999887666555566667779999999
Q ss_pred CCCCcchhhcCCcc---------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 168 PNKSLDFFLFDPTK---------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 168 ~~g~L~~~l~~~~~---------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
+|++|..++..... ...+|..+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999877654321 1246777889999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.8e-15 Score=130.68 Aligned_cols=125 Identities=16% Similarity=0.087 Sum_probs=91.8
Q ss_pred CCCCCCcccccCCeeEEEEE--EcCCCEEEEEEccCCCcc------------------------cHHHHHHHHHHHHhcC
Q 041766 90 KFSDANKLGEGGFGPVYKGV--LKKGDEIAVKRLPGRSGQ------------------------GLREMKNEASVIAKVQ 143 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 143 (387)
-|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37788999999999999998 456899999988643210 0123568999999996
Q ss_pred CC--ceeeeeeeEEeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhh-hhhcccCCCceEEcC
Q 041766 144 HK--NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSA-NYSSRLKVSNILLDK 204 (387)
Q Consensus 144 h~--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~-~~h~dlk~~Nill~~ 204 (387)
+. .+.+++++ ...++||||+++++|......... ...+|..+ ++|+||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444443 234899999999887654422111 12367788 99999999999999
Q ss_pred CCCeEEeeccCceec
Q 041766 205 DINPKISDFGMARIC 219 (387)
Q Consensus 205 ~~~~kl~Dfg~a~~~ 219 (387)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.3e-15 Score=147.28 Aligned_cols=129 Identities=19% Similarity=0.256 Sum_probs=99.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEc-cCC-Cc------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL-PGR-SG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
...|...+.||+|+||.||+|.+... .+++|+. ... .. ...+.+.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987643 3444432 211 11 123567899999999999999988888877778
Q ss_pred eEEEEEecCCCCcchhhcCCc--------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 160 KILIYEYMPNKSLDFFLFDPT--------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.++||||+++++|.+++.... ....+|..+++|+||||+|||+ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999988774211 1135778889999999999999 577999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.6e-16 Score=153.24 Aligned_cols=238 Identities=18% Similarity=0.208 Sum_probs=172.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCCC--cccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv 163 (387)
..|.+.+.||+|+|+.|-...... ...+|+|.+.... .........|..+=..+. |+|++++++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457778889999999999887643 3456666664332 222334445777766775 99999999999999999999
Q ss_pred EEecCCCCcchhh-cCCc-----------------cccccc-hhhhhhcccCCCceEEcCCC-CeEEeeccCceecCC-C
Q 041766 164 YEYMPNKSLDFFL-FDPT-----------------KRMLLD-WSANYSSRLKVSNILLDKDI-NPKISDFGMARICGG-N 222 (387)
Q Consensus 164 ~e~~~~g~L~~~l-~~~~-----------------~~~~l~-~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~-~ 222 (387)
++|..++++...+ .... ...++| ..+..|+|+||+|.+++..+ ..|++|||+|..... .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999987777 3221 113466 77789999999999999999 999999999987765 4
Q ss_pred CcccccccccC-CCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 223 ELQANTSRIVG-TYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 223 ~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.........+| ++.|+|||...+.. .....|+||.|+++.-+++|..|+............|... . .
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-----~-----~- 248 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-----K-----G- 248 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-----c-----c-
Confidence 44444455678 99999999998854 4678999999999999999999976544332111111110 0 0
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...............++..+++..+|..|.+.+++..
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0001122233446778889999999999999988765
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-13 Score=117.98 Aligned_cols=122 Identities=18% Similarity=0.184 Sum_probs=82.4
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--cHHH----------------------HHHHHHHHHhcCCCc--e
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--GLRE----------------------MKNEASVIAKVQHKN--L 147 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--I 147 (387)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988643211 1111 134556666654332 3
Q ss_pred eeeeeeEEeCCceEEEEEecCCCC-----cchhhcCCcc----------ccccch-hhhhhcccCCCceEEcCCCCeEEe
Q 041766 148 VRLLGCCIDKDEKILIYEYMPNKS-----LDFFLFDPTK----------RMLLDW-SANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 148 v~~~~~~~~~~~~~lv~e~~~~g~-----L~~~l~~~~~----------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
.+.++. ...++||||++++. |......... ...+|. .+++|+||||+||+++ ++.++|+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEE
Confidence 444433 24589999999943 3332221000 123566 7889999999999999 8899999
Q ss_pred eccCceecC
Q 041766 212 DFGMARICG 220 (387)
Q Consensus 212 Dfg~a~~~~ 220 (387)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1e-12 Score=116.90 Aligned_cols=124 Identities=19% Similarity=0.217 Sum_probs=93.0
Q ss_pred CCccc-ccCCeeEEEEEEcCCCEEEEEEccCCC-------------cccHHHHHHHHHHHHhcCCCce--eeeeeeEEeC
Q 041766 94 ANKLG-EGGFGPVYKGVLKKGDEIAVKRLPGRS-------------GQGLREMKNEASVIAKVQHKNL--VRLLGCCIDK 157 (387)
Q Consensus 94 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~~~~~~~~~ 157 (387)
...|| .|+.|+||..... +..++||.+.... ......+.+|++++.+++|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 7888999998876 7789999874211 1223467889999999988775 6777765443
Q ss_pred C----ceEEEEEecCC-CCcchhhcCCcc-----------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 158 D----EKILIYEYMPN-KSLDFFLFDPTK-----------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 158 ~----~~~lv~e~~~~-g~L~~~l~~~~~-----------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
. ..++||||+++ .+|..++..... ...+|..+++|+||||.|||++.++.++|+|||.+..
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 23599999997 688777654321 1247888899999999999999888999999998864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-12 Score=107.95 Aligned_cols=123 Identities=20% Similarity=0.162 Sum_probs=96.1
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--CceeeeeeeEEeCCceEEEEEecCCC
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
+.+.||.|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999864 7899999865433 4678899999999976 58999999888778899999999988
Q ss_pred Ccchh----hcCC-----ccccccch---hhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 171 SLDFF----LFDP-----TKRMLLDW---SANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 171 ~L~~~----l~~~-----~~~~~l~~---~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.+..+ .... .....+|. ..++|+|++|+||+++..+.+++.|||.+..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77643 0000 00112333 3588999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.5e-12 Score=124.29 Aligned_cols=126 Identities=20% Similarity=0.219 Sum_probs=86.9
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccH----------------------------------------HHHHH
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGL----------------------------------------REMKN 134 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 134 (387)
+.||.|++|.||+|++++|+.||||+.+....... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999854311100 02344
Q ss_pred HHHHHHhc----CCCceeeeeeeEEe-CCceEEEEEecCCCCcchhhcCCcc-----c----------cccchhhhhhcc
Q 041766 135 EASVIAKV----QHKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFLFDPTK-----R----------MLLDWSANYSSR 194 (387)
Q Consensus 135 E~~~l~~l----~h~nIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~-----~----------~~l~~~~~~h~d 194 (387)
|+..+.++ +|.+-+.+-.++.+ ....+|||||++|++|.++...... . ..++..+.+|+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~D 282 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHAD 282 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 55555554 23333333333322 3456899999999999876532100 0 124556678999
Q ss_pred cCCCceEEcCCCCeEEeeccCceecC
Q 041766 195 LKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 195 lk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
++|.||+++.++.++++|||++..+.
T Consensus 283 ~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 283 LHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4e-12 Score=121.69 Aligned_cols=235 Identities=20% Similarity=0.210 Sum_probs=162.0
Q ss_pred HHhcCCCCCCcccc--cCCeeEEEEEE--c-CCCEEEEEEcc--CCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 86 TATNKFSDANKLGE--GGFGPVYKGVL--K-KGDEIAVKRLP--GRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~--G~~g~V~~~~~--~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
.....|.+.+.+|. |.+|.||.+.. . ++..+|+|+-. .........=.+|+....++ .|+|.|+.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34456777889999 99999999987 3 37788998743 22223333344666666677 699999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCc---------------------cccccchhhhhhcccCCCceEEcCC-CCeEEeeccC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPT---------------------KRMLLDWSANYSSRLKVSNILLDKD-INPKISDFGM 215 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~ 215 (387)
+..++-+|+|. .+|..+..... ....+|...++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999985 56654443211 1234677778999999999999988 8899999999
Q ss_pred ceecCCCCcccc---cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 216 ARICGGNELQAN---TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 216 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
....+....... .....|...|++||.. .+.++...||||+|.+..+-.++...+.....+. |.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~------- 336 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS------- 336 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc-------
Confidence 988765442211 1223577889999977 4568899999999999999998876642211110 00
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.++...............+...+.++++.+|..|+++..+..
T Consensus 337 ----~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ----QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111110011111234445888999999999999988776
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-12 Score=124.36 Aligned_cols=133 Identities=17% Similarity=0.174 Sum_probs=88.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc----------------------------------cHH--
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ----------------------------------GLR-- 130 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 130 (387)
...|+. +-||.|++|.||+|++++ |+.||||+....... ...
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999988 999999998643100 011
Q ss_pred ----HHHHHHHHHHhcC----CCceeeeeeeEEe-CCceEEEEEecCCCCcchhh--cCCcc---cc----------ccc
Q 041766 131 ----EMKNEASVIAKVQ----HKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFL--FDPTK---RM----------LLD 186 (387)
Q Consensus 131 ----~~~~E~~~l~~l~----h~nIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~----------~l~ 186 (387)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.+.++. ..... .. .+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1333444444432 3333443343333 34557999999999987642 21110 00 122
Q ss_pred hhhhhhcccCCCceEEcCCC----CeEEeeccCceecCC
Q 041766 187 WSANYSSRLKVSNILLDKDI----NPKISDFGMARICGG 221 (387)
Q Consensus 187 ~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 221 (387)
..+.+|+|+||.||+++.++ .+++.|||+...+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 35668999999999999888 999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.8e-10 Score=95.02 Aligned_cols=119 Identities=20% Similarity=0.128 Sum_probs=83.5
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCceEEEEEecCCCCc
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
.+.|+.|.++.||++... +..|++|....... ....+.+|+.++..+.+.++ .+++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356889999999999876 77899998754432 12346789999998865554 3455443 3345899999999888
Q ss_pred chhhcCCc--------cccccchhh-----hhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 173 DFFLFDPT--------KRMLLDWSA-----NYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 173 ~~~l~~~~--------~~~~l~~~~-----~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
........ ....+|... .+|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 64211000 011244444 49999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-09 Score=89.71 Aligned_cols=122 Identities=20% Similarity=0.227 Sum_probs=90.9
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCC---c-----ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS---G-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..+++|+=+.+|.+.+. |..+++|.-.... + -...+..+|+.++.+++--.|..-+=+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775 5557777543221 1 1123566799999998655554444455667777899999
Q ss_pred cCCCCcchhhcCCccc---------cccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 167 MPNKSLDFFLFDPTKR---------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~---------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
++|..|.+.+...... ..+|+.+++|+||.++||++.++. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888766221 258999999999999999998875 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.7e-10 Score=108.31 Aligned_cols=231 Identities=16% Similarity=0.120 Sum_probs=154.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc--CCCEEEEEEccCCCcccHHH--HHHHHHHHHhc-CCCceeeeeeeEEeCCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLPGRSGQGLRE--MKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~ 160 (387)
....+|..+..||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+-+...+ .|.++++++..+..-.+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999998755 36778999886543322222 23455555555 699999988777777777
Q ss_pred EEEEEecCCCCcchhhcC----------------CccccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFD----------------PTKRMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~----------------~~~~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~ 223 (387)
|+=.|||.++++...... ......+|....+|.|+||+||++..+ +..++.|||.++.+.-.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 899999999987543311 011234677788999999999999886 88899999998642211
Q ss_pred cccccccccCCCccc--cccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 LQANTSRIVGTYGYM--SPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
........+++ ++.......+..++|++|||..+.|..++..-.. .......+....
T Consensus 421 ----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-----------------~~~~~~~i~~~~ 479 (524)
T KOG0601|consen 421 ----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-----------------SGVQSLTIRSGD 479 (524)
T ss_pred ----cccccccccccccchhhccccccccccccccccccccccccCcccCc-----------------ccccceeeeccc
Confidence 11112233344 5555566788999999999999999999875421 011111111110
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~ 341 (387)
. .........+..+.+.+...++..||.+.++....+
T Consensus 480 ~---p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 T---PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred c---cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 111122256777888899999999999988776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.9e-10 Score=114.98 Aligned_cols=234 Identities=15% Similarity=0.163 Sum_probs=154.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..+.+.+.+-+-+|.++.++.+.-.. |...++|..... .....+....+-.++-..+||.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34566777788889999998876432 333333333211 11222233334444444567888877766666778899
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC-----
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG----- 221 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~----- 221 (387)
+++|..+++|...++.... ...++...+.|+|++|.|.|+..++..+++|||.....+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999887765431 1245556689999999999999999999999984322210
Q ss_pred -C-------------------Ccc----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041766 222 -N-------------------ELQ----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD 277 (387)
Q Consensus 222 -~-------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~ 277 (387)
. ... .......||+.|.+||.+.+......+|+|++|++++|.++|.+||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 000 1122356899999999999999999999999999999999999997533222
Q ss_pred cchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHH
Q 041766 278 SLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMN 334 (387)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ 334 (387)
.. ...++........-+........+++...+..+|.+|-.+.
T Consensus 1042 ~~--------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI--------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh--------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 10 01111111111112334455677888889999999998776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.7e-08 Score=83.34 Aligned_cols=125 Identities=21% Similarity=0.271 Sum_probs=89.9
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--------cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+..+-+|+-+.|+++.+. |+.+.||.-.... .-...+..+|++.|.+++--.|.--.=++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678899999999999987 7888888543221 112346778999999986555544444556666678999
Q ss_pred EecCC-CCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCC---CeEEeeccCcee
Q 041766 165 EYMPN-KSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDI---NPKISDFGMARI 218 (387)
Q Consensus 165 e~~~~-g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~---~~kl~Dfg~a~~ 218 (387)
||+++ .++..+++.... -..+|+..++|+||..+||++..++ .+-++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 356666643211 1248999999999999999996554 358999999853
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.1e-09 Score=95.91 Aligned_cols=184 Identities=20% Similarity=0.213 Sum_probs=114.7
Q ss_pred HHHHHhcCCCceeeeeeeEEeCC-----ceEEEEEecCCCCcchhhcCCccc--------------------cccch--h
Q 041766 136 ASVIAKVQHKNLVRLLGCCIDKD-----EKILIYEYMPNKSLDFFLFDPTKR--------------------MLLDW--S 188 (387)
Q Consensus 136 ~~~l~~l~h~nIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~--~ 188 (387)
..-|-++.|.|||+++.|+.+.. ...+++||+..|++..+|++.... .+||. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455567999999999987643 467999999999999999764321 12222 2
Q ss_pred hhhhcccCCCceEEcCCCCeEEeeccCceecCC--CCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh
Q 041766 189 ANYSSRLKVSNILLDKDINPKISDFGMARICGG--NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266 (387)
Q Consensus 189 ~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t 266 (387)
.++|+++..+-|++..++-+|+.--.-...... ...........+-++|.|||.-.....+.++|||+||....||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 357899999999999988888753211110000 000111122345678999997766667889999999999999988
Q ss_pred CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 267 GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 267 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..-........ ...+.+......... ..-..++.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~--------------~~ee~ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKV--------------EVEENIANVIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCccee--------------ehhhhhhhheeeccC-----ccccCcCcccccCCCCCCcchhhhhc
Confidence 764321110000 000001110000000 01125778999999999999998775
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.2e-08 Score=97.48 Aligned_cols=152 Identities=16% Similarity=0.196 Sum_probs=107.2
Q ss_pred cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcchhhcCCcc---------
Q 041766 111 KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--------- 181 (387)
Q Consensus 111 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------- 181 (387)
.++.+|.|...........+...+-++.|+.++||||++++..+...+..|||+|-+.- |..++.+...
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~~~~v~~Gl~q 112 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELGKEEVCLGLFQ 112 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhHHHHHHHHHHH
Confidence 34788888888766554455677888999999999999999999999999999998743 3333322221
Q ss_pred ----cccc-chhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchh
Q 041766 182 ----RMLL-DWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256 (387)
Q Consensus 182 ----~~~l-~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 256 (387)
..+| +.+..+|++|.-.-|+++..|..||++|-++.......... .....-..|..|+.+.... ...|.|-
T Consensus 113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~--~s~D~~~ 188 (690)
T KOG1243|consen 113 ILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE--WSIDSWG 188 (690)
T ss_pred HHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc--cchhhhh
Confidence 1123 46778999999999999999999999998875443222100 0111112356666543222 4569999
Q ss_pred HHHHHHHHHhCC
Q 041766 257 FGVLLLEIVSGK 268 (387)
Q Consensus 257 ~Gvil~el~tg~ 268 (387)
|||++||++.|.
T Consensus 189 Lg~li~el~ng~ 200 (690)
T KOG1243|consen 189 LGCLIEELFNGS 200 (690)
T ss_pred HHHHHHHHhCcc
Confidence 999999999994
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.72 E-value=1e-07 Score=81.45 Aligned_cols=120 Identities=13% Similarity=0.064 Sum_probs=81.0
Q ss_pred CcccccCCeeEEEEEEcC-------CCEEEEEEccCC-------------C---------cccHHHHH----HHHHHHHh
Q 041766 95 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLPGR-------------S---------GQGLREMK----NEASVIAK 141 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 141 (387)
..||.|.=+.||.|...+ +..+|||..+.. + ......+. +|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998543 478999976311 0 11122333 79999999
Q ss_pred cC--CCceeeeeeeEEeCCceEEEEEecCCCCcch-hhcCCc----c----------c--cccchhhhhhcccCCCceEE
Q 041766 142 VQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSLDF-FLFDPT----K----------R--MLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 142 l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~----~----------~--~~l~~~~~~h~dlk~~Nill 202 (387)
+. .-++...+++ ..-+|||||+.++.+.. .+.+.. . . ..+|..+++|+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 84 3566666664 34589999997653311 111110 0 0 12367789999999999999
Q ss_pred cCCCCeEEeeccCceec
Q 041766 203 DKDINPKISDFGMARIC 219 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~ 219 (387)
++ +.+.|+|||.+-..
T Consensus 159 ~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 159 HD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EC-CcEEEEECCCceeC
Confidence 74 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.5e-07 Score=79.65 Aligned_cols=81 Identities=16% Similarity=0.227 Sum_probs=61.5
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCC--CceeeeeeeEEeC---CceEEEEEecC
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQH--KNLVRLLGCCIDK---DEKILIYEYMP 168 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~---~~~~lv~e~~~ 168 (387)
+.|+.|..+.||++...+|..+++|....... .....+..|.+++..+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987668899998754322 134578899999999965 4467777776654 25689999999
Q ss_pred CCCcchh
Q 041766 169 NKSLDFF 175 (387)
Q Consensus 169 ~g~L~~~ 175 (387)
+.++...
T Consensus 84 G~~l~~~ 90 (223)
T cd05154 84 GRVLRDR 90 (223)
T ss_pred CEecCCC
Confidence 8877554
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=4.9e-07 Score=76.94 Aligned_cols=111 Identities=22% Similarity=0.197 Sum_probs=70.7
Q ss_pred eEEEEEEcCCCEEEEEEccCCC-------------c-------------ccHHHHHHHHHHHHhcCCC--ceeeeeeeEE
Q 041766 104 PVYKGVLKKGDEIAVKRLPGRS-------------G-------------QGLREMKNEASVIAKVQHK--NLVRLLGCCI 155 (387)
Q Consensus 104 ~V~~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~ 155 (387)
.||.|...+|..+|+|..+... . .......+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999763210 0 0123466899999999655 566666542
Q ss_pred eCCceEEEEEecC--CCCcchhhcCC-----cc----------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 156 DKDEKILIYEYMP--NKSLDFFLFDP-----TK----------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 156 ~~~~~~lv~e~~~--~g~L~~~l~~~-----~~----------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.-+|||||++ |..+..+.... .. ...+|..+++|+||.+.|||++++ .+.|+|||.+..
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 3379999998 54443332221 00 113567788999999999999988 999999998875
Q ss_pred c
Q 041766 219 C 219 (387)
Q Consensus 219 ~ 219 (387)
.
T Consensus 156 ~ 156 (188)
T PF01163_consen 156 S 156 (188)
T ss_dssp T
T ss_pred c
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-06 Score=76.83 Aligned_cols=123 Identities=17% Similarity=0.164 Sum_probs=88.3
Q ss_pred CCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC-----------C-----------cccHHHHHHHHHHHHhcCCC--c
Q 041766 91 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR-----------S-----------GQGLREMKNEASVIAKVQHK--N 146 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-----------~-----------~~~~~~~~~E~~~l~~l~h~--n 146 (387)
..+...||-|.=+.||.|..++|.++|||.=+.. + ...+....+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3467899999999999999999999999942110 0 11234567899999998544 6
Q ss_pred eeeeeeeEEeCCceEEEEEecCCCCcchhh--cCCcccc---------ccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--FDPTKRM---------LLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 147 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~---------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
+.+.+++ +...+||||++|-.|...- ....... ..-..+++|+|+.+=||+++++|.+.++||--
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ 248 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ 248 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence 7776665 4457999999887665433 1111100 11256679999999999999999999999975
Q ss_pred ce
Q 041766 216 AR 217 (387)
Q Consensus 216 a~ 217 (387)
+.
T Consensus 249 ~v 250 (304)
T COG0478 249 AV 250 (304)
T ss_pred cc
Confidence 54
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=3.4e-07 Score=88.83 Aligned_cols=169 Identities=15% Similarity=0.062 Sum_probs=119.7
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCCceEEEEEecC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~~ 168 (387)
-+.....+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34455668999999999987544444445554322 34456889999999999 7888888888888899999998
Q ss_pred CC-CcchhhcC-----------------CccccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 169 NK-SLDFFLFD-----------------PTKRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 169 ~g-~L~~~l~~-----------------~~~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
.+ +....... ......++....+|+| ||+.++ +..|..||+.+..+.... ....
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 77 22111100 0001123333345666 777766 579999999987665332 3455
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCC
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
..++..|+|||+.....+..+.|.|++|+-..++.-|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 68899999999999999999999999999888887777663
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.8e-06 Score=83.18 Aligned_cols=127 Identities=17% Similarity=0.195 Sum_probs=83.6
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--------------------------c--------------HHHHHH
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--------------------------G--------------LREMKN 134 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~--------------~~~~~~ 134 (387)
+-|+.++-|.||+|++++|+.||||+....-.. . .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999999999999987432100 0 012334
Q ss_pred HHHHHHhcC----CCceeeeeeeEEe-CCceEEEEEecCCCCcchhh--cCCccc--c-----------ccchhhhhhcc
Q 041766 135 EASVIAKVQ----HKNLVRLLGCCID-KDEKILIYEYMPNKSLDFFL--FDPTKR--M-----------LLDWSANYSSR 194 (387)
Q Consensus 135 E~~~l~~l~----h~nIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~--~-----------~l~~~~~~h~d 194 (387)
|...+.+++ +.-=+++=.+|.+ .....|+|||++|-.+.+.. ...... . .+-..+.+|.|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHaD 290 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHAD 290 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCccccC
Confidence 555554442 2222222233332 34568999999998887663 221111 0 11224568999
Q ss_pred cCCCceEEcCCCCeEEeeccCceecCC
Q 041766 195 LKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 195 lk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
..|.||+++.++.+-+.|||+......
T Consensus 291 pHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 291 PHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred CCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999876643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=72.91 Aligned_cols=122 Identities=14% Similarity=0.062 Sum_probs=80.3
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcc-----------cHHHHHHHHHHHHhcCCC--ceeeeeeeEEe-----
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ-----------GLREMKNEASVIAKVQHK--NLVRLLGCCID----- 156 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~----- 156 (387)
+.+-.-....|++..+. |+.+.||........ -...+.+|...+.++..- .+...+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444457777664 778999977433211 111477899999888433 33444555443
Q ss_pred CCceEEEEEecCCC-CcchhhcCC---cc---------------ccccchhhhhhcccCCCceEEcC-------CCCeEE
Q 041766 157 KDEKILIYEYMPNK-SLDFFLFDP---TK---------------RMLLDWSANYSSRLKVSNILLDK-------DINPKI 210 (387)
Q Consensus 157 ~~~~~lv~e~~~~g-~L~~~l~~~---~~---------------~~~l~~~~~~h~dlk~~Nill~~-------~~~~kl 210 (387)
....++|||++++. +|.+++... .. ...+|..+++|+||++.|||++. +..+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 12468999999876 787776421 10 01478888999999999999975 467999
Q ss_pred eeccCce
Q 041766 211 SDFGMAR 217 (387)
Q Consensus 211 ~Dfg~a~ 217 (387)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999875
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.2e-05 Score=66.53 Aligned_cols=120 Identities=22% Similarity=0.259 Sum_probs=85.1
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCceEEEEEecCCC
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~g 170 (387)
...+.||+|.+|.||+|.+. +..+|+|+-...+ .+..+..|+++|..+.-.++. +++.+- ..++.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 45578999999999999998 6689999875443 346788999999998766664 344432 234669999998
Q ss_pred CcchhhcCCcc---------ccccchhhhhhcccC-CCceEEcCCCCeEEeeccCcee
Q 041766 171 SLDFFLFDPTK---------RMLLDWSANYSSRLK-VSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 171 ~L~~~l~~~~~---------~~~l~~~~~~h~dlk-~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.|...-..... ...|+..++-|..|. |...+|..+..+-|+||.-|+.
T Consensus 98 ~L~~~~~~~~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcccHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88665442111 234666777787764 5555555555899999998874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2e-06 Score=84.37 Aligned_cols=142 Identities=18% Similarity=0.223 Sum_probs=90.9
Q ss_pred ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-cc------cccccCCCccccccccccCCCCccccchh
Q 041766 184 LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-AN------TSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256 (387)
Q Consensus 184 ~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 256 (387)
.+.....+|++|.|++|.++..+..||+.|+.+......... .. ..-......|.|||++.....+.++|++|
T Consensus 115 lh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fS 194 (700)
T KOG2137|consen 115 LHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFS 194 (700)
T ss_pred hccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccccccccee
Confidence 344567899999999999999999999999987544331110 00 01122346799999999888899999999
Q ss_pred HHHHHHHHHhCCCC-CCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 041766 257 FGVLLLEIVSGKKT-TGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNE 335 (387)
Q Consensus 257 ~Gvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~ 335 (387)
+|+++|.+..|..+ +....... ...... .. .+. ..-......+.++.+=+.+.+..++.-||++.+
T Consensus 195 lG~li~~i~~~gk~i~~a~~~~~----~~~~~~----~~---~~~--~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 195 LGVLIYTIYNGGKSIIAANGGLL----SYSFSR----NL---LNA--GAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred eeeEEEEEecCCcchhhccCCcc----hhhhhh----cc---ccc--ccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 99999999954444 22111100 000000 00 000 000012344567777888899999999997776
Q ss_pred HHH
Q 041766 336 VVS 338 (387)
Q Consensus 336 v~~ 338 (387)
+..
T Consensus 262 l~~ 264 (700)
T KOG2137|consen 262 LLS 264 (700)
T ss_pred hhc
Confidence 654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.5e-05 Score=65.75 Aligned_cols=122 Identities=18% Similarity=0.232 Sum_probs=84.0
Q ss_pred cCCCCCCcccccCC-eeEEEEEEcCCCEEEEEEccC---CC---------c---------ccHHHHHHHHHHHHhcC---
Q 041766 89 NKFSDANKLGEGGF-GPVYKGVLKKGDEIAVKRLPG---RS---------G---------QGLREMKNEASVIAKVQ--- 143 (387)
Q Consensus 89 ~~~~~~~~lG~G~~-g~V~~~~~~~~~~vavK~~~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 143 (387)
.+++.++.||.|.- |.||+++.. |+.+|+|.+.. .. . .....|..|++...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 999999998 78999999321 00 0 12345778999888874
Q ss_pred CCce--eeeeeeEEeC------------------CceEEEEEecCCCC-c-chhhcC-CccccccchhhhhhcccCCCce
Q 041766 144 HKNL--VRLLGCCIDK------------------DEKILIYEYMPNKS-L-DFFLFD-PTKRMLLDWSANYSSRLKVSNI 200 (387)
Q Consensus 144 h~nI--v~~~~~~~~~------------------~~~~lv~e~~~~g~-L-~~~l~~-~~~~~~l~~~~~~h~dlk~~Ni 200 (387)
+.++ |+++||..-. ....||.||.+... + ..-+.+ ......+|..+++-+|+++.|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny 195 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLKILHKLGIVPRDVKPRNY 195 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHHHHHHCCeeeccCccccc
Confidence 4566 9999997432 12358999987655 1 011110 1112346667777789999998
Q ss_pred EEcCCCCeEEeeccCc
Q 041766 201 LLDKDINPKISDFGMA 216 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a 216 (387)
. .-||+|||.+
T Consensus 196 ~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 196 R-----GGKLVDFSSS 206 (207)
T ss_pred c-----CCEEEecccC
Confidence 6 5689999854
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=69.48 Aligned_cols=150 Identities=21% Similarity=0.321 Sum_probs=99.4
Q ss_pred CeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceEEEEEecCCC-Ccchh
Q 041766 102 FGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIYEYMPNK-SLDFF 175 (387)
Q Consensus 102 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~e~~~~g-~L~~~ 175 (387)
-.+.|++... +|..|++|++.............-++.++++.|+|||.+..++.. +..+++|++|.|+- +|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578888854 588999999954433333344556788999999999999998873 34678999999863 44333
Q ss_pred hcCCcccc-------------------------------ccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 176 LFDPTKRM-------------------------------LLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 176 l~~~~~~~-------------------------------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
-....... .+|..+...+-|.+.+||++.+.+++|+..|....+..+.
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~- 447 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP- 447 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence 22211100 1222222224588999999999999999888876554322
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p 270 (387)
. |.+.+ -.+-|.=.||.+++-|.||..-
T Consensus 448 -------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 448 -------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred -------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 0 11111 1345888999999999999643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00011 Score=68.47 Aligned_cols=246 Identities=17% Similarity=0.133 Sum_probs=133.5
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEE------eCC-ceEEEE
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI------DKD-EKILIY 164 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~------~~~-~~~lv~ 164 (387)
...-||+|+-+.+|-.--- +..|| |+.......... +.+..|... .||-+..-+.|-. +.. ..-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchhh-eeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4567999999999864211 22333 766544332222 223334444 6775544233221 111 245677
Q ss_pred EecCCCC-cchhhcCCccc----------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC
Q 041766 165 EYMPNKS-LDFFLFDPTKR----------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 165 e~~~~g~-L~~~l~~~~~~----------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
..+++.. ...+..-...+ ..+|..+..-+|+.++|+|+++++.+.|.|=..-... .
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~-~ 168 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN-A 168 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec-c
Confidence 7766542 11222111110 0134444455899999999999999999974322221 1
Q ss_pred CCcccccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcch---Hh-HHHHHHhhc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSG-KKTTGFYRTDSLT---LL-GYAWDLWTS 291 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg-~~p~~~~~~~~~~---~~-~~~~~~~~~ 291 (387)
++ ......+|...|.+||.-. +..-+...|-|.||+++++++.| +.||......... .. ......+..
T Consensus 169 ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 169 NG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred CC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 11 1223357888999999654 33346779999999999999885 8887543211110 00 000000000
Q ss_pred Cc-cccccccccccccccHHHHHHHHHHHHhcccCC--CCCCCCHHHHHHHhhhhhhcc
Q 041766 292 NR-TLELIDPILEDEYSSKHMLLRYVNIALLCVQES--ADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 292 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. ...-..+. .......-.++.+..|..+|+... +.-|||++.-+..|.++..++
T Consensus 247 a~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 247 ASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred chhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00 00000000 011122334567778888998643 568999999888888776654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=3.4e-05 Score=75.42 Aligned_cols=125 Identities=14% Similarity=0.168 Sum_probs=80.8
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCccc-------------------------------H------HHHHHHH
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQG-------------------------------L------REMKNEA 136 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~------~~~~~E~ 136 (387)
-+-||.-+.|.||+|++++|+.||||+-+..-... . -+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999864321100 0 1233444
Q ss_pred HHHHhc----CCCc------eeeeeeeEEeCCceEEEEEecCCCCcchhhc--CCccc-------------cccchhhhh
Q 041766 137 SVIAKV----QHKN------LVRLLGCCIDKDEKILIYEYMPNKSLDFFLF--DPTKR-------------MLLDWSANY 191 (387)
Q Consensus 137 ~~l~~l----~h~n------Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~-------------~~l~~~~~~ 191 (387)
+-..++ .|-+ |.+++-.+ .....|+||||+|.-+.+... ..... ..+-..+.+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCc
Confidence 443333 3444 33333322 235689999999987765432 11110 012233468
Q ss_pred hcccCCCceEEc----CCCCeEEeeccCceecC
Q 041766 192 SSRLKVSNILLD----KDINPKISDFGMARICG 220 (387)
Q Consensus 192 h~dlk~~Nill~----~~~~~kl~Dfg~a~~~~ 220 (387)
|+|=.|.||++. .++.+.+-|||+.....
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999998 36789999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.7e-05 Score=65.82 Aligned_cols=73 Identities=25% Similarity=0.214 Sum_probs=54.2
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc--eeeeeeeEEeCCceEEEEEecCCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
...||.|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 357899999999984 25567788876432 3345788999999885333 4677888777777889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00025 Score=61.29 Aligned_cols=131 Identities=15% Similarity=0.091 Sum_probs=82.2
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHH---------HHHHHHHhcCC---Cceeeeeee
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMK---------NEASVIAKVQH---KNLVRLLGC 153 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h---~nIv~~~~~ 153 (387)
....+|...+.+-......|.+-..+ |..+++|..........+.|. +++..+.+++. -..+.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34567777778877777778777766 688899987654322222221 23333333322 233333333
Q ss_pred EEeC-----CceEEEEEecCCCCcchhhcCCc--------cccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 154 CIDK-----DEKILIYEYMPNKSLDFFLFDPT--------KRMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 154 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.... ...+++|||++|..|.++..-.. .-..+|..+.+|+|..|.|++++++ .+++.||+..+.
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 3321 23468999999988765432111 1124778888999999999999866 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00021 Score=62.15 Aligned_cols=89 Identities=21% Similarity=0.187 Sum_probs=65.5
Q ss_pred HHHHHHHHHHHhcC--CCceeeeeeeEEeCC----ceEEEEEecCCC-CcchhhcCC-----cc-----------ccccc
Q 041766 130 REMKNEASVIAKVQ--HKNLVRLLGCCIDKD----EKILIYEYMPNK-SLDFFLFDP-----TK-----------RMLLD 186 (387)
Q Consensus 130 ~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~-----~~-----------~~~l~ 186 (387)
....+|...+..+. .-.+.+.+++..... ..++|+|++++. +|.+++... .. -..+|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 46778888888774 334556666665532 347999999874 788877651 11 02478
Q ss_pred hhhhhhcccCCCceEEcCCC---CeEEeeccCcee
Q 041766 187 WSANYSSRLKVSNILLDKDI---NPKISDFGMARI 218 (387)
Q Consensus 187 ~~~~~h~dlk~~Nill~~~~---~~kl~Dfg~a~~ 218 (387)
..+++|+|+++.|||++.+. .+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 88999999999999998887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00069 Score=58.21 Aligned_cols=122 Identities=15% Similarity=0.189 Sum_probs=82.4
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEccCCC----------------cccHHHHHHHHHHHHhcC------CCceeee
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS----------------GQGLREMKNEASVIAKVQ------HKNLVRL 150 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~nIv~~ 150 (387)
....||+|+.-.||. +++.....||+..... .....+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999986 4445567788876443 122355667776666655 8899999
Q ss_pred eeeEEeCCceEEEEEecCCC------CcchhhcCCccc-----------cccchhhhhhcccCCCceEEcCC--C--CeE
Q 041766 151 LGCCIDKDEKILIYEYMPNK------SLDFFLFDPTKR-----------MLLDWSANYSSRLKVSNILLDKD--I--NPK 209 (387)
Q Consensus 151 ~~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~-----------~~l~~~~~~h~dlk~~Nill~~~--~--~~k 209 (387)
+|+.+.+....+|+|.+... +|.+++...... ..+....++.+|++|.||++... + .+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lv 162 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLV 162 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEE
Confidence 99999998889999987532 356666433211 12333455778999999999533 2 477
Q ss_pred Eee-ccCc
Q 041766 210 ISD-FGMA 216 (387)
Q Consensus 210 l~D-fg~a 216 (387)
|+| ||..
T Consensus 163 lIDG~G~~ 170 (199)
T PF10707_consen 163 LIDGLGEK 170 (199)
T ss_pred EEeCCCCc
Confidence 777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00063 Score=60.76 Aligned_cols=73 Identities=18% Similarity=0.191 Sum_probs=52.1
Q ss_pred ccccCC-eeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 97 LGEGGF-GPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 97 lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
|-.|.. ..||+.... +..+.+|...... ...+.+|++++..+ .+--+.+++++....+..++|||+++|..+.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444555 688998765 4678888876443 23567899998888 3444567788777666789999999987764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00073 Score=59.26 Aligned_cols=136 Identities=17% Similarity=0.176 Sum_probs=83.3
Q ss_pred cchhhHHHHhcCCCCCCc---ccccCCeeEEEEEEcCCCEEEEEEccCCCcc-------------------cHH-----H
Q 041766 79 FSFSSVSTATNKFSDANK---LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ-------------------GLR-----E 131 (387)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~---lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~ 131 (387)
.+...+....++..+... |++|.-+.||+|.-.++..+|||++...... ... -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344445555555555444 5567778999999877899999987532111 111 1
Q ss_pred HHHHHHHHHhcC--CCceeeeeeeEEeCCceEEEEEecCCCC-----cchhhcCC--cc----------ccccchhhhhh
Q 041766 132 MKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKS-----LDFFLFDP--TK----------RMLLDWSANYS 192 (387)
Q Consensus 132 ~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~-----L~~~l~~~--~~----------~~~l~~~~~~h 192 (387)
..+|...|.++. +-.+.+-+++. .-.|||||++... |.+.-... .. ...+...+.+|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVH 190 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVH 190 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCccc
Confidence 235777777662 34444444443 2369999986541 22211111 00 11233466799
Q ss_pred cccCCCceEEcCCCCeEEeeccCceec
Q 041766 193 SRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 193 ~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
+||..=|||+. ++.+.|+|||-|...
T Consensus 191 gDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 191 GDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred ccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999 779999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0006 Score=60.05 Aligned_cols=77 Identities=21% Similarity=0.308 Sum_probs=55.7
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCC--ceeeeeeeEEeC---CceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHK--NLVRLLGCCIDK---DEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~~~~~---~~~~lv~e~~~~ 169 (387)
+.++.|..+.||+....+ ..+++|..... .....+..|..++..+... -+.++++.+... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568899999999999886 68999987543 3456777899998888422 356667654332 346899999998
Q ss_pred CCcch
Q 041766 170 KSLDF 174 (387)
Q Consensus 170 g~L~~ 174 (387)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0021 Score=55.42 Aligned_cols=120 Identities=16% Similarity=0.118 Sum_probs=81.4
Q ss_pred ccccCCeeEEEEEEcCCCEEEEEEccCCC------cccHHHHHHHHHHHHhcCC--CceeeeeeeEEeC----CceEEEE
Q 041766 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRS------GQGLREMKNEASVIAKVQH--KNLVRLLGCCIDK----DEKILIY 164 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~----~~~~lv~ 164 (387)
-|+||-+-|+.-.+. |..+-+|+-.+.. +.....|.+|...|.++.. -.+.+........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888899998776 4578888764221 2345689999999999843 3344444222221 1357999
Q ss_pred EecCC-CCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCC--eEEeeccCce
Q 041766 165 EYMPN-KSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDIN--PKISDFGMAR 217 (387)
Q Consensus 165 e~~~~-g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~--~kl~Dfg~a~ 217 (387)
|-+++ -+|.+++.+.... ..+|..++.|+|+-+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97653 4677776442211 1377888899999999999986667 9999997654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0046 Score=59.03 Aligned_cols=74 Identities=15% Similarity=0.253 Sum_probs=53.7
Q ss_pred CcccccCCeeEEEEEEcCC-CEEEEEEccCC-----C--cccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEE
Q 041766 95 NKLGEGGFGPVYKGVLKKG-DEIAVKRLPGR-----S--GQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv 163 (387)
+.||.|.+..||+....+| +.|+||.-... . ....+++..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998876 48999975311 1 124456777888888762 2467777776 44557899
Q ss_pred EEecCCC
Q 041766 164 YEYMPNK 170 (387)
Q Consensus 164 ~e~~~~g 170 (387)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0029 Score=60.99 Aligned_cols=165 Identities=21% Similarity=0.195 Sum_probs=89.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeEEeC-CceEEEEEecCCCCcchhhcCCccccccchhhhhhcccCCCceEEcCCCCe
Q 041766 130 REMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRLKVSNILLDKDINP 208 (387)
Q Consensus 130 ~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~h~dlk~~Nill~~~~~~ 208 (387)
..+.....+++.+.|+|+..++.+.... ....+|+|++ +.+|.+.+....... .....|+ .-+-|+ .
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---~s~~~~~-~~~~~~-------~ 94 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---ESLLAHG-VLHLNI-------I 94 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---hhhcccc-cceehh-------h
Confidence 4556677889999999999999987664 3467899998 558887775543111 1111221 112222 2
Q ss_pred EEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH
Q 041766 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 209 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 288 (387)
+++| .++. .| | .+..+|+||||+|.++.|+.-|..-+..-. ...........
T Consensus 95 ~~td-~~~t------------------~~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~--~s~~l~~i~k~ 146 (725)
T KOG1093|consen 95 YITD-HFLT------------------KY--P-----SPIGPKSDVWSLGFIILELYLGISLEAELT--ESEYLEILLKY 146 (725)
T ss_pred hccc-cccc------------------cC--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHH--HHHHHHHHHHh
Confidence 2233 0000 00 1 011249999999999999998865431100 00001111111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVV 337 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~ 337 (387)
+..+.....+. .......++...++++..+|+-..|..||...+..
T Consensus 147 ~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 147 YTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred ccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 11111110000 00012334566788999999999999888665543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0059 Score=54.20 Aligned_cols=73 Identities=12% Similarity=0.241 Sum_probs=45.4
Q ss_pred CcccccCCe-eEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCC---ceeeeeeeEEeC---CceEEEEEec
Q 041766 95 NKLGEGGFG-PVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDK---DEKILIYEYM 167 (387)
Q Consensus 95 ~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~~~---~~~~lv~e~~ 167 (387)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456766666 58875 345677765432 2345788899999887421 344444443332 2358999999
Q ss_pred CCCCcc
Q 041766 168 PNKSLD 173 (387)
Q Consensus 168 ~~g~L~ 173 (387)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0093 Score=62.96 Aligned_cols=78 Identities=18% Similarity=0.387 Sum_probs=57.7
Q ss_pred CCcccccCCeeEEEEEEcCC---CEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCce--eeeeeeEEeC---CceEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKG---DEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNL--VRLLGCCIDK---DEKILI 163 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~~~~~~~~~---~~~~lv 163 (387)
.+.++.|.++.+|+.....+ ..+++|+.+... ......+.+|.++|+.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877653 367778765432 123357889999999995 6665 7888888765 467899
Q ss_pred EEecCCCC
Q 041766 164 YEYMPNKS 171 (387)
Q Consensus 164 ~e~~~~g~ 171 (387)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.002 Score=41.17 Aligned_cols=43 Identities=51% Similarity=0.733 Sum_probs=36.5
Q ss_pred hccCCCCCCceeeeeccccccCCCCCC--ccccccceeeeccccC
Q 041766 345 AALFPPKQPAFSYVRNTVTSTSSTGKT--EDCSINQVTISLLEAR 387 (387)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~~~~~~~~ 387 (387)
..++.|.+|.|...+......+++... ..+|.|..+++.|++|
T Consensus 4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 468999999999999876665555555 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.00039 Score=74.50 Aligned_cols=139 Identities=14% Similarity=0.028 Sum_probs=101.9
Q ss_pred HHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEEEEecCCCCcchhhcCCccccc---------cc-------------
Q 041766 131 EMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILIYEYMPNKSLDFFLFDPTKRML---------LD------------- 186 (387)
Q Consensus 131 ~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~---------l~------------- 186 (387)
....|.+.++...|+++.....-.... ...+.+++|+.+|++...+.....+.. .+
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344455566667899998877655433 345899999999999877754332210 00
Q ss_pred ---hhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHH
Q 041766 187 ---WSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 263 (387)
Q Consensus 187 ---~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~e 263 (387)
....+|++||+.|.+|..+..+|++++|+.+... ......+...+++.|+.|+....-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 0112578899999999999999999999998332 11223344577889999999988889999999999999999
Q ss_pred HHhCCCCC
Q 041766 264 IVSGKKTT 271 (387)
Q Consensus 264 l~tg~~p~ 271 (387)
...|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99888764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0088 Score=53.81 Aligned_cols=115 Identities=11% Similarity=0.066 Sum_probs=70.3
Q ss_pred ccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCceEEEEEecCCCCcchh
Q 041766 97 LGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPNKSLDFF 175 (387)
Q Consensus 97 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~g~L~~~ 175 (387)
+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ .++++.+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998874 366788887543322211235678889988853333 34444432 3689999988765321
Q ss_pred -----------------hcCCcc---c--------c----------c------cc-----------hhhhhhcccCCCce
Q 041766 176 -----------------LFDPTK---R--------M----------L------LD-----------WSANYSSRLKVSNI 200 (387)
Q Consensus 176 -----------------l~~~~~---~--------~----------~------l~-----------~~~~~h~dlk~~Ni 200 (387)
++.... . . . +. ....+|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 010000 0 0 0 00 01237999999999
Q ss_pred EEcCCCCeEEeeccCce
Q 041766 201 LLDKDINPKISDFGMAR 217 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a~ 217 (387)
+++.++ +.|+||..|.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.023 Score=52.25 Aligned_cols=120 Identities=13% Similarity=0.052 Sum_probs=76.0
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCC--ceeeeeee------EEeCCceEEEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHK--NLVRLLGC------CIDKDEKILIYE 165 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~~~~~------~~~~~~~~lv~e 165 (387)
.+.+..|....+|+.... +..+++|.... ........|++++..+.+. .+.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777877899998765 44688898764 2234566788888877432 24454432 122445689999
Q ss_pred ecCCCCcchh----h----------c----CCccc------------------cc---------------c-------ch
Q 041766 166 YMPNKSLDFF----L----------F----DPTKR------------------ML---------------L-------DW 187 (387)
Q Consensus 166 ~~~~g~L~~~----l----------~----~~~~~------------------~~---------------l-------~~ 187 (387)
|++|..+... . + ..... .. + ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998775320 0 0 00000 00 0 00
Q ss_pred hhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 188 SANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 188 ~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
...+|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 235799999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.017 Score=51.07 Aligned_cols=73 Identities=19% Similarity=0.293 Sum_probs=47.6
Q ss_pred CcccccCCeeEEEEEEcC--CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 95 NKLGEGGFGPVYKGVLKK--GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
+.|..|-...+|+....+ +..|++|........ .....+|+.++..+. +.-..++++.+. + .++|||++|..
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 456778888999988664 578888976543221 123347888888884 333455555432 2 48999998876
Q ss_pred c
Q 041766 172 L 172 (387)
Q Consensus 172 L 172 (387)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.039 Score=51.38 Aligned_cols=75 Identities=8% Similarity=0.017 Sum_probs=43.8
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--Cceeeeeee------EEeCCceEEEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH--KNLVRLLGC------CIDKDEKILIYE 165 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~------~~~~~~~~lv~e 165 (387)
.+.++.|....+|+....+| .+++|++.... ......|..++..+.. -.+.+.+.. ....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777788999876644 68889875222 2333345555555421 123333321 122456789999
Q ss_pred ecCCCCc
Q 041766 166 YMPNKSL 172 (387)
Q Consensus 166 ~~~~g~L 172 (387)
|++|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9988754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.016 Score=52.98 Aligned_cols=73 Identities=15% Similarity=0.225 Sum_probs=47.5
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
.+.++-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.+. --.+.+++++....+..+|||||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568888888999877 5578899998752 23357888988888883 446778899888777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.0086 Score=46.58 Aligned_cols=34 Identities=26% Similarity=0.484 Sum_probs=22.6
Q ss_pred CCCCchhhhHHHHHHHHHHHHHHHHhhhhcccCC
Q 041766 2 TSAPFLALLSLSIVLAAVAILGLIFYCARRKPRS 35 (387)
Q Consensus 2 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~rr~~~~ 35 (387)
.+.+.++.++++++++++.++++++||.||++++
T Consensus 61 fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 61 FSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 3556788888888888887777777765544433
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.061 Score=49.79 Aligned_cols=76 Identities=11% Similarity=0.065 Sum_probs=46.0
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC--CceeeeeeeE------EeCCceEEEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCC------IDKDEKILIYE 165 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~------~~~~~~~lv~e 165 (387)
.+.++.|....+|+....++ .+++|....... ......|.+++..+.. -.+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 577887654221 2344566777766632 2244444421 12345789999
Q ss_pred ecCCCCc
Q 041766 166 YMPNKSL 172 (387)
Q Consensus 166 ~~~~g~L 172 (387)
|++|..+
T Consensus 104 ~i~G~~~ 110 (307)
T TIGR00938 104 FLQGLSV 110 (307)
T ss_pred eCCCCCC
Confidence 9988654
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.034 Score=58.80 Aligned_cols=179 Identities=17% Similarity=0.161 Sum_probs=109.4
Q ss_pred HHHHHHHHHHhcCCCceeeeeeeEEeCCc----eEEEEEecCCCCcchhhcCCccccccchhh-----------hhhccc
Q 041766 131 EMKNEASVIAKVQHKNLVRLLGCCIDKDE----KILIYEYMPNKSLDFFLFDPTKRMLLDWSA-----------NYSSRL 195 (387)
Q Consensus 131 ~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~-----------~~h~dl 195 (387)
...-|...+.++.|+|++.+++|-..... ..+..|+|..-++...+..... ..++... .+|..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHHHh-
Confidence 34457777888899999999998765432 2345677777777666544322 1111111 12322
Q ss_pred CCCceEE----------cCCCCeEEe--eccCceecCCCCcccccccccCCCccccccccccCCCCcc--ccchhHHHHH
Q 041766 196 KVSNILL----------DKDINPKIS--DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK--SDVFSFGVLL 261 (387)
Q Consensus 196 k~~Nill----------~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwS~Gvil 261 (387)
+-.|+.+ +..+.+.++ ||+.++........ ....-+..|.++|......++.+ .|+|.+|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 4444444 334556666 88887766544322 12234566888998877665544 7999999999
Q ss_pred HHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041766 262 LEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340 (387)
Q Consensus 262 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L 340 (387)
..+..|..+.... . .....+... ......+...+|+..++++|+++.+++...
T Consensus 383 ~~~~~~~~i~~~~-----------------~----~~~~~l~~~-----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS-----------------A----VPVSLLDVL-----STSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccc-----------------c----chhhhhccc-----cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999887652110 0 000111111 111456788899999999999999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.0082 Score=54.83 Aligned_cols=122 Identities=14% Similarity=0.121 Sum_probs=84.4
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEcc----------C-------CCcc-----cHHHHHHHHHHHHhcC-CCc
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP----------G-------RSGQ-----GLREMKNEASVIAKVQ-HKN 146 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~----------~-------~~~~-----~~~~~~~E~~~l~~l~-h~n 146 (387)
-+.+++.||-|.-+.||.+-...|++.++|.-+ . .... .+-...+|...|+.+. |-.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456788999999999999999989998888321 0 0111 1234567888888883 332
Q ss_pred -eeeeeeeEEeCCceEEEEEecCCCCcchhhcCCcccc----------ccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 147 -LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----------LLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 147 -Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
+.+.+++ +..|+|||++.+-.|...-+...... .+...+.||+|..-=||++++++.++++||--
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechH
Confidence 3333433 45689999998887765442222211 13445668999999999999999999999963
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.097 Score=50.03 Aligned_cols=73 Identities=12% Similarity=0.132 Sum_probs=50.2
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCC----C---cccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR----S---GQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv 163 (387)
.+.||-|....||+.... +..++||.-... . .....+-..|.+.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998764 567899976411 1 113344445677776653 257888888886 445789
Q ss_pred EEecCC
Q 041766 164 YEYMPN 169 (387)
Q Consensus 164 ~e~~~~ 169 (387)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.043 Score=46.82 Aligned_cols=82 Identities=24% Similarity=0.358 Sum_probs=55.3
Q ss_pred HHHHHHHHhcCC-CceeeeeeeEEeCCceEEEEEecCCCCcc-------hhhcCCcc---ccccch------------hh
Q 041766 133 KNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYEYMPNKSLD-------FFLFDPTK---RMLLDW------------SA 189 (387)
Q Consensus 133 ~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~g~L~-------~~l~~~~~---~~~l~~------------~~ 189 (387)
..|.-+|..+++ +++.+++|+|- .+++.||.+.+++. .+....-. ...+.. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888866 69999999992 36799999876553 22221110 000000 11
Q ss_pred hhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 190 NYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 190 ~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
.+..|++++|+-+++++++|+.|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 34479999999999999999999886543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.076 Score=49.85 Aligned_cols=72 Identities=17% Similarity=0.242 Sum_probs=47.3
Q ss_pred cccccCCeeEEEEEEcCC-CEEEEEEccC-------CCcccHHHHHHHHHHHHhcC--CC-ceeeeeeeEEeCCceEEEE
Q 041766 96 KLGEGGFGPVYKGVLKKG-DEIAVKRLPG-------RSGQGLREMKNEASVIAKVQ--HK-NLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~~~~lv~ 164 (387)
.||-|....||++...+| +.|+||.-.. .-+-..++..-|.+.|.... -| .+.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 5899996421 11233455566778886652 23 45555543 455567999
Q ss_pred EecCC
Q 041766 165 EYMPN 169 (387)
Q Consensus 165 e~~~~ 169 (387)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99855
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.099 Score=48.22 Aligned_cols=72 Identities=24% Similarity=0.319 Sum_probs=45.7
Q ss_pred cccccCCeeEEEEEEcC-------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCCceEEEEEec
Q 041766 96 KLGEGGFGPVYKGVLKK-------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~ 167 (387)
.+..|--..+|+....+ ++.+++|...... ........|.+++..+.... ..++++.+.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45556666889887654 4778888865432 22235567888888874322 3455555532 3689998
Q ss_pred CCCCc
Q 041766 168 PNKSL 172 (387)
Q Consensus 168 ~~g~L 172 (387)
+|..+
T Consensus 80 ~G~~l 84 (302)
T cd05156 80 PSRTL 84 (302)
T ss_pred CCCcC
Confidence 87665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.16 Score=46.73 Aligned_cols=79 Identities=11% Similarity=0.127 Sum_probs=58.0
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC---CceeeeeeeEEeC---CceEEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH---KNLVRLLGCCIDK---DEKILIYE 165 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~~~~~~~~~---~~~~lv~e 165 (387)
...+.||.|..+.||.....++ .+.+|..+.. .....+..|.+.|+.+.- ..+.+++++|... +..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876655 4666765331 122578899999998842 4678888887653 56899999
Q ss_pred ecCCCCcc
Q 041766 166 YMPNKSLD 173 (387)
Q Consensus 166 ~~~~g~L~ 173 (387)
+++++.+.
T Consensus 94 ~i~G~~~~ 101 (297)
T PRK10593 94 RLRGVSVE 101 (297)
T ss_pred ccCCEecC
Confidence 99987664
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.11 Score=49.46 Aligned_cols=74 Identities=12% Similarity=0.171 Sum_probs=49.7
Q ss_pred CCcccccCCeeEEEEEEcC-CCEEEEEEccC------CCcccHHHHHHHHHHHHhcC--CC-ceeeeeeeEEeCCceEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG------RSGQGLREMKNEASVIAKVQ--HK-NLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-nIv~~~~~~~~~~~~~lv 163 (387)
.+.||-|.-..||++.... ++.|+||.-.. .-.-..++..-|.+.|+... -| ++.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 56899996421 11334556667888887652 23 45556654 44555789
Q ss_pred EEecCC
Q 041766 164 YEYMPN 169 (387)
Q Consensus 164 ~e~~~~ 169 (387)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.18 Score=44.11 Aligned_cols=68 Identities=22% Similarity=0.362 Sum_probs=48.1
Q ss_pred eeEEEEE-EcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 103 GPVYKGV-LKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 103 g~V~~~~-~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
|.|..|. ..+ ..++-||+=. ......|..|+.-|..+. .-++.+++.+-....+.|+||||++-|.++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4555554 222 5667888642 344567888888887773 356778888888888999999999987764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.32 Score=45.80 Aligned_cols=73 Identities=15% Similarity=0.161 Sum_probs=45.8
Q ss_pred cccccCCeeEEEEEEcC-----CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCceEEEEEecCC
Q 041766 96 KLGEGGFGPVYKGVLKK-----GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~ 169 (387)
.+-.|-...+|+....+ +..|++|..........+ -..|..++..+..-++ .++++.+... .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44446677899987542 357888877554333322 3678888888854333 3556655322 58999977
Q ss_pred CCcc
Q 041766 170 KSLD 173 (387)
Q Consensus 170 g~L~ 173 (387)
..+.
T Consensus 118 ~~l~ 121 (344)
T PLN02236 118 RTLS 121 (344)
T ss_pred CCCC
Confidence 6663
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.47 Score=43.89 Aligned_cols=66 Identities=17% Similarity=0.265 Sum_probs=41.3
Q ss_pred eEEEEEEcCCCEEEEEEccC--CCcccHHHHHHHHHHHHhcCC--CceeeeeeeEEeCC--ceEEEEEecCCCC
Q 041766 104 PVYKGVLKKGDEIAVKRLPG--RSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKD--EKILIYEYMPNKS 171 (387)
Q Consensus 104 ~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~--~~~lv~e~~~~g~ 171 (387)
.+|..... ++.+++. .+. ..........+|..+|..+.- .=+...++.|.++. ..|.||+|++|..
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~ 111 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV 111 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence 44444433 6677777 432 233444566778888887632 23445677777765 6799999998843
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.046 Score=42.84 Aligned_cols=49 Identities=20% Similarity=0.386 Sum_probs=35.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHh
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK 141 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 141 (387)
..|+ .+-||.|+.|.||+|++++|+.||||+.+..- .+.+...+.+|..
T Consensus 12 ~~fd-~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i---~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 12 DEFD-PEPLASASIAQVHRARLKDGEEVAVKVQRPGI---EEQIEADLRILRR 60 (119)
T ss_pred HHCC-cchhhheehhhheeeeecccchhhhhhcchHH---HHHHHHHHHHHHH
Confidence 3444 36799999999999999999999999986432 2344455555544
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.025 Score=54.51 Aligned_cols=73 Identities=27% Similarity=0.447 Sum_probs=58.5
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
.....++|+....+|.|+||+|+.+.... +..+|||++.-. ......+..+|..-+.++.|++++++.-.+..
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence 45567889999999999999999998765 447999988533 34455678889999999999999998766554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.66 Score=43.58 Aligned_cols=122 Identities=16% Similarity=0.148 Sum_probs=73.9
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCC----------------------CcccHH----HHHHHHHHHHhcCCCce
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR----------------------SGQGLR----EMKNEASVIAKVQHKNL 147 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~----------------------~~~~~~----~~~~E~~~l~~l~h~nI 147 (387)
-..|..|.-+.||.+.-.+|..+|||+++.. ...-+. -..+|++-|.+++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4568889999999999888999999976321 000111 13357777777765443
Q ss_pred eeeeeeEEeCCceEEEEEecCCCC-----cchhhcCCc------------cccccchhhhhhcccCCCceEEcCCCCeEE
Q 041766 148 VRLLGCCIDKDEKILIYEYMPNKS-----LDFFLFDPT------------KRMLLDWSANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 148 v~~~~~~~~~~~~~lv~e~~~~g~-----L~~~l~~~~------------~~~~l~~~~~~h~dlk~~Nill~~~~~~kl 210 (387)
..---. .-. ...|||+|+.... |.+.-.... .+.+.+.++.+|.||.-=|+|+.+ |.+.|
T Consensus 229 P~PePI-lLk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyi 305 (520)
T KOG2270|consen 229 PCPEPI-LLK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYI 305 (520)
T ss_pred CCCCce-eee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEE
Confidence 221111 111 2259999995322 111111100 012355677799999999999865 47899
Q ss_pred eeccCcee
Q 041766 211 SDFGMARI 218 (387)
Q Consensus 211 ~Dfg~a~~ 218 (387)
+|-+-+-.
T Consensus 306 IDVSQSVE 313 (520)
T KOG2270|consen 306 IDVSQSVE 313 (520)
T ss_pred EEcccccc
Confidence 99876643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.86 Score=42.55 Aligned_cols=70 Identities=16% Similarity=0.215 Sum_probs=42.8
Q ss_pred CCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-C--Cc---eeeeee----eEEeCCceEEEEEecCCC
Q 041766 101 GFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-H--KN---LVRLLG----CCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 101 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~n---Iv~~~~----~~~~~~~~~lv~e~~~~g 170 (387)
.-..+|+....+|.. ++|..... ....++..|...|..+. + +- +...=| ....+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345789988776665 88887654 33456667777777763 2 11 111111 111122667899999998
Q ss_pred Ccc
Q 041766 171 SLD 173 (387)
Q Consensus 171 ~L~ 173 (387)
.+.
T Consensus 114 ~~~ 116 (331)
T COG2334 114 PLE 116 (331)
T ss_pred CcC
Confidence 776
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.38 Score=28.71 Aligned_cols=7 Identities=43% Similarity=0.937 Sum_probs=3.2
Q ss_pred hhhcccC
Q 041766 28 CARRKPR 34 (387)
Q Consensus 28 ~~rr~~~ 34 (387)
|++||.+
T Consensus 28 Ccykk~~ 34 (38)
T PF02439_consen 28 CCYKKHR 34 (38)
T ss_pred HHHcccc
Confidence 5544433
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls | Back alignment and domain information |
|---|
Probab=91.41 E-value=0.15 Score=40.70 Aligned_cols=6 Identities=50% Similarity=1.586 Sum_probs=2.3
Q ss_pred HHhhhh
Q 041766 25 IFYCAR 30 (387)
Q Consensus 25 ~~~~~r 30 (387)
+++|++
T Consensus 18 ~~~~~~ 23 (130)
T PF12273_consen 18 LFYCHN 23 (130)
T ss_pred HHHHHH
Confidence 333433
|
Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 []. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=90.25 E-value=0.93 Score=40.59 Aligned_cols=78 Identities=19% Similarity=0.210 Sum_probs=53.0
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec-CCCCcc
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM-PNKSLD 173 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~-~~g~L~ 173 (387)
..+-.|..+.|+.++..+|.++++|......... .+. .....|...+-...|++++.- ...-.|++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchh
Confidence 4466789999999998889999999886433211 111 112457777778889999864 33446889998 555665
Q ss_pred hhh
Q 041766 174 FFL 176 (387)
Q Consensus 174 ~~l 176 (387)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.30 E-value=0.28 Score=41.61 Aligned_cols=29 Identities=14% Similarity=0.133 Sum_probs=24.8
Q ss_pred hhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 189 ANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 189 ~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
...|+|+.|.|+++++++ ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 347999999999998877 99999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=88.04 E-value=1.2 Score=38.85 Aligned_cols=131 Identities=17% Similarity=0.104 Sum_probs=75.1
Q ss_pred EEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCcch--hhcC-Ccccccc--chhh
Q 041766 116 IAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF--FLFD-PTKRMLL--DWSA 189 (387)
Q Consensus 116 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~~--~l~~-~~~~~~l--~~~~ 189 (387)
..+|+++...-. ...-|..+.+++.+++ .|+++..- +...+-+++|+|-...... ++.- ....+.. ...+
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINFSNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccchhHHHHHhHHHHHHhhccCCC
Confidence 455666433222 2235667888888874 46666521 2234569999985433211 1110 1111112 2345
Q ss_pred hhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhC
Q 041766 190 NYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG 267 (387)
Q Consensus 190 ~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg 267 (387)
.+|+|..|+||+-|..|.+||.|-+.--. .+..|.--| ....+.++.+-+|=.-++++...
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999764210 111232211 23346777777777777777763
|
The function of this family is unknown. |
| >PF05568 ASFV_J13L: African swine fever virus J13L protein; InterPro: IPR008385 This family consists of several African swine fever virus (ASFV) j13L proteins [, , ] | Back alignment and domain information |
|---|
Probab=86.34 E-value=0.67 Score=36.59 Aligned_cols=29 Identities=28% Similarity=0.615 Sum_probs=0.0
Q ss_pred hhhhHHHHHHHHHHHHHHHHhhhhcccCC
Q 041766 7 LALLSLSIVLAAVAILGLIFYCARRKPRS 35 (387)
Q Consensus 7 i~~~~~~~~~~~~~~~~~~~~~~rr~~~~ 35 (387)
+.++++++++.++++++++.+|-+|||+.
T Consensus 31 m~tILiaIvVliiiiivli~lcssRKkKa 59 (189)
T PF05568_consen 31 MYTILIAIVVLIIIIIVLIYLCSSRKKKA 59 (189)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhhHHH
|
|
| >KOG3021 consensus Predicted kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=85.45 E-value=3.2 Score=36.03 Aligned_cols=129 Identities=17% Similarity=0.090 Sum_probs=0.0
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC--CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeee---eeeEE
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRL---LGCCI 155 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~---~~~~~ 155 (387)
.+++....-....++.+|.-+-|.+-.+++.+ ...|-||.=+. ...+.|.-|+.-|..++.-+.|.+ +.+..
T Consensus 1 mee~l~ael~~~~vr~~gs~gggcI~~~r~ydtDaG~~FvK~nr~---~~~~mfeGE~~sLeAi~sT~tv~vprpikvid 77 (313)
T KOG3021|consen 1 MEELLRAELGLNNVRALGSVGGGCISDGRHYDTDAGKVFVKVNRS---IARDMFEGELASLEAIQSTETVLVPRPIKVID 77 (313)
T ss_pred ChHHHHHhcCcceeeeecCCCCceeccccccccCCccEEEEeccc---cchHHHhhHHHHHHHHHhcCceecCCceeeEe
Q ss_pred e-CCceEEEEEecCCCCcchhhcCCccccccchhhh--------------------------------------------
Q 041766 156 D-KDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSAN-------------------------------------------- 190 (387)
Q Consensus 156 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~-------------------------------------------- 190 (387)
. .+..++||||+..+.|...-.....+..--+..-
T Consensus 78 ~p~Ggs~lime~idf~~lr~~~a~lG~qlAdmHl~n~kl~e~r~~~~~tv~rgge~~e~~~v~~FGF~v~tccG~lpQvN 157 (313)
T KOG3021|consen 78 LPGGGSSLIMEHIDFQGLRSDAAKLGSQLADMHLKNEKLAEARRTEAGTVGRGGEEGEQIGVENFGFHVVTCCGRLPQVN 157 (313)
T ss_pred cCCCceeeeeehhhcccchhHHHHHHHHHHHHhhhhHHHHHHHHHhccccccCcccccccchhccceeeeeecccCcccc
Q ss_pred -------------------------------------------------------hhcccCCCceEEcCCCCeEEee
Q 041766 191 -------------------------------------------------------YSSRLKVSNILLDKDINPKISD 212 (387)
Q Consensus 191 -------------------------------------------------------~h~dlk~~Nill~~~~~~kl~D 212 (387)
+|+||-..|+--|..+.+.|-|
T Consensus 158 dW~edW~eFf~rhRlq~Qldl~~~~~~Dre~~el~~~L~~kia~Lf~~~eI~PaLlHGDLW~GNva~D~~~ePiIfD 234 (313)
T KOG3021|consen 158 DWQEDWEEFFARHRLQPQLDLLEKTYGDREAFELWSILQTKIADLFKCLEILPALLHGDLWSGNVAEDGAGEPIIFD 234 (313)
T ss_pred cchhhHHHHHHHHhhhHHHHHHHHhhccHHHHHHHHHHHHhhHHHhccceeehhhhccccccCcccccCCCCceEeC
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 387 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-39 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-121
Identities = 103/306 (33%), Positives = 147/306 (48%), Gaps = 43/306 (14%)
Query: 75 QLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR---- 124
+ FSF + TN F + NK+GEGGFG VYKG + +AVK+L
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT 69
Query: 125 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 184
+ + ++ E V+AK QH+NLV LLG D D+ L+Y YMPN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 185 LDWSANYSSRLKV-----------------------SNILLDKDINPKISDFGMARICGG 221
L W R K+ +NILLD+ KISDFG+AR
Sbjct: 130 LSWHM----RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 222 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281
TSRIVGT YM+PE ++G + KSD++SFGV+LLEI++G +R L
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LL 243
Query: 282 LGYAWDLWTSNRTLE-LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
L ++ +T+E ID + D S + ++A C+ E + RP + +V +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 341 TDEAAA 346
+ A+
Sbjct: 302 QEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 344 bits (886), Expect = e-118
Identities = 102/299 (34%), Positives = 156/299 (52%), Gaps = 29/299 (9%)
Query: 75 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGL-REMK 133
QL FS + A++ FS+ N LG GGFG VYKG L G +AVKRL QG + +
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 134 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWSANY- 191
E +I+ H+NL+RL G C+ E++L+Y YM N S+ L + + + LDW
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 192 ----SSR-----------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230
S+R +K +NILLD++ + DFG+A++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-A 194
Query: 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRT---DSLTLLGYAWD 287
+ GT G+++PEY G S K+DVF +GV+LLE+++G++ R D + LL +
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346
L + L+D L+ Y + + + + +ALLC Q S +RP M+EVV ML + A
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-103
Identities = 88/287 (30%), Positives = 150/287 (52%), Gaps = 30/287 (10%)
Query: 79 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV 138
+ ATN F +G G FG VYKGVL+ G ++A+KR S QG+ E + E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 139 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWSANYSSRLKV 197
++ +H +LV L+G C +++E ILIY+YM N +L L+ M + W RL++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ----RLEI 144
Query: 198 -----------------------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
NILLD++ PKI+DFG+++ + ++ + GT
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYR-TDSLTLLGYAWDLWTSNR 293
GY+ PEY I+G + KSDV+SFGV+L E++ + + + L +A + + +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+++DP L D+ + + ++ + A+ C+ S++DRP+M +V+ L
Sbjct: 265 LEQIVDPNLADKIRPESL-RKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-73
Identities = 58/311 (18%), Positives = 110/311 (35%), Gaps = 56/311 (18%)
Query: 79 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV 138
++ + G FG V+K L + +AVK P + Q + + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 139 IAKVQHKNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS- 193
+ ++H+N+++ +G + LI + SL FL K ++ W+
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 194 ---------------------------R-LKVSNILLDKDINPKISDFGMARICGGNELQ 225
R +K N+LL ++ I+DFG+A +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 226 ANTSRIVGTYGYMSPEYAIQGI-----FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT 280
+T VGT YM+PE I ++ D+++ G++L E+ S +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY-- 245
Query: 281 LLGYAWDLWTSNRTLE---------LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP 331
+L + ++ + +LE P+L D + + C A+ R
Sbjct: 246 MLPFEEEIG-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 332 TMNEVVSMLTD 342
+ V +T
Sbjct: 305 SAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-61
Identities = 60/329 (18%), Positives = 108/329 (32%), Gaps = 57/329 (17%)
Query: 79 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV 138
+ S S + +G G +G VYKG L +AVK + Q NE ++
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 139 --IAKVQHKNLVRLLGCCI-----DKDEKILIYEYMPNKSLDFFLFDPT------KRMLL 185
+ ++H N+ R + + E +L+ EY PN SL +L T R+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118
Query: 186 D------------WSANYSSR------LKVSNILLDKDINPKISDFGMARICGGN----- 222
++ L N+L+ D ISDFG++ GN
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 223 -ELQANTSRIVGTYGYMSPEYAIQGI-------FSIKSDVFSFGVLLLEIVSGKKTTGFY 274
E VGT YM+PE + + D+++ G++ EI
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 275 RTDSLTLLGYAWDLWTSNRTLELID--------PILEDEYSSKHMLLR-YVNIALLCVQE 325
+ + + ++ ++ P + + + +R C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 326 SADDRPTMNEVVSMLTDEAAALFPPKQPA 354
A+ R T + + K +
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 41/281 (14%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
K+G G FG V++ G ++AVK L + + E E +++ +++H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA------------NY--SSR---- 194
++ EY+ SL L R LD NY +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK N+L+DK K+ DFG++R+ L + ++ GT +M+PE + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEK 219
Query: 252 SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311
SDV+SFGV+L E+ + ++ + +L + + LE+ +
Sbjct: 220 SDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQ------- 267
Query: 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQ 352
I C RP+ ++ +L + PP
Sbjct: 268 ---VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-46
Identities = 58/280 (20%), Positives = 106/280 (37%), Gaps = 48/280 (17%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
LG+G FG K ++ G+ + +K L + R E V+ ++H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 154 CIDKDEKILIYEYMPNKSLDFFL------FDPTKR--MLLDWSA--NY-SSR------LK 196
I EY+ +L + + ++R D ++ Y S L
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSR------------IVGTYGYMSPEYAI 244
N L+ ++ N ++DFG+AR+ + Q R +VG +M+PE
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+ K DVFSFG++L EI+ A + RT++ +
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLP-RTMDFGLNVRGF 239
Query: 305 E--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
Y + + I + C + RP+ ++ L
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 48/308 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+ +G G FG V K + ++A+K++ S + E +++V H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA------------NY--SSR 194
+L G C++ L+ EY SL L + Y S +
Sbjct: 65 KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 195 --------LKVSNILLDKDIN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
LK N+LL KI DFG A ++Q + + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
+S K DVFS+G++L E+++ +K + W + R LI + +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-PPLIKNLPKP- 232
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNTVTST 365
++ C + RP+M E+V ++ FP Y
Sbjct: 233 ---------IESLMTRCWSKDPSQRPSMEEIVKIM-THLMRYFPGADEPLQYPCQHSLPP 282
Query: 366 SSTGKTED 373
G+ E
Sbjct: 283 GEDGRVEP 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-44
Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 50/278 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL----PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
+G GGFG VY+ GDE+AVK Q + ++ EA + A ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDP--TKRMLLDWSA------NY--SSR------ 194
G C+ + L+ E+ L+ L +L++W+ NY
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 195 --LKVSNILLDKDINP--------KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
LK SNIL+ + + KI+DFG+AR + G Y +M+PE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAPEVIR 187
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+FS SDV+S+GVLL E+++G+ + + L A+ + + L + E
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ + C RP+ ++ LT
Sbjct: 243 ----------FAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-43
Identities = 62/270 (22%), Positives = 118/270 (43%), Gaps = 36/270 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
++G G FG VYKG ++AVK L + Q L+ KNE V+ K +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWSA------------NYSSR-L 195
+ ++ ++ SL L + L+D + + R L
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YAIQGIFSIKS 252
K +NI L +D KI DFG+A ++ G+ +M+PE +S +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 253 DVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312
DV++FG++L E+++G+ Y ++ + R + P L S+
Sbjct: 207 DVYAFGIVLYELMTGQLP---Y--SNINNRDQI--IEMVGR--GSLSPDLSKVRSNCPKR 257
Query: 313 LRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ + C+++ D+RP+ +++ + +
Sbjct: 258 MK--RLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 52/276 (18%), Positives = 101/276 (36%), Gaps = 52/276 (18%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 152
KL E G ++KG + G++I VK L R S + R+ E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 153 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTK-----RMLLDWSA------NY--SSR--- 194
C I +MP SL L + T + ++ + +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG---- 246
L ++++D+D+ +IS + + + +++PE A+Q
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKPED 186
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306
+D++SF VLL E+V+ + + L+ + + + I
Sbjct: 187 TNRRSADMWSFAVLLWELVTREV---PF--ADLSNMEIGMKVALEGLRPTIPPGISP--- 238
Query: 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ +C+ E RP + +V +L
Sbjct: 239 -------HVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-43
Identities = 61/288 (21%), Positives = 121/288 (42%), Gaps = 54/288 (18%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG-------LREMKNEASVIA 140
N+ ++G+GGFG V+KG L K +A+K L +G +E + E +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK--------RMLLDWSA--N 190
+ H N+V+L G + ++ E++P L L D R++LD +
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 191 Y--SSR-------LKVSNILLDK-----DINPKISDFGMARICGGNELQANTSRIVGTYG 236
Y + L+ NI L + K++DFG+++ + + S ++G +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191
Query: 237 YMSPE--YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294
+M+PE A + ++ K+D +SF ++L I++G+ + S + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREEGLR 248
Query: 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ + R N+ LC RP + +V L++
Sbjct: 249 PTIPEDCPP----------RLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 55/288 (19%)
Query: 95 NKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LG+G FG V G+ +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 150 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------NY-SSR-- 194
G C + LI EY+P SL +L LL +++ Y ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 244
L NIL++ + KI DFG+ ++ L + + +PE
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNRTLELIDPILE 303
+ FS+ SDV+SFGV+L E+ + + + + + ++G +EL L+
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL----LK 246
Query: 304 DEY---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ +M++ C + + RP+ ++ +
Sbjct: 247 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 55/288 (19%)
Query: 95 NKLGEGGFGPVYKGVL-----KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+LG+G FG V G+ +AVK+L + + LR+ + E ++ +QH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 150 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------NY-SSR-- 194
G C + LI EY+P SL +L LL +++ Y ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 244
L NIL++ + KI DFG+ ++ L + + +PE
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNRTLELIDPILE 303
+ FS+ SDV+SFGV+L E+ + + + + + ++G +EL L+
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL----LK 277
Query: 304 DEY---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ +M++ C + + RP+ ++ +
Sbjct: 278 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 74/287 (25%), Positives = 112/287 (39%), Gaps = 55/287 (19%)
Query: 95 NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
LGEG FG V G+ +AVK L Q K E ++ + H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 149 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFD--PTKRMLLDWSA------------NYS 192
+ GCC D L+ EY+P SL +L LL ++ +Y
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYI 156
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
R L N+LLD D KI DFG+A+ V G + +PE +
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEY 212
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID------- 299
F SDV+SFGV L E+++ ++ T L L+G A T R EL++
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 300 ----PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
P + Y ++ C + A RPT ++ +L
Sbjct: 273 PDKCP--AEVY----------HLMKNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 58/289 (20%), Positives = 110/289 (38%), Gaps = 57/289 (19%)
Query: 95 NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
LGEG FG V G+++AVK L P G + ++K E ++ + H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 149 RLLGCCIDKDEK--ILIYEYMPNKSLDFFLFDPTKRM----LLDWSA------------N 190
+ G C + LI E++P+ SL +L ++ L ++
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 191 YSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 243
Y R L N+L++ + KI DFG+ + ++ + + +PE
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 244 IQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302
+Q F I SDV+SFGV L E+++ + + + + L++ L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM--TVT--RLVN-TL 256
Query: 303 EDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ + L+ C + +R + ++
Sbjct: 257 KEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 62/272 (22%), Positives = 97/272 (35%), Gaps = 46/272 (16%)
Query: 96 KLGEGGFGPVYKGVLKKGD-EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
++G G FG V+ G L+ + +AVK + EA ++ + H N+VRL+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 154 CIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSSR-LK 196
C K ++ E + FL + LL R L
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFS 256
N L+ + KISDFGM+R A+ + +PE G +S +SDV+S
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWS 300
Query: 257 FGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLWTSNRTLELIDPILEDEY---SSKH 310
FG+LL E S LG Y ++ +T E + E +
Sbjct: 301 FGILLWETFS---------------LGASPYPN--LSNQQTREFV----EKGGRLPCPEL 339
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ C RP+ + + L
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 54/313 (17%)
Query: 95 NKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
++LG+G FG V G +AVK+L R+ + E ++ + +V+
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 150 LLGCCIDKDEK--ILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------------NY 191
G + L+ EY+P+ L FL LL +S+
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 192 SSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAI 244
R L NIL++ + + KI+DFG+A++ L + V + +PE
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
IFS +SDV+SFGV+L E+ + + + L ++G D+ +R LEL LE+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL----LEE 259
Query: 305 EY---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAF 355
+ H L+ LC S DRP+ + + L + + AF
Sbjct: 260 GQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313
Query: 356 SYVRNTVTSTSST 368
+ + S
Sbjct: 314 TAHPEGKHHSLSF 326
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-39
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 49/279 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+G+G FG VY G E+A++ + + L+ K E + +H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTK----RMLLDWSA------NY--SSR-----L 195
C+ +I ++L + D + Y + L
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRI---VGTYGYMSPE---------YA 243
K N+ D I+DFG+ I G + ++ G +++PE
Sbjct: 157 KSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 244 IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303
+ FS SDVF+ G + E+ + + ++ + W + T + + +
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWP---FK--TQPAEAIIWQMGTGMKP-----NLSQ 265
Query: 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ +I L C ++RPT +++ ML
Sbjct: 266 IGMGKE-----ISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 80/313 (25%), Positives = 136/313 (43%), Gaps = 69/313 (22%)
Query: 96 KLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G G FG VYKG+LK +A+K L G + + + EA ++ + H N++R
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSS 193
L G ++I EYM N +LD FL + + L+ NY
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQG 246
R L NIL++ ++ K+SDFG++R+ + T+ G + +PE
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAISYR 225
Query: 247 IFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
F+ SDV+SFG+++ E+++ G++ Y W+L SN E++ I D
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP---Y-----------WEL--SNH--EVMKAI-NDG 266
Query: 306 Y---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFS 356
+ S+ + L+ + C Q+ RP ++VS+L A K A
Sbjct: 267 FRLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
Query: 357 YVRNTVTSTSSTG 369
R ++ S++G
Sbjct: 321 DPRVSIRLPSTSG 333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 69/286 (24%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------NY-SSR--- 194
RLLG C+ LI + MP L ++ + + LL+W NY R
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
L N+L+ + KI+DFG+A++ G E + + G +M+ E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHR 194
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNRTLELID------ 299
I++ +SDV+S+GV + E+++ G +D ++ +++
Sbjct: 195 IYTHQSDVWSYGVTVWELMT---------------FGSKPYDGIPASEISSILEKGERLP 239
Query: 300 -PIL--EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
P + D Y I C AD RP E++ +
Sbjct: 240 QPPICTIDVY----------MIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 57/296 (19%), Positives = 107/296 (36%), Gaps = 58/296 (19%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 152
+G+G +G V++G + G+ +AVK R + E + ++H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 153 CCIDKDEKI----LIYEYMPNKSLDFFL----FDPTK--RMLLDWSA--NY--SSR---- 194
+ LI Y SL +L D R++L ++ +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 195 ---------LKVSNILLDKDINPKISDFGMARI---CGGNELQANTSRIVGTYGYMSPE- 241
LK NIL+ K+ I+D G+A + N R VGT YM+PE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYMAPEV 188
Query: 242 -----YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW-DLWTSNRTL 295
+ D+++FG++L E+ + G + D+ ++ +
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPNDPSF 243
Query: 296 ELID---------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
E + P + + + S L + C ++ R T + LT
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 27/193 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
++G G FG V+ G D++A+K + G + + EA V+ K+ H LV+L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------------NYSSR-LK 196
C+++ L+ E+M + L +L LL R L
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSD 253
N L+ ++ K+SDFGM R ++ ++T GT + SPE +S KSD
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSD 187
Query: 254 VFSFGVLLLEIVS 266
V+SFGVL+ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-37
Identities = 69/285 (24%), Positives = 115/285 (40%), Gaps = 64/285 (22%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G G FG VY G L D AVK L + + E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 150 LLGCCIDKDEKIL-IYEYMPNKSLDFFL----FDPTKRMLLDWSA------NY-SSR--- 194
LLG C+ + L + YM + L F+ +PT + L+ + Y +S+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQ 245
L N +LD+ K++DFG+AR + + G +M+ E
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDLWTSNRTLELIDPILE 303
F+ KSDV+SFGVLL E+++ G D+ + ++ +L+
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDV--NTF--DITVYLLQ 247
Query: 304 D------EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
EY + Y + L C A+ RP+ +E+VS ++
Sbjct: 248 GRRLLQPEYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRISA 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 79/276 (28%), Positives = 122/276 (44%), Gaps = 56/276 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
KLG G FG V+ K ++AVK + PG EA+V+ +QH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV 251
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR-L 195
K+ +I E+M SL FL L+D+SA NY R L
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKS 252
+ +NIL+ + KI+DFG+AR+ NE A G + +PE G F+IKS
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKS 366
Query: 253 DVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDEY 306
DV+SFG+LL+EIV+ G+ Y ++ + ++ P E+
Sbjct: 367 DVWSFGILLMEIVTYGRI-------------PYPG--MSNPEVIRALERGYRMPRPENCP 411
Query: 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ ++ + C + ++RPT + S+L D
Sbjct: 412 EELYNIM------MRCWKNRPEERPTFEYIQSVLDD 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-37
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 68/286 (23%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G G G V G L+ + +A+K L G + + R+ +EAS++ + H N++R
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSS 193
L G +++ EYM N SLD FL T L+ Y
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQG 246
R L N+L+D ++ K+SDFG++R+ + A T+ G + +PE
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPEAIAFR 229
Query: 247 IFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
FS SDV+SFGV++ E+++ G++ Y W+ T+ + + E+
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP---Y-----------WN-MTNRDVISSV----EEG 270
Query: 306 Y---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
Y + H L+ L C + RP +++VS+L
Sbjct: 271 YRLPAPMGCPHALHQLM------LDCWHKDRAQRPRFSQIVSVLDA 310
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 27/193 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+LG G FG V G + ++A+K + G + E EA V+ + H+ LV+L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 154 CIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSSR-LK 196
C + +I EYM N L +L + LL+ + R L
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 147
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSD 253
N L++ K+SDFG++R +E ++ G+ + PE + FS KSD
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 254 VFSFGVLLLEIVS 266
+++FGVL+ EI S
Sbjct: 204 IWAFGVLMWEIYS 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 62/277 (22%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+G+G FG V G + G+++AVK + ++ + EASV+ +++H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 155 IDKDEKI-LIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR-L 195
+++ + ++ EYM SL +L LL +S N+ R L
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIQGIFSIKSD 253
N+L+ +D K+SDFG+ + +A++++ G +PE + FS KSD
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLWTSNRTLELID-----PILEDE 305
V+SFG+LL EI S G Y + ++ +
Sbjct: 369 VWSFGILLWEIYS---------------FGRVPYPR--IPLKDVVPRVEKGYKMDAPDGC 411
Query: 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ + +++ C A RPT ++ L
Sbjct: 412 PPAVYDVMKN------CWHLDAATRPTFLQLREQLEH 442
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-36
Identities = 59/296 (19%), Positives = 101/296 (34%), Gaps = 87/296 (29%)
Query: 96 KLGEGGFGPVYKGVLKKGD--------EIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
LG+G F ++KGV ++ E+ +K L AS+++K+ HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWSA------------NY 191
V G C+ DE IL+ E++ SLD +L L+ +
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 192 SSR-LKVSNILLDKDINP--------KISDFGMARICGGNELQANTSRIVGTYGY----- 237
+ NILL ++ + K+SD G++ ++
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQERIP 182
Query: 238 -MSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNR 293
+ PE I+ ++ +D +SFG L EI S G S R
Sbjct: 183 WVPPE-CIENPKNLNLATDKWSFGTTLWEICS---------------GGDKPLSALDSQR 226
Query: 294 TLELID-------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
L+ + P + N+ C+ D RP+ ++ L
Sbjct: 227 KLQFYEDRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 73/273 (26%), Positives = 118/273 (43%), Gaps = 48/273 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGD-EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+KLG G +G VY+GV KK +AVK L E EA+V+ +++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 283
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR- 194
C + +I E+M +L +L + + +LL + N+ R
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
L N L+ ++ K++DFG++R+ G+ A+ + +PE FSIKSDV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDV 402
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDEYSSK 309
++FGVLL EI + + Y ++ EL++ E
Sbjct: 403 WAFGVLLWEIATYGMSP------------YPG--IDLSQVYELLEKDYRMERPEGCPEKV 448
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ L+ C Q + DRP+ E+
Sbjct: 449 YELM------RACWQWNPSDRPSFAEIHQAFET 475
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-36
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 27/192 (14%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG G FG V G K ++AVK + G + E EA + K+ H LV+ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 155 IDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSSR-LKV 197
+ ++ EY+ N L +L LL+ + R L
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIKSDV 254
N L+D+D+ K+SDFGM R ++ ++ GT + +PE +S KSDV
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 255 FSFGVLLLEIVS 266
++FG+L+ E+ S
Sbjct: 189 WAFGILMWEVFS 200
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-36
Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 31/200 (15%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G+G FG VY G + A+K L Q + E ++ + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 150 LLGCCIDKDEKILI-YEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYS 192
L+G + + + YM + L F+ +PT + L+ + +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
R L N +LD+ K++DFG+AR E S + + + E
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALESLQTY 203
Query: 247 IFSIKSDVFSFGVLLLEIVS 266
F+ KSDV+SFGVLL E+++
Sbjct: 204 RFTTKSDVWSFGVLLWELLT 223
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-36
Identities = 60/290 (20%), Positives = 107/290 (36%), Gaps = 46/290 (15%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 152
++G+G +G V+ G + G+++AVK E + ++H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 153 CCIDKDEKI----LIYEYMPNKSLDFFL----FDPTKRMLLDWSA----NY--SSR---- 194
I LI +Y N SL +L D + L +S+ + +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 195 ---------LKVSNILLDKDINPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPE-- 241
LK NIL+ K+ I+D G+A NE+ + VGT YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 242 ----YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRT-----DSLTLLGYAWDLWTSN 292
I +D++SFG++L E+ + G L +++
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ + P + +SS L + + C + R T V L
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 62/283 (21%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G G FG V G LK + +A+K L G + + R+ EAS++ + H N++R
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSS 193
L G +++ EYM N SLD FL T L+ Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFS 249
R L NIL++ ++ K+SDFG+ R+ + A T+R G + SPE F+
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFT 228
Query: 250 IKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY-- 306
SDV+S+G++L E++S G++ Y W+ ++ ++ + ++ Y
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP---Y-----------WE-MSNQDVIKAV----DEGYRL 269
Query: 307 -------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ + L+ L C Q+ ++RP ++VS+L
Sbjct: 270 PPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILDK 306
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 69/193 (35%), Positives = 98/193 (50%), Gaps = 27/193 (13%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+LG G FG V+ G ++AVK L G EA+++ ++QH+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 154 CIDKDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWSA------------NYSSR-L 195
++ +I EYM N SL FL T LLD +A NY R L
Sbjct: 77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIQGIFSIKSD 253
+ +NIL+ ++ KI+DFG+AR+ NE T+R + +PE G F+IKSD
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 254 VFSFGVLLLEIVS 266
V+SFG+LL EIV+
Sbjct: 193 VWSFGILLTEIVT 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 61/285 (21%), Positives = 102/285 (35%), Gaps = 70/285 (24%)
Query: 96 KLGEGGFGPVYKGVLKKGDE---IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+LG G FG V +GV + + +A+K L G EM EA ++ ++ + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 152 GCCIDKDEKILI-YEYMPNKSLDFFLFDP----TKRMLLDWSA------------NYSSR 194
G C + E +++ E L FL + + N+ R
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQGI 247
L N+LL KISDFG+++ G ++ + +PE
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRK 189
Query: 248 FSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID------- 299
FS +SDV+S+GV + E +S G+K + + I+
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQGKRMEC 234
Query: 300 PIL--EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
P + Y + C +DRP V +
Sbjct: 235 PPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 31/193 (16%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+G+G FG V G + G+++AVK + ++ + EASV+ +++H NLV+LLG
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 155 IDKDEKILI-YEYMPNKSLDFFL-----FDPTKRMLLDWSA------NYSSRLKV----- 197
+++ + I EYM SL +L LL +S Y
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 198 --SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYAIQGIFSIKSD 253
N+L+ +D K+SDFG+ + +A++++ G +PE + FS KSD
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 254 VFSFGVLLLEIVS 266
V+SFG+LL EI S
Sbjct: 197 VWSFGILLWEIYS 209
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 62/289 (21%), Positives = 102/289 (35%), Gaps = 79/289 (27%)
Query: 96 KLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
LGEG FG VY+GV +AVK + + +EA ++ + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSSR 194
+G +++ +I E P L +L L+ +S N R
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY------------MSPE 241
+ V NIL+ K+ DFG++R + Y MSPE
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTRLPIKWMSPE 184
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA-WDLWTSNRTLELID- 299
F+ SDV+ F V + EI+S G + + + +++
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVIGVLEK 229
Query: 300 ------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
P + + Y + C DRP E+V L+D
Sbjct: 230 GDRLPKP----DLCPPVL---Y-TLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 34/200 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLV 148
LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------------NYS 192
RLLG C+ LI + MP L ++ + + LL+W
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
R L N+L+ + KI+DFG+A++ G E + + G +M+ E +
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHR 194
Query: 247 IFSIKSDVFSFGVLLLEIVS 266
I++ +SDV+S+GV + E+++
Sbjct: 195 IYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 62/284 (21%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G G FG VY G L D AVK L + + E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 150 LLGCCIDKDEKIL-IYEYMPNKSLDFFL----FDPTKRMLLDWSA------NY-SSR--- 194
LLG C+ + L + YM + L F+ +PT + L+ + + +S+
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
L N +LD+ K++DFG+AR E + ++ T +M+ E
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALESLQTQ 271
Query: 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDLWTSNRTLELIDPILED 304
F+ KSDV+SFGVLL E+++ G D+ + ++ +L+
Sbjct: 272 KFTTKSDVWSFGVLLWELMT---------------RGAPPYPDV--NTF--DITVYLLQG 312
Query: 305 ------EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
EY + Y + L C A+ RP+ +E+VS ++
Sbjct: 313 RRLLQPEYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRISA 352
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 65/285 (22%), Positives = 101/285 (35%), Gaps = 66/285 (23%)
Query: 96 KLGEGGFGPVYKGVLKKGD----EIAVKRL-PGR--SGQGLREMKNEASVIAKVQHKNLV 148
KLG+G FG V +G +AVK L P + + + E + + + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR----MLLDWSA------------NYS 192
RL G + K+ + E P SL L L ++ +
Sbjct: 85 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIF 248
R L N+LL KI DFG+ R N+ + + +PE F
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTF 201
Query: 249 SIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------- 299
S SD + FGV L E+ + G++ W ++ L ID
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHKIDKEGERLPR 246
Query: 300 PIL--EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
P +D Y N+ + C +DRPT + L +
Sbjct: 247 PEDCPQDIY----------NVMVQCWAHKPEDRPTFVALRDFLLE 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 71/302 (23%), Positives = 109/302 (36%), Gaps = 84/302 (27%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
+LGE FG VYKG L +A+K L G E ++EA + A++QH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANYSSRLKVS------ 198
V LLG +I+ Y + L FL + D S L+
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 199 -----------------------NILLDKDINPKISDFGMARICGGNELQANTSRIVGTY 235
N+L+ +N KISD G+ R E+ A +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKLLGN 189
Query: 236 G-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDL 288
+M+PE + G FSI SD++S+GV+L E+ S G
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------------YGLQPYCGY 234
Query: 289 WTSNRTLELIDPILEDEYSSKHMLLR--------YVNIALLCVQESADDRPTMNEVVSML 340
SN+ ++++ I +L Y + + C E RP ++ S L
Sbjct: 235 --SNQ--DVVEMIRNR-----QVLPCPDDCPAWVY-ALMIECWNEFPSRRPRFKDIHSRL 284
Query: 341 TD 342
Sbjct: 285 RA 286
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 63/195 (32%), Positives = 98/195 (50%), Gaps = 29/195 (14%)
Query: 95 NKLGEGGFGPVYKGVLKKGD-EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+KLG G +G VY+GV KK +AVK L E EA+V+ +++H NLV+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR- 194
C + +I E+M +L +L + + +LL + N+ R
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIK 251
L N L+ ++ K++DFG++R+ G+ A+ G + +PE FSIK
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNKFSIK 192
Query: 252 SDVFSFGVLLLEIVS 266
SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 73/345 (21%), Positives = 122/345 (35%), Gaps = 95/345 (27%)
Query: 50 KANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV 109
K + + + N + + + + +LGEG FG V+
Sbjct: 15 KGSGLQGHIIENPQYFSDACVHHIKR-------------RDIVLKWELGEGAFGKVFLAE 61
Query: 110 LKKGDE------IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163
+AVK L S ++ + EA ++ +QH+++VR G C + +++
Sbjct: 62 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121
Query: 164 YEYMPNKSLDFFL--FDPTKRMLLDWSANYSSRLKVS----------------------- 198
+EYM + L+ FL P ++L L +
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181
Query: 199 ------NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQGI 247
N L+ + + KI DFGM+R ++ + VG +M PE +
Sbjct: 182 RDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDLWTSNRTLELIDPILEDE 305
F+ +SDV+SFGV+L EI + G + L SN E ID I +
Sbjct: 237 FTTESDVWSFGVVLWEIFT---------------YGKQPWYQL--SNT--EAIDCITQG- 276
Query: 306 YSSKHMLLR--------YVNIALLCVQESADDRPTMNEVVSMLTD 342
L R Y I C Q R ++ +V + L
Sbjct: 277 ----RELERPRACPPEVY-AIMRGCWQREPQQRHSIKDVHARLQA 316
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 54/294 (18%), Positives = 99/294 (33%), Gaps = 89/294 (30%)
Query: 96 KLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
+GEG FG V++G+ + +A+K S + EA + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 151 LGCCIDKDEKILI-YEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSS 193
+G + + I E L FL + L+ ++ +
Sbjct: 82 IGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY------------MSP 240
R + N+L+ + K+ DFG++R + Y M+P
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLPIKWMAP 186
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLWTSNRTLEL 297
E F+ SDV+ FGV + EI+ G + + N ++
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM---------------HGVKPF-QGV--KNN--DV 226
Query: 298 IDPILEDEY---------SSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
I I E+ + + L+ C RP E+ + L+
Sbjct: 227 IGRI-ENGERLPMPPNCPPTLYSLM------TKCWAYDPSRRPRFTELKAQLST 273
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 78/303 (25%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
+LG+G FG VY+GV K + +A+K + S + E NEASV+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWSA----- 189
VRLLG ++I E M L +L P+ ++ +
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 190 -NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY---- 237
Y + K N ++ +D KI DFGM R ++ G G
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPVR 205
Query: 238 -MSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDLWTSNRT 294
MSPE G+F+ SDV+SFGV+L EI + L L SN
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGL--SNE- 247
Query: 295 LELIDPILEDEYSSKHMLLR--------YVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346
+++ ++E +L + + + +C Q + RP+ E++S + +E
Sbjct: 248 -QVLRFVMEG-----GLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 347 LFP 349
F
Sbjct: 301 GFR 303
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
KLG+G FG V+ G +A+K L PG EA V+ K++H+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR-L 195
++ I + EYM SL FL L+D +A NY R L
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
+ +NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IKSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 365
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDEYSSKH 310
SFG+LL E+ + + Y + L+ ++ P + S H
Sbjct: 366 SFGILLTELTTKGRVP------------YPG--MVNREVLDQVERGYRMPCPPECPESLH 411
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354
L+ C ++ ++RPT + + L D + P QP
Sbjct: 412 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 75/329 (22%), Positives = 128/329 (38%), Gaps = 87/329 (26%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE---IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKNLVR 149
+ +GEG FG V K +KK A+KR+ S R+ E V+ K+ H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFL-------------------FDPTKRMLLDWSA- 189
LLG C + L EY P+ +L FL + + LL ++A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 190 -----NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTS-----RIV 232
+Y S+ + NIL+ ++ KI+DFG++R G T R
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR-- 206
Query: 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLW 289
+M+ E +++ SDV+S+GVLL EIVS LG Y +
Sbjct: 207 ----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------------LGGTPY-CGM- 245
Query: 290 TSNRTLELIDPILED------EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS----M 339
+ EL + + + + Y ++ C +E +RP+ +++ M
Sbjct: 246 -TCA--ELYEKLPQGYRLEKPLNCDDEV---Y-DLMRQCWREKPYERPSFAQILVSLNRM 298
Query: 340 LTDEAAALFPPKQPAFSYVRNTVTSTSST 368
L + + F+Y ++ +
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAEEAA 327
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-34
Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 34/200 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE-----IAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLV 148
LG G FG V+KGV E + +K + +SG Q + + + I + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------------NYS 192
RLLG C L+ +Y+P SL + ++LL+W
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAIQG 246
R L N+LL +++DFG+A + ++ Q S +M+ E G
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFG 192
Query: 247 IFSIKSDVFSFGVLLLEIVS 266
++ +SDV+S+GV + E+++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 62/293 (21%), Positives = 104/293 (35%), Gaps = 62/293 (21%)
Query: 96 KLGEGGFGPVYKGVLKKGDE---IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+LG G FG V +GV + + +A+K L G EM EA ++ ++ + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWSA------------NYSSR- 194
G C + +L+ E L FL + + N+ R
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAIQGIFSIK 251
L N+LL KISDFG+++ G ++ + +PE FS +
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSR 519
Query: 252 SDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------PIL- 302
SDV+S+GV + E +S G+K + + I+ P
Sbjct: 520 SDVWSYGVTMWEALSYGQK---------------PYKKMKGPEVMAFIEQGKRMECPPEC 564
Query: 303 -EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354
+ Y + C +DRP V + +L +
Sbjct: 565 PPELY----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 153
KLG+G FG V+ G +A+K L + G E EA V+ K++H+ LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA------------NYSSR-L 195
++ I + EYM SL FL L+D +A NY R L
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
+ +NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+IKSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVW 448
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-----PILEDEYSSKH 310
SFG+LL E+ + + Y + L+ ++ P + S H
Sbjct: 449 SFGILLTELTTKGRVP------------YPG--MVNREVLDQVERGYRMPCPPECPESLH 494
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354
L+ C ++ ++RPT + + L D + P QP
Sbjct: 495 DLM------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 62/298 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 152
+G+G FG V++G + G+E+AVK + R EA + ++H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 153 CCIDKDEKI----LIYEYMPNKSLDFFL----FDPTKRMLLDWSA----NY--------- 191
+ L+ +Y + SL +L + L S +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 192 -----SSR-LKVSNILLDKDINPKISDFGMARI---CGGNELQANTSRIVGTYGYMSPE- 241
+ R LK NIL+ K+ I+D G+A A R VGT YM+PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYMAPEV 222
Query: 242 -----YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA---WDLWTSNR 293
++D+++ G++ EI G + Y +DL S+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-------YQLPYYDLVPSDP 275
Query: 294 TLELID---------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++E + P + + + S L I C + R T + L+
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-34
Identities = 70/301 (23%), Positives = 118/301 (39%), Gaps = 83/301 (27%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+LGEG FG V+ +AVK L + ++ + EA ++ +QH+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFD-------------------PTKRMLLDWSA 189
+ G C D D I+++EYM + L+ FL +L ++
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 190 ------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
Y + N L+ ++ KI DFGM+R ++ + VG +
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGGHT 195
Query: 237 -----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA--WDLW 289
+M PE + F+ +SDV+SFGV+L EI + G + L
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------YGKQPWFQL- 239
Query: 290 TSNRTLELIDPILEDEYSSKHMLLR--------YVNIALLCVQESADDRPTMNEVVSMLT 341
SN E+I+ I + +L R Y ++ L C Q R + E+ +L
Sbjct: 240 -SNT--EVIECI-----TQGRVLERPRVCPKEVY-DVMLGCWQREPQQRLNIKEIYKILH 290
Query: 342 D 342
Sbjct: 291 A 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 64/282 (22%)
Query: 96 KLGEGGFGPVYKGVLKKGD---EIAVKRL-PGRSGQGLR-EMKNEASVIAKVQHKNLVRL 150
+LG G FG V KG + +AVK L + L+ E+ EA+V+ ++ + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDP---TKRMLLDWSA------------NYSSR- 194
+G C + + +L+ E L+ +L + +++ N+ R
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYAIQGIF 248
L N+LL KISDFG+++ +E + +PE F
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKF 197
Query: 249 SIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID-------P 300
S KSDV+SFGVL+ E S G+K + + +++ P
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQK---------------PYRGMKGSEVTAMLEKGERMGCP 242
Query: 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ M Y ++ LC ++RP V L +
Sbjct: 243 ----AGCPREM---Y-DLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 43/210 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLV 148
LGEG FG V +G LK+ D +AVK + S + + E +EA+ + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 149 RLLGCCIDKD-----EKILIYEYMPNKSLDFFL---------FDPTKRMLLDWSA----- 189
RLLG CI+ + ++I +M L +L + LL +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 190 -NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG----- 236
Y S N +L D+ ++DFG+++ ++ + G
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPVK 214
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+++ E +++ KSDV++FGV + EI +
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 55/215 (25%), Positives = 82/215 (38%), Gaps = 44/215 (20%)
Query: 95 NKLGEGGFGPVYKGV---LKKGDE---IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKN 146
LG G FG V + L K D +AVK L P + +E V++ + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------FDPTKRMLL 185
+V LLG C ++I EY L FL LL
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 186 DWSA------NYSSRLKV-------SNILLDKDINPKISDFGMAR-ICGGNELQANTSRI 231
+S + + NILL KI DFG+AR I + +
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+ +M+PE +++ +SDV+S+G+ L E+ S
Sbjct: 209 L-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 51/218 (23%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKN 146
LG G FG V + D+ +AVK L G + R + +E ++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 147 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFL-------------------FDPTKRMLLD 186
+V LLG C + +I E+ +L +L T L+
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 187 WSA------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIVG 233
+S + + K NILL + KI DFG+AR ++ + +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRK 207
Query: 234 TYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++I+SDV+SFGVLL EI S
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 44/211 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE----IAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLV 148
LG+G FG V + LK+ D +AVK L + + E EA+ + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 149 RLLGCCIDKDEKI------LIYEYMPNKSLDFFL---------FDPTKRMLLDWSA---- 189
+L+G + K +I +M + L FL F+ + L+ +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 190 --NY-SSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG---- 236
Y SSR L N +L +D+ ++DFG++R ++ + G
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASKLPV 203
Query: 237 -YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+++ E ++++ SDV++FGV + EI++
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 59/225 (26%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
LGEG FG V K +AVK L S LR++ +E +V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL---------------------------FDPT 180
++L G C +LI EY SL FL T
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 181 KRMLLDWSA------NYSSRLKV-------SNILLDKDINPKISDFGMAR-ICGGNELQA 226
L+ ++ Y + +K+ NIL+ + KISDFG++R + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 227 NTS-----RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+ + +M+ E I++ +SDV+SFGVLL EIV+
Sbjct: 209 RSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 60/210 (28%), Positives = 83/210 (39%), Gaps = 43/210 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGD------EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
LG G FG VY+G + ++AVK L S Q + EA +I+K H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----------FDPTKRMLLDWSA------NY 191
VR +G + + ++ E M L FL LL + Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 192 SSRLKV-------SNILLDKDINP---KISDFGMARICGGNELQANTSRIVGTYGY---- 237
N LL KI DFGMAR ++ + G
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPVK 210
Query: 238 -MSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
M PE ++GIF+ K+D +SFGVLL EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 40/211 (18%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKN 146
LG G FG V + + +AVK L + +E +++ + QH+N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------------FDPTKRMLLDWSA 189
+V LLG C ++I EY L FL + R LL +S+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 190 ------NYSSRLKV-------SNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTY 235
+ + N+LL KI DFG+AR I + + +
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PV 230
Query: 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+M+PE +++++SDV+S+G+LL EI S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 52/219 (23%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-PGRSGQGLREMKNEASVIAKV-QH 144
LGEG FG V D+ +AVK L + + L ++ +E ++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------FDPTKRMLL 185
KN++ LLG C +I EY +L +L T + L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 186 DWSA------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
+ Y + K N+L+ ++ KI+DFG+AR ++
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKK 215
Query: 233 GTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
T G +M+PE +++ +SDV+SFGVL+ EI +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-32
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 52/219 (23%)
Query: 95 NKLGEGGFGPVYKGVLKKGD--------EIAVKRL-PGRSGQGLREMKNEASVIAKV-QH 144
LGEG FG V D ++AVK L + + L ++ +E ++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------FDPTKRMLL 185
KN++ LLG C +I EY +L +L + + L+
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 186 DWSA------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
+ Y + K N+L+ +D KI+DFG+AR ++
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYKK 249
Query: 233 GTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
T G +M+PE I++ +SDV+SFGVLL EI +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-32
Identities = 60/210 (28%), Positives = 82/210 (39%), Gaps = 43/210 (20%)
Query: 95 NKLGEGGFGPVYKGVLKKGD------EIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
LG G FG VY+G + ++AVK L S Q + EA +I+K H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL----------FDPTKRMLLDWSA------NY 191
VR +G + + ++ E M L FL LL + Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 192 SSRLKV-------SNILLDKDINP---KISDFGMARICGGNELQANTSRIVGTYGY---- 237
N LL KI DFGMAR ++ G
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPVK 251
Query: 238 -MSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
M PE ++GIF+ K+D +SFGVLL EI S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 53/274 (19%), Positives = 99/274 (36%), Gaps = 49/274 (17%)
Query: 96 KLGEGGFGPVYKGVLKKGDE----IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRL 150
+GEG FG V++G+ + +A+K S + EA + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSA------------NYSSR 194
+G ++ +I E L FL F L+ ++ + R
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 515
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+ N+L+ + K+ DFG++R + + + +M+PE F+ SD
Sbjct: 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASD 574
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLG---YAWDLWTSNRTLELIDPILEDEYSSKH 310
V+ FGV + EI+ G + + N ++I I E
Sbjct: 575 VWMFGVCMWEILM---------------HGVKPF-QGV--KNN--DVIGRIENGERLPMP 614
Query: 311 ML--LRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ C RP E+ + L+
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 54/225 (24%), Positives = 83/225 (36%), Gaps = 59/225 (26%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKN 146
LG G FG V + +AVK L + +E ++ ++ H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFL--------------------------FDPT 180
+V LLG C LI+EY L +L T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 181 KRMLLDWSA------NYSSRLKV-------SNILLDKDINPKISDFGMAR-ICGGNELQA 226
LL ++ + N+L+ KI DFG+AR I +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 227 NTS-----RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+ + +M+PE +GI++IKSDV+S+G+LL EI S
Sbjct: 231 RGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 49/224 (21%), Positives = 83/224 (37%), Gaps = 57/224 (25%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKVQHKNL 147
+GEG FG V++ +AVK L S + + EA+++A+ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWSANYSSRLK 196
V+LLG C L++EYM L+ FL S+ L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 197 VS-----------------------------NILLDKDINPKISDFGMARICGGNELQAN 227
+ N L+ +++ KI+DFG++R + +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSA 227
Query: 228 TSRIVGTYGY-----MSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
M PE ++ +SDV+++GV+L EI S
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 52/219 (23%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-PGRSGQGLREMKNEASVIAKV-QH 144
LGEG FG V D+ +AVK L + + L ++ +E ++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-------------------FDPTKRMLL 185
KN++ LLG C +I EY +L +L T + L+
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 186 DWSA------NYSSRLKV-------SNILLDKDINPKISDFGMARICGGNELQANTSRIV 232
+ Y + K N+L+ ++ KI+DFG+AR ++
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYYKK 261
Query: 233 GTYG-----YMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
T G +M+PE +++ +SDV+SFGVL+ EI +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 58/270 (21%), Positives = 107/270 (39%), Gaps = 41/270 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHK 145
K+ K+GEG FG + G + +K + S + E + E +V+A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-----LDWSA------NY--S 192
N+V+ + ++ +Y L + + LDW +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 193 SR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
+ +K NI L KD ++ DFG+AR+ A +GT Y+SPE +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPE-ICENK 200
Query: 248 -FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306
++ KSD+++ G +L E+ + K F L+ + + P + Y
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHA--FEAGSMKNLV---------LKIISGSFPPVSLHY 249
Query: 307 SSKHMLLRYVNIALLCVQESADDRPTMNEV 336
S LR ++ + + DRP++N +
Sbjct: 250 SYD---LR--SLVSQLFKRNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 41/273 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLPGRSGQGLREM-KNEASVIAKVQH 144
F K+G G F VY+ G +A+K ++ R E ++ ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWSA------NY 191
N+++ I+ +E ++ E L + K+ + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 192 --SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
S R +K +N+ + K+ D G+ R A++ +VGT YMSPE I
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE-RI 208
Query: 245 QGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303
++ KSD++S G LL E+ + + + D + L + + P+
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCD-----YPPLPS 260
Query: 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
D YS + LR + +C+ + RP + V
Sbjct: 261 DHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 54/231 (23%), Positives = 83/231 (35%), Gaps = 27/231 (11%)
Query: 61 NSKQTKRSKKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKKGDEI-AV 118
+ + R + E Q P + S + F ++LG G +G V+K K+ + AV
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 119 K--RLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 175
K P R + E KV QH VRL + L E SL
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 176 LFDPTKRM----LLDWSA------NY--SSR-----LKVSNILLDKDINPKISDFGMARI 218
+ + + + S +K +NI L K+ DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKK 269
G G YM+PE +QG + +DVFS G+ +LE+ +
Sbjct: 207 LGTAGA-GEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 61/277 (22%), Positives = 101/277 (36%), Gaps = 54/277 (19%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVK--RLPGRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
+G G +G K K +I K + + + +E +++ +++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 153 CCIDKDEKIL--IYEYMPNKSLDFFLFDPTKR-------MLLDW------------SANY 191
ID+ L + EY L + TK +L +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 192 SSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
LK +N+ LD N K+ DFG+ARI + A T VGT YMSPE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPE-QMN 189
Query: 246 GI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+ ++ KSD++S G LL E+ + + S EL I E
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQ---------------KELAGKIREG 231
Query: 305 EYS--SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339
++ I + RP++ E++
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 63/289 (21%), Positives = 104/289 (35%), Gaps = 67/289 (23%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ 143
F + +G GGFG V+K + G +KR+ + + E +AK+
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLD 62
Query: 144 HKNLVRLLGCCIDKDEKI----------------LIYEYMPNKSLDFFLFDPTKRML--- 184
H N+V GC D + E+ +L+ ++ L
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 185 --LDWSA------NY--SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTS 229
L+ +Y S + LK SNI L KI DFG+ N+ +
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTR- 180
Query: 230 RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL 288
GT YMSPE I + + D+++ G++L E++ T + T
Sbjct: 181 -SKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTD------ 230
Query: 289 WTSNRTLELIDPILEDEYSSK-HMLLRYVNIALLCVQESADDRPTMNEV 336
L D I+ D + K LL+ + + +DRP +E+
Sbjct: 231 --------LRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 64/292 (21%), Positives = 111/292 (38%), Gaps = 63/292 (21%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLP-GRSGQGLREMKNEASVIAKVQHKN 146
F LG GGFG V++ K D A+KR+ ++ E +AK++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 147 LVRLLGCCIDKDE---------KILIY---EYMPNKSLDFFL------FDPTKRMLLDW- 187
+VR ++K+ K+ +Y + ++L ++ + + + L
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 188 ----SA-NY--SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANT------- 228
A + S LK SNI D K+ DFG+ +E +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 229 ---SRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGY 284
+ VGT YMSPE I G +S K D+FS G++L E++ F
Sbjct: 185 ARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVR--- 235
Query: 285 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
T R L+ P+ +Y ++++++ + S +RP +
Sbjct: 236 ---TLTDVRNLK-FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 48/232 (20%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 64 QTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK--R 120
Q +R+++++ + +S ++G G F VYKG+ + E+A +
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 121 LPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK----ILIYEYMPNKSLDFFL 176
+ + K EA ++ +QH N+VR + +L+ E M + +L +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 177 FDPTKRMLLDWSANYS-----------SR--------LKVSNILLD-KDINPKISDFGMA 216
K M + ++ +R LK NI + + KI D G+A
Sbjct: 121 -KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ + ++GT +M+PE + + DV++FG+ +LE+ + +
Sbjct: 180 TLKRAS----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 29/197 (14%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
LG+G +G VY G L IA+K +P R + + + E ++ ++HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 156 DKDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWS--ANYSSRL----------------- 195
+ + I I+ E +P SL L + + Y+ ++
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 196 KVSNILLD-KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI---FSIK 251
K N+L++ KISDFG ++ G T GT YM+PE I +
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPE-IIDKGPRGYGKA 205
Query: 252 SDVFSFGVLLLEIVSGK 268
+D++S G ++E+ +GK
Sbjct: 206 ADIWSLGCTIIEMATGK 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 59/291 (20%), Positives = 101/291 (34%), Gaps = 71/291 (24%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
KLGEGGF V G A+KR+ Q E + EA + H N++RL+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 155 IDKDEK----ILIYEYMPNKSLDFFLFDPTKRML-----------LDW------------ 187
+ + L+ + + L++ +R+ L
Sbjct: 96 LRERGAKHEAWLLLPFFKRGT----LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIV-------GTYGYMS 239
+ Y+ R LK +NILL + P + D G + + + + T Y +
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 240 PE----YAIQGIFSIKSDVFSFGVLLLEIVSGKK--TTGFYRTDSLTLL---GYAWDLWT 290
PE + I ++DV+S G +L ++ G+ F + DS+ L +
Sbjct: 212 PELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS- 269
Query: 291 SNRTLELIDPILEDEYSSK-HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+SS LL + RP + ++S L
Sbjct: 270 -------------PRHSSALWQLLNS------MMTVDPHQRPHIPLLLSQL 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 37/222 (16%)
Query: 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP--GRSGQGLREMKNEAS 137
F S+S +S ++G GG V++ + +K A+K + Q L +NE +
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 138 VIAKVQHKNL--VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-- 193
+ K+Q + +RL I ++ E N L K + +Y
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL-NSWLKKKKSIDPWERKSYWKNM 136
Query: 194 --------------R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
LK +N L+ K+ DFG+A + VGT YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 239 SPEYAIQGI------------FSIKSDVFSFGVLLLEIVSGK 268
PE AI+ + S KSDV+S G +L + GK
Sbjct: 196 PPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 34/234 (14%)
Query: 57 ELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI 116
EL ++ +Q KR + + + + F ++LG G G V+K K +
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 117 -AVKRLPGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDF 174
A K + ++ E V+ + +V G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 175 FLFDP-----------TKRMLLDWSANYSSR------LKVSNILLDKDINPKISDFGMAR 217
L + ++ + +K SNIL++ K+ DFG++
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 218 ICGGNEL---QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+L AN+ VGT YMSPE +S++SD++S G+ L+E+ G+
Sbjct: 181 -----QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 37/207 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNL--VRL 150
++G GG V++ + +K A+K + Q L +NE + + K+Q + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R 194
I ++ E N L+ +L K + +Y
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI------ 247
LK +N L+ K+ DFG+A + VGT YM PE AI+ +
Sbjct: 133 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSREN 190
Query: 248 ------FSIKSDVFSFGVLLLEIVSGK 268
S KSDV+S G +L + GK
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 50/207 (24%), Positives = 79/207 (38%), Gaps = 37/207 (17%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKR--LPGRSGQGLREMKNEASVIAKVQHKNL--VRL 150
++G GG V++ + +K A+K L Q L +NE + + K+Q + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R 194
I ++ E N L+ +L K + +Y
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI------ 247
LK +N L+ K+ DFG+A + VG YM PE AI+ +
Sbjct: 180 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSREN 237
Query: 248 ------FSIKSDVFSFGVLLLEIVSGK 268
S KSDV+S G +L + GK
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 45/224 (20%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN 146
+ F + LG+G FG V K A+K++ + L + +E ++A + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFF---------LFDPTKRMLLDWSANYSSR--- 194
+VR +++ + + KS F L+D L+ + R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 195 ------------------LKVSNILLDKDINPKISDFGMARIC------------GGNEL 224
LK NI +D+ N KI DFG+A+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 225 QANTSRIVGTYGYMSPE-YAIQGIFSIKSDVFSFGVLLLEIVSG 267
N + +GT Y++ E G ++ K D++S G++ E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 38/219 (17%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKV 142
ST+ + + ++ LG+G V++G KK GD A+K S + E V+ K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 143 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD-------------- 186
HKN+V+L K+LI E+ P SL L +P+ L
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 187 ----WSANYSSR-LKVSNILL----DKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
R +K NI+ D K++DFG AR +E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEY 181
Query: 238 MSPE--------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ P+ Q + D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-21
Identities = 43/234 (18%), Positives = 83/234 (35%), Gaps = 33/234 (14%)
Query: 59 PVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIA 117
+ + ++L + + + ++G G FG V++ + G + A
Sbjct: 29 RLGPETEDNEGVLLTEKLKPVDYEY-REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87
Query: 118 VKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY-EYMPNKSLDFFL 176
VK++ + E A + +V L G + + I+ E + SL +
Sbjct: 88 VKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR-EGPWVNIFMELLEGGSLGQLI 141
Query: 177 FDPTKRMLLDWSANYSSRL-----------------KVSNILLDKD-INPKISDFGMARI 218
+ D + Y + K N+LL D + DFG A
Sbjct: 142 -KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 219 CGGNELQANTSR---IVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGK 268
+ L + I GT +M+PE + G K D++S ++L +++G
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 38/219 (17%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKV 142
ST+ + + ++ LG+G V++G KK GD A+K S + E V+ K+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 143 QHKNLVRLLGC--CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD-------------- 186
HKN+V+L K+LI E+ P SL L +P+ L
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 187 ----WSANYSSR-LKVSNILL----DKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
R +K NI+ D K++DFG AR +E + + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEY 181
Query: 238 MSPE--------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ P+ Q + D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 68/319 (21%), Positives = 111/319 (34%), Gaps = 67/319 (21%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 153
L EGGF VY+ G E A+KRL + R + E + K+ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 154 CIDKDEK--------ILIYEYMPNKSLDFFLFDPTKRML-----LDW------------- 187
E+ +L+ E + ++F ++ L L
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 188 -SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRI----------VGTY 235
R LKV N+LL K+ DFG A + +++ T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 236 GYMSPE----YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291
Y +PE Y+ I K D+++ G +L + F L ++
Sbjct: 215 MYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFR--QHPFEDGAKLRIV--------- 262
Query: 292 NRTLELIDPILEDEYSSK-HMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL-FP 349
N + D + H L+R +Q + ++R ++ EVV L + AAA
Sbjct: 263 NGKYSIPPH---DTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVN 313
Query: 350 PKQPAFSYVRNTVTSTSST 368
PK P + S+T
Sbjct: 314 PKSPITELLEQNGGYGSAT 332
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 61/237 (25%), Positives = 93/237 (39%), Gaps = 45/237 (18%)
Query: 59 PVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKK 112
PV SK+T F V+ + LG G FG V+K
Sbjct: 53 PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112
Query: 113 -GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 171
G ++A K + R + E+KNE SV+ ++ H NL++L K++ +L+ EY+
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172
Query: 172 LDFFLFDPTKRMLLDWSANYSSR-------------------------LKVSNILL-DKD 205
LFD ++D S N + LK NIL ++D
Sbjct: 173 ----LFD----RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224
Query: 206 INP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261
KI DFG+AR E GT +++PE S +D++S GV+
Sbjct: 225 AKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-20
Identities = 47/230 (20%), Positives = 97/230 (42%), Gaps = 21/230 (9%)
Query: 58 LPVNSKQTKRSKKKEVDQLPLFSFSSVSTATN---KFSDANKLGEGGFGPVYKGVLKK-G 113
+ + ++ + + V + K+GEG G V K G
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 114 DEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL- 172
++AVK + R Q + NE ++ QH N+V + + +E ++ E++ +L
Sbjct: 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 173 DFFLFDP---------TKRMLLDWSANYSSR-----LKVSNILLDKDINPKISDFGMARI 218
D + +L + ++ +K +ILL D K+SDFG
Sbjct: 131 DIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190
Query: 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ + + +VGT +M+PE + +++ + D++S G++++E+V G+
Sbjct: 191 ISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN 146
K++ K+G+G G VY + G E+A++++ + + NE V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDP---------TKRMLLDWSANYSSR-- 194
+V L + DE ++ EY+ SL D + L +S++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
+K NILL D + K++DFG + + +T +VGT +M+PE + + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 252 SDVFSFGVLLLEIVSGK 268
D++S G++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 51/203 (25%), Positives = 78/203 (38%), Gaps = 33/203 (16%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLL-- 151
+LG GGFG V + + + G+++A+K+ RE E ++ K+ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 152 ----GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLD------------------WSA 189
D +L EY L +L L
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 190 NYSSR-LKVSNILLD---KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
R LK NI+L + + KI D G A+ EL VGT Y++PE Q
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPELLEQ 197
Query: 246 GIFSIKSDVFSFGVLLLEIVSGK 268
+++ D +SFG L E ++G
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGF 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 51/241 (21%), Positives = 89/241 (36%), Gaps = 48/241 (19%)
Query: 63 KQTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIA 117
+ R L +++ S+ KLG G +G V K E A
Sbjct: 7 HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 118 VKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 175
+K + S ++ E +V+ + H N+++L DK L+ E L
Sbjct: 67 IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--- 123
Query: 176 LFDPTKRMLLDWSANYSSR-------------------------LKVSNILL---DKDIN 207
FD ++ ++ LK N+LL +KD
Sbjct: 124 -FD---EIIH--RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177
Query: 208 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSG 267
KI DFG++ + + +GT Y++PE ++ + K DV+S GV+L +++G
Sbjct: 178 IKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233
Query: 268 K 268
Sbjct: 234 Y 234
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 47/233 (20%), Positives = 78/233 (33%), Gaps = 43/233 (18%)
Query: 61 NSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKK-GDE 115
+ D + V + D +LG G FG V++ + G+
Sbjct: 125 KGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN 184
Query: 116 IAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 175
A K + ++ E ++ ++H LV L D +E ++IYE+M
Sbjct: 185 FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE---- 240
Query: 176 LFDPTKRMLLDWSANYSSR-------------------------LKVSNILL-DKDINP- 208
LF+ + D S LK NI+ K N
Sbjct: 241 LFE----KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNEL 296
Query: 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261
K+ DFG+ + + GT + +PE A +D++S GVL
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-19
Identities = 48/196 (24%), Positives = 97/196 (49%), Gaps = 29/196 (14%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 152
LG+G F VY+ + G E+A+K + ++ G+ + ++NE + +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS-----------SR------L 195
D + L+ E N ++ +L + K + + ++ S L
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIQGIFSIKS 252
+SN+LL +++N KI+DFG+A +L+ + + GT Y+SPE A + ++S
Sbjct: 139 TLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 253 DVFSFGVLLLEIVSGK 268
DV+S G + ++ G+
Sbjct: 194 DVWSLGCMFYTLLIGR 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 48/196 (24%), Positives = 83/196 (42%), Gaps = 30/196 (15%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 152
LG+GGF ++ + A K +P RE M E S+ + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS-----------SR------L 195
D D ++ E +SL L K + + Y L
Sbjct: 83 FFEDNDFVFVVLELCRRRSL-LELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYAIQGIFSIKS 252
K+ N+ L++D+ KI DFG+A +++ + R + GT Y++PE + S +
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 253 DVFSFGVLLLEIVSGK 268
DV+S G ++ ++ GK
Sbjct: 197 DVWSIGCIMYTLLVGK 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 61 NSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK 119
+ Q + ++++ +L S F KLGEG +G VYK + K+ G +A+K
Sbjct: 3 ETVQLRNPPRRQLKKLD--EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 120 RLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP 179
++P L+E+ E S++ + ++V+ G + ++ EY S+ +
Sbjct: 61 QVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118
Query: 180 TKRMLLDWSA----------NY--SSR-----LKVSNILLDKDINPKISDFGMARICGGN 222
K + D A Y R +K NILL+ + + K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178
Query: 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ NT ++GT +M+PE + ++ +D++S G+ +E+ GK
Sbjct: 179 MAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 50/236 (21%), Positives = 93/236 (39%), Gaps = 32/236 (13%)
Query: 57 ELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDE 115
+P + + ++P + ++ LG+GGF ++ +
Sbjct: 11 GVPGVAAPGAPAAAPPAKEIP--EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEV 68
Query: 116 IAVKRLPGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172
A K +P RE M E S+ + H+++V G D D ++ E +SL
Sbjct: 69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL 128
Query: 173 DFFLFDPTKRMLLDWSANYS-----------SR------LKVSNILLDKDINPKISDFGM 215
L K + + Y LK+ N+ L++D+ KI DFG+
Sbjct: 129 -LELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 216 ARICGGNELQANTSR---IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
A +++ + R + GT Y++PE + S + DV+S G ++ ++ GK
Sbjct: 188 A-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 49/244 (20%), Positives = 81/244 (33%), Gaps = 43/244 (17%)
Query: 50 KANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSD----ANKLGEGGFGPV 105
+ + + + K D + V D +LG G FG V
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67
Query: 106 YKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164
++ V K G K + +KNE S++ ++ H L+ L DK E +LI
Sbjct: 68 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127
Query: 165 EYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------------LKVSN 199
E++ LFD + S +K N
Sbjct: 128 EFLSGGE----LFD----RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 200 ILL-DKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
I+ K + KI DFG+A +E+ T + +PE + +D+++
Sbjct: 180 IMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAI 236
Query: 258 GVLL 261
GVL
Sbjct: 237 GVLG 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-19
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 36/216 (16%)
Query: 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSG-QGLREMKNEASVIA 140
S+ + +LG G +G V K +I AVKR+ Q + + + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 141 K-VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWSANYS---- 192
+ V V G + + + E M + SLD F D + + D +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 193 -------SRLKV-------SNILLDKDINPKISDFGMARICG--GNELQANTSRIVGTYG 236
S+L V SN+L++ K+ DFG I G +++ + G
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--AGCKP 174
Query: 237 YMSPE----YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
YM+PE Q +S+KSD++S G+ ++E+ +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 46/232 (19%), Positives = 80/232 (34%), Gaps = 52/232 (22%)
Query: 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKR--LPGRSGQGLREMKNEASV 138
S T +F + K+G G FG V+K V + G A+KR P + E
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 139 IAKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-------LLDWSA- 189
A + QH ++VR + D ++ EY SL + + + M L D
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 190 -----NY--SSR-----LKVSNILLDKD-------------------INPKISDFGMARI 218
Y S +K SNI + + + KI D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFS--IKSDVFSFGVLLLEIVSGK 268
+ G +++ E +Q ++ K+D+F+ + ++ +
Sbjct: 184 IS------SPQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 47/217 (21%), Positives = 81/217 (37%), Gaps = 49/217 (22%)
Query: 96 KLGEGGFGPVY---------------KGVLKKGDEIAVKRLPGRSGQGLRE-MKNEASVI 139
L +G F + K +L+K + S + + KNE +I
Sbjct: 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 140 AKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWSANY- 191
++++ + G + DE +IYEYM N S+ + T + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 192 -----------SSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
+ + +K SNIL+DK+ K+SDFG + +++ S GT
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--RGT 213
Query: 235 YGYMSPEYAIQGIFSI---KSDVFSFGVLLLEIVSGK 268
Y +M PE S K D++S G+ L +
Sbjct: 214 YEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 45/204 (22%), Positives = 91/204 (44%), Gaps = 25/204 (12%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN 146
+ +LG+G FG VYK K+ G A K + +S + L + E ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSA----------NY--SSR 194
+V+LLG + ++ E+ P ++D + + + + N+ S R
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 195 -----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-----YAI 244
LK N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMK 195
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
+ K+D++S G+ L+E+ +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIE 219
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 45/205 (21%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRL 150
LG+G FG V K G E AVK + R + E ++ ++ H N+++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------------- 194
DK L+ E L FD ++ +S
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGEL----FD---EIIS--RKRFSEVDAARIIRQVLSGITYM 142
Query: 195 ---------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
LK N+LL KD N +I DFG++ ++ +GT Y++PE
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE- 198
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSG 267
+ G + K DV+S GV+L ++SG
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 44/204 (21%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLL 151
LG+G FG V K + E AVK + + + E ++ K+ H N+++L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
D ++ E L FD ++ +S
Sbjct: 88 EILEDSSSFYIVGELYTGGEL----FD---EIIK--RKRFSEHDAARIIKQVFSGITYMH 138
Query: 195 --------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
LK NILL +KD + KI DFG++ N +GT Y++PE
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPE-V 194
Query: 244 IQGIFSIKSDVFSFGVLLLEIVSG 267
++G + K DV+S GV+L ++SG
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 36/198 (18%), Positives = 70/198 (35%), Gaps = 36/198 (18%)
Query: 96 KLGEGGFGPVYKGV--LKKGDEIAVKRLPGRSGQGLREM-KNEASVIAKVQHKNLVRLL- 151
+ GG G +Y + G + +K L + M E +A+V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 152 -GCCIDKDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
D+ + Y EY+ +SL + + + Y
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGL 203
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
LK NI+L ++ K+ D G + GT G+ +PE + ++
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-RTGPTV 255
Query: 251 KSDVFSFGVLLLEIVSGK 268
+D+++ G L +
Sbjct: 256 ATDIYTVGRTLAALTLDL 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 47/214 (21%), Positives = 75/214 (35%), Gaps = 43/214 (20%)
Query: 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREM-KNEAS 137
+ T + F KLG G FG V+ + G E +K + Q E + E
Sbjct: 13 NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML--LDWSANYSSR- 194
V+ + H N++++ D ++ E L + R++ S
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LE---RIVSAQARGKALSEGY 125
Query: 195 ------------------------LKVSNILL---DKDINPKISDFGMARICGGNELQAN 227
LK NIL KI DFG+A + +E N
Sbjct: 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261
GT YM+PE + + K D++S GV++
Sbjct: 186 ---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 48/253 (18%), Positives = 91/253 (35%), Gaps = 59/253 (23%)
Query: 61 NSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDE 115
+ + + + + V K ++ KLG G +G V K E
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 116 IAVKRLP-------------GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162
A+K + + E+ NE S++ + H N+++L DK L
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123
Query: 163 IYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------------LKV 197
+ E+ L F+ +++ + +K
Sbjct: 124 VTEFYEGGEL----FE---QIIN--RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 198 SNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
NILL + +N KI DFG++ + +GT Y++PE ++ ++ K DV
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDV 230
Query: 255 FSFGVLLLEIVSG 267
+S GV++ ++ G
Sbjct: 231 WSCGVIMYILLCG 243
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 28/202 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP----GRSGQGLREMKNEASVIAKVQ 143
F LG+G FG VY K+ +A+K L ++G +++ E + + ++
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------- 194
H N++RL G D LI EY P ++ + + +A Y +
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 195 --------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
+K N+LL KI+DFG + + + GT Y+ PE
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPEMIEGR 182
Query: 247 IFSIKSDVFSFGVLLLEIVSGK 268
+ K D++S GVL E + GK
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK 204
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 41/205 (20%), Positives = 73/205 (35%), Gaps = 31/205 (15%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLV 148
F + LG G G + + ++AVKR+ E ++ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 149 RLLGCCIDKDEKILIYEYMP--------NKSLDFFLFDPTKRM--LLDWSANY--SSR-- 194
R D+ + + E K +P + + S
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTS-GLAHLHSLNIV 140
Query: 195 ---LKVSNILL-----DKDINPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEY--- 242
LK NIL+ I ISDFG+ + G + S + GT G+++PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSG 267
+ + D+FS G + ++S
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 44/197 (22%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 152
LG+G FG V K + E AVK + + + E ++ K+ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------ 194
D ++ E L FD ++ +S
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FD---EIIK--RKRFSEHDAARIIKQVFSGITYMHK 139
Query: 195 -------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
LK NILL +KD + KI DFG++ N +GT Y++PE +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VL 195
Query: 245 QGIFSIKSDVFSFGVLL 261
+G + K DV+S GV+L
Sbjct: 196 RGTYDEKCDVWSAGVIL 212
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 46/195 (23%), Positives = 94/195 (48%), Gaps = 19/195 (9%)
Query: 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG-LREMKNEASVIAKVQHKNLV 148
F+ K+G+G FG V+KG+ + +A+K + + + +++ E +V+++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 149 RLLGCCIDKDEKILIYEYMPNKSL-DFFLFDP---------TKRMLLDWSANYSSR---- 194
+ G + + +I EY+ S D P + +L +S +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K +N+LL + K++DFG+A +++ NT VGT +M+PE Q + K+D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKAD 201
Query: 254 VFSFGVLLLEIVSGK 268
++S G+ +E+ G+
Sbjct: 202 IWSLGITAIELARGE 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 43/201 (21%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G+G F V + + ++ G + AVK + G ++K EAS+ ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWSANYSSR-------------- 194
LL +++E+M L KR D YS
Sbjct: 91 LLETYSSDGMLYMVFEFMDGAD----LCFEIVKRA--DAGFVYSEAVASHYMRQILEALR 144
Query: 195 -----------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSP 240
+K +LL + K+ FG+A G + L A VGT +M+P
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAP 202
Query: 241 EYAIQGIFSIKSDVFSFGVLL 261
E + + DV+ GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 28/152 (18%)
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTS----------RIVGTYGYMSPEYAI 244
LK SNI D K+ DFG+ +E + VGT YMSPE
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+S K D+FS G++L E++ T R +T + R L+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELLYSFS-TQMERVRIITDV----------RNLK-FPLLFTQ 297
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
+Y +HM+++ + S +RP ++
Sbjct: 298 KYPQEHMMVQ------DMLSPSPTERPEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 21/109 (19%), Positives = 37/109 (33%), Gaps = 2/109 (1%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKN 146
F +G GGFG V++ K A+KR+ ++ E +AK++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRL 195
+VR ++ + E D P + + R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 35/226 (15%)
Query: 71 KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPG-RSGQG 128
K+ L + N + ++G G G V+K +K + AVK++ + +
Sbjct: 8 KQTGYLTI-GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE 66
Query: 129 LREMKNEASVIAK-VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW 187
+ + + V+ K +V+ G I + + E M + +
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERI 125
Query: 188 SAN------------YSSR------LKVSNILLDKDINPKISDFGMARICG--GNELQAN 227
+K SNILLD+ K+ DFG I G ++ +
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKD 182
Query: 228 TSRIVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
S G YM+PE + + I++DV+S G+ L+E+ +G+
Sbjct: 183 RS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 41/195 (21%), Positives = 70/195 (35%), Gaps = 42/195 (21%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+G G +G V V K A K++P + + K E ++ + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------- 194
D + L+ E L F+ +
Sbjct: 76 EDNTDIYLVMELCTGGEL----FERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 195 -----LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
LK N L D K+ DFG+A ++ VGT Y+SP+ ++G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEG 182
Query: 247 IFSIKSDVFSFGVLL 261
++ + D +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 37/204 (18%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSG-QGLREMKNEASVIAK-VQHKNLVRLLG 152
++G G +G V K V K +I AVKR+ + +++ + V+ + +V+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------ 194
+ + + E M + S D F + +
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSR--IVGTYGYMSPE----YAI 244
+K SNILLD+ N K+ DFG I G +L + ++ G YM+PE A
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
+ + ++SDV+S G+ L E+ +G+
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGR 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 36/194 (18%), Positives = 72/194 (37%), Gaps = 40/194 (20%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
LG G FG V++ V K + + G +K E S++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------- 194
+E ++I+E++ +F+ + + + R
Sbjct: 71 ESMEELVMIFEFISGLD----IFE----RINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 195 -----LKVSNILL-DKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
++ NI+ + + KI +FG AR + + Y +PE +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179
Query: 248 FSIKSDVFSFGVLL 261
S +D++S G L+
Sbjct: 180 VSTATDMWSLGTLV 193
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 47/194 (24%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLP---GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
KLG GG VY ++A+K + + L+ + E +++ H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
+ D L+ EY+ +L ++ + +D + N++++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRD 136
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K NIL+D + KI DFG+A+ L T+ ++GT Y SPE A +D+
Sbjct: 137 IKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDI 195
Query: 255 FSFGVLLLEIVSGK 268
+S G++L E++ G+
Sbjct: 196 YSIGIVLYEMLVGE 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 33/228 (14%)
Query: 66 KRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP-- 122
+ + + FSD ++G G FG VY + + +A+K++
Sbjct: 31 AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS 90
Query: 123 -GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK 181
+S + +++ E + K++H N ++ GC + + L+ EY + D L + K
Sbjct: 91 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHK 148
Query: 182 RMLLDWSANYSSR------------------LKVSNILLDKDINPKISDFGMARICGGNE 223
+ L + + +K NILL + K+ DFG A
Sbjct: 149 KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIM 204
Query: 224 LQANTSRIVGTYGYMSPE---YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
AN+ VGT +M+PE +G + K DV+S G+ +E+ K
Sbjct: 205 APANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 46/194 (23%), Positives = 75/194 (38%), Gaps = 28/194 (14%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLP----GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LG+G FG VY K+ +A+K L + G +++ E + + ++H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS-----------SR------ 194
D+ L+ E+ P L + R SA + R
Sbjct: 81 NYFHDRKRIYLMLEFAPRGEL-YKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
+K N+L+ KI+DFG + T GT Y+ PE K D+
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLDYLPPEMIEGKTHDEKVDL 195
Query: 255 FSFGVLLLEIVSGK 268
+ GVL E + G
Sbjct: 196 WCAGVLCYEFLVGM 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 47/198 (23%), Positives = 72/198 (36%), Gaps = 42/198 (21%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQH-KNLVRLL 151
+LG G F V + + K G E A K L R E+ +E +V+ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR----------------- 194
+ E ILI EY +F L + + S
Sbjct: 96 EVYENTSEIILILEYAAGGE----IFS---LCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 195 --------LKVSNILL-DKDINP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
LK NILL KI DFGM+R G I+GT Y++PE
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 244 IQGIFSIKSDVFSFGVLL 261
+ +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 4e-16
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 49/210 (23%)
Query: 88 TNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIA 140
+ KFSD +LG+G F V + V K G E A K + + S + ++++ EA +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 141 KVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWSANYSSR----- 194
K+QH N+VRL ++ L+++ + LF+ R YS
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAR------EFYSEADASHC 110
Query: 195 --------------------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRI 231
LK N+LL K K++DFG+A +E
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGF 167
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261
GT GY+SPE + +S D+++ GV+L
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 48/202 (23%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLRE-MKNEASVIAKVQHKNLV 148
+LG G F V K K G E A K + RE ++ E S++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
L ++ + +LI E + LFD + + S
Sbjct: 79 TLHDVYENRTDVVLILELVSGGE----LFD---FLAQK--ESLSEEEATSFIKQILDGVN 129
Query: 195 -----------LKVSNILL-DKDINP---KISDFGMARICGGNELQANTSRIVGTYGYMS 239
LK NI+L DK+I K+ DFG+A I GT +++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVA 186
Query: 240 PEYAIQGIFSIKSDVFSFGVLL 261
PE +++D++S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 28/212 (13%), Positives = 58/212 (27%), Gaps = 38/212 (17%)
Query: 95 NKLGEGGFGPVYKGV------LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+ LGEG F VY+ K + +K + + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWSANYSSR---------- 194
+ + ++ +L+ E +L + P K M +++ R
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 195 -------LKVSNILL-----------DKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
+K N +L D + D G + + T G
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ E ++ + D F + ++ G
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 5e-16
Identities = 45/202 (22%), Positives = 75/202 (37%), Gaps = 48/202 (23%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLREM-KNEASVIAKVQHKNLV 148
+LG G F V K K G E A K RL RE + E +++ +++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
L +K + +LI E + LFD + + +
Sbjct: 72 TLHDIFENKTDVVLILELVSGGE----LFD---FLAEK--ESLTEDEATQFLKQILDGVH 122
Query: 195 -----------LKVSNILL----DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMS 239
LK NI+L + K+ DFG+A I GT +++
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVA 179
Query: 240 PEYAIQGIFSIKSDVFSFGVLL 261
PE +++D++S GV+
Sbjct: 180 PEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 48/202 (23%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLRE-MKNEASVIAKVQHKNLV 148
+LG G F V K K G E A K + RE ++ E S++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
L ++ + +LI E + LFD + + S
Sbjct: 79 TLHDVYENRTDVVLILELVSGGE----LFD---FLAQK--ESLSEEEATSFIKQILDGVN 129
Query: 195 -----------LKVSNILL-DKDINP---KISDFGMARICGGNELQANTSRIVGTYGYMS 239
LK NI+L DK+I K+ DFG+A I GT +++
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVA 186
Query: 240 PEYAIQGIFSIKSDVFSFGVLL 261
PE +++D++S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 51/249 (20%), Positives = 90/249 (36%), Gaps = 59/249 (23%)
Query: 59 PVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-G 113
+N Q K ++ + A +F + +G G V + V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 114 DEIAVK-------RLPGRSGQGLREM-KNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164
E AVK RL + +RE + E ++ +V H +++ L+ L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 165 EYMPNKSLDFFLFDP-TKRMLLDWSANYSSR-------------------------LKVS 198
+ M L FD T++ S + LK
Sbjct: 180 DLMRKGEL----FDYLTEK------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------YAIQGIFSIKS 252
NILLD ++ ++SDFG + E + GT GY++PE + +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEV 286
Query: 253 DVFSFGVLL 261
D+++ GV+L
Sbjct: 287 DLWACGVIL 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 26/246 (10%), Positives = 51/246 (20%), Gaps = 59/246 (23%)
Query: 77 PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREM 132
S +S K L G V+ + ++ A+K S L +
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 133 KNEASVIAKVQHKNLVRLLGCC-----------------------IDKDEKILIYEYMPN 169
A++ ++ D MP
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 170 KSLDFFLFDPTKRMLLDWSANYSSR-------------------------LKVSNILLDK 204
S+D L T + + + N+ +
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229
Query: 205 DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLL 262
D + D G Y E+ F+ + + G+ +
Sbjct: 230 DGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284
Query: 263 EIVSGK 268
+
Sbjct: 285 RVWCLF 290
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 45/198 (22%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 152
+LG+G F V + V K G E A K + + S + ++++ EA + K+QH N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWSANYSSR----------------- 194
++ L+++ + LF+ R YS
Sbjct: 96 SIQEESFHYLVFDLVTGGE----LFEDIVAR------EFYSEADASHCIQQILESIAYCH 145
Query: 195 --------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
LK N+LL K K++DFG+A +E GT GY+SPE
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVL 202
Query: 244 IQGIFSIKSDVFSFGVLL 261
+ +S D+++ GV+L
Sbjct: 203 KKDPYSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 48/202 (23%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLRE-MKNEASVIAKVQHKNLV 148
+LG G F V K K G + A K R RE ++ E S++ ++QH N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
L +K + ILI E + LFD + + +
Sbjct: 78 TLHEVYENKTDVILILELVAGGE----LFD---FLAEK--ESLTEEEATEFLKQILNGVY 128
Query: 195 -----------LKVSNILL----DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMS 239
LK NI+L KI DFG+A I GT +++
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVA 185
Query: 240 PEYAIQGIFSIKSDVFSFGVLL 261
PE +++D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVIT 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 47/193 (24%), Positives = 79/193 (40%), Gaps = 22/193 (11%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
LGEG F V A+K L R + + E V++++ H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D ++ Y N L + Y++ R L
Sbjct: 98 TFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 156
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
K NILL++D++ +I+DFG A++ QA + VGT Y+SPE + SD++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 256 SFGVLLLEIVSGK 268
+ G ++ ++V+G
Sbjct: 217 ALGCIIYQLVAGL 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 41/190 (21%), Positives = 73/190 (38%), Gaps = 32/190 (16%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
LG G F V+ + G A+K + ++NE +V+ K++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 155 IDKDEKILIYEYMPNKSLDFFLFD--------------PTKRMLLDWSANYSSR------ 194
L+ + + LFD + +L
Sbjct: 76 ESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 195 LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
LK N+L +++ I+DFG++++ + GT GY++PE Q +S
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQKPYSKA 187
Query: 252 SDVFSFGVLL 261
D +S GV+
Sbjct: 188 VDCWSIGVIT 197
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 32/178 (17%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLP------GRSGQGLREMKNEASVIAK 141
F K+GEG +G VYK K E+ A+K++ G +RE+ S++ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKE 58
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPN------KSLDFFLFDPTK-----RMLLDWSAN 190
+ H N+V+LL +++ L++E++ + LL
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ-GLA 117
Query: 191 Y--SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
+ S R LK N+L++ + K++DFG+AR G ++ T +V T Y +PE
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 173
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 46/209 (22%), Positives = 73/209 (34%), Gaps = 56/209 (26%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE---------MKNEASVIAKV-QH 144
LG G V + + K E AVK + G E ++ KV H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWSANYSSR--------- 194
N+++L L+++ M L FD T++ S +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEK------VTLSEKETRKIMRAL 133
Query: 195 ----------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
LK NILLD D+N K++DFG + E + GT Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYL 190
Query: 239 SPE------YAIQGIFSIKSDVFSFGVLL 261
+PE + + D++S GV++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-15
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 43/210 (20%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP------GRSGQGLREMKNEASVIAKV 142
K+ K+GEG +G VYK +G +A+KR+ G +RE+ S++ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTK-----RMLLDWSANY- 191
H N+V L+ + L++E+M K LD ++ LL +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR-GVAHC 135
Query: 192 -SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 241
R LK N+L++ D K++DFG+AR G +++ T +V T Y +P+
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 242 ---YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y S D++S G + E+++GK
Sbjct: 194 SKKY------STSVDIWSIGCIFAEMITGK 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 41/197 (20%), Positives = 74/197 (37%), Gaps = 29/197 (14%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLPGR--SGQGLRE-MKNEASVIAKVQHKNLVRLL 151
+G GG G VY+ + +A+K + S R M+ EA ++Q ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFD----PTKRML---------LDWSANYSSR---- 194
+ + + L L R + LD +
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD----AAHAAGAT 156
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK 251
+K NIL+ D + DFG+A +L VGT YM+PE + + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYR 215
Query: 252 SDVFSFGVLLLEIVSGK 268
+D+++ +L E ++G
Sbjct: 216 ADIYALTCVLYECLTGS 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 27/199 (13%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLP---GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LG GG V+ L+ ++AVK L R + EA A + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 152 GCCIDKDEKILIY----EYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
+ + EY+ +L + M + +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 195 ----LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
+K +NI++ K+ DFG+AR I T+ ++GT Y+SPE A
Sbjct: 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 197
Query: 250 IKSDVFSFGVLLLEIVSGK 268
+SDV+S G +L E+++G+
Sbjct: 198 ARSDVYSLGCVLYEVLTGE 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 46/213 (21%)
Query: 84 VSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREM--KNEA 136
+ +F++ +LG+G F V + V G E A + + + EA
Sbjct: 2 ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-- 194
+ ++H N+VRL ++ LI++ + LF+ YS
Sbjct: 62 RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAR-----EYYSEADA 112
Query: 195 -----------------------LKVSNILL---DKDINPKISDFGMARICGGNELQANT 228
LK N+LL K K++DFG+A G +
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLL 261
GT GY+SPE + + D+++ GV+L
Sbjct: 173 --FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 36/233 (15%)
Query: 68 SKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG 126
+ L S++ F +G G +G VYKG K G A+K + +G
Sbjct: 3 ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTG 61
Query: 127 QGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI------LIYEYMPNKSL-DFFLFD 178
E+K E +++ K H+N+ G I K+ L+ E+ S+ D
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 179 PTKRMLLDWSANYSSR------------------LKVSNILLDKDINPKISDFGMARICG 220
+ +W A Y R +K N+LL ++ K+ DFG++
Sbjct: 122 KGNTLKEEWIA-YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 221 GNELQANTSRIVGTYGYMSPE-----YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ NT +GT +M+PE + KSD++S G+ +E+ G
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 41/217 (18%), Positives = 72/217 (33%), Gaps = 30/217 (13%)
Query: 82 SSVSTATNKFSDANKLGEG--GFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEA 136
SS + +G+G V K G+ + V+R+ S + + ++ E
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 137 SVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWSANYSS-- 193
V H N+V I +E ++ +M S D M A
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137
Query: 194 --------------R-LKVSNILLDKDINPKISDFGMARICGGNELQANT-----SRIVG 233
R +K S+IL+ D +S + + V
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 234 TYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGK 268
++SPE Q + + KSD++S G+ E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.5 bits (179), Expect = 2e-14
Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP------GRSGQGLREMKNEASVIAKV 142
K+ K+GEG +G VYK G+ A+K++ G +RE+ S++ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKEL 57
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTK-----RMLLDWSANYS 192
+H N+V+L K +L++E++ K LD + LL+ A
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 193 SR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
R LK N+L++++ KI+DFG+AR G ++ T IV T Y +P+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQ-GLREMKNEASVIAKV 142
S + + +G G V E A+KR+ Q + E+ E +++
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------- 193
H N+V + KDE L+ + + S + D K ++
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGS----VLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 194 ------------------R-LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSR--I 231
R +K NILL +D + +I+DFG+ A + G ++ N R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 232 VGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGK 268
VGT +M+PE Q + K+D++SFG+ +E+ +G
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 44/213 (20%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
+++ +G G FG V++ L + DE+A+K++ RE++ ++ V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 148 VRLLGC----CIDKDEKI--LIYEYMP---NKSLDFFLFDPTKRMLLDW----------- 187
V L KDE L+ EY+P ++ + + M +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA-KLKQTMPMLLIKLYMYQLLRS 153
Query: 188 -----SANYSSR-LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 240
S R +K N+LLD K+ DFG A+I + N S I Y Y +P
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAP 210
Query: 241 EYAIQGIF-----SIKSDVFSFGVLLLEIVSGK 268
E IF + D++S G ++ E++ G+
Sbjct: 211 EL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 35/184 (19%)
Query: 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-----LREMKNEASVI 139
+++++F KLG G + VYKG+ K A+K + S +G +RE+ S++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57
Query: 140 AKVQHKNLVRLLGCCIDKDEKILIYEYM----------PNKSLDFFLFDPTK-----RML 184
+++H+N+VRL +++ L++E+M + L
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 185 LDWSANYSSR-------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
L + LK N+L++K K+ DFG+AR G + +S +V T Y
Sbjct: 118 LQ-GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWY 174
Query: 238 MSPE 241
+P+
Sbjct: 175 RAPD 178
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 28/197 (14%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 152
LG GGFG V+ +K ++ A K+L + +G + E ++AKV + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLL---DWSANYSS---------------- 193
K + L+ M + + +++ + + Y++
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
R LK N+LLD D N +ISD G+A + + GT G+M+PE + G S
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPE-LLLGEEYDFS 369
Query: 253 -DVFSFGVLLLEIVSGK 268
D F+ GV L E+++ +
Sbjct: 370 VDYFALGVTLYEMIAAR 386
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 31/177 (17%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLP------GRSGQGLREMKNEASVIAK 141
K+ K+GEG +G V+K ++ EI A+KR+ G LRE+ ++ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKE 57
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTK-----RMLLDWSANY 191
++HKN+VRL + L++E+ K D DP LL +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK-GLGF 116
Query: 192 --SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
S LK N+L++++ K+++FG+AR G ++ ++ +V T Y P+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 41/224 (18%), Positives = 72/224 (32%), Gaps = 48/224 (21%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNL 147
N LG G G V +G +AVKR+ E ++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFF----LFDPTKRMLLDWSANYSSR--------- 194
+R + E D + D ++ +++ R
Sbjct: 72 IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 195 ---------LKVSNILLD-------------KDINPKISDFGMARICGGNE--LQANTSR 230
LK NIL+ +++ ISDFG+ + + + N +
Sbjct: 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 231 IVGTYGYMSPE-------YAIQGIFSIKSDVFSFGVLLLEIVSG 267
GT G+ +PE + + D+FS G + I+S
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 42/206 (20%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLP----GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
LGEG +G V + + + AVK L R G +K E ++ +++HKN+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 152 GCCIDKDEKILIY---EYMPNKSLDFFLFD--PTKRMLLDWSANY-----------SSR- 194
+ +EK +Y EY + + D P KR + + Y S+
Sbjct: 73 D-VLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 195 -----LKVSNILLDKDINPKISDFGMARI----CGGNELQANTSRIVGTYGYMSPEYAIQ 245
+K N+LL KIS G+A + + TS+ G+ + PE
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TSQ--GSPAFQPPE-IAN 184
Query: 246 GIFS---IKSDVFSFGVLLLEIVSGK 268
G+ + K D++S GV L I +G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 41/206 (19%), Positives = 74/206 (35%), Gaps = 53/206 (25%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLRE---MKNEASVIAKVQHKN 146
LG G G V +K ++A++ + S + ++ E ++ K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------ 194
++++ D ++ ++ E M L FD
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGN-----KRLKEATCKLYFYQMLLA 251
Query: 195 -------------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
LK N+LL ++D KI+DFG ++I G L + GT Y+
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL 308
Query: 239 SPE---YAIQGIFSIKSDVFSFGVLL 261
+PE ++ D +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 25/194 (12%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 152
LG+GGFG V ++ ++ A K+L + +G NE ++ KV + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRML-LDWSANYSSR----------------- 194
KD L+ M L F ++ + + Y++
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLD + +ISD G+A + VGT GYM+PE ++ D
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDW 368
Query: 255 FSFGVLLLEIVSGK 268
++ G LL E+++G+
Sbjct: 369 WALGCLLYEMIAGQ 382
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 28/236 (11%), Positives = 64/236 (27%), Gaps = 70/236 (29%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVK---RLPGRSGQGLREMKNEASVIAKVQ--------- 143
LG+ + ++ G+ V +++MK E + ++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 144 ----------------HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLDFF--LFD--PTK 181
K ++R+ D +Y M + F L T
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 182 RMLLDWSANYSSR------------------LKVSNILLDKDINPKISDFGMARICGGNE 223
+ L+ + + L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--- 257
Query: 224 LQANTSRIVGTYGYMSPEYAI-----------QGIFSIKSDVFSFGVLLLEIVSGK 268
+ G+ PE + + + D ++ G+++ I
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 42/206 (20%), Positives = 74/206 (35%), Gaps = 53/206 (25%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLRE---MKNEASVIAKVQHKN 146
LG G G V +K ++A+K + S + ++ E ++ K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------ 194
++++ D ++ ++ E M L FD
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGN-----KRLKEATCKLYFYQMLLA 126
Query: 195 -------------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
LK N+LL ++D KI+DFG ++I G L + GT Y+
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYL 183
Query: 239 SPE---YAIQGIFSIKSDVFSFGVLL 261
+PE ++ D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 28/175 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQG-----LREMKNEASVIAKV 142
+ +KLGEG + VYKG K D + A+K + +G +RE+ S++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDL 57
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPN---KSLD--FFLFDPTK-----RMLLDWSANYS 192
+H N+V L + L++EY+ + LD + + LL A
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 193 SR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
+ LK N+L+++ K++DFG+AR + + +V T Y P+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPD 170
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 25/230 (10%), Positives = 58/230 (25%), Gaps = 59/230 (25%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRL---PGRSGQGLREMKNEASVIAKVQH-------- 144
LG+ + + G+ V +++MK E + ++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 145 --------KNLVRLLGCCIDKDEK-----------ILIYEYMPNKSLDFF--LFD--PTK 181
+LV+ + +Y M + F L T
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 182 RMLLDWSANYSSR------------------LKVSNILLDKDINPKISDFGMARICGGNE 223
+ L+ + + L+ +I+LD+ ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGAS 264
Query: 224 LQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGK 268
+ R + + + D ++ G+ + I
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 46/212 (21%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSGQGLREMKNEASVIAK 141
K+ K+GEG +G V+K + +I A+K+ P LRE++ ++ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPN---KSLDFF--LFDPTK-----RMLLDW---- 187
++H NLV LL K L++EY + LD + L
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 188 -SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---- 241
N R +K NIL+ K K+ DFG AR+ G + T Y SPE
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWYRSPELLVG 176
Query: 242 ---Y--AIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y + DV++ G + E++SG
Sbjct: 177 DTQYGPPV--------DVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 61/220 (27%)
Query: 96 KLGEGGFGPVYKGVLKK---GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLVRL 150
K+G G +G VYK K + A+K++ G S RE+ ++ +++H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 83
Query: 151 LGCCIDK-DEKI-LIYEYM-------------PNKSLDFFLFDPTK-----RMLLDWSAN 190
+ D K+ L+++Y + +LD +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD-GIH 142
Query: 191 Y--SSR-----LKVSNILLDKDINP----KISDFGMARICG--GNELQANTSRIVGTYGY 237
Y ++ LK +NIL+ + KI+D G AR+ L +V T+ Y
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 238 MSPE-------Y--AIQGIFSIKSDVFSFGVLLLEIVSGK 268
+PE Y AI D+++ G + E+++ +
Sbjct: 202 RAPELLLGARHYTKAI--------DIWAIGCIFAELLTSE 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 51/241 (21%)
Query: 60 VNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AV 118
+ S ++ F S+ K+ + +GEG +G V K K I A+
Sbjct: 1 MGHHHHHHSSGVDLGT-ENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAI 55
Query: 119 KRL------PGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN--- 169
K+ +RE+K ++ +++H+NLV LL C K L++E++ +
Sbjct: 56 KKFLESDDDKMVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTIL 111
Query: 170 KSLDFF--LFDPTK-----RMLLDW-----SANYSSR-LKVSNILLDKDINPKISDFGMA 216
L+ F D +++ S N R +K NIL+ + K+ DFG A
Sbjct: 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
Query: 217 RICGGNELQANTSRIVGTYGYMSPE-------Y--AIQGIFSIKSDVFSFGVLLLEIVSG 267
R + + T Y +PE Y A+ DV++ G L+ E+ G
Sbjct: 172 RTLAA-PGEVYDDEVA-TRWYRAPELLVGDVKYGKAV--------DVWAIGCLVTEMFMG 221
Query: 268 K 268
+
Sbjct: 222 E 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 44/206 (21%), Positives = 74/206 (35%), Gaps = 51/206 (24%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 154
LGEG V + E AVK + + G + E ++ + Q H+N++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWSANYSSR------------------- 194
++D L++E M S + KR +++
Sbjct: 81 EEEDRFYLVFEKMRGGS----ILSHIHKR------RHFNELEASVVVQDVASALDFLHNK 130
Query: 195 ------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSR-----IVGTYGYMSP 240
LK NIL ++ KI DF + N + S G+ YM+P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 241 E-----YAIQGIFSIKSDVFSFGVLL 261
E I+ + D++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 45/214 (21%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN 146
++D +G G FG VY+ L G+ +A+K++ RE++ ++ K+ H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 147 LVRLLGCCIDKDEKI------LIYEYMP---NKSLDFFLFDPTKRMLLDW---------- 187
+VRL EK L+ +Y+P + + + + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFR 167
Query: 188 ------SANYSSR-LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMS 239
S R +K N+LLD D K+ DFG A+ E N S I Y Y +
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRA 224
Query: 240 PEYAIQGIFSIKS-----DVFSFGVLLLEIVSGK 268
PE IF DV+S G +L E++ G+
Sbjct: 225 PEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 34/185 (18%)
Query: 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVK--RLPGRSGQ-------GLREMK 133
V + ++ + LGEG F VYK K ++I A+K +L RS LRE+K
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 134 NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-----------R 182
++ ++ H N++ LL K L++++M L+ + D +
Sbjct: 65 ----LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYML 119
Query: 183 MLLDWSANYSSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
M L LK +N+LLD++ K++DFG+A+ G+ +A T ++V T
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRW 177
Query: 237 YMSPE 241
Y +PE
Sbjct: 178 YRAPE 182
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 49/243 (20%), Positives = 89/243 (36%), Gaps = 43/243 (17%)
Query: 48 NLKANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYK 107
+L N+ + + + + S+ ++ F ++LG G VY+
Sbjct: 12 DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71
Query: 108 GVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166
K A+K L + + ++ E V+ ++ H N+++L E L+ E
Sbjct: 72 CKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129
Query: 167 MPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------------LKVSNIL 201
+ L FD R++ YS R LK N+L
Sbjct: 130 VTGGEL----FD---RIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 202 L---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFG 258
D KI+DFG+++I L + GT GY +PE + + D++S G
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 259 VLL 261
++
Sbjct: 238 IIT 240
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLP------GRSGQGLREMKNEAS 137
+T+ +++ KLGEG +G VYK + +E A+KR+ G G +RE+ S
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----S 85
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFL-----FDPTK-----RMLLDW 187
++ ++QH+N++ L LI+EY L ++ L++
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLIN- 143
Query: 188 SANY--SSR-----LKVSNILLDKDINP-----KISDFGMARICGGNELQANTSRIVGTY 235
N+ S R LK N+LL KI DFG+AR G ++ T I+ T
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TL 201
Query: 236 GYMSPE-------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y PE Y S D++S + E++
Sbjct: 202 WYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 51/228 (22%)
Query: 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL---PGRSGQGLREMKNE 135
+ ++F G+G FG V G K G +A+K++ P + L+ M+
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-- 71
Query: 136 ASVIAKVQHKNLVRLLGCCIDKDEK-------ILIYEYMP-------------NKSLD-- 173
+A + H N+V+L E+ ++ EY+P +
Sbjct: 72 --DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 174 ---FFLFDPTKRMLL---DWSANYSSR-LKVSNILLDKDINP-KISDFGMARICGGNELQ 225
FLF R + S N R +K N+L+++ K+ DFG A+ +E
Sbjct: 130 LIKVFLFQ-LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-- 186
Query: 226 ANTSRIVGTYGYMSPEYAIQGIFSIKS-----DVFSFGVLLLEIVSGK 268
N + I Y Y +PE IF + D++S G + E++ G+
Sbjct: 187 PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 40/200 (20%), Positives = 69/200 (34%), Gaps = 50/200 (25%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 153
LG G G V + ++ G + A+K L + + E + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 154 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
+ +I E M L F R+ ++ R
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 195 ----------LKVSNILL---DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
+K N+L +KD K++DFG A+ N LQ T Y++PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPE 199
Query: 242 YAIQGIFSIKSDVFSFGVLL 261
+ D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGR---SGQGLREMKNEASVIAKVQHKN---LVR 149
+G GGFG VY ++ A+K L + QG NE +++ V + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
+ D+ I + M L + Y++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
LK +NILLD+ + +ISD G+A C ++ + + S VGT+GYM+PE +G+ S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSS 371
Query: 253 -DVFSFGVLLLEIVSGK 268
D FS G +L +++ G
Sbjct: 372 ADWFSLGCMLFKLLRGH 388
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 41/201 (20%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+G+G F V + G E+A+K + + L+++ E ++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 154 CIDKDEKI-LIYEYMPNKSLDFFLFD---PTKRM-----------LLDWSA-NYSSR--- 194
I+ ++ + LI EY + FD RM ++ SA Y +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIV--SAVQYCHQKRI 135
Query: 195 ----LKVSNILLDKDINPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
LK N+LLD D+N KI+DFG + G +L + G Y +PE QG
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAF--CGAPPYAAPE-LFQGKKY 190
Query: 250 I--KSDVFSFGVLLLEIVSGK 268
+ DV+S GV+L +VSG
Sbjct: 191 DGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 61/225 (27%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVK----------------------RLPGRSGQGLREM- 132
+G+G +G V A+K R R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 133 ---KNEASVIAKVQHKNLVRLLGCCIDKDEKILIY---EYMPNKSLDFFLFD-PTKRMLL 185
E +++ K+ H N+V+L+ +D + +Y E + + + PT + L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 186 DWSANYSSR------------------LKVSNILLDKDINPKISDFGMARICGGNELQAN 227
+ A + + +K SN+L+ +D + KI+DFG++ G++ +
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 228 TSRIVGTYGYMSPEYAIQGIFSI----KSDVFSFGVLLLEIVSGK 268
+ VGT +M+PE ++ I DV++ GV L V G+
Sbjct: 196 NT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 63/240 (26%)
Query: 75 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQ------ 127
Q +K+ K+G+G FG V+K +K + A+K++
Sbjct: 4 QYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFP 60
Query: 128 --GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI--------LIYEYMPN--KSL--- 172
LRE+K ++ ++H+N+V L+ C K L++++ + L
Sbjct: 61 ITALREIK----ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 173 --DFFLFDPTK---RMLLDWSANY--SSR-----LKVSNILLDKDINPKISDFGMARICG 220
F K +MLL+ Y ++ +K +N+L+ +D K++DFG+AR
Sbjct: 117 VLVKFTLSEIKRVMQMLLN-GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 221 ---GNELQANTSRIVGTYGYMSPE-------Y--AIQGIFSIKSDVFSFGVLLLEIVSGK 268
++ T+R+V T Y PE Y I D++ G ++ E+ +
Sbjct: 176 LAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPI--------DLWGAGCIMAEMWTRS 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 3/104 (2%)
Query: 165 EYMPNKSLDFFLFDPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGN 222
+++ + L + F K M S R L NILL + KI DFG+AR I
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266
+ + +M+PE +++I+SDV+SFGVLL EI S
Sbjct: 248 DYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 9/109 (8%)
Query: 95 NKLGEGGFGPVYKGVLKKGDE------IAVKRL-PGRSGQGLREMKNEASVIAKV-QHKN 146
LG G FG V + D+ +AVK L G + R + +E ++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 147 LVRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR 194
+V LLG C + +I E+ +L +L + + R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR 136
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 31/196 (15%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 154
LGEG +G V V + +AVK + + E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 155 IDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANY-----------SSR------ 194
+ + + L EY L FD P M + +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 195 LKVSNILLDKDINPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPE-YAIQGIFSIK 251
+K N+LLD+ N KISDFG+A + E N GT Y++PE + +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKRREFHAEP 188
Query: 252 SDVFSFGVLLLEIVSG 267
DV+S G++L +++G
Sbjct: 189 VDVWSCGIVLTAMLAG 204
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 49/196 (25%), Positives = 73/196 (37%), Gaps = 44/196 (22%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 153
LGEG F K V KK AVK + R + E + + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------- 194
D+ L+ E + L F+ R+ ++S
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE---RIKK--KKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 195 ------LKVSNILL-DKDINP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
LK N+L D++ N KI DFG AR+ + T T Y +PE Q
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQ 183
Query: 246 GIFSIKSDVFSFGVLL 261
+ D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 41/201 (20%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 154
LGEG +G V V + +AVK + + E +K E + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 155 IDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANY-----------SSR------ 194
+ + + L EY L FD P M + +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130
Query: 195 LKVSNILLDKDINPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK- 251
+K N+LLD+ N KISDFG+A + E N GT Y++PE + +
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE-----LLKRRE 183
Query: 252 -----SDVFSFGVLLLEIVSG 267
DV+S G++L +++G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 50/204 (24%), Positives = 79/204 (38%), Gaps = 40/204 (19%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKN------EASVIAKVQHK--NL 147
LG GGFG VY G+ + +A+K + E+ N E ++ KV +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANYS-----------S 193
+RLL D +LI E P D LFD + + + ++ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 194 R------LKVSNILLDKDI-NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
+K NIL+D + K+ DFG + GT Y PE+ I+
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DGTRVYSPPEW-IRY 222
Query: 247 I--FSIKSDVFSFGVLLLEIVSGK 268
+ V+S G+LL ++V G
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 44/197 (22%), Positives = 68/197 (34%), Gaps = 44/197 (22%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+G G + + + K E AVK + E ++ QH N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------------- 194
D ++ E M L D ++L +S R
Sbjct: 85 YDDGKYVYVVTELMKGGEL----LD---KILR--QKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 195 ------LKVSNILL-DKDINP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
LK SNIL D+ NP +I DFG A+ T T +++PE
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLE 193
Query: 245 QGIFSIKSDVFSFGVLL 261
+ + D++S GVLL
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 42/205 (20%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASV---IA-------KVQHK 145
LG+GGFG V+ G L ++A+K +P G + + + +A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANY----------- 191
++RLL ++ +L+ E P + D LFD + S +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 192 SSR------LKVSNILLDKDINP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
SR +K NIL+D K+ DFG + GT Y PE+ I
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DGTRVYSPPEW-I 210
Query: 245 QGI--FSIKSDVFSFGVLLLEIVSG 267
++ + V+S G+LL ++V G
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCG 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 7e-12
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 44/220 (20%)
Query: 85 STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------PGRSG---QGLRE--- 131
S AT+++ ++G G +G VYK A+K + G G +RE
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 132 MKNEASVIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMPN------KSLDFFLFDPT 180
++ + +H N+VRL+ D++ K+ L++E++
Sbjct: 65 LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 181 K-----RMLLDWSANY--SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANT 228
R L ++ ++ LK NIL+ K++DFG+ARI A T
Sbjct: 121 TIKDLMRQFLR-GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALT 177
Query: 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+V T Y +PE +Q ++ D++S G + E+ K
Sbjct: 178 PVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 49/277 (17%)
Query: 22 LGLIFYCARRKPRSRGEDLMTLDLDLNLKANNVNIELPVNSKQTKRSKKKEVDQLPLFS- 80
L ++YC+ + D +++ +K SK K +Q
Sbjct: 3 LHFLYYCSEPTLDVKIAFCQGFDKQVDV---------SYIAKHYNMSKSKVDNQFYSVEV 53
Query: 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLR 130
S T ++ + +G G G V +A+K+L R+ R
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA---YR 110
Query: 131 EMKNEASVIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP-------NKSLD---- 173
E+ ++ V HKN++ LL +++ + + L+ E M LD
Sbjct: 111 ELV----LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM 166
Query: 174 -FFLFDPTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231
+ L+ + SA R LK SNI++ D KI DFG+AR G + + +
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPY 223
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
V T Y +PE + + D++S G ++ E+V K
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 42/244 (17%), Positives = 78/244 (31%), Gaps = 57/244 (23%)
Query: 59 PVNSKQTKRSKKKEVDQLPLFSF-SSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKK 112
P + Q P F S + N D + LG G G V + K+
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85
Query: 113 -GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKI----LIYEY 166
++ A+K L + + E + + ++VR++ + ++ E
Sbjct: 86 TQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 167 MPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------------LKVSNIL 201
+ L F R+ ++ R +K N+L
Sbjct: 141 LDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 202 L---DKDINPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
+ K++DFG A+ N L T Y++PE + D++S
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 258 GVLL 261
GV++
Sbjct: 250 GVIM 253
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 42/214 (19%)
Query: 89 NKFSDANKLGEGGFGPVYKGV-LKKGDEI-AVKRLP------GRSGQGLRE---MKNEAS 137
++ ++GEG +G V+K LK G A+KR+ G +RE +++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67
Query: 138 VIAKVQHKNLVRLL----GCCIDKDEKI-LIYEYMP--------NKSLDFFLFDPTK--- 181
+ +H N+VRL D++ K+ L++E++ + K
Sbjct: 68 -LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 182 RMLLDWSANY--SSR-----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
LL ++ S R LK NIL+ K++DFG+ARI A TS +V T
Sbjct: 127 FQLLR-GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV-T 182
Query: 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y +PE +Q ++ D++S G + E+ K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 44/205 (21%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVK--------RLPGRSGQGLREMKNEASVIAKVQHKNL 147
LG G FG V+ V +K E+ VK L ++ E +++++V+H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
+++L ++ L+ E + LD F F L + A+Y R
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150
Query: 195 -----LKVSNILLDKDINPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
+K NI++ +D K+ DFG A + G T GT Y +PE +
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CGTIEYCAPE-----VL 201
Query: 249 SIKS------DVFSFGVLLLEIVSG 267
+++S GV L +V
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 33/206 (16%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
+G G FG V LK D++ A+K L E + E V+ K + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D + L+ +Y L L R+ + + Y + R +
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 196 KVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS-- 252
K NIL+D + + +++DFG ++ +Q++ VGT Y+SPE +Q + K
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE-ILQAMEGGKGRY 258
Query: 253 ----DVFSFGVLLLEIVSGKKTTGFY 274
D +S GV + E++ G+ T FY
Sbjct: 259 GPECDWWSLGVCMYEMLYGE--TPFY 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 47/193 (24%), Positives = 78/193 (40%), Gaps = 29/193 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
LG G FG V K+ A+K L + L++ NE ++ V LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D ++ EY+ + F R + Y++ R L
Sbjct: 109 SFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS-DV 254
K N+L+D+ +++DFG A+ G T + GT ++PE I K+ D
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE-IILSKGYNKAVDW 221
Query: 255 FSFGVLLLEIVSG 267
++ GVL+ E+ +G
Sbjct: 222 WALGVLIYEMAAG 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 42/215 (19%), Positives = 88/215 (40%), Gaps = 53/215 (24%)
Query: 88 TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL-PGRSGQGLREMKNEASVIAK--VQ 143
+ + KLG G + V++ + + +++ VK L P + + RE+K I +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-----ILENLRG 89
Query: 144 HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLD------------FFLFDPTKRML--LDW 187
N++ L D + L++E++ N F+++ +L LD+
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY----EILKALDY 145
Query: 188 --SANYSSR-LKVSNILLDKDI-NPKISDFGMARICGGNELQANTSRIVGTYGYMSPE-- 241
S R +K N+++D + ++ D+G+A + Q R+ Y + PE
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELL 202
Query: 242 -------YAIQGIFSIKSDVFSFGVLLLEIVSGKK 269
Y++ D++S G +L ++ K+
Sbjct: 203 VDYQMYDYSL--------DMWSLGCMLASMIFRKE 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 39/210 (18%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
++ + +G G G V +A+K+L R+ RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELV---- 76
Query: 138 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP-------NKSLD-----FFLFDP 179
++ V HKN++ LL + + ++ E M LD + L+
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 180 TKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
+ SA R LK SNI++ D KI DFG+AR G + + V T Y
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYR 193
Query: 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+PE + + D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 34/198 (17%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 152
LG G FG V G G ++AVK L + + +K E + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANY-----------SSR---- 194
+ ++ EY+ L FD R+ +
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH 134
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF--SI 250
LK N+LLD +N KI+DFG++ + E TS G+ Y +PE I G
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE-VISGRLYAGP 190
Query: 251 KSDVFSFGVLLLEIVSGK 268
+ D++S GV+L ++ G
Sbjct: 191 EVDIWSCGVILYALLCGT 208
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 45/207 (21%), Positives = 83/207 (40%), Gaps = 33/207 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
+G G F V +K+ ++ A+K + E + E V+ + + +L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D++ L+ EY L L +R+ + + Y + R +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188
Query: 196 KVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-------YAIQGI 247
K NILLD+ + +++DFG ++ +++ VGT Y+SPE G
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGS 246
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFY 274
+ + D ++ GV E+ G+ T FY
Sbjct: 247 YGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 42/219 (19%), Positives = 74/219 (33%), Gaps = 46/219 (21%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK------ 141
+ ++ + G +G V GV +G +A+KR+ G S + K
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 142 -----VQHKNLVRLLGCCI----DKDEKI-LIYEYMPN------KSLDFFLFDPTKRMLL 185
H N++ L + K+ L+ E M + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 186 DW----------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234
+ A R L NILL + + I DF +AR + N + V
Sbjct: 141 -YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTH 196
Query: 235 YGYMSPEYAIQGIFSIKS-----DVFSFGVLLLEIVSGK 268
Y +PE + K D++S G ++ E+ + K
Sbjct: 197 RWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 32/204 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
+G G FG V K ++ A+K L + E ++A +V+L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D ++ EYMP L L + W+ Y++ R +
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL-VNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 196 KVSNILLDKDINPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE----YAIQGIFSI 250
K N+LLDK + K++DFG ++ ++ +T+ VGT Y+SPE G +
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGR 252
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFY 274
+ D +S GV L E++ G T FY
Sbjct: 253 ECDWWSVGVFLYEMLVG--DTPFY 274
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 34/198 (17%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 152
LG G FG V G G ++AVK L + S + +++ E + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWSANY-----------SSR---- 194
+ ++ EY+ L FD R+ S
Sbjct: 84 VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 195 --LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF--SI 250
LK N+LLD +N KI+DFG++ + E TS G+ Y +PE I G
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE-VISGRLYAGP 195
Query: 251 KSDVFSFGVLLLEIVSGK 268
+ D++S GV+L ++ G
Sbjct: 196 EVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 51/206 (24%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGR--SGQGLRE-MKNEASVIAKVQHKNLVRLLG 152
LGEG FG V K ++A+K + + + ++ E S + ++H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 153 CCIDKDEKILIYEYMPNKSLDFF--------LFD---PTKRMLLDWSANY---------- 191
Y+ + + LFD KRM D +
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 192 -SSR------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
LK N+LLD ++N KI+DFG++ I TS G+ Y +PE I
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNYAAPE-VI 179
Query: 245 QGIF--SIKSDVFSFGVLLLEIVSGK 268
G + DV+S G++L ++ G+
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 152
LG G FG V+ + A+K L L++ +E +++ V H ++R+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R-L 195
D + +I +Y+ L F L ++R + Y++ R L
Sbjct: 74 TFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 132
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS-DV 254
K NILLDK+ + KI+DFG A+ + T + GT Y++PE + KS D
Sbjct: 133 KPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE-VVSTKPYNKSIDW 186
Query: 255 FSFGVLLLEIVSG 267
+SFG+L+ E+++G
Sbjct: 187 WSFGILIYEMLAG 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 40/202 (19%), Positives = 78/202 (38%), Gaps = 40/202 (19%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLP----GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G+G FG V ++ A+K + + +R + E ++ ++H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNLW 81
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R- 194
D+++ ++ + + L + + + R
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS-- 252
+K NILLD+ + I+DF +A + + + GT YM+PE +FS +
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE-----MFSSRKGA 192
Query: 253 ------DVFSFGVLLLEIVSGK 268
D +S GV E++ G+
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGR 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 42/211 (19%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
+ +G G +G V + K+ G+++A+K+L R+ RE+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELL---- 75
Query: 138 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP------------NKSLDFFLFDP 179
++ +QH+N++ LL + L+ +M + + + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 180 TKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYM 238
K + SA R LK N+ +++D KI DFG+AR A + V T Y
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYR 190
Query: 239 SPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGK 268
+PE + ++ D++S G ++ E+++GK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 44/247 (17%), Positives = 88/247 (35%), Gaps = 75/247 (30%)
Query: 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQH 144
T++ K+S LG G FG V + + G A+K++ RE+ ++ + H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 145 KNLVRLLGCCIDKDEKI--------------------------------------LIYEY 166
N+++L+ ++ +I EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 167 MP-------------NKSLD-----FFLFDPTKRMLLDWSANYSSR-LKVSNILLD-KDI 206
+P +S+ +++ + + S R +K N+L++ KD
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 207 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS-----DVFSFGVLL 261
K+ DFG A+ + + + I + Y +PE + D++S G +
Sbjct: 180 TLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPEL----MLGATEYTPSIDLWSIGCVF 232
Query: 262 LEIVSGK 268
E++ GK
Sbjct: 233 GELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 45/200 (22%), Positives = 74/200 (37%), Gaps = 42/200 (21%)
Query: 97 LGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
+G G FG + +AVK + R ++ E ++H N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 156 DKDEKILIYEYMPNKSLDFFLFD----------PTKRML-------LDW--SANYSSR-L 195
+I EY L ++ R + + S R L
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 196 KVSNILLDKDINP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIK-- 251
K+ N LLD P KI DFG ++ + ++ VGT Y++PE + +
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPE-----VLLRQEY 194
Query: 252 ----SDVFSFGVLLLEIVSG 267
+DV+S GV L ++ G
Sbjct: 195 DGKIADVWSCGVTLYVMLVG 214
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 48/214 (22%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL-----PGRSGQGLREMKNEASVIAK 141
++++ + +GEG +G V +A+K++ + LRE+K ++ +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 142 VQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPTKRM 183
+H+N++ + I++ + + ++ + M + L +FL+ + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 184 LLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPE 241
SAN R LK SN+LL+ + KI DFG+AR+ + + V T Y +PE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 242 -------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
Y + I D++S G +L E++S +
Sbjct: 202 IMLNSKGYT-KSI-----DIWSVGCILAEMLSNR 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 47/202 (23%), Positives = 74/202 (36%), Gaps = 41/202 (20%)
Query: 97 LGEGGFGPVY----KG--------VLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH 144
LG+G FG V K +LKK +A + E V+ +H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--------AHTLTENRVLQNSRH 207
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------- 193
L L D + EY L FF + D + Y +
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 194 -------RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
LK+ N++LDKD + KI+DFG+ + + T GT Y++PE
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDN 324
Query: 247 IFSIKSDVFSFGVLLLEIVSGK 268
+ D + GV++ E++ G+
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 195 LKVSNILL--DKDINPKISDFGMARICGGNELQANT--SRIVGTYGYMSPE--YAIQGIF 248
+K N L +K K+ DFG+++ + GT +++PE +
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 249 SIKSDVFSFGVLLLEIVSGK 268
K D +S GVLL ++ G
Sbjct: 254 GPKCDAWSAGVLLHLLLMGA 273
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVK-----RLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
+G+G +G V + + A+K ++ + + + +K E ++ K+ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 150 LLGCCIDKDEKILIYEYMPNKSL 172
L D+ L+ E L
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHL 115
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 6e-08
Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 57 ELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVY---KGVLKKG 113
E+ + + +K + Q F V LG+G FG V+ K
Sbjct: 7 EIAITHHVKEGHEKADPSQ---FELLKV------------LGQGSFGKVFLVKKISGSDA 51
Query: 114 DEI-AVKRLPGRSGQGLR----EMKNEASVIAKVQHKNLVRLLGCCIDKDEKI-LIYEYM 167
++ A+K L + K E ++ +V H +V+L + K+ LI +++
Sbjct: 52 RQLYAMKVL--KKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFL 108
Query: 168 PNKSLDFFLFDPTKRMLLDWSANYSS----------------R-LKVSNILLDKDINPKI 210
L F + Y + R LK NILLD++ + K+
Sbjct: 109 RGGDL-FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 211 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+DFG+++ +E +A + GT YM+PE + + +D +SFGVL+ E+++G
Sbjct: 168 TDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 40/226 (17%), Positives = 87/226 (38%), Gaps = 41/226 (18%)
Query: 52 NNVNIELPVNSKQTKRSKKKEVDQLPLFS----FSSVSTATNKFSDANKLGEGGFGPVYK 107
+N + V+ Q + ++K+ + S +++ + +G G +G V +
Sbjct: 12 HNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCE 71
Query: 108 GV-LKKGDEIAVKRLPG---------RSGQGLREMKNEASVIAKVQHKNLVRLLGCCI-- 155
+ +A+K++ R LRE+ ++ ++ H ++V++L I
Sbjct: 72 AYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIA----ILNRLNHDHVVKVLDIVIPK 124
Query: 156 --DKDEKI-LIYEYMP---------NKSLD-----FFLFDPTKRMLLDWSANYSSR-LKV 197
+K +++ ++ E L L++ + SA R LK
Sbjct: 125 DVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
+N L+++D + K+ DFG+AR E + I M+
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 30/196 (15%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKVQHKNLVRL 150
LG+G FG V K A+K L R + + E+ V+ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 151 LGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS---------------- 193
+++ + EY L FF + + + Y +
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 128
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
R +K+ N++LDKD + KI+DFG+ + + T GT Y++PE +
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGRAV 186
Query: 253 DVFSFGVLLLEIVSGK 268
D + GV++ E++ G+
Sbjct: 187 DWWGLGVVMYEMMCGR 202
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 46/212 (21%), Positives = 93/212 (43%), Gaps = 43/212 (20%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
++ + + +G G +G V K G +AVK+L R+ RE++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELR---- 80
Query: 138 VIAKVQHKNLVRLL-----GCCIDKDEKI-LIYEYMP--------NKSLD-----FFLFD 178
++ ++H+N++ LL +++ + L+ M + L F ++
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 179 PTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
+ + SA+ R LK SN+ +++D KI DFG+AR + V T Y
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 238 MSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGK 268
+PE + ++ D++S G ++ E+++G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 32/199 (16%)
Query: 97 LGEGGFGPVY---KGVLKKGDEI-AVK-----RLPGRSGQGLREMKNEASVIAKVQHKNL 147
LG+GG+G V+ K +I A+K + + K E +++ +V+H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKHPFI 83
Query: 148 VRLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS------------- 193
V L+ K+ LI EY+ L F + + D + Y +
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 194 ---R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R LK NI+L+ + K++DFG+ + + +T GT YM+PE ++ +
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRSGHN 199
Query: 250 IKSDVFSFGVLLLEIVSGK 268
D +S G L+ ++++G
Sbjct: 200 RAVDWWSLGALMYDMLTGA 218
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 43/212 (20%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
+ D +G G +G V V + G ++A+K+L R+ RE++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELR---- 76
Query: 138 VIAKVQHKNLVRLL------GCCIDKDEKILIYEYMP--------NKSLD-----FFLFD 178
++ ++H+N++ LL D + L+ +M ++ L F ++
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 179 PTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
K + +A R LK N+ +++D KI DFG+AR + + V T Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGYVVTRWY 191
Query: 238 MSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGK 268
+PE + ++ D++S G ++ E+++GK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
LG+G FG V K DE+ AVK L + +++ E V+A + L +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS---------------- 193
L C D + EY+ L + R + Y++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 194 R-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
R LK+ N++LD + + KI+DFGM + I G T GT Y++PE +
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 251 KSDVFSFGVLLLEIVSGK 268
D ++FGVLL E+++G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 52/223 (23%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG----LREMKNEASVIAKV 142
+++ D LG GG G V+ V +A+K++ Q LRE+K +I ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65
Query: 143 QHKNLVRLL--------------GCCIDKDEKILIYEYMP--------NKSLD-----FF 175
H N+V++ G + + ++ EYM L F
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 176 LFDPTKRMLLDWSANYSSR-LKVSNILLD-KDINPKISDFGMARICGGNELQANT-SRIV 232
++ + + SAN R LK +N+ ++ +D+ KI DFG+ARI + S +
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 233 GTYGYMSPE-------YAIQGIFSIKSDVFSFGVLLLEIVSGK 268
T Y SP Y + I D+++ G + E+++GK
Sbjct: 186 VTKWYRSPRLLLSPNNYT-KAI-----DMWAAGCIFAEMLTGK 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 51/240 (21%), Positives = 87/240 (36%), Gaps = 50/240 (20%)
Query: 97 LGEGGFGPVY---KGVLKKGDEI-AVKRLP----GRSGQGLREMKNEASVIAKVQHKN-L 147
LG G +G V+ K ++ A+K L + + + E V+ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-------------- 193
V L + + LI +Y+ L F +R Y
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 194 --R-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPE---YAIQ 245
R +K+ NILLD + + ++DFG+++ + E GT YM+P+
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDIVRGGDS 237
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
G D +S GVL+ E+++G + F N E+ IL+ E
Sbjct: 238 G-HDKAVDWWSLGVLMYELLTGA--SPFTVDG------------EKNSQAEISRRILKSE 282
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 32/189 (16%), Positives = 65/189 (34%), Gaps = 37/189 (19%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
+ + + +G G +G VY K +A+K++ R LRE+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREIT---- 77
Query: 138 VIAKVQHKNLVRLLGCCIDKDEKI-----LIYEYMP---------NKSLD-----FFLFD 178
++ +++ ++RL I D ++ E L L++
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 179 PTKRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGY 237
+ R LK +N LL++D + K+ DFG+AR + + +
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 238 MSPEYAIQG 246
++
Sbjct: 198 GPHNKNLKK 206
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
LG+G FG V +K+ ++ AVK L + L++ E +++ H L +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
L C D + E++ L F ++R + Y++
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIY 147
Query: 195 --LKVSNILLDKDINPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
LK+ N+LLD + + K++DFGM IC G T+ GT Y++PE + ++
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQEMLYGP 203
Query: 251 KSDVFSFGVLLLEIVSGK 268
D ++ GVLL E++ G
Sbjct: 204 AVDWWAMGVLLYEMLCGH 221
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 1e-06
Identities = 23/128 (17%), Positives = 39/128 (30%), Gaps = 21/128 (16%)
Query: 71 KEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLP-------- 122
E Q FS T K K+GEG FG V++ + +A+K +
Sbjct: 3 GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVN 60
Query: 123 GRSGQGLREMKNEASV---------IAKVQHKNLVRLLG--CCIDKDEKILIYEYMPNKS 171
G + E+ E + + + + L C +L+ + S
Sbjct: 61 GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120
Query: 172 LDFFLFDP 179
D
Sbjct: 121 TKGSANDR 128
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL-----PGRSGQGLREMKNEASVIAK 141
++ F + LGEG +G V K G+ +A+K++ P + + LRE+K ++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 142 VQHKNLVRLLGC----CIDKDEKI-LIYEYMP--------NKSLD-----FFLFDPTKRM 183
+H+N++ + + ++ +I E M + L +F++ + +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 184 LLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRI--------VGT 234
+ +N R LK SN+L++ + + K+ DFG+ARI + + V T
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 235 YGYMSPEYAIQGIFSIKS-----DVFSFGVLLLEIVSGK 268
Y +PE + + DV+S G +L E+ +
Sbjct: 186 RWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 18/191 (9%), Positives = 54/191 (28%), Gaps = 47/191 (24%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLP---GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
G ++ + ++A+ + L+E + ++++ + R+L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWSA--NYS-------SRLKV 197
+ +++ E++ SL R + +A + + S
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHP 157
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
S + + D + ++ M + + D+
Sbjct: 158 SRVRVSIDGDVVLAYP----------------------ATMPDA-------NPQDDIRGI 188
Query: 258 GVLLLEIVSGK 268
G L ++ +
Sbjct: 189 GASLYALLVNR 199
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 35/199 (17%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
LG+G FG V K DE+ AVK L + +++ E V+A + L +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL--KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 150 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------------- 193
L C +++ + EY+ L + R + Y++
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 194 -R-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R LK+ N++LD + + KI+DFGM + I G T GT Y++PE +
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYG 199
Query: 250 IKSDVFSFGVLLLEIVSGK 268
D ++FGVLL E+++G+
Sbjct: 200 KSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
+G G + V LKK D I A+K + + + ++ E V + H LV
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 150 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------------- 193
L C + ++ + EY+ L F +++ + + YS+
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 132
Query: 194 -R-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R LK+ N+LLD + + K++D+GM + + G+ TS GT Y++PE +
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYG 188
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
D ++ GVL+ E+++G+ + F S D N L ILE +
Sbjct: 189 FSVDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 55/380 (14%), Positives = 114/380 (30%), Gaps = 115/380 (30%)
Query: 24 LIFYCARRKPRSRGEDLM--TLDLDLNLKANNVNIELPVNSKQTKRSKKKEVDQL----- 76
+F+ K + + L ++ + + E +Q + ++Q
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE----QRQPSMMTRMYIEQRDRLYN 121
Query: 77 --PLFSFSSVS---------TATNKFSDANKL---GEGGFGPVYKGVLKKG---DEIAVK 119
+F+ +VS A + A + G G G K +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVALDVCLSYKVQC 178
Query: 120 RLPGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFF 175
++ + + L+ + +V+ +Q L+ ID + ++ N L
Sbjct: 179 KMDFKIFWLN---LKNCNSPETVLEMLQ--KLLYQ----IDPNWTSRS-DHSSNIKLRIH 228
Query: 176 LFDPTKRMLLDWSANYSSRLKVSNILLDKDI-NPKISD-FGMARICGGNELQANTSRIVG 233
R LL Y + L ++L ++ N K + F ++ C +I+
Sbjct: 229 SIQAELRRLLKS-KPYENCL----LVLL-NVQNAKAWNAFNLS--C----------KILL 270
Query: 234 TYGYMSPEYAIQGIFSIKSDVFSF--GVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291
T + V F I + + +LL +
Sbjct: 271 T--------------TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL----KYLD 312
Query: 292 NRTLEL------IDPI--------LEDEYSS----KHMLLRYVNIAL---LCVQESADDR 330
R +L +P + D ++ KH+ + + L V E A+ R
Sbjct: 313 CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372
Query: 331 PTMNEVVSMLTDEAAALFPP 350
++ L ++FPP
Sbjct: 373 ----KMFDRL-----SVFPP 383
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 6e-06
Identities = 45/322 (13%), Positives = 95/322 (29%), Gaps = 100/322 (31%)
Query: 137 SVIAKVQHKNLV----------RLLGCCIDKDEKILIYEYMPNKSLDF---FLFDPTKRM 183
S+++K + +++ RL + K E++ + + L FL P K
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM--VQKFVEEVLRINYKFLMSPIKTE 101
Query: 184 LLDWSANYS---------------------SR----LKVSNILLDKDINPKISDFGMARI 218
S SR LK+ LL+ + G+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG- 160
Query: 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF--SFG-----VLLLEI------- 264
G + + Y +Q K +F + +LE+
Sbjct: 161 SGKTWVALDVCL----------SYKVQCKMDFK--IFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 265 VSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE-------LIDPILEDEYSSKH------- 310
+ T+ + ++ L ++ R L+ L+ +L + ++K
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELR-RLLKSKPYENCLL--VLLNVQNAKAWNAFNLS 265
Query: 311 --MLL--RYVNIALLCVQESADDRPTMNEVVSMLT-DEAAALFPPKQPAFSYVRNTVTST 365
+LL R+ + + + +++ LT DE +L Y+
Sbjct: 266 CKILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRPQDL 318
Query: 366 SSTGKTEDCSINQVTISLLEAR 387
E + N +S++
Sbjct: 319 PR----EVLTTNPRRLSIIAES 336
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 44/236 (18%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
+G G + V LKK D I A++ + + + ++ E V + H LV
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV--KKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 150 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------------- 193
L C + ++ + EY+ L F +++ + + YS+
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 175
Query: 194 -R-LKVSNILLDKDINPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R LK+ N+LLD + + K++D+GM + + G+ TS GT Y++PE +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYG 231
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
D ++ GVL+ E+++G+ + F S D N L ILE +
Sbjct: 232 FSVDWWALGVLMFEMMAGR--SPFDIVGS-------SDNPDQNTEDYLFQVILEKQ 278
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 149
LG+G FG V+ KK ++ A+K L + L + E V++ +H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS---------------- 193
+ K+ + EY+ L + + L + Y++
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 141
Query: 194 R-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
R LK+ NILLDKD + KI+DFGM + + + NT GT Y++PE + ++
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSV 199
Query: 253 DVFSFGVLLLEIVSG 267
D +SFGVLL E++ G
Sbjct: 200 DWWSFGVLLYEMLIG 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 25/194 (12%)
Query: 97 LGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLRE---MKNEASVIAK-VQHKNLVRLL 151
+G+G FG V K + AVK L ++ +E + +E +V+ K V+H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS----------------R- 194
D+ + +Y+ L F+ + L + Y++ R
Sbjct: 106 FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLD + ++DFG+ + + +T GT Y++PE + + D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 255 FSFGVLLLEIVSGK 268
+ G +L E++ G
Sbjct: 223 WCLGAVLYEMLYGL 236
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 36/182 (19%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPG---------RSGQGLREMKNEAS 137
K+ KLG+G +G V+K + ++ G+ +AVK++ R+ RE+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIM---- 60
Query: 138 VIAK--VQHKNLVRLLGCCI-DKDEKI-LIYEYMP--------NKSLD-----FFLFDPT 180
I H+N+V LL D D + L+++YM L+ + ++
Sbjct: 61 -ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 181 KRMLLDWSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMS 239
K + S R +K SNILL+ + + K++DFG++R N + +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 240 PE 241
+
Sbjct: 180 FD 181
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 26/155 (16%), Positives = 51/155 (32%), Gaps = 46/155 (29%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC 153
LG G G V + K+ ++ A+K L + + E + + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 154 CIDKDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------------- 194
+ ++ E + LF R+ ++ R
Sbjct: 80 YENLYAGRKCLLIVMECLDGGE----LFS---RIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 195 ----------LKVSNILL---DKDINPKISDFGMA 216
+K N+L + K++DFG A
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 43/224 (19%), Positives = 84/224 (37%), Gaps = 68/224 (30%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSG-----QGLREMK-----NEASVIAKVQ- 143
KLG G F V+ + +A+K + R E+K N+A +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 144 -HKNLVRLLGC-----------CIDKDEKILIYEYMPNKSLDFFL----FDP-------- 179
++++LL + ++E + ++L +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVM-------VFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 180 -TKRMLLDWSANYSSR--------LKVSNILLD------KDINPKISDFGMARICGGNEL 224
+K++LL +Y R +K N+L++ I KI+D G A C +E
Sbjct: 136 ISKQLLL--GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE- 190
Query: 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
+ + + T Y SPE + + +D++S L+ E+++G
Sbjct: 191 --HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 32/145 (22%), Positives = 62/145 (42%), Gaps = 27/145 (18%)
Query: 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV-RLLGC 153
K+G G FG +Y G ++ +E+A+K ++ ++ E+ + +Q + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDW---------SANYSSR-L 195
++ D +L+ + + SL+ LF+ R ML D S ++ R +
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
Query: 196 KVSNILLDKDINPK---ISDFGMAR 217
K N L+ I DFG+A+
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 14/65 (21%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLE 263
+ + KI+D G A + + + + T Y S E I ++ +D++S + E
Sbjct: 231 EKLKVKIADLGNACW-----VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFE 285
Query: 264 IVSGK 268
+ +G
Sbjct: 286 LATGD 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 32/154 (20%), Positives = 55/154 (35%), Gaps = 29/154 (18%)
Query: 89 NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH-KN 146
F K+G G FG + G L + +A+K P +S ++ E ++
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDW---------SA 189
+ ++ ++ E + SL+ LFD R M+ S
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 190 NYSSR-LKVSNILLDKDINPK-----ISDFGMAR 217
N R +K N L+ + N I DF +A+
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.21 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.36 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.32 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.15 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.62 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.08 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 93.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 93.83 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 93.83 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.18 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 90.57 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 89.03 | |
| 1afo_A | 40 | Glycophorin A; integral membrane protein, transmem | 88.56 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.08 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=407.92 Aligned_cols=243 Identities=25% Similarity=0.377 Sum_probs=195.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|.+.+.||+|+||.||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..||
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999874 256799999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
|||||++|+|.+++..... ..++|..+++||||||+||||+.++.+||+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCc
Confidence 9999999999999864320 12578888999999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
|+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.... ...+...... .
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i~~----~ 246 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIECITQ----G 246 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHH----T
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc----C
Confidence 99987655444444445679999999999999999999999999999999999 899975322 1111111111 1
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. ...+..++..+.+|+.+||+.||++||||++|++.|+++....
T Consensus 247 ~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 247 RV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 10 0122334567899999999999999999999999999886643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=409.42 Aligned_cols=242 Identities=26% Similarity=0.355 Sum_probs=188.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|.+.++||+|+||.||+|+++ ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999875 266899999987766677889999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 163 IYEYMPNKSLDFFLFDPTK-------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
|||||++|+|.++++.... ..++|..+++||||||+||||+.++.+||+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEc
Confidence 9999999999999865321 125788888999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.... .......+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--~~~~~~~i~~--- 275 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--NTEAIDCITQ--- 275 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--HHHHHHHHHH---
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc---
Confidence 9999987755444444455689999999999999999999999999999999999 899975322 1111111111
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
... ...+..+++.+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 276 g~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GRE-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCC-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCC-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 100 012233456789999999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=400.79 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=189.3
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++...++|.+.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +..|
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3455678888999999999999999976 36999998643 34456789999999999999999999998865 5689
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||||||++|+|.+++...... .++|..+++||||||+||||++++.+||+|||+|+.......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999998654321 357888999999999999999999999999999987654333
Q ss_pred ccccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||...... ..+.... ..... .+.
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~----~~~~~----~p~ 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMV----GRGYA----SPD 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHH----HTTCC----CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHH----hcCCC----CCC
Confidence 334455789999999999964 46999999999999999999999998532211 1111111 11100 011
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
+. .....++..+.+|+.+||+.||++||||.||++.|+.+...++
T Consensus 259 ~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 LS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11 1123345678899999999999999999999999988866553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=405.42 Aligned_cols=239 Identities=27% Similarity=0.378 Sum_probs=191.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
+.+++.+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999973 3568999999754 3345678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 162 LIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
||||||++|+|.++|..... ..++|..+++||||||+||||++++.+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence 99999999999999854211 1257788889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.... ...+...+
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~~~~~i--- 260 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVVEMI--- 260 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHHHHHHH---
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHHHHHHH---
Confidence 999999987654444444455689999999999999999999999999999999999 888975332 11111111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..... ...+..++..+.+|+.+||+.||++||||+||++.|+..
T Consensus 261 -~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 -RNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -HcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 012334566789999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=401.73 Aligned_cols=232 Identities=21% Similarity=0.298 Sum_probs=182.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+|++.. |+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999765 899999999644 34456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 166 YMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||++|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+|+..... ...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VEL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--ccc
Confidence 9999999998853221 12578888999999999999999999999999999865422 112
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .. ........... . ..
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~---~~~~~i~~~~~-~----------~~ 245 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MK---NLVLKIISGSF-P----------PV 245 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HH---HHHHHHHHTCC-C----------CC
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HH---HHHHHHHcCCC-C----------CC
Confidence 344689999999999999999999999999999999999999985322 11 11111111110 0 11
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+...+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2233557889999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=392.58 Aligned_cols=246 Identities=19% Similarity=0.158 Sum_probs=191.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+.|+..++||+|+||.||+|++.. |+.||||+++.... ..+|+.+|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457778899999999999999875 89999999975422 246999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCcc---cc
Q 041766 168 PNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQ---AN 227 (387)
Q Consensus 168 ~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~---~~ 227 (387)
++|+|.+++..... ..++|..+++||||||+||||+.++ .+||+|||+|+........ ..
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 99999998864321 1357888999999999999999887 6999999999977543221 12
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ... ...... . ...
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~i---~~~~~~-------~--~~~ 278 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC--LKI---ASEPPP-------I--REI 278 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--HHH---HHSCCG-------G--GGS
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHH---HcCCCC-------c--hhc
Confidence 23468999999999999999999999999999999999999998543322211 111 111000 0 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCC
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQP 353 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~ 353 (387)
+..++..+.+++.+||+.||++|||+.|+++.|.....+...-..|
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 2334567889999999999999999999999998887765544444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=393.91 Aligned_cols=235 Identities=23% Similarity=0.318 Sum_probs=190.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.+.|+..++||+|+||.||+|++.. |+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4579999999999999999999875 899999999755445556788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
|++|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+|+...... ......
T Consensus 153 ~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~ 230 (346)
T 4fih_A 153 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 230 (346)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCC
T ss_pred CCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cccccc
Confidence 999999988864321 135888899999999999999999999999999999765432 223457
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......... . ..+.+. .....
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~----~-----~~~~~~---~~~~~ 296 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRD----N-----LPPRLK---NLHKV 296 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHH----S-----SCCCCS---CGGGS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHc----C-----CCCCCC---ccccC
Confidence 89999999999999999999999999999999999999985321 1111111111 0 001111 12234
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..+.+|+.+||+.||++|||++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 567889999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=394.69 Aligned_cols=250 Identities=26% Similarity=0.330 Sum_probs=198.3
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcC-CCceeeeeee
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGC 153 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~~~~~ 153 (387)
..++...++|++.+.||+|+||.||+|++.. ++.||||++.... ....+.|.+|+++|.+++ |||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4566777899999999999999999998653 2479999997543 344567999999999995 5999999999
Q ss_pred EEeC-CceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCce
Q 041766 154 CIDK-DEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNI 200 (387)
Q Consensus 154 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Ni 200 (387)
|... +..+||||||++|+|.++|+.... ..++|..+++||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 9765 568999999999999999864321 1247778889999999999
Q ss_pred EEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 041766 201 LLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSL 279 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~ 279 (387)
|+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999997765444444556789999999999999999999999999999999998 899985432221
Q ss_pred hHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 280 TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.+...... ... ...+..+++.+.+++.+||+.||++||||.||++.|+++.++
T Consensus 296 ~~~~~i~~----g~~----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 EFCRRLKE----GTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHH----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHc----CCC----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11111111 110 011223456788999999999999999999999999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=389.65 Aligned_cols=232 Identities=22% Similarity=0.267 Sum_probs=189.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999765 889999998642 2344578899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||++|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+|+.+.........
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 99999999998864322 13588889999999999999999999999999999987654444445
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
.+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ...+. ....... . . .+
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~---~~i~~~~-~------~-----~p 254 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIF---AKIIKLE-Y------D-----FP 254 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHHTC-C------C-----CC
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHH---HHHHcCC-C------C-----CC
Confidence 66799999999999999999999999999999999999999985321 11111 1111110 0 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVV 337 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~ 337 (387)
...+..+.+|+.+||+.||++|||++|++
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22345788999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=386.79 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=181.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHH--HHHHHHHhcCCCceeeeeeeEEeCC----ceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMK--NEASVIAKVQHKNLVRLLGCCIDKD----EKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~nIv~~~~~~~~~~----~~~l 162 (387)
.+|.+.+.||+|+||+||+|++. |+.||||++.... ...+. .|+..+.+++|||||+++|+|.+++ ..||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 34667789999999999999985 8899999996432 23333 4555567789999999999998754 5799
Q ss_pred EEEecCCCCcchhhcCCccc---------------cccchh--------hhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 163 IYEYMPNKSLDFFLFDPTKR---------------MLLDWS--------ANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~---------------~~l~~~--------~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
|||||++|+|.+++...... .++|.. +++||||||+||||+.++.+||+|||+|+..
T Consensus 79 V~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999998654321 234433 7899999999999999999999999999876
Q ss_pred CCCCccc--ccccccCCCccccccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH---------h
Q 041766 220 GGNELQA--NTSRIVGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL---------L 282 (387)
Q Consensus 220 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~---------~ 282 (387)
....... .....+||+.|||||++.+. .|+.++|||||||++|||+||+.|+.......... .
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5433221 22346899999999999754 47889999999999999999988765433211110 0
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
........ ...+++.+.......+.+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 239 ~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 01111111 1112222322223445677899999999999999999999999999988653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=395.27 Aligned_cols=235 Identities=23% Similarity=0.318 Sum_probs=191.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.+.|+..+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4679999999999999999999875 899999999766556667889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
|++|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+|+...... ......
T Consensus 230 ~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~ 307 (423)
T 4fie_A 230 LEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 307 (423)
T ss_dssp CTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCC
T ss_pred CCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cccccc
Confidence 999999988854321 136888999999999999999999999999999998765432 223457
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......... . ..+.+. .....
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~----~-----~~~~~~---~~~~~ 373 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRD----N-----LPPRLK---NLHKV 373 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHH----S-----CCCCCS---CTTSS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHc----C-----CCCCCc---ccccC
Confidence 89999999999999999999999999999999999999984321 1111111111 0 001111 11223
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..+.+|+.+||+.||++|||+.|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 457889999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=378.06 Aligned_cols=228 Identities=24% Similarity=0.352 Sum_probs=175.3
Q ss_pred CCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY 164 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~ 164 (387)
++.+.||+|+||.||+|++.. +..||+|.+... .....+.|.+|+++|++++|||||+++++|.+ .+..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455679999999999999875 889999998543 34456789999999999999999999999875 24579999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhh--hhhcccCCCceEEcC-CCCeEEeeccCceecCCCCcc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSA--NYSSRLKVSNILLDK-DINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~--~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||++|+|.+++..... ..++|..+ ++||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC---
Confidence 99999999998864321 12467666 999999999999985 789999999999854322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... .. . ......... +.
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~---~-~~~i~~~~~-----~~---- 249 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ---I-YRRVTSGVK-----PA---- 249 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH---H-HHHHTTTCC-----CG----
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HH---H-HHHHHcCCC-----CC----
Confidence 2345689999999998865 6999999999999999999999998532211 11 1 111111100 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122346889999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=370.63 Aligned_cols=229 Identities=21% Similarity=0.301 Sum_probs=170.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999765 899999998643 2344567899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||| +|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+|+...... ..
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 168 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FL 168 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---cc
Confidence 999 6788877754322 135788899999999999999999999999999998754332 23
Q ss_pred ccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.+.+||+.|||||++.+..| +.++||||+||++|||++|+.||.... ... ......... . . .
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~---~~~~i~~~~-~------~-----~ 231 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPV---LFKNISNGV-Y------T-----L 231 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH---HHHHHHHTC-C------C-----C
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHH---HHHHHHcCC-C------C-----C
Confidence 45689999999999998886 579999999999999999999985321 111 111111110 0 0 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+...+..+.+|+.+||+.||++|||++|+++
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1223457889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=377.02 Aligned_cols=231 Identities=22% Similarity=0.251 Sum_probs=176.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|++.+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999999999999863 36789999986432 2233468889999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||||++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+|+...... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--c
Confidence 9999999999988865322 135788899999999999999999999999999998654322 2
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..... ....... . .
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~---~~i~~~~---------~---~ 244 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETM---TMILKAK---------L---G 244 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHH---HHHHHCC---------C---C
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHH---HHHHcCC---------C---C
Confidence 2345689999999999999999999999999999999999999985321 11111 1111100 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTM-----NEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~-----~~v~~ 338 (387)
.+...++.+.+|+.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 122345578899999999999999984 67765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=365.21 Aligned_cols=232 Identities=23% Similarity=0.289 Sum_probs=170.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--------
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-------- 158 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-------- 158 (387)
++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 458889999999999999999765 889999998643 3344567899999999999999999999987644
Q ss_pred ----ceEEEEEecCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 159 ----EKILIYEYMPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 159 ----~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
..|+|||||++|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 36899999999999998865321 1257888899999999999999999999999999
Q ss_pred ceecCCCCcc----------cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH
Q 041766 216 ARICGGNELQ----------ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA 285 (387)
Q Consensus 216 a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 285 (387)
|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||... .......
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc----cHHHHHH
Confidence 9876543211 11234579999999999999999999999999999999996 55311 0100001
Q ss_pred HHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 286 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... ... ..+.......+.+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~-~~~----------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDV-RNL----------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HTT----------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-hcC----------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 010 000 001112233456778999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=357.68 Aligned_cols=190 Identities=22% Similarity=0.295 Sum_probs=156.1
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCc
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~ 159 (387)
....++|++.+.||+|+||+||+|+.+ .++.||+|.+.... ....+.+|+++|..+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999864 35689999986543 345788999999998 79999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc-------------ccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecCCCCcc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK-------------RMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICGGNELQ 225 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~~ 225 (387)
.|+|||||++|+|.+++..... ..++|..+++||||||+|||++.+ +.+||+|||+|+........
T Consensus 95 ~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred EEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 9999999999999988855332 135888999999999999999876 79999999999865432211
Q ss_pred --------------------------cccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCC
Q 041766 226 --------------------------ANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRT 276 (387)
Q Consensus 226 --------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~ 276 (387)
......+||+.|||||++.+.. |+.++||||+||++|||++|+.||....+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1123357999999999998764 89999999999999999999999854443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=361.88 Aligned_cols=252 Identities=16% Similarity=0.219 Sum_probs=183.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------Cc
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DE 159 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~ 159 (387)
++|++.+.||+|+||.||+|++.. |+.||||++.... ....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999865 8999999997542 33456788999999999999999999987643 56
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|||||||+ |+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 899999996 678888765432 135888999999999999999999999999999998764322
Q ss_pred --cccccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc--c--
Q 041766 224 --LQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL--E-- 296 (387)
Q Consensus 224 --~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~-- 296 (387)
......+.+||+.|||||++.+.. |+.++||||+||++|||++|+.||..... ................. .
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCGGGTC--
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCChHHhhhh
Confidence 122334578999999999988754 69999999999999999999999854321 11111111111100000 0
Q ss_pred -------ccccccccccc-----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 297 -------LIDPILEDEYS-----SKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 297 -------~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
.+......... ....+..+.+|+.+||+.||++|||++|+++. +.+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00000000000 01224578899999999999999999999873 5443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=340.05 Aligned_cols=265 Identities=33% Similarity=0.557 Sum_probs=214.9
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
+.++....++|+..+.||+|+||.||+|++++++.||||++........+.+.+|+.++++++||||+++++++...+..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34455677899999999999999999999888999999999776666678899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
++||||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999998865431 124677888999999999999999999999999998754
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-chHhHHHHHHhhcCccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS-LTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (387)
............||..|+|||++.+..++.++|||||||++|||++|+.||....... .....+.............++
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 3332223344568999999999999999999999999999999999999986543322 233334433333444444444
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
+..... .....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 271 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 271 PNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred hhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 444332 3566788999999999999999999999999999988754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=370.83 Aligned_cols=235 Identities=20% Similarity=0.262 Sum_probs=189.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|+.+. |+.||+|.+........+.+.+|+++|+.++|||||++++++.+.+..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999999875 899999999776666667889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCC--CCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKD--INPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|++|+|.+++..... ..++|..+++||||||+|||++.+ +.+||+|||+|+.+.... .
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---E
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---c
Confidence 999999888854322 125788899999999999999854 899999999999875433 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....+||+.|||||++.+..|+.++|||||||++|||++|..||..... .... ........ . .. ...
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~---~~i~~~~~--~-----~~-~~~ 379 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETL---RNVKSCDW--N-----MD-DSA 379 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHTTCC--C-----CC-SGG
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHH---HHHHhCCC--C-----CC-ccc
Confidence 3346899999999999999999999999999999999999999853221 1111 11111000 0 00 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+..+.+|+.+||+.||++|||+.|+++
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223457889999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=365.08 Aligned_cols=233 Identities=24% Similarity=0.251 Sum_probs=180.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHH---HHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKN---EASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|++.+.||+|+||.||+|+... |+.||||++.+. .......+.. ++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999999876 899999998532 1112223333 46667778999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
|||||||+||+|..++..... ..++|..+++||||||+||||+.+|.+||+|||+|+......
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 999999999999988865322 135888999999999999999999999999999998765432
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
..+.+||+.|||||++.+ ..|+.++|||||||++|||++|..||........ ...........
T Consensus 347 ---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~~----------- 410 (689)
T 3v5w_A 347 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMA----------- 410 (689)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHCC-----------
T ss_pred ---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCCC-----------
Confidence 345699999999999974 5799999999999999999999999854322211 11111111000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
...+...+..+.+|+.+||+.||++|++ ++||++
T Consensus 411 -~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0012234567889999999999999998 678776
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=336.91 Aligned_cols=268 Identities=35% Similarity=0.597 Sum_probs=213.2
Q ss_pred CCCccchhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc-ccHHHHHHHHHHHHhcCCCceeeeeee
Q 041766 75 QLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-QGLREMKNEASVIAKVQHKNLVRLLGC 153 (387)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~~~ 153 (387)
....+++.++....++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3445677888899999999999999999999999987899999999975422 223368899999999999999999999
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCccc--------------------cccchh---hhhhcccCCCceEEcCCCCeEE
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKR--------------------MLLDWS---ANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~---~~~h~dlk~~Nill~~~~~~kl 210 (387)
+...+..++||||+++|+|.+++...... ..+|.. +++|+||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999988654321 246766 8999999999999999999999
Q ss_pred eeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC---CCCCcchHhHHHHH
Q 041766 211 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF---YRTDSLTLLGYAWD 287 (387)
Q Consensus 211 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~---~~~~~~~~~~~~~~ 287 (387)
+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.. ..........+...
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999876533222 23345689999999999988999999999999999999999999852 12222333444444
Q ss_pred HhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
...........+...... .....+..+.+++.+||+.||++|||+.+|++.|++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TTSSCCSTTSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HhhchhhhhhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 333444444444444333 45667889999999999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=331.71 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=195.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
++|.+.+.||+|+||.||+|.+.. +..||+|.+........+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 578889999999999999999875 8899999997766677788999999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc----
Q 041766 168 PNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA---- 226 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~---- 226 (387)
++|+|.+++...... .++|..+++|+||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 999999988653221 24778888999999999999999999999999998764332211
Q ss_pred --------ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 227 --------NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 227 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
......||+.|+|||++.+..++.++||||||+++|||++|..|+................. .
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~---------~ 240 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF---------L 240 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH---------H
T ss_pred cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc---------c
Confidence 11145789999999999999999999999999999999999998754433221110000000 0
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
. ...+..++..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus 241 ~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 241 D-----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp H-----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c-----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 00122234568899999999999999999999999999887653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.74 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=185.4
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++...++|++.+.||+|+||.||+|++. +..||||.+.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3445578899999999999999999875 7889999986543 334567889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc-------------------cccchhh--hhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-------------------MLLDWSA--NYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-------------------~~l~~~~--~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
+||||+++|+|.+++...... ..+|..+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999988764321 2467777 9999999999999999999999999997543
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~~------ 257 (309)
T 3p86_A 191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVVAAVGFKCKR------ 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHHSCCC------
T ss_pred ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCCC------
Confidence 321 1233457899999999999999999999999999999999999997532211 111111000000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCC
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPP 350 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~ 350 (387)
...+...+..+.+++.+||+.||++|||+.++++.|+.+.....||
T Consensus 258 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 258 ----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 0112233457889999999999999999999999999998765444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=332.32 Aligned_cols=257 Identities=20% Similarity=0.239 Sum_probs=192.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----ceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~l 162 (387)
..++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++.+++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3468899999999999999999987 7899999996432 23345667899999999999999999998754 3699
Q ss_pred EEEecCCCCcchhhcCCcc---------------ccccchh----------hhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 163 IYEYMPNKSLDFFLFDPTK---------------RMLLDWS----------ANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~---------------~~~l~~~----------~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
||||+++|+|.+++..... ..++|.. +++|+||||+|||++.++.+||+|||+++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 9999999999998865321 1245655 89999999999999999999999999998
Q ss_pred ecCCCCcccccccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH------H
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA------W 286 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~------~ 286 (387)
...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 7765443333444679999999999986 3567889999999999999999999865433221110000 0
Q ss_pred HHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.............+.+.........+..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000000111112222222334556779999999999999999999999999998864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=323.70 Aligned_cols=236 Identities=22% Similarity=0.337 Sum_probs=188.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|++.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 45789999999999999999999654 88999999875555556788999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 166 YMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|+++|+|.+++..... ..++|..+++|+||||+|||++.++.+||+|||++........ ....
T Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRST 175 (297)
T ss_dssp CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCC
T ss_pred CCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCC
Confidence 9999999988864321 1257788899999999999999999999999999987654322 2344
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........... .. ..+..
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~---~~~~~~~~~~~------~~---~~~~~ 241 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R---ALYLIATNGTP------EL---QNPEK 241 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H---HHHHHHHHCSC------CC---SCGGG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHhCCCC------CC---CCccc
Confidence 67999999999999999999999999999999999999997532211 0 01111000000 00 01223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 3456889999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=317.29 Aligned_cols=264 Identities=37% Similarity=0.530 Sum_probs=204.0
Q ss_pred CccchhhHHHHhcCCCCC------CcccccCCeeEEEEEEcCCCEEEEEEccCC----CcccHHHHHHHHHHHHhcCCCc
Q 041766 77 PLFSFSSVSTATNKFSDA------NKLGEGGFGPVYKGVLKKGDEIAVKRLPGR----SGQGLREMKNEASVIAKVQHKN 146 (387)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~n 146 (387)
..+++.++...+++|... +.||+|+||.||+|... +..||+|.+... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 446677788888887766 89999999999999874 889999998643 2334578899999999999999
Q ss_pred eeeeeeeEEeCCceEEEEEecCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCC
Q 041766 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDIN 207 (387)
Q Consensus 147 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~ 207 (387)
|+++++++.+.+..++||||+++++|.+++..... ...+|..+++|+||||+|||++.++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 99999999999999999999999999988864221 12467788899999999999999999
Q ss_pred eEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHH
Q 041766 208 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 208 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~ 287 (387)
+||+|||+++...............||..|+|||++.+ .++.++||||||+++|||++|..||........ ...+...
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~ 249 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEE 249 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHH
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHH
Confidence 99999999987654333333344678999999998865 589999999999999999999999865443321 1112111
Q ss_pred Hhhc-CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 288 LWTS-NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 288 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.... ....+.++..+. ......+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111 111222222221 1345667889999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=335.73 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=193.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc--------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID 156 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 156 (387)
..++|.+.+.||+|+||.||+|++. .+..||||.+.... ......+.+|+.+|+++ +||||++++++|..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578889999999999999999863 24469999997543 34456789999999999 89999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDK 204 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~ 204 (387)
.+..|+||||+++|+|.+++..... ..++|..+++||||||+|||++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 9999999999999999998864321 12467788899999999999999
Q ss_pred CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhH
Q 041766 205 DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLG 283 (387)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~ 283 (387)
++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~~~ 316 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELFK 316 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH
Confidence 99999999999997765443333444567889999999999999999999999999999999 88887543211 1111
Q ss_pred HHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 284 YAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
. ...... ...+..++..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 317 ~----~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 L----LKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp H----HHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1 111100 001223455788999999999999999999999999998753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=340.88 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=191.5
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
....++|.+.+.||+|+||.||+|++. ++..||||.+.... ......+.+|+++|++++||||+++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567888999999999999999987 48899999987542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999999988864321 12477888899999999999999999999999999875443222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....... .....
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~----~~~~~---------- 333 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFV----EKGGR---------- 333 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHH----HTTCC----------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC----------
Confidence 22222345778999999998999999999999999999998 8888753221 1111111 11100
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 01122234578899999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=322.42 Aligned_cols=239 Identities=22% Similarity=0.278 Sum_probs=186.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..++|++.+.||+|+||.||+|++. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3478999999999999999999987 48899999986442 233456889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|.+++..... ..++|..+++|+||||+|||++.++.+||+|||+++...........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999999988865432 12477888899999999999999999999999999866433333333
Q ss_pred ccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+.. ... ... .
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-----~~~--~~~-------~ 230 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKT--YLN-------P 230 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-----TCT--TST-------T
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-----ccc--cCC-------c
Confidence 45689999999999988775 78999999999999999999998654433222111110 000 000 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12234567899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=324.66 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=188.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|.+.+.||+|+||.||+|++.. +..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4678889999999999999999853 445999999754 34455689999999999999999999999999889999
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999999998654221 2477888899999999999999999999999999876543211
Q ss_pred -cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.......+|..|+|||++.+..++.++|||||||++|||++ |..||..... ..... .. .... .
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~---~~-~~~~---------~ 272 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVIS---SV-EEGY---------R 272 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHH---HH-HTTC---------C
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHH---HH-HcCC---------C
Confidence 12223456778999999998999999999999999999999 9999743221 11111 11 0000 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 273 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 -LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 011223455788999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=329.92 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=196.1
Q ss_pred chhhHHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeee
Q 041766 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLL 151 (387)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~ 151 (387)
....++...++|++.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34556667789999999999999999999843 24689999997543 33456789999999999 899999999
Q ss_pred eeEEeCCc-eEEEEEecCCCCcchhhcCCcc-------------------------------------------------
Q 041766 152 GCCIDKDE-KILIYEYMPNKSLDFFLFDPTK------------------------------------------------- 181 (387)
Q Consensus 152 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------- 181 (387)
+++...+. .++|||||++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99988654 8999999999999988865421
Q ss_pred ---------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 182 ---------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 182 ---------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
..++|..+++|+||||+|||++.++.+||+|||+++...........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 12467778899999999999999999999999999876544333334
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....||..|+|||++.+..++.++|||||||++|||++ |..||........ .. ......... ..
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~----~~~~~~~~~----------~~ 317 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FC----RRLKEGTRM----------RA 317 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH----HHHHHTCCC----------CC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HH----HHHHcCCCC----------CC
Confidence 45678899999999999999999999999999999998 9999754332211 11 111111000 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+...+..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1223456889999999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.14 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=188.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
.++|++.+.||+|+||.||+|++. .++.||||++........+.+.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 467889999999999999999852 3778999999877666677899999999999999999999998653 458
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999999999988654321 24777888999999999999999999999999998764332
Q ss_pred cc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--------
Q 041766 224 LQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT-------- 294 (387)
Q Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 294 (387)
.. .......++..|+|||++.+..++.++||||||+++|||++|..|+...... +. ........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FM-RMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH------HH-HHHCTTCCTHHHHHHH
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH------HH-hhhcCccccchhHHHH
Confidence 11 1223345677899999999999999999999999999999999886432110 00 00000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.+.+..... ...+..++..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000000 1122344567899999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=325.13 Aligned_cols=232 Identities=21% Similarity=0.266 Sum_probs=185.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.++|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468999999999999999999985 5899999998643 3345567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||++....... ..
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~ 170 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KL 170 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---cc
Confidence 99999999888754221 125788889999999999999999999999999997654332 23
Q ss_pred ccccCCCccccccccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFS-IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
...+||+.|+|||++.+..++ .++|||||||++|||++|+.||..... .. .......... . .
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~---~~~~i~~~~~---------~---~ 233 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KE---LRERVLRGKY---------R---I 233 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHCCC---------C---C
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HH---HHHHHHhCCC---------C---C
Confidence 446899999999999988875 899999999999999999999753221 11 1111111100 0 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11234568899999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=313.97 Aligned_cols=248 Identities=22% Similarity=0.271 Sum_probs=186.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCCceeeeeeeEEeC----Cce
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDK----DEK 160 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~----~~~ 160 (387)
..++|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 3478999999999999999999984 889999998642 34566677777777 7999999999987653 357
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccc--------hhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLD--------WSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~--------~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
++||||+++|+|.+++..... ..++| ..+++||||||+|||++.++.+||+|||+++
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 899999999999998865332 12466 7788999999999999999999999999998
Q ss_pred ecCCCCccc--ccccccCCCccccccccccC------CCCccccchhHHHHHHHHHhC----------CCCCCCCCCCcc
Q 041766 218 ICGGNELQA--NTSRIVGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIVSG----------KKTTGFYRTDSL 279 (387)
Q Consensus 218 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwS~Gvil~el~tg----------~~p~~~~~~~~~ 279 (387)
......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 764432221 12334789999999999876 566899999999999999999 777654333332
Q ss_pred hHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 280 TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
............. ..+...........+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 242 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 SFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222211111111 1111122223345677899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.03 Aligned_cols=257 Identities=25% Similarity=0.335 Sum_probs=197.8
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC--------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeee
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGC 153 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 153 (387)
.+...++|.+.+.||+|+||.||+|++.. +..||||++... .......+.+|+++++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 34456789999999999999999998632 347999999754 334456789999999999 99999999999
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceE
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNIL 201 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nil 201 (387)
+...+..++||||+++|+|.+++..... ...+|..+++|+||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 9999999999999999999998864321 12467788899999999999
Q ss_pred EcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcch
Q 041766 202 LDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLT 280 (387)
Q Consensus 202 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~ 280 (387)
++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~ 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 99999999999999987654433333444567889999999999999999999999999999999 9988743221 11
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCcee
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFS 356 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~ 356 (387)
.. .......... .+..++..+.+++.+||+.||++|||++++++.|+.+...........+.
T Consensus 302 ~~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 363 (382)
T 3tt0_A 302 LF----KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYH 363 (382)
T ss_dssp HH----HHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-----
T ss_pred HH----HHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 11 1111111000 11223457889999999999999999999999999998766555544443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=318.79 Aligned_cols=257 Identities=15% Similarity=0.139 Sum_probs=195.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|.+.+.||+|+||.||+|+.. +++.||||.+..... ...+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 67889999999999999999975 488899999865432 24678999999999 999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCC-----eEEeeccCceecCCCCc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDIN-----PKISDFGMARICGGNEL 224 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~~~~~ 224 (387)
+ +++|.+++..... ..++|..+++||||||+|||++.++. +||+|||+++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 9 9999988864321 12478888999999999999998887 99999999987644322
Q ss_pred cc-----ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 225 QA-----NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 225 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......... .
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~~~i~~~~-~----- 237 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERYQKIGDTK-R----- 237 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHHHHHHHHH-H-----
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHHHHHHhhh-c-----
Confidence 11 124568999999999999999999999999999999999999998654322211 1111100000 0
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
. ..........+ .+.+++..||+.||.+||++.+|++.|+++...........++|.
T Consensus 238 ~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 238 A-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp H-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred c-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 0 00000001123 789999999999999999999999999998876655555555554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.69 Aligned_cols=243 Identities=27% Similarity=0.380 Sum_probs=179.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|.+.+.||+|+||.||+|++. .+..||||.+... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999875 4677999999754 33455689999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|.+++...... .++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999998754321 2477888899999999999999999999999999876433211
Q ss_pred c-ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 226 A-NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 226 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... .... ..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~----i~~~---------~~ 268 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKA----VDEG---------YR 268 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHH----HHTT---------EE
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHcC---------CC
Confidence 1 1122345778999999999999999999999999999998 9999743221 111111 1000 00
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
. ..+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 269 ~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 L-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0 01223345788999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.03 Aligned_cols=240 Identities=26% Similarity=0.398 Sum_probs=190.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 36788899999999999999999888899999997543 33467899999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
++++|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++...... ......
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 166 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG 166 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTS
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccccC
Confidence 999999988654321 24677888999999999999999999999999998654322 122233
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
..+|..|+|||++.+..++.++||||||+++|||++ |+.||...... . ..... .... .. ..+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~---~~~~~-~~~~-----~~-----~~~~ 230 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--E---VVEDI-STGF-----RL-----YKPR 230 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H---HHHHH-HTTC-----CC-----CCCT
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--H---HHHHH-hcCc-----cC-----CCCC
Confidence 456778999999998999999999999999999999 88887532211 1 11111 1000 00 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 224568899999999999999999999999998865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=339.19 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=195.2
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
..++...++|.+.+.||+|+||.||+|.++.+..||||.+.... ...+.+.+|+.+|++++|||||++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 44556667888999999999999999999888899999997543 45678999999999999999999999986 56789
Q ss_pred EEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999999999865321 124778889999999999999999999999999998664322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......+|..|+|||++....++.++|||||||++|||++ |+.||.... .......... ..
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~~~~~~~i~~----~~--------- 402 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALER----GY--------- 402 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHH----TC---------
T ss_pred e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc----CC---------
Confidence 1 11223456788999999998999999999999999999999 999975322 1111111111 00
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
. ...+..++..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 403 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 R-MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred C-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 0112234567889999999999999999999999999886544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=323.56 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=176.8
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCC----EEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 157 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 157 (387)
.....++|++.+.||+|+||.||+|++.... .||||.+... .....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3445578999999999999999999976532 7999999754 344567899999999999999999999999877
Q ss_pred Cce------EEEEEecCCCCcchhhcCCcc----------------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 158 DEK------ILIYEYMPNKSLDFFLFDPTK----------------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 158 ~~~------~lv~e~~~~g~L~~~l~~~~~----------------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
... ++||||+++|+|..++..... ...+|..+++|+||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 654 899999999999888743210 1247778889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~--- 252 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYL--- 252 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH---
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHH---
Confidence 999999987654433333334566788999999999999999999999999999999 88887533221 111111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
..... ...+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 253 -~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 -IGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -hcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000 0012233457889999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=337.37 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=193.2
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
..++...++|.+.+.||+|+||.||+|.++.+..||||.+.... ...+.+.+|+.+|++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 33455567788899999999999999999877889999997543 345789999999999999999999999876 6789
Q ss_pred EEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999998864211 124778888999999999999999999999999998764332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .... ... ....
T Consensus 335 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~---~~i-~~~~--------- 398 (452)
T 1fmk_A 335 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL---DQV-ERGY--------- 398 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH---HHH-HTTC---------
T ss_pred ee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHH---HHH-HcCC---------
Confidence 21 2223456789999999999999999999999999999999 8888743221 1111 111 1100
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~ 354 (387)
. ...+..++..+.+++.+||+.||++|||++++++.|+++.....+..+|.
T Consensus 399 ~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~ 449 (452)
T 1fmk_A 399 R-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449 (452)
T ss_dssp C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred C-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence 0 01123345678899999999999999999999999999987766655543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=313.13 Aligned_cols=241 Identities=27% Similarity=0.385 Sum_probs=191.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..++|++.+.||+|+||.||+|.++++..||+|.+.... ...+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 346788999999999999999999888889999997543 3346789999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++......... ...
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 163 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSV 163 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECC
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-ccc
Confidence 999999988865322 12467788899999999999999999999999999876543322 223
Q ss_pred cccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+|..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ..... . ..+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~-~~~~~--~--------~~~ 227 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKV-SQGHR--L--------YRP 227 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHH-HTTCC--C--------CCC
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHH-HcCCC--C--------CCC
Confidence 3456778999999999899999999999999999999 999975332111 11111 00000 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1123468899999999999999999999999998854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=318.13 Aligned_cols=233 Identities=22% Similarity=0.306 Sum_probs=185.8
Q ss_pred CCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 91 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 556678999999999999987 4899999999766666677899999999999999999999999999999999999999
Q ss_pred CCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCC
Q 041766 170 KSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGT 234 (387)
Q Consensus 170 g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (387)
++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ......||
T Consensus 127 ~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt 204 (321)
T 2c30_A 127 GALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGT 204 (321)
T ss_dssp CBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSC
T ss_pred CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCC
Confidence 999988865321 1247778889999999999999999999999999987653321 22345799
Q ss_pred CccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHH
Q 041766 235 YGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314 (387)
Q Consensus 235 ~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (387)
+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ... .... .+... .....+..
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~---~~~-~~~~-----~~~~~---~~~~~~~~ 270 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAM---KRL-RDSP-----PPKLK---NSHKVSPV 270 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH---HHH-HHSS-----CCCCT---TGGGSCHH
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHH-hcCC-----CCCcC---ccccCCHH
Confidence 999999999999999999999999999999999999753221 1111 111 1100 00010 11223456
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 315 YVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 315 ~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+.+++.+||+.||++|||+.++++.
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=320.66 Aligned_cols=245 Identities=27% Similarity=0.369 Sum_probs=193.8
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 157 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 157 (387)
+...++|.+.+.||+|+||.||+|.+. .+..||+|.+... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 334578889999999999999999863 2468999999754 334557888999999999999999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCcc----------------------------------------ccccchhhhhhcccCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK----------------------------------------RMLLDWSANYSSRLKV 197 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------~~~l~~~~~~h~dlk~ 197 (387)
+..++||||+++|+|.+++..... ...+|..+++|+||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 999999999999999988864321 1246778889999999
Q ss_pred CceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 041766 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRT 276 (387)
Q Consensus 198 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~ 276 (387)
+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755443333444567889999999999999999999999999999999 9999754322
Q ss_pred CcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 277 DSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
. ..... ....... ..+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 259 ~--~~~~~----~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 E--RLFNL----LKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp G--GHHHH----HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHHHH----hhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 11111 1111000 0112334578899999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=321.26 Aligned_cols=236 Identities=21% Similarity=0.229 Sum_probs=185.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
..++|.+.+.||+|+||.||+|+... |+.||+|.+..... ...+.+.+|+.+|.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 34679999999999999999999875 88999999864321 235788999999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC----CeEEeeccCceec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI----NPKISDFGMARIC 219 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~ 219 (387)
.++||||+++|+|.+++..... ..++|..+++|+||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999998865432 1257888899999999999998876 7999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... ... ...... ... .
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~---~~~i~~-~~~-~--- 236 (361)
T 2yab_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QET---LANITA-VSY-D--- 236 (361)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH---HHHHHT-TCC-C---
T ss_pred CCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHh-cCC-C---
Confidence 5432 23345799999999999999999999999999999999999999753221 111 111000 000 0
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001123456889999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.46 Aligned_cols=241 Identities=26% Similarity=0.396 Sum_probs=180.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|++.+.||+|+||.||+|++.. ++ .||+|.+... .......+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 678899999999999999999754 44 3588877543 3455678999999999999999999999998754 789
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||+++|+|.+++...... .++|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 99999999999888653221 2478888999999999999999999999999999876544333
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......+|..|+|||++.+..++.++|||||||++|||++ |..||....... ..... .....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~----~~~~~---------- 237 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----EKGER---------- 237 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTCC----------
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH----HcCCC----------
Confidence 33334566889999999999999999999999999999999 999975432221 11111 00000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 001222345688999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.03 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=182.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|+..+.||+|+||.||+|++.. ++ .||+|.+... .......+.+|+.++++++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568889999999999999999754 44 3688888543 3345678999999999999999999999998754 789
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+||+++|+|..++...... .++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 173 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCccc
Confidence 99999999999888653321 2477888999999999999999999999999999876544433
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... .... .
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~----~~~~---------~- 237 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL----EKGE---------R- 237 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH----HTTC---------C-
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHH----HcCC---------C-
Confidence 33344567889999999999999999999999999999999 999975432211 11111 0000 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00122234578899999999999999999999999988765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.79 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=183.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
++|++.+.||+|+||.||+|++. ++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56888899999999999999986 788999999643 34578899999999999999999999886 45799999999
Q ss_pred CCCcchhhcCCccc-------------------cccch---hhhhhcccCCCceEEcCCCC-eEEeeccCceecCCCCcc
Q 041766 169 NKSLDFFLFDPTKR-------------------MLLDW---SANYSSRLKVSNILLDKDIN-PKISDFGMARICGGNELQ 225 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-------------------~~l~~---~~~~h~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~ 225 (387)
+|+|.+++...... .++|. .+++|+||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 99999988754321 13555 67899999999999988886 799999999755322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....||..|+|||++.+..++.++||||||+++|||++|+.||......... ..+...... ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~-~~---------- 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGT-RP---------- 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH---HHHHHHTTC-CC----------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH---HHHHHhcCC-CC----------
Confidence 22346899999999999999999999999999999999999998643322211 111111110 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCc
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~ 354 (387)
......+..+.+++.+||+.||++|||+.++++.|+.+....+....|.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 0112234568899999999999999999999999999987665544443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=310.30 Aligned_cols=258 Identities=15% Similarity=0.194 Sum_probs=199.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+|+.++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999975 488999999864432 24578899999999 89999999999999999999999
Q ss_pred ecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCC-----eEEeeccCceecCCCC
Q 041766 166 YMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDIN-----PKISDFGMARICGGNE 223 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~~~~ 223 (387)
|+ +++|.+++...... ..+|..+++|+||||+|||++.++. +||+|||+++......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 99999988743221 2477888999999999999987766 9999999998765432
Q ss_pred cc-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch-HhHHHHHHhhcCccccc
Q 041766 224 LQ-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT-LLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 224 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 297 (387)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.||......... ...............+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE- 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH-
Confidence 21 1234467999999999999999999999999999999999999998654322211 1111100000000000
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
....++..+.+++.+||+.||++|||+++|++.|+++...........++|.
T Consensus 245 ---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 245 ---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp ---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred ---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 0112345788999999999999999999999999999988777766666664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=333.85 Aligned_cols=237 Identities=25% Similarity=0.347 Sum_probs=187.9
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-ceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD-EKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~-~~~lv~ 164 (387)
...++|++.+.||+|+||.||+|.+. ++.||||.++... ..+.+.+|+.+|++++||||+++++++.... ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567888899999999999999987 7799999997543 4578999999999999999999999988765 789999
Q ss_pred EecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 99999999998864321 12467788899999999999999999999999999864322
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...... ... . .
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~----~~~---------~-~ 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE----KGY---------K-M 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHH----TTC---------C-C
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH----cCC---------C-C
Confidence 122366889999999999999999999999999999998 999975432221 111111 000 0 0
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..+..++..+.++|.+||+.||++|||+.++++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12233456788999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.18 Aligned_cols=244 Identities=27% Similarity=0.381 Sum_probs=194.0
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++...++|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+.+|++++|||||+++++|...+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 44455678888999999999999999886 7889999997543 346789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 163 IYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999998864321 1247778889999999999999999999999999987654332
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ... ..
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~----~~~---------~~ 437 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL----EKD---------YR 437 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH----HTT---------CC
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----HcC---------CC
Confidence 2 2233456789999999999999999999999999999999 88887533211 111111 110 00
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
. ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 438 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 M-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred C-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0 1122345678899999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.08 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=194.0
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCC 154 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 154 (387)
..+....++|++.+.||+|+||.||+|++.. +..||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445566889999999999999999999753 3789999997543 34456789999999999999999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCCcc----------------------------------------ccccchhhhhhcc
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDPTK----------------------------------------RMLLDWSANYSSR 194 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------~~~l~~~~~~h~d 194 (387)
.+.+..++||||+++|+|.+++..... ..++|..+++|+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 999999999999999999998865310 1246778889999
Q ss_pred cCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 041766 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGF 273 (387)
Q Consensus 195 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~ 273 (387)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986643332233344567889999999999999999999999999999999 9888743
Q ss_pred CCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 274 YRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
... .. ..... ...... ..+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 280 ~~~--~~---~~~~~-~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAH--EE---VIYYV-RDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCH--HH---HHHHH-HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCh--HH---HHHHH-hCCCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 221 11 11111 111110 01223345788999999999999999999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=310.86 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=193.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--ceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv 163 (387)
.++|.+.+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3678899999999999999999876 8899999996432 344577889999999999999999999998765 67999
Q ss_pred EEecCCCCcchhhcCCccc-------------------cccchhhhhhcccCCCceEE----cCCCCeEEeeccCceecC
Q 041766 164 YEYMPNKSLDFFLFDPTKR-------------------MLLDWSANYSSRLKVSNILL----DKDINPKISDFGMARICG 220 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-------------------~~l~~~~~~h~dlk~~Nill----~~~~~~kl~Dfg~a~~~~ 220 (387)
|||+++++|..++...... .++|..+++|+||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999988764321 24677888999999999999 778889999999998765
Q ss_pred CCCcccccccccCCCccccccccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAI--------QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
... ......||..|+|||++. +..++.++|||||||++|||++|+.||.......... ..........
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIITGK 243 (319)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHHHHC
T ss_pred CCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHhcCC
Confidence 432 223457899999999986 4678999999999999999999999986443322111 1111111111
Q ss_pred c--cccccc-----------cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 293 R--TLELID-----------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 293 ~--~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
. ....+. ...............+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1 000000 000111234667788999999999999999999999999987764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.81 Aligned_cols=239 Identities=19% Similarity=0.247 Sum_probs=187.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4688999999999999999999875 7789999987443 3456788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcC--CCCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDK--DINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|++|+|.+++...... .++|..+++|+||||+|||++. ++.+||+|||+++...... .
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---E
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---c
Confidence 9999999888654321 2478888899999999999987 7899999999998765432 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ........... ... ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~---~~~~i~~~~~~-------~~~-~~ 226 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQ---IIENIMNAEYT-------FDE-EA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHHHHHTCCC-------CCH-HH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HH---HHHHHHcCCCC-------CCh-hh
Confidence 2345789999999999998899999999999999999999999753221 11 11111110000 000 00
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
....+..+.+++.+||+.||++|||+.|+++. +.+.
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 11234578899999999999999999999983 4443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=314.60 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=190.1
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.....++|++.+.||+|+||.||++.+.++..||+|.+.... ...+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 344457889999999999999999999888899999997543 3346789999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++....... .
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 9999999999988653221 247778889999999999999999999999999976543221 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .. .... ... ...
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~---~~~~-~~~-----~~~----- 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ET---AEHI-AQG-----LRL----- 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH---HHHH-HTT-----CCC-----
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HH---HHHH-hcc-----cCC-----
Confidence 2233456788999999998999999999999999999998 99997533211 11 1111 000 000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..+...+..+.+++.+||+.||++|||++++++.|+++...
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01112235688999999999999999999999999988653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.12 Aligned_cols=234 Identities=22% Similarity=0.297 Sum_probs=180.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc-----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----- 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----- 159 (387)
..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.+|++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467889999999999999999987 5899999998643 33455789999999999999999999999866432
Q ss_pred ----------------------------------------------------eEEEEEecCCCCcchhhcCCccc-----
Q 041766 160 ----------------------------------------------------KILIYEYMPNKSLDFFLFDPTKR----- 182 (387)
Q Consensus 160 ----------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~----- 182 (387)
.++|||||++|+|.+++......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 78999999999999988653221
Q ss_pred --------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc----------cccccccCCCccc
Q 041766 183 --------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ----------ANTSRIVGTYGYM 238 (387)
Q Consensus 183 --------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~ 238 (387)
.++|..+++|+||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 2467788899999999999999999999999999877543211 1223457999999
Q ss_pred cccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHH
Q 041766 239 SPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNI 318 (387)
Q Consensus 239 aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (387)
|||++.+..++.++|||||||++|||++|..|+. ......... ... ............+.++
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-------~~~~~~~~~-~~~----------~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-------ERVRIITDV-RNL----------KFPLLFTQKYPQEHMM 305 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-------HHHHHHHHH-HTT----------CCCHHHHHHCHHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-------HHHHHHHHh-hcc----------CCCcccccCChhHHHH
Confidence 9999999999999999999999999999876631 000000000 000 0011223445677899
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 041766 319 ALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 319 i~~cl~~dP~~RPt~~~v~~ 338 (387)
+.+||+.||++|||+.|+++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=320.45 Aligned_cols=232 Identities=22% Similarity=0.253 Sum_probs=184.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||+|.+... .......+.+|+.+|..++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 578889999999999999999875 889999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ...
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~ 162 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCB
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--Ccc
Confidence 99999999887754221 125788889999999999999999999999999998643222 123
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ....... . . ..+
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~---~~~i~~~-~--------~---~~p 225 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERL---FELILME-E--------I---RFP 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHHHHC-C--------C---CCC
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHH---HHHHHcC-C--------C---CCC
Confidence 45689999999999999999999999999999999999999975321 1111 1111110 0 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
...+..+.+++.+||+.||++|| +++++++.
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 22345788999999999999999 89999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=330.20 Aligned_cols=243 Identities=28% Similarity=0.371 Sum_probs=188.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|.+.+.||+|+||.||+|++. .+..||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999954 2557999999654 334456788999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------------ccccchhhhhhcccCCCceEEcCCC---CeEEeecc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------------RMLLDWSANYSSRLKVSNILLDKDI---NPKISDFG 214 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~l~~~~~~h~dlk~~Nill~~~~---~~kl~Dfg 214 (387)
++||||+++|+|.+++..... ..++|..+++||||||+|||++.++ .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 999999999999988864321 1247888899999999999999554 59999999
Q ss_pred CceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... ....... ....
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i----~~~~ 303 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV----TSGG 303 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----HTTC
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC
Confidence 9975532222233344577899999999999999999999999999999998 8888753221 1111111 1110
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
. ...+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 304 ~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 R----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 0 001222345688999999999999999999999999888753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.63 Aligned_cols=240 Identities=24% Similarity=0.354 Sum_probs=183.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCE----EEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDE----IAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|++.+.||+|+||.||+|++.. +.. ||+|.+.... ......+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578889999999999999999764 443 8888875432 233456778999999999999999999986 456889
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+++|+|.+++...... .++|..+++||||||+|||++.++.+||+|||+++........
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999999888664321 2477888999999999999999999999999999876544433
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......+|..|+|||++.+..++.++|||||||++|||++ |..||...... ...... ......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~----~~~~~~--------- 236 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLL----EKGERL--------- 236 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHH----HTTCBC---------
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHH----HcCCCC---------
Confidence 33445677889999999999999999999999999999999 99997543221 111111 110000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 -AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111123357789999999999999999999999998865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=324.36 Aligned_cols=268 Identities=15% Similarity=0.142 Sum_probs=195.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCCccc-----------HHHHHHHHHHHHhcCCCceee
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQG-----------LREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~ 149 (387)
..++|.+.+.||+|+||.||+|.+.. ++.||||.+....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999999865 3679999986543211 112334555667778999999
Q ss_pred eeeeEEeC----CceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEc--CCC
Q 041766 150 LLGCCIDK----DEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLD--KDI 206 (387)
Q Consensus 150 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~--~~~ 206 (387)
+++++... ...++||||+ +++|..++...... .++|..+++||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998875 3479999999 99999888653221 257888899999999999998 889
Q ss_pred CeEEeeccCceecCCCCccc-----ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH
Q 041766 207 NPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281 (387)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~ 281 (387)
.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.. .
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~-~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK-Y 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-H
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH-H
Confidence 99999999998764322111 11334599999999999999999999999999999999999999864322211 1
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeeeecc
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVRNT 361 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~~~~ 361 (387)
........ .....+.+++.+. ...++..+.+++..||+.||++||++.++++.|+++...........++|....
T Consensus 271 ~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 271 VRDSKIRY-RENIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHH-HHCHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHHh-hhhHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 11111111 1111122222221 112345788999999999999999999999999999998888888888876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.94 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=187.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|++.+.||+|+||.||+|+... +..||+|.+... .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34689999999999999999999765 889999988543 23345678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++....... .
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-T 167 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-c
Confidence 9999999999988754321 1257788899999999999999999999999999976543221 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ... ... .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~-~~~-----~~~-~ 235 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----SIAIKHIQDS-VPN-----VTT-D 235 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----HHHHHHHSSC-CCC-----HHH-H
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhhcc-CCC-----cch-h
Confidence 233457899999999999999999999999999999999999998532211 0111111100 000 000 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhhhhhcc
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRP-TMNEVVSMLTDEAAAL 347 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RP-t~~~v~~~L~~~~~~~ 347 (387)
.....+..+.+++.+||+.||++|| +++++.+.|+......
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 1122356788999999999999998 9999999999876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=321.81 Aligned_cols=261 Identities=26% Similarity=0.326 Sum_probs=191.3
Q ss_pred cCC-CCCCcccccCCeeEEEEEEc-----CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cc
Q 041766 89 NKF-SDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DE 159 (387)
Q Consensus 89 ~~~-~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~ 159 (387)
++| ++.+.||+|+||.||++.+. +++.||||++.... ......+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 444 88899999999999998753 46789999997543 34456789999999999999999999999884 56
Q ss_pred eEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
.++||||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++........
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 7899999999999998865432 1246778889999999999999999999999999987754322
Q ss_pred c-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 Q-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. .......+|..|+|||++.+..++.++||||||+++|||++|+.||............+...........+.+.....
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 1 223345678889999999998999999999999999999999999743211100000000000000000011111111
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCC
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPP 350 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~ 350 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+.+.+....+
T Consensus 270 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 270 -LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred -CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1122334567899999999999999999999999999998765443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.40 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=183.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
...++|++.+.||+|+||.||+|+..+++.||+|++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999988999999998643 223346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++ +|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-- 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--
Confidence 999985 67666654322 1247788889999999999999999999999999987643221
Q ss_pred ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc--cc----
Q 041766 227 NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL--ID---- 299 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---- 299 (387)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ ................ ..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhccch
Confidence 2233578999999999976 5689999999999999999999999865433321 1111111111111000 00
Q ss_pred ------cccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 ------PILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ------~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...... .........+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 001123457889999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=315.62 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=194.5
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCCc-ccHHHHHHHHHHHHhc-CCCceeeeeeeEEe
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCID 156 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~ 156 (387)
+...++|.+.+.||+|+||.||+|++. .+..||+|.+..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 344578889999999999999999852 256899999975432 4457889999999999 99999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc----------------------------------ccccchhhhhhcccCCCceEE
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK----------------------------------RMLLDWSANYSSRLKVSNILL 202 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------~~~l~~~~~~h~dlk~~Nill 202 (387)
.+..++||||+++|+|.+++..... ...+|..+++|+||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 9999999999999999988864321 124677888999999999999
Q ss_pred cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchH
Q 041766 203 DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTL 281 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~ 281 (387)
+.++.+||+|||++................+|..|+|||++.+..++.++||||||+++|||++ |..||........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 9999999999999987654433333344567889999999999999999999999999999999 9988754332211 1
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
...... .. .. ..+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 258 ~~~~~~----~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 YKMIKE----GF-----RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHH----TC-----CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhcc----CC-----CC-----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111111 00 00 011223457889999999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=321.82 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=191.7
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
.+...++|.+.+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678999999999999999999962 2457999999744 334457889999999999 9999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc---------------------------------------ccccchhhhhhcccC
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK---------------------------------------RMLLDWSANYSSRLK 196 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------~~~l~~~~~~h~dlk 196 (387)
..+..++||||+++|+|.+++..... ...+|..+++|+|||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 99999999999999999998865431 124677888999999
Q ss_pred CCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 041766 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYR 275 (387)
Q Consensus 197 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~ 275 (387)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986644333333344567889999999999999999999999999999998 999975433
Q ss_pred CCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 276 TDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
... ... ........ . ..+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 280 ~~~-~~~----~~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDA-NFY----KLIQNGFK-----M-----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSH-HHH----HHHHTTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHH-HHH----HHHhcCCC-----C-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 221 111 11111100 0 011223457889999999999999999999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.47 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=189.6
Q ss_pred cCCCCCCcccccCCeeEEEEEE-----cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 161 (387)
++|++.+.||+|+||.||+|++ ..+..||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999985 2377899999987766666789999999999999999999999874 45688
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++++|.+++...... ..+|..+++|+||||+|||++.++.+||+|||++........
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 182 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence 999999999999888652221 246778889999999999999999999999999987654322
Q ss_pred c-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 Q-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. .......+|..|+|||++.+..++.++||||||+++|||++|+.||........................+.+.....
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 3lxl_A 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR 262 (327)
T ss_dssp EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC
T ss_pred cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccC
Confidence 1 222335678889999999999999999999999999999999998642111000000000000000000000000000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 263 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 263 -LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred -CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0122334567889999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=316.91 Aligned_cols=237 Identities=24% Similarity=0.344 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-C-------CEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-G-------DEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
.++|.+.+.||+|+||.||+|++.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678889999999999999998764 3 4699999976666667889999999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCC--------eEEeecc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDIN--------PKISDFG 214 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~--------~kl~Dfg 214 (387)
.++||||+++|+|.+++...... ..+|..+++|+||||+|||++.++. +||+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 99999999999999988654321 2467788899999999999988887 9999999
Q ss_pred CceecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|..|+....... ... .......
T Consensus 167 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~----~~~~~~~ 235 (289)
T 4fvq_A 167 ISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKL----QFYEDRH 235 (289)
T ss_dssp SCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHH----HHHHTTC
T ss_pred ccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHH----HHhhccC
Confidence 9864422 123467889999999987 679999999999999999999665543221111 000 0000000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. +...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 236 -------~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 236 -------QL-----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -------CC-----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -------CC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 00 0011235778999999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=313.72 Aligned_cols=237 Identities=23% Similarity=0.249 Sum_probs=185.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
..++|.+.+.||+|+||.||+|.... +..||+|.+..... ...+.+.+|+.+|++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34678899999999999999999875 88999999864321 246789999999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC----CeEEeeccCceec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI----NPKISDFGMARIC 219 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~ 219 (387)
.++||||+++|+|.+++..... ..++|..+++|+||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999998865332 1247788889999999999998887 7999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ........
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~~~~~~~------ 234 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETL---ANVSAVNY------ 234 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHHTCC------
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHH---HHHHhcCC------
Confidence 4332 22345789999999999989999999999999999999999999743221 1111 11000000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 235 -~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 -EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -CCCH-HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CcCc-cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0011224568899999999999999999999973
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.44 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=193.6
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc--------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
...++|.+.+.||+|+||.||+|++. ++..||+|.+... .......+.+|+.++.++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578899999999999999999864 3678999999754 334456788999999999 9999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEc
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
..+..++||||+++|+|.+++..... ...+|..+++|+||||+|||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 99999999999999999998865431 1246777889999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHh
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLL 282 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 282 (387)
.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~ 269 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELF 269 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHHH
Confidence 999999999999987765443333444567889999999998899999999999999999999 9988753221 1111
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
... ...... ..+..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 270 ~~~----~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 270 KLL----KEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHH----HHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH----hcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111 111000 011223457889999999999999999999999999997644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.55 Aligned_cols=257 Identities=22% Similarity=0.272 Sum_probs=188.9
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc--CCCceeeeeeeEEeC--
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV--QHKNLVRLLGCCIDK-- 157 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~~~~~~~~~-- 157 (387)
.......++|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334456688999999999999999999987 889999998532 234555666666655 899999999999887
Q ss_pred --CceEEEEEecCCCCcchhhcCCcc---------------ccccchh--------hhhhcccCCCceEEcCCCCeEEee
Q 041766 158 --DEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWS--------ANYSSRLKVSNILLDKDINPKISD 212 (387)
Q Consensus 158 --~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~--------~~~h~dlk~~Nill~~~~~~kl~D 212 (387)
...++||||+++|+|.+++..... ..++|.. +++|+||||+|||++.++.+||+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 678999999999999998854321 1235555 889999999999999999999999
Q ss_pred ccCceecCCCCccc--ccccccCCCccccccccccCCCCcc------ccchhHHHHHHHHHhC----------CCCCCCC
Q 041766 213 FGMARICGGNELQA--NTSRIVGTYGYMSPEYAIQGIFSIK------SDVFSFGVLLLEIVSG----------KKTTGFY 274 (387)
Q Consensus 213 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwS~Gvil~el~tg----------~~p~~~~ 274 (387)
||+++......... ......||..|+|||++.+..++.+ +|||||||++|||++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998764332211 1234578999999999987766554 9999999999999999 4554332
Q ss_pred CCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 275 RTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
............. .. .....+..........++..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 266 ~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 266 VPSDPSYEDMREI-VC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SCSSCCHHHHHHH-HT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCCCCchhhhHHH-Hh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 2222211111111 11 11111222222234467888999999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=311.46 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=179.0
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.+...++|.+.+.||+|+||.||+|++. ..||+|.+... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3445678999999999999999999875 35999998644 334456789999999999999999999965 455689
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++++|..++...... ..+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999998888543321 246778889999999999999999999999999976543222
Q ss_pred ccccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
........||..|+|||++. +..++.++||||||+++|||++|+.||....... ...... ...........
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~- 249 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMV----GRGSLSPDLSK- 249 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHH----HHTSCCCCTTS-
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHh----cccccCcchhh-
Confidence 23334457899999999986 5678999999999999999999999985433221 111111 11111100000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
....++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 250 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 -----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 112334678899999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=306.44 Aligned_cols=235 Identities=24% Similarity=0.429 Sum_probs=181.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCccc-------HHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQG-------LREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
++|++.+.||+|+||.||+|++. +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67888999999999999999986 48899999986432211 167889999999999999999999986554
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhh--hhhcccCCCceEEcCCCC-----eEEeeccCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSA--NYSSRLKVSNILLDKDIN-----PKISDFGMA 216 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~--~~h~dlk~~Nill~~~~~-----~kl~Dfg~a 216 (387)
++||||+++|+|..++...... ..+|..+ ++|+||||+|||++.++. +||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 7999999999998777544321 2467777 999999999999988776 999999999
Q ss_pred eecCCCCcccccccccCCCccccccccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAI--QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
+.... ......||..|+|||++. ...++.++|||||||++|||++|+.||................ ...
T Consensus 177 ~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~ 247 (287)
T 4f0f_A 177 QQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE----EGL 247 (287)
T ss_dssp BCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH----SCC
T ss_pred ccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc----cCC
Confidence 75432 233457899999999984 4568899999999999999999999986544332211111111 000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
.+ ..+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 248 ----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 ----RP-----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----CC-----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 01223345788999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=319.62 Aligned_cols=234 Identities=20% Similarity=0.279 Sum_probs=184.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+++... ++.||+|.+... .......+.+|+.+|..++|||||++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3678899999999999999999876 788999998532 223456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+.+|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---Q 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---C
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---c
Confidence 999999999988865422 125788889999999999999999999999999998764332 2
Q ss_pred cccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||......... ........ ..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~-~~----------- 236 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFET-TV----------- 236 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHH-CC-----------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhh-cc-----------
Confidence 345689999999999974 45899999999999999999999998643332211 11111100 00
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPT-MNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~~v~~ 338 (387)
...+...+..+.+|+.+||+.||++||+ ++++.+
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0012223457889999999999999998 777765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.89 Aligned_cols=230 Identities=19% Similarity=0.276 Sum_probs=181.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|.+.+.||+|+||.||+|.+.. ++.||+|.+... .......+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3678999999999999999999754 889999998532 122345788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+ +|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||++....... .
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---F 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---T
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---c
Confidence 9999 6777776643211 125788889999999999999999999999999998654332 2
Q ss_pred cccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc-
Q 041766 228 TSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE- 305 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 305 (387)
....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... +.........
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------------------~~~~~i~~~~~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP------------------NLFKKVNSCVY 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST------------------TCBCCCCSSCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH------------------HHHHHHHcCCC
Confidence 344579999999999988876 78999999999999999999997532211 1111111100
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122345578899999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=321.50 Aligned_cols=236 Identities=21% Similarity=0.240 Sum_probs=186.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|.... ++.||+|.+..........+.+|+++|.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4689999999999999999999875 889999999766555566889999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcC--CCCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDK--DINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
+++|+|.+++...... .++|..+++|+||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--- 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc---
Confidence 9999998888654321 2477888899999999999974 57799999999987654322
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ......... ... ..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~---~~i~~~~~~---~~~-----~~ 273 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETL---QNVKRCDWE---FDE-----DA 273 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHHCCCC---CCS-----ST
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHH---HHHHhCCCC---CCc-----cc
Confidence 2334789999999999999999999999999999999999999753221 1111 111110000 000 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+++.+||+.||++|||+.++++.
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 12234578899999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.09 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=185.6
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
...++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 445789999999999999999999875 889999999644 33445678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC---CCeEEeeccCceecCCCC
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARICGGNE 223 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~ 223 (387)
||||+++|+|.+++..... ..++|..+++|+||||+|||++.+ +.+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999999999887754322 125788889999999999999765 459999999998765332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
......||+.|+|||++.+..|+.++|||||||++|||++|..||.... .......... ... ....+
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~----~~~-~~~~~--- 252 (362)
T 2bdw_A 186 ---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKA----GAY-DYPSP--- 252 (362)
T ss_dssp ---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH----TCC-CCCTT---
T ss_pred ---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHh----CCC-CCCcc---
Confidence 2234579999999999999899999999999999999999999974322 1111111110 000 00000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....+..+.+++.+||+.||++|||+.++++.
T Consensus 253 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 ---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112234578899999999999999999998863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=323.22 Aligned_cols=232 Identities=23% Similarity=0.325 Sum_probs=179.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|++.. ++.||||++... .......+..|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 4689999999999999999999875 889999998643 223456788899999988 79999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~ 179 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--V 179 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--c
Confidence 9999999999888754321 135788889999999999999999999999999998543221 2
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ... ........ . .
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~---~~~i~~~~---------~---~ 242 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDL---FEAILNDE---------V---V 242 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCC---------C---C
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHH---HHHHHcCC---------C---C
Confidence 23456899999999999999999999999999999999999999853221 111 11111100 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTM------NEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~------~~v~~ 338 (387)
.+......+.+++.+||+.||++||++ .++++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 112234568899999999999999998 77776
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=307.02 Aligned_cols=247 Identities=18% Similarity=0.216 Sum_probs=180.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+|++.. ++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578889999999999999999875 889999998643 23344678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|++++.+..+...... ...+|..+++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cccc
Confidence 9986444433321111 125788889999999999999999999999999998764322 1233
Q ss_pred cccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc--cccc------
Q 041766 230 RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE--LIDP------ 300 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~------ 300 (387)
...||..|+|||++.+.. ++.++|||||||++|||++|..|+......... ............... ....
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhhhhhcccccccc
Confidence 457899999999998766 899999999999999999998886433222211 111111111110000 0000
Q ss_pred ------ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000011234567889999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=328.10 Aligned_cols=239 Identities=21% Similarity=0.256 Sum_probs=184.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
...++|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456789999999999999999999765 7889999986543 2345678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc---CCCCeEEeeccCceecCCCC
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD---KDINPKISDFGMARICGGNE 223 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||||++|+|.+.+..... ..++|..+++||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999999999877754321 1357888899999999999998 46789999999998765332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ........ ..... ....+
T Consensus 168 ~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i----~~~~~-~~~~~--- 235 (444)
T 3soa_A 168 Q--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQI----KAGAY-DFPSP--- 235 (444)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH----HHTCC-CCCTT---
T ss_pred c--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH----HhCCC-CCCcc---
Confidence 1 2234689999999999999999999999999999999999999974322 11111111 00000 00000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ---~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 ---EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 112234578899999999999999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.60 Aligned_cols=236 Identities=27% Similarity=0.404 Sum_probs=174.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+|.+. +..||||.+.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367888999999999999999986 8889999986432 23356788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc---------------ccccchhh---hhhcccCCCceEEcC--------CCCeEEeeccCce
Q 041766 164 YEYMPNKSLDFFLFDPTK---------------RMLLDWSA---NYSSRLKVSNILLDK--------DINPKISDFGMAR 217 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~---------------~~~l~~~~---~~h~dlk~~Nill~~--------~~~~kl~Dfg~a~ 217 (387)
|||+++++|..++..... ...+|..+ ++|+||||+|||++. ++.+||+|||+++
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999999988854321 12456666 789999999999986 6789999999998
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
...... .....||..|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 165 EWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGVAMNKLA--- 232 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHTSCCC---
T ss_pred cccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhhhcCCCC---
Confidence 654322 22347899999999999999999999999999999999999997532211 111111111000
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 -------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 001223345788999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.92 Aligned_cols=234 Identities=20% Similarity=0.255 Sum_probs=175.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--------------------------ccHHHHHHHHHHHH
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--------------------------QGLREMKNEASVIA 140 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 140 (387)
.++|.+.+.||+|+||.||+|+... ++.||||.+..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678999999999999999999765 78899999864321 12356889999999
Q ss_pred hcCCCceeeeeeeEEe--CCceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEc
Q 041766 141 KVQHKNLVRLLGCCID--KDEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLD 203 (387)
Q Consensus 141 ~l~h~nIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~ 203 (387)
+++||||+++++++.+ .+..++||||+++++|..++..... ...+|..+++|+||||+|||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 9999999999999987 4678999999999999876543221 1247788899999999999999
Q ss_pred CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcch
Q 041766 204 KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT 280 (387)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~ 280 (387)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~- 246 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--IM- 246 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--HH-
T ss_pred CCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--HH-
Confidence 999999999999987654322 223457899999999998655 4788999999999999999999975321 11
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...... ...... . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 247 --~~~~~~-~~~~~~------~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 --CLHSKI-KSQALE------F---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --HHHHHH-HHCCCC------C---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHHHHH-hcccCC------C---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111111 111000 0 011123456889999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=316.18 Aligned_cols=248 Identities=19% Similarity=0.233 Sum_probs=178.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc---
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--- 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--- 159 (387)
..++|++.+.||+|+||.||+|++.. ++.||||++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 34789999999999999999999754 7889999997542 2334578899999999999999999999887543
Q ss_pred -eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 160 -KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 160 -~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
.|+||||+++++|.+++..... ..++|..+++|+||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 3999999999999988854221 12477888999999999999999999999999999866433
Q ss_pred Ccc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 223 ELQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 223 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~------ 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIP------ 238 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCC------
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCCC------
Confidence 211 1223457899999999999999999999999999999999999997532211 1111111111000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHH-HHhhhhhhcc
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVV-SMLTDEAAAL 347 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~-~~L~~~~~~~ 347 (387)
........+..+.+++.+||+.||++||++.+++ ..+.......
T Consensus 239 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 239 --PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp --HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred --cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 0001112345788999999999999999766655 4555554433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=316.57 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=185.4
Q ss_pred cCCCCCCcccccCCeeEEEEEE-----cCCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--Cce
Q 041766 89 NKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEK 160 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~ 160 (387)
..|++.+.||+|+||.||+|++ ..++.||+|.+... .......+.+|+.++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5578889999999999999984 24788999999743 334557889999999999999999999999876 568
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++.......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 999999999999998843221 124777888999999999999999999999999998765433
Q ss_pred cc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC---------CcchHhHHHHHHhhcCc
Q 041766 224 LQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRT---------DSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~---------~~~~~~~~~~~~~~~~~ 293 (387)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.|+..... ..............
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 257 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK--- 257 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH---
T ss_pred cceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh---
Confidence 21 223345678889999999999999999999999999999999988421100 00000000000000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
... ....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 258 ------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 ------EGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp ------TTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------ccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 00112334567889999999999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=315.74 Aligned_cols=236 Identities=21% Similarity=0.278 Sum_probs=182.8
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
..++|++.+.||+|+||.||+|.... ++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999765 889999998421 223457899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCc-------c-------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCce
Q 041766 161 ILIYEYMPNKSLDFFLFDPT-------K-------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMAR 217 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~-------~-------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~ 217 (387)
|+|||||++|+|...+.... . ..++|..+++||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 99999999999977664321 0 12477888999999999999986654 9999999998
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .. ...........
T Consensus 182 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~---~~~~i~~~~~~--- 250 (351)
T 3c0i_A 182 QLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ER---LFEGIIKGKYK--- 250 (351)
T ss_dssp ECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HH---HHHHHHHTCCC---
T ss_pred EecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HH---HHHHHHcCCCC---
Confidence 7654322 2234579999999999999999999999999999999999999985321 11 11111000000
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+ ......+..+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNP-----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 001123457889999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=320.40 Aligned_cols=238 Identities=19% Similarity=0.317 Sum_probs=181.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|+.+. ++.||+|++... .......+..|..++.++ +|||||++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4678999999999999999999876 778999998643 223334678899999887 89999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++...... .
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~ 208 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 208 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--C
Confidence 9999999999888754321 125788889999999999999999999999999998532221 2
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc---hHhHHHHHHhhcCccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL---TLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ .............. .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~- 279 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I- 279 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--------C-
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--------c-
Confidence 23456899999999999999999999999999999999999999854322110 00111111111100 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTM------NEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~~v~~ 338 (387)
..+...+..+.+|+.+||+.||++||++ +|+++
T Consensus 280 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0122345578899999999999999985 56665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=338.41 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=196.5
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
..++...++|++.+.||+|+||.||+|.+..+..||||++.... ...+.|.+|+++|++++||||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34455567788899999999999999999887889999997543 345789999999999999999999999876 6789
Q ss_pred EEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999998864211 124778888999999999999999999999999998654321
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..... .. ....
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~---~i-~~~~--------- 481 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLD---QV-ERGY--------- 481 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHH---HH-HTTC---------
T ss_pred e-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HH-HcCC---------
Confidence 1 12223456788999999999999999999999999999999 8888743221 11111 11 1100
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCC
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQP 353 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~ 353 (387)
. ...+..++..+.+||.+||+.||++|||+.+|++.|+++.....+...+
T Consensus 482 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~ 531 (535)
T 2h8h_A 482 R-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531 (535)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence 0 0112234567889999999999999999999999999987665554433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=312.46 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=194.3
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeee
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC 153 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 153 (387)
.......++|.+.+.||+|+||.||+|++. .++.||||.+.... ......+.+|+.++.++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 344455678999999999999999999852 35789999997543 33456788999999999 79999999999
Q ss_pred EEeCC-ceEEEEEecCCCCcchhhcCCccc--------------------------------cccchhhhhhcccCCCce
Q 041766 154 CIDKD-EKILIYEYMPNKSLDFFLFDPTKR--------------------------------MLLDWSANYSSRLKVSNI 200 (387)
Q Consensus 154 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~--------------------------------~~l~~~~~~h~dlk~~Ni 200 (387)
+...+ ..++||||+++|+|.+++...... ..+|..+++|+||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88755 489999999999999988654321 246778889999999999
Q ss_pred EEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 041766 201 LLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSL 279 (387)
Q Consensus 201 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~ 279 (387)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999987654433333344567889999999999999999999999999999998 9998754332211
Q ss_pred hHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 280 TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.... ....... ..+...+..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus 260 -~~~~----~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 260 -FCRR----LKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp -HHHH----HHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHH----hccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111 1111000 011123456889999999999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=313.56 Aligned_cols=229 Identities=23% Similarity=0.296 Sum_probs=183.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+++... ++.||+|.+... .....+.+.+|..+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 578889999999999999999874 889999998643 1234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ...+|..+++||||||+|||++.++.+||+|||+++..... .
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~ 160 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 160 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-----c
Confidence 99999999988864321 12478888999999999999999999999999999875432 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ......... .. .+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~---~~~~i~~~~---------~~---~p 223 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMK---TYEKILNAE---------LR---FP 223 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHH---HHHHHHHCC---------CC---CC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHH---HHHHHHhCC---------CC---CC
Confidence 34689999999999999999999999999999999999999975321 111 111111110 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
...+..+.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 22345788999999999999999 89999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=316.72 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=192.4
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-C-----CEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
.+...++|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34445789999999999999999999753 2 479999997543 34456789999999999 8999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc------------------------------ccccchhhhhhcccCCCceEEcCC
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK------------------------------RMLLDWSANYSSRLKVSNILLDKD 205 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------~~~l~~~~~~h~dlk~~Nill~~~ 205 (387)
..+..++||||+++|+|.+++..... ...+|..+++|+||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 99999999999999999988754210 124777888999999999999999
Q ss_pred CCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHH
Q 041766 206 INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGY 284 (387)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~ 284 (387)
+.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-HHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-HHHHH
Confidence 9999999999986643332223334567889999999999999999999999999999999 888875432221 11111
Q ss_pred HHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 285 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
... ... . ..+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 280 ~~~----~~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 280 VKD----GYQ-----M-----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHH----TCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhc----CCC-----C-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111 000 0 01112245688999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=306.82 Aligned_cols=249 Identities=29% Similarity=0.397 Sum_probs=192.2
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++...++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 344457888999999999999999998878889999997543 34578999999999999999999999986 4568999
Q ss_pred EEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 164 YEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999999998865321 12467788899999999999999999999999999876543322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... ... ..... ..
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~---~~~-~~~~~-----~~---- 229 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV---IQN-LERGY-----RM---- 229 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH---HHH-HHTTC-----CC----
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHH---HHH-Hhccc-----CC----
Confidence 2233456788999999998899999999999999999999 8888753221 111 111 11100 00
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCC
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPK 351 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~ 351 (387)
..+...+..+.+++.+||+.||++|||+.++++.|+++........
T Consensus 230 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred -CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 0112234578899999999999999999999999999987654433
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=307.77 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=179.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||+|+...++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999779999999986442 23346788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 158 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYT 158 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccc
Confidence 975 78777754322 125788889999999999999999999999999997654321 1223
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc--------ccccc
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL--------ELIDP 300 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 300 (387)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ................ ...++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhccccccc
Confidence 35789999999999764 5899999999999999999999998543211 1111111111110000 00000
Q ss_pred ccc------cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILE------DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... ........+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00011223457889999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=309.12 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=177.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
...++|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 345788899999999999999999753 3469999987543 344567899999999999999999999984 4678
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 999999999999988864321 124777888999999999999999999999999998764332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ...... .....
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i----~~~~~-------- 235 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRI----ENGER-------- 235 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH----HTTCC--------
T ss_pred cc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHH----HcCCC--------
Confidence 21 1233456788999999998999999999999999999997 88887543221 111111 00000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00122335578899999999999999999999999998865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.66 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=193.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.++...++|++.+.||+|+||.||+|.+.. +..||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 334456788899999999999999999876 778999999754 344578899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
+||||+++++|.+++...... ..+|..+++|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999888643221 24677888999999999999999999999999998665332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......+|..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ... .
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~----~~~---------~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL----EKD---------Y 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH----HTT---------C
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH----hcc---------C
Confidence 2 22233456788999999999999999999999999999999 88887543211 111111 000 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
. ...+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 230 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 001223345788999999999999999999999999887653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=308.12 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=194.7
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHh--cCCCceeeeeeeEEeCC
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~~~~~~~~~~ 158 (387)
+.......++|.+.+.||+|+||.||+|++. ++.||||.+.. .....+.+|.+++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3444566789999999999999999999985 88999999853 234677889999988 69999999999998876
Q ss_pred ----ceEEEEEecCCCCcchhhcCCcc---------------ccccc--------hhhhhhcccCCCceEEcCCCCeEEe
Q 041766 159 ----EKILIYEYMPNKSLDFFLFDPTK---------------RMLLD--------WSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 159 ----~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~--------~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
..++||||+++|+|.+++..... ...+| ..+++|+||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 78999999999999998864321 12356 6788999999999999999999999
Q ss_pred eccCceecCCCCccc--ccccccCCCccccccccccC------CCCccccchhHHHHHHHHHhC----------CCCCCC
Q 041766 212 DFGMARICGGNELQA--NTSRIVGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIVSG----------KKTTGF 273 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwS~Gvil~el~tg----------~~p~~~ 273 (387)
|||++.......... ......||..|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999998765433211 23445789999999999765 345789999999999999999 566644
Q ss_pred CCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 274 YRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..........+..... . ....+.+............+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 270 ~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVC-E----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TSCSSCCHHHHHHHHT-T----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCcCcccHHHHHHHHH-H----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 3332222222221111 1 111122222223345677899999999999999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=304.85 Aligned_cols=247 Identities=22% Similarity=0.285 Sum_probs=188.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CC---EEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce-EEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK-ILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~-~lv 163 (387)
.|...+.||+|+||.||+|.+.+ +. .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45556899999999999998643 22 69999987543 34557889999999999999999999999876655 999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ- 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 225 (387)
|||+.+|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999999988753321 2477788899999999999999999999999999865432211
Q ss_pred -cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ......... ...
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~----~~~---------- 246 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQ----GRR---------- 246 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHT----TCC----------
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhc----CCC----------
Confidence 1223356788999999999999999999999999999999976664322211 111111111 000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCC
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPK 351 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~ 351 (387)
...+...+..+.+++.+||+.||++|||+.++++.|+++...+....
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 00122234578899999999999999999999999999988765443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.27 Aligned_cols=248 Identities=27% Similarity=0.364 Sum_probs=193.4
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCC 154 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 154 (387)
.+++...++|.+.+.||+|+||.||+|++. .+..||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445556688999999999999999999865 26779999997543 33455788999999999999999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCCcc--------------------------ccccchhhhhhcccCCCceEEcCCCCe
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDPTK--------------------------RMLLDWSANYSSRLKVSNILLDKDINP 208 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~ 208 (387)
.+.+..++||||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 999999999999999999988854210 124777888999999999999999999
Q ss_pred EEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHH
Q 041766 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 209 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 287 (387)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..... .... ..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~---~~ 252 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVL---RF 252 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HHHH---HH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HHHH---HH
Confidence 9999999986543333333334567889999999999999999999999999999999 7888643211 1111 11
Q ss_pred HhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
....... ......+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 253 -~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 -VMEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111100 0112334568899999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=316.64 Aligned_cols=245 Identities=18% Similarity=0.168 Sum_probs=184.7
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhcCCCceeeeeeeE
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCC 154 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~ 154 (387)
..++....++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp CBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 34566778899999999999999999999765 788999988532 344567899999999999999999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCCc------------------------------------------------------
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDPT------------------------------------------------------ 180 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 180 (387)
.+.+..++||||+++|+|.+++....
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999999999988874100
Q ss_pred --cccccchhhhhhcccCCCceEEcCCC--CeEEeeccCceecCCCCc--ccccccccCCCcccccccccc--CCCCccc
Q 041766 181 --KRMLLDWSANYSSRLKVSNILLDKDI--NPKISDFGMARICGGNEL--QANTSRIVGTYGYMSPEYAIQ--GIFSIKS 252 (387)
Q Consensus 181 --~~~~l~~~~~~h~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 252 (387)
....+|..+++|+||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 01246777889999999999998776 899999999987533211 112334578999999999975 6789999
Q ss_pred cchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCC
Q 041766 253 DVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPT 332 (387)
Q Consensus 253 DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt 332 (387)
|||||||++|||++|+.||...... ............. . .......+..+.+++.+||+.||++|||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKLCF-------E-NPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCT-------T-SGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhccccc-------C-CcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999997533211 1111111111000 0 0011123457889999999999999999
Q ss_pred HHHHHH
Q 041766 333 MNEVVS 338 (387)
Q Consensus 333 ~~~v~~ 338 (387)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=303.44 Aligned_cols=258 Identities=17% Similarity=0.212 Sum_probs=191.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeE-EeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~ 164 (387)
..++|++.+.||+|+||.||+|++.. ++.||||.+...... ..+.+|+.++..++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999754 788999987543322 3578899999999988877777665 5567789999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
||+ +++|.+++..... ...+|..+++|+||||+|||+ +.++.+||+|||+++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 9999988863221 125788888999999999999 7889999999999987654322
Q ss_pred c-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc-hHhH-HHHHHhhcCccccc
Q 041766 225 Q-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL-TLLG-YAWDLWTSNRTLEL 297 (387)
Q Consensus 225 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~ 297 (387)
. .......||..|+|||++.+..++.++|||||||++|||++|+.||........ .... ......... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~-- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--I-- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--H--
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--h--
Confidence 1 122346789999999999999999999999999999999999999865332211 1111 100000000 0
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
.......+..+.+++.+||+.||++|||+.++++.|+++...........++|.
T Consensus 240 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 240 -------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp -------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred -------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 000012245788999999999999999999999999999987776666666654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=304.87 Aligned_cols=240 Identities=26% Similarity=0.380 Sum_probs=189.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
.++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888899999999999999998888999999975433 3468899999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
++++|.+++...... ..+|..+++|+||||+||+++.++.+||+|||++....... ......
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~ 164 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTG 164 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTS
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-cccccc
Confidence 999999888653221 24677888999999999999999999999999997654321 112233
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (387)
..++..|+|||++.+..++.++||||||+++|||++ |+.||..... . ...... ..... . ..+.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~---~~~~~i-~~~~~-----~-----~~~~ 228 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--S---EVVEDI-STGFR-----L-----YKPR 228 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H---HHHHHH-HTTCC-----C-----CCCT
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--H---HHHHHH-hcCCc-----C-----CCCc
Confidence 456788999999998899999999999999999999 8888753221 1 111111 11000 0 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 310 ~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234568899999999999999999999999998865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=310.05 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=168.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|.... ++.||+|.+... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999765 889999998644 23344678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCc-----c-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 166 YMPNKSLDFFLFDPT-----K-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~-----~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|++ |+|..++.... . ..++|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 998 58877764321 0 124677888999999999999999999999999998764322
Q ss_pred cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--ccc----
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--TLE---- 296 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 296 (387)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............. ...
T Consensus 163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 163 --NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhhhhh
Confidence 12234578999999999976 46899999999999999999999998543221 11111111111000 000
Q ss_pred --ccccccc-----------cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 --LIDPILE-----------DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 --~~~~~~~-----------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+... ........+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00001123457889999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=314.24 Aligned_cols=238 Identities=20% Similarity=0.244 Sum_probs=171.5
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
....++|++.+.||+|+||.||+|++.. ++.||||.+.... ..+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3456789999999999999999999875 7889999997543 335678899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcC---CCCeEEeeccCceecCCCCc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARICGGNEL 224 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~~ 224 (387)
|||+++|+|.+++..... ..++|..+++|+||||+|||++. ++.+||+|||+++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999999888865432 12477888899999999999975 8899999999998654322
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... ......... ....+
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~i~~~~~-~~~~~---- 273 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----FRRILNCEY-YFISP---- 273 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-----HHHHHTTCC-CCCTT----
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-----HHHHHhCCC-ccCCc----
Confidence 223457899999999999999999999999999999999999997543222111 111111100 00000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....+..+.+|+.+||+.||++|||+.++++.
T Consensus 274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234578899999999999999999999873
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.02 Aligned_cols=238 Identities=22% Similarity=0.284 Sum_probs=187.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..++|++.+.||+|+||.||+|.... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45678899999999999999999874 889999998643 2344578889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++............
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 99999999988865422 12477788899999999999999999999999999865433222223
Q ss_pred ccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....|+..|+|||++.+..+ +.++||||||+++|||++|+.||............+. .... .. ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~--~~-------~~ 230 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-----EKKT--YL-------NP 230 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH-----TTCT--TS-------TT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh-----hccc--cc-------Cc
Confidence 44678999999999987775 7899999999999999999999865443322221111 1000 00 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1223456789999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=316.92 Aligned_cols=229 Identities=21% Similarity=0.260 Sum_probs=184.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+++... ++.||+|.+... .....+.+.+|+.+|..++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 678899999999999999999875 889999998532 1234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++..... .
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~ 195 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----c
Confidence 99999999888864221 12578888999999999999999999999999999876432 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|+|||++.+..++.++|||||||++|||++|..||.... ... ........ .. ..+
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~---~~~~i~~~-~~-----------~~p 258 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQ---IYEKIVSG-KV-----------RFP 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH---HHHHHHHC-CC-----------CCC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--HHH---HHHHHHcC-CC-----------CCC
Confidence 34589999999999999999999999999999999999999975321 111 11111111 00 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~~ 339 (387)
...+..+.+++.+||+.||++||+ ++++++.
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 223457889999999999999998 8888763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=318.31 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=176.7
Q ss_pred CCCCCCcccccCCeeEEEEEEcC--C--CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceEEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK--G--DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILI 163 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv 163 (387)
.|.+.+.||+|+||.||+|.+.. + ..||+|.+... .....+.+.+|+.++++++||||++++++|.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 45667899999999999998643 2 35899998653 33456789999999999999999999998765 4578999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++|+|.+++...... .++|..+++||||||+|||++.++.+||+|||+++.........
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999999999998654321 24777888999999999999999999999999998654332211
Q ss_pred --ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 227 --NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 227 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
......+|..|+|||++.+..++.++|||||||++|||++ |.+||...... ........ ...
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~~~~~---~~~---------- 314 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ---GRR---------- 314 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHHHHHT---TCC----------
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHHHHHc---CCC----------
Confidence 1233457788999999999999999999999999999999 56665432221 11111110 000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 315 -~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 315 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00122234578899999999999999999999999999976554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=301.65 Aligned_cols=259 Identities=18% Similarity=0.201 Sum_probs=195.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeE-EeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~-~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...... ..+.+|+.++..++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 468999999999999999999975 4889999998654332 4688999999999988877666655 55677899999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCCCcc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+ +++|.+++..... ...+|..+++|+||||+|||+ +.++.+||+|||+++........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99 8999988863221 124788888999999999999 48889999999999876543221
Q ss_pred -----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-chHhHHHHHHhhcCccccccc
Q 041766 226 -----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS-LTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 226 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.......||..|+|||++.+..++.++|||||||++|||++|+.||....... ................ .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~--- 240 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E--- 240 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H---
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-H---
Confidence 11244578999999999999999999999999999999999999986533221 1111111110000000 0
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeeee
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYVR 359 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~~ 359 (387)
......+..+.+++.+||+.||++|||+.++++.|+++......+....++|..
T Consensus 241 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 241 ------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp ------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred ------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 001123457889999999999999999999999999999887777666677654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=315.92 Aligned_cols=234 Identities=24% Similarity=0.264 Sum_probs=178.0
Q ss_pred CCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 94 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
.+.||+|+||.||+|.... +..||+|.+........+.+.+|+++|.+++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5679999999999999764 889999999876556667899999999999999999999999999999999999999999
Q ss_pred chhhcCCcc-----------------ccccchhhhhhcccCCCceEE--cCCCCeEEeeccCceecCCCCcccccccccC
Q 041766 173 DFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILL--DKDINPKISDFGMARICGGNELQANTSRIVG 233 (387)
Q Consensus 173 ~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 233 (387)
.+++..... ..++|..+++|+||||+|||+ +.++.+||+|||+++...... ......|
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~g 250 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFG 250 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCS
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccC
Confidence 877754321 124677888999999999999 567889999999998765432 1233478
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (387)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........... ... ......+.
T Consensus 251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~---~~~~i~~~~~~--~~~------~~~~~~~~ 317 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--E---TLNNILACRWD--LED------EEFQDISE 317 (373)
T ss_dssp SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHHTCCC--SCS------GGGTTSCH
T ss_pred CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHhccCC--CCh------hhhccCCH
Confidence 99999999999889999999999999999999999997533211 1 11111111000 000 01122345
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH--Hhhhh
Q 041766 314 RYVNIALLCVQESADDRPTMNEVVS--MLTDE 343 (387)
Q Consensus 314 ~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~ 343 (387)
.+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 7889999999999999999999997 44443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=318.06 Aligned_cols=255 Identities=16% Similarity=0.190 Sum_probs=186.1
Q ss_pred hcCCCCCCccccc--CCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEG--GFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G--~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+| +||.||+|+... ++.||||++... .......+.+|+.++++++|||||++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 999999999874 889999998643 23445678889999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 163 IYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
|||||++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||.+........
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 9999999999988854311 1257888899999999999999999999999999865422111
Q ss_pred -----ccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh-------
Q 041766 225 -----QANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT------- 290 (387)
Q Consensus 225 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 290 (387)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||.............. ....
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~ 262 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTST 262 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCccccccc
Confidence 111223478899999999987 5799999999999999999999999865433221111000 0000
Q ss_pred --cC-------------ccccccc---c-----ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 291 --SN-------------RTLELID---P-----ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 291 --~~-------------~~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
.. ...+... + ...........+..+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00 0000000 0 000000122345678899999999999999999999864 4443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.98 Aligned_cols=259 Identities=12% Similarity=0.095 Sum_probs=194.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC---------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceee---------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK---------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR--------- 149 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--------- 149 (387)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... ..+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999764 678999998643 36789999999999999998
Q ss_pred ------eeeeEEe-CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC
Q 041766 150 ------LLGCCID-KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK 204 (387)
Q Consensus 150 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~ 204 (387)
+++++.. ....++||||+ +++|.+++..... ..++|..+++|+||||+|||++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 5677766 66789999999 9999999875411 12477888999999999999999
Q ss_pred CC--CeEEeeccCceecCCCCcc-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 041766 205 DI--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTD 277 (387)
Q Consensus 205 ~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~ 277 (387)
++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999865432211 1123357899999999999999999999999999999999999998654323
Q ss_pred cchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceee
Q 041766 278 SLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSY 357 (387)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~ 357 (387)
............. ........... ....+..+.+++.+||+.||++|||+.++++.|+++...........++|
T Consensus 275 ~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw 348 (352)
T 2jii_A 275 TEDIMKQKQKFVD--KPGPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGL 348 (352)
T ss_dssp HHHHHHHHHHHHH--SCCCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCC
T ss_pred HHHHHHHHHhccC--Chhhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccC
Confidence 2222222111111 11111111110 11224578899999999999999999999999999998776665555555
Q ss_pred e
Q 041766 358 V 358 (387)
Q Consensus 358 ~ 358 (387)
.
T Consensus 349 ~ 349 (352)
T 2jii_A 349 P 349 (352)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=311.10 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=181.0
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 155 (387)
..+....++|.+.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344455788999999999999999998653 347999998644 3344567899999999999999999999998
Q ss_pred eCC-----ceEEEEEecCCCCcchhhcCCc-----c-----------------ccccchhhhhhcccCCCceEEcCCCCe
Q 041766 156 DKD-----EKILIYEYMPNKSLDFFLFDPT-----K-----------------RMLLDWSANYSSRLKVSNILLDKDINP 208 (387)
Q Consensus 156 ~~~-----~~~lv~e~~~~g~L~~~l~~~~-----~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~ 208 (387)
..+ ..++||||+++|+|..++.... . ...+|..+++|+||||+|||++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 754 3599999999999998873211 0 124777888999999999999999999
Q ss_pred EEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHH
Q 041766 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWD 287 (387)
Q Consensus 209 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~ 287 (387)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ......
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~-- 262 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYL-- 262 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHH--
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH--
Confidence 9999999987654433333344567889999999999999999999999999999999 88886433221 111111
Q ss_pred HhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
. .... ...+...+..+.+++.+||+.||++|||+.++++.|+++...++
T Consensus 263 -~-~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 -L-HGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp -H-TTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -H-cCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 0000 00122334578899999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.10 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=184.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCC----CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKG----DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKI 161 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~ 161 (387)
..+|++.+.||+|+||.||+|.+..+ ..||+|.+... .....+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35688889999999999999996532 25899998754 33455778999999999999999999998654 55789
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999998653321 246778889999999999999999999999999986643322
Q ss_pred c--cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 Q--ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... ........ ..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~~---~~---------- 249 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ---GR---------- 249 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHHT---TC----------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhc---CC----------
Confidence 1 12233467788999999999999999999999999999999555432221111 11111100 00
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCC
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~ 349 (387)
....+...+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 250 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0001122345688999999999999999999999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=313.45 Aligned_cols=237 Identities=19% Similarity=0.205 Sum_probs=174.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+++... ++.||+|.+..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 4689999999999999999999874 88999999975432 236788999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCC--eEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDIN--PKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++|+|..++..... ..++|..+++||||||+|||++.++. +||+|||+++...... ..
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~ 174 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP 174 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CC
Confidence 999999888754221 13578888999999999999987765 9999999997533221 22
Q ss_pred ccccCCCccccccccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIK-SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ............. ... .
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~-------~~~---~ 243 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKY-------SIP---D 243 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCC-------CCC---T
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCC-------CCC---C
Confidence 34579999999999988887655 8999999999999999999864332211 1111111111000 000 0
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11124568899999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.62 Aligned_cols=191 Identities=28% Similarity=0.335 Sum_probs=161.3
Q ss_pred CCccchhhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----CCceee
Q 041766 76 LPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-----HKNLVR 149 (387)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~ 149 (387)
...+++.......++|.+.+.||+|+||.||+|++.. ++.||||++... ......+..|+.++.+++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3445566666777899999999999999999999864 889999999643 334456788999999986 999999
Q ss_pred eeeeEEeCCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC-------
Q 041766 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK------- 204 (387)
Q Consensus 150 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~------- 204 (387)
+++++...+..++||||+ +++|.+++..... ..++|..+++||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 999999999999999999 8899888764331 12477888899999999999975
Q ss_pred ------------------CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh
Q 041766 205 ------------------DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS 266 (387)
Q Consensus 205 ------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t 266 (387)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865432 234578999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 041766 267 GKKTTGF 273 (387)
Q Consensus 267 g~~p~~~ 273 (387)
|+.||..
T Consensus 255 g~~pf~~ 261 (360)
T 3llt_A 255 GSLLFRT 261 (360)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=312.86 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCC-----CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKG-----DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.++|...+.||+|+||.||+|.+... ..||+|.+... .......+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 35677789999999999999987642 25999999754 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999999988643221 246778889999999999999999999999999987643221
Q ss_pred c-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 Q-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... .... .. ......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~---~~-~~~~~~-------- 268 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM---KA-INDGFR-------- 268 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH---HH-HHTTCC--------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHH---HH-HHCCCc--------
Confidence 1 11222356788999999998999999999999999999999 9999743221 1111 11 111100
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
...+..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 269 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001122345788999999999999999999999999988753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=325.05 Aligned_cols=243 Identities=20% Similarity=0.224 Sum_probs=186.5
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
.+....++|++.+.||+|+||.||+|++.. ++.||+|++... .......+.+|..++..++|||||++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 344456789999999999999999999876 889999998532 1122245788999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+|||||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999999988864321 125788889999999999999999999999999998765433
Q ss_pred cccccccccCCCccccccccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGI----FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
. ......+||+.|+|||++.+.. |+.++|||||||++|||++|+.||..... .... ......... ...
T Consensus 223 ~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~---~~i~~~~~~--~~~ 294 (410)
T 3v8s_A 223 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTY---SKIMNHKNS--LTF 294 (410)
T ss_dssp E-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH---HHHHTHHHH--CCC
T ss_pred c-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--hhHH---HHHHhcccc--ccC
Confidence 2 2234568999999999998665 88999999999999999999999853221 1111 111000000 000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
+ .....+..+.+|+.+||+.+|.+ ||+++||++.
T Consensus 295 p------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 P------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp C------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred C------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 01123457889999999999988 9999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.34 Aligned_cols=233 Identities=24% Similarity=0.341 Sum_probs=182.9
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 161 (387)
..++|.+.+.||+|+||.||+|+++. ++.||+|.+... .......+..|..++..+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34688999999999999999999875 788999998643 123456778899999887 9999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 172 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-- 172 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--
Confidence 99999999999888854221 135788889999999999999999999999999998643221
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ... ........ ..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~---~~~i~~~~-------~~---- 236 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EEL---FHSIRMDN-------PF---- 236 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCC-------CC----
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHH---HHHHHhCC-------CC----
Confidence 123456899999999999999999999999999999999999999753221 111 11111100 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMN-EVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~-~v~~ 338 (387)
.+...+..+.+++.+||+.||++||++. ++++
T Consensus 237 -~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1122345788999999999999999997 6654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=315.64 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=194.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--ceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~~lv 163 (387)
.++|.+.+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3678899999999999999999876 8899999996432 334567889999999999999999999998765 67999
Q ss_pred EEecCCCCcchhhcCCccc-------------------cccchhhhhhcccCCCceEE----cCCCCeEEeeccCceecC
Q 041766 164 YEYMPNKSLDFFLFDPTKR-------------------MLLDWSANYSSRLKVSNILL----DKDINPKISDFGMARICG 220 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-------------------~~l~~~~~~h~dlk~~Nill----~~~~~~kl~Dfg~a~~~~ 220 (387)
|||+++|+|.+++...... .++|..+++|+||||+|||+ +.++.+||+|||+++...
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999988764321 24777888999999999999 777889999999998765
Q ss_pred CCCcccccccccCCCcccccccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQ--------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... ..........
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIITGK 243 (396)
T ss_dssp CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHHHSC
T ss_pred CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHhcCC
Confidence 332 2234578999999999875 568899999999999999999999986443322211 1112211111
Q ss_pred cc--ccccc-----------cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 293 RT--LELID-----------PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 293 ~~--~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.. ...+. ...............+.+++.+||+.||++|||+.++++.++++..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 10 00000 0001111246677889999999999999999999999999888765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=303.38 Aligned_cols=235 Identities=22% Similarity=0.306 Sum_probs=184.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--CceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK--DEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~--~~~~lv 163 (387)
.++|.+.+.||+|+||.||+|++. +..||+|.+... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 367889999999999999999986 888999999754 334456789999999999999999999999887 678999
Q ss_pred EEecCCCCcchhhcCCccc------------------cccchhh--hhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 164 YEYMPNKSLDFFLFDPTKR------------------MLLDWSA--NYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~------------------~~l~~~~--~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||+++|+|.+++...... .++|..+ ++|+||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 9999999999999764421 2467767 9999999999999999999999998875422
Q ss_pred cccccccccCCCccccccccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSI---KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... ............ +
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-----~ 230 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIGMKVALEGLR-----P 230 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHHHHHHHSCCC-----C
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHHHHHHhcCCC-----C
Confidence 22347789999999998765544 899999999999999999997532211 111111111100 0
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
. .+...+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 231 ~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 T-----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred C-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 112234578899999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.08 Aligned_cols=234 Identities=20% Similarity=0.317 Sum_probs=186.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|.+.+.||+|+||.||+|++. +|+.||||.+... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67889999999999999999987 4899999998532 1233467889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||++....... ..
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~ 172 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FL 172 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CB
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---cc
Confidence 99999999998865432 124778889999999999999999999999999998765432 23
Q ss_pred ccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
...+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .... .... ... .. .
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--~~~~---~~i~-~~~--------~~---~ 235 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--PTLF---KKIC-DGI--------FY---T 235 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--HHHH---HHHH-TTC--------CC---C
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--HHHH---HHHh-cCC--------cC---C
Confidence 34589999999999988776 7899999999999999999999853221 1111 1111 100 00 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTD 342 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~ 342 (387)
+...+..+.+|+.+||+.||++|||+.++++ .+..
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 1123456889999999999999999999997 4544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.58 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=188.6
Q ss_pred cCCCCCC-cccccCCeeEEEEEEc---CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|.+.+ .||+|+||.||+|.+. .+..||+|.+... .....+.+.+|++++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 8999999999999864 3678999999764 334567889999999999999999999999 45668999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ- 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 225 (387)
|||+++++|..++...... ..+|..+++|+||||+|||++.++.+||+|||++.........
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 9999999999988643221 2467788899999999999999999999999999876543222
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... .....
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i----~~~~~---------- 231 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI----EQGKR---------- 231 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHH----HTTCC----------
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH----hcCCc----------
Confidence 12233456889999999998889999999999999999998 99997543221 111111 11100
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
...+..++..+.+++.+||+.||++|||+.++++.|+++..+.
T Consensus 232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0112234567889999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=309.50 Aligned_cols=230 Identities=22% Similarity=0.227 Sum_probs=173.9
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~ 161 (387)
...++|+..++||+|+||+||+|++. +++.||||++... .......+..|+..+.++ +||||++++++|.+.+..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34578999999999999999999987 4899999998643 223334556677666666 9999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+ +++|..++..... ..++|..+++|+||||+|||++.++.+||+|||++.......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999999 6688776654221 124777888999999999999999999999999998764332
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+....... ...
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~--------~~~ 271 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGY--------LPP 271 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTC--------CCH
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccC--------CCc
Confidence 2234568999999999876 79999999999999999999977653110 011111110 000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+..+.+++.+||+.||++|||++++++
T Consensus 272 -~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 -EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011223467889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=316.18 Aligned_cols=236 Identities=23% Similarity=0.285 Sum_probs=175.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCC--CceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||++...+++.||||++... .......+.+|+.+|.+++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4678899999999999999999888999999998643 33445678899999999976 9999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|| +.+++|.+++..... ..++|..+++||||||+|||++ ++.+||+|||+++..........
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 99 557899888765322 1257788899999999999997 56899999999987654333323
Q ss_pred cccccCCCcccccccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~- 240 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHEI- 240 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHCTTSCC-
T ss_pred CCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HHHHHHhcCCccc-
Confidence 345679999999999865 678999999999999999999999985322211 1111111100000
Q ss_pred ccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .+......+.+++.+||+.||++|||+.|+++.
T Consensus 241 --------~-~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 --------E-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------C-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------C-CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0 111113467899999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.76 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=180.9
Q ss_pred cccccCCeeEEEEEEc---CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 96 KLGEGGFGPVYKGVLK---KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 96 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+++|++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999875 35579999997543 3456789999999999999999999999976 56899999999999
Q ss_pred cchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-ccccccccC
Q 041766 172 LDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL-QANTSRIVG 233 (387)
Q Consensus 172 L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~g 233 (387)
|.+++...... .++|..+++||||||+|||++.++.+||+|||+++....... ........+
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 501 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCC
Confidence 99988653321 247888899999999999999999999999999986543221 111222345
Q ss_pred CCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHH
Q 041766 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHML 312 (387)
Q Consensus 234 t~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (387)
|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....... ..... ...+..++
T Consensus 502 ~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i----~~~~~----------~~~p~~~~ 565 (613)
T 2ozo_A 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI----EQGKR----------MECPPECP 565 (613)
T ss_dssp CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHH----HTTCC----------CCCCTTCC
T ss_pred ccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HcCCC----------CCCCCcCC
Confidence 689999999999999999999999999999998 9999754322 1111111 11100 01223345
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 313 LRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 313 ~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
..+.+||.+||+.||++|||+.+|++.|+.......
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 678999999999999999999999999999876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=311.61 Aligned_cols=233 Identities=21% Similarity=0.261 Sum_probs=174.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEE----cCCCEEEEEEccCCC----cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLPGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
.++|++.+.||+|+||.||+++. ..++.||+|++.... ......+.+|+.+|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36789999999999999999997 358899999997542 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 9999999999999888754221 124778889999999999999999999999999997543221
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ......... ..
T Consensus 176 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~---~~~~i~~~~---------~~ 239 (327)
T 3a62_A 176 --TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KK---TIDKILKCK---------LN 239 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH---HHHHHHHTC---------CC
T ss_pred --ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HH---HHHHHHhCC---------CC
Confidence 122345789999999999999999999999999999999999999853221 11 111111100 00
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
.+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1122345788999999999999999 77888763
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=310.87 Aligned_cols=237 Identities=20% Similarity=0.320 Sum_probs=182.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|+++. ++.||+|++... .......+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 568889999999999999999875 788999999643 233455688999999988 899999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... ..
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--Cc
Confidence 999999999888754221 125788889999999999999999999999999998543221 12
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc---hHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL---TLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............. .
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~-- 236 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------I-- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--------C--
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--------C--
Confidence 3456899999999999999999999999999999999999999854221110 00111111111110 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTM------NEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~~v~~ 338 (387)
..+...+..+.+++.+||+.||++||++ .++++
T Consensus 237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0112234578899999999999999996 56665
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=325.81 Aligned_cols=244 Identities=18% Similarity=0.204 Sum_probs=185.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
.+....++|++.+.||+|+||.||+|++.. ++.||+|++... .......+.+|..++..++||||++++++|.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 344456789999999999999999999876 678999998532 1112234788999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
..|+|||||++|+|..++...... .++|..+++||||||+||||+.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999999998763221 247788889999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||..... ....... ......
T Consensus 228 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~~~~i---~~~~~~-- 299 (437)
T 4aw2_A 228 DGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKI---MNHKER-- 299 (437)
T ss_dssp TSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHH---HTHHHH--
T ss_pred CCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHHHHhh---hhcccc--
Confidence 332 2233468999999999997 45789999999999999999999999853221 1111111 000000
Q ss_pred ccccccccccccHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041766 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADD--RPTMNEVVSM 339 (387)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~~v~~~ 339 (387)
..-+......+..+.+|+.+||+.+|++ ||+++|+++.
T Consensus 300 -----~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 300 -----FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -----CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -----ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000001123457889999999998888 9999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.51 Aligned_cols=256 Identities=22% Similarity=0.260 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHH--HhcCCCceeeeeeeEEe-----CCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVI--AKVQHKNLVRLLGCCID-----KDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~h~nIv~~~~~~~~-----~~~~ 160 (387)
.++|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++ ..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 467889999999999999999874 789999998643 234455555554 45799999999986543 2256
Q ss_pred EEEEEecCCCCcchhhcCCccc---------------cccchh---------hhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR---------------MLLDWS---------ANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~---------------~~l~~~---------~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
++||||+++|+|.+++...... .++|.. +++||||||+|||++.++.+||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 8999999999999988543321 246666 8999999999999999999999999999
Q ss_pred eecCCCCc------ccccccccCCCcccccccccc-------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhH
Q 041766 217 RICGGNEL------QANTSRIVGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLG 283 (387)
Q Consensus 217 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 283 (387)
+....... ........||..|+|||++.+ ..++.++|||||||++|||++|..|+............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 87653321 112234579999999999986 45778999999999999999998776433322111000
Q ss_pred HHHHHhhcCcc--------cccccccccc-ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 284 YAWDLWTSNRT--------LELIDPILED-EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 284 ~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+.......... .....+.+.. .......+..+.+++.+||+.||++|||++|+++.|+++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 00000000000 0000111111 1122345678999999999999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.90 Aligned_cols=251 Identities=15% Similarity=0.151 Sum_probs=181.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCCcc-----------cHHHHHHHHHHHHhcCCCceeeeee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRSGQ-----------GLREMKNEASVIAKVQHKNLVRLLG 152 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~~~~ 152 (387)
.++|.+.+.||+|+||.||+|.+. .+..||+|.+...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367899999999999999999976 4678999998654321 1234667888999999999999999
Q ss_pred eEEe----CCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC--CeEE
Q 041766 153 CCID----KDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI--NPKI 210 (387)
Q Consensus 153 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~--~~kl 210 (387)
++.. ....|+||||+ +++|.+++..... ..++|..+++|+||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 67889999999 9999998865421 1247788889999999999998877 9999
Q ss_pred eeccCceecCCCCcc-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH
Q 041766 211 SDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA 285 (387)
Q Consensus 211 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~ 285 (387)
+|||+++........ .......||..|+|||++.+..++.++|||||||++|||++|+.||.....+........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 274 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence 999999876432111 112345789999999999999999999999999999999999999853322221111111
Q ss_pred HHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 286 WDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.. ..... . ..+.........+..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 275 ~~-~~~~~-~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 275 TN-LLDEL-P----QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHTT-T----HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred Hh-hcccc-c----HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11 11000 0 0000000011234578999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.24 Aligned_cols=245 Identities=20% Similarity=0.232 Sum_probs=179.3
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+.|.+. +.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999965 4889999999766666678899999999995 7999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCceecCCCCc-
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMARICGGNEL- 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~~- 224 (387)
||+++|+|.+++..... ...+|..+++|+||||+|||++.++. +||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99999999888854221 12578888999999999999988766 99999999876532211
Q ss_pred ----ccccccccCCCcccccccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH---------hHHHH
Q 041766 225 ----QANTSRIVGTYGYMSPEYAIQ-----GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL---------LGYAW 286 (387)
Q Consensus 225 ----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~---------~~~~~ 286 (387)
........||..|+|||++.+ ..++.++|||||||++|||++|+.||.......... .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 111223468999999999975 568999999999999999999999986543221100 00000
Q ss_pred HHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........ . ... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~i~~~~~-~-----~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKY-E-----FPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCC-C-----CCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCc-c-----cCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000000 0 000 0001234578899999999999999999999983
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=305.65 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=180.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357889999999999999999975 4889999998643 334456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCc-------c-------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 164 YEYMPNKSLDFFLFDPT-------K-------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~-------~-------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||+++++|.+++.... . ...+|..+++|+||||+||+++.++.+||+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99999999988875311 0 124677888999999999999999999999999987654322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ... ...... .
T Consensus 191 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~~~-----~-- 257 (310)
T 2wqm_A 191 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---KKI-EQCDYP-----P-- 257 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH---HHH-HTTCSC-----C--
T ss_pred c--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH---HHh-hcccCC-----C--
Confidence 1 12335689999999999999999999999999999999999999753322211111 111 000000 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCC
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPP 350 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~ 350 (387)
......+..+.+++.+||+.||++|||+.++++.|+++.+....+
T Consensus 258 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 258 --LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp --CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred --CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 011223457889999999999999999999999999998765433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=315.17 Aligned_cols=246 Identities=22% Similarity=0.215 Sum_probs=171.4
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEe-----
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID----- 156 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~----- 156 (387)
++....+|++.+.||+|+||.||+|++.. ++.||+|++..........+.+|+.++.++. ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 33445688999999999999999999764 8899999986665566678899999999995 9999999999853
Q ss_pred ---CCceEEEEEecCCCCcchhhcCCc--c-----------------ccccchhh--hhhcccCCCceEEcCCCCeEEee
Q 041766 157 ---KDEKILIYEYMPNKSLDFFLFDPT--K-----------------RMLLDWSA--NYSSRLKVSNILLDKDINPKISD 212 (387)
Q Consensus 157 ---~~~~~lv~e~~~~g~L~~~l~~~~--~-----------------~~~l~~~~--~~h~dlk~~Nill~~~~~~kl~D 212 (387)
....++||||+. |+|.+++.... . ..++|..+ ++|+||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 68877764311 0 12467777 99999999999999999999999
Q ss_pred ccCceecCCCCccc----------ccccccCCCcccccccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 041766 213 FGMARICGGNELQA----------NTSRIVGTYGYMSPEYA---IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL 279 (387)
Q Consensus 213 fg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~ 279 (387)
||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998764322111 11134689999999998 56678999999999999999999999974321110
Q ss_pred hHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCC
Q 041766 280 TLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFP 349 (387)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~ 349 (387)
......... ........+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 261 -----------------~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 261 -----------------IVNGKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ----------------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred -----------------hhcCcccCC-cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 000000000 0111123477899999999999999999999999999875433
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=301.38 Aligned_cols=235 Identities=19% Similarity=0.207 Sum_probs=184.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|.+.+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45678999999999999999999876 77899999976555567889999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCCCccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|+++++|.+++..... ...+|..+++|+||||+|||+ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--- 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--- 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---
Confidence 9999999877654221 124778888999999999999 788999999999998765332
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......||+.|+|||++.+. ++.++||||||+++|||++|+.||...... .. ...... .... .. ..
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~---~~~~~~-~~~~------~~-~~ 229 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EV---MLKIRE-GTFT------FP-EK 229 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHH-CCCC------CC-HH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HH---HHHHHh-CCCC------CC-ch
Confidence 22345789999999998654 899999999999999999999997532211 11 111000 0000 00 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00123457889999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.30 Aligned_cols=248 Identities=20% Similarity=0.203 Sum_probs=185.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~ 160 (387)
...++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34578999999999999999999975 488999999876555667789999999999999999999999873 3467
Q ss_pred EEEEEecCCCCcchhhcCC---cc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 161 ILIYEYMPNKSLDFFLFDP---TK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~---~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
++||||+++|+|.+++... .. ...+|..+++|+||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 8999999999998887541 11 124777888999999999999999999999999987643
Q ss_pred CCCcc-------cccccccCCCccccccccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 221 GNELQ-------ANTSRIVGTYGYMSPEYAIQGI---FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 221 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
..... .......||..|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------- 257 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------- 257 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH--------
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh--------
Confidence 21100 0012245789999999987554 78999999999999999999999742111110000
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
........ .......+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 258 -----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 258 -----LAVQNQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -----HHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -----HHhhccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00000000 0011223457889999999999999999999999999875433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=314.59 Aligned_cols=233 Identities=24% Similarity=0.281 Sum_probs=183.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|+... ++.||+|.+... .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3678999999999999999999876 788999998643 223456788999999988 89999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 176 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--V 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--c
Confidence 9999999999988864221 125788889999999999999999999999999998643221 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ........ . .
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~---~~~i~~~~---------~---~ 239 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDEL---FQSIMEHN---------V---A 239 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHHHHCC---------C---C
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHH---HHHHHhCC---------C---C
Confidence 2345689999999999999999999999999999999999999975322 1111 11111100 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPT-----MNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~~ 339 (387)
.+...+..+.+++.+||+.||++||+ ++++++.
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11233457889999999999999995 5777653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=308.18 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=187.6
Q ss_pred ccchhhHHHHhcCCCCC-CcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCCceeeeee
Q 041766 78 LFSFSSVSTATNKFSDA-NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKV-QHKNLVRLLG 152 (387)
Q Consensus 78 ~~~~~~~~~~~~~~~~~-~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~ 152 (387)
...+...+.+.++|.+. +.||+|+||.||+|+... ++.||+|.+... .......+.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34556677788888887 889999999999999875 889999998643 334467889999999999 5799999999
Q ss_pred eEEeCCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC---CCCeEEe
Q 041766 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK---DINPKIS 211 (387)
Q Consensus 153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~ 211 (387)
++.+.+..++||||+++|+|..++..... ...+|..+++|+||||+|||++. ++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999999988854321 12467788899999999999988 7899999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 291 (387)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ......
T Consensus 177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~---~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETY---LNISQV 248 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHT
T ss_pred eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHH---HHHHhc
Confidence 999998764332 223457899999999999999999999999999999999999997532211 110 000000
Q ss_pred CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 292 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. . . .. .......+..+.+++.+||+.||++|||++++++.
T Consensus 249 ~-~-~-----~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N-V-D-----YS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-C-C-----CC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-c-c-----cC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 0 0 00 00112234568899999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=318.53 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=173.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCC--c
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKD--E 159 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~--~ 159 (387)
...++|++.+.||+|+||.||+|.+.. ++.||||++... .......+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 445789999999999999999999765 889999998643 3345567889999999996 999999999998654 6
Q ss_pred eEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC-
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE- 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 223 (387)
.|+|||||+ ++|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 899999997 578777654211 135788889999999999999999999999999998653211
Q ss_pred ------------------cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHH
Q 041766 224 ------------------LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGY 284 (387)
Q Consensus 224 ------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~ 284 (387)
........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~ 242 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST--MNQLER 242 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence 0111234579999999999986 6789999999999999999999999854321 111111
Q ss_pred HHHHhhcCcccc-----------cc----------ccccccc-----------cccHHHHHHHHHHHHhcccCCCCCCCC
Q 041766 285 AWDLWTSNRTLE-----------LI----------DPILEDE-----------YSSKHMLLRYVNIALLCVQESADDRPT 332 (387)
Q Consensus 285 ~~~~~~~~~~~~-----------~~----------~~~~~~~-----------~~~~~~~~~~~~li~~cl~~dP~~RPt 332 (387)
............ .+ ....... ......+..+.+|+.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 111111000000 00 0000000 000122457889999999999999999
Q ss_pred HHHHHHH
Q 041766 333 MNEVVSM 339 (387)
Q Consensus 333 ~~~v~~~ 339 (387)
++|+++.
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.63 Aligned_cols=235 Identities=23% Similarity=0.283 Sum_probs=176.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcC--CCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.+|.+.+.||+|+||.||++....++.||||.+... .......+.+|+.+|.+++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468999999999999999999888999999998643 3345578899999999996 599999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
| +.+++|.+++..... ..++|..+++||||||+|||++ ++.+||+|||+++...........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccC
Confidence 9 568899888764322 1247778889999999999996 578999999999876543322223
Q ss_pred ccccCCCcccccccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 229 SRIVGTYGYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..............
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~~~~~~~~~~- 288 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDPNHEIE- 288 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHCTTSCCC-
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHHHhCccccCC-
Confidence 45679999999999865 368999999999999999999999985332111 11111111110000
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+......+.+|+.+||+.||++|||+.|+++.
T Consensus 289 ---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 289 ---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011113468899999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=305.68 Aligned_cols=236 Identities=22% Similarity=0.231 Sum_probs=185.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc------ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
..++|.+.+.||+|+||.||+|+... +..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34678899999999999999999875 88999999864321 236789999999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC----CeEEeeccCceec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI----NPKISDFGMARIC 219 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~ 219 (387)
.++||||+++++|.+++..... ...+|..+++|+||||+|||++.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999998865432 1247788889999999999999887 7999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||...... . ....... ... ...
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~i~~-~~~--~~~ 238 (321)
T 2a2a_A 170 EDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--E---TLANITS-VSY--DFD 238 (321)
T ss_dssp CTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--H---HHHHHHT-TCC--CCC
T ss_pred Cccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--H---HHHHHHh-ccc--ccC
Confidence 5432 223457899999999999999999999999999999999999997532211 1 1111100 000 000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+. .....+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 239 EE-----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HH-----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hh-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 01123456889999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=304.58 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=179.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+|++.. ++.||+|++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 678899999999999999999875 88999998865432 334678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ...
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccC
Confidence 9999999887654322 1247778889999999999999999999999999987653321 223
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH-----------hhcCccccc
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL-----------WTSNRTLEL 297 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 297 (387)
...||..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........ +........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD--QLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhccccccccccccccccccc
Confidence 4578999999999976 668999999999999999999999985433211 11111110 000000000
Q ss_pred cc-ccccc----ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 ID-PILED----EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~-~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. +.... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000 00012234568899999999999999999999973
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=322.82 Aligned_cols=247 Identities=19% Similarity=0.201 Sum_probs=176.5
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC-----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----- 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----- 158 (387)
..++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 34789999999999999999999765 788999999643 3344567889999999999999999999997653
Q ss_pred -ceEEEEEecCCCCcchhhcCCc-c-------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 -EKILIYEYMPNKSLDFFLFDPT-K-------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 -~~~lv~e~~~~g~L~~~l~~~~-~-------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+||||++++ |...+.... . ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred CeEEEEEeCCCCC-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 469999999775 444443211 1 135788889999999999999999999999999998764322
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc----------
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR---------- 293 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 293 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ..............
T Consensus 219 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~~~i~~~lg~p~~~~~~~~~~~ 293 (464)
T 3ttj_A 219 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMKKLQPT 293 (464)
T ss_dssp ---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred ---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHHcchh
Confidence 233468899999999999999999999999999999999999998543211 11111111000000
Q ss_pred ---------c-c-----ccccccc-cc-ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 294 ---------T-L-----ELIDPIL-ED-EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 294 ---------~-~-----~~~~~~~-~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. . ..+.... .. ..........+.+|+.+||+.||++|||++|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 0000000 00 00112235678999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.53 Aligned_cols=243 Identities=19% Similarity=0.200 Sum_probs=184.3
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD 158 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~ 158 (387)
+.....++|++.+.||+|+||.||+++.+. ++.||+|++... .......+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 334456789999999999999999999864 899999998642 1122345788999999999999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGG 221 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 221 (387)
..|+||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 99999999999999998864321 1247788899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccccccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAI-------QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||..... ..... .......
T Consensus 215 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~---~i~~~~~- 287 (412)
T 2vd5_A 215 DGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AETYG---KIVHYKE- 287 (412)
T ss_dssp TSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHH---HHHTHHH-
T ss_pred CCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHHHH---HHHhccc-
Confidence 322 1223468999999999997 35689999999999999999999999853221 11111 1000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHH
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR---PTMNEVVSM 339 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~~v~~~ 339 (387)
...........+..+.+|+.+||+ +|++| |+++|+++.
T Consensus 288 ------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 288 ------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000000112235678899999999 99998 589999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.35 Aligned_cols=228 Identities=21% Similarity=0.302 Sum_probs=182.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc--------ccHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
...++|++.+.||+|+||.||+|+... ++.||||.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456789999999999999999999765 78899999865421 123456789999999999999999999999
Q ss_pred CCceEEEEEecCCC-CcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 157 KDEKILIYEYMPNK-SLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 157 ~~~~~lv~e~~~~g-~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
.+..++||||+.+| +|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999777 88888765432 12477788899999999999999999999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
..... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 181 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------------~~ 237 (335)
T 3dls_A 181 ERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------------TV 237 (335)
T ss_dssp CTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------GT
T ss_pred CCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------HH
Confidence 54322 234578999999999988877 8899999999999999999999742110 00
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 EAAIH---PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hhccC---CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 111134568899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=316.68 Aligned_cols=247 Identities=17% Similarity=0.235 Sum_probs=187.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|++.. ++.||||++...... ..+..|++++..++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999754 889999988654332 357889999999976 566666677777888899999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCCCcc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|+ +++|.+++..... ..++|..+++||||||+|||| +.++.+||+|||+++........
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99 9999988863222 125788889999999999999 68899999999999876543321
Q ss_pred -----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch-HhHHHHHHhhcCccccccc
Q 041766 226 -----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT-LLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 226 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 299 (387)
.......||..|+|||++.+..++.++|||||||++|||++|+.||......... ........ .....+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~~~~~~ 238 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KVATSIE 238 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HHHSCHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cccccHH
Confidence 1223568999999999999999999999999999999999999998654332211 11111000 0000000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
. ....++..+.+++..||+.||++||++.+|++.|+++....
T Consensus 239 ~------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 239 A------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp H------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0 01122457899999999999999999999999999886543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=302.20 Aligned_cols=247 Identities=22% Similarity=0.293 Sum_probs=178.3
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-----CcccHHHHHHHHHHHHhc---CCCceeeeeeeEEe
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-----SGQGLREMKNEASVIAKV---QHKNLVRLLGCCID 156 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~ 156 (387)
...++|++.+.||+|+||.||+|++.. ++.||+|.+... .......+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 345789999999999999999999754 889999998522 122234667788887776 49999999999987
Q ss_pred CC-----ceEEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcCCCCeEEeec
Q 041766 157 KD-----EKILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDKDINPKISDF 213 (387)
Q Consensus 157 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Df 213 (387)
.. ..++||||+. ++|..++...... .++|..+++|+||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 65 4789999997 5888887654321 2477888899999999999999999999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 165 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 165 GLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLPP 239 (308)
T ss_dssp SCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred ccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence 9997654322 234457899999999999999999999999999999999999998543221 11111111111100
Q ss_pred ccc---cc---ccccccc-c-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 TLE---LI---DPILEDE-Y-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ~~~---~~---~~~~~~~-~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... .. ....... . ........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 00 0000000 0 01123457889999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.28 Aligned_cols=241 Identities=25% Similarity=0.346 Sum_probs=183.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
..++|.+.+.||+|+||.||+|++.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34678889999999999999998653 235999999754 33455788999999999999999999999865 4568
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++........
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 99999999999988854321 1247778889999999999999999999999999986543322
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ....
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~----~~~~-------- 233 (281)
T 3cc6_A 169 Y-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEK----GDRL-------- 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHH----TCCC--------
T ss_pred c-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhc----CCCC--------
Confidence 1 1233456788999999998999999999999999999998 999975432221 1111111 0000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0112234568899999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=313.75 Aligned_cols=231 Identities=26% Similarity=0.395 Sum_probs=178.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..+.|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3456888899999999999999975 48889999986432 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||+. |+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++....
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 999997 566666532111 1247778889999999999999999999999999976532
Q ss_pred cccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ............ +..
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~------~~~ 273 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES------PAL 273 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC------CCC
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC------CCC
Confidence 23457899999999985 56789999999999999999999999743221 111111111110 111
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.....+..+.+++.+||+.||++|||++++++.
T Consensus 274 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 ----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112234568899999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=317.99 Aligned_cols=232 Identities=21% Similarity=0.222 Sum_probs=172.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHH-HHhcCCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|+.+. +..||+|++.... ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3678999999999999999999876 7889999986432 2233456677776 466899999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++...... .
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~ 194 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--S 194 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--C
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--C
Confidence 9999999999888754221 125788889999999999999999999999999997543221 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||..... .. ......... ..
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~---~~~~i~~~~---------~~--- 257 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AE---MYDNILNKP---------LQ--- 257 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HH---HHHHHHHSC---------CC---
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HH---HHHHHHhcc---------cC---
Confidence 23456899999999999999999999999999999999999999753211 11 111111110 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...+..+.+|+.+||+.||++||++.+.++
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 11123456889999999999999999854333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=309.84 Aligned_cols=233 Identities=16% Similarity=0.176 Sum_probs=172.2
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe----CCce
Q 041766 88 TNKFSDA-NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDEK 160 (387)
Q Consensus 88 ~~~~~~~-~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~----~~~~ 160 (387)
.++|.+. +.||+|+||.||++.+.. ++.||||++... ..+.+|+.++.++ +||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3556665 689999999999999875 889999999632 4677889888554 89999999999875 4568
Q ss_pred EEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC---CCCeEEeeccCceec
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARIC 219 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 219 (387)
|+|||||++|+|.+++..... ..++|..+++||||||+|||++. ++.+||+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 999999999999998876432 12578888999999999999987 789999999999875
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch--HhHHHHHHhhcCccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT--LLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 297 (387)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ....... ... ..
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~-~~ 286 (400)
T 1nxk_A 215 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY-EF 286 (400)
T ss_dssp C--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC-CC
T ss_pred CCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc-cC
Confidence 4322 233467899999999999999999999999999999999999998644322110 1111000 000 00
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .......+..+.+|+.+||+.||++|||+.++++.
T Consensus 287 -----~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -----P-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----C-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----C-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00112234578899999999999999999999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=306.41 Aligned_cols=232 Identities=21% Similarity=0.210 Sum_probs=159.5
Q ss_pred CCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEEecCCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKS 171 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 171 (387)
.+.||+|+||.||+|.+.. ++.||||.+.. .....+.+|+.++..+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 4789999999999999875 88999999864 23467789999999996 9999999999999999999999999999
Q ss_pred cchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC---CeEEeeccCceecCCCCccccccccc
Q 041766 172 LDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI---NPKISDFGMARICGGNELQANTSRIV 232 (387)
Q Consensus 172 L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~ 232 (387)
|.+++..... ..++|..+++|+||||+|||++.++ .+||+|||+++...... .......
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~ 170 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPC 170 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccC
Confidence 9888865322 1257888899999999999997765 79999999998654322 1223457
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--chHhHHHHHHhhcCccccccccccccccccHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS--LTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
||..|+|||++.+..++.++|||||||++|||++|..||....... ......... ...... ... ......
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~------~~~-~~~~~~ 242 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDF------SFE-GEAWKN 242 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCC------CCC-SHHHHT
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCC------CCC-cccccC
Confidence 8999999999999999999999999999999999999986433211 000111111 000000 000 001123
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+..+.+|+.+||+.||++|||+.++++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 4567889999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=299.87 Aligned_cols=232 Identities=22% Similarity=0.360 Sum_probs=163.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357889999999999999999975 4889999998532 122346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++++|..++...... ..+|..+++|+||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999888654221 247778889999999999999999999999999987643221
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ .
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~---~ 230 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------------NKVVLADY---E 230 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCC---C
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------------HHHhhccc---C
Confidence 122357899999999999989999999999999999999999997543221100 00000000 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11223457889999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=325.73 Aligned_cols=233 Identities=22% Similarity=0.248 Sum_probs=173.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+|+... ++.||||.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4678899999999999999999765 889999998632 233445678899999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccch-hhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDW-SANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~-~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|||+++|+|..++..... ..++|. .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--c
Confidence 999999999887754221 124676 779999999999999999999999999997543222 2
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .... ....... . .
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~---~~i~~~~---------~---~ 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLF---ELILMEE---------I---R 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHCC---------C---C
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHH---HHHHhCC---------C---C
Confidence 23446899999999999999999999999999999999999999743221 1111 1111000 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
.+...+..+.+|+.+||+.||++|| |++|+++.
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1122345788999999999999999 99999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=300.86 Aligned_cols=236 Identities=22% Similarity=0.287 Sum_probs=183.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
..++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999875 889999998543 334456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCceecCCCCc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMARICGGNEL 224 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~~~ 224 (387)
|||+++++|...+..... ...+|..+++|+||||+||+++.++. +||+|||++.......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 999999999776643221 12577888999999999999976655 9999999998765332
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ....... ..... ....+
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~----~~~~~-~~~~~---- 229 (284)
T 3kk8_A 163 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQI----KAGAY-DYPSP---- 229 (284)
T ss_dssp --BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCC-CCCTT----
T ss_pred --cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHH----Hhccc-cCCch----
Confidence 22345789999999999999999999999999999999999999743221 1111111 00000 00000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 --EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11123456889999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=308.93 Aligned_cols=251 Identities=23% Similarity=0.358 Sum_probs=189.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEE-----cCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC--ce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD--EK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~--~~ 160 (387)
.++|++.+.||+|+||.||++++ ..++.||+|.+........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999985 247889999998766666778999999999999999999999987654 68
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++++|.+++...... ..+|..+++|+||||+|||++.++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999988654321 24677888999999999999999999999999998765432
Q ss_pred cc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--------c
Q 041766 224 LQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--------T 294 (387)
Q Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 294 (387)
.. .......++..|+|||++.+..++.++||||||+++|||++|..|+..... .+. ....... .
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFM-RMIGNDKQGQMIVFHL 272 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH------HHH-HHHCTTCCTHHHHHHH
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH------HHH-HhhccccchhhhHHHH
Confidence 21 112334567789999999988899999999999999999999988642100 000 0000000 0
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.+.+..... ...+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 273 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000000 011233456789999999999999999999999999988654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.15 Aligned_cols=240 Identities=26% Similarity=0.339 Sum_probs=184.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCE--EEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDE--IAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|++.. +.. ||+|.+... .......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 678889999999999999999764 544 599988643 333456788999999999 999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
|||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 999999999998865430 124677888999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||+++.... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... ... ....
T Consensus 185 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~-~~~~ 255 (327)
T 1fvr_A 185 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY-EKLP 255 (327)
T ss_dssp CTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH-HHGG
T ss_pred ccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHH-HHhh
Confidence 9999874321 112233456789999999998889999999999999999998 99997432211 111 1111
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
... .. ..+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 256 ~~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 QGY-----RL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GTC-----CC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cCC-----CC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 100 00 011223457889999999999999999999999999988754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=307.57 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=185.3
Q ss_pred hcCCCCCC-cccccCCeeEEEEEEc---CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 88 TNKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 88 ~~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
.++|.+.+ .||+|+||.||+|.+. .+..||||.+.... ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 8999999999999653 25789999997542 23356889999999999999999999999 566789
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999999988865321 12477788899999999999999999999999999876543322
Q ss_pred -cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .........
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~~~~-------- 239 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGERM-------- 239 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCCC--------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcCCCC--------
Confidence 12223456788999999998889999999999999999999 99997542211 111 111111100
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
..+..++..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 012233557889999999999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=297.54 Aligned_cols=234 Identities=24% Similarity=0.340 Sum_probs=178.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+.|.....||+|+||.||+|.... +..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345556699999999999999764 7899999998766666678999999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecCCCCcccc
Q 041766 168 PNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 168 ~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
++++|.+++..... ...+|..+++|+||||+|||++. ++.+||+|||++....... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Cc
Confidence 99999988864321 12467778899999999999987 8999999999998764322 12
Q ss_pred cccccCCCccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....|+..|+|||++.+.. ++.++||||||+++|||++|+.||......... ....... . ..+.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~-~-----~~~~---- 246 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMF-K-----VHPE---- 246 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHH-C-----CCCC----
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccc-c-----cccc----
Confidence 23457899999999997654 889999999999999999999997432211110 0000000 0 0000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 247 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 -IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12223457889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=304.24 Aligned_cols=245 Identities=16% Similarity=0.170 Sum_probs=179.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|.+.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4789999999999999999999764 7889999986432 22346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++........ ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-cc
Confidence 999999999988864221 1247778889999999999999999999999999976543321 12
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...... ........... .....
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~--------~~~~~ 257 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIP--------RPSTV 257 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCC--------CGGGT
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCC--------Ccccc
Confidence 23457899999999999999999999999999999999999997532211 11111111000 00001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhhhhhcc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRP-TMNEVVSMLTDEAAAL 347 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RP-t~~~v~~~L~~~~~~~ 347 (387)
....+..+.+++.+||+.||++|| |++++++.|+......
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 222345688999999999999999 9999999999887654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.49 Aligned_cols=243 Identities=15% Similarity=0.229 Sum_probs=182.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEe--CCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--KDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~--~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||+|.+... ....+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 678999999999999999999754 889999999643 3467889999999996 9999999999988 56789999
Q ss_pred EecCCCCcchhhcCCcc-------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCccccccc
Q 041766 165 EYMPNKSLDFFLFDPTK-------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
||+++++|..++..... ...+|..+++|+||||+|||++.++ .+||+|||+++...... ....
T Consensus 113 e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 189 (330)
T 3nsz_A 113 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 189 (330)
T ss_dssp ECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCS
T ss_pred eccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---cccc
Confidence 99999999888754332 1357888899999999999999776 89999999998765332 2234
Q ss_pred ccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH--------hhcCc--------
Q 041766 231 IVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL--------WTSNR-------- 293 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~-------- 293 (387)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+....... .....
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 578999999999987 6689999999999999999999999854433222211111100 00000
Q ss_pred ------cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 ------TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.......... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 270 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 270 DILGRHSRKRWERFVH-SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHCCCCCCCGGGGCC-TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhccccchhhhcc-ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0011224567899999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=308.78 Aligned_cols=242 Identities=29% Similarity=0.385 Sum_probs=184.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|.+.+.||+|+||.||+|++. .+..||||.+... .......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999842 3678999999644 334556788999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------------ccccchhhhhhcccCCCceEEcC---CCCeEEeecc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------------RMLLDWSANYSSRLKVSNILLDK---DINPKISDFG 214 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg 214 (387)
++||||+++++|.+++..... ...+|..+++|+||||+|||++. +..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 999999999999998865321 12467788899999999999984 4569999999
Q ss_pred CceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
++................+|+.|+|||++.+..++.++||||||+++|||++ |..||..... ....... ....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~----~~~~ 262 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV----TSGG 262 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH----HTTC
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHH----hcCC
Confidence 9976543333333344567899999999999999999999999999999998 8888743221 1111111 1110
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.. .....++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 263 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00 0112234578899999999999999999999999998865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.48 Aligned_cols=236 Identities=24% Similarity=0.302 Sum_probs=186.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|...+.||+|+||.||+|+... |+.||+|++... .......+.+|+.+|.+++|||||++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 4668889999999999999999874 899999998532 123346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 164 YEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 999999999988865432 1247888899999999999999999999999999987653321
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ............ .
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~~-------~----- 406 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVP-------E----- 406 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHCC-------C-----
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhccc-------c-----
Confidence 2335899999999999998999999999999999999999999864332211 111111100000 0
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
..+...+..+.+|+.+||+.||++|| +++|+++.
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01122345788999999999999999 78888863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.74 Aligned_cols=240 Identities=12% Similarity=0.077 Sum_probs=187.2
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEE------EcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CCceeeeeeeE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGV------LKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCC 154 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~ 154 (387)
+....++|.+.+.||+|+||.||+|. ...++.||+|++... ....+..|.+++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34445778999999999999999994 334788999999754 3457788888888886 99999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCC----cc-----------------ccccchhhhhhcccCCCceEEcC---------
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDP----TK-----------------RMLLDWSANYSSRLKVSNILLDK--------- 204 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~-----------------~~~l~~~~~~h~dlk~~Nill~~--------- 204 (387)
...+..|+|||||++|+|.+++... .. ..++|..+++||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999988531 11 12578888999999999999998
Q ss_pred --CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh
Q 041766 205 --DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282 (387)
Q Consensus 205 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~ 282 (387)
++.+||+|||+|+..............+||..|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----- 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----- 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence 8999999999998654322223344568999999999999999999999999999999999999997321110
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHhhhhhhcc
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDR-PTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Pt~~~v~~~L~~~~~~~ 347 (387)
...+...+.... ....+.+++..|++.+|.+| |++.++.+.|++.....
T Consensus 292 ------------~~~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 ------------ECKPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------EEEECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------ceeechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 111111111111 13456689999999999999 68888889898887654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.89 Aligned_cols=237 Identities=19% Similarity=0.180 Sum_probs=181.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..++|++.+.||+|+||.||+|..+. ++.||+|.+...... ..+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45789999999999999999999875 788999999754332 34688889888 7999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC----CCeEEeeccCceecCCCCc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD----INPKISDFGMARICGGNEL 224 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~----~~~kl~Dfg~a~~~~~~~~ 224 (387)
|||++|+|.+++..... ..++|..+++||||||+|||+.++ +.+||+|||+++.......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99999999888765432 125788889999999999998543 3599999999987643321
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ ....... ...... ...
T Consensus 176 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~i-~~~~~~------~~~ 244 (342)
T 2qr7_A 176 --LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARI-GSGKFS------LSG 244 (342)
T ss_dssp --CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH--HHHHHHH-HHCCCC------CCS
T ss_pred --ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH--HHHHHHH-ccCCcc------cCc
Confidence 23346789999999999988899999999999999999999999864322211 1111111 111000 000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .....+..+.+|+.+||+.||++|||+.++++.
T Consensus 245 ~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 245 G-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp T-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 112234578899999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=306.54 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=179.2
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||.||+|+... ++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 678899999999999999999876 8899999985442 2334567899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
|+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++....... ...
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 182 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYD 182 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccC
Confidence 9999988877643322 1247788889999999999999999999999999976543221 223
Q ss_pred cccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHH----------HHHhhcCcc-ccc
Q 041766 230 RIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYA----------WDLWTSNRT-LEL 297 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~----------~~~~~~~~~-~~~ 297 (387)
...||..|+|||++.+. .++.++|||||||++|||++|+.||........ ..... ...+..... ...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhccccccc
Confidence 45789999999999875 689999999999999999999999854332111 11000 000000000 000
Q ss_pred ccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+...... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000010000 11234567899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.29 Aligned_cols=239 Identities=19% Similarity=0.260 Sum_probs=173.5
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--------cccHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCI 155 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 155 (387)
....++|.+.+.||+|+||.||+|.... ++.||||.+.... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456889999999999999999999775 7899999985321 112235789999999999999999999975
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC---CCeEEeeccCc
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD---INPKISDFGMA 216 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a 216 (387)
.+..++||||+++|+|.+++..... ..++|..+++||||||+|||++.+ +.+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4557999999999999888765432 125788889999999999999654 45999999999
Q ss_pred eecCCCCcccccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
+...... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||......... ..... ...
T Consensus 290 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~i~----~~~ 361 (419)
T 3i6u_A 290 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-KDQIT----SGK 361 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-HHHHH----TTC
T ss_pred eecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-HHHHh----cCC
Confidence 8754322 2334679999999999863 56899999999999999999999998643322211 11110 000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 362 ~-~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 362 Y-NFIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp C-CCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C-CCCc------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000 0011234578899999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=298.36 Aligned_cols=234 Identities=23% Similarity=0.338 Sum_probs=184.1
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--------
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-------- 156 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------- 156 (387)
...++|+..+.||+|+||.||+|++. +++.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34567899999999999999999987 58999999997543 356789999999999999999998864
Q ss_pred --------CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEE
Q 041766 157 --------KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKI 210 (387)
Q Consensus 157 --------~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl 210 (387)
....++||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 3347899999999999998854311 12467788899999999999999999999
Q ss_pred eeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 211 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 211 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|..|+.. .... .....
T Consensus 164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~-~~~~~ 232 (284)
T 2a19_B 164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-------TSKF-FTDLR 232 (284)
T ss_dssp CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHH-HHHHH
T ss_pred Ccchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHH-HHHhh
Confidence 9999998765432 12335789999999999999999999999999999999999988421 0000 11111
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. .. ....+..+.+++.+||+.||++|||+.++++.|+......
T Consensus 233 ~~--------~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 233 DG--------II-----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp TT--------CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred cc--------cc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 10 01 1122346789999999999999999999999999886543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=311.59 Aligned_cols=248 Identities=24% Similarity=0.304 Sum_probs=183.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||.||+|.+.. +..||+|.+... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4678899999999999999999874 889999998754 33445678999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++++|.+++..... ...+|.. +++|+||||+|||++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~ 187 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 187 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C-
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cc
Confidence 9999999988854321 1245664 7899999999999999999999999998654211 22
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHH----------H-------------
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGY----------A------------- 285 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~----------~------------- 285 (387)
....||..|+|||++.+..++.++|||||||++|||++|+.||............. .
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 34578999999999999999999999999999999999999986433211100000 0
Q ss_pred -HHHhhcCccccccccccc---cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 286 -WDLWTSNRTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 286 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..........+.++.... ........+..+.+++.+||+.||++|||++++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000000000 000112234578899999999999999999999973
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=313.59 Aligned_cols=179 Identities=22% Similarity=0.355 Sum_probs=135.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 159 (387)
.++|++.+.||+|+||.||+|++.. ++.||||++... .......+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999774 889999998643 334456788999999999999999999998543 46
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+||||+ +++|..++..... ..++|..+++||||||+||||+.++.+||+|||+|+......
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999998 4688777765421 135788899999999999999999999999999998764221
Q ss_pred cc-------------------------cccccccCCCcccccccc-ccCCCCccccchhHHHHHHHHHhC
Q 041766 224 LQ-------------------------ANTSRIVGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEIVSG 267 (387)
Q Consensus 224 ~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwS~Gvil~el~tg 267 (387)
.. ......+||+.|+|||++ .+..|+.++|||||||++|||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 10 122345789999999986 456799999999999999999994
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=299.71 Aligned_cols=235 Identities=25% Similarity=0.341 Sum_probs=179.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||++.+. ++.||+|.+.... ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999886 8899999997543 457889999999999999999999997654 478999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----c
Confidence 999999988864321 12467788899999999999999999999999998754322 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .. ..... .. ..
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~---~~-~~~~~-----~~-----~~ 235 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV---PR-VEKGY-----KM-----DA 235 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH---HH-HTTTC-----CC-----CC
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HH-HhcCC-----CC-----CC
Confidence 23357889999999999999999999999999999998 99987543211 111 11 10000 00 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 223355788999999999999999999999999988653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=332.03 Aligned_cols=236 Identities=25% Similarity=0.321 Sum_probs=178.9
Q ss_pred CcccccCCeeEEEEEEc---CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLK---KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.+|.+++|||||+++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 36999999999999764 2568999999653 23446789999999999999999999999964 557899999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc-cccccccc
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL-QANTSRIV 232 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~ 232 (387)
|+|.+++..... ..++|..+++||||||+||||+.++.+||+|||+++....... ........
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 999998864321 1257888899999999999999999999999999987643321 12223345
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
+|..|+|||++.+..++.++|||||||++|||++ |+.||...... ... ........ ...+..+
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~----~~i~~~~~----------~~~p~~~ 597 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGER----------MGCPAGC 597 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCC----------CCCCTTC
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCC----------CCCCCCC
Confidence 6788999999999999999999999999999998 99997532211 111 11111100 0112234
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
+..+.+|+.+||+.||++|||+++|++.|++...++
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 567899999999999999999999999999876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=302.78 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=177.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-----ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
..++|++.+.||+|+||.||+|++.. ++.||||.+..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45789999999999999999999765 88999999864321 1124678999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++ +|..++..... ..++|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999986 77777654322 124788889999999999999999999999999998654322
Q ss_pred cccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc---cc--
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL---EL-- 297 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 297 (387)
.......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ................. ..
T Consensus 167 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 167 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred --ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCChhhhhhhcc
Confidence 122345789999999999764 589999999999999999999988753321 11111111111111000 00
Q ss_pred -cccc----cccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 -IDPI----LEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 -~~~~----~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+.. .... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000 0012234678999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=305.86 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=177.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc-cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|.+.+.||+|+||.||+|+... ++.||+|.+...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 568889999999999999999874 889999998643221 112445799999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
+++ +|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccc
Confidence 974 77776654322 124777888999999999999999999999999998654222 1223
Q ss_pred cccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc---ccccc------
Q 041766 230 RIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT---LELID------ 299 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------ 299 (387)
...||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ................ .....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV--EEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 3578999999999976 5689999999999999999999999854322 1111112111111100 00000
Q ss_pred ---cccccc---cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhhh
Q 041766 300 ---PILEDE---YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEAA 345 (387)
Q Consensus 300 ---~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~~ 345 (387)
+..... .........+.+|+.+||+.||++|||++|+++ .+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 000000 001123457889999999999999999999997 4555544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=301.63 Aligned_cols=235 Identities=20% Similarity=0.242 Sum_probs=181.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|.+.+.||+|+||.||+++... ++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 44678899999999999999999864 88999999976544445678899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCCCccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
|+++++|.+++..... ...+|..+++|+||||+|||+ +.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----
Confidence 9999999887753221 124778888999999999999 78899999999998754322
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......||..|+|||++.+..++.++||||||+++|||++|..||..... ....... ..... .. . ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i----~~~~~-~~-----~-~~ 229 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKI----KEGYY-EF-----E-SP 229 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHH----HHCCC-CC-----C-TT
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH----HcCCC-CC-----C-cc
Confidence 12335689999999999999999999999999999999999999753221 1111111 11000 00 0 00
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223457889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.27 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=182.5
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~ 159 (387)
...+...++|++.+.||+|+||.||+|.++. .||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 4444556889999999999999999999863 4999998643 22334567789999999999999999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
.++||||+++++|.+++...... ..+|..+++|+||||+|||++ ++.+||+|||+++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999998764321 247778889999999999998 679999999998754321
Q ss_pred C---cccccccccCCCcccccccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 223 E---LQANTSRIVGTYGYMSPEYAIQ---------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 223 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
. .........|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... ...+....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGT 257 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHHT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcc
Confidence 1 1112233468899999999874 45789999999999999999999997533211 11111111
Q ss_pred cCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 291 SNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
... +.. .....+..+.+++.+||+.||++|||+.++++.|+++.........|...|.
T Consensus 258 -~~~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 258 -GMK-----PNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp -TCC-----CCC----CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred -CCC-----CCC----CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 100 101 0111234678999999999999999999999999999877666665555543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=303.09 Aligned_cols=236 Identities=19% Similarity=0.361 Sum_probs=178.8
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
..++|++.+.||+|+||.||+|++.. +..||+|.+........+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999875 88999999976666677889999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+++++|..++..... ...+|..+++|+||||+|||++.++.+||+|||++...... ....
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 174 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKR 174 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cccc
Confidence 9999999887754211 12477788899999999999999999999999987532111 1112
Q ss_pred ccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
....||..|+|||++. +..++.++||||||+++|||++|..||...... ............ .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~------- 241 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDPP-T------- 241 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCC-C-------
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCCc-c-------
Confidence 3357899999999984 567899999999999999999999997543211 111111111100 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112233457889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.30 Aligned_cols=234 Identities=21% Similarity=0.378 Sum_probs=186.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.+.|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 4678889999999999999999764 8899999986443 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 166 YMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++........ ....
T Consensus 101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNT 178 (303)
T ss_dssp CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCC
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCc
Confidence 9999999988865321 1247778889999999999999999999999999987654321 2234
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
..|+..|+|||++.+..++.++||||||+++|||++|+.||..... .. ..... ..... +.. ...
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~-~~~~~-----~~~-----~~~ 242 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MK---VLFLI-PKNNP-----PTL-----EGN 242 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH---HHHHH-HHSCC-----CCC-----CSS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HH---HHHHh-hcCCC-----CCC-----ccc
Confidence 5789999999999999999999999999999999999999753221 11 11110 00100 011 112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+..+.+++.+||+.||++|||+.++++.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 24468899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=300.13 Aligned_cols=231 Identities=23% Similarity=0.281 Sum_probs=179.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|++.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3678899999999999999999776 678999998532 122346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+++|+|..++..... ...+|..+++|+||||+|||++.++.+||+|||++...... .
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----R 163 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc----c
Confidence 999999999887754221 12477888899999999999999999999999988654322 1
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||...... . ......... . ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~~-------~-----~~ 226 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--E---TYKRISRVE-------F-----TF 226 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHHTC-------C-----CC
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--H---HHHHHHhCC-------C-----CC
Confidence 23457899999999999999999999999999999999999997532211 1 111100000 0 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11234567899999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.22 Aligned_cols=236 Identities=22% Similarity=0.322 Sum_probs=184.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|...+.||+|+||.||+|++.. |+.||+|++... .......+..|+.+|.+++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678888999999999999999875 899999998532 123346788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||+++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+++......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999999999888865321 124777888999999999999999999999999998765332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... ............. .
T Consensus 344 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i~~~~---------~- 410 (543)
T 3c4z_A 344 T--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRVLEQA---------V- 410 (543)
T ss_dssp C--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHHHHCC---------C-
T ss_pred c--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHHhhcc---------c-
Confidence 1 2234589999999999999999999999999999999999999986433211 1111111111100 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTM-----NEVVS 338 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~~v~~ 338 (387)
..+...+..+.+++.+||+.||++||++ +++++
T Consensus 411 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 --TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0112335578899999999999999975 66664
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=299.21 Aligned_cols=234 Identities=20% Similarity=0.272 Sum_probs=176.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..++|.+.+.||+|+||.||++.... +..||+|.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 34678899999999999999999765 889999998643 3345678999999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCc-------c-------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCC
Q 041766 165 EYMPNKSLDFFLFDPT-------K-------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGG 221 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~-------~-------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 221 (387)
||+++|+|.+++.... . ...+|..+++|+||||+|||+ +.++.+||+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9999999988774321 0 124777888999999999999 4567899999999976543
Q ss_pred CCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.. ......||..|+|||++. ..++.++||||||+++|||++|+.||...... ...............
T Consensus 180 ~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~~~~~---- 246 (285)
T 3is5_A 180 DE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKATYKEPNYAV---- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCCC----
T ss_pred cc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhhccCCccccc----
Confidence 22 223457899999999885 56899999999999999999999997532211 111111000000000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 247 -----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 -----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00112356789999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.20 Aligned_cols=183 Identities=22% Similarity=0.353 Sum_probs=147.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 159 (387)
.++|.+.+.||+|+||.||+|++.. ++.||||++... .......+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999776 778999999653 334456888999999999999999999999876 56
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+||||++ |+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 899999996 588888765432 125788889999999999999999999999999998764332
Q ss_pred cc--------------------cccccccCCCcccccccc-ccCCCCccccchhHHHHHHHHHhCCCCC
Q 041766 224 LQ--------------------ANTSRIVGTYGYMSPEYA-IQGIFSIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 224 ~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
.. ......+||+.|+|||++ .+..|+.++|||||||++|||++|..|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 11 112456889999999986 4566999999999999999999865554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.10 Aligned_cols=228 Identities=13% Similarity=0.140 Sum_probs=172.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccC---CCcccHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPG---RSGQGLREMKNEA---SVIAKVQHKNLVRLL-------GC 153 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~nIv~~~-------~~ 153 (387)
.++|.+.+.||+|+||.||+|++. +++.||||++.. ......+.+.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999975 489999999863 2334567888999 555566899999998 55
Q ss_pred EEeCC-----------------ceEEEEEecCCCCcchhhcCCc---c--------------------ccccchhhhhhc
Q 041766 154 CIDKD-----------------EKILIYEYMPNKSLDFFLFDPT---K--------------------RMLLDWSANYSS 193 (387)
Q Consensus 154 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~---~--------------------~~~l~~~~~~h~ 193 (387)
+.+.+ ..|+||||+ +|+|.+++.... . ..++|..+++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 278999999 679988886421 0 124677888999
Q ss_pred ccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccC-----------CCCccccchhHHHHHH
Q 041766 194 RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-----------IFSIKSDVFSFGVLLL 262 (387)
Q Consensus 194 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwS~Gvil~ 262 (387)
||||+|||++.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999986432 2234567 999999999887 8999999999999999
Q ss_pred HHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hh
Q 041766 263 EIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--ML 340 (387)
Q Consensus 263 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L 340 (387)
||++|+.||....... ........ ....+..+.+++.+||+.||++|||+.++++ .+
T Consensus 305 elltg~~Pf~~~~~~~------------------~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALG------------------GSEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------C------------------CSGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCccccccc------------------chhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 9999999974322111 11111110 0122457889999999999999999999986 34
Q ss_pred hhh
Q 041766 341 TDE 343 (387)
Q Consensus 341 ~~~ 343 (387)
+++
T Consensus 364 ~~~ 366 (377)
T 3byv_A 364 EQL 366 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.43 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=177.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC--CC--EEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK--GD--EIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|++.+.||+|+||.||+|++.. +. .||+|.+... .....+.+.+|+.++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3678899999999999999998643 33 5899988643 2345578899999999999999999999998755 7
Q ss_pred EEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 899999999999888764321 124777888999999999999999999999999998765433
Q ss_pred cc-cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 LQ-ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.. .......+|..|+|||++.+..++.++||||||+++|||++ |+.||...... ............
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~------- 243 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGER------- 243 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCC-------
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCC-------
Confidence 22 12233467788999999998889999999999999999999 99997533211 111111111000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
.......+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 244 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 ---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 001223345788999999999999999999999999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=305.91 Aligned_cols=234 Identities=22% Similarity=0.290 Sum_probs=185.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|.+.+.||+|+||.||++++.. ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34678899999999999999999876 788999998543 23455678899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+++.......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-- 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--
Confidence 9999999999887754221 1257788899999999999999999999999999987643221
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
......||..|+|||++.+..++.++||||||+++|||++|+.||...... .......... . .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~------~----- 259 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKNE-Y------S----- 259 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTC-C------C-----
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHhcCC-C------C-----
Confidence 223457899999999999989999999999999999999999997532211 1111110000 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467899999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.03 Aligned_cols=237 Identities=22% Similarity=0.247 Sum_probs=181.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
...++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+++|++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 355789999999999999999999874 889999998532 23345788999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc---CCCCeEEeeccCceecCCCC
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD---KDINPKISDFGMARICGGNE 223 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~ 223 (387)
|||||++|+|.+.+..... ..++|..+++||||||+|||++ .++.+||+|||+++......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999999999777643221 1257888899999999999995 45679999999997654332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .... ...........
T Consensus 179 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~~~~~~~------- 242 (486)
T 3mwu_A 179 ---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDIL---KRVETGKYAFD------- 242 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHTCCCSC-------
T ss_pred ---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHhCCCCCC-------
Confidence 2234578999999999875 599999999999999999999999753221 1111 11111100000
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......+..+.+++.+||+.||++|||+.++++.
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112234578899999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=306.06 Aligned_cols=248 Identities=20% Similarity=0.247 Sum_probs=172.9
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
...++|++.+.||+|+||.||+|+... ++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 345789999999999999999999764 7889999996442 2234567899999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc-----CCCCeEEeeccCceecCC
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD-----KDINPKISDFGMARICGG 221 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~-----~~~~~kl~Dfg~a~~~~~ 221 (387)
||||+++ +|..++..... ...+|..+++|+||||+|||++ .++.+||+|||+++....
T Consensus 111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 9999975 88877754322 1257888899999999999994 455699999999976543
Q ss_pred CCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--ccccc
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--TLELI 298 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 298 (387)
.. .......||..|+|||++.+. .++.++|||||||++|||++|+.||...... .............. .....
T Consensus 190 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 190 PI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSTTG
T ss_pred cc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCCCchhhhhhh
Confidence 22 122335779999999999874 4899999999999999999999998543221 11111111110000 00000
Q ss_pred ---------ccccccc----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 ---------DPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ---------~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+..... .........+.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 001113457889999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=297.41 Aligned_cols=235 Identities=19% Similarity=0.217 Sum_probs=184.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... +..||+|.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 678889999999999999999875 678999998532 1223467889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++....... .
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~ 169 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----R 169 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----B
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc----c
Confidence 99999999888754221 124777888999999999999999999999999997654321 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....|+..|+|||++.+..++.++||||||+++|||++|..||...... . ....... .. .. .+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~-~~------~~-----~~ 232 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--E---THRRIVN-VD------LK-----FP 232 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHT-TC------CC-----CC
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--H---HHHHHhc-cc------cC-----CC
Confidence 3457899999999999999999999999999999999999997532211 1 1111110 00 00 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
...+..+.+++.+||+.||++|||+.++++ .+....
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 123456889999999999999999999997 455443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.78 Aligned_cols=240 Identities=22% Similarity=0.266 Sum_probs=180.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
..++|++.+.||+|+||.||+|+... +..||+|.+.... ......+.+|+.+++.++|||||++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999874 8899999986442 33456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC---CCeEEeeccCceecCCCCc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARICGGNEL 224 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~ 224 (387)
||||++|+|.+.+..... ..++|..+++||||||+|||++.. +.+||+|||+++......
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~- 193 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence 999999999776643211 135788889999999999999764 559999999998765432
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
......||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ... .......... ...+
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~~~~~~--~~~~---- 259 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEI---LRKVEKGKYT--FDSP---- 259 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHTCCC--CCSG----
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHhCCCC--CCch----
Confidence 233457999999999886 5699999999999999999999999853221 111 1111110000 0000
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDE 343 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~ 343 (387)
.....+..+.+++.+||+.||++|||+.++++ .+.+.
T Consensus 260 --~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 260 --EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 11123457889999999999999999999996 35544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=300.18 Aligned_cols=249 Identities=18% Similarity=0.244 Sum_probs=179.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------- 157 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------- 157 (387)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999985 48899999985432 23345788999999999999999999999874
Q ss_pred -CceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 158 -DEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 158 -~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
+..++||||+++ +|...+..... ...+|..+++|+||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 457999999976 56555543321 12577888999999999999999999999999999876
Q ss_pred CCCCc--ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc--c
Q 041766 220 GGNEL--QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--T 294 (387)
Q Consensus 220 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 294 (387)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............. .
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhh
Confidence 43221 122234578999999999976 45899999999999999999999997543221 11111111110000 0
Q ss_pred -c--------cccccccccccccH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 295 -L--------ELIDPILEDEYSSK------HMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 295 -~--------~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. +.+........... .....+.+|+.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00000000000001 113468899999999999999999999973
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.88 Aligned_cols=241 Identities=20% Similarity=0.246 Sum_probs=183.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC------cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|.+.+.||+|+||.||+|+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3568889999999999999999874 8899999885431 12467899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC----CeEEeeccCceecC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI----NPKISDFGMARICG 220 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~~ 220 (387)
++||||+++++|.+++..... ...+|..+++|+||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999988854211 1247778889999999999998877 89999999998764
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||...... . .... ......
T Consensus 164 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~-~~~~~~------ 228 (283)
T 3bhy_A 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--E---TLTN-ISAVNY------ 228 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHH-HHTTCC------
T ss_pred CCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--H---HHHH-hHhccc------
Confidence 322 123356899999999999899999999999999999999999997532211 1 1111 000000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
.... ......+..+.+++.+||+.||++|||+.++++ .++...
T Consensus 229 ~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 DFDE-EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCCH-HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCcc-hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0000 001122456889999999999999999999997 455543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.29 Aligned_cols=233 Identities=22% Similarity=0.293 Sum_probs=184.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|.+.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3678889999999999999999875 788999988543 234456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||++........ .
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--R 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--c
Confidence 999999999887754221 1247788889999999999999999999999999987643221 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||..|+|||++.+..++.++||||||+++|||++|+.||...... ....... .... ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~-~~~~-----------~~ 234 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIK-KNEY-----------SI 234 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHH-TTCC-----------CC
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHh-hccC-----------CC
Confidence 23357899999999999988999999999999999999999997532211 1111110 0000 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+......+.+++.+||+.||++|||++++++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11234568899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=320.51 Aligned_cols=237 Identities=22% Similarity=0.263 Sum_probs=185.0
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
...++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345789999999999999999999874 889999998543 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEE---cCCCCeEEeeccCceecCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILL---DKDINPKISDFGMARICGGN 222 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 222 (387)
+|||||.+|+|.+.+..... ..++|..+++||||||+|||+ +.++.+||+|||+++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999999999887755332 125788889999999999999 56789999999999866433
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... .... ...........
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~~~~~~~~------ 247 (484)
T 3nyv_A 183 K---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDIL---KKVEKGKYTFE------ 247 (484)
T ss_dssp C---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHCCCCCC------
T ss_pred c---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHHcCCCCCC------
Confidence 2 2234578999999999866 699999999999999999999999853221 1111 11111100000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.......+..+.+++.+||+.||++|||+.++++.
T Consensus 248 --~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 --LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00112335578899999999999999999999963
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=306.26 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=177.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
.++|++.+.||+|+||.||+|.... |+.||||++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678999999999999999999864 899999999543 2334567889999999999999999999998753
Q ss_pred ceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+||||+ +++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 181 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence 459999999 7899888754221 12578888999999999999999999999999999875432
Q ss_pred cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc---
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID--- 299 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 299 (387)
.....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... ........... ....+...
T Consensus 182 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g-~~~~~~~~~~~ 254 (367)
T 1cm8_A 182 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTG-TPPAEFVQRLQ 254 (367)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC-CCCHHHHHTCS
T ss_pred ----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcC-CCCHHHHHHhh
Confidence 234578999999999987 67999999999999999999999998543211 11111111000 00000000
Q ss_pred ------------cccccc--cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhh
Q 041766 300 ------------PILEDE--YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEA 344 (387)
Q Consensus 300 ------------~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~ 344 (387)
...... .........+.+|+.+||+.||++|||++++++. +++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000000 0112234578899999999999999999999983 55443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.92 Aligned_cols=235 Identities=23% Similarity=0.265 Sum_probs=179.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-------------ccHHHHHHHHHHHHhcCCCceeeeee
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-------------QGLREMKNEASVIAKVQHKNLVRLLG 152 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~~~~ 152 (387)
..++|.+.+.||+|+||.||+|+... +..||+|.+..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999875 78999999864321 33567889999999999999999999
Q ss_pred eEEeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC---CeEEeec
Q 041766 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI---NPKISDF 213 (387)
Q Consensus 153 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~---~~kl~Df 213 (387)
++.+....|+|||||++|+|..++..... ..++|..+++||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999877743221 1257888899999999999998775 6999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR 293 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 293 (387)
|+++...... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||..... ... .........
T Consensus 194 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~~~~~ 264 (504)
T 3q5i_A 194 GLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDI---IKKVEKGKY 264 (504)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHCCC
T ss_pred CCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHHcCCC
Confidence 9998765432 223457999999999986 4699999999999999999999999753221 111 111110000
Q ss_pred cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.. . .......+..+.+++.+||+.||.+|||++|+++
T Consensus 265 ~~-------~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 265 YF-------D-FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CC-------C-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-------C-ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0 0001123457889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=305.63 Aligned_cols=241 Identities=20% Similarity=0.306 Sum_probs=184.3
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCc--------ccHHHHHHHHHHHHhc-CCCceeeee
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSG--------QGLREMKNEASVIAKV-QHKNLVRLL 151 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~~~ 151 (387)
.......++|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334556678999999999999999999986 489999999864321 1245678899999999 899999999
Q ss_pred eeEEeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 152 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
+++......++||||+++++|.+++..... ...+|..+++|+||||+|||++.++.+||+|||+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 999999999999999999999888754211 1246778889999999999999999999999999
Q ss_pred ceecCCCCcccccccccCCCcccccccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQ------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ........ .
T Consensus 247 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i---~ 318 (365)
T 2y7j_A 247 SCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMI---M 318 (365)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH---H
T ss_pred ccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHH---H
Confidence 98765432 2234678999999999863 358899999999999999999999974321 11111111 0
Q ss_pred hcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. ... ....+ .....+..+.+++.+||+.||++|||+.++++
T Consensus 319 ~-~~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 E-GQY-QFSSP------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-TCC-CCCHH------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred h-CCC-CCCCc------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000 00000 00112456889999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=296.06 Aligned_cols=231 Identities=23% Similarity=0.324 Sum_probs=175.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~ 161 (387)
..|.+.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 346777889999999999999765 788999988643 34456778999999999999999999999875 34579
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhh--hhhcccCCCceEEc-CCCCeEEeeccCceecCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSA--NYSSRLKVSNILLD-KDINPKISDFGMARICGGN 222 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~--~~h~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~ 222 (387)
+||||+++++|.+++..... ...+|..+ ++|+||||+|||++ .++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999999988864221 12467677 99999999999997 7899999999999754332
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
......||+.|+|||++. ..++.++||||||+++|+|++|+.||....... ..... ........
T Consensus 186 ----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~~------ 249 (290)
T 1t4h_A 186 ----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRR-VTSGVKPA------ 249 (290)
T ss_dssp ----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHH-HTTTCCCG------
T ss_pred ----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHHH-HhccCCcc------
Confidence 123357899999999886 459999999999999999999999985432211 11111 11110000
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+..+.+++.+||+.||++|||+.++++
T Consensus 250 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011112346889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=295.71 Aligned_cols=228 Identities=19% Similarity=0.284 Sum_probs=178.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4577899999999999999999987 4899999998753 334456788999999999 99999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc--------------------ccccchhhhhhcccCCCceEEcC------------------
Q 041766 163 IYEYMPNKSLDFFLFDPTK--------------------RMLLDWSANYSSRLKVSNILLDK------------------ 204 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~h~dlk~~Nill~~------------------ 204 (387)
||||+++++|.+++..... ...+|..+++|+||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 9999999999988864311 12477888899999999999984
Q ss_pred -CCCeEEeeccCceecCCCCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh
Q 041766 205 -DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282 (387)
Q Consensus 205 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~ 282 (387)
...+||+|||.+...... ....||..|+|||++.+. .++.++|||||||++|||++|.+++.... .
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~-- 236 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q-- 236 (289)
T ss_dssp -CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H--
T ss_pred CceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H--
Confidence 447999999999876532 223589999999999876 57789999999999999999987752110 0
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
+........ +. .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 ---~~~~~~~~~-----~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 ---WHEIRQGRL-----PR-----IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHHHTTCC-----CC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHHcCCC-----CC-----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111111 00 111234578899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=297.29 Aligned_cols=235 Identities=23% Similarity=0.397 Sum_probs=179.2
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
...++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+|+.++.+++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 445789999999999999999999875 8899999997543 3467899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++........ .
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~ 181 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--K 181 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--C
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--c
Confidence 99999999988752111 1247778889999999999999999999999999987643321 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....|+..|+|||++.+..++.++||||||+++|||++|..||...... ........ ... +... .
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-----~~~~---~ 247 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPT-NPP-----PTFR---K 247 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHH-SCC-----CCCS---S
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhc-CCC-----cccC---C
Confidence 23457899999999999989999999999999999999999997532211 00111000 000 0000 1
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+...+..+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1223457889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=295.23 Aligned_cols=234 Identities=19% Similarity=0.187 Sum_probs=176.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC----CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~ 160 (387)
.++|.+.+.||+|+||.||++.... +..||+|.+... .......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4789999999999999999999764 789999998643 12345678999999999999999999999853 4578
Q ss_pred EEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
++||||++++ |..++..... ...+|..+++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999887 5444432211 12477888899999999999999999999999999876543
Q ss_pred CcccccccccCCCccccccccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGI--FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
..........||..|+|||++.+.. ++.++||||||+++|||++|+.||..... ......... ...
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~-~~~------ 230 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENIGK-GSY------ 230 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH-CCC------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHHhc-CCC------
Confidence 3223334457899999999997644 47899999999999999999999753211 111111111 000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
. .+..++..+.+++.+||+.||++|||+.++++.
T Consensus 231 ~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 A-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp C-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred C-----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 111234568899999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=304.27 Aligned_cols=246 Identities=20% Similarity=0.210 Sum_probs=172.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
.++|++.+.||+|+||.||+|.... ++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999765 788999998643 2344567889999999999999999999998764
Q ss_pred ceEEEEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
..|+||||+++ +|...+..... ...+|..+++|+||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 181 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 181 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred ceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc-
Confidence 67999999975 66665543211 125788889999999999999999999999999998654321
Q ss_pred ccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH----------------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL---------------- 288 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 288 (387)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 223457899999999999999999999999999999999999998543211 100000000
Q ss_pred ---hhcCcc------cccccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 289 ---WTSNRT------LELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 289 ---~~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...... ...+...... ..........+.+|+.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 0000000000 00122346688999999999999999999999973
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=298.59 Aligned_cols=238 Identities=23% Similarity=0.277 Sum_probs=182.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~l 162 (387)
.++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 3678899999999999999999874 889999998643 33445678999999999999999999998864 567899
Q ss_pred EEEecCCCCcchhhcCCcc--------------------ccccchhh-----hhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 163 IYEYMPNKSLDFFLFDPTK--------------------RMLLDWSA-----NYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~-----~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
||||+++++|.+++..... ...+|..+ ++|+||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999988854211 12466666 9999999999999999999999999987
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL 297 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (387)
....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... ....... ......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i----~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKI----REGKFR-- 234 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCCC--
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHH----hhcccc--
Confidence 6543221 12235789999999999998999999999999999999999999754321 1111111 111100
Q ss_pred cccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 298 IDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+...+..+.+++.+||+.||++|||+.++++.+...
T Consensus 235 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 --------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred --------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 01122345788999999999999999999999876544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=303.12 Aligned_cols=239 Identities=21% Similarity=0.248 Sum_probs=182.2
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCCC----cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCC
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKD 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~ 158 (387)
.++|++.+.||+|+||.||+++.. .++.||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367899999999999999999973 58899999986431 22345677899999999 7999999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
..++||||+++|+|.+++..... ..++|..+++|+||||+|||++.++.+||+|||+++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999888754221 12477888999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ............
T Consensus 213 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~-------- 282 (355)
T 1vzo_A 213 ET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-------- 282 (355)
T ss_dssp GG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--------
T ss_pred CC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC--------
Confidence 21 22334579999999999986 3478999999999999999999999864332221 111111111100
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHh
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVSML 340 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~L 340 (387)
...+...+..+.+|+.+||+.||++|| |+.++++..
T Consensus 283 ----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 001222345688999999999999999 999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=304.83 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=178.1
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc-----------ccHHHHHHHHHHHHhcCCCceee
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG-----------QGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
..++....++|.+.+.||+|+||.||+|....+..||||++..... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4567778899999999999999999999988899999998853211 12367899999999999999999
Q ss_pred eeeeEEeC-----CceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCC
Q 041766 150 LLGCCIDK-----DEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDIN 207 (387)
Q Consensus 150 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~ 207 (387)
+++++... ...|+||||++ |+|..++..... ...+|..+++|+||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 99998653 35799999997 577666654321 12478888999999999999999999
Q ss_pred eEEeeccCceecCCCCcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH
Q 041766 208 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286 (387)
Q Consensus 208 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~ 286 (387)
+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 173 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~ 247 (362)
T 3pg1_A 173 ITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--NQLNKIV 247 (362)
T ss_dssp EEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred EEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence 9999999997543322 2234578899999999987 67899999999999999999999998543211 1111111
Q ss_pred HHhhcCcc-----------ccccccccccc------cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 287 DLWTSNRT-----------LELIDPILEDE------YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 287 ~~~~~~~~-----------~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........ .+.+....... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11100000 00000000000 0112234568899999999999999999999973
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.85 Aligned_cols=232 Identities=23% Similarity=0.276 Sum_probs=183.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~l 162 (387)
.++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4678889999999999999999875 788999998632 223446778899999988 79999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||+++|+|..++..... ..++|..+++||||||+||||+.++.+||+|||+|+...... .
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~ 497 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--V 497 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--C
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC--c
Confidence 9999999999888864321 135788889999999999999999999999999998643222 1
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .. ....... .. . .
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~---~~~~i~~-~~--------~---~ 560 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DE---LFQSIME-HN--------V---A 560 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHS-SC--------C---C
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HH---HHHHHHh-CC--------C---C
Confidence 23456899999999999999999999999999999999999999853221 11 1111111 00 0 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTM-----NEVVS 338 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~-----~~v~~ 338 (387)
.+...+..+.+|+.+||+.||++||++ +||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122345678899999999999999997 67765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.04 Aligned_cols=234 Identities=22% Similarity=0.303 Sum_probs=164.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHH-HHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~-~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
..++|++.+.||+|+||.||+|+... ++.||+|.+.... ..... .+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 34788999999999999999999754 8889999996542 22222 344445557778999999999999999999999
Q ss_pred EEecCCCCcchhhcC----Ccc----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 164 YEYMPNKSLDFFLFD----PTK----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~----~~~----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
|||+++ +|..++.. ... ...+|.. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 999975 77665532 110 1247777 8999999999999999999999999999865433
Q ss_pred CcccccccccCCCcccccccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYA----IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
. ......||+.|+|||++ .+..++.++|||||||++|||++|+.||........... ........
T Consensus 164 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~---- 232 (290)
T 3fme_A 164 V---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK----QVVEEPSP---- 232 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH----HHHHSCCC----
T ss_pred c---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH----HHhccCCC----
Confidence 2 12334789999999996 456789999999999999999999999854322211111 11111100
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.......+..+.+++.+||+.||++|||+.++++
T Consensus 233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 ------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0011223456889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=301.49 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=177.9
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe--
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-- 156 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~-- 156 (387)
+..+....++|++.+.||+|+||.||+|++. +++.||+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3444556788999999999999999999985 48899999986543 3346788999999999 89999999999987
Q ss_pred ----CCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeecc
Q 041766 157 ----KDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFG 214 (387)
Q Consensus 157 ----~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg 214 (387)
.+..++||||+++|+|.+++..... ...+|..+++|+||||+|||++.++.+||+|||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCc
Confidence 4578999999999999988864321 124677888999999999999999999999999
Q ss_pred CceecCCCCcccccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh
Q 041766 215 MARICGGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW 289 (387)
Q Consensus 215 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~ 289 (387)
++....... .......|+..|+|||++. +..++.++|||||||++|||++|..||...... .......
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIP 247 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHH
T ss_pred CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHhh
Confidence 997654321 1223457899999999997 566899999999999999999999997432211 0111111
Q ss_pred hcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 290 TSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... . +.. .....+..+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~-~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNP-A-----PRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSC-C-----CCC----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCc-c-----ccC----CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 100 0 000 11122457889999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=302.40 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=182.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc---c--------------cHHHHHHHHHHHHhcCCCceeee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG---Q--------------GLREMKNEASVIAKVQHKNLVRL 150 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~--------------~~~~~~~E~~~l~~l~h~nIv~~ 150 (387)
.++|.+.+.||+|+||.||+|.. +++.||+|.+..... . ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 789999999853211 1 11789999999999999999999
Q ss_pred eeeEEeCCceEEEEEecCCCCcchh------hcCCcc------------------ccccch-hhhhhcccCCCceEEcCC
Q 041766 151 LGCCIDKDEKILIYEYMPNKSLDFF------LFDPTK------------------RMLLDW-SANYSSRLKVSNILLDKD 205 (387)
Q Consensus 151 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~------------------~~~l~~-~~~~h~dlk~~Nill~~~ 205 (387)
++++.+.+..++||||+++|+|.++ +..... ...+|. .+++|+||||+|||++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999988 543211 124676 889999999999999999
Q ss_pred CCeEEeeccCceecCCCCcccccccccCCCccccccccccC-CCCc-cccchhHHHHHHHHHhCCCCCCCCCCCcchHhH
Q 041766 206 INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSI-KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLG 283 (387)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~ 283 (387)
+.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|||++|..||....... ....
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~ 263 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-ELFN 263 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-HHHH
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHH
Confidence 99999999999876433 23345789999999999887 6776 9999999999999999999986433311 1111
Q ss_pred HHHHHhhcCccc-c-----cccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 284 YAWDLWTSNRTL-E-----LIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 284 ~~~~~~~~~~~~-~-----~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. ....... . ...+.... .......+..+.+++.+||+.||++|||+.++++
T Consensus 264 ---~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 ---N-IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---H-HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---H-HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1111000 0 00000000 0011234567889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=308.67 Aligned_cols=181 Identities=19% Similarity=0.265 Sum_probs=151.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc------CCCceeeeeeeEEeCCc
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV------QHKNLVRLLGCCIDKDE 159 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~~~~~~~~~ 159 (387)
...+|++.+.||+|+||.||+|.... ++.||||++... ......+.+|+.++..+ .|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 45679999999999999999999776 788999999753 23345677888888887 57799999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCC--eEEeeccCceec
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDIN--PKISDFGMARIC 219 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~--~kl~Dfg~a~~~ 219 (387)
.++||||+. ++|.+++..... ..++|..+++||||||+|||++.++. +||+|||+++..
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999999996 578777654321 12478888999999999999999887 999999999765
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFY 274 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~ 274 (387)
... .....||+.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus 253 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 432 23457899999999999999999999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=297.36 Aligned_cols=236 Identities=21% Similarity=0.285 Sum_probs=177.0
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--------cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~ 157 (387)
..++|.+.+.||+|+||.||+|.... ++.||||.+.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45679999999999999999999875 7889999986432 12234578999999999999999999998765
Q ss_pred CceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCcee
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMARI 218 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~~ 218 (387)
. .++||||+++++|.+++..... ...+|..+++|+||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 4 8999999999999887764322 12477888899999999999987654 99999999987
Q ss_pred cCCCCcccccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
..... ......||..|+|||++. ...++.++|||||||++|||++|..||........ +...... ...
T Consensus 167 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~----~~~- 237 (322)
T 2ycf_A 167 LGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITS----GKY- 237 (322)
T ss_dssp CCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHH----TCC-
T ss_pred ccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHh----Ccc-
Confidence 64332 123357899999999974 46689999999999999999999999864433221 1111111 000
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... +. .....+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~-~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 238 NFI-PE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC-HH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccC-ch-----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000 00 01123457889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=305.25 Aligned_cols=246 Identities=18% Similarity=0.207 Sum_probs=180.4
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC--------CCceeeeeeeEE--
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ--------HKNLVRLLGCCI-- 155 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~~~~~~~-- 155 (387)
..++|.+.+.||+|+||.||+|+... ++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 45789999999999999999999765 778999999643 344567889999999985 788999999988
Q ss_pred --eCCceEEEEEecCCCCcchhhcCCcc-----------------ccccchh-hhhhcccCCCceEEcCCC---------
Q 041766 156 --DKDEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWS-ANYSSRLKVSNILLDKDI--------- 206 (387)
Q Consensus 156 --~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~-~~~h~dlk~~Nill~~~~--------- 206 (387)
.....|+||||+.++.+..++..... ..++|.. +++||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 44578999999955444443333211 1247776 899999999999998775
Q ss_pred ----------------------------------------CeEEeeccCceecCCCCcccccccccCCCccccccccccC
Q 041766 207 ----------------------------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246 (387)
Q Consensus 207 ----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 246 (387)
.+||+|||+++..... .....||..|+|||++.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTS
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 2345789999999999999
Q ss_pred CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH----hHHHHHHhhc---------Ccccccccc-------------
Q 041766 247 IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL----LGYAWDLWTS---------NRTLELIDP------------- 300 (387)
Q Consensus 247 ~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~~~------------- 300 (387)
.++.++|||||||++|||++|+.||.......... .......... ....+....
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 99999999999999999999999986544332111 0111110000 000000000
Q ss_pred -----ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 -----ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 -----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..............+.+|+.+||+.||++|||++|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00001124566778999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=293.78 Aligned_cols=232 Identities=21% Similarity=0.303 Sum_probs=175.0
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999987 4889999998532 223456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++....... .
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---F 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc---c
Confidence 999999999888754221 124778888999999999999999999999999997654322 1
Q ss_pred cccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEY 306 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (387)
.....|+..|+|||.+.+..+ +.++||||||+++|||++|..||..... .. .... ...... .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~---~~~~-~~~~~~-----------~ 229 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PT---LFKK-IRGGVF-----------Y 229 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHH-HHHCCC-----------C
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HH---HHHH-hhcCcc-----------c
Confidence 233478999999999988765 6899999999999999999999753211 11 1111 110000 0
Q ss_pred ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 307 SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 307 ~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.+......+.+++.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111224568899999999999999999999973
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.61 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=165.5
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44578999999999999999999965 48899999886432 33456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCC-------cc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 164 YEYMPNKSLDFFLFDP-------TK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~-------~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
|||+++++|.+++... .. ...+|..+++|+||||+||+++.++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999998887531 00 12477788899999999999999999999999998755
Q ss_pred CCCCc---ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc
Q 041766 220 GGNEL---QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295 (387)
Q Consensus 220 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (387)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ...... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~~ 245 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-----MLTLQN-DPP 245 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHTS-SCC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-----HHHhcc-CCC
Confidence 32211 111233578999999999976 56899999999999999999999998644322111 111111 000
Q ss_pred cccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. ..............+..+.+++.+||+.||++|||+.++++
T Consensus 246 ~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 S-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp C-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00000000011123456889999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.66 Aligned_cols=246 Identities=21% Similarity=0.264 Sum_probs=186.8
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
...+...++|++.+.||+|+||.||+|.+.. +..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3444556788899999999999999999753 346999998754 3344568899999999999999999999985
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
.+..++||||+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 4568999999999999998864321 12477888999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ........ . ....
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i~---~-~~~~--- 611 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIE---N-GERL--- 611 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH---H-TCCC---
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHH---c-CCCC---
Confidence 433221 2233456789999999998999999999999999999997 8888753221 11111111 0 0000
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..++..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 612 -------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 612 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 0122335578899999999999999999999999998864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=303.59 Aligned_cols=243 Identities=20% Similarity=0.271 Sum_probs=164.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------C
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------D 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~ 158 (387)
.++|++.+.||+|+||.||+|.... |+.||||++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999765 788999999643 233456788999999999999999999998764 4
Q ss_pred ceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+|+||+ +++|..++..... ..++|..+++||||||+|||++.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE- 185 (367)
T ss_dssp CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence 579999999 6788887754221 12578888999999999999999999999999999865422
Q ss_pred cccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc---
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID--- 299 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 299 (387)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. ..+.+.
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p-~~~~~~~~~ 258 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTP-GAELLKKIS 258 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSC-CHHHHTTCC
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC-CHHHHHHhh
Confidence 234578999999999987 6789999999999999999999999854321 11111111111000 000000
Q ss_pred ---------ccccccc-c----cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 ---------PILEDEY-S----SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 ---------~~~~~~~-~----~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....... . .......+.+|+.+||+.||++|||+.++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 0 01224568899999999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=304.60 Aligned_cols=236 Identities=11% Similarity=0.044 Sum_probs=162.3
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---ccHHHHHHHHHHHHhc--CCCceeeee-------eeEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---QGLREMKNEASVIAKV--QHKNLVRLL-------GCCI 155 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~~~-------~~~~ 155 (387)
.+|...+.||+|+||.||+|++.. ++.||||++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 458889999999999999999764 88899999976432 3345677785544444 699988755 4444
Q ss_pred eC-----------------CceEEEEEecCCCCcchhhcCCc------cc-----------------cccchhhhhhccc
Q 041766 156 DK-----------------DEKILIYEYMPNKSLDFFLFDPT------KR-----------------MLLDWSANYSSRL 195 (387)
Q Consensus 156 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~------~~-----------------~~l~~~~~~h~dl 195 (387)
.. ...|+||||++ |+|.+++.... .. .++|..+++||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 23799999998 89988875421 01 2367778899999
Q ss_pred CCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 196 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999876422 113456799999999987 6799999999999999999999999864
Q ss_pred CCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 274 YRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........ +................ .....+..+.+|+.+||+.||++|||+.++++
T Consensus 296 ~~~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS-------WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC-------CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc-------hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 43221100 00000000000000000 11234567889999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=293.58 Aligned_cols=237 Identities=20% Similarity=0.241 Sum_probs=182.3
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---------cccHHHHHHHHHHHHhcC-CCceeeeeeeE
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---------GQGLREMKNEASVIAKVQ-HKNLVRLLGCC 154 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~ 154 (387)
...++|++.+.||+|+||.||+|.+.. ++.||||.+.... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345789999999999999999999875 7889999986442 122456789999999995 99999999999
Q ss_pred EeCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 155 IDKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 155 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
......++||||+++++|.+++..... ...+|..+++|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 999999999999999999988864211 1247778889999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccccccccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAI------QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
..... ......|+..|+|||++. ...++.++||||||+++|||++|..||..... .... ..... .
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~---~~~~~-~ 244 (298)
T 1phk_A 174 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML---RMIMS-G 244 (298)
T ss_dssp CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHH-T
T ss_pred cCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHH---HHHhc-C
Confidence 65332 223457899999999985 45688999999999999999999999743221 1111 11111 0
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... .. .......+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~-~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ-FG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC-CC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc-cC------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 00 0011233557889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=300.13 Aligned_cols=249 Identities=16% Similarity=0.219 Sum_probs=180.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~ 160 (387)
.++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 3679999999999999999999775 7789999997433 34456788999999999999999999999765 367
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||||++ |+|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEcccC-cCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence 99999997 488777654321 12577888999999999999999999999999999876432211
Q ss_pred c-ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc------
Q 041766 226 A-NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL------ 297 (387)
Q Consensus 226 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 297 (387)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .................
T Consensus 185 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCSCCHHHHHTCCCH
T ss_pred cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 1234588999999998765 458999999999999999999999985433221 11111111110000000
Q ss_pred -----ccccccc-c----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 298 -----IDPILED-E----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 298 -----~~~~~~~-~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....... . ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0 0011234578899999999999999999999973
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=298.47 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=178.6
Q ss_pred chhhHHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcC--CCceeeeeeeEE
Q 041766 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCCI 155 (387)
Q Consensus 80 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~ 155 (387)
.+..+....++|++.+.||+|+||.||++...+++.||+|.+... .....+.+.+|+.++.+++ ||||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344455556789999999999999999999888999999998643 3345578899999999996 599999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
..+..++||| +.+++|.+++..... ...+|..+++|+||||+|||+++ +.+||+|||+++..
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999999 567899888764322 12477788899999999999965 78999999999876
Q ss_pred CCCCcccccccccCCCcccccccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHH
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQ-----------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 288 (387)
.............|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ .....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~ 252 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAI 252 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----HHHHH
Confidence 44332222334578999999999875 4688999999999999999999999853322111 11111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....... . .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~---------~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 253 IDPNHEI---------E-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HCTTSCC---------C-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhccccc---------C-CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1110000 0 011113468899999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.11 Aligned_cols=254 Identities=18% Similarity=0.216 Sum_probs=169.0
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc--
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE-- 159 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~-- 159 (387)
......++|++.+.||+|+||.||+|++.. +..||||++.... .....+.+|+..+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345566899999999999999999999865 8899999886432 223456778888999999999999999976433
Q ss_pred -----eEEEEEecCCCCcchhhc----CCcc----------------ccccc--hhhhhhcccCCCceEEcC-CCCeEEe
Q 041766 160 -----KILIYEYMPNKSLDFFLF----DPTK----------------RMLLD--WSANYSSRLKVSNILLDK-DINPKIS 211 (387)
Q Consensus 160 -----~~lv~e~~~~g~L~~~l~----~~~~----------------~~~l~--~~~~~h~dlk~~Nill~~-~~~~kl~ 211 (387)
.++||||++++ |...+. .... ..++| ..+++|+||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 78999999875 332221 1111 12356 788999999999999996 8999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhh
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWT 290 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 290 (387)
|||+++...... ......||..|+|||++.+.. ++.++|||||||++|||++|+.||...... ...........
T Consensus 175 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~ 249 (360)
T 3e3p_A 175 DFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVRVLG 249 (360)
T ss_dssp CCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC
T ss_pred eCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHHHcC
Confidence 999998765332 223457899999999997654 899999999999999999999998543221 11111111100
Q ss_pred cCc------------cccccccc-c--cc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 291 SNR------------TLELIDPI-L--ED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 291 ~~~------------~~~~~~~~-~--~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
... ........ . .. .......+..+.+|+.+||+.||++|||+.|+++. +++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 000 00000000 0 00 00011235678999999999999999999999973 4444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.70 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=175.5
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------ 157 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------ 157 (387)
+...++|++.+.||+|+||.||+|+... ++.||||++...... ..+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999999754 899999998644222 23799999999999999999998543
Q ss_pred --------------------------------CceEEEEEecCCCCcchhhcC----Ccc----------------cccc
Q 041766 158 --------------------------------DEKILIYEYMPNKSLDFFLFD----PTK----------------RMLL 185 (387)
Q Consensus 158 --------------------------------~~~~lv~e~~~~g~L~~~l~~----~~~----------------~~~l 185 (387)
...++||||+++ +|...+.. ... ..++
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 237899999985 66555532 110 1257
Q ss_pred chhhhhhcccCCCceEEc-CCCCeEEeeccCceecCCCCcccccccccCCCccccccccccC-CCCccccchhHHHHHHH
Q 041766 186 DWSANYSSRLKVSNILLD-KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLE 263 (387)
Q Consensus 186 ~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~e 263 (387)
|..+++||||||+|||++ .++.+||+|||+++...... ......+|..|+|||++.+. .++.++|||||||++||
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 788899999999999997 68899999999998764332 22335789999999998875 48999999999999999
Q ss_pred HHhCCCCCCCCCCCcchHhHHHHHHhhcC----------ccccccccccccc----cccHHHHHHHHHHHHhcccCCCCC
Q 041766 264 IVSGKKTTGFYRTDSLTLLGYAWDLWTSN----------RTLELIDPILEDE----YSSKHMLLRYVNIALLCVQESADD 329 (387)
Q Consensus 264 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~ 329 (387)
|++|+.||....... .+.... ...... ...+...+..... ..+...+..+.+|+.+||+.||++
T Consensus 235 ll~g~~pf~~~~~~~-~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 235 LILGKPLFSGETSID-QLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHSSCSSCCSSHHH-HHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHhCCCCCCCCChHH-HHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999985432111 111111 100000 0000000000000 012223556889999999999999
Q ss_pred CCCHHHHHH--Hhhhhh
Q 041766 330 RPTMNEVVS--MLTDEA 344 (387)
Q Consensus 330 RPt~~~v~~--~L~~~~ 344 (387)
|||+.|+++ .++++.
T Consensus 313 R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SCCHHHHHTSGGGHHHH
T ss_pred CCCHHHHhcCHHHHHHH
Confidence 999999996 344443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=303.00 Aligned_cols=249 Identities=19% Similarity=0.259 Sum_probs=163.9
Q ss_pred hcCCCC-CCcccccCCeeEEEEEEc---CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceE
Q 041766 88 TNKFSD-ANKLGEGGFGPVYKGVLK---KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKI 161 (387)
Q Consensus 88 ~~~~~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~ 161 (387)
.+.|++ .++||+|+||.||+|++. .+..||||.+.... ....+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345655 458999999999999976 36789999997543 23578899999999999999999999965 56789
Q ss_pred EEEEecCCCCcchhhcCCc-------------------------cccccchhhhhhcccCCCceEE----cCCCCeEEee
Q 041766 162 LIYEYMPNKSLDFFLFDPT-------------------------KRMLLDWSANYSSRLKVSNILL----DKDINPKISD 212 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~-------------------------~~~~l~~~~~~h~dlk~~Nill----~~~~~~kl~D 212 (387)
+||||+++ +|..++.... ...++|..+++||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 6655553110 0125788889999999999999 6778999999
Q ss_pred ccCceecCCCCc-ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCc-------chHhH
Q 041766 213 FGMARICGGNEL-QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS-------LTLLG 283 (387)
Q Consensus 213 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~-------~~~~~ 283 (387)
||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+. .....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987643211 1223446789999999999874 58999999999999999999999986443321 01111
Q ss_pred HHHHHhhcCcc--cccccc----------cccccc---ccH--------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 284 YAWDLWTSNRT--LELIDP----------ILEDEY---SSK--------HMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 284 ~~~~~~~~~~~--~~~~~~----------~~~~~~---~~~--------~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
........... ...+.. ...... ... .....+.+|+.+||+.||++|||++|+++.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111110000 000000 000000 000 013467899999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=295.18 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=174.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEE-----------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----------- 155 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~----------- 155 (387)
.++|.+.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4688999999999999999999876 8899999997666666778999999999999999999999874
Q ss_pred ---eCCceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEc-CCCCeEEeeccCc
Q 041766 156 ---DKDEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLD-KDINPKISDFGMA 216 (387)
Q Consensus 156 ---~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~a 216 (387)
.....++||||++ |+|..++..... ...+|..+++|+||||+|||++ .++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~ 168 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccc
Confidence 3457799999997 589888765321 1247788889999999999997 5679999999999
Q ss_pred eecCCCCc-ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc-
Q 041766 217 RICGGNEL-QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR- 293 (387)
Q Consensus 217 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 293 (387)
+....... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..............
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--EQMQLILESIPVVHE 246 (320)
T ss_dssp BCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHSCCCCH
T ss_pred cccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCch
Confidence 86543211 112233467899999998875 67899999999999999999999998543211 11111110000000
Q ss_pred ---------cccccccccccc-----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 294 ---------TLELIDPILEDE-----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 294 ---------~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
....+....... ......+..+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000000000000 001123567889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.78 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=175.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc------eE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE------KI 161 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~------~~ 161 (387)
..+|.+.+.||+|+||.||+|++..+..||+|++...... ..+|+++|+.++||||+++++++...+. .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3578999999999999999999987777999988543221 2369999999999999999999965432 78
Q ss_pred EEEEecCCCCcchhhc---CCc----------------cccccchhhhhhcccCCCceEEc-CCCCeEEeeccCceecCC
Q 041766 162 LIYEYMPNKSLDFFLF---DPT----------------KRMLLDWSANYSSRLKVSNILLD-KDINPKISDFGMARICGG 221 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~---~~~----------------~~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~ 221 (387)
+||||++++.+..... ... ...++|..+++||||||+|||++ .++.+||+|||+++....
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9999998764433221 010 11357888899999999999998 789999999999987643
Q ss_pred CCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc---------
Q 041766 222 NELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS--------- 291 (387)
Q Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 291 (387)
.. ......||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... .+.... .....
T Consensus 195 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~-~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 195 GE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEII-KVLGTPSREQIKTM 269 (394)
T ss_dssp TC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH-HHHCCCCHHHHHHH
T ss_pred CC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HHhCCCCHHHHHhh
Confidence 32 12345789999999999765 58999999999999999999999985432111 111111 10000
Q ss_pred -Cccccccccccccc----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhh
Q 041766 292 -NRTLELIDPILEDE----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEA 344 (387)
Q Consensus 292 -~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~ 344 (387)
....+...+..... ......+..+.+|+.+||+.||++|||+.|+++. ++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00000000000000 0112234678999999999999999999999974 55443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=299.36 Aligned_cols=243 Identities=19% Similarity=0.274 Sum_probs=176.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce----
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK---- 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~---- 160 (387)
.++|.+.+.||+|+||.||+|.... ++.||||++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4688999999999999999999775 788999999754 233356788999999999999999999999877654
Q ss_pred --EEEEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 161 --ILIYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 161 --~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
++||||+. ++|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-- 197 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 197 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred eEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence 99999997 577666643211 13577888999999999999999999999999999865322
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc----
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID---- 299 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 299 (387)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. ..+...
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~-~~~~~~~~~~ 271 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVP-GTEFVQKLND 271 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC-CHHHHTTCSC
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCC-cHHHHHHhhh
Confidence 234578999999999987 6799999999999999999999999854321 11111111100000 000000
Q ss_pred --------cccccc-----cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 --------PILEDE-----YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 --------~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...... ......+..+.+|+.+||+.||++|||++|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 0011235678999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=295.73 Aligned_cols=243 Identities=21% Similarity=0.247 Sum_probs=183.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc--CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc------eeeeeeeEEeCC
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDKD 158 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~~ 158 (387)
..++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++|+| |+++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 4578999999999999999999973 4778999999643 334567889999999987664 999999999999
Q ss_pred ceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC----------------
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK---------------- 204 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~---------------- 204 (387)
..++||||+ +++|.+++..... ..++|..+++|+||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999999 8888887754331 12477888899999999999987
Q ss_pred ---CCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH
Q 041766 205 ---DINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281 (387)
Q Consensus 205 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~ 281 (387)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|..||...... ..
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~ 242 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK--EH 242 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH--HH
T ss_pred cccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH--HH
Confidence 668999999999865432 23457899999999999999999999999999999999999998643321 11
Q ss_pred hHHHHHHhhcCcccc------------------------------ccccccccccccHHHHHHHHHHHHhcccCCCCCCC
Q 041766 282 LGYAWDLWTSNRTLE------------------------------LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRP 331 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 331 (387)
......... ..... ...+..............+.+|+.+||+.||++||
T Consensus 243 ~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 LAMMERILG-PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHC-SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHhC-CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 111111100 00000 00000111112334567899999999999999999
Q ss_pred CHHHHHHH
Q 041766 332 TMNEVVSM 339 (387)
Q Consensus 332 t~~~v~~~ 339 (387)
|+.|+++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=294.59 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=178.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~~ 160 (387)
.++|.+.+.||+|+||.||+|.+.. ++.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4688999999999999999999875 7889999996433 33456788999999999999999999988764 568
Q ss_pred EEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||||+. ++|..++..... ...+|..+++|+||||+|||++.++.+||+|||+++........
T Consensus 90 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 99999997 588777654211 12578888999999999999999999999999999876432211
Q ss_pred c--------ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 226 A--------NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 226 ~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
. ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .................
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCSTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCchhc
Confidence 1 1223478999999998765 67899999999999999999999998543211 11111111111100000
Q ss_pred c---c---------cccc--cc---ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 L---I---------DPIL--ED---EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ~---~---------~~~~--~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. + .... .. .......+..+.+++.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0 0000 00 0001233567889999999999999999999997
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=305.37 Aligned_cols=246 Identities=21% Similarity=0.236 Sum_probs=173.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC----C--ceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK----D--EKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~----~--~~~ 161 (387)
.+|+..+.||+|+||.||+|++.. ++.||||++..... ...+|+++|++++|||||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 468889999999999999999865 89999999864322 234799999999999999999998642 1 357
Q ss_pred EEEEecCCCCcchhhcC----Cc----------------cccccchhhhhhcccCCCceEEcCC-CCeEEeeccCceecC
Q 041766 162 LIYEYMPNKSLDFFLFD----PT----------------KRMLLDWSANYSSRLKVSNILLDKD-INPKISDFGMARICG 220 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~----~~----------------~~~~l~~~~~~h~dlk~~Nill~~~-~~~kl~Dfg~a~~~~ 220 (387)
+||||+++ +|...+.. .. ...++|..+++||||||+|||++.+ +.+||+|||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999986 44433321 10 1135788889999999999999965 568999999998764
Q ss_pred CCCcccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHh---------h
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLW---------T 290 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~---------~ 290 (387)
... ......||..|+|||++.+. .|+.++|||||||++|||++|+.||...... ..+........ .
T Consensus 209 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHHHH
T ss_pred cCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhh
Confidence 332 12335789999999999765 7999999999999999999999998543211 11111111000 0
Q ss_pred cCcccccccccccccc----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 291 SNRTLELIDPILEDEY----SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 291 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
.....+...+.+.... .....+..+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0001111111111000 111234678899999999999999999999963 4444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=298.66 Aligned_cols=184 Identities=23% Similarity=0.309 Sum_probs=150.4
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CC-----ceeeeeeeEE
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HK-----NLVRLLGCCI 155 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~~~~~~~ 155 (387)
..+...++|++.+.||+|+||.||+|+... ++.||||++... ......+..|+.++..++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 344456889999999999999999999775 778999999743 233466778999988874 55 4999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCccc------------------cccc--hhhhhhcccCCCceEEc--CCCCeEEeec
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTKR------------------MLLD--WSANYSSRLKVSNILLD--KDINPKISDF 213 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~--~~~~~h~dlk~~Nill~--~~~~~kl~Df 213 (387)
..+..|+||||++ |+|.+++...... .++| ..+++||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999999996 5888877543210 1344 35789999999999994 4788999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999876432 2345789999999999999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=291.45 Aligned_cols=236 Identities=24% Similarity=0.370 Sum_probs=155.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHH-HHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.++|+..+.||+|+||.||+|.... ++.||||.+.... ......+..|.. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4678899999999999999999864 8889999997542 333445666666 666779999999999999999999999
Q ss_pred EecCCCCcchhhcC------Ccc---------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 165 EYMPNKSLDFFLFD------PTK---------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 165 e~~~~g~L~~~l~~------~~~---------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
||+++ +|..++.. ... ...+|.. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99986 66555531 100 1246666 8999999999999999999999999999765432
Q ss_pred CcccccccccCCCcccccccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYA----IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
. ......||..|+|||++ .+..++.++|||||||++|||++|+.||......... . .......
T Consensus 180 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--------~--~~~~~~~ 246 (327)
T 3aln_A 180 I---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--------L--TQVVKGD 246 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCCCCSC
T ss_pred c---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--------H--HHHhcCC
Confidence 2 12234789999999998 4567899999999999999999999997532211000 0 0000000
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+.+... .....+..+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0001100 11223457889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=288.28 Aligned_cols=236 Identities=20% Similarity=0.296 Sum_probs=171.3
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC--------
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-------- 157 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-------- 157 (387)
..++|++.+.||+|+||.||+|+.. +++.||||.+... ......+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3567889999999999999999976 4889999998542 33456788999999999999999999988653
Q ss_pred -----CceEEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccC
Q 041766 158 -----DEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGM 215 (387)
Q Consensus 158 -----~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~ 215 (387)
...++||||+++|+|.+++...... ..+|..+++|+||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 4578999999999999988643221 247778889999999999999999999999999
Q ss_pred ceecCCCCc------------ccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh
Q 041766 216 ARICGGNEL------------QANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL 282 (387)
Q Consensus 216 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~ 282 (387)
+........ ........||..|+|||++.+. .++.++|||||||++|||++ |+... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----~~~~ 235 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----MERV 235 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----HHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----hhHH
Confidence 976542210 1122345689999999999864 68999999999999999998 33211 0001
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..... ..... ...... .....+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~-~~~~~------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKK-LRSVS------IEFPPD-FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHH-HHSTT------CCCCTT-CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHh-ccccc------cccCcc-ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111 11000 000000 12233456789999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.91 Aligned_cols=244 Identities=19% Similarity=0.250 Sum_probs=176.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc-----
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE----- 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~----- 159 (387)
.++|...+.||+|+||.||+|++.. |+.||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3678889999999999999999865 889999999653 23335678899999999999999999999987654
Q ss_pred -eEEEEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 160 -KILIYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 160 -~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
.|+||||++ ++|..++...-. ...+|..+++|+||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 179 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 179 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred eEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence 499999997 588776643211 12578888999999999999999999999999999764322
Q ss_pred ccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc--c------
Q 041766 225 QANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT--L------ 295 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~------ 295 (387)
.....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... ............... .
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHHhhH
Confidence 234578999999999987 67899999999999999999999998543211 111111110000000 0
Q ss_pred ------ccccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 ------ELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ------~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
..+...... .......+..+.+++.+||+.||++|||++++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 00112335678899999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=288.22 Aligned_cols=237 Identities=21% Similarity=0.240 Sum_probs=181.3
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
....++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999987 4889999998543 2345678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCC---CCeEEeeccCceecCCC
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKD---INPKISDFGMARICGGN 222 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~ 222 (387)
+||||+++++|.+++..... ...+|..+++|+||||+||+++.+ +.+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999777643211 124777888999999999999754 46999999998765432
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||..... .. ............. .
T Consensus 178 ~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~---~~~~~~~~~~~~~-----~ 243 (287)
T 2wei_A 178 T---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YD---ILKRVETGKYAFD-----L 243 (287)
T ss_dssp S---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHCCCCCC-----S
T ss_pred C---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHcCCCCCC-----c
Confidence 2 1223467889999998865 489999999999999999999999753221 11 1111111110000 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......+..+.+++.+||+.||++|||+.++++
T Consensus 244 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 ---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 011223457889999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.05 Aligned_cols=233 Identities=20% Similarity=0.215 Sum_probs=171.0
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEecC
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+.+..|+|||||.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999998776667999999998542 335678999999986 89999999999999999999999995
Q ss_pred CCCcchhhcCCcc-----------------------ccccchhhhhhcccCCCceEEcCC-------------CCeEEee
Q 041766 169 NKSLDFFLFDPTK-----------------------RMLLDWSANYSSRLKVSNILLDKD-------------INPKISD 212 (387)
Q Consensus 169 ~g~L~~~l~~~~~-----------------------~~~l~~~~~~h~dlk~~Nill~~~-------------~~~kl~D 212 (387)
|+|.+++..... ..++|..+++||||||+|||++.+ +.+||+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 699888764321 124677888999999999999754 4899999
Q ss_pred ccCceecCCCCcc--cccccccCCCcccccccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHh
Q 041766 213 FGMARICGGNELQ--ANTSRIVGTYGYMSPEYAIQ-------GIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLL 282 (387)
Q Consensus 213 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~ 282 (387)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... .
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~ 248 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---S 248 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---H
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---H
Confidence 9999876543211 11234579999999999976 568999999999999999999 898875322111 0
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.. ......... . ........+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~i----~~~~~~~~~----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NI----IRGIFSLDE----M-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH----HHTCCCCCC----C-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----hcCCCCccc----c-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 111000000 0 11124456778999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=288.62 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=177.7
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEc--CCCEEEEEEccCC--CcccHHHHHHHHHHHHhc---CCCceeeeeeeEE----
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLPGR--SGQGLREMKNEASVIAKV---QHKNLVRLLGCCI---- 155 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~---- 155 (387)
..++|++.+.||+|+||.||+|++. +++.||+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4478999999999999999999984 4778999988532 122223566777777766 8999999999987
Q ss_pred -eCCceEEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCc
Q 041766 156 -DKDEKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMA 216 (387)
Q Consensus 156 -~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a 216 (387)
.....++||||++ |+|..++..... ...+|..+++|+||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 4456899999997 688887754321 12477888899999999999999999999999999
Q ss_pred eecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc
Q 041766 217 RICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296 (387)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (387)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..................
T Consensus 168 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 168 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGGG
T ss_pred ccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCCccc
Confidence 765422 123345789999999999999999999999999999999999999754321 111111111111000000
Q ss_pred ----------cccccc--ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 ----------LIDPIL--EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 ----------~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...... .........+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000011223457889999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.16 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=177.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----------CCceeeeeeeEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCI 155 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~ 155 (387)
.++|.+.+.||+|+||.||+|+... ++.||||.+... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3679999999999999999999754 788999999643 334567889999999886 899999999998
Q ss_pred eCC----ceEEEEEecCCCCcchhhcCCcc------------------ccccchh-hhhhcccCCCceEEc------CCC
Q 041766 156 DKD----EKILIYEYMPNKSLDFFLFDPTK------------------RMLLDWS-ANYSSRLKVSNILLD------KDI 206 (387)
Q Consensus 156 ~~~----~~~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~-~~~h~dlk~~Nill~------~~~ 206 (387)
..+ ..++||||+ +++|..++..... ...+|.. +++|+||||+|||++ ..+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 678999999 8899888754221 1246776 899999999999994 445
Q ss_pred CeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch----Hh
Q 041766 207 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT----LL 282 (387)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~----~~ 282 (387)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 7999999999876432 23357899999999999999999999999999999999999998644322110 00
Q ss_pred HHHHHHhh------------------cCcccccccc--------cc-ccccccHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 041766 283 GYAWDLWT------------------SNRTLELIDP--------IL-EDEYSSKHMLLRYVNIALLCVQESADDRPTMNE 335 (387)
Q Consensus 283 ~~~~~~~~------------------~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~ 335 (387)
........ .......+.. .+ .....+......+.+|+.+||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 00000000 0000000000 00 001123566788999999999999999999999
Q ss_pred HHH
Q 041766 336 VVS 338 (387)
Q Consensus 336 v~~ 338 (387)
+++
T Consensus 331 ll~ 333 (373)
T 1q8y_A 331 LVN 333 (373)
T ss_dssp HHT
T ss_pred Hhh
Confidence 987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=298.09 Aligned_cols=233 Identities=21% Similarity=0.264 Sum_probs=168.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
..+|...+.||+|+||+|+.....+++.||||++...... .+.+|+.+|+++ +|||||++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3468888999999999976555566899999999654332 356899999999 899999999999999999999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcC-----CCCeEEeeccCceecCCCCc
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDK-----DINPKISDFGMARICGGNEL 224 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~~~ 224 (387)
|+ |+|.+++..... ..++|..+++||||||+|||++. ...+||+|||+++.......
T Consensus 100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 96 588888765432 12477888999999999999943 34688999999987643221
Q ss_pred -ccccccccCCCccccccccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 225 -QANTSRIVGTYGYMSPEYAI---QGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 225 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
........||+.|+|||++. ...++.++|||||||++|||++ |..||....... . ...........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~------~-~~~~~~~~~~~-- 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ------A-NILLGACSLDC-- 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH------H-HHHTTCCCCTT--
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH------H-HHHhccCCccc--
Confidence 12234467999999999997 4567889999999999999999 888874321110 0 00001100000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..........+.+|+.+||+.||++|||+.++++
T Consensus 250 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 -----LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0112234556789999999999999999999995
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=289.64 Aligned_cols=230 Identities=21% Similarity=0.336 Sum_probs=171.0
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcc------cHHHHHHHHHHHHhc----CCCceeeee
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQ------GLREMKNEASVIAKV----QHKNLVRLL 151 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~nIv~~~ 151 (387)
..+...++|.+.+.||+|+||.||+|+... ++.||+|.+...... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344566889999999999999999998754 889999999654221 223455799999998 899999999
Q ss_pred eeEEeCCceEEEEEe-cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc-CCCCeEEeec
Q 041766 152 GCCIDKDEKILIYEY-MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD-KDINPKISDF 213 (387)
Q Consensus 152 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Df 213 (387)
+++...+..++|||| +.+++|.+++..... ...+|..+++|+||||+||+++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999888754221 1257888899999999999999 8899999999
Q ss_pred cCceecCCCCcccccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC
Q 041766 214 GMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN 292 (387)
Q Consensus 214 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 292 (387)
|++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... .....
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~~~~- 248 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------EILEA- 248 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHT-
T ss_pred chhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------HHhhh-
Confidence 9998765432 234578999999999987776 458999999999999999999974210 00000
Q ss_pred ccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 293 RTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
... ........+.+++.+||+.||++|||+.++++.
T Consensus 249 --------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 --------ELH---FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --------CCC---CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------ccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 112234568899999999999999999999973
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.51 Aligned_cols=243 Identities=20% Similarity=0.236 Sum_probs=179.4
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-C-CEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc------eeeeeeeEEeC
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-G-DEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCCIDK 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~~~~~~~~~ 157 (387)
...++|++.+.||+|+||.||+|.... + ..||+|.+... ....+.+.+|+.++++++|+| ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 345789999999999999999999764 4 58999999643 344567888999999997766 99999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCc-c-----------------ccccchhhhhhcccCCCceEE-----------------
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPT-K-----------------RMLLDWSANYSSRLKVSNILL----------------- 202 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~-~-----------------~~~l~~~~~~h~dlk~~Nill----------------- 202 (387)
+..++||||+ +++|..++.... . ...+|..+++|+||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999999 455555543322 1 124778888999999999999
Q ss_pred --cCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch
Q 041766 203 --DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLT 280 (387)
Q Consensus 203 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~ 280 (387)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||++|..||...... .
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~ 246 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--E 246 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred cccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence 56789999999999865432 23457899999999999999999999999999999999999998643321 1
Q ss_pred HhHHHHHHhhcCcccc------------------------------ccccccccccccHHHHHHHHHHHHhcccCCCCCC
Q 041766 281 LLGYAWDLWTSNRTLE------------------------------LIDPILEDEYSSKHMLLRYVNIALLCVQESADDR 330 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 330 (387)
.......... ..... ...+..............+.+|+.+||+.||++|
T Consensus 247 ~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 HLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHC-CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHcC-CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111111100 00000 0000000011223445688999999999999999
Q ss_pred CCHHHHHH
Q 041766 331 PTMNEVVS 338 (387)
Q Consensus 331 Pt~~~v~~ 338 (387)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.02 Aligned_cols=234 Identities=18% Similarity=0.174 Sum_probs=152.6
Q ss_pred HhcCCCCCC-cccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHH-HHHHhcCCCceeeeeeeEEe----CCc
Q 041766 87 ATNKFSDAN-KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEA-SVIAKVQHKNLVRLLGCCID----KDE 159 (387)
Q Consensus 87 ~~~~~~~~~-~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~~~~~~~~----~~~ 159 (387)
..++|.+.+ .||+|+||.||+|++.. ++.||||++... ....+|+ ..+..+.||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 346788855 69999999999999875 889999998642 1222333 34556799999999999876 345
Q ss_pred eEEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcC---CCCeEEeeccCcee
Q 041766 160 KILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARI 218 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~ 218 (387)
.++||||+++|+|.+++...... .++|..+++|+||||+|||++. ++.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 78999999999999988764321 2477788899999999999976 45599999999986
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||........... ...... ..
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~------~~ 248 (336)
T 3fhr_A 181 TTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIR------LG 248 (336)
T ss_dssp C--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred ccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhh------cc
Confidence 54322 2345789999999999888999999999999999999999999854322211000 000000 00
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..... .......+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QYGFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0011233557889999999999999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.14 Aligned_cols=234 Identities=23% Similarity=0.338 Sum_probs=157.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-ccH-HHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-QGL-REMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
.++|++.+.||+|+||.||+|++.. ++.||||.+..... ... ..+..+..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4678889999999999999999864 88999999965432 222 23444455677789999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc-----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 165 EYMPNKSLDFFLFDPTK-----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||+ ++.+..+...... ...+|.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--- 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--- 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---
Confidence 999 4455444322111 1246664 79999999999999999999999999997654322
Q ss_pred ccccccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 227 NTSRIVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
......|+..|+|||++. ...++.++||||||+++|||++|+.||........ .......... +.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~------~~ 249 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE----VLTKVLQEEP------PL 249 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHHSCC------CC
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH----HHHHHhccCC------CC
Confidence 123347899999999994 45689999999999999999999999854322111 1111111110 00
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LP---GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC---ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 01123456889999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.58 Aligned_cols=229 Identities=22% Similarity=0.312 Sum_probs=177.3
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc------ccHHHHHHHHHHHHhcC--CCceeeeeee
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG------QGLREMKNEASVIAKVQ--HKNLVRLLGC 153 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~~~~~ 153 (387)
..+...++|++.+.||+|+||.||+|+... ++.||||.+..... .....+.+|+.++.+++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344456789999999999999999999764 78899999854311 11245668999999996 5999999999
Q ss_pred EEeCCceEEEEEecCC-CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc-CCCCeEEeeccC
Q 041766 154 CIDKDEKILIYEYMPN-KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD-KDINPKISDFGM 215 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~-~~~~~kl~Dfg~ 215 (387)
+...+..++||||+.+ ++|.+++..... ...+|..+++|+||||+|||++ +++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 888887754211 1247778889999999999999 788999999999
Q ss_pred ceecCCCCcccccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 216 ARICGGNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
++...... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||.... .......
T Consensus 197 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~~~~~~- 260 (320)
T 3a99_A 197 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQV- 260 (320)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCC-
T ss_pred cccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hhhcccc-
Confidence 98765332 233578999999999987776 788999999999999999999974210 0000000
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. .....+..+.+++.+||+.||++|||++++++
T Consensus 261 ------~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ------F-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------C-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11122456889999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.67 Aligned_cols=250 Identities=21% Similarity=0.251 Sum_probs=180.8
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe------CCc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID------KDE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~------~~~ 159 (387)
.++|++.+.||+|+||.||+|.+.. ++.||||.+... .....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3789999999999999999999764 889999998654 34455678999999999999999999998765 567
Q ss_pred eEEEEEecCCCCcchhhcCCcc-------------------ccccchhhhhhcccCCCceEEcCCCC---eEEeeccCce
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK-------------------RMLLDWSANYSSRLKVSNILLDKDIN---PKISDFGMAR 217 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~h~dlk~~Nill~~~~~---~kl~Dfg~a~ 217 (387)
.++||||+++|+|..++..... ..++|..+++|+||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 7999999999999998876331 12478888999999999999987665 9999999998
Q ss_pred ecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC----c
Q 041766 218 ICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN----R 293 (387)
Q Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 293 (387)
...... ......||..|+|||++.+..++.++|||||||++|||++|..||...... ..|........ .
T Consensus 173 ~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 173 ELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEHIV 245 (676)
T ss_dssp BTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------CC
T ss_pred cccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchhhh
Confidence 765332 223457899999999999999999999999999999999999998542110 00000000000 0
Q ss_pred ccccc------cccc-ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHH-----HHHhhhhh
Q 041766 294 TLELI------DPIL-EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEV-----VSMLTDEA 344 (387)
Q Consensus 294 ~~~~~------~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v-----~~~L~~~~ 344 (387)
..+.. .... .........+..+.+++.+||+.||++|||++++ .+.++++.
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000 0000 0111233456789999999999999999999884 34454444
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=274.44 Aligned_cols=219 Identities=11% Similarity=0.046 Sum_probs=169.1
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
..++|++.+.||+|+||.||+|++.. ++.||||.+.... ......+.+|+.++.+++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34679999999999999999999876 8899999997543 2334678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 163 IYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||||+++++|.+++..... ..++|..+++|+||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 9999999999998865321 125788889999999999999999999998543
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc-cccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE-DEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 307 (387)
|++ +++.++|||||||++|||++|+.||.......... .....+..... ....
T Consensus 175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAERDTAGQPIEPADI 228 (286)
T ss_dssp --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECCBCTTSCBCCHHHH
T ss_pred --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHHHHhccCCCChhhc
Confidence 333 37899999999999999999999985433211000 00000000000 0001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
....+..+.+++.+||+.||++| |+.++++.|+++...
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 12345678999999999999999 999999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.86 Aligned_cols=228 Identities=19% Similarity=0.262 Sum_probs=176.0
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEc--CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCc---
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDE--- 159 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~--- 159 (387)
...++|++.+.||+|+||.||+|++. +++.||||.+... .......+.+|+.++.+++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34578999999999999999999986 4788999998643 33445678899999999999999999999987665
Q ss_pred --eEEEEEecCCCCcchhhcCCcc--------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 --KILIYEYMPNKSLDFFLFDPTK--------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 --~~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+||||+++++|..++...-. ..++|..+++||||||+|||++.+ .+||+|||+++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 6999999999999887654211 125788889999999999999886 8999999999876432
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (387)
....||+.|+|||++.+. ++.++|||||||++|||++|..|+...... .. .
T Consensus 235 -----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~-----~ 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GL-----P 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SC-----C
T ss_pred -----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------------------cc-----c
Confidence 345789999999998765 489999999999999999998875321000 00 0
Q ss_pred cccccHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHhhhhh
Q 041766 304 DEYSSKHMLLRYVNIALLCVQESADDRPT-MNEVVSMLTDEA 344 (387)
Q Consensus 304 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~~v~~~L~~~~ 344 (387)
...........+.+++.+||+.||++||+ ++++...|....
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 11112233467889999999999999995 666666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=284.16 Aligned_cols=222 Identities=15% Similarity=0.133 Sum_probs=158.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCC-Cceeeee------------
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQH-KNLVRLL------------ 151 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~~~------------ 151 (387)
..|...+.||+|+||.||+|++.. |+.||||++.... ....+.+.+|+.++..++| +|...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 446677899999999999999664 8899999987332 2335788999999999977 3221111
Q ss_pred ---------eeEEe-----CCceEEEEEecCCCCcchhhcC------Ccc-----------------ccccchhhhhhcc
Q 041766 152 ---------GCCID-----KDEKILIYEYMPNKSLDFFLFD------PTK-----------------RMLLDWSANYSSR 194 (387)
Q Consensus 152 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~------~~~-----------------~~~l~~~~~~h~d 194 (387)
.++.. ....+++|+++ +++|.+++.. ... ..++|..+++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 12356777765 6788877731 111 1257888899999
Q ss_pred cCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCcccccccc----------ccCCCCccccchhHHHHHHHH
Q 041766 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA----------IQGIFSIKSDVFSFGVLLLEI 264 (387)
Q Consensus 195 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwS~Gvil~el 264 (387)
|||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|||
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999865422 334577 999999999 555689999999999999999
Q ss_pred HhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 265 VSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 265 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
++|+.||...... +.....+... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 311 ltg~~Pf~~~~~~------------------~~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 311 WCADLPNTDDAAL------------------GGSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHSSCCCCTTGGG------------------SCSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCcchh------------------hhHHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999997532211 1111111111 112357889999999999999999877754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=266.68 Aligned_cols=212 Identities=17% Similarity=0.169 Sum_probs=158.4
Q ss_pred hcCCCCC-CcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHH-HhcCCCceeeeeeeEEe----CCce
Q 041766 88 TNKFSDA-NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVI-AKVQHKNLVRLLGCCID----KDEK 160 (387)
Q Consensus 88 ~~~~~~~-~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~~~~~~~~----~~~~ 160 (387)
.++|.+. +.||+|+||.||++.... ++.||+|.+... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567766 679999999999999764 889999998632 4677899988 45599999999999987 5678
Q ss_pred EEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcC---CCCeEEeeccCceec
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARIC 219 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 219 (387)
++||||+++|+|.+++..... ..++|..+++|+||||+|||++. ++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 999999999999988865431 12477788899999999999998 788999999998753
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
. +..++.++|||||||++|||++|+.||........ .......+.
T Consensus 171 ~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~ 215 (299)
T 3m2w_A 171 T------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIR 215 (299)
T ss_dssp T------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSC
T ss_pred c------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHh
Confidence 2 24578899999999999999999999853221100 000000000
Q ss_pred -cccccc-cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 300 -PILEDE-YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 300 -~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
...... ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0012245678999999999999999999999973
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=274.76 Aligned_cols=226 Identities=14% Similarity=0.119 Sum_probs=162.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--------CcccHHHHHHHHHHHHhcC---------CCceeee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--------SGQGLREMKNEASVIAKVQ---------HKNLVRL 150 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~---------h~nIv~~ 150 (387)
.++|++.+.||+|+||.||+|++ +++.||||++... .....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 5789999998643 2234478899999999886 5555555
Q ss_pred -----------------eeeEEe-------------CCceEEEEEecCCCCcchhhcCCcc---------------cccc
Q 041766 151 -----------------LGCCID-------------KDEKILIYEYMPNKSLDFFLFDPTK---------------RMLL 185 (387)
Q Consensus 151 -----------------~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l 185 (387)
++++.+ .+..|+|||||++|++...+..... ..++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 444443 6788999999999976555533211 1257
Q ss_pred c-hhhhhhcccCCCceEEcCCC--------------------CeEEeeccCceecCCCCcccccccccCCCccccccccc
Q 041766 186 D-WSANYSSRLKVSNILLDKDI--------------------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244 (387)
Q Consensus 186 ~-~~~~~h~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 244 (387)
| ..+++||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||++.
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGC
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhc
Confidence 7 78999999999999999887 899999999987642 2347899999999998
Q ss_pred cCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccc-cccccccccccHHHHHHHHHHHHhc
Q 041766 245 QGIFSIKSDVFSFGVL-LLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLEL-IDPILEDEYSSKHMLLRYVNIALLC 322 (387)
Q Consensus 245 ~~~~~~~~DiwS~Gvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~c 322 (387)
+.. +.++||||||++ .+++++|..||.. ..|.... ....... ..............+..+.+|+.+|
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYL--TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHH--HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHH--HHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 766 899999998777 7788889888521 0010000 0000000 0000011112345778899999999
Q ss_pred ccCCCCCCCCHHHHH
Q 041766 323 VQESADDRPTMNEVV 337 (387)
Q Consensus 323 l~~dP~~RPt~~~v~ 337 (387)
|+.| |++|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=244.66 Aligned_cols=172 Identities=13% Similarity=0.071 Sum_probs=116.9
Q ss_pred cccccCCeeEEEEE-EcCCCEEEEEEccCCC----------cccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 96 KLGEGGFGPVYKGV-LKKGDEIAVKRLPGRS----------GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 96 ~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
..+.|++|.+..++ +.-|+.+|+|.+.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35566666666554 2238889999986431 22345799999999999 799999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|||++|++|.+.+...... .++|..+++||||||+||||+.++.+||+|||+|+...... ....+
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t 398 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTN 398 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHH
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccC
Confidence 9999999999999765431 35788999999999999999999999999999998764332 22345
Q ss_pred ccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041766 231 IVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p 270 (387)
.+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 399 ~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 399 LVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 689999999999975 467789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=221.83 Aligned_cols=176 Identities=18% Similarity=0.147 Sum_probs=135.0
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcc--------cHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQ--------GLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..+.||+|+||.||+|... +..+++|+....... ..+.+.+|+++|++++||||+++..++...+..|+||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 4568999999999999554 788999986433211 1345789999999999999997777777888889999
Q ss_pred EecCCCCcchhhcCCcc--------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc-----ccccc
Q 041766 165 EYMPNKSLDFFLFDPTK--------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA-----NTSRI 231 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~ 231 (387)
||+++++|.+++..... ..++|..+++||||||+|||++. .+||+|||+|+......... .....
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 496 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAV 496 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhh
Confidence 99999999998876111 23578889999999999999999 99999999999875432111 12356
Q ss_pred cCCCcccccccccc--CCCCccccchhHHHHHHHHHhCCCCC
Q 041766 232 VGTYGYMSPEYAIQ--GIFSIKSDVFSFGVLLLEIVSGKKTT 271 (387)
Q Consensus 232 ~gt~~y~aPE~~~~--~~~~~~~DiwS~Gvil~el~tg~~p~ 271 (387)
.||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|
T Consensus 497 ~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 497 LSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 89999999999987 66889999999999999988877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=179.19 Aligned_cols=148 Identities=17% Similarity=0.079 Sum_probs=113.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc------------------ccHHHHHHHHHHHHhcCCCceee
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG------------------QGLREMKNEASVIAKVQHKNLVR 149 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~ 149 (387)
...|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+.+|++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 345566799999999999999996688999999864321 13456889999999998 5 77
Q ss_pred eeeeEEeCCceEEEEEecCCCCcchhhcCCcc----------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 150 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
+.+++.. +..|+||||+++++|.. +..... ...+|..+++||||||+|||++ ++.+||+|||+|+.
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~- 241 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE- 241 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-
Confidence 7775544 55699999999999988 432211 1247888899999999999999 99999999999863
Q ss_pred CCCCcccccccccCCCcccccccccc----------CCCCccccchh
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQ----------GIFSIKSDVFS 256 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DiwS 256 (387)
+..|+|||.+.+ ..|+..+|+|.
T Consensus 242 --------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 242 --------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp --------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 234789998854 34556666664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.6e-17 Score=145.40 Aligned_cols=123 Identities=14% Similarity=0.072 Sum_probs=89.8
Q ss_pred CCCCCcccccCCeeEEEEEE-cCCCE--EEEEEccCCCcc------------------------cHHHHHHHHHHHHhcC
Q 041766 91 FSDANKLGEGGFGPVYKGVL-KKGDE--IAVKRLPGRSGQ------------------------GLREMKNEASVIAKVQ 143 (387)
Q Consensus 91 ~~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 143 (387)
|++.+.||+|+||.||+|.+ .+|+. ||||.++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 56888 999987533111 1136788999999998
Q ss_pred CCce--eeeeeeEEeCCceEEEEEecCC-C----CcchhhcCCcc-------------ccccc-hhhhhhcccCCCceEE
Q 041766 144 HKNL--VRLLGCCIDKDEKILIYEYMPN-K----SLDFFLFDPTK-------------RMLLD-WSANYSSRLKVSNILL 202 (387)
Q Consensus 144 h~nI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~-------------~~~l~-~~~~~h~dlk~~Nill 202 (387)
|+++ ..+++. ...++||||+.+ | .|..+...... ...+| ..+++||||||+|||+
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl 204 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY 204 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 8764 333432 356899999943 4 55544332100 12467 7889999999999999
Q ss_pred cCCCCeEEeeccCceec
Q 041766 203 DKDINPKISDFGMARIC 219 (387)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~ 219 (387)
+. .++|+|||+|...
T Consensus 205 ~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 205 ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SS--SEEECCCTTCEET
T ss_pred cC--cEEEEECcccccC
Confidence 98 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=3.9e-15 Score=139.30 Aligned_cols=127 Identities=12% Similarity=0.082 Sum_probs=85.2
Q ss_pred CCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--------------cccHHHH--------HHHHHHHHhcCCCce
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--------------GQGLREM--------KNEASVIAKVQHKNL 147 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~E~~~l~~l~h~nI 147 (387)
-|++.+.||+|+||.||+|...+|+.||||+++... ....... .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388899999999999999999889999999874320 0011122 235555555533332
Q ss_pred eeeeeeEEeCCceEEEEEecCCCCcchhhcCCcc----------ccccchhhhhhcccCCCceEEcCCC----------C
Q 041766 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSRLKVSNILLDKDI----------N 207 (387)
Q Consensus 148 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~l~~~~~~h~dlk~~Nill~~~~----------~ 207 (387)
.-..-+.. ...+|||||++++.|..+...... ...+|..+++||||||.|||+++++ .
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccc
Confidence 21111111 123799999999888765533221 1246778899999999999998776 3
Q ss_pred eEEeeccCcee
Q 041766 208 PKISDFGMARI 218 (387)
Q Consensus 208 ~kl~Dfg~a~~ 218 (387)
+.|+||+-+-.
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 88999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=4.3e-10 Score=100.49 Aligned_cols=88 Identities=11% Similarity=0.007 Sum_probs=69.6
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
....|.....++.|+.+.||+.... ++.+++|............+.+|+.++..+ .|..+.++++++.+.+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456777778888889999999755 688999998642112224588999999998 47788899999998888999999
Q ss_pred ecCCCCcchh
Q 041766 166 YMPNKSLDFF 175 (387)
Q Consensus 166 ~~~~g~L~~~ 175 (387)
|++|.+|...
T Consensus 91 ~i~G~~l~~~ 100 (263)
T 3tm0_A 91 EADGVLCSEE 100 (263)
T ss_dssp CCSSEEHHHH
T ss_pred ecCCeehhhc
Confidence 9999888654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-09 Score=97.35 Aligned_cols=73 Identities=15% Similarity=0.151 Sum_probs=56.8
Q ss_pred cccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc--eeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 98 GEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 98 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
+.|..+.||+....+|..+++|..... ....+..|+.++..+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 456669999998766788999987543 2245778999999885434 566888888777889999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.54 E-value=6.4e-08 Score=90.48 Aligned_cols=80 Identities=16% Similarity=0.321 Sum_probs=57.7
Q ss_pred CCCcccccCCeeEEEEEEcCCCEEEEEEcc--CCC-cccHHHHHHHHHHHHhcC--CCceeeeeeeEEeC---CceEEEE
Q 041766 93 DANKLGEGGFGPVYKGVLKKGDEIAVKRLP--GRS-GQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDK---DEKILIY 164 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~---~~~~lv~ 164 (387)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998876 4678888775 321 122346788999999986 45688899988776 3479999
Q ss_pred EecCCCCcc
Q 041766 165 EYMPNKSLD 173 (387)
Q Consensus 165 e~~~~g~L~ 173 (387)
||++|..+.
T Consensus 121 e~v~G~~l~ 129 (359)
T 3dxp_A 121 EFVSGRVLW 129 (359)
T ss_dssp ECCCCBCCC
T ss_pred EecCCeecC
Confidence 999988773
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.21 E-value=3.5e-07 Score=83.35 Aligned_cols=75 Identities=12% Similarity=0.130 Sum_probs=51.9
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCc--eeeeeeeEEeCC---ceEEEEEec
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKN--LVRLLGCCIDKD---EKILIYEYM 167 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~~~~~~~~~~---~~~lv~e~~ 167 (387)
.+.++.|....||+.. ..+++|.... ......+.+|..+|..+ .+.. +.++++.....+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 5688888643 23446788999999888 3333 345555443333 348999999
Q ss_pred CCCCcch
Q 041766 168 PNKSLDF 174 (387)
Q Consensus 168 ~~g~L~~ 174 (387)
+|..+..
T Consensus 99 ~G~~l~~ 105 (304)
T 3sg8_A 99 KGVPLTP 105 (304)
T ss_dssp CCEECCH
T ss_pred CCeECCc
Confidence 9987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.9e-05 Score=69.06 Aligned_cols=75 Identities=17% Similarity=0.174 Sum_probs=55.1
Q ss_pred cccccCCe-eEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEEecCCCCc
Q 041766 96 KLGEGGFG-PVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 96 ~lG~G~~g-~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~L 172 (387)
.+..|..| .||+..... +..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 689877654 56788898653 23456788999998883 44467889999999999999999988765
Q ss_pred c
Q 041766 173 D 173 (387)
Q Consensus 173 ~ 173 (387)
.
T Consensus 108 ~ 108 (272)
T 4gkh_A 108 F 108 (272)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00015 Score=65.27 Aligned_cols=77 Identities=17% Similarity=0.199 Sum_probs=57.2
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-C--CceeeeeeeEEeCCceEEEEEecC
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
...+.+|.|..+.||+.+..+|+.|.+|+-..........|..|...|+.+. . --+.+++++. ..++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 3456789999999999999999999999876554444457888999998884 2 2345555542 3479999998
Q ss_pred CCCc
Q 041766 169 NKSL 172 (387)
Q Consensus 169 ~g~L 172 (387)
++..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00019 Score=65.19 Aligned_cols=75 Identities=16% Similarity=0.128 Sum_probs=54.3
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCC---ceeeeeeeEE-eCCceEEEEEecCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCI-DKDEKILIYEYMPN 169 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~~~~~~~-~~~~~~lv~e~~~~ 169 (387)
.+.++.|....||+. +..+++|.-. .......+.+|..+|..+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346788888899987 5668888742 223446788999999999642 3566676664 34567899999999
Q ss_pred CCcch
Q 041766 170 KSLDF 174 (387)
Q Consensus 170 g~L~~ 174 (387)
..+..
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 87754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0003 Score=66.33 Aligned_cols=74 Identities=14% Similarity=0.253 Sum_probs=49.5
Q ss_pred CCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-------cccHHHHHHHHHHHHhcC-C-C-ceeeeeeeEEeCCceEE
Q 041766 94 ANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-------GQGLREMKNEASVIAKVQ-H-K-NLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h-~-nIv~~~~~~~~~~~~~l 162 (387)
.+.+|.|..+.||++... .+..++||...... ......+..|.++|..+. + + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 36789999764321 112345678999998873 2 3 34456654 4455689
Q ss_pred EEEecCC
Q 041766 163 IYEYMPN 169 (387)
Q Consensus 163 v~e~~~~ 169 (387)
||||+++
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0011 Score=60.84 Aligned_cols=73 Identities=11% Similarity=0.179 Sum_probs=42.0
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC--CCceeeeee------eEEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ--HKNLVRLLG------CCIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~~------~~~~~~~~~lv~e~ 166 (387)
+.|+.|..+.||+....++ .+++|..... ...+..|..++..+. .-.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987644 5889988642 133444555555542 112334443 12345677899999
Q ss_pred cCCCCc
Q 041766 167 MPNKSL 172 (387)
Q Consensus 167 ~~~g~L 172 (387)
++|..+
T Consensus 113 i~G~~~ 118 (346)
T 2q83_A 113 IEGRPF 118 (346)
T ss_dssp CCCBCC
T ss_pred ecCccC
Confidence 998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0015 Score=59.37 Aligned_cols=75 Identities=16% Similarity=0.106 Sum_probs=60.1
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC---CCceeeeeeeEEeCCceEEEEEecCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDKDEKILIYEYMPNK 170 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~g 170 (387)
.+.|+.|....+|+.... +..+++|..... ....+..|...|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 457899999999998764 678889987532 3567889999998883 367888999888888899999999987
Q ss_pred Cc
Q 041766 171 SL 172 (387)
Q Consensus 171 ~L 172 (387)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 65
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00031 Score=65.11 Aligned_cols=79 Identities=9% Similarity=0.036 Sum_probs=54.2
Q ss_pred Ccc-cccCCeeEEEEEEc-------CCCEEEEEEccCCC---cccHHHHHHHHHHHHhcC-C--CceeeeeeeEEeC---
Q 041766 95 NKL-GEGGFGPVYKGVLK-------KGDEIAVKRLPGRS---GQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDK--- 157 (387)
Q Consensus 95 ~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~~~~~~~~~--- 157 (387)
+.| +.|....+|+.... ++..+++|...... ......+..|..++..+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 77888899988754 25678888764322 001245678888888873 3 3577888887665
Q ss_pred CceEEEEEecCCCCcc
Q 041766 158 DEKILIYEYMPNKSLD 173 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~ 173 (387)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0054 Score=58.14 Aligned_cols=73 Identities=11% Similarity=0.165 Sum_probs=45.2
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccC------CC-c--ccHHHHHHHHHHHHh-cCCCceeeeeeeEEeCCceEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPG------RS-G--QGLREMKNEASVIAK-VQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~------~~-~--~~~~~~~~E~~~l~~-l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.+.||.|..+.||+... ++..++||.... .. . .....+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 45689999999999964 367899994321 11 1 122334444433322 2334567777765 5667999
Q ss_pred EEec-CC
Q 041766 164 YEYM-PN 169 (387)
Q Consensus 164 ~e~~-~~ 169 (387)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0055 Score=37.24 Aligned_cols=28 Identities=18% Similarity=0.084 Sum_probs=12.8
Q ss_pred chhhhHHHHHHHHHHHHHHHHhhhhccc
Q 041766 6 FLALLSLSIVLAAVAILGLIFYCARRKP 33 (387)
Q Consensus 6 ~i~~~~~~~~~~~~~~~~~~~~~~rr~~ 33 (387)
.|+..+++.++++++++++++++.|||+
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 3444444444444444444444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0096 Score=36.28 Aligned_cols=28 Identities=21% Similarity=0.146 Sum_probs=13.0
Q ss_pred CchhhhHHHHHHHHHHHHHHHHhhhhcc
Q 041766 5 PFLALLSLSIVLAAVAILGLIFYCARRK 32 (387)
Q Consensus 5 ~~i~~~~~~~~~~~~~~~~~~~~~~rr~ 32 (387)
+.|+..+++.++++++++++++++.|||
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 3445555554444444444444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0073 Score=36.61 Aligned_cols=28 Identities=18% Similarity=0.198 Sum_probs=12.6
Q ss_pred hhhhHHHHHHHHHHHHHHHHhhhhcccC
Q 041766 7 LALLSLSIVLAAVAILGLIFYCARRKPR 34 (387)
Q Consensus 7 i~~~~~~~~~~~~~~~~~~~~~~rr~~~ 34 (387)
++..++++++++++.+++.+|++||+..
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 4555555333333334444455554443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.62 E-value=0.026 Score=51.01 Aligned_cols=75 Identities=9% Similarity=0.008 Sum_probs=43.5
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc--eeeeeee------EEeCCceEEEEEe
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDKDEKILIYEY 166 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~~~~~------~~~~~~~~lv~e~ 166 (387)
+.|+.|....+|+....++ .+++|...... ....+..|..++..+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466788889999987655 67889886521 1234556777777663111 3334321 1234567899999
Q ss_pred cCCCCc
Q 041766 167 MPNKSL 172 (387)
Q Consensus 167 ~~~g~L 172 (387)
++|..+
T Consensus 105 l~G~~~ 110 (322)
T 2ppq_A 105 LEGMWL 110 (322)
T ss_dssp CCCBCC
T ss_pred CCCcCC
Confidence 988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.60 E-value=0.054 Score=49.06 Aligned_cols=76 Identities=8% Similarity=0.015 Sum_probs=49.1
Q ss_pred CcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-C-Cceeeeeee-----EEeCCceEEEEEec
Q 041766 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-H-KNLVRLLGC-----CIDKDEKILIYEYM 167 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~nIv~~~~~-----~~~~~~~~lv~e~~ 167 (387)
..++ |....||+....+|+.+++|...... .....+..|..++..+. + -.+++++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77789998877667789999986321 23356677888887773 2 224455543 12245567899999
Q ss_pred CCCCc
Q 041766 168 PNKSL 172 (387)
Q Consensus 168 ~~g~L 172 (387)
+|..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 87543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.08 E-value=0.045 Score=50.96 Aligned_cols=73 Identities=16% Similarity=0.217 Sum_probs=45.4
Q ss_pred CcccccCCeeEEEEEEcC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEE
Q 041766 95 NKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+.|..|-...+|+....+ +..+++|+... .......+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456667778899988642 46788888632 2234566778999998873 3334667766543 38999
Q ss_pred ecCCCCc
Q 041766 166 YMPNKSL 172 (387)
Q Consensus 166 ~~~~g~L 172 (387)
|++|..|
T Consensus 131 ~i~G~~l 137 (379)
T 3feg_A 131 YIPSRPL 137 (379)
T ss_dssp CCSEEEC
T ss_pred EecCccC
Confidence 9988655
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.96 E-value=0.045 Score=32.21 Aligned_cols=26 Identities=23% Similarity=0.553 Sum_probs=13.9
Q ss_pred chhhhHHHHHHHHHHHHHHHHhhhhc
Q 041766 6 FLALLSLSIVLAAVAILGLIFYCARR 31 (387)
Q Consensus 6 ~i~~~~~~~~~~~~~~~~~~~~~~rr 31 (387)
.++.++++.++.+++++++.|+++||
T Consensus 12 aIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 12 EIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34555555555555555555555544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=93.91 E-value=0.22 Score=45.16 Aligned_cols=30 Identities=17% Similarity=0.196 Sum_probs=25.4
Q ss_pred hhhcccCCCceEEcCC----CCeEEeeccCceec
Q 041766 190 NYSSRLKVSNILLDKD----INPKISDFGMARIC 219 (387)
Q Consensus 190 ~~h~dlk~~Nill~~~----~~~kl~Dfg~a~~~ 219 (387)
.+|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3799999999999874 67999999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=93.83 E-value=0.086 Score=49.97 Aligned_cols=73 Identities=12% Similarity=0.213 Sum_probs=49.0
Q ss_pred CCcccccCCeeEEEEEEcC--------CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCc-eeeeeeeEEeCCceEEEE
Q 041766 94 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~~~~~~~~~~~lv~ 164 (387)
.+.|+.|....+|+....+ +..+++|+..... ....+..|..++..+...+ ..++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3467788889999998753 4688888874321 1145568999988884333 356776653 2 3899
Q ss_pred EecCCCCc
Q 041766 165 EYMPNKSL 172 (387)
Q Consensus 165 e~~~~g~L 172 (387)
||++|..+
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.066 Score=32.18 Aligned_cols=12 Identities=33% Similarity=0.772 Sum_probs=5.1
Q ss_pred HHHHHHhhhhcc
Q 041766 21 ILGLIFYCARRK 32 (387)
Q Consensus 21 ~~~~~~~~~rr~ 32 (387)
+++++++++||+
T Consensus 29 iv~~~~~~~rRr 40 (41)
T 2k9y_A 29 LAGVGFFIHRRR 40 (41)
T ss_dssp HHHHHHSSSSSC
T ss_pred HHHHheeEeeec
Confidence 333344444443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.65 E-value=0.054 Score=48.54 Aligned_cols=71 Identities=10% Similarity=0.135 Sum_probs=43.8
Q ss_pred CCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCce-eeeeeeEEeCCceEEEEEec-CCCC
Q 041766 94 ANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDKDEKILIYEYM-PNKS 171 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~~~~~~~~~~~~~lv~e~~-~~g~ 171 (387)
.+.|+.|....+|+. ..+++|......... .....|..++..+...++ .++++.+ .+.-++++||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 577888999999998 457888775432111 123467777777632222 4555543 33457899999 6655
Q ss_pred c
Q 041766 172 L 172 (387)
Q Consensus 172 L 172 (387)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.18 E-value=0.23 Score=42.01 Aligned_cols=59 Identities=8% Similarity=0.058 Sum_probs=35.0
Q ss_pred CCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCC
Q 041766 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKT 270 (387)
Q Consensus 196 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p 270 (387)
.|..|++..+|.|.+.+ +.+. .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 77 ~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 77 SAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp SGGGEEEETTSCEEECC-C--------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEecCCceeccc-cccc--------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 45778888888887764 2111 1123467888763 3446778899999999999975444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=90.57 E-value=0.044 Score=52.53 Aligned_cols=61 Identities=10% Similarity=0.072 Sum_probs=18.8
Q ss_pred CCCcccccCCeeEEEEEEcC-CCEEEE------EEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe
Q 041766 93 DANKLGEGGFGPVYKGVLKK-GDEIAV------KRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID 156 (387)
Q Consensus 93 ~~~~lG~G~~g~V~~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~ 156 (387)
+.+.|| ||.||+|.+.. ..+||| |..... .......+.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 456776 99999999875 357888 766432 22333568889999999999999999998654
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.03 E-value=0.79 Score=30.05 Aligned_cols=24 Identities=17% Similarity=0.275 Sum_probs=11.8
Q ss_pred CCCchhhhHHHHHHHHHHHHHHHHh
Q 041766 3 SAPFLALLSLSIVLAAVAILGLIFY 27 (387)
Q Consensus 3 ~~~~i~~~~~~~~~~~~~~~~~~~~ 27 (387)
+++.++ +++++++.+++++++.++
T Consensus 6 ~~p~~L-ivlGg~~~lll~~glcI~ 29 (70)
T 2klu_A 6 RGSMAL-IVLGGVAGLLLFIGLGIF 29 (70)
T ss_dssp CCSSHH-HHHHHHHHHHHHHHHHHH
T ss_pred hhHHHH-HHHhHHHHHHHHHHHHHH
Confidence 345554 455555555554444433
|
| >1afo_A Glycophorin A; integral membrane protein, transmembrane helix interactions, membrane protein folding; NMR {Homo sapiens} SCOP: j.35.1.1 PDB: 2kpf_A | Back alignment and structure |
|---|
Probab=88.56 E-value=0.66 Score=26.84 Aligned_cols=30 Identities=27% Similarity=0.442 Sum_probs=22.9
Q ss_pred CCCchhhhHHHHHHHHHHHHHHHHhhhhcc
Q 041766 3 SAPFLALLSLSIVLAAVAILGLIFYCARRK 32 (387)
Q Consensus 3 ~~~~i~~~~~~~~~~~~~~~~~~~~~~rr~ 32 (387)
|.+.+++++.++.++++..+.++-||-||.
T Consensus 8 s~p~i~lII~~vmaGiIG~IllI~y~I~rl 37 (40)
T 1afo_A 8 SEPEITLIIFGVMAGVIGTILLISYGIRRL 37 (40)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 567788888888888777777787877654
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.08 E-value=0.13 Score=29.45 Aligned_cols=7 Identities=29% Similarity=0.211 Sum_probs=3.0
Q ss_pred HHhhhhc
Q 041766 25 IFYCARR 31 (387)
Q Consensus 25 ~~~~~rr 31 (387)
.+|++||
T Consensus 28 ~~~iRRr 34 (35)
T 1iij_A 28 GILIKRR 34 (35)
T ss_dssp THHHHHC
T ss_pred heEEeec
Confidence 3444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 387 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-58
Identities = 54/283 (19%), Positives = 118/283 (41%), Gaps = 34/283 (12%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+ + ++G G FG VYKG + + + + Q L+ KNE V+ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
+G + ++ ++ SL L + + + + +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSII 126
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA---IQGIF 248
LK +NI L +D+ KI DFG+A + ++ G+ +M+PE + +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308
S +SDV++FG++L E+++G+ + ++ + + + +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLP--YSNINNRDQI---IFMVGRGYLSPDLSKV------R 235
Query: 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPK 351
+ + C+++ D+RP ++++ + A +L PK
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-56
Identities = 70/284 (24%), Positives = 120/284 (42%), Gaps = 36/284 (12%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
KLG+G FG V+ G +A+K L EA V+ K++H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM-----LLDWSANYSSR--------- 194
+L ++ ++ EYM SL FL T + L+D +A +S
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 195 ----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
L+ +NIL+ +++ K++DFG+AR+ NE A + +PE A+ G F+I
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTI 193
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310
KSDV+SFG+LL E+ + + + + L+ ++
Sbjct: 194 KSDVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC-PPE 238
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPA 354
++ C ++ ++RPT + + L D + P QP
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-56
Identities = 62/265 (23%), Positives = 106/265 (40%), Gaps = 34/265 (12%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
++G G FG V+ G D++A+K + + EA V+ K+ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------LKV 197
+++ L++E+M + L +L + L
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 129
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
N L+ ++ K+SDFGM R ++ +++ + SPE +S KSDV+SF
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 258 GVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVN 317
GVL+ E+ S K R++S + + L P L
Sbjct: 189 GVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFRLYKPRLAST--------HVYQ 233
Query: 318 IALLCVQESADDRPTMNEVVSMLTD 342
I C +E +DRP + ++ L +
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-56
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 34/265 (12%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG G FG V G + ++A+K + E EA V+ + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-----------------RLKV 197
+ +I EYM N L +L + R L
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128
Query: 198 SNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSF 257
N L++ K+SDFG++R +E ++ + PE + FS KSD+++F
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 258 GVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVN 317
GVL+ EI S K ++ +T++ T E I L +
Sbjct: 188 GVLMWEIYSLGKMP--------------YERFTNSETAEHIAQGLRLYRPH-LASEKVYT 232
Query: 318 IALLCVQESADDRPTMNEVVSMLTD 342
I C E AD+RPT ++S + D
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-54
Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+LG G FG V+ G ++AVK L + EA+++ ++QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW-----------------SANY 191
RL + +I EYM N SL FL P+ L NY
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 192 SSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSI 250
R L+ +NIL+ ++ KI+DFG+AR+ NE A + +PE G F+I
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYGTFTI 189
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310
KSDV+SFG+LL EIV+ + + T+ ++ ++ +
Sbjct: 190 KSDVWSFGILLTEIVTHGRI--------------PYPGMTNPEVIQNLERGYRMVRPD-N 234
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ LC +E +DRPT + + S+L D
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 4e-53
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 49/296 (16%)
Query: 79 FSFSSVSTATNKFSDA---------NKLGEGGFGPVYKGVLKKGDE----IAVKRL-PGR 124
F+F + A +F+ +G G FG V G LK + +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 125 SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML 184
+ + R+ +EAS++ + H N++ L G ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 185 LDWSANY-----------------SSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227
+ L NIL++ ++ K+SDFG++R +
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 228 TSRIVG---TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGY 284
+ +G + +PE F+ SDV+S+G+++ E++S +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-------------- 232
Query: 285 AWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ T+ + I+ + L C Q+ + RP ++V+ L
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPP-PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-53
Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 40/273 (14%)
Query: 95 NKLGEGGFGPVYKGVLKKGD----EIAVKRLPGRSGQG-LREMKNEASVIAKVQHKNLVR 149
+G G FG VY G L D AVK L + G + + E ++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 150 LLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------- 194
LLG C+ + ++ YM + L F+ + T + + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 195 ---LKVSNILLDKDINPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAIQGIFS 249
L N +LD+ K++DFG+AR E + ++ +M+ E F+
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309
KSDV+SFGVLL E+++ Y + + L R +L+ EY
Sbjct: 213 TKSDVWSFGVLLWELMTRGAP--PYPDVNTFDI--TVYLLQGRR-------LLQPEYCPD 261
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ + L C A+ RP+ +E+VS ++
Sbjct: 262 PL----YEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-51
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 39/276 (14%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKV 142
+ + +G G FG VYKG+LK +A+K L G + + + EA ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 143 QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS--------- 193
H N++RL G ++I EYM N +LD FL + +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 194 --------RLKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAI 244
L NIL++ ++ K+SDFG++R+ + T S + +PE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
F+ SDV+SFG+++ E+++ + + +++ ++ I+
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERP--------------YWELSNHEVMKAINDGFRL 232
Query: 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ + C Q+ RP ++VS+L
Sbjct: 233 PT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 2e-51
Identities = 68/271 (25%), Positives = 117/271 (43%), Gaps = 36/271 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
+ +KLG G +G VY+GV KK +AVK L + E EA+V+ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRML------------------LDWSA 189
V+LLG C + +I E+M +L +L + ++ + L+
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 190 NYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
L N L+ ++ K++DFG++R+ G+ A+ + +PE FS
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFS 194
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309
IKSDV++FGVLL EI + + + ++ EL++ E +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRMER-PE 239
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ + C Q + DRP+ E+
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-51
Identities = 54/286 (18%), Positives = 101/286 (35%), Gaps = 42/286 (14%)
Query: 96 KLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155
+G+G FG V++G + G+E+AVK R + + E ++H+N++ +
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67
Query: 156 DKDEKI----LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSR- 194
+ L+ +Y + SL +L T L +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 195 ------LKVSNILLDKDINPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEYAIQG 246
LK NIL+ K+ I+D G+A + + + VGT YM+PE
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 247 I------FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDS-----LTLLGYAWDLWTSNRTL 295
I ++D+++ G++ EI G + L + +
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLT 341
+ + P + + + S L I C + R T + L+
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-50
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 42/271 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV 148
+ +G+G FG V G + G+++AVK + ++ + EASV+ +++H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 149 RLLGCCIDKDEKI-LIYEYMPNKSLDFFLFDPTKRML-LDWSANYSS------------- 193
+LLG +++ + ++ EYM SL +L + +L D +S
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 194 ----RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
L N+L+ +D K+SDFG+ + E + + +PE + FS
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFS 178
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309
KSDV+SFG+LL EI S + Y L + ++ D
Sbjct: 179 TKSDVWSFGILLWEIYSFGRV--PYPRIPLKDV---VPRVEKGYKMDAPDGCPPA----- 228
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ C A RP+ ++ L
Sbjct: 229 -----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 8e-50
Identities = 59/276 (21%), Positives = 98/276 (35%), Gaps = 46/276 (16%)
Query: 95 NKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNL 147
KLG+G FG V +G K +AVK L + + + E + + + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS--------------- 192
+RL G + K+ + E P SL L LL + Y+
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 193 --SRLKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
L N+LL KI DFG+ R + ++ + + +PE FS
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS-- 307
SD + FGV L E+ + + W +++ I ++
Sbjct: 193 HASDTWMFGVTLWEMFTYGQE-----------------PWIGLNGSQILHKIDKEGERLP 235
Query: 308 -SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ N+ + C +DRPT + L +
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-49
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 39/273 (14%)
Query: 91 FSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRL-PGRSGQGLREMKNEASVIAKVQH 144
F LG G FG VYKG+ E +A+K L S + +E+ +EA V+A V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------- 194
++ RLLG C+ + LI + MP L ++ + + + N+ +
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 195 -------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI 247
L N+L+ + KI+DFG+A++ G E + + +M+ E + I
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307
++ +SDV+S+GV + E+++ +D ++ +++
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK--------------PYDGIPASEISSILEKGERLPQ- 234
Query: 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ I + C AD RP E++
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-49
Identities = 59/267 (22%), Positives = 98/267 (36%), Gaps = 38/267 (14%)
Query: 96 KLGEGGFGPVYKGVLK---KGDEIAVKRL-PGRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+LG G FG V +GV + K ++A+K L G EM EA ++ ++ + +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 152 GCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-----------------R 194
G C + +L+ E L FL + + + A
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYAIQGIFSIKSD 253
L N+LL KISDFG+++ G ++ S + +PE FS +SD
Sbjct: 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 194
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313
V+S+GV + E +S + + + I+ E
Sbjct: 195 VWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMECPP-ECPP 239
Query: 314 RYVNIALLCVQESADDRPTMNEVVSML 340
+ C +DRP V +
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 3e-48
Identities = 61/301 (20%), Positives = 108/301 (35%), Gaps = 66/301 (21%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRL-PGRSGQGLREMKNEASVIAK 141
N +GEG FG V++ +AVK L S + + EA+++A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------- 194
+ N+V+LLG C L++EYM L+ FL + + S + S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 195 ---------------------------------LKVSNILLDKDINPKISDFGMARICGG 221
L N L+ +++ KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 222 NELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281
+ +M PE ++ +SDV+++GV+L EI S
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP---------- 242
Query: 282 LGYAWDLWTSNRTLELIDPILEDEYSS--KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339
+ E+I + + + ++ L N+ LC + DRP+ + +
Sbjct: 243 -------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 340 L 340
L
Sbjct: 296 L 296
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-47
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 50/302 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRL-PGRSGQGLREMKNEASVIAK 141
K + + +LG+G FG VY+GV K +A+K + S + E NEASV+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 142 VQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------- 194
++VRLLG ++I E M L +L M + S
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 195 -------------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTY 235
L N ++ +D KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 236 GYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL 295
+MSPE G+F+ SDV+SFGV+L EI + + + + +L L
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVL----RFVMEGGLL 254
Query: 296 ELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAF 355
+ D + + +C Q + RP+ E++S + +E F ++ +F
Sbjct: 255 DKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF--REVSF 302
Query: 356 SY 357
Y
Sbjct: 303 YY 304
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-47
Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 52/297 (17%)
Query: 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQH 144
+ F ++LG G G V+K K G +A K + +R + E V+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------- 194
+V G E + E+M SLD L R+ S
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 195 --------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
+K SNIL++ K+ DFG++ + + VGT YMSPE
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGT 178
Query: 247 IFSIKSDVFSFGVLLLEIVSGK------------------------KTTGFYRTDSLTLL 282
+S++SD++S G+ L+E+ G+ +T RT L
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 283 GYAWDLWTSNRTLELIDPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEV 336
Y D EL+D I+ + S L + + C+ ++ +R + ++
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-47
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 38/272 (13%)
Query: 93 DANKLGEGGFGPVYKGVLKK---GDEIAVKRLPGRSGQG--LREMKNEASVIAKVQHKNL 147
+ +LG G FG V KG + +AVK L + E+ EA+V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK---RMLLDWSA------------NYS 192
VR++G C + + +L+ E L+ +L + +++ N+
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTS-RIVGTYGYMSPEYAIQGIFSI 250
R L N+LL KISDFG+++ +E + +PE FS
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310
KSDV+SFGVL+ E S + + + +++ +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQK--------------PYRGMKGSEVTAMLEKGERMGCPA-G 234
Query: 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ LC ++RP V L +
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 8e-47
Identities = 55/270 (20%), Positives = 106/270 (39%), Gaps = 45/270 (16%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLL 151
++G G F VYKG+ + E+A L R + + K EA ++ +QH N+VR
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 152 GCCID----KDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR--- 194
K +L+ E M + +L +L R +L +R
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 195 -----LKVSNILL-DKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
LK NI + + KI D G+A + + ++GT +M+PE + +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEKY 189
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308
DV++FG+ +LE+ + + R + P D+ +
Sbjct: 190 DESVDVYAFGMCMLEMATSE----------YPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338
+ I C++++ D+R ++ ++++
Sbjct: 240 PEV----KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 1e-46
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 50/277 (18%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG---LREMKNEASVIAKVQ 143
FSD ++G G FG VY + + +A+K++ Q +++ E + K++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS----------- 192
H N ++ GC + + L+ EY + D + L +
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 193 --------SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
+K NILL + K+ DFG A I A + VGT +M+PE +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVIL 184
Query: 245 ---QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301
+G + K DV+S G+ +E+ K + ++++ L + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQNESPA 233
Query: 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338
L+ + S++ N C+Q+ DRPT ++
Sbjct: 234 LQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-45
Identities = 66/289 (22%), Positives = 106/289 (36%), Gaps = 55/289 (19%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRL-PGRSGQGLREMKNEASVIAKV-Q 143
N + +GEG FG V K +KK + A+KR+ S R+ E V+ K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 144 HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR--------- 194
H N++ LLG C + L EY P+ +L FL A +S
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 195 -----------------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231
L NIL+ ++ KI+DFG++R +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMG 186
Query: 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291
+M+ E +++ SDV+S+GVLL EIVS T + T
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--------------PYCGMTC 232
Query: 292 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
E + E + ++ C +E +RP+ +++ L
Sbjct: 233 AELYEKLPQGYRLEKPL-NCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-45
Identities = 67/339 (19%), Positives = 114/339 (33%), Gaps = 74/339 (21%)
Query: 49 LKANNVNIELPVNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKG 108
+ ++ N V+ ++ + K E + LG G FG V
Sbjct: 10 VTGSSDNEYFYVDFREYEYDLKWEFPR-------------ENLEFGKVLGSGAFGKVMNA 56
Query: 109 VLKKGDE------IAVKRLPGRSGQGLRE-MKNEASVIAKV-QHKNLVRLLGCCIDKDEK 160
+ +AVK L ++ RE + +E ++ ++ H+N+V LLG C
Sbjct: 57 TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116
Query: 161 ILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-------------------------- 194
LI+EY L +L ++ D + +
Sbjct: 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 176
Query: 195 -------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 241
L N+L+ KI DFG+AR + +M+PE
Sbjct: 177 MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236
Query: 242 YAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301
+GI++IKSDV+S+G+LL EI S + + L + ++
Sbjct: 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANF---YKLIQNGFKMDQPFYA 292
Query: 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
E+ Y I C + RP+ + S L
Sbjct: 293 TEEIY----------IIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-44
Identities = 55/267 (20%), Positives = 111/267 (41%), Gaps = 43/267 (16%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 153
+LG+G FG VYK K+ A K + +S + L + E ++A H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 154 CIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------LK 196
++ ++ E+ ++D + + + + + LK
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137
Query: 197 VSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-----QGIFSIK 251
NIL D + K++DFG++ + ++ +GT +M+PE + + K
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 252 SDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS--K 309
+DV+S G+ L+E+ + + + + +L + L P +SS K
Sbjct: 196 ADVWSLGITLIEMAEIE--PPHHELNPMRVL----LKIAKSEPPTLAQP---SRWSSNFK 246
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEV 336
L + C++++ D R T +++
Sbjct: 247 DFLKK-------CLEKNVDARWTTSQL 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 65/294 (22%), Positives = 102/294 (34%), Gaps = 56/294 (19%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQGLRE-MKNEASVIAK 141
N+ S LG G FG V + +AVK L + RE + +E V++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 142 V-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFD---------------PTKRMLL 185
+ H N+V LLG C ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 186 DW------------------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQA 226
D S N R L NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286
+M+PE +++ +SDV+S+G+ L E+ S +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-------------PYP 249
Query: 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
+ ++ ++I +H +I C RPT ++V ++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-43
Identities = 59/264 (22%), Positives = 106/264 (40%), Gaps = 35/264 (13%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLP-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 152
LGEG +G V V + + +AVK + R+ +K E + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 153 CCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------L 195
+ + + L EY L + P M + + + +
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 129
Query: 196 KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDV 254
K N+LLD+ N KISDFG+A + N + +++ GT Y++PE + F + DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLR 314
+S G++L +++G+ +DS + T + ID LL
Sbjct: 190 WSCGIVLTAMLAGELPW-DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-------LLH 241
Query: 315 YVNIALLCVQESADDRPTMNEVVS 338
+ E+ R T+ ++
Sbjct: 242 ------KILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-43
Identities = 63/275 (22%), Positives = 102/275 (37%), Gaps = 52/275 (18%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHKNLVRLL 151
+G G +G K K G + K L + + + +E +++ +++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 152 GCCIDKDEKI--LIYEYMPNKSLDFFLFDPTK-RMLLDW--------------------- 187
ID+ ++ EY L + TK R LD
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 188 --SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
R LK +N+ LD N K+ DFG+ARI + A VGT YMSPE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304
+ ++ KSD++S G LL E+ + +T+ EL I E
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAGKIREG 229
Query: 305 EYSS--KHMLLRYVNIALLCVQESADDRPTMNEVV 337
++ I + RP++ E++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-43
Identities = 50/269 (18%), Positives = 96/269 (35%), Gaps = 39/269 (14%)
Query: 96 KLGEGGFGPVYKGVLKKGDE----IAVKRLPGRSGQGLRE-MKNEASVIAKVQHKNLVRL 150
+GEG FG V++G+ + +A+K + +RE EA + + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------------- 194
+G + + +I E L FL + L Y+ +
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+ N+L+ + K+ DFG++R + S+ +M+PE F+ SD
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASD 191
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLL 313
V+ FGV + EI+ ++ + + L +
Sbjct: 192 VWMFGVCMWEILMHGVKPFQGVKNNDVI-----GRIENGERLPMPPNCPPT--------- 237
Query: 314 RYVNIALLCVQESADDRPTMNEVVSMLTD 342
++ C RP E+ + L+
Sbjct: 238 -LYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-43
Identities = 67/275 (24%), Positives = 120/275 (43%), Gaps = 36/275 (13%)
Query: 80 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASV 138
S SV K++ K+G+G G VY + G E+A++++ + + NE V
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 139 IAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK---------RMLLD--- 186
+ + ++ N+V L + DE ++ EY+ SL + + R L
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 187 --WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
S R +K NILL D + K++DFG Q+ S +VGT +M+PE
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVV 188
Query: 244 IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILE 303
+ + K D++S G++ +E++ G+ + + L L L +N T EL +P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRAL----YLIATNGTPELQNP--- 239
Query: 304 DEYSS--KHMLLRYVNIALLCVQESADDRPTMNEV 336
++ S+ + L R C+ + R + E+
Sbjct: 240 EKLSAIFRDFLNR-------CLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-42
Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 45/266 (16%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEI-AVKRLP---GRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG+G FG VY K+ I A+K L +++ E + + ++H N++RL
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---------------- 194
G D LI EY P ++ L + +A Y +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHR 130
Query: 195 -LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSD 253
+K N+LL KI+DFG + + + + GT Y+ PE + K D
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVD 186
Query: 254 VFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS-SKHML 312
++S GVL E + GK + +N E I E++ +
Sbjct: 187 LWSLGVLCYEFLVGKP------------------PFEANTYQETYKRISRVEFTFPDFVT 228
Query: 313 LRYVNIALLCVQESADDRPTMNEVVS 338
++ ++ + RP + EV+
Sbjct: 229 EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-41
Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 39/263 (14%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRL 150
LGEG F V E A+K L R + + E V++++ H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR------ 194
D ++ Y N L ++ ++ +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILL++D++ +I+DFG A++ QA + VGT Y+SPE + SD+
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 193
Query: 255 FSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS-SKHMLL 313
++ G ++ ++V+G + + + I++ EY +
Sbjct: 194 WALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 314 RYVNIALLCVQESADDRPTMNEV 336
+ ++ + A R E+
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEM 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-39
Identities = 63/295 (21%), Positives = 99/295 (33%), Gaps = 55/295 (18%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRSGQG-LREMKNEASVIAK 141
++ LG G FG V + +AVK L + R + +E ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 142 -VQHKNLVRLLGCCIDKDEKILI-YEYMPNKSLDFFLF-------------DPTKRMLLD 186
H N+V LLG C +++ E+ +L +L + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 187 W------------------SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQAN 227
S R L NILL + KI DFG+AR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWD 287
+M+PE +++I+SDV+SFGVLL EI S + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEFCR 248
Query: 288 LWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
+ D + Y L C RPT +E+V L +
Sbjct: 249 RLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-38
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 57/294 (19%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRL-PGRSGQGLREMKNEASVI 139
++ LGEG FG V + ++AVK L + + L ++ +E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 140 AKV-QHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR---- 194
+ +HKN++ LLG C +I EY +L +L L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 195 ----------------------------LKVSNILLDKDINPKISDFGMARICGGNELQA 226
L N+L+ +D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW 286
T+ +M+PE I++ +SDV+SFGVLL EI + + Y + L +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL---F 247
Query: 287 DLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSML 340
L ++ + + C RPT ++V L
Sbjct: 248 KLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 3e-38
Identities = 48/266 (18%), Positives = 93/266 (34%), Gaps = 46/266 (17%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG G FG V++ + G+ A K + ++ E ++ ++H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-----------------RLKV 197
D +E ++IYE+M L + D +M D + Y LK
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 152
Query: 198 SNILLDKDINP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
NI+ + K+ DFG+ + + GT + +PE A +D++
Sbjct: 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMW 209
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315
S GVL ++SG + E + + +++
Sbjct: 210 SVGVLSYILLSGLS------------------PFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 316 V-----NIALLCVQESADDRPTMNEV 336
+ + + + R T+++
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (343), Expect = 2e-37
Identities = 52/266 (19%), Positives = 93/266 (34%), Gaps = 46/266 (17%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
+LG G FG V++ V K G K + +KNE S++ ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS-----------------RLKV 197
DK E +LI E++ L + +M NY +K
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKP 155
Query: 198 SNILLDKDINP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
NI+ + KI DFG+A +E+ T + +PE + +D++
Sbjct: 156 ENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMW 212
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315
+ GVL ++SG + LE + + ++
Sbjct: 213 AIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 316 VNIALL-----CVQESADDRPTMNEV 336
V+ +Q+ R T+++
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (330), Expect = 6e-36
Identities = 50/276 (18%), Positives = 99/276 (35%), Gaps = 49/276 (17%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHK 145
+ + + LG G F V K+ +A+K + ++ +G M+NE +V+ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRL---------- 195
N+V L LI + + L + + ++ ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL 126
Query: 196 ----------KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+ LD+D ISDFG++++ + S GT GY++PE Q
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQ 183
Query: 246 GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305
+S D +S GV+ ++ G + +L + IL+ E
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFEQILKAE 225
Query: 306 YSSKHMLLRYV-----NIALLCVQESADDRPTMNEV 336
Y + + +++ + R T +
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-35
Identities = 46/266 (17%), Positives = 97/266 (36%), Gaps = 47/266 (17%)
Query: 96 KLGEGGFGPVYKGVLKKGDEI-AVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 154
LG G FG V++ V + K + G +K E S++ +H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 155 IDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR-----------------LKV 197
+E ++I+E++ + + + +Y + ++
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 198 SNILLD--KDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVF 255
NI+ + KI +FG AR + N + Y +PE + S +D++
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMW 187
Query: 256 SFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRY 315
S G L+ ++SG + + ++I+ I+ EY+ +
Sbjct: 188 SLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 316 VNIALL-----CVQESADDRPTMNEV 336
++I + + + R T +E
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 126 bits (317), Expect = 2e-34
Identities = 51/284 (17%), Positives = 103/284 (36%), Gaps = 49/284 (17%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSGQGLREMKNEASVIAKVQ 143
++++ LG GG V+ + ++AVK L R + EA A +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 144 HKNLVRLLGCCIDKDEKI----LIYEYMPNKSLDFFLFDPTKR---------------ML 184
H +V + + ++ EY+ +L + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 185 LDWSANYSSR-LKVSNILLDKDINPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 242
R +K +NI++ K+ DFG+AR I T+ ++GT Y+SPE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302
A +SDV+S G +L E+++G+ +T + + + +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGDSPVSVAYQHV 227
Query: 303 EDEYSSKHMLLRYV-----NIALLCVQESADDRP-TMNEVVSML 340
++ + + L + ++ ++R T E+ + L
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-34
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 41/288 (14%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLRE-MKNEASVIAKVQHK 145
++++ + +GEG +G V +A+K++ Q + E ++ + +H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW------------------ 187
N++ + + + Y+ + L+ K L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 188 SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAIQ 245
SAN R LK SN+LL+ + KI DFG+AR+ + + V T Y +PE +
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 246 GIFSIKS-DVFSFGVLLLEIVSGKKTTGFYRTDSLTLL--------GYAWDLWTSNRTLE 296
KS D++S G +L E++S + F L L + + L+
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNR--PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 297 LIDPILEDEYSSKHMLLRYVN------IALL--CVQESADDRPTMNEV 336
+ +L + +K R + LL + + R + +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 6e-34
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSGQGLREMKNEASVIAKVQHKNLVRL 150
LG G FG V+ + G A+K L + + +E +++ V H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 151 LGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR------ 194
G D + +I +Y+ L L + + S+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 195 LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDV 254
LK NILLDK+ + KI+DFG A+ + T + GT Y++PE ++ D
Sbjct: 130 LKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 255 FSFGVLLLEIVSGKK 269
+SFG+L+ E+++G
Sbjct: 185 WSFGILIYEMLAGYT 199
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-34
Identities = 54/273 (19%), Positives = 96/273 (35%), Gaps = 53/273 (19%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLP------GRSGQGLREMKNEASVIAKVQHKNLV 148
+LG G F V K K G + A K + R G +++ E S++ ++QH N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR---- 194
L +K + ILI E + L FL + + +L+ S
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 195 --LKVSNILLDKD----INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
LK NI+L KI DFG+A I GT +++PE
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPL 193
Query: 249 SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308
+++D++S GV+ ++SG + + E + + Y
Sbjct: 194 GLEADMWSIGVITYILLSGA------------------SPFLGDTKQETLANVSAVNYEF 235
Query: 309 KHMLLRYVNIALL-----CVQESADDRPTMNEV 336
+ + + + R T+ +
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 1e-33
Identities = 43/280 (15%), Positives = 92/280 (32%), Gaps = 37/280 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
N++ K+G G FG +Y G G+E+A+K ++ ++ E+ + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
+ + C + + ++ + SL+ +++ L + +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 195 ----LKVSNIL---LDKDINPKISDFGMARICGGNELQAN-----TSRIVGTYGYMSPEY 242
+K N L K I DFG+A+ + + GT Y S
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 243 AIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302
+ S + D+ S G +L+ G + + + +E++
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342
E + C DD+P + + + +
Sbjct: 245 PSE---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-33
Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 46/299 (15%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQG-----LREMKNEASVIAKVQHKNLV 148
+ LGEG F VYK K +A+K++ R E ++ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 149 RLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANY----------------- 191
LL K L++++M + D + + Y
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 192 SSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ-GIFSI 250
LK +N+LLD++ K++DFG+A+ G + V T Y +PE ++ +
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 251 KSDVFSFGVLLLEIVSGKKTTGFYRTDSL---------TLLGYAWDLWTSNRTLELIDPI 301
D+++ G +L E++ F DS TL + W +L
Sbjct: 181 GVDMWAVGCILAELLLRVP---FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 302 LEDEYSSKHMLLRYVNIALL-----CVQESADDRPTMNEVVSM--LTDEAAALFPPKQP 353
H + LL + R T + + M ++ + P
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (301), Expect = 6e-32
Identities = 39/288 (13%), Positives = 92/288 (31%), Gaps = 51/288 (17%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
+ ++GEG FG +++G ++A+K P RS ++++E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 148 VRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------- 194
+ + + ++ + SL+ L ++ + A + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 195 ----LKVSNILLDKDINP-----KISDFGMARICGGNELQAN-----TSRIVGTYGYMSP 240
+K N L+ + + + DFGM + + + + GT YMS
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 241 EYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300
+ S + D+ + G + + + G W + + +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGS---------------LPWQGLKAATNKQKYER 227
Query: 301 ILEDEYSSKHMLLR------YVNIALLCVQESADDRPTMNEVVSMLTD 342
I E + S+ L + + D P + + + +
Sbjct: 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-32
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 33/237 (13%)
Query: 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSGQGLREMKNEASVIAKV-QHKNLVR 149
LG+G FG V+ KK A+K L + E V++ +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 150 LLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSRL-------------- 195
+ K+ + EY+ L + + + L + Y++ +
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVY 126
Query: 196 ---KVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKS 252
K+ NILLDKD + KI+DFGM + + + NT GT Y++PE + ++
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSV 184
Query: 253 DVFSFGVLLLEIVSGKKTTGFYRTDSLTLL------GYAWDLWTSNRTLELIDPILE 303
D +SFGVLL E++ G+ + F+ D L + W +L+ +
Sbjct: 185 DWWSFGVLLYEMLIGQ--SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (301), Expect = 2e-31
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 28/204 (13%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSGQGLREMKNEASVIAKVQ- 143
N FS +G GGFG VY G A+K L + QG NE +++ V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 144 --HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDW-------------- 187
+V + D+ I + M L + L D
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 188 -SANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQ 245
+ R LK +NILLD+ + +ISD G+A + VGT+GYM+PE +
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK 179
Query: 246 GI-FSIKSDVFSFGVLLLEIVSGK 268
G+ + +D FS G +L +++ G
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 118 bits (296), Expect = 3e-31
Identities = 57/285 (20%), Positives = 97/285 (34%), Gaps = 59/285 (20%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP--------GRSGQGLRE-MKNEASVI 139
+ LG G V + + K E AVK + Q LRE E ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 140 AKVQ-HKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLD-- 186
KV H N+++L L+++ M L +L + R LL+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 187 ---WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 242
N R LK NILLD D+N K++DFG + E + GT Y++PE
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEI 180
Query: 243 A------IQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296
+ + D++S GV++ +++G + + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PFWHRKQML 222
Query: 297 LIDPILEDEYSSKHMLLRYV-----NIALLCVQESADDRPTMNEV 336
++ I+ Y ++ + R T E
Sbjct: 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-31
Identities = 55/269 (20%), Positives = 89/269 (33%), Gaps = 55/269 (20%)
Query: 96 KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKN------EASVIAKVQ--HKN 146
LG GGFG VY G+ +A+K + E+ N E ++ KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------ 194
++RLL D +LI E F + + + ++ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 195 -----LKVSNILLDKD-INPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY-AIQGI 247
+K NIL+D + K+ DFG + + GT Y PE+
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186
Query: 248 FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307
+ V+S G+LL ++V G F + + + S+ LI
Sbjct: 187 HGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSSECQHLIR-------- 236
Query: 308 SKHMLLRYVNIALLCVQESADDRPTMNEV 336
C+ DRPT E+
Sbjct: 237 -------------WCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 9e-31
Identities = 55/281 (19%), Positives = 104/281 (37%), Gaps = 37/281 (13%)
Query: 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHKN 146
F K+GEG +G VYK K G+ +A+K RL + E S++ ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSSR------------ 194
+V+LL +++ L++E++ F + L +Y +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 195 -----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
LK N+L++ + K++DFG+AR G ++ T +V + +S
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL-----------GYAWDLWTSNRTLELI 298
D++S G + E+V+ + F + L W TS +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRAL--FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 299 DPILEDEYSSK---HMLLRYVNIALLCVQESADDRPTMNEV 336
P + SK + ++ + + R +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-30
Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 48/292 (16%)
Query: 87 ATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLPGRSGQG------LREMKNEASV 138
A ++ ++GEG +G V+K K G +A+KR+ ++G+ +RE+
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRH 63
Query: 139 IAKVQHKNLVRLLGCCIDKDEK-----ILIYEYMPNKSLDFFLFDPTKRMLLDWSANYSS 193
+ +H N+VRL C L++E++ + P + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 194 R-----------------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYG 236
+ LK NIL+ K++DFG+ARI + +V T
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 180
Query: 237 YMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE 296
Y +PE +Q ++ D++S G + E+ K F + + LG D+ +
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGEED 238
Query: 297 LIDPILEDEYSSKHMLLRYVN----------IALL--CVQESADDRPTMNEV 336
+ + + + LL C+ + R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (282), Expect = 3e-29
Identities = 52/280 (18%), Positives = 105/280 (37%), Gaps = 35/280 (12%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHKN 146
K+ K+GEG +G VYK G+ A+K RL E S++ +++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 147 LVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKR---------------MLLDWSANY 191
+V+L K +L++E++ +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 192 SSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI-QGIFS 249
R LK N+L++++ KI+DFG+AR G + + T Y +P+ + +S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYS 179
Query: 250 IKSDVFSFGVLLLEIVSGK-------------KTTGFYRTDSLTLLGYAWDLWTSNRTLE 296
D++S G + E+V+G + T + +L +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 297 LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEV 336
+ +P+ + + K + +++ ++ + R T +
Sbjct: 240 VYEPLPWESF-LKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-29
Identities = 53/293 (18%), Positives = 107/293 (36%), Gaps = 45/293 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP--GRSGQGLREMKNEASVIAKVQHK 145
+K+ K+G+G FG V+K +K G ++A+K++ E ++ ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 146 NLVRLLGCCIDKDEKI--------LIYEYMPNKSLDFFLFDPTK----------RMLLDW 187
N+V L+ C K L++++ + K +MLL+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 188 SANYSSR------LKVSNILLDKDINPKISDFGMARI--CGGNELQANTSRIVGTYGYMS 239
+K +N+L+ +D K++DFG+AR N + V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 240 PEYAIQGI-FSIKSDVFSFGVLLLEIVSGKK-TTGFYRTDSL--------TLLGYAWDLW 289
PE + + D++ G ++ E+ + G L ++ W
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 290 TSNRTLELIDPILEDEYSSKHMLLRYVN----IALL--CVQESADDRPTMNEV 336
+ E ++ + + K L YV + L+ + R ++
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 50/206 (24%), Positives = 82/206 (39%), Gaps = 35/206 (16%)
Query: 91 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVR 149
++D +G G FG VY+ L G+ +A+K++ Q R E ++ K+ H N+VR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 150 LLGCCIDKDEK------ILIYEYMPNKSLDFFLFDPTKRMLLDW---------------- 187
L EK L+ +Y+P + L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 188 --SANYSSR-LKVSNILLDKDIN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 243
S R +K N+LLD D K+ DFG A+ E + + + Y +PE
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAPELI 194
Query: 244 IQGI-FSIKSDVFSFGVLLLEIVSGK 268
++ DV+S G +L E++ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-27
Identities = 55/280 (19%), Positives = 105/280 (37%), Gaps = 33/280 (11%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLPGRSGQGLREMKNEASVIAKVQHK 145
K+ K+GEG +G V+K ++ + +A+K RL E ++ +++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLD---------------FFLFDPTKRMLLDWSAN 190
N+VRL + L++E+ FLF K + S N
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 191 YSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R LK N+L++++ K+++FG+AR G ++ ++ +V + ++S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL-----LGYAWDLWTSNRTLELIDPILED 304
D++S G + E+ + + L L +L D
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 305 EYSSKHMLLRYVN------IALL--CVQESADDRPTMNEV 336
Y + L+ V LL ++ + R + E
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-27
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 22/200 (11%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLP---GRSGQGLREMKNEASVIAKVQH 144
N F LG+G FG V K G A+K L + + E+ V+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 145 KNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR 194
L L D + EY L F L ++ SR
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 195 ------LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIF 248
+K+ N++LDKD + KI+DFG+ + + A GT Y++PE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDY 182
Query: 249 SIKSDVFSFGVLLLEIVSGK 268
D + GV++ E++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 44/267 (16%)
Query: 97 LGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC 154
LG G G V + K+ ++ A+K L Q + + E + + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 155 IDKDEK----ILIYEYMPNKSLDFFLFDPTKRMLLDW-----------------SANYSS 193
+ +++ E + L + D + + S N +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 134
Query: 194 R-LKVSNILLDKDINP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFS 249
R +K N+L K++DFG A+ + T Y++PE +
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYD 191
Query: 250 IKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSK 309
D++S GV++ ++ G FY L + + T R + P E S+
Sbjct: 192 KSCDMWSLGVIMYILLCGY--PPFYSNHGLAIS---PGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 310 HMLLRYVNIALLCVQESADDRPTMNEV 336
+ + ++ R T+ E
Sbjct: 247 EV----KMLIRNLLKTEPTQRMTITEF 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 102 bits (256), Expect = 2e-25
Identities = 37/228 (16%), Positives = 91/228 (39%), Gaps = 32/228 (14%)
Query: 60 VNSKQTKRSKKKEVDQLPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAV 118
VN+ + + E + + + + KLG G + V++ + +++ V
Sbjct: 13 VNTHRPREYWDYESHVVEWGNQ-------DDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 119 KRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEK--ILIYEYMPNKSLD-- 173
K L +++K E ++ ++ N++ L D + L++E++ N
Sbjct: 66 KILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 174 ----------FFLFDPTKRMLLDWSANYSSR-LKVSNILLD-KDINPKISDFGMARICGG 221
F++++ K + S R +K N+++D + ++ D+G+A
Sbjct: 123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182
Query: 222 NELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGK 268
+ + V + + PE + ++ D++S G +L ++ K
Sbjct: 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 69 KKKEVDQLPLFSFSSVSTAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG 126
K + D L + S +TA ++F LG G FG V K+ G+ A+K L +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 127 QGLREMK---NEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTKRM 183
L++++ NE ++ V LV+L D ++ EY+ + L R
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRF 138
Query: 184 LLDWSANYSSR-----------------LKVSNILLDKDINPKISDFGMARICGGNELQA 226
+ Y+++ LK N+L+D+ +++DFG A+ G
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194
Query: 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
T + GT ++PE + ++ D ++ GVL+ E+ +G
Sbjct: 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 1e-23
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 43/286 (15%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHK 145
+ D +G G +G V V + G ++A+K+L P +S + E ++ ++H+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 146 NLVRLLGCCIDKD------EKILIYEYMPNKSLDF-----FLFDPTKRMLLD-------- 186
N++ LL + + L+ +M D + ++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 187 WSANYSSR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI- 244
+A R LK N+ +++D KI DFG+AR + + + V T Y +PE +
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILN 192
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK---------KTTGFYRTDSLTLLGYAWDLWTSNRTL 295
++ D++S G ++ E+++GK + T S+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 296 ELIDPILEDEYSSKHMLLRYVN---IALL--CVQESADDRPTMNEV 336
+ + E E +L + + LL + A+ R T E
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.1 bits (243), Expect = 2e-23
Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 25/202 (12%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--PGRSGQGLREMKNEASVIAKVQHK 145
++ + +G G G V +A+K+L P ++ + E ++ V HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 146 NLVRLLGCCIDKD------EKILIYEYMPNKSLDFFLFDPTKRML-------------LD 186
N++ LL + + L+ E M + + L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 187 WSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQG 246
+ LK SNI++ D KI DFG+AR G + + + V T Y +PE +
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGM 193
Query: 247 IFSIKSDVFSFGVLLLEIVSGK 268
+ D++S G ++ E+V K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 4e-21
Identities = 39/204 (19%), Positives = 77/204 (37%), Gaps = 27/204 (13%)
Query: 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--PGRSGQGLREMKNEASVIAKVQH 144
++ + + +G G +G V K G +AVK+L P +S + E ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 145 KNLVRLLGCCIDKD---EKILIYEYMPNKSLDFFLFDPTKRMLLDWSANYS--------- 192
+N++ LL E +Y D +++ D
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 193 --------SRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAI 244
LK SN+ +++D KI DFG+AR T + +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLN 192
Query: 245 QGIFSIKSDVFSFGVLLLEIVSGK 268
++ D++S G ++ E+++G+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 4e-21
Identities = 42/201 (20%), Positives = 77/201 (38%), Gaps = 28/201 (13%)
Query: 95 NKLGEGGFGPVYKGVLKK----GDEIAVKRLP----GRSGQGLREMKNEASVIAKVQHK- 145
LG G +G V+ G A+K L + + + E V+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 146 NLVRLLGCCIDKDEKILIYEYMPNKSLDFFLFDPTK----------RMLLDWSANYSSR- 194
LV L + + LI +Y+ L L + ++ +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149
Query: 195 -----LKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGI-- 247
+K+ NILLD + + ++DFG+++ +E + GT YM+P+ G
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSG 208
Query: 248 FSIKSDVFSFGVLLLEIVSGK 268
D +S GVL+ E+++G
Sbjct: 209 HDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.9 bits (211), Expect = 3e-19
Identities = 32/215 (14%), Positives = 72/215 (33%), Gaps = 36/215 (16%)
Query: 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL 147
++ KLG G F V+ +A+K + G ++E ++ +V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 148 VRLLGCCIDKDEKILIY---------------EYMPNKSLDFFLFDPTKRMLLDWSANYS 192
+ + K+L + E + L + + L + S
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 193 SR------------------LKVSNILLDK-DINPKISDFGMARICGGNELQANTSRIVG 233
+ +K N+L++ D + +A + + + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 234 TYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK 268
T Y SPE + + +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 6e-15
Identities = 32/193 (16%), Positives = 58/193 (30%), Gaps = 31/193 (16%)
Query: 95 NKLGEGGFGPVYKGVLKKGDEIAVKRL----------PGRSGQGLREMKNEASVIAKVQH 144
+GEG V+ +K E VK + G A A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 145 KNLVRLLGCCI----DKDEKILIYEYMPNKSLDFFLFDPTKRMLLD--------WSANYS 192
+ L +L G + + ++ E + K L + +L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 193 SR-LKVSNILLDKDINPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYAIQGIFSI 250
L N+L+ + I DF + G + R + Y S Y
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RT 178
Query: 251 KSDVFSFGVLLLE 263
+ D+ S +L+
Sbjct: 179 EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.82 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.93 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=382.27 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=188.8
Q ss_pred HHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 85 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 85 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+...++|++.+.||+|+||.||+|+++ ..||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 344578999999999999999999875 36999998643 34556789999999999999999999998754 56799
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||||++|+|.+++...... .++|..+++||||||+||||+.++.+||+|||+|+........
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999988654321 2578888999999999999999999999999999876543333
Q ss_pred cccccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||....... ........ ... .+..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~----~~~----~p~~ 231 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGR----GYL----SPDL 231 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHH----TSC----CCCG
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhc----CCC----CCcc
Confidence 34455689999999999964 358999999999999999999999985432211 11111111 100 0111
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccC
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALF 348 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~ 348 (387)
. .....++..+.+|+.+||+.||++||||+||++.|+.+.+++|
T Consensus 232 ~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 232 S--KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp G--GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred h--hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0 1122345678899999999999999999999999999876654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=376.47 Aligned_cols=240 Identities=26% Similarity=0.385 Sum_probs=181.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468888999999999999999988888999999754 3445789999999999999999999999999999999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+|+|.+++...... .++|..+++||||||+|||++.++.+||+|||+|+........ .....
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~ 162 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGT 162 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce-eecce
Confidence 99999987654321 2477788899999999999999999999999999876543322 22335
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
.||..|+|||++.+..|+.++|||||||++|||+|+..|+..... .......... ... ...+..+
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~---~~~-----------~~~p~~~ 227 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDIST---GFR-----------LYKPRLA 227 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHH---TCC-----------CCCCTTS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHh---cCC-----------CCCcccc
Confidence 789999999999999999999999999999999996555432211 1111111111 000 0112233
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
+..+.+|+.+||+.||++||||+||++.|+++.+
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 4578899999999999999999999999998865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=375.54 Aligned_cols=237 Identities=22% Similarity=0.280 Sum_probs=186.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4679999999999999999999865 8899999986542 2334578899999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
||++|+|.+++..... ..++|..+++||||||+|||+++++.+||+|||+|+............
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 9999999998865432 125788889999999999999999999999999999765444333445
Q ss_pred cccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 230 RIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
..+||+.|||||++.+..+ +.++|||||||++|||++|+.||............. ...... ....
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~---------~~~~ 229 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY---------LNPW 229 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTT---------STTG
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCC---------CCcc
Confidence 5789999999999988876 678999999999999999999986443322211111 000000 0011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223456789999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-52 Score=380.48 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=195.7
Q ss_pred hhHHHHhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 82 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 82 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
..++...++|++.+.||+|+||+||+|++.. ++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 4455566788899999999999999999875 788999999754 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGN 222 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 222 (387)
++|||||++|+|..++..... ..++|..+++||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999888754321 12578888999999999999999999999999999876543
Q ss_pred CcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
... ......|++.|+|||++.+..|+.++|||||||++|||++|..|+...... ... ........
T Consensus 169 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~----~~~i~~~~--------- 233 (287)
T d1opja_ 169 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQV----YELLEKDY--------- 233 (287)
T ss_dssp SSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHH----HHHHHTTC---------
T ss_pred Cce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHH----HHHHhcCC---------
Confidence 322 223346889999999999999999999999999999999987775332211 111 11111110
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
.. ..+..++..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 234 ~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 RM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 1122345678999999999999999999999999987753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=374.03 Aligned_cols=243 Identities=29% Similarity=0.404 Sum_probs=191.1
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++...++|++.+.||+|+||.||+|+++++..||||++... ....+.|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 44456788899999999999999999988888999999754 3445789999999999999999999998864 567999
Q ss_pred EEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 164 YEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||++|+|.+++..... ..++|..+++||||||+||||++++.+||+|||+|+.......
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 999999999887754322 1257888889999999999999999999999999998764432
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.......||+.|||||++.+..|+.++|||||||++|||+||..|+...... ....... .... .+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i----~~~~-----~~----- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNL----ERGY-----RM----- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHH----HTTC-----CC-----
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HhcC-----CC-----
Confidence 2234457899999999999999999999999999999999976664322211 1111111 1100 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
..+..++..+.+|+.+||+.||++||||++|++.|++..
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 112234557889999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=371.78 Aligned_cols=235 Identities=22% Similarity=0.349 Sum_probs=189.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||+||+|+... |+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4579999999999999999999764 899999998755555667899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 167 MPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
|++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+....... .....
T Consensus 99 ~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTM 176 (293)
T ss_dssp CTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCC
T ss_pred cCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--ccccc
Confidence 999999887754321 1358888999999999999999999999999999987653322 23446
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .. ........... .. ..+...
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~---~~~~~~~~~~~------~~---~~~~~~ 242 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LR---ALYLIATNGTP------EL---QNPEKL 242 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH---HHHHHHHHCSC------CC---SSGGGS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HH---HHHHHHhCCCC------CC---CCcccC
Confidence 899999999999999999999999999999999999999843221 11 11111111100 00 012234
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
+..+.+|+.+||+.||++|||++|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 567889999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=362.91 Aligned_cols=236 Identities=28% Similarity=0.391 Sum_probs=191.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecC
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMP 168 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 168 (387)
++|++.+.||+|+||+||+|+++++..||||+++... ...++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6789999999999999999999878899999997543 345789999999999999999999999999999999999999
Q ss_pred CCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 169 NKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 169 ~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
+|+|..++...... .++|..+++||||||+|||++.++.+||+|||+++........ .....
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 99998886554331 2578889999999999999999999999999999876544322 23345
Q ss_pred cCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHH
Q 041766 232 VGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKH 310 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (387)
.||..|+|||.+.+..|+.++|||||||++|||+| |+.||..... ....... ..... ...+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i----~~~~~----------~~~p~~ 225 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHI----AQGLR----------LYRPHL 225 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHH----HTTCC----------CCCCTT
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHH----HhCCC----------CCCccc
Confidence 78999999999999999999999999999999998 7888753321 1111111 11100 011223
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 311 MLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 311 ~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
.+..+.+|+.+||+.||++||||+++++.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 34578899999999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-51 Score=374.18 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=179.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC---EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||+||+|+++. ++ .||||.+... .....+.|.+|+++|++++|||||+++|+|...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 567778899999999999999764 32 5899998654 444567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
||||++|+|..++...... .++|..+++||||||+||||+.++.+||+|||+|+.........
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcc
Confidence 9999999999887664321 25788889999999999999999999999999998765432221
Q ss_pred ---ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 227 ---NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 227 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
......||+.|||||.+.+..|+.++|||||||++|||+| |+.||..... ..+...... ..
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~---~~---------- 250 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQ---DY---------- 250 (299)
T ss_dssp ----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT---TC----------
T ss_pred eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CC----------
Confidence 1122457899999999999999999999999999999998 8888743221 111111111 00
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
. ...+..++..+.+|+.+||+.||++||||.||++.|+++..
T Consensus 251 ~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 R-LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 0 01223345678899999999999999999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=367.45 Aligned_cols=229 Identities=23% Similarity=0.281 Sum_probs=185.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+++. ++.||+|++... .......+.+|+++|++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 568899999999999999999875 889999998532 2334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+...... .
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~ 161 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----R 161 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----C
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc----c
Confidence 99999999888754322 135788889999999999999999999999999998654332 3
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||+.|||||++.+..|+.++|||||||++|||++|+.||..... .. ....... .. . ..+
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~---~~~~i~~-~~------~-----~~p 224 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QE---TYKRISR-VE------F-----TFP 224 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHHHHT-TC------C-----CCC
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HH---HHHHHHc-CC------C-----CCC
Confidence 346899999999999999999999999999999999999999853221 11 1111111 00 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 223457889999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=370.51 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=192.9
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++...++|++.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.+|++++|||||+++|+|.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 344457899999999999999999999888889999997543 345789999999999999999999999854 567899
Q ss_pred EEecCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 164 YEYMPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
||||++|+|..++..... ..++|..+++||||||+||||++++.+||+|||+|+.......
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 999999999877754221 1257888899999999999999999999999999987643322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.......||+.|+|||++.+..++.++|||||||++|||++|..|+....... ....... ... ..
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~----~~~---------~~- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE----RGY---------RM- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH----TTC---------CC-
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHH----hcC---------CC-
Confidence 22334578999999999999999999999999999999999777754332211 1111111 010 00
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCce
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAF 355 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~ 355 (387)
..+..++..+.+++.+||+.||++|||+.+|++.|++......|+.+|..
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 12223455788999999999999999999999999998877766666543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=371.34 Aligned_cols=234 Identities=23% Similarity=0.358 Sum_probs=186.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+.|++.+.||+|+||.||+|++.. +..||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 568889999999999999999865 8899999998766666778999999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 168 PNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 168 ~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+..... ......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cccccc
Confidence 99999888654221 12478889999999999999999999999999999765321 112345
Q ss_pred ccCCCccccccccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 231 IVGTYGYMSPEYAI-----QGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 231 ~~gt~~y~aPE~~~-----~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
..||+.|||||++. +..|+.++|||||||++|||++|+.||...... ... ....... . +.+
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~---~~i~~~~-~-----~~~--- 235 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVL---LKIAKSE-P-----PTL--- 235 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHH---HHHHHSC-C-----CCC---
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHH---HHHHcCC-C-----CCC---
Confidence 68999999999984 456899999999999999999999998543221 111 1111111 0 000
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234567889999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=367.28 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=188.8
Q ss_pred cCCCCCC-cccccCCeeEEEEEEcC---CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDAN-KLGEGGFGPVYKGVLKK---GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~-~lG~G~~g~V~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|.+.+ +||+|+||.||+|.++. +..||||+++.. .....+.|.+|+++|++++|||||+++|+|.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455566 49999999999998753 447999999754 34456789999999999999999999999865 467999
Q ss_pred EEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-
Q 041766 164 YEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ- 225 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 225 (387)
||||++|+|..++...... .++|..+++||||||+|||++.++.+||+|||+|+........
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999999999987554321 2478888999999999999999999999999999987654322
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ....... .....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i----~~~~~---------- 230 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI----EQGKR---------- 230 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH----HTTCC----------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCCC----------
Confidence 22334578999999999999999999999999999999998 8999754321 1111111 11110
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
...+..++..+.+|+.+||+.||++||||.+|++.|+.....+
T Consensus 231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0122334567889999999999999999999999998776543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=366.65 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=181.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCC-----CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKG-----DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
+.|+..+.||+|+||.||+|.++.+ ..||||++... .......|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5677888999999999999997652 36999999654 33445678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||||.+|++..++..... ..++|..+++||||||+||||+.++.+||+|||+|+........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 9999999998877654322 12578888999999999999999999999999999876543221
Q ss_pred -cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 -ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......||+.|||||++.+..|+.++|||||||++|||++|..|+...... ....... .... +.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i----~~~~---------~~ 232 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAI----NDGF---------RL 232 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHH----HTTC---------CC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHH----hccC---------CC
Confidence 1223356899999999999999999999999999999999977665432221 1111111 1110 00
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
..+..++..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 233 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1122345678899999999999999999999999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=376.17 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=185.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
.++|++.+.||+|+||+||+|++.. |+.||+|+++.. .......+.+|+.+|++++|||||+++++|.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999999865 788999998654 33445688999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchh-hhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWS-ANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~-~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||++|+|..++.+... ..++|.. +++||||||+||||+.++.+||+|||+|+..... ..
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~ 160 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 160 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----cc
Confidence 9999999988864322 1247764 7999999999999999999999999999865321 23
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC----------------
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN---------------- 292 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 292 (387)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||.....................
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 4568999999999999999999999999999999999999998654332211100000000000
Q ss_pred --------ccccccccccc---cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 293 --------RTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 293 --------~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000000 00011122457889999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=371.12 Aligned_cols=233 Identities=22% Similarity=0.266 Sum_probs=182.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 568999999999999999999864 889999998532 2334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||++|+|.+++..... ..++|..+++||||||+|||+++++.+||+|||+|+...........
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 99999999887754321 13578888999999999999999999999999999987544433344
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .... ...... ... . .+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~---~~~i~~-~~~------~-----~p 230 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLI---FQKIIK-LEY------D-----FP 230 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHHHT-TCC------C-----CC
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHH---HHHHHc-CCC------C-----CC
Confidence 55689999999999999999999999999999999999999985321 1111 111111 000 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 223457889999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=367.12 Aligned_cols=232 Identities=23% Similarity=0.302 Sum_probs=171.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--CCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--KDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~--~~~~~lv 163 (387)
++|++.+.||+|+||.||+|+... |+.||||.+... .....+.+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578999999999999999999765 889999998654 33445678999999999999999999999875 4568999
Q ss_pred EEecCCCCcchhhcCCcc--------------------ccccchhh-----hhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------RMLLDWSA-----NYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~-----~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
||||++|+|.+++..... ..++|..+ ++||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999988753211 11355543 89999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccc
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELI 298 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (387)
..... .......||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+. ... .......
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~---~~i-~~~~~~~-- 233 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA---GKI-REGKFRR-- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH---HHH-HHTCCCC--
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHH---HHH-HcCCCCC--
Confidence 64322 123446899999999999999999999999999999999999999853221 1111 111 1111100
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 --------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11223457889999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=375.17 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=189.7
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC-C-----CEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeC
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDK 157 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~ 157 (387)
...++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.+|.++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 445788999999999999999999754 2 26999998643 344556889999999998 899999999999999
Q ss_pred CceEEEEEecCCCCcchhhcCCcc---------------------------------------ccccchhhhhhcccCCC
Q 041766 158 DEKILIYEYMPNKSLDFFLFDPTK---------------------------------------RMLLDWSANYSSRLKVS 198 (387)
Q Consensus 158 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------~~~l~~~~~~h~dlk~~ 198 (387)
+..++|||||++|+|.+++..... ..++|..+++||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 999999999999999999865321 12477788899999999
Q ss_pred ceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 041766 199 NILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTD 277 (387)
Q Consensus 199 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~ 277 (387)
|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333445678999999999999999999999999999999998 89987543322
Q ss_pred cchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhh
Q 041766 278 SLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTD 342 (387)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~ 342 (387)
. .+.... ..... ...+..++..+.+|+.+||+.||++||||+||++.|.-
T Consensus 274 ~-~~~~~~----~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 A-NFYKLI----QNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp H-HHHHHH----HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHH----hcCCC----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 111111 11100 01122345678999999999999999999999999853
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=371.12 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=194.0
Q ss_pred hhhHHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeee
Q 041766 81 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGC 153 (387)
Q Consensus 81 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~ 153 (387)
+.+++.+.++|++.+.||+|+||+||+|+++. +..||||++.... ....++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34556677899999999999999999999752 4679999997543 3345679999999999999999999999
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCcc----------------------------------------ccccchhhhhhc
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTK----------------------------------------RMLLDWSANYSS 193 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------~~~l~~~~~~h~ 193 (387)
|...+..+++|||+++|+|.+++..... ..++|..+++||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 9999999999999999999988853211 124677788999
Q ss_pred ccCCCceEEcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 041766 194 RLKVSNILLDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGF 273 (387)
Q Consensus 194 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~ 273 (387)
||||+|||++.++.+||+|||+|+...............|++.|+|||.+.+..|+.++|||||||++|||++|..|+..
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 99999999999999999999999876544433444456788999999999999999999999999999999998654322
Q ss_pred CCCCcchHhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 274 YRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
.. +.......+ ...... ..+..++..+.+|+.+||+.||++||||.||++.|+++.
T Consensus 245 ~~-~~~e~~~~v----~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GM-AHEEVIYYV----RDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TS-CHHHHHHHH----HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC-CHHHHHHHH----HcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 21 111111111 111110 112234457889999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=363.50 Aligned_cols=233 Identities=26% Similarity=0.319 Sum_probs=179.7
Q ss_pred CcccccCCeeEEEEEEcC---CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEecCC
Q 041766 95 NKLGEGGFGPVYKGVLKK---GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYMPN 169 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 169 (387)
++||+|+||.||+|.++. ++.||||+++.. +....+.|.+|+++|++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998754 457999999643 33345689999999999999999999999865 457899999999
Q ss_pred CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-ccccccc
Q 041766 170 KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-ANTSRIV 232 (387)
Q Consensus 170 g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~ 232 (387)
|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+........ .......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 999988865432 12578888899999999999999999999999999876543322 2233457
Q ss_pred CCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccccHHH
Q 041766 233 GTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSSKHM 311 (387)
Q Consensus 233 gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (387)
||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ....... ..... ...+..+
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i----~~~~~----------~~~p~~~ 235 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAML----EKGER----------MGCPAGC 235 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHH----HTTCC----------CCCCTTC
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHH----HcCCC----------CCCCccc
Confidence 8999999999999999999999999999999998 8999753221 1111111 11110 0112334
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhh
Q 041766 312 LLRYVNIALLCVQESADDRPTMNEVVSMLTDEA 344 (387)
Q Consensus 312 ~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~ 344 (387)
+..+.+|+.+||+.||++|||+++|++.|++..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 567889999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=358.61 Aligned_cols=228 Identities=24% Similarity=0.353 Sum_probs=174.5
Q ss_pred CCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe----CCceEEEE
Q 041766 92 SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----KDEKILIY 164 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~----~~~~~lv~ 164 (387)
++.+.||+|+||+||+|++.. +..||+|.+... .....+.+.+|+++|++++|||||++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999999875 789999998643 33455678999999999999999999999875 34578999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhh--hhhcccCCCceEEc-CCCCeEEeeccCceecCCCCcc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSA--NYSSRLKVSNILLD-KDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~--~~h~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||++|+|.+++..... ..++|..+ ++||||||+|||++ .++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC---
Confidence 99999999988854321 12467666 89999999999996 4789999999999864332
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....+||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .+ . ........ + .
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~---~-~~i~~~~~-----~----~ 232 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI---Y-RRVTSGVK-----P----A 232 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH---H-HHHTTTCC-----C----G
T ss_pred -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HH---H-HHHHcCCC-----C----c
Confidence 2334689999999998865 69999999999999999999999985322111 11 1 11111100 0 0
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......++.+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 011122346889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-50 Score=365.78 Aligned_cols=236 Identities=20% Similarity=0.222 Sum_probs=171.2
Q ss_pred HhcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 87 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 87 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
..+.|++.+.||+|+||+||+|++.. ++.||||++.... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45779999999999999999999875 8899999986442 233456789999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEc---CCCCeEEeeccCceecCCCCcc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLD---KDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
|||++|+|.+++..... ..++|..+++||||||+|||+. .++.+||+|||+|+......
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 99999999998865432 1257888999999999999994 57899999999998654332
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDE 305 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (387)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .... ......... . . .
T Consensus 165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~---~~i~~~~~~--~-----~-~ 230 (307)
T d1a06a_ 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLF---EQILKAEYE--F-----D-S 230 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH---HHHHTTCCC--C-----C-T
T ss_pred -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHH---HHHhccCCC--C-----C-C
Confidence 23346899999999999999999999999999999999999999853221 1111 111111100 0 0 0
Q ss_pred cccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 306 YSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 306 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
......++.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011233557889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-49 Score=367.43 Aligned_cols=236 Identities=19% Similarity=0.262 Sum_probs=188.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|++.. |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3689999999999999999999865 889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEc--CCCCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLD--KDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|++|+|.+++...... .++|..+++||||||+|||++ .++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---C
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---c
Confidence 9999998888543321 257888899999999999995 45789999999998775433 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||+.|||||++.+..|+.++|||||||++|||++|+.||.... .... .......... .. ...
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~---~~~i~~~~~~-------~~-~~~ 248 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDET---LRNVKSCDWN-------MD-DSA 248 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH---HHHHHHTCCC-------SC-CGG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHH---HHHHHhCCCC-------CC-ccc
Confidence 334689999999999999999999999999999999999999985321 1111 1111111000 00 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....+..+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12234578899999999999999999999984
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.1e-49 Score=367.79 Aligned_cols=240 Identities=21% Similarity=0.254 Sum_probs=190.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|+... |+.||||++..........+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3679999999999999999999764 899999999766555667888999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEc--CCCCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLD--KDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|++|+|.+++...... .++|..+++||||||+||||+ .++.+||+|||+|+.......
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--- 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc---
Confidence 9999998776543321 257888899999999999997 578999999999998754332
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .... ......... .. ...
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~---~~i~~~~~~-------~~-~~~ 251 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETL---QNVKRCDWE-------FD-EDA 251 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHH---HHHHHCCCC-------CC-SST
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHhCCCC-------CC-ccc
Confidence 3345789999999999999999999999999999999999999853221 1111 111110000 00 001
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
....+..+.+|+.+||+.||++|||++|+++. +++.
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 12335578899999999999999999999873 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=364.81 Aligned_cols=230 Identities=25% Similarity=0.409 Sum_probs=181.1
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEE
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
.+.|+..+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 3458889999999999999999765 7789999986543 23345788999999999999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 999999998765543221 1358888999999999999999999999999999986432
Q ss_pred cccccCCCcccccccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQ---GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... . ........... +..
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~---~~~~~i~~~~~------~~~-- 234 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--M---SALYHIAQNES------PAL-- 234 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--H---HHHHHHHHSCC------CCC--
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--H---HHHHHHHhCCC------CCC--
Confidence 234589999999999864 4589999999999999999999999753211 1 11111111110 001
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 235 --~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 12223457889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=358.16 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=184.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEcC------CCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeE
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCC 154 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~ 154 (387)
.++...++|++.+.||+|+||.||+|++.. ++.||||++... .....+.+.+|..++.++ +|+|||.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 344556789999999999999999999653 357999999754 334456788888888887 799999999998
Q ss_pred EeC-CceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceE
Q 041766 155 IDK-DEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNIL 201 (387)
Q Consensus 155 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nil 201 (387)
... ...++|||||++|+|.+++..... ..++|..+++||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 765 468999999999999998854321 12478888899999999999
Q ss_pred EcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCcch
Q 041766 202 LDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKK-TTGFYRTDSLT 280 (387)
Q Consensus 202 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~-p~~~~~~~~~~ 280 (387)
|+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|.. ||...... ..
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HH
Confidence 99999999999999987655444444455689999999999999999999999999999999999754 55322211 11
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
+...... .... ..+..+++.+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 246 ~~~~~~~----~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FCRRLKE----GTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHH----TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc----CCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111 1110 01222345788999999999999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=357.17 Aligned_cols=243 Identities=21% Similarity=0.278 Sum_probs=178.8
Q ss_pred HHhcCCCCCCcccccCCeeEEEEEEcC----CCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 86 TATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 86 ~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
...++|++.+.||+|+||.||+|++.. +..||||.+... .....+.+.+|+.+|++++|||||+++|++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345688999999999999999998754 346899998654 3344567999999999999999999999986 4678
Q ss_pred EEEEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
++|||||++|+|..++...... .++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999998876543221 24778888999999999999999999999999998765332
Q ss_pred cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
. .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...... .+..... .....
T Consensus 163 ~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~----~~~~~------- 228 (273)
T d1mp8a_ 163 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIE----NGERL------- 228 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHH----TTCCC-------
T ss_pred c-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHH----cCCCC-------
Confidence 2 22334578999999999999999999999999999999998 78886543221 1111111 11100
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
..+..++..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12233456789999999999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=353.49 Aligned_cols=234 Identities=26% Similarity=0.346 Sum_probs=178.5
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEe-CCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-KDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||.||+|+++ |..||||+++.. ...+.+.+|++++++++|||||+++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456888899999999999999986 788999999654 344789999999999999999999999865 4568999999
Q ss_pred cCCCCcchhhcCCcc------------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 167 MPNKSLDFFLFDPTK------------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
+++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----Q 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----C
Confidence 999999999864321 12578888999999999999999999999999999865432 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
....+|..|+|||++.+..++.++|||||||++|||+| |+.|+.... ........ .... .+ ..
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i----~~~~-----~~-----~~ 221 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRV----EKGY-----KM-----DA 221 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHH----TTTC-----CC-----CC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcCC-----CC-----CC
Confidence 33467899999999999999999999999999999998 566654321 11111111 1110 11 12
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
+..++..+.+|+.+||+.||++||||.++++.|+++..
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 22334678899999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=354.61 Aligned_cols=235 Identities=23% Similarity=0.255 Sum_probs=185.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC------CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCce
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR------SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEK 160 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~ 160 (387)
.++|++.+.||+|+||+||+|++.. |+.||||++... .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4689999999999999999999864 889999998532 223467899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCC----CeEEeeccCceecC
Q 041766 161 ILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDI----NPKISDFGMARICG 220 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~----~~kl~Dfg~a~~~~ 220 (387)
|+|||||++|+|.+++..... ..++|..+++||||||+|||++.++ .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999988854322 1257888899999999999998776 49999999998765
Q ss_pred CCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDP 300 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (387)
... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .. ..........
T Consensus 169 ~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~---~~~~i~~~~~------- 233 (293)
T d1jksa_ 169 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE---TLANVSAVNY------- 233 (293)
T ss_dssp TSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHTTCC-------
T ss_pred CCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HH---HHHHHHhcCC-------
Confidence 332 23345789999999999999999999999999999999999999853221 11 1111111000
Q ss_pred ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
.... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCH-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCc-hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 011223457889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=360.87 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=182.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC----EEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~l 162 (387)
++|++.+.||+|+||+||+|++.. |+ .||+|++... .....+.|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 458899999999999999999764 43 5899988643 345567899999999999999999999999865 5678
Q ss_pred EEEecCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 163 IYEYMPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
++||+.+|+|..++...... .++|..+++||||||+|||++.++.+||+|||+|+........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc
Confidence 89999999998776543321 2578888999999999999999999999999999877654444
Q ss_pred cccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.......||+.|+|||++.++.|+.++|||||||++|||+| |..||..... ..+....... . +
T Consensus 168 ~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~i~~~---~----------~- 231 (317)
T d1xkka_ 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG---E----------R- 231 (317)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHHHHHT---C----------C-
T ss_pred ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcC---C----------C-
Confidence 44445578999999999999999999999999999999999 6777643221 1121111111 0 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
...+..++..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01223345678899999999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=355.04 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=181.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHH--HHHhcCCCceeeeeeeEEeCC----ceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEAS--VIAKVQHKNLVRLLGCCIDKD----EKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~nIv~~~~~~~~~~----~~~l 162 (387)
..|.+.+.||+|+||.||+|+++ |+.||||++... ....+..|.+ .+.+++|||||+++|+|.+.+ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 34666788999999999999975 889999998643 2234444444 455789999999999998754 5789
Q ss_pred EEEecCCCCcchhhcCCccc---------------cccc--------hhhhhhcccCCCceEEcCCCCeEEeeccCceec
Q 041766 163 IYEYMPNKSLDFFLFDPTKR---------------MLLD--------WSANYSSRLKVSNILLDKDINPKISDFGMARIC 219 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~~---------------~~l~--------~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~ 219 (387)
|||||++|+|..++.+.... ..+| ..+++||||||+||||+.++.+||+|||+++..
T Consensus 79 v~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999999998754321 1122 357899999999999999999999999999877
Q ss_pred CCCCccc--ccccccCCCccccccccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh---------
Q 041766 220 GGNELQA--NTSRIVGTYGYMSPEYAIQG------IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL--------- 282 (387)
Q Consensus 220 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~--------- 282 (387)
....... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5433221 23346799999999998754 367899999999999999999988654332211110
Q ss_pred HHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 283 GYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
....... ..+..++.+............+.+|+.+||+.||++||||.||++.|+++...
T Consensus 239 ~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0111111 11112222222223445567799999999999999999999999999988654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=360.90 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=193.9
Q ss_pred hHHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEE
Q 041766 83 SVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCI 155 (387)
Q Consensus 83 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~ 155 (387)
+++...++|++.+.||+|+||.||+|.++ .+..||||++... .......|.+|++++++++|||||+++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34555678899999999999999999874 2467999999754 3344457899999999999999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc--------------------------ccccchhhhhhcccCCCceEEcCCCCeE
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK--------------------------RMLLDWSANYSSRLKVSNILLDKDINPK 209 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~k 209 (387)
..+..++|||||++|+|..++..... ..++|..+++||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 99999999999999999887753211 1247778889999999999999999999
Q ss_pred EeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCcchHhHHHHHH
Q 041766 210 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGK-KTTGFYRTDSLTLLGYAWDL 288 (387)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~-~p~~~~~~~~~~~~~~~~~~ 288 (387)
|+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||... +. .......
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--~~---~~~~~~i 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SN---EQVLRFV 248 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CH---HHHHHHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--CH---HHHHHHH
Confidence 99999998775544444445567899999999999999999999999999999999986 444221 11 1111111
Q ss_pred hhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 289 WTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
. ..... ..+..++..+.+++.+||+.||++||||++|++.|++..+
T Consensus 249 ~-~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 M-EGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H-TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-hCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 11110 1122344679999999999999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=350.64 Aligned_cols=239 Identities=26% Similarity=0.368 Sum_probs=185.3
Q ss_pred CCcccccCCeeEEEEEEcCC----CEEEEEEccCC-CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-CceEEEEEec
Q 041766 94 ANKLGEGGFGPVYKGVLKKG----DEIAVKRLPGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-DEKILIYEYM 167 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-~~~~lv~e~~ 167 (387)
.++||+|+||+||+|++..+ ..||||+++.. .....++|.+|+++|++++|||||+++|++... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997642 25899999743 445667899999999999999999999998764 5789999999
Q ss_pred CCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc--cc
Q 041766 168 PNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA--NT 228 (387)
Q Consensus 168 ~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 228 (387)
++|+|.+++...... .++|..+++||||||+||||++++.+||+|||+++......... ..
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999999888654321 24677888999999999999999999999999998765432221 22
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||..|+|||.+....++.++||||||+++|||++|+.||....... ....... ..... ..+
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~---~g~~~-----------~~p 256 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLL---QGRRL-----------LQP 256 (311)
T ss_dssp TCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHH---TTCCC-----------CCC
T ss_pred ccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHH---cCCCC-----------CCc
Confidence 33578999999999999999999999999999999999888865332221 1111111 11110 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 309 KHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
..++..+.+|+.+||+.||++||||.||++.|+++....
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 233457889999999999999999999999999997653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=354.98 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=196.1
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEc------CCCEEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 155 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~ 155 (387)
++...++|++.+.||+|+||.||+|++. .+..||||+++.. .......+.+|+.+++++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 4445578899999999999999999863 2457999999754 334556789999999999 7999999999999
Q ss_pred eCCceEEEEEecCCCCcchhhcCCcc----------------------------------ccccchhhhhhcccCCCceE
Q 041766 156 DKDEKILIYEYMPNKSLDFFLFDPTK----------------------------------RMLLDWSANYSSRLKVSNIL 201 (387)
Q Consensus 156 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------~~~l~~~~~~h~dlk~~Nil 201 (387)
+.+..++|||||++|+|..+++.... ..++|..+++||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 99999999999999999988864321 12478888899999999999
Q ss_pred EcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchH
Q 041766 202 LDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTL 281 (387)
Q Consensus 202 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~ 281 (387)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+..|+.........+
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998765544444556788999999999999999999999999999999999555543332222222
Q ss_pred hHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhc
Q 041766 282 LGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAA 346 (387)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~ 346 (387)
........ .+ ..+...+..+.+|+.+||+.||++||||++|++.|++...+
T Consensus 258 ~~~i~~~~---------~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGF---------RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTC---------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCC---------CC-----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 22221110 00 01122345788999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=353.44 Aligned_cols=239 Identities=24% Similarity=0.306 Sum_probs=176.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC--C--CEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK--G--DEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++|++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998653 2 26899998643 33445689999999999999999999999976 4678
Q ss_pred EEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+|||||++|++.+.+..... ..++|..+++||||||+|||++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999876654322 1257888899999999999999999999999999998754432
Q ss_pred cc-ccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 225 QA-NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 225 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
.. ......||..|+|||++.+..++.++|||||||++|||+| |+.||..... . .............
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~---~~~~~i~~~~~~~------- 234 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--S---QILHKIDKEGERL------- 234 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--H---HHHHHHHTSCCCC-------
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--H---HHHHHHHhCCCCC-------
Confidence 22 2334567889999999999999999999999999999998 8988743211 1 1111111111110
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDE 343 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~ 343 (387)
..+..++..+.+|+.+||+.||++||||.+|++.|+++
T Consensus 235 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 ---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11223345788999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-48 Score=356.80 Aligned_cols=229 Identities=22% Similarity=0.283 Sum_probs=185.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||+||+|+++. |+.||||++... .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 568899999999999999999865 899999998532 2344578899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||++|+|..++..... ..++|..+++||||||+||||+.++.+||+|||+|+..... .
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----T 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----B
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----c
Confidence 99999999877754332 13578888999999999999999999999999999876533 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ... .......... ..+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~---~~~~i~~~~~------------~~p 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMK---TYEKILNAEL------------RFP 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHH---HHHHHHHCCC------------CCC
T ss_pred ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--HHH---HHHHHHcCCC------------CCC
Confidence 34689999999999999999999999999999999999999985321 111 1111111100 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVSM 339 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~~ 339 (387)
...+..+.+++.+||+.||.+|| |++++++.
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 22345688999999999999996 89999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=358.31 Aligned_cols=231 Identities=22% Similarity=0.261 Sum_probs=185.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 578999999999999999999765 899999998643 2334577889999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+...... ...
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~ 162 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCB
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--ccc
Confidence 99999999888764322 135788899999999999999999999999999998654332 223
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+.. .... ... ..+
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~---~i~~-~~~-----------~~p 225 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFE---LILM-EEI-----------RFP 225 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH---HHHH-CCC-----------CCC
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHH---HHhc-CCC-----------CCC
Confidence 456899999999999999999999999999999999999999754321 11111 1110 000 012
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
...+..+.+|+.+||+.||++||+ +.|+++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 234557889999999999999995 788876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=354.59 Aligned_cols=241 Identities=27% Similarity=0.337 Sum_probs=183.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CC--EEEEEEccCC-CcccHHHHHHHHHHHHhc-CCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLPGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||.||+|++++ +. .||||++... .....+.+.+|+++|+++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678888999999999999999875 33 4788988543 334556899999999998 799999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceEEcCCCCeEEe
Q 041766 164 YEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNILLDKDINPKIS 211 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~ 211 (387)
|||+++|+|.++++.... ..++|..+++||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 999999999999865421 124677788999999999999999999999
Q ss_pred eccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhc
Q 041766 212 DFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTS 291 (387)
Q Consensus 212 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 291 (387)
|||+|+..... .......||..|+|||.+.+..|+.++|||||||++|||++|..|+.... +...+. ... ..
T Consensus 170 DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~---~~i-~~ 241 (309)
T d1fvra_ 170 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELY---EKL-PQ 241 (309)
T ss_dssp CTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHH---HHG-GG
T ss_pred ccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHH---HHH-Hh
Confidence 99999864322 12234578999999999999999999999999999999999765432111 111111 111 11
Q ss_pred CccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhcc
Q 041766 292 NRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAAL 347 (387)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~ 347 (387)
.. + ...+..++..+.+|+.+||+.||++||||++|++.|+++.+..
T Consensus 242 ~~---------~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 242 GY---------R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp TC---------C-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cC---------C-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 00 0 0112234567899999999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=351.79 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=189.4
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcC--------CCEEEEEEccCCC-cccHHHHHHHHHHHHhc-CCCceeeeeee
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLPGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC 153 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~~~~~ 153 (387)
++...++|++.+.||+|+||.||+|+... +..||||++.... ......+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 33456789999999999999999998643 2369999997543 34457888999999998 89999999999
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCcc--------------------------------ccccchhhhhhcccCCCceE
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTK--------------------------------RMLLDWSANYSSRLKVSNIL 201 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------~~~l~~~~~~h~dlk~~Nil 201 (387)
|.+++..++|||||++|+|.+++..... ..++|..+++||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 9999999999999999999999864421 02478888899999999999
Q ss_pred EcCCCCeEEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcch
Q 041766 202 LDKDINPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVS-GKKTTGFYRTDSLT 280 (387)
Q Consensus 202 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~t-g~~p~~~~~~~~~~ 280 (387)
++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||..... ..
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~ 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HH
Confidence 99999999999999987765444444455678999999999999999999999999999999998 6777642221 11
Q ss_pred HhHHHHHHhhcCccccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhh
Q 041766 281 LLGYAWDLWTSNRTLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAA 345 (387)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~ 345 (387)
............ .+..++..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 246 ----~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ----LFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111111111110 112234578899999999999999999999999998854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=349.07 Aligned_cols=240 Identities=19% Similarity=0.247 Sum_probs=187.9
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
.++|++.+.||+|+||+||+|.+.. ++.||||.++... .....+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4789999999999999999999875 7789999997543 3345688999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcCC--CCeEEeeccCceecCCCCcccc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDKD--INPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
|++|+|.+++...... .++|..+++||||||+|||++.+ ..+||+|||+++...... .
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---N 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---E
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---c
Confidence 9999999988754321 25788899999999999999754 589999999998765432 2
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....+|+.|+|||.+.+..|+.++|||||||++|||++|..||...... . ........... ... ..
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~---~~~~i~~~~~~-------~~~-~~ 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--Q---IIENIMNAEYT-------FDE-EA 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHHTCCC-------CCH-HH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHhCCCC-------CCh-hh
Confidence 33457899999999999999999999999999999999999998533211 1 11111110000 000 00
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
....+..+.+|+.+||+.||++|||++|+++ .+.+..
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 1123456889999999999999999999997 354433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-47 Score=353.74 Aligned_cols=228 Identities=21% Similarity=0.261 Sum_probs=184.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~ 164 (387)
++|++++.||+|+||.||+|+++. |+.||||++... .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 579999999999999999999864 899999998532 2344567899999999999999999999999999999999
Q ss_pred EecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 165 EYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
||+.+|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+..... .
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~ 195 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----T 195 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----B
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----c
Confidence 99999999888754321 13578889999999999999999999999999999976532 2
Q ss_pred ccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccccccc
Q 041766 229 SRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYSS 308 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (387)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.... ... ......... . ..+
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~---~~~~i~~~~-~-----------~~p 258 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQ---IYEKIVSGK-V-----------RFP 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH---HHHHHHHCC-C-----------CCC
T ss_pred ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHH---HHHHHhcCC-C-----------CCC
Confidence 34689999999999999999999999999999999999999985321 111 111111110 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 309 KHMLLRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 309 ~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
...+..+.+++.+||+.||.+|+ |++++++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 23345788999999999999994 8999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-47 Score=344.97 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=181.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----c
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----E 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~ 159 (387)
.++|++.+.||+|+||.||+|++.. ++.||||++... +......+.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999764 889999999654 2334567899999999999999999999998754 3
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.|+|||||++|+|..++..... ..++|..+++||||||+|||++.++..+|+|||.++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 7899999999999877754321 135788889999999999999999999999999987654322
Q ss_pred -cccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccc
Q 041766 224 -LQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPIL 302 (387)
Q Consensus 224 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (387)
........+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .............. +
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~----~-- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIP----P-- 234 (277)
T ss_dssp -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCC----G--
T ss_pred ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCC----C--
Confidence 12233456899999999999999999999999999999999999999853221 11111111111110 0
Q ss_pred ccccccHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhhhh
Q 041766 303 EDEYSSKHMLLRYVNIALLCVQESADDRP-TMNEVVSMLTDEA 344 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~~v~~~L~~~~ 344 (387)
.......+..+.+++.+||+.||++|| |+++++..|..+.
T Consensus 235 --~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 --SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 001122345788999999999999999 8999998887653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-46 Score=351.25 Aligned_cols=232 Identities=24% Similarity=0.252 Sum_probs=179.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHH---HHHHHHhcCCCceeeeeeeEEeCCceE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKN---EASVIAKVQHKNLVRLLGCCIDKDEKI 161 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~nIv~~~~~~~~~~~~~ 161 (387)
++|++.+.||+|+||.||+|++.. |+.||||++... .......+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 578899999999999999999875 899999998532 1112223334 467777788999999999999999999
Q ss_pred EEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc
Q 041766 162 LIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ 225 (387)
Q Consensus 162 lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 225 (387)
+|||||++|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-- 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 161 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC--
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc--
Confidence 99999999999988854322 135788889999999999999999999999999998765432
Q ss_pred cccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccccccccccc
Q 041766 226 ANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILED 304 (387)
Q Consensus 226 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (387)
.....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||......... ....... .. .
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~--~~----------~ 225 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTL--TM----------A 225 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSS--SC----------C
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcc--cC----------C
Confidence 344589999999999975 56899999999999999999999998654332211 1100000 00 0
Q ss_pred ccccHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041766 305 EYSSKHMLLRYVNIALLCVQESADDRPT-----MNEVVS 338 (387)
Q Consensus 305 ~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~~v~~ 338 (387)
...+...++.+.+|+.+||+.||++||| ++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011223457889999999999999999 688876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=344.79 Aligned_cols=233 Identities=16% Similarity=0.156 Sum_probs=178.5
Q ss_pred hcCCCCCC-cccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhc-CCCceeeeeeeEEe----CCce
Q 041766 88 TNKFSDAN-KLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID----KDEK 160 (387)
Q Consensus 88 ~~~~~~~~-~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~~~~~~----~~~~ 160 (387)
.++|++.. .||+|+||.||+|++.. ++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788775 59999999999999754 889999998642 4677899997765 89999999999876 3568
Q ss_pred EEEEEecCCCCcchhhcCCccc------------------cccchhhhhhcccCCCceEEcC---CCCeEEeeccCceec
Q 041766 161 ILIYEYMPNKSLDFFLFDPTKR------------------MLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARIC 219 (387)
Q Consensus 161 ~lv~e~~~~g~L~~~l~~~~~~------------------~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 219 (387)
|+|||||++|+|.+++...... .++|..+++||||||+|||+++ .+.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999999999998764221 2578888999999999999975 467999999999876
Q ss_pred CCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 220 GGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.... ......||+.|||||++.+..|+.++|||||||++|||+||+.||........ ..... .....
T Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~--------~~i~~ 231 (335)
T d2ozaa1 165 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMK--------TRIRM 231 (335)
T ss_dssp CCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------CCCS
T ss_pred cCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHH--------HHHhc
Confidence 5433 23446899999999999999999999999999999999999999853221110 00000 00000
Q ss_pred ccccc-ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILED-EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..... .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 0112345678999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=339.91 Aligned_cols=241 Identities=19% Similarity=0.204 Sum_probs=175.2
Q ss_pred CCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc-----ccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEec
Q 041766 94 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEYM 167 (387)
Q Consensus 94 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 167 (387)
+++||+|+||+||+|++.. |+.||||+++.... .....+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 5789999999999999765 88999999864321 12346889999999999999999999999999999999999
Q ss_pred CCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccccc
Q 041766 168 PNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSRI 231 (387)
Q Consensus 168 ~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 231 (387)
.++++..+...... ..++|..+++||||||+|||++.++.+||+|||+|+....... .....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~ 160 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQ 160 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCS
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc--cccce
Confidence 98877665543221 1257888899999999999999999999999999986543322 22345
Q ss_pred cCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc---ccc-------c
Q 041766 232 VGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE---LID-------P 300 (387)
Q Consensus 232 ~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-------~ 300 (387)
+||+.|+|||++.+. .|+.++|||||||++|||++|..||..... .................. ... .
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 789999999998754 589999999999999999999988753321 111111111111100000 000 0
Q ss_pred cccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 301 ILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 301 ~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
...... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 01122457889999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-46 Score=339.29 Aligned_cols=235 Identities=21% Similarity=0.264 Sum_probs=183.6
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCc---------ccHHHHHHHHHHHHhcC-CCceeeeeeeEEe
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSG---------QGLREMKNEASVIAKVQ-HKNLVRLLGCCID 156 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~ 156 (387)
.++|++.+.||+|+||+||+|+... ++.||||++..... ...+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999764 88999999864321 12346889999999996 9999999999999
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
++..|||||||++|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999998854322 125788889999999999999999999999999998765
Q ss_pred CCCcccccccccCCCcccccccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQ------GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT 294 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 294 (387)
... ......||..|+|||++.+ ..++.++||||+||++|||++|+.||..... .... ....... .
T Consensus 162 ~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~~~---~~i~~~~-~ 232 (277)
T d1phka_ 162 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML---RMIMSGN-Y 232 (277)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHHHTC-C
T ss_pred CCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HHHH---HHHHhCC-C
Confidence 432 2234579999999999863 3478899999999999999999999853321 1111 1111111 0
Q ss_pred ccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 295 LELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. . . .......++.+.+|+.+||+.||++|||++||++
T Consensus 233 ~-~-----~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q-F-----G-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C-C-----C-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-C-----C-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 0 0012234567889999999999999999999976
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=349.44 Aligned_cols=231 Identities=24% Similarity=0.348 Sum_probs=182.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC---CcccHHHHHHHHHHHH-hcCCCceeeeeeeEEeCCceEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR---SGQGLREMKNEASVIA-KVQHKNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nIv~~~~~~~~~~~~~lv 163 (387)
++|++.+.||+|+||+||+|++.. ++.||||++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578899999999999999999875 888999998632 2234566778888776 57999999999999999999999
Q ss_pred EEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccc
Q 041766 164 YEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQAN 227 (387)
Q Consensus 164 ~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 227 (387)
||||++|+|..++..... ..++|..+++||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--cc
Confidence 999999999998864322 135788889999999999999999999999999998654332 22
Q ss_pred cccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccccccccc
Q 041766 228 TSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPILEDEYS 307 (387)
Q Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (387)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ..+ .... .... + ..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~---~~~i-~~~~------~-----~~ 222 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EEL---FHSI-RMDN------P-----FY 222 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH-HHCC------C-----CC
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHH---HHHH-HcCC------C-----CC
Confidence 3446899999999999999999999999999999999999999853221 111 1111 1110 0 01
Q ss_pred cHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 041766 308 SKHMLLRYVNIALLCVQESADDRPTMN-EVVS 338 (387)
Q Consensus 308 ~~~~~~~~~~li~~cl~~dP~~RPt~~-~v~~ 338 (387)
+...+..+.+|+.+||+.||++|||+. ++++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122345788999999999999999995 6764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=337.99 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=182.4
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++.+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 578899999999999999999764 8999999996432 2345788999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccc
Q 041766 166 YMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANT 228 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 228 (387)
|+.++.+......... ..++|..+++||||||+|||++.++.+||+|||+|+...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--ccc
Confidence 9977655443333221 135788899999999999999999999999999998765332 223
Q ss_pred ccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC-cccccc--------
Q 041766 229 SRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN-RTLELI-------- 298 (387)
Q Consensus 229 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-------- 298 (387)
....||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ..+........... ......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhcccccccccccc
Confidence 4458999999999987766 478999999999999999999998543211 11111111100000 000000
Q ss_pred --cccccccc--ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhh
Q 041766 299 --DPILEDEY--SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDE 343 (387)
Q Consensus 299 --~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~ 343 (387)
........ .....+..+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000000 011234578899999999999999999999974 5544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-45 Score=332.83 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=181.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788999999999999999999889999999996542 33457899999999999999999999999999999999999
Q ss_pred cCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccccccc
Q 041766 167 MPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
+.++.+..+...... ..++|..+++||||||+|||++.++.+||+|||.|........ ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 159 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTH 159 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccce
Confidence 988877666554332 1357888899999999999999999999999999987643322 2233
Q ss_pred ccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc------cc------
Q 041766 231 IVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL------EL------ 297 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~------ 297 (387)
..+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ................. ..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 4688999999999764 569999999999999999999999854321 11111111111110000 00
Q ss_pred ccc--ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 298 IDP--ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 298 ~~~--~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000011223457889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=333.25 Aligned_cols=224 Identities=22% Similarity=0.319 Sum_probs=174.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC---c---ccHHHHHHHHHHHHhcC--CCceeeeeeeEEeCC
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS---G---QGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKD 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~---~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~ 158 (387)
.++|++.+.||+|+||.||+|+... ++.||||++.... . .....+.+|+.+|++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3679999999999999999999764 8899999985321 1 11234668999999986 899999999999999
Q ss_pred ceEEEEEecCC-CCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcC-CCCeEEeeccCceecC
Q 041766 159 EKILIYEYMPN-KSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDK-DINPKISDFGMARICG 220 (387)
Q Consensus 159 ~~~lv~e~~~~-g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~-~~~~kl~Dfg~a~~~~ 220 (387)
..++||||+.+ +++..++..... ..++|..+++||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 566555543211 13578888999999999999985 4789999999998754
Q ss_pred CCCcccccccccCCCccccccccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccc
Q 041766 221 GNELQANTSRIVGTYGYMSPEYAIQGIF-SIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELID 299 (387)
Q Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (387)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .......
T Consensus 163 ~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~~------ 221 (273)
T d1xwsa_ 163 DT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQV------ 221 (273)
T ss_dssp SS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCCC------
T ss_pred cc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhccc------
Confidence 33 2344689999999999987775 677999999999999999999974210 0000000
Q ss_pred cccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 300 PILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
. .+...+..+.+|+.+||+.||++|||++|+++
T Consensus 222 -~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -F-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -C-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -C-----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 11122456889999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-43 Score=322.16 Aligned_cols=256 Identities=15% Similarity=0.191 Sum_probs=193.7
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||+||+|++.. ++.||||.+..... ...+.+|++++..++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 679999999999999999999765 78899998864432 2356789999999965 8999999999999999999999
Q ss_pred cCCCCcchhhcCCccc-----------------cccchhhhhhcccCCCceEEcC-----CCCeEEeeccCceecCCCCc
Q 041766 167 MPNKSLDFFLFDPTKR-----------------MLLDWSANYSSRLKVSNILLDK-----DINPKISDFGMARICGGNEL 224 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~~-----------------~~l~~~~~~h~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~~~ 224 (387)
+ +++|..++...... ..+|..+++||||||+|||++. ++.+||+|||+|+.......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 67888777543321 2578888999999999999974 57899999999987653221
Q ss_pred c-----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHh-HHHHHHhhcCcccccc
Q 041766 225 Q-----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLL-GYAWDLWTSNRTLELI 298 (387)
Q Consensus 225 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 298 (387)
. .......||+.|||||++.+..++.++|||||||++|||++|+.||........... .............+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-- 239 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-- 239 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH--
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH--
Confidence 1 123346799999999999999999999999999999999999999864433322111 11111100000000
Q ss_pred ccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceee
Q 041766 299 DPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSY 357 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~ 357 (387)
....++.++.+++..||+.+|++||+++.+.+.|+++...........++|
T Consensus 240 --------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw 290 (293)
T d1csna_ 240 --------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW 290 (293)
T ss_dssp --------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred --------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 011234578899999999999999999999999999877665555555555
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=328.57 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=176.3
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-C-CCEEEEEEccCC--CcccHHHHHHHHHHHHhc---CCCceeeeeeeEEeC---
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-K-GDEIAVKRLPGR--SGQGLREMKNEASVIAKV---QHKNLVRLLGCCIDK--- 157 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~nIv~~~~~~~~~--- 157 (387)
.++|++++.||+|+||+||+|++. . ++.||||++... .......+.+|+.+|+.+ +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999975 3 456999998532 222233566777777665 899999999998642
Q ss_pred --CceEEEEEecCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCcee
Q 041766 158 --DEKILIYEYMPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARI 218 (387)
Q Consensus 158 --~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~ 218 (387)
...+++|||+.++++......... ..++|..+++||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 367899999998877544433221 1358888999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc---
Q 041766 219 CGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL--- 295 (387)
Q Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 295 (387)
.... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .................
T Consensus 166 ~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCGGGSC
T ss_pred hccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCchhccc
Confidence 4322 234456899999999999999999999999999999999999999854321 11111111111100000
Q ss_pred -------cccccccc--cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 -------ELIDPILE--DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 -------~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
........ ........+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00011223456889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-43 Score=323.59 Aligned_cols=258 Identities=17% Similarity=0.173 Sum_probs=183.9
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCcee-eeeeeEEeCCceEEEEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDKDEKILIYEY 166 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~~~~~~~~~~~~~lv~e~ 166 (387)
++|++.+.||+|+||.||+|++.. ++.||||.+...... ..+..|++++++++|+|++ .+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 579999999999999999999765 789999988654322 3577899999999777655 455556677888999999
Q ss_pred cCCCCcchhhcCCcc-----------------ccccchhhhhhcccCCCceEEcC---CCCeEEeeccCceecCCCCcc-
Q 041766 167 MPNKSLDFFLFDPTK-----------------RMLLDWSANYSSRLKVSNILLDK---DINPKISDFGMARICGGNELQ- 225 (387)
Q Consensus 167 ~~~g~L~~~l~~~~~-----------------~~~l~~~~~~h~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~~~- 225 (387)
+++ ++...+..... ..++|..+++||||||+|||++. +..+||+|||+|+........
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 954 55444432221 13578889999999999999853 557999999999987543221
Q ss_pred ----cccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 226 ----ANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 226 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......................
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------- 235 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-------- 235 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--------
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--------
Confidence 22345689999999999999999999999999999999999999986544322211100000000000
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhhhhhccCCCCCCceeee
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSMLTDEAAALFPPKQPAFSYV 358 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~L~~~~~~~~~~~~~~~~~~ 358 (387)
........++..+.+++..||+.||++||++.++.+.|++............++|.
T Consensus 236 -~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 236 -PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp -CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred -ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 00001122346788999999999999999999999999887654443444445553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=327.27 Aligned_cols=250 Identities=17% Similarity=0.222 Sum_probs=178.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEe--------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-------- 156 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~-------- 156 (387)
.++|++.+.||+|+||+||+|++. +|+.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999986 4899999998543 33445678899999999999999999999865
Q ss_pred CCceEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecC
Q 041766 157 KDEKILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICG 220 (387)
Q Consensus 157 ~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 220 (387)
.+..|+|||||.++.+......... ..++|..+++||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 3457999999988777654433221 135788889999999999999999999999999998765
Q ss_pred CCCcc--cccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcC--ccc
Q 041766 221 GNELQ--ANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSN--RTL 295 (387)
Q Consensus 221 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 295 (387)
..... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||..... .............. ...
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--QHQLALISQLCGSITPEVW 246 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH--HHHHHHHHHhcCCCChhhc
Confidence 33221 122335799999999999765 689999999999999999999999853221 11111111111100 000
Q ss_pred cc---------ccccccccccc------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 296 EL---------IDPILEDEYSS------KHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 296 ~~---------~~~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. +.......... ......+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 00000000011 1123467799999999999999999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-43 Score=325.10 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=176.7
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC------
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD------ 158 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~------ 158 (387)
.++|++.+.||+|+||+||+|++.. |+.||||++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4789999999999999999999765 899999999743 3344567889999999999999999999998754
Q ss_pred ceEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 159 EKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 159 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
..|+||||| +.+|..+...... ..++|..+++||||||+|||++.++.+||+|||+|+.....
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence 469999999 5566665543211 13588889999999999999999999999999999876432
Q ss_pred cccccccccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCc---------
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNR--------- 293 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 293 (387)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..............
T Consensus 175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH--HHHHHHHhccCCCcHHHHhhhcc
Confidence 2345789999999999764 5689999999999999999999998543211 11111110000000
Q ss_pred ---------cccccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hhhhh
Q 041766 294 ---------TLELIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM--LTDEA 344 (387)
Q Consensus 294 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~--L~~~~ 344 (387)
..+........ ......+.+.+|+.+||+.||++|||++|+++. ++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 112234567899999999999999999999984 66554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=319.25 Aligned_cols=247 Identities=18% Similarity=0.216 Sum_probs=185.6
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeCCceEEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~~~~lv~e 165 (387)
++|++++.||+|+||+||+|++.. ++.||||+++.. .......+.+|+.+|+.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578999999999999999999764 888999998543 33456788999999999999999999999999999999999
Q ss_pred ecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcccccc
Q 041766 166 YMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQANTS 229 (387)
Q Consensus 166 ~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 229 (387)
++.+++|..++..... ..++|..+++||||||+|||++.++.+||+|||.|+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cce
Confidence 9999988777654432 1357888899999999999999999999999999987654332 223
Q ss_pred cccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccc------c------
Q 041766 230 RIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTL------E------ 296 (387)
Q Consensus 230 ~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~------ 296 (387)
...++..|+|||.+.+.. ++.++|||||||++|||++|+.||....+.... .............. .
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHHHHhhcCCCChhhhhhhhhcccccc
Confidence 346778899999988765 689999999999999999999997443322211 11111111110000 0
Q ss_pred --ccccccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 297 --LIDPILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 297 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..................+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001112233457889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=320.48 Aligned_cols=244 Identities=15% Similarity=0.237 Sum_probs=181.0
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeC--CceEEEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDK--DEKILIY 164 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~--~~~~lv~ 164 (387)
++|++.++||+|+||+||+|++.. ++.||||+++.. ..+.+.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 579999999999999999999865 888999999643 3467889999999995 99999999999854 4689999
Q ss_pred EecCCCCcchhhcCCcc-------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCCCccccccc
Q 041766 165 EYMPNKSLDFFLFDPTK-------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGNELQANTSR 230 (387)
Q Consensus 165 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 230 (387)
|||.+++|..+...... ..++|..+++||||||+|||++.++ .+||+|||+|+...... ....
T Consensus 112 e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~ 188 (328)
T d3bqca1 112 EHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 188 (328)
T ss_dssp ECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCS
T ss_pred eecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---cccc
Confidence 99999999877644322 1358889999999999999998655 59999999998765432 2344
Q ss_pred ccCCCccccccccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH--------HH---hhcCccc---
Q 041766 231 IVGTYGYMSPEYAIQG-IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW--------DL---WTSNRTL--- 295 (387)
Q Consensus 231 ~~gt~~y~aPE~~~~~-~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~--------~~---~~~~~~~--- 295 (387)
..+|..|+|||.+.+. .++.++||||+||++|||++|+.||............... .. .......
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 5789999999998765 4799999999999999999999998654432211111000 00 0000000
Q ss_pred ccccc-------ccccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041766 296 ELIDP-------ILEDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS 338 (387)
Q Consensus 296 ~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~ 338 (387)
..... ...........+..+.+|+.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000112233457889999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=325.97 Aligned_cols=249 Identities=16% Similarity=0.207 Sum_probs=176.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEc-CCCEEEEEEccCCC-cccHHHHHHHHHHHHhcCCCceeeeeeeEEeCC----ceEE
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLPGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDKD----EKIL 162 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~~----~~~l 162 (387)
++|++++.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 57999999999999999999975 48999999997543 344568889999999999999999999997653 2344
Q ss_pred EEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCcc-c
Q 041766 163 IYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQ-A 226 (387)
Q Consensus 163 v~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 226 (387)
+++|+.+|+|.+++..... ..++|..+++||||||+|||++.++.+||+|||+|+........ .
T Consensus 88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~ 167 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167 (345)
T ss_dssp EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence 5556779999988854321 13588889999999999999999999999999999876433221 1
Q ss_pred ccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcccc---------
Q 041766 227 NTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLE--------- 296 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 296 (387)
.....+||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ................
T Consensus 168 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 168 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred eeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCChhhhhhhhhhhh
Confidence 2344679999999999854 567899999999999999999999985432211 1111100000000000
Q ss_pred --cc--cccccccc---ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 297 --LI--DPILEDEY---SSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 297 --~~--~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
.. .+...... .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000 011223468899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=324.78 Aligned_cols=247 Identities=20% Similarity=0.229 Sum_probs=175.1
Q ss_pred CCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------CceEE
Q 041766 90 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DEKIL 162 (387)
Q Consensus 90 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~~~l 162 (387)
+|...++||+|+||+||+|++.. ++.||||++..... ...+|+++|++++|||||+++++|... ...|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57788899999999999999875 89999999965432 234799999999999999999998653 24689
Q ss_pred EEEecCCCCcchhhc---CCcc----------------ccccchhhhhhcccCCCceEEcCCC-CeEEeeccCceecCCC
Q 041766 163 IYEYMPNKSLDFFLF---DPTK----------------RMLLDWSANYSSRLKVSNILLDKDI-NPKISDFGMARICGGN 222 (387)
Q Consensus 163 v~e~~~~g~L~~~l~---~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 222 (387)
|||||+++.+..+.. .... ..++|..+++||||||+|||++.++ .+||+|||+++.....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 999998765433321 1110 1358888999999999999998765 8999999999876543
Q ss_pred CcccccccccCCCcccccccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH----------HHhhc
Q 041766 223 ELQANTSRIVGTYGYMSPEYAIQ-GIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW----------DLWTS 291 (387)
Q Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~----------~~~~~ 291 (387)
. ......||..|+|||.+.+ ..|+.++||||+||++|||++|+.||....... .+..... .....
T Consensus 177 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 177 E---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp S---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCC
T ss_pred c---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhhhcc
Confidence 3 2234578999999998875 468999999999999999999999985433211 1111100 00000
Q ss_pred Cccccccccccc---cccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 292 NRTLELIDPILE---DEYSSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 292 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
......+..... ........++.+.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000000000000 00112234557889999999999999999999996 365554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=322.06 Aligned_cols=236 Identities=20% Similarity=0.259 Sum_probs=181.8
Q ss_pred cCCCCCCcccccCCeeEEEEEEc----CCCEEEEEEccCC----CcccHHHHHHHHHHHHhcCC-CceeeeeeeEEeCCc
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLPGR----SGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDKDE 159 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~~~~~~~~~~~ 159 (387)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 66999999999999999999852 3789999998643 22344678899999999965 899999999999999
Q ss_pred eEEEEEecCCCCcchhhcCCcc----------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCC
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK----------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNE 223 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~----------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 223 (387)
.+++|||+.+|+|..++..... ..++|..+++||||||+|||++.++.+||+|||+|+......
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 9999999999999888754332 125778889999999999999999999999999998765433
Q ss_pred cccccccccCCCccccccccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCccccccccc
Q 041766 224 LQANTSRIVGTYGYMSPEYAIQG--IFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRTLELIDPI 301 (387)
Q Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (387)
.. ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||......... ...........
T Consensus 184 ~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~~~--------- 252 (322)
T d1vzoa_ 184 TE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSE--------- 252 (322)
T ss_dssp GG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHCC---------
T ss_pred cc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcccCC---------
Confidence 22 23446889999999999765 3688999999999999999999998544332211 11111111100
Q ss_pred cccccccHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041766 302 LEDEYSSKHMLLRYVNIALLCVQESADDRP-----TMNEVVS 338 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~~v~~ 338 (387)
...+...+..+.+++.+||+.||++|| |++|+++
T Consensus 253 ---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001223456889999999999999999 4788886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=323.57 Aligned_cols=246 Identities=19% Similarity=0.207 Sum_probs=173.1
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCC--CcccHHHHHHHHHHHHhcCCCceeeeeeeEEeC------Cc
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDK------DE 159 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~------~~ 159 (387)
++|++.++||+|+||+||+|++.. |+.||||++... .......+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 689999999999999999999875 889999999754 234455788999999999999999999999643 57
Q ss_pred eEEEEEecCCCCcchhhcCCcc-------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCccc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK-------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNELQA 226 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (387)
.|+|||||.++.+..+...... ..++|..+++||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~--- 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--- 173 (355)
T ss_dssp EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc---
Confidence 8999999987666544322211 135888899999999999999999999999999988654332
Q ss_pred ccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHH-------------------H
Q 041766 227 NTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAW-------------------D 287 (387)
Q Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~-------------------~ 287 (387)
......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .
T Consensus 174 ~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp -------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH--HHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 234457899999999999999999999999999999999999998533211 1100000 0
Q ss_pred HhhcCcc------cccccccccc--ccccHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041766 288 LWTSNRT------LELIDPILED--EYSSKHMLLRYVNIALLCVQESADDRPTMNEVVSM 339 (387)
Q Consensus 288 ~~~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~~ 339 (387)
....... ...+...... .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000000000 01123456788999999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=317.15 Aligned_cols=250 Identities=18% Similarity=0.228 Sum_probs=178.4
Q ss_pred hcCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCC--cccHHHHHHHHHHHHhcCCCceeeeeeeEEeC-----Cc
Q 041766 88 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDK-----DE 159 (387)
Q Consensus 88 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~~~~~~~-----~~ 159 (387)
.++|++.+.||+|+||+||+|++.. |+.||||++.... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4789999999999999999999764 8899999997542 33456788999999999999999999998643 23
Q ss_pred eEEEEEecCCCCcchhhcCCcc---------------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 160 KILIYEYMPNKSLDFFLFDPTK---------------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 160 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
.+++++|+.+|+|.+++..... ..++|..+++||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG---
T ss_pred eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc---
Confidence 4666777889999998864322 1357888999999999999999999999999999975432
Q ss_pred ccccccccCCCccccccccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchHhHHHHHHhhcCcc-------c-
Q 041766 225 QANTSRIVGTYGYMSPEYAIQGI-FSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSLTLLGYAWDLWTSNRT-------L- 295 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~- 295 (387)
......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ............... .
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHHhhhccch
Confidence 234457899999999877654 689999999999999999999998543211 111111111000000 0
Q ss_pred ---ccccccccccc-----ccHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--Hhhhhh
Q 041766 296 ---ELIDPILEDEY-----SSKHMLLRYVNIALLCVQESADDRPTMNEVVS--MLTDEA 344 (387)
Q Consensus 296 ---~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~~--~L~~~~ 344 (387)
........... .....+..+.+|+.+||+.||++|||++|+++ .+.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000000000 01123456889999999999999999999997 465543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-36 Score=284.44 Aligned_cols=250 Identities=18% Similarity=0.192 Sum_probs=171.5
Q ss_pred cCCCCCCcccccCCeeEEEEEEcC-CCEEEEEEccCCCcccHHHHHHHHHHHHhcC-----------CCceeeeeeeEEe
Q 041766 89 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCID 156 (387)
Q Consensus 89 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~~~~~~~~ 156 (387)
++|++.++||+|+||+||+|+... |+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 469999999999999999999764 8899999997542 33467788999988875 5789999998865
Q ss_pred C--CceEEEEEecCCCCcchhhc--CCcc-----------------ccccch-hhhhhcccCCCceEEcCCCC------e
Q 041766 157 K--DEKILIYEYMPNKSLDFFLF--DPTK-----------------RMLLDW-SANYSSRLKVSNILLDKDIN------P 208 (387)
Q Consensus 157 ~--~~~~lv~e~~~~g~L~~~l~--~~~~-----------------~~~l~~-~~~~h~dlk~~Nill~~~~~------~ 208 (387)
. ...+++++++..+....... .... ...+|. .+++||||||+||||+.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3 45667777776554322211 1000 124565 67999999999999976653 9
Q ss_pred EEeeccCceecCCCCcccccccccCCCccccccccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc-----hHhH
Q 041766 209 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYAIQGIFSIKSDVFSFGVLLLEIVSGKKTTGFYRTDSL-----TLLG 283 (387)
Q Consensus 209 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS~Gvil~el~tg~~p~~~~~~~~~-----~~~~ 283 (387)
|++|||.|...... .....||+.|+|||++.+..|+.++||||+||+++||++|+.||........ .+..
T Consensus 172 kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999865422 3446799999999999999999999999999999999999999864332110 0000
Q ss_pred HHHHH-----------------hhcCcccccccccc---------ccccccHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041766 284 YAWDL-----------------WTSNRTLELIDPIL---------EDEYSSKHMLLRYVNIALLCVQESADDRPTMNEVV 337 (387)
Q Consensus 284 ~~~~~-----------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~~v~ 337 (387)
..... +........+.... ............+.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 00000000000000 01112355677899999999999999999999998
Q ss_pred HH--hhhhh
Q 041766 338 SM--LTDEA 344 (387)
Q Consensus 338 ~~--L~~~~ 344 (387)
+. +++..
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 73 55443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=1.9e-21 Score=164.48 Aligned_cols=154 Identities=16% Similarity=0.129 Sum_probs=107.9
Q ss_pred CCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCc------------------ccHHHHHHHHHHHHhcCCCceeeeeee
Q 041766 92 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSG------------------QGLREMKNEASVIAKVQHKNLVRLLGC 153 (387)
Q Consensus 92 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~~~~~ 153 (387)
.+.++||+|+||.||+|+..+|+.||||.++.... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35678999999999999988899999998642110 011234568899999999999988765
Q ss_pred EEeCCceEEEEEecCCCCcchhhcCCcc---------ccccchhhhhhcccCCCceEEcCCCCeEEeeccCceecCCCCc
Q 041766 154 CIDKDEKILIYEYMPNKSLDFFLFDPTK---------RMLLDWSANYSSRLKVSNILLDKDINPKISDFGMARICGGNEL 224 (387)
Q Consensus 154 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 224 (387)
. ..+++|||++++.+..+...... ...+|..+++||||||+|||++++ .++|+|||+|.....+..
T Consensus 83 ~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~ 157 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157 (191)
T ss_dssp E----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH
T ss_pred c----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc
Confidence 3 23799999988766543322211 135788899999999999999865 599999999986542211
Q ss_pred ccccccccCCCccccc--cc---cccCCCCccccchhHHHH
Q 041766 225 QANTSRIVGTYGYMSP--EY---AIQGIFSIKSDVFSFGVL 260 (387)
Q Consensus 225 ~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~DiwS~Gvi 260 (387)
. .|... +. .....|+.++|+||..--
T Consensus 158 ~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 158 R----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp H----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred H----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 1 11111 00 113568899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=3.4e-06 Score=72.66 Aligned_cols=89 Identities=11% Similarity=0.054 Sum_probs=60.8
Q ss_pred HHHHhcCCCCCCcccccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEE
Q 041766 84 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKIL 162 (387)
Q Consensus 84 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~l 162 (387)
+......|+..+..+-++.+.||+.... ++.+.+|+...........+.+|...+..+. +--+.++++++.+++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3444455655555444555789988644 6678888876443333445678888887763 4446778888888888999
Q ss_pred EEEecCCCCcc
Q 041766 163 IYEYMPNKSLD 173 (387)
Q Consensus 163 v~e~~~~g~L~ 173 (387)
||++++|..+.
T Consensus 88 v~~~l~G~~~~ 98 (263)
T d1j7la_ 88 LMSEADGVLCS 98 (263)
T ss_dssp EEECCSSEEHH
T ss_pred EEEeccccccc
Confidence 99999887663
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.46 E-value=0.00017 Score=61.17 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=52.7
Q ss_pred ccccC-CeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcC--CCceeeeeeeEEeCCceEEEEEecCCCCcc
Q 041766 97 LGEGG-FGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDKDEKILIYEYMPNKSLD 173 (387)
Q Consensus 97 lG~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~~~~~~~~~~~~~lv~e~~~~g~L~ 173 (387)
+..|. -+.||+.....+..+.+|....... ..+..|...++.+. .-.+.++++++.+++..++||+|++|..+.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 34444 3578999887777788898754433 34567788777663 334677888888888889999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.82 E-value=0.0017 Score=58.75 Aligned_cols=75 Identities=13% Similarity=0.248 Sum_probs=48.4
Q ss_pred CcccccCCeeEEEEEEcC-CCEEEEEEccC------C-CcccHHHHHHHHHHHHhc-CC--CceeeeeeeEEeCCceEEE
Q 041766 95 NKLGEGGFGPVYKGVLKK-GDEIAVKRLPG------R-SGQGLREMKNEASVIAKV-QH--KNLVRLLGCCIDKDEKILI 163 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~-~~~vavK~~~~------~-~~~~~~~~~~E~~~l~~l-~h--~nIv~~~~~~~~~~~~~lv 163 (387)
+.||.|....||+....+ ++.++||.-.. . -....++...|.+.|..+ .+ ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998665 67899996432 1 112234556688888766 33 345666654 45566899
Q ss_pred EEecCCCC
Q 041766 164 YEYMPNKS 171 (387)
Q Consensus 164 ~e~~~~g~ 171 (387)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.80 E-value=0.011 Score=51.58 Aligned_cols=69 Identities=7% Similarity=0.040 Sum_probs=45.5
Q ss_pred eeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCCCce--eeee-----eeEEeCCceEEEEEecCCCCc
Q 041766 103 GPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQHKNL--VRLL-----GCCIDKDEKILIYEYMPNKSL 172 (387)
Q Consensus 103 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~~~-----~~~~~~~~~~lv~e~~~~g~L 172 (387)
-.||+....+|..+++|..... .....++..|...+..+...++ +..+ ..+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 4899999988999999987543 2234667788888887742221 1111 122345567899999977544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.59 E-value=0.19 Score=42.90 Aligned_cols=135 Identities=9% Similarity=-0.026 Sum_probs=73.5
Q ss_pred chhhHHHHhcCCCCCCcc-----cccCCeeEEEEEEcCCCEEEEEEccCCCcccHHHHHHHHHHHHhcCC-----Cceee
Q 041766 80 SFSSVSTATNKFSDANKL-----GEGGFGPVYKGVLKKGDEIAVKRLPGRSGQGLREMKNEASVIAKVQH-----KNLVR 149 (387)
Q Consensus 80 ~~~~~~~~~~~~~~~~~l-----G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~nIv~ 149 (387)
+.+++.....+|.+.+.. ..|---+.|+....+|+ +++|+....... ..+..|++++..+.. |..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccce
Confidence 345566667778765543 35555678998877654 888988643222 344456666666532 22221
Q ss_pred ee-e--eEEeCCceEEEEEecCCCCcchhhc------------------CCc--c--cc---------------------
Q 041766 150 LL-G--CCIDKDEKILIYEYMPNKSLDFFLF------------------DPT--K--RM--------------------- 183 (387)
Q Consensus 150 ~~-~--~~~~~~~~~lv~e~~~~g~L~~~l~------------------~~~--~--~~--------------------- 183 (387)
.. | +.........++.+..+........ ... . ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 1122345567777776644321100 000 0 00
Q ss_pred ------------------ccchhhhhhcccCCCceEEcCCCCeEEeeccCce
Q 041766 184 ------------------LLDWSANYSSRLKVSNILLDKDINPKISDFGMAR 217 (387)
Q Consensus 184 ------------------~l~~~~~~h~dlk~~Nill~~~~~~kl~Dfg~a~ 217 (387)
.-...+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011224799999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.93 E-value=0.065 Score=47.89 Aligned_cols=72 Identities=13% Similarity=0.196 Sum_probs=48.4
Q ss_pred CcccccCCeeEEEEEEcCC--------CEEEEEEccCCCcccHHHHHHHHHHHHhcC-CCceeeeeeeEEeCCceEEEEE
Q 041766 95 NKLGEGGFGPVYKGVLKKG--------DEIAVKRLPGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDKDEKILIYE 165 (387)
Q Consensus 95 ~~lG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~~~~~~~~~~~lv~e 165 (387)
+.|+-|---.+|+....++ ..|.++... .. .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5677788889999986532 456666554 22 23345668999998884 4434577887642 68999
Q ss_pred ecCCCCc
Q 041766 166 YMPNKSL 172 (387)
Q Consensus 166 ~~~~g~L 172 (387)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|